0001144204-13-061887.txt : 20131114 0001144204-13-061887.hdr.sgml : 20131114 20131114162244 ACCESSION NUMBER: 0001144204-13-061887 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131114 DATE AS OF CHANGE: 20131114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bacterin International Holdings, Inc. CENTRAL INDEX KEY: 0001453593 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205313323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34951 FILM NUMBER: 131220428 BUSINESS ADDRESS: STREET 1: 600 CRUISER LANE CITY: BELGRADE STATE: MT ZIP: 59714 BUSINESS PHONE: 406-388-0480 MAIL ADDRESS: STREET 1: 600 CRUISER LANE CITY: BELGRADE STATE: MT ZIP: 59714 FORMER COMPANY: FORMER CONFORMED NAME: K KITZ INC DATE OF NAME CHANGE: 20090108 10-Q 1 v359011_10q.htm FORM 10-Q
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
 
(Mark one)
  
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended
September 30, 2013
  
OR
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from
 
to
 
 
Commission file number: 001-34951
 
BACTERIN INTERNATIONAL HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
20-5313323
(State or other jurisdiction
 
(I.R.S. Employer
of incorporation or organization)
 
Identification No.)
 
600 CRUISER LANE
BELGRADE, MONTANA 59714
(Address of principal executive offices) (Zip code)
 
(406) 388-0480
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes þ    No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer  ¨
Accelerated filer                     ¨
Non-accelerated filer   ¨   (Do not check if a smaller reporting company) 
Smaller reporting company    þ
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨No þ
 
Number of shares of common stock, $0.000001 par value, of registrant outstanding at November 13, 2013:  51,744,136
 
 
 
BACTERIN INTERNATIONAL HOLDINGS, INC.
FORM 10-Q
 
TABLE OF CONTENTS
 
PART I.
 
FINANCIAL INFORMATION
 
 
 
 
Item 1.
 
Financial Statements
 
 
 
 
 
 
Condensed Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012
 
 
 
 
 
 
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012 (unaudited)
 
 
 
 
 
 
Condensed Consolidated Statements of Cash Flows for the three and nine months ended September 30, 2013 and 2012 (unaudited)
 
 
 
 
 
 
Notes to Consolidated Financial Statements
 
 
 
 
Item 2.
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
19 
 
 
 
 
Item 3.
 
Quantitative and Qualitative Disclosures About Market Risk
24 
 
 
 
 
Item 4.
 
Controls and Procedures
24 
 
 
 
 
PART II.
 
OTHER INFORMATION
25 
 
 
 
 
Item 1.
 
Legal Proceedings
25 
 
 
 
 
Item 1A.
 
Risk Factors
25 
 
 
 
 
Item 2.
 
Unregistered Sales of Equity Securities and Use of Proceeds
36 
 
 
 
 
Item 3.
 
Defaults Upon Senior Securities
36 
 
 
 
 
Item 4.
 
Mine Safety Disclosures
36 
 
 
 
 
Item 5.
 
Other Information
36 
 
 
 
 
Item 6.
 
Exhibits
36 
 
 
2

 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
 
The statements contained in this Form 10-Q that are not purely historical are forward-looking statements within the meaning of applicable securities laws. Our forward-looking statements include, but are not limited to, statements regarding our “expectations,” “hopes,” “beliefs,” “intentions,” “plans,” or “strategies” regarding the future. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should” and “would,” as well as similar expressions, may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward looking. Forward-looking statements in this Form 10-Q may include, for example, statements about:
 
 
¨
the future performance and market acceptance of our products;
 
 
¨
our ability to maintain our competitive position;
 
 
¨
negative media publicity;
 
 
¨
our ability to obtain donor cadavers for our products;
  
 
¨
our ability to expand our production capacity;
 
 
¨
our efforts to innovate and develop new products;
 
 
¨
our ability to engage and retain qualified technical personnel and members of our management team;
 
 
¨
our reliance on our current facilities;
 
 
¨
our ability to generate funds or raise capital to finance our growth;
 
 
¨
the ability of our sales force to achieve expected results;
 
 
¨
government regulations and additional taxes;
 
 
¨
fluctuations in our operating results;
 
 
¨
government and third-party coverage and reimbursement for our products;
 
 
¨
our ability to manage our growth and our ability to scale expenses accordingly;
  
 
¨
our ability to meet the obligations of our secured lending facility;
 
 
¨
our ability to manage our cash flow and achieve profitability;
 
 
¨
our ability to successfully conclude government investigations;
 
 
¨
our ability to successfully integrate future business combinations or acquisitions;
 
 
¨
our ability to obtain regulatory approvals;
 
 
¨
product liability claims and other litigation to which we may be subjected;
 
 
¨
product recalls and defects;
 
 
¨
timing and results of clinical trials;
 
 
¨
our ability to obtain and protect our intellectual property and proprietary rights;
 
 
3

 
 
¨
infringement and ownership of intellectual property;
 
 
¨
our ability to attract broker coverage;
 
 
¨
the trading market, market prices and dilution of our common stock;
 
 
¨
our ability to remain listed on the NYSE MKT exchange;
 
 
¨
influence by our management; and
 
 
¨
our ability to issue preferred stock.
 
The forward-looking statements contained in this Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties, or assumptions, many of which are beyond our control, which may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the “Risk Factors” section of this Quarterly Report on Form 10-Q. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
 
 
4

 
PART I - FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 
BACTERIN INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 
 
 
As of
 
 
 
 
 
 
September 30,
 
As of
 
 
 
2013
 
December 31,
 
 
 
(Unaudited)
 
2012
 
 
 
 
 
 
 
 
 
ASSETS
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
3,437,549
 
$
4,926,066
 
Trade accounts receivable, net of allowance for doubtful accounts of $1,297,335 and $1,576,955, respectively
 
 
4,633,067
 
 
7,154,065
 
Inventories, net
 
 
13,228,383
 
 
13,141,421
 
Prepaid and other current assets
 
 
486,685
 
 
353,271
 
Total current assets
 
 
21,785,684
 
 
25,574,823
 
Non-current inventories
 
 
1,238,225
 
 
1,238,225
 
Property and equipment, net
 
 
5,320,992
 
 
5,234,867
 
Intangible assets, net
 
 
563,524
 
 
592,378
 
Goodwill
 
 
728,618
 
 
728,618
 
Other assets
 
 
1,401,854
 
 
1,126,643
 
 
 
 
 
 
 
 
 
Total Assets
 
$
31,038,897
 
$
34,495,554
 
 
 
 
 
 
 
 
 
LIABILITIES & STOCKHOLDERS' (DEFICIT) EQUITY
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
Accounts payable
 
$
3,225,377
 
$
3,997,789
 
Accounts payable - related party
 
 
555,361
 
 
418,922
 
Accrued liabilities
 
 
1,814,472
 
 
2,400,090
 
Warrant derivative liability
 
 
2,223,332
 
 
984,356
 
Current portion of capital lease obligations
 
 
165,844
 
 
149,729
 
Current portion of royalty liability
 
 
820,500
 
 
698,408
 
Current portion of long-term debt
 
 
47,018
 
 
45,135
 
Total current liabilities
 
 
8,851,904
 
 
8,694,429
 
Long-term Liabilities:
 
 
 
 
 
 
 
Capital lease obligation, less current portion
 
 
119,543
 
 
245,703
 
Long term royalty liability, less current portion
 
 
6,639,435
 
 
6,839,935
 
Long-term debt, less current portion
 
 
16,064,064
 
 
14,483,102
 
Total Liabilities
 
 
31,674,946
 
 
30,263,169
 
Commitments and Contingencies
 
 
 
 
 
 
 
Stockholders' Equity
 
 
 
 
 
 
 
Preferred stock, $.000001 par value; 5,000,000 shares authorized; no shares issued and
 
 
 
 
 
 
 
outstanding
 
 
-
 
 
-
 
Common stock, $.000001 par value; 95,000,000 shares authorized; 51,781,044 shares issued and outstanding as of September 30, 2013 and 42,877,770 shares issued and outstanding as of December 31, 2012
 
 
52
 
 
43
 
Additional paid-in capital
 
 
55,558,330
 
 
51,897,890
 
Accumulated deficit
 
 
(56,194,431)
 
 
(47,665,548)
 
Total Stockholders’ (Deficit) Equity
 
 
(636,049)
 
 
4,232,385
 
 
 
 
 
 
 
 
 
Total Liabilities & Stockholders’ (Deficit) Equity
 
$
31,038,897
 
$
34,495,554
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
5

 
BACTERIN INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 
 
Three months ended September 30,
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
2013
 
2012
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue sales
 
$
7,710,256
 
$
8,643,299
 
$
24,430,158
 
$
24,427,853
 
Royalties and other
 
 
219,727
 
 
236,466
 
 
385,480
 
 
430,185
 
Total Revenue
 
 
7,929,983
 
 
8,879,765
 
 
24,815,638
 
 
24,858,038
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost of tissue and medical devices sales
 
 
3,318,327
 
 
2,600,452
 
 
10,011,687
 
 
6,788,606
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross Profit
 
 
4,611,656
 
 
6,279,313
 
 
14,803,951
 
 
18,069,432
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
General and administrative
 
 
2,764,328
 
 
2,439,229
 
 
7,877,697
 
 
7,349,852
 
Sales and marketing
 
 
4,053,679
 
 
3,352,394
 
 
12,057,389
 
 
11,333,946
 
Depreciation and amortization
 
 
97,923
 
 
88,112
 
 
304,771
 
 
302,392
 
Non-cash consulting expense
 
 
43,153
 
 
186,867
 
 
11,924
 
 
491,051
 
Total Operating Expenses
 
 
6,959,083
 
 
6,066,602
 
 
20,251,781
 
 
19,477,241
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Loss) Income from Operations
 
 
(2,347,427)
 
 
212,711
 
 
(5,447,830)
 
 
(1,407,809)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other Income (Expense)
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
(1,197,370)
 
 
(867,894)
 
 
(3,436,006)
 
 
(1,276,946)
 
Change in warrant derivative liability
 
 
(849,288)
 
 
(125,972)
 
 
246,337
 
 
1,393,155
 
Other income (expense)
 
 
17,551
 
 
(1,738,202)
 
 
108,616
 
 
(1,544,035)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total Other Expense
 
 
(2,029,107)
 
 
(2,732,068)
 
 
(3,081,053)
 
 
(1,427,826)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Loss Before (Provision) Benefit for Income Taxes
 
 
(4,376,534)
 
 
(2,519,357)
 
 
(8,528,883)
 
 
(2,835,635)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Provision) Benefit for Income Taxes
 
 
 
 
 
 
 
 
 
 
 
 
 
Current
 
 
-
 
 
-
 
 
-
 
 
-
 
Deferred
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net Loss
 
$
(4,376,534)
 
$
(2,519,357)
 
$
(8,528,883)
 
$
(2,835,635)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.08)
 
$
(0.06)
 
$
(0.18)
 
$
(0.07)
 
Dilutive
 
$
(0.08)
 
$
(0.06)
 
$
(0.18)
 
$
(0.07)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares used in the computation:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
 
51,616,319
 
 
42,796,244
 
 
46,611,358
 
 
42,341,796
 
Dilutive
 
 
51,616,319
 
 
42,796,244
 
 
46,611,358
 
 
42,341,796
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
6

 
BACTERIN INTERNATIONAL HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
Operating activities:
 
 
 
 
 
 
 
Net income (loss)
 
$
(8,528,883)
 
$
(2,835,635)
 
Noncash adjustments:
 
 
 
 
 
 
 
Depreciation and amortization
 
 
586,771
 
 
577,145
 
Amortization of debt discount
 
 
917,153
 
 
228,505
 
Write-off of debt discount
 
 
-
 
 
139,228
 
Non-cash consulting expense/stock option expense
 
 
603,058
 
 
1,114,846
 
Warrants issued for services
 
 
-
 
 
342,485
 
Non-cash interest
 
 
(78,408)
 
 
50,659
 
Provision for losses on accounts receivable and inventory
 
 
1,197,669
 
 
136,637
 
(Gain) loss on disposal of assets
 
 
(500)
 
 
7,902
 
Change in derivative warrant liability
 
 
(246,337)
 
 
(1,393,155)
 
Reduction of contingent liability
 
 
(91,740)
 
 
(358,426)
 
Changes in operating assets and liabilities:
 
 
 
 
 
 
 
Accounts receivable
 
 
970,971
 
 
(237,841)
 
Inventories
 
 
265,396
 
 
(5,092,496)
 
Prepaid and other assets
 
 
291,375
 
 
(957,628)
 
Accounts payable
 
 
(635,973)
 
 
1,316,973
 
Accrued liabilities
 
 
(428,751)
 
 
(848,488)
 
Net cash used in operating activities
 
 
(5,178,199)
 
 
(7,809,289)
 
 
 
 
 
 
 
 
 
Investing activities:
 
 
 
 
 
 
 
Purchases of property and equipment
 
 
(633,393)
 
 
(1,216,723)
 
Intangible asset additions
 
 
(10,149)
 
 
-
 
Net cash used in investing activities
 
 
(643,542)
 
 
(1,216,723)
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
Proceeds from the issuance of long-term debt
 
 
-
 
 
22,741,719
 
Payments on long-term debt
 
 
(34,308)
 
 
(9,773,075)
 
Payments on capital leases
 
 
(110,045)
 
 
(21,085)
 
Net proceeds from issuance of stock
 
 
4,450,002
 
 
3,899,996
 
Proceeds from exercise of options
 
 
27,575
 
 
43,334
 
Net cash provided by financing activities
 
 
4,333,224
 
 
16,890,889
 
 
 
 
 
 
 
 
 
Net change in cash and cash equivalents
 
 
(1,488,517)
 
 
7,864,877
 
 
 
 
 
 
 
 
 
Cash and cash equivalents at beginning of period
 
 
4,926,066
 
 
751,111
 
Cash and cash equivalents at end of period
 
$
3,437,549
 
$
8,615,988
 
 
See notes to unaudited condensed consolidated financial statements.
 
 
7

 
Notes to Unaudited Condensed Consolidated Financial Statements
 
(1)           Business Description and Summary of Significant Accounting Policies
 
Business Description
 
The accompanying consolidated financial statements include the accounts of Bacterin International Holdings, Inc., a Delaware corporation, and its wholly owned subsidiary, Bacterin International, Inc., a Nevada corporation, (collectively, the “Company” or “Bacterin”). All intercompany balances and transactions have been eliminated in consolidation. Bacterin’s biologics division develops, manufactures and markets biologics products to domestic and international markets.  Bacterin’s proprietary methods are used in human allografts to create cell scaffolds and promote bone and other tissue growth.  These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and regeneration in knee and other joint surgeries.
 
Bacterin’s device division develops and licenses coatings for various medical device applications.
 
An operating segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The primary performance measure used by management is net income or loss. The Company operates in two distinct lines of business consisting of the biologics and devices divisions. However, due to the immaterial revenue from devices to date, the Company reports as one segment.
 
The Company's revenue is derived principally from the sale or license of its medical products, coatings and device implants. The markets in which the Company competes are highly competitive and rapidly changing. Significant technological advances, changes in customer requirements, or the emergence of competitive products with new capabilities or technologies could adversely affect the Company's operating results. The Company's business could be harmed by a decline in demand for, or in the prices of, its products or as a result of, among other factors, any change in pricing or distribution model, increased price competition, changes in government regulations or a failure by the Company to keep up with technological change.  Further, a decline in available tissue donors could have an adverse impact on our business.
 
The accompanying interim condensed consolidated financial statements of Bacterin for the three and nine months ended September 30, 2013 and 2012 are unaudited and are prepared in accordance with accounting principles generally accepted in the United States of America. They do not include all disclosures required by generally accepted accounting principles for annual financial statements, but in the opinion of management, include all adjustments, consisting only of normal recurring items, necessary for a fair presentation. Interim results are not necessarily indicative of results which may be achieved in the future for the full year ending December 31, 2013.
 
These financial statements should be read in conjunction with the financial statements and notes thereto which are included in Bacterin’s Annual Report on Form 10-K for the year ended December 31, 2012. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.
 
Concentrations and Credit Risk
 
The Company’s accounts receivable are due from a variety of health care organizations and distributors throughout the world. Approximately 98% and 97% of sales were in the United States for the nine months ended September 30, 2013 and 2012, respectively. One customer accounted for approximately 5% and 6% of the Company’s revenue for the nine months ended September 30, 2013 and 2012, respectively.  One customer represented 19% and 21% of gross accounts receivable at September 30, 2013 and 2012, respectively. The Company provides for uncollectible amounts when specific credit issues arise. Management believes its estimate for uncollectible amounts have been adequate during prior periods, and management believes that all significant credit risks have been identified at September 30, 2013.
 
Revenue by geographical region is as follows:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
United States
 
$
24,285,028
 
$
24,084,836
 
Rest of World
 
 
530,610
 
 
773,202
 
 
 
$
24,815,638
 
$
24,858,038
 
 
 
8

 
Use of Estimates
 
The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period; the carrying amount of property and equipment and intangible assets; valuation allowances for trade receivables and deferred income tax assets; valuation of the warrant derivative liability; inventory reserve; contingent consideration from acquisitions; royalty liability; and estimates for the fair value of stock options grants and other equity awards upon which the Company determines stock-based compensation expense. Actual results could differ from those estimates.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments purchased with an original maturity date of three months or less to be cash equivalents.  Cash equivalents are recorded at cost, which approximates market value. At times the Company maintains deposits in financial institutions in excess of federally insured limits.
 
Accounts Receivable
 
Accounts receivable represents amounts due from customers for which revenue has been recognized. Normal terms on trade accounts receivable are net 30 days and some customers are offered discounts for early pay.  The Company performs credit evaluations when considered necessary, but generally does not require collateral to extend credit.
 
The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables. The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance, general economic conditions that may affect a customer's ability to pay and management judgment. Actual customer collections could differ from estimates. Account balances are charged to the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Provisions to the allowance for doubtful accounts are charged to expense. The Company does not have any off-balance sheet credit exposure related to its customers.
 
Accounts Payable - Related Party
 
Accounts payable to a related party includes amounts due to American Donor Services, a supplier of donors to the Company. See Note 14, “Related Party Transactions” below.
 
Inventories
 
Inventories are stated at the lower of cost or market.  Cost is determined using the specific identification method and includes materials, labor and overhead. The Company calculates an inventory reserve for estimated obsolescence or excess inventory based on historical usage and sales, as well as assumptions about future demand for its products. These estimates for excess and obsolete inventory are reviewed and updated on a quarterly basis. Increases in the inventory reserves result in a corresponding expense, which is generally recorded to cost of tissue and medical devices sales. Inventories where the sales cycle is estimated to be beyond twelve months are classified as Non-current inventories.
 
Property and Equipment
 
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to seven years for computers and equipment, and 30 years for buildings. Leasehold improvements are depreciated over the shorter of their estimated useful life or the remaining term of the lease. Repairs and maintenance are expensed as incurred.
 
Goodwill
 
Goodwill represents the excess of costs over fair value of assets of businesses acquired. Goodwill and intangible assets acquired in a purchase business combination and determined to have indefinite useful lives are not amortized, instead are tested for impairment at least annually and whenever events or circumstances indicate the carrying amount of the asset may not be recoverable. In its evaluation of goodwill, the Company performs an assessment of qualitative factors to determine if it is more-likely-than-not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment. The Company conducts its annual impairment test on December 31 of each year.
 
 
9

 
Derivative Instruments
 
The Company accounts for its derivative instruments in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815 “Accounting for Derivative Instruments and Hedging Activities”. The only derivative instruments presented in the accompanying consolidated financial statements relates to warrants issued in connection with certain debt financings. The Company has not designated its warrant derivative liability as a hedging instrument as described in ASC 815 and any changes in the fair market value of the warrant derivative liability are recognized in the consolidated statement of operations during the period of change. See Note 10, “Warrants” below.
 
Intangible Assets
 
Intangible assets with estimable useful lives must be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment whenever events or circumstances indicate their carrying amount may not be recoverable. Intangible assets include trademarks, customer lists and patents and include costs to acquire and protect Company patents. Intangible assets are carried at cost less accumulated amortization. The Company amortizes these assets on a straight-line basis over their estimated useful lives of five years for customer lists and 15 years for all other intangible assets.
 
Revenue Recognition
 
Revenue is recognized when all of the following criteria are met: a) the Company has entered into a legally binding agreement with the customer; b) the products or services have been delivered; c) the Company's fee for providing the products and services is fixed or determinable; and d) collection of the Company’s fee is probable.
 
The Company’s policy is to record revenue net of any applicable sales, use, or excise taxes.  If an arrangement includes a right of acceptance or a right to cancel, revenue is recognized when acceptance is received or the right to cancel has expired.
 
The Company ships to certain customers under consignment arrangements whereby the Company’s product is stored by the customer.  The customer is required to report the use to the Company and upon such notice, the Company invoices the customer and revenue is recognized when above criteria has been met.
 
The Company also receives royalty revenue from third parties related to licensing agreements. The Company has royalty agreements with Nufix, RyMed and Bard Access Systems. Revenue under these agreements represented less than 1% of total revenue for the three and nine months ended September 30, 2013 and 2012.
 
Non-Cash Consulting Expense
 
From time to time, the Company issues restricted stock awards to consultants and advisors to the Company. These awards are measured at fair value at each reporting date, recognized ratably over the vesting period and are recorded in non-cash consulting expense.
 
Advertising Costs
 
The Company expenses advertising costs as incurred. The Company had no Advertising expense in the nine months ended September 30, 2013 and $50,000 for the nine months ended September 30, 2012.
 
Research and Development
 
Research and development costs, which are principally related to internal costs for the development of new technologies and processes for tissue and coatings, are expensed as incurred and included in general and administrative expenses.
 
Income Taxes
 
The Company accounts for income taxes under the asset and liability method of accounting for deferred taxes as prescribed under FASB ASC 740, Accounting for Income Taxes.  Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When applicable, a valuation allowance is established to reduce any deferred tax asset when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the statement of operations or accrued on the balance sheet. See Note 12, “Income Taxes” below.
 
 
10

 
Long-Lived Assets
 
Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. No impairment was recorded during the nine months ended September 30, 2013 or 2012.
 
Net Loss Per Share
 
Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Diluted net income (loss) per share is computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares outstanding during the period, which include the assumed exercise of stock options and warrants using the treasury stock method. Diluted net loss per share was the same as basic net loss per share for the nine months ended September 30, 2013 and 2012 and the three months ended September 30, 2013 and 2012 as shares issuable upon the exercise of stock options and warrants were anti-dilutive as a result of the net losses incurred for those periods.
 
Stock-Based Compensation
 
The Company records stock-compensation expense according to the provisions of ASC 718.  Under ASC 718, stock-based compensation costs are recognized based on the estimated fair value at the grant date for all stock-based awards.  The Company estimates grant date fair values using the Black-Scholes-Merton option pricing model, which requires assumptions of the life of the award and the stock price volatility over the term of the award.  The Company records compensation cost of stock-based awards using the straight line method, which is recorded into earnings over the vesting period of the award. Pursuant to the income tax provisions included in ASC 718-740, the Company has elected the “short cut method” of computing its hypothetical pool of additional paid-in capital that is available to absorb future tax benefit shortfalls.
 
Fair Value of Financial Instruments
 
The carrying values of financial instruments, including trade accounts receivable, accounts payable, other accrued expenses and long-term debt, approximate their fair values based on terms and related interest rates.
 
We follow a framework for measuring fair value. The framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
 
Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.
 
Level 2: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
 
Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the nine months ended September 30, 2013 and 2012, there was no reclassification in financial assets or liabilities between Level 1, 2 or 3 categories.
 
The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:
 
Accrued stock compensation
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
$
171,174
 
$
218,850
 
Level 2
 
 
-
 
 
-
 
Level 3
 
 
-
 
 
-
 
 
The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.
 
 
11

 
Warrant derivative liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
2,223,332
 
$
984,356
 
 
Acquisition contingent consideration liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
-
 
$
91,740
 
 
The valuation technique used to measure fair value of the warrant liability is based on a lattice model and significant assumptions and inputs determined by the Company.
 
Level 3 Changes
 
The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:
 
Warrant derivative liability
Balance at January 1, 2013
 
$
984,356
 
Gain recognized in earnings
 
 
(246,337)
 
New warrants issued
 
 
1,485,313
 
Balance at September 30, 2013
 
$
2,223,332
 
 
Acquisition contingent consideration liability
Balance at January 1, 2013
 
$
91,740
 
Gain recognized in earnings
 
 
(91,740)
 
Balance at September 30, 2013
 
$
-
 
 
During the nine months ended September 30, 2013, the Company did not change any of the valuation techniques used to measure its liabilities at fair value.
 
Items measured at fair value on a non-recurring basis:
 
The Company’s royalty liability is carried at its estimated fair value based upon the discounted present value of the payments using an estimated discount rate. The Company did not have access to a readily traded market for similar credit risks and the estimated interest rate was based upon the Company’s estimate of a market interest rate to obtain similar financing. The Company originally discounted the $16.8 million of estimated payments at an interest rate of 16.7%. This was adjusted to an estimated royalty total of $13.8 million as of December 31, 2012 and was not adjusted in the first nine months of 2013. Accordingly, these inputs are classified as Level 3 inputs.
 
Recent Accounting Pronouncements
 
There are no recently issued accounting standards for which the Company expects a material impact to its consolidated financial statements.

(2)           Equity
 
During the first quarter of 2012, we issued 1,475,037 shares of our common stock to Lincoln Park Capital for aggregate proceeds of $3,899,996. We used the proceeds for working capital and general corporate purposes.
 
On June 10, 2013, the Company issued approximately 8.51 million shares of common stock to new and existing investors at a price per share of $0.57, which represented a 10% discount to the closing price on June 4, 2013. For each common share purchased in the offering, investors received a warrant providing the right to purchase 0.5 shares of Bacterin common stock at an exercise price of $0.72, a 15% premium to the June 4, 2013 closing price. The warrants will be exercisable for seven years beginning 6 months from the date of issuance. The transaction resulted in net proceeds to Bacterin International of approximately $4.45 million, after deducting approximately $400,000 of placement agent’s fees and offering expenses. Proceeds from the transaction will be used to fund the Company's operations and working capital requirements.
 
 
12

 
(3)           Acquisition
 
In 2011, the Company acquired the assets of a medical devices company. As part of the purchase agreement, we agreed to pay an additional $500,000 in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $1 million, and an additional $500,000 in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $2 million, provided that such gross revenue thresholds were achieved within 2 years. The revenue thresholds were not achieved within 2 years of the asset acquisition, so no additional stock issuances were required.
 
The initial valuation of the contingent consideration was based upon management’s estimates of the probability of reaching the milestones that would trigger the requirement to pay the contingent amounts. During 2013, management reviewed and adjusted the assumptions associated with the contingent liability which resulted in an elimination of the contingent liability as of June 30, 2013.

(4)           Inventories
 
Inventories consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Current inventories
 
 
 
 
 
 
 
Raw materials
 
$
2,223,978
 
$
1,919,250
 
Work in process
 
 
4,176,764
 
 
4,991,032
 
Finished goods
 
 
8,004,314
 
 
7,350,332
 
 
 
 
14,405,056
 
 
14,260,614
 
Reserve
 
 
(1,176,673)
 
 
(1,119,193)
 
Current inventories, total
 
$
13,228,383
 
$
13,141,421
 
Non-current inventories
 
 
 
 
 
 
 
Finished goods
 
$
1,238,225
 
$
1,238,225
 
Non-current inventories, total
 
$
1,238,225
 
$
1,238,225
 
Total inventories
 
$
14,466,608
 
$
14,379,646
 

(5)           Property and Equipment, Net
 
Property and equipment, net are as follows:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Buildings
 
$
1,653,263
 
$
1,653,263
 
Equipment
 
 
5,761,079
 
 
5,172,523
 
Computer equipment
 
 
312,650
 
 
312,650
 
Computer software
 
 
395,146
 
 
392,206
 
Furniture and fixtures
 
 
170,118
 
 
170,118
 
Leasehold improvements
 
 
1,808,461
 
 
1,793,756
 
Vehicles
 
 
41,099
 
 
78,306
 
Total cost
 
 
10,141,816
 
 
9,572,822
 
Less: accumulated depreciation
 
 
(4,820,824)
 
 
(4,337,955)
 
 
 
$
5,320,992
 
$
5,234,867
 
 
The Company leases certain equipment under capital leases. For financial reporting purposes, minimum lease payments relating to the assets have been capitalized. As of September 30, 2013, the Company has recorded $549,603 gross assets in Equipment, and $142,307 of accumulated depreciation relating to assets under capital leases.
 
Maintenance and repairs expense for the first nine months of 2013 and 2012 was $198,986 and $204,947, respectively.  Depreciation expense related to property and equipment, including property under capital lease for the first nine months of 2013 and 2012 was $530,020 and $516,162 respectively.

(6)           Intangible Assets
 
Bacterin has applied for various patents with regards to processes for its products.
 
 
13

 
The following table sets forth information regarding intangible assets:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Intellectual Property
 
 
 
 
 
 
 
Gross carrying value
 
$
848,675
 
$
820,778
 
Accumulated amortization
 
$
(285,151)
 
$
(228,400)
 
Net carrying value
 
$
563,524
 
$
592,378
 
 
 
 
 
 
 
 
 
Aggregate amortization expense:
 
$
56,750
 
$
74,918
 
 
 
 
 
 
 
 
 
Estimated amortization expense:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remainder of 2013
 
 
 
 
$
18,729
 
2014
 
 
 
 
$
74,918
 
2015
 
 
 
 
$
74,918
 
2016
 
 
 
 
$
74,918
 
2017
 
 
 
 
$
74,918
 
Thereafter
 
 
 
 
$
245,123
 
Total
 
 
 
 
$
563,524
 

(7)           Accrued Liabilities
 
Accrued liabilities consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Acquisition contingent liability
 
$
-
 
$
91,740
 
Accrued stock compensation
 
 
171,174
 
 
218,850
 
Wages/commissions payable
 
 
1,129,555
 
 
1,013,909
 
Other accrued expenses
 
 
513,743
 
 
1,075,591
 
 
 
$
1,814,472
 
$
2,400,090
 

(8)          Long-term Debt
 
On April 23, 2012, the Company secured an accounts receivable credit facility with Midcap Financial LLC and Silicon Valley Bank. The revolving loan credit facility allowed Bacterin to borrow up to $5 million through January 1, 2015. The facility allowed borrowings based upon a predetermined formula of up to 80% of Bacterin's eligible accounts receivable, as defined in the credit and security agreement. The Company also amended its existing Loan and Security Agreement with MidCap to allow the Company to borrow up to an additional $3 million in connection with a permitted acquisition. The credit facility carried an interest rate of LIBOR plus 4%, subject to a LIBOR floor rate of 2.5%. The Company also agreed to pay a 0.5% collateral management fee on the average outstanding balance of the facility and 1% of the average unused portion of the facility, as well as a 1% origination fee. We repaid the outstanding balance owed on this credit facility in full with the proceeds from our credit facility with ROS Acquisition Offshore LP (“ROS”) on August 24, 2012.
 
On August 24, 2012, the Company entered into a Credit Agreement with ROS, whereby ROS agreed to provide an initial $20 million term loan and Bacterin may also borrow an additional $5 million upon achievement of certain revenue objectives prior to December 31, 2013. The loan carries an interest rate of LIBOR plus 12.13%, subject to a LIBOR floor rate of 1.0%. Bacterin also agreed to pay a royalty of 1.75% on the first $45,000,000 of net sales, plus 1.0% of net sales in excess of $45,000,000 for each of the next ten years. Bacterin has the right to repay the loan and royalty interest at amounts to be determined based on the date of repayment and the amount of prior principal, interest and royalty payments. The loan is secured by substantially all of our assets. The estimate of the royalty component of the facility over the life of the agreement resulted in a debt discount and a royalty liability of $7,341,520. The debt discount will be amortized to interest expense over the seven year term of the loan using the effective interest method. The royalty liability will be accreted to $13.8 million through interest expense over the ten year term of the royalty agreement using the effective interest method. Payments made under the royalty agreement, per the table below, will directly reduce the royalty liability.
 
The Company received net proceeds of approximately $10 million following repayment of the existing term loan and accounts receivable credit facility with MidCap Financial, including prepayment penalties. The Company used the net proceeds for working capital and general corporate purposes.
 
On May 16, 2013, we entered into an amendment to our Credit Agreement with ROS, whereby ROS agreed to reduce our minimum liquidity requirement from $1,500,000 to $750,000 until September 30, 2013. In exchange, we agreed to pay a fee of $300,000 required to be paid pursuant to the Credit Agreement or other loan documents which is recorded in Long-term debt and in Other long term assets which will be amortized to interest expense over the term of the debt.
 
There were two compliance violations of covenants in the ROS Credit Agreement in the second quarter of 2013. The Company did not achieve the $8.5 million revenue in the second quarter of 2013 for which we received a waiver, in exchange, the Company agreed to pay a fee of $400,000 when the Company pays, prepays or is required to pay any principal amount of the loan. In addition, the Company did not hire a Chief Executive Officer within 90 days of the resignation of the prior Chief Executive Officer for which we received a waiver in exchange for Board observer rights.
 
 
14

 
Long-term debt consists of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Loan payable to ROS Acquisition Offshore, LIBOR plus 12.13% maturing August 2019
 
$
20,000,000
 
$
20,000,000
 
Adjustment fee payable to ROS Acquisition Offshore August 2019
 
 
700,000
 
 
-
 
6.00% loan payable to Valley Bank of Belgrade, $10,746 monthly payments including interest, maturing December 24, 2030; secured by building
 
 
1,387,112
 
 
1,421,420
 
 
 
 
22,087,112
 
 
21,421,420
 
 
 
 
 
 
 
 
 
Less: Current portion
 
 
(47,018)
 
 
(45,135)
 
Debt discount
 
 
(5,976,030)
 
 
(6,893,183)
 
Long-term debt
 
$
16,064,064
 
$
14,483,102
 
 
The following is a summary of maturities due on the debt as of September 30, 2013:
 
Remainder of 2013
 
 
11,357
 
2014
 
 
47,727
 
2015
 
 
50,670
 
2016
 
 
1,720,463
 
2017
 
 
6,723,781
 
Thereafter
 
 
13,533,114
 
Total
 
$
22,087,112
 
 
The following is a summary of estimated future royalty payments as of September 30, 2013:
 
Remainder of 2013
 
 
197,000
 
2014
 
 
853,000
 
2015
 
 
1,050,000
 
2016
 
 
1,289,000
 
2017
 
 
1,384,000
 
Thereafter
 
 
8,477,000
 
Total
 
$
13,250,000
 

(9)           Stock-Based Compensation
 
Our Equity Incentive Plan ("The Plan") provides for stock awards, including options and performance stock awards, to be granted to employees, consultants, independent contractors, officers and directors. The purpose of the Plan is to enable us to attract, retain and motivate key employees, directors and consultants, by providing them with stock options and restricted stock grants. Stock options granted under the Plan may be either incentive stock options to employees, as defined in Section 422A of the Internal Revenue Code of 1986, or non-qualified stock options. The Plan is administered by the compensation committee of our Board of Directors. The administrator of the Plan has the power to determine the terms of any stock options granted under the Plan, including the exercise price, the number of shares subject to the stock option and conditions of exercise. Stock options granted under the Plan are generally not transferable, vest in installments over the requisite service period and are exercisable during the stated contractual term of the option only by such optionee. The exercise price of all incentive stock options granted under the Plan must be at least equal to the fair market value of the shares of common stock on the date of the grant. Nine million shares are authorized under the Plan and at September 30, 2013, we had approximately 622,648 shares available for issuance. Shares issued under the Plan may be authorized, but unissued, or reacquired shares.
 
Stock compensation expense recognized in the statement of operations for the nine months ended September 30, 2013 and 2012 is based on awards ultimately expected to vest and reflects an estimate of awards that will be forfeited. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
The estimated fair value of stock options granted is done using the Black-Sholes-Merton method applied to individual grants. The Company utilizes historical employee termination behavior to determine the estimated forfeiture rates. If the actual forfeitures differ from those estimated by management, adjustments to compensation expense will be made in future periods. Assumed forfeiture rates range from 17.00% to 20.00% for the first nine months of 2013.
 
 
15

 
Key assumptions used to estimate the fair value of stock awards are as follows:
 
·
Risk-Free Rate: The risk-free rate is determined by reference to U.S. Treasury yields at or near the time of grant for time periods similar to the expected term of the award. We used a weighted-average rate of 1.68% for the nine months ended September 30, 2013.
 
·
Expected Term: We do not have adequate history to estimate an expected term of stock-based awards, and accordingly, we use the short-cut method as prescribed by Staff Accounting Bulletin 107 to determine an expected term. We used a weighted-average expected term of 6.4 years for the nine months ended September 30, 2013.
 
·
Volatility: We estimate expected volatility based on peer-companies as prescribed by ASC 718. We used a weighted-average volatility rate of 62.6% for the nine months ended September 30, 2013.
 
·
Dividend Yield: The dividend yield assumption is based on our history and expectation of dividend payouts and was 0% for the nine months ended September 30, 2013.
 
Activity under our stock option plans was as follows:
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
 
 
Average
 
Value at Grant
 
 
 
 
Average
 
Value at Grant
 
 
 
Shares
 
Exercise Price
 
Date
 
Shares
 
Exercise Price
 
Date
 
Outstanding at January 1
 
 
5,266,535
 
$
2.02
 
$
1.03
 
 
4,828,910
 
$
2.14
 
$
1.01
 
Granted
 
 
3,331,250
 
 
0.63
 
 
0.53
 
 
1,105,000
 
 
2.00
 
 
1.19
 
Exercised
 
 
(230,000)
 
 
0.10
 
 
0.06
 
 
(39,375)
 
 
0.87
 
 
0.37
 
Cancelled or expired
 
 
(729,000)
 
 
1.78
 
 
0.90
 
 
(1,152,250)
 
 
2.01
 
 
0.78
 
Outstanding at September 30
 
 
7,638,785
 
$
1.49
 
$
0.86
 
 
4,742,285
 
$
2.11
 
$
1.04
 
Exercisable at September 30
 
 
2,531,534
 
$
2.03
 
$
0.98
 
 
2,242,118
 
$
1.77
 
$
0.76
 
 
The aggregate intrinsic value of options outstanding as of September 30, 2013 is $799,941. The aggregate intrinsic value of exercisable options as of September 30, 2013 is $132,766. As of September 30, 2013, there were 5,107,251 unvested options with a weighted average fair value at the grant date of $0.80 per option. As of September 30, 2013, compensation expense related to nonvested awards not yet recognized was $667,175.
 
In addition, on May 24, 2013, the Company issued 335,000 restricted stock awards to certain employees. These restricted shares vest after one year and were issued when the stock price was $0.68 per share. The total expense of $227,800 is recognized ratably over the vesting period in General and Administrative and Sales and Marketing Expenses.
 
From time to time we may grant stock options and restricted stock grants to consultants. We account for consultant stock options in accordance with ASC 505-50. Consulting expense for the grant of stock options to consultants is determined based on the estimated fair value of the stock options at the measurement date as defined in ASC 505-50 and is recognized over the vesting period.
 
The following table summarizes restricted stock award activity during the period ended September 30, 2013:
 
 
 
Shares
 
Outstanding at Jan. 1, 2013
 
 
733,900
 
Awarded
 
 
-
 
Cancelled
 
 
(112,500)
 
Vested
 
 
(164,500)
 
Outstanding at September 30, 2013
 
 
456,900
 
 
The restricted stock awards generally vest over three to five year periods. The Company recognized reduction of non-cash consulting expense of $11,924 for the first nine months of 2013 and expense of $491,051 for the nine months ended September 30, 2012. As of September 30, 2013, the total expense related to nonvested restricted stock awards not yet recognized is $160,021 and is expected to be recognized over three years.

(10)           Warrants
 
In the fourth quarter of 2012, the Company issued 297,991 warrants with an exercise price of $2.30 to a broker in conjunction with the August 24, 2012 financing arrangement with ROS. These were recorded in “Other Assets” and will be amortized over the life of the financing term. In addition, on July 23, 2012 the Company issued 300,895 warrants with an exercise price of $1.03 to a private party resulting in $342,485 recorded in “Other Expense”.
 
 
16

 
The following table summarizes our warrant activities for the nine months ended September 30, 2013:
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Average
 
 
 
 
 
 
Exercise
 
 
 
Shares
 
Price
 
Outstanding at January 1, 2013
 
 
7,321,667
 
$
2.20
 
Issued
 
 
4,352,215
 
 
0.72
 
Exercised
 
 
-
 
 
-
 
Expired
 
 
(533,173)
 
 
2.00
 
Outstanding at September 30, 2013
 
 
11,140,709
 
$
1.63
 
 
We utilize a lattice model to determine the fair market value of the warrants accounted for as liabilities. The 1,570,565 warrants issued in connection with a 2010 bridge financing, the 375,000 warrants issued in connection with a 2010 debt financing and the 4,254,387 warrants issued in connection with the second quarter 2013 equity financing were accounted for as derivative liabilities in connection with the price protection provisions of the warrants in compliance with ASC 815. The warrants issued in the second quarter of 2013 resulted in a warrant derivative liability of $1,485,313 as of the issuance on June 5, 2013. There were an additional 143,700 warrants in the first quarter of 2012 as a result of the LPC share issuance triggering the anti-dilution clause in the original warrant agreement and an additional 97,828 related to the second quarter of 2013 equity financing. The lattice model accommodates the probability of exercise price adjustment features as outlined in the warrant agreements. We recorded an unrealized gain of $246,337 resulting from the change in the fair value of the warrant derivative liability for the first nine months of 2013. Under the terms of the warrant agreement, at any time while the warrant is outstanding, the exercise price per share can be reduced to the price per share of future subsequent equity sales of our common stock or common stock equivalents that is lower than the exercise price per share as stated in the warrant agreement.
 
The estimated fair value was derived using the lattice model with the following weighted-average assumptions:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
 
2012
 
Value of underlying common stock (per share)
 
$
0.68
 
 
$
1.55
 
Risk free interest rate
 
 
0.72
%
 
 
0.38
%
Term to expiration/implied expected life
 
 
5.96 years
 
 
 
4.15 years
 
Dividend yield
 
 
0
%
 
 
0
%
Volatility
 
 
63
%
 
 
62
%
 
The following table summarizes our activities related to number of warrants used in the derivative liability for the nine months ended September 30, 2013 and 2012:
 
 
 
2013
 
2012
 
Balance at January 1
 
 
1,649,707
 
 
1,506,007
 
Derivative warrants issued
 
 
4,352,215
 
 
143,700
 
Derivative warrants exercised
 
 
-
 
 
-
 
Balance at September 30
 
 
6,001,922
 
 
1,649,707
 

(11)           Commitments and Contingencies
 
Operating Leases
 
We lease two office facilities under non-cancelable operating lease agreements with expiration dates in 2019 and 2023. We have the option to extend both the leases for another ten year term and for one facility, we have the right of first refusal on any sale. We lease an additional office facility under a month-to-month arrangement. Future minimum payments for the next five years and thereafter as of September 30, 2013, under these leases, are as follows:
 
Remainder of 2013
 
$
61,599
 
2014
 
$
269,400
 
2015
 
$
263,136
 
2016
 
$
263,136
 
2017
 
$
263,136
 
Thereafter
 
$
823,730
 
Total
 
$
1,944,137
 
 
 
17

 
Rent expense was $204,180 and $234,316 for the nine months ended September 30, 2013 and 2012, respectively. Rent expense is determined using the straight-line method of the minimum expected rent paid over the term of the agreement. We have no contingent rent agreements.
 
Indemnifications
 
Our arrangements generally include limited warranties and certain provisions for indemnifying customers against liabilities if our products or services infringe a third-party's intellectual property rights. To date, we have not incurred any material costs as a result of such warranties or indemnifications and have not accrued any liabilities related to such obligations in the accompanying financial statements.
 
We have also agreed to indemnify our directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person's service as a director or officer, including any action by us, arising out of that person's services as our director or officer or that person's services provided to any other company or enterprise at our request.
 
Litigation
 
On January 29, 2013, we received two warning letters from the Food and Drug Administration (“FDA”): one related to our procedures to ensure compliance with regulatory requirements regarding the production of medical devices; and one related to our procedures to ensure compliance with regulatory requirements regarding the production of human tissue cellular products (H/TCP). We responded to both warning letters and, on April 17, 2013, we received two letters from FDA in which the agency stated that it was in receipt of our response letters and found that the corrective actions in those letters appeared to be adequate. The letters also stated, however, that the corrections would be further evaluated in conjunction with our operations during the next inspection of our facilities. FDA conducted two follow-up inspections as a result of the warning letters of our facilities in July 2013: one inspection focused on our production of medical devices and one inspection focused on our production of H/TCPs. At the conclusion of the inspection focused on medical devices, no Form 483 was issued. At the conclusion of the inspection focused on H/TCPs, FDA issued a one-item Form 483, to which we responded, and we are in the process of providing further updates to FDA. FDA also conducted a routine inspection focused on H/TCPs in July 2013 and issued two observations on a Form 483. We have fully responded to that Form 483. On September 19, 2013, we received a letter from FDA indicating that, based on a review of our corrective actions, it appears we have addressed the violations contained in the warning letter regarding our production of medical devices.
 
Market Exchange Notification
 
On May 13, 2013, we received a deficiency notice from the New York Stock Exchange (“Exchange”) notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders’ equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders’ equity of less than $4,000,000 and net losses in three of our four most recent fiscal years. On June 12, 2013 we submitted a plan to regain compliance with the continued listing requirements, and on June 21, 2013 the Exchange informed us of the acceptance of our plan and gave us an extension until November 13, 2014 to regain compliance with the continued listing standards. We will be subject to periodic review by Exchange staff during the extension period and failure to make progress consistent with our Plan or to regain compliance with the continued listing standards by the end of the extension period could result in our delisting from the Exchange.

(12)           Income Taxes
 
In evaluating the realizability of the net deferred tax assets, we take into account a number of factors, primarily relating to the ability to generate taxable income. Where it is determined that it is likely that we will be unable to realize deferred tax assets, a valuation allowance is established against the portion of the deferred tax asset. Because it cannot be accurately determined when or if we will become profitable, a valuation allowance was provided against the entire deferred income tax asset balance.
 
The 2008 through 2012 tax years remain open to examination by the Internal Revenue Service and the 2006 to 2012 tax years remain open to the Montana Department of Revenue. These taxing authorities have the authority to examine those tax years until the applicable statute of limitations expire.
 
The Company did not recognize any interest or penalties related to income taxes for the nine months ended September 30, 2013 and 2012.
 
 
18

 
(13)           Supplemental Disclosure of Cash Flow Information
 
Supplemental cash flow information is as follows:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
Supplemental disclosure of cash flow information
 
 
 
 
 
 
 
Cash paid during the period for:
 
 
 
 
 
 
 
Interest
 
$
3,436,006
 
$
815,031
 
Income taxes
 
 
-
 
 
-
 
Non-cash activities:
 
 
 
 
 
 
 
ROS adjustment fee
 
$
700,000
 
$
-
 
Settlement of SeaArk accounts receivable
 
$
1,829,647
 
$
-
 
Inventory received in SeaArk settlement
 
$
409,838
 
$
-
 
Write-off of SeaArk allowance for doubtful accounts
 
$
1,419,809
 
$
-
 
Net shares issued for non-cash consulting expense
 
$
157,561
 
$
-
 
Capital lease acquisition
 
$
-
 
$
408,257
 
Issuance of warrants
 
$
-
 
$
220,872
 
Non-cash accrued compensation
 
$
-
 
$
304,680
 
Debt discount related to financing
 
$
-
 
$
7,341,520
 
Royalty liability related to financing
 
$
-
 
$
7,341,520
 

(14)           Related Party Transactions
 
Guy Cook, our former President and Chief Executive Officer, formerly served as a board member of West Coast Tissue Services (“WCTS”) and American Donor Services (“ADS”). Mr. Cook did not received any compensation for his board service for either entity as of the date of his resignation. Mitchell Godfrey, a director, is on the board of ADS and also serves as secretary and treasurer for ADS. Mr. Godfrey receives $5,000 annually for his service to ADS.
 
ADS and WCTS recover tissue from donors. We reimburse them for their recovery fees, which are comprised primarily of labor costs. The approximate aggregate amount of all transactions with WCTS for the first nine months of 2013 and 2012 was $577,200 and $389,500, respectively, and the approximate aggregate amount of all transactions with ADS for the first nine months of 2013 and 2012 was $1,558,360 and $1,004,036, respectively. These relationships benefit us as these entities provide us with donors, thus insuring that we have a pipeline of current and future donors, which is necessary to our success. As of September 30, 2013, we had an accounts payable balance of $555,361 to American Donor Services.
 
On June 27, 2012, the Board of Directors granted a waiver of certain provisions of the Company’s Code of Conduct to allow an entity controlled by two of our former CEO’s adult children to become a distributor of the Company’s products. This entity acquired inventory from Allograft Tissue Management, a non-affiliated distributor that had previously acquired inventory from the Company. The affiliated distributor, Silver Forest Fund, LP, exchanged products initially purchased from the non-affiliated distributor with Bacterin for different Bacterin products of equivalent value. Other than product exchanges and payment of amounts owed by the non-affiliated distributor, there have been no other direct transactions between Bacterin and the affiliated distributor. Mr. Cook pledged 1,850,000 of his shares of Bacterin stock as collateral for loans made to the affiliated distributor by independent third parties.
 
On April 5, 2013, Guy Cook resigned from his roles of Chief Executive Officer, President and Chairman of the Board effective immediately. The Board unanimously voted to have Kent Swanson, an existing independent director, serve as Acting Chairman of the Board. Our current Chief Financial Officer, John Gandolfo, and our Chief Operating Officer, Darrel Holmes, served as interim Co-Chief Executive Officers until the Board appointed Daniel Goldberger as the new Chief Executive Officer on August 14, 2013. Mr. Goldberger received inducement grant stock options to purchase up to 2,000,000 shares of the Company's common stock, with a per share exercise price of $0.60, which was the closing price of the Company’s common stock on the August 14, 2013 grant date. The option will vest over five years, with 20% of the underlying shares vesting after one year and the remaining eighty percent (80%) vesting in forty-seven (47) equal monthly installments as to 33,334 underlying shares, beginning September 15, 2014, and one final installment as to 33,302 underlying shares.

(15)           Subsequent Events
 
On November 5, 2013, the United States Patent and Trademark Office issued US Patent No. 8,574,825 entitled “Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors” to the Company.  The issued claims in the patent are for a method to produce a demineralized cancellous bone matrix, such as Bacterin’s OsteoSponge® product line.   Bacterin has a pending divisional application in the United States to pursue protection on other aspects of its bone demineralization technology and is pursuing protection on related applications in Canada, Europe, and Korea. 
 
On November 14, 2013, the Company received a waiver from ROS for failure to achieve $10.5 million of revenue in the third quarter of 2013. In exchange for the waiver and reduction of future quarterly minimum revenue thresholds, the Company agreed to issue 1,500,000 shares of restricted stock to ROS by December 2, 2013. If the Company does not or is unable to issue the restricted shares by December 2, 2013, the Company agreed to pay an additional exit fee in the amount equal to 3.5% of the aggregate principal amount of the loan.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation
 
This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include statements relating to the intended usage and markets for our products and services, the market for our common stock, the ability of our sales force to achieve expected results; and our liquidity, results of operations, and ability to meet our anticipated cash requirements. Actual results could differ materially from those currently anticipated as a result of a number of factors, including those set forth under “Risk Factors” in this Quarterly Report on Form 10-Q.
 
 
19

 
You should read the following discussion of our financial condition and results of operations in conjunction with our financial statements and related notes set forth in this report. Unless the context otherwise requires, “we,” “our,” “us” and similar expressions used in this Management’s Discussion and Analysis of Financial Condition and Results of Operation section refer to Bacterin International, Inc., a Nevada corporation (“Bacterin”).
 
Comparison of Three Months Ended September 30, 2013 and September 30, 2012
 
Revenue
 
Total revenue for the third quarter ended September 30, 2013 decreased 11% to $7,929,983 compared to $8,879,765 for the third quarter of 2012. The decrease of $949,782 was due to the 2012 period including a stocking order of approximately $1.5 million. Net of that one time stocking order, total revenue for the quarter ended September 30, 2013 increased 14% compared to the quarter ended September 30, 2102.
 
Cost of tissue sales
 
Costs of tissue sales consist primarily of tissue and device manufacturing costs. Costs of tissue sales increased by 28% or $717,875 to $3,318,327 for the third quarter of 2013 from $2,600,452 for the third quarter of 2012. As a percentage of sales, cost of sales was 41.8% of revenues for the third quarter of 2013 compared to 29.3% for the third quarter of 2012. This increase was largely the result of lower revenue per item sold due to pricing pressure, write-offs of contaminated inventory related to our dermis production process and an increase in expired product in the 2013 period.
 
Operating Expenses
 
Operating expenses include general and administrative expenses, selling and marketing expenses, depreciation, research and development expenses, and compensation costs, including incentive compensation.  Operating expenses increased 15%, or $892,481, for the three months ended September 30, 2013 compared to the same period of 2012, primarily due to the reasons set forth below.
 
General and Administrative
 
General and administrative expenses consist principally of corporate personnel cash based and stock option compensation related costs and corporate expenses for legal, accounting and other professional fees as well as occupancy costs. General and administrative expenses increased 13%, or $325,099, to $2,764,328, for the third quarter of 2013 compared to the third quarter of 2012. The increase is primarily due to bad debt expense of approximately $642,000 recorded in the 2013 period associated with a stocking order placed in 2012. General and administrative expenses, net of the bad debt adjustment, decreased 13% for the quarter ended September 30, 2013 compared to the quarter ended September 30, 2012.
 
Selling and Marketing
 
Selling and marketing expenses primarily consist of costs for trade shows, sales conventions and meetings, travel expenses, advertising and other sales and marketing related costs. In addition, stock option compensation expense associated with our sales force is also included in sales and marketing expenses. Selling and marketing expenses increased 21%, or $701,285, to $4,053,679 for the three months ended September 30, 2013 from $3,352,394 for the comparable prior year period. As a percentage of revenue, selling and marketing expenses increased to 51.1% in the third quarter of 2013 from 37.8% in the third quarter of 2012.  The increases were primarily the difference of commissions not being earned on the 2012 stocking orders as compared to commissions being earned on the higher core revenues in the 2013 period.
 
Depreciation
 
Depreciation expense consists of depreciation of long-lived property and equipment. Depreciation expense increased 11% to $97,923 for the three months ended September 30, 2013 from $88,112 for the three months ended September 30, 2012. The increase reflects the depreciation of fixed assets acquired over the past twelve months in connection with equipment required to increase manufacturing capacity.
 
Non-cash Consulting Expense
 
Non-cash consulting expense consists of non-cash expense associated with granting restricted stock to consultants. Non-cash consulting expense decreased $143,714 to $43,153 for the third quarter of 2013 from $186,867 in the third quarter of 2012. The decrease is due to a combination of fewer contracts in 2013 and a reduced stock price at the end of the third quarter.
 
Other Income (Expense)
 
Other expenses include interest, warrant derivative liability changes and other miscellaneous items.  Other expenses decreased 26%, or $702,961, for the quarter ended September 30, 2013 compared to the same period of 2012, primarily due to the reasons set forth below.
 
 
20

 
Interest Expense
 
Interest expense for the third quarter of 2013 increased $329,476 to $1,197,370 as compared to $867,894 in the third quarter of 2012. The increase was the result of a higher average debt balance in 2013 and the higher interest rate related to the debt financing entered into with ROS Acquisition Offshore LP during the third quarter of 2012.
 
Change in Warrant Derivative Liability
 
For the third quarter of 2013, the Company recorded expense from an increase in the warrant derivative liability of $849,288 based upon the increase in the closing price of the Company’s common stock at September 30, 2013 compared to June 30, 2013. The liability is associated with the issuance of warrants as part of the Company’s prior convertible debt financing, the Company’s 2010 financing and the Company’s 2013 equity financing which contain anti dilution adjustment provisions requiring the Company to record a change in the warrant derivative liability from period to period.
 
Other Income (Expense)
 
Other income for the third quarter of 2013 was $17,551 as compared to expense of $1,738,202 in the third quarter of 2012. The expense in 2012 was primarily related to the write-off of the debt discount and prepayment penalties related to termination of the MidCap financing in the third quarter of 2012.
 
Comparison of Nine months Ended September 30, 2013 and September 30, 2012
 
Revenue
 
Total revenue for the first nine months ended September 30, 2013 decreased $42,400 to $24,815,638 compared to $24,858,038 for the first nine months of 2012.
 
Cost of tissue sales
 
Costs of tissue sales consist primarily of tissue and device manufacturing costs. Costs of tissue sales increased by 47% or $3,223,081 to $10,011,687 for the first nine months of 2013 from $6,788,606 for the first nine months of 2012. As a percentage of sales, cost of sales was 40.3% of revenues for the first nine months of 2013 compared to 27.3% for the first nine months of 2012. This increase was largely the result of lower revenue per item sold due to pricing pressure, write-offs of contaminated inventory related to our dermis production process and an increase in expired product and inventory reserves to cover future expiring product in the 2013 period.
 
Operating Expenses
 
Operating expenses include general and administrative expenses, selling and marketing expenses, depreciation, research and development expenses, and compensation costs, including incentive compensation.  Operating expenses increased 4%, or $774,540, for the nine months ended September 30, 2013 compared to the same period of 2012, primarily due to the reasons set forth below.
 
General and Administrative
 
General and administrative expenses consist principally of corporate personnel cash based and stock option compensation related costs and corporate expenses for legal, accounting and other professional fees as well as occupancy costs. General and administrative expenses increased $527,845, or 7% to $7,877,697, compared to the first nine months of 2012. The increase is primarily due to an increase in bad debt expense of approximately $990,000 in 2013, primarily associated with large stocking orders to distributors, a strategy which the Company is no longer pursuing. General and administrative expenses, net of the bad debt adjustment, decreased 6% for the nine months ended September 30, 2013 compared to the nine months ended September 30, 2012.
 
Selling and Marketing
 
Selling and marketing expenses primarily consist of costs for trade shows, sales conventions and meetings, travel expenses, advertising and other sales and marketing related costs. In addition, stock option compensation expense associated with our sales force is also included in sales and marketing expenses. Selling and marketing expenses increased by $723,443, or 6%, for the nine months ended September 30, 2013 compared to the prior year period. As a percentage of revenue, selling and marketing expenses increased to 48.6% in the first nine months of 2013 from 45.6% in the first nine months of 2012.  The increases were primarily the difference of commissions not being earned on the 2012 stocking orders as compared to commissions being earned on the higher core revenues in 2013.
 
 
21

 
Depreciation
 
Depreciation expense consists of depreciation of long-lived property and equipment. Depreciation expense remained relatively flat at $304,771 for the nine months ended September 30, 2013 from $302,392 for the nine months ended September 30, 2012.
 
Non-cash Consulting Expense
 
Non-cash consulting expense consists of non-cash expense associated with granting restricted stock to consultants. Non-cash consulting expense decreased $479,127 to $11,924 for the first nine months of 2013 from an expense of $491,051 in the first nine months of 2012. The decrease is due to a combination of fewer contracts in 2013 and a reduced stock price at the end of the third quarter.
 
Other Income (Expense)
 
Other expenses include interest, warrant derivative liability changes and other miscellaneous items.  Other expenses increased 116%, or $1,653,227, for the nine months ended September 30, 2013 compared to the same period of 2012, primarily due to the reasons set forth below.
 
Interest Expense
 
Interest expense for the first nine months of 2013 increased $2,159,060 to $3,436,006 as compared to $1,276,946 in the first nine months of 2012. The increase was the result a higher average debt balance in 2013 and the higher interest rate related to the debt financing with ROS Acquisition Offshore LP.
 
Change in Warrant Derivative Liability
 
For the first nine months of 2013, the Company recorded income from a decrease in its non cash warrant derivative liability of $246,337 based upon the decrease in the closing price of the Company’s common stock at September 30, 2013 compared to December 31, 2012 which was partially offset by the issuance of additional derivative warrants in 2013. The liability is associated with the issuance of warrants as part of the Company’s prior convertible debt financing, the Company’s 2010 financing and the Company’s 2013 equity financing which contain anti dilution adjustment provisions requiring the Company to record a change in the warrant derivative liability from period to period.
 
Other Income (Expense)
 
Other income for the first nine months of 2013 was $108,616 as compared to expense of $1,544,035 in the first nine months of 2012. The expense in 2012 was primarily related to the write-off of the debt discount and prepayment penalties related to termination of the MidCap financing in the third quarter of 2012.
 
Liquidity and Capital Resources
 
Since our inception, we have historically financed our operations through operating cash flows, as well as the private placement of equity securities and convertible debt, an equity credit line and other debt transactions. In August 2012, we closed on a $20 million term loan transaction with ROS Acquisition Offshore LP. The net proceeds were used to pay off the previous loans with MidCap Financial LLC and Silicon Valley Bank of approximately $9.3 million with the remainder adding to our working capital. In addition, on June 10, 2013, the Company issued approximately 8.51 million shares of common stock to new and existing investors with net proceeds to Bacterin International of approximately $4.45 million. Proceeds from the transaction will be used to fund the Company's operations and working capital requirements. At September 30, 2013, we had $8,070,616 of cash and cash equivalents and accounts receivables.
 
Net cash used in operating activities the first nine months of 2013 was $5,178,199. For the comparable period of 2012, net cash used in operating activities was $7,809,289. The decrease was primarily due to a reduction in cash used in purchases of inventory.
 
Net cash used in investing activities for the first nine months of 2013 was $643,542 due to the purchase of property and equipment and intangible assets.
 
Net cash provided by financing activities was $4,333,224 for the nine months ended September 30, 2013 primarily due to the equity capital raise in the second quarter of 2013.
 
On November 14, 2013, we entered into a Waiver and Fifth Amendment to our Credit Agreement with ROS Acquisition Offshore LP (“ROS”) whereby ROS (i) waived our failure to achieve the revenue required by Section 8.4.1 of the Credit Agreement for the quarter ended September 30, 2013, and (ii) agreed to revise our future revenue requirements as described in Part II, Item 3 of this 10-Q. In exchange, we agreed to issue 1,500,000 shares (the “Shares”) of our common stock to ROS. If we do not issue the Shares by December 2, 2013, we will be required to pay an additional fee in the amount of 3.5% of any principal payment required to be paid pursuant to the Credit Agreement or other loan documents.
 
Off Balance Sheet Arrangements
 
We do not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity or capital expenditures or capital resources that are material to an investor in our shares.
 
 
22

 
Cash Requirements
 
We believe that our September 30, 2013 cash on hand and accounts receivable balance of $8,070,616, combined with anticipated cash receipts from sales expected from operations, expense reductions and access to addition capital resources will be sufficient to meet our anticipated cash requirements through September 30, 2014; however there can be no assurance that we will achieve expected sales results, raise additional capital, reduce expenses or collect our accounts receivable.We incurred approximately $16 million in sales and marketing expenses in 2012 and expect to incur $18 million in 2013 based upon our current sales estimates. The sales and marketing expenses are largely variable expenses and are anticipated to be funded from operating cash flow. An increase of these expenses may impact our operating results and there can be no assurance of their effectiveness. If we do not meet our revenue objectives over that period, we may need to sell additional equity securities, which could result in dilution to our stockholders, or seek additional loans. The incurrence of indebtedness would result in increased debt service obligations and could require us to agree to operating and financial covenants that would restrict our operations. Financing may not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.
 
In addition, we currently anticipate that we will need to spend between $4 and $5 million over the next 5 years in order to increase, expand or update our existing facilities to meet our expected growth over that period.
 
 
23

 
Item 3.   Quantitative and Qualitative Disclosures About Market Risk
 
As a smaller reporting company, we are not required to provide the information required by this Item.
 
Item 4.   Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
Our senior management with the participation of our chief executive officer and chief financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a - 15(e) under the Exchange Act) as of September 30, 2013.  Based upon that evaluation, we concluded that as of September 30, 2013, our disclosure controls and procedures were ineffective due to the material weakness in our internal controls over financial reporting detailed below that have not been fully remediated as of September 30, 2013.
 
Management’s Report on Internal Control over Financial Reporting
 
Management is responsible for maintaining adequate internal control over financial reporting as such term is defined in rule 13a-15 (f) under the Securities and Exchange Act of 1934 as amended.  Under the supervision and with the participation of senior and executive management, we conducted an evaluation of our internal controls over financial reporting based upon the Internal Control - Integrated Framework as outlined by COSO, the Committee of Sponsoring Organizations of the Treadway Commission.  Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of an evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
 
Based on our evaluation under the framework Internal Control - Integrated Framework, management concluded that our internal control over financial reporting was ineffective as of September 30, 2013 due to material weaknesses in our internal control over financial reporting that have not been fully remediated as of September 30, 2013 as detailed below:
 
1) At December 31, 2012, the Company had an insufficient number of personnel with the appropriate level of experience and technical expertise to appropriately resolve account reconciliations while completing the financial statement close process. Until this design deficiency in our internal control over financial reporting is remediated, there is a reasonable possibility that a material misstatement in our annual or interim financial statements could occur and not be corrected or prevented by our internal control system in a timely manner. Since December 31, 2012, we have expanded the training of qualified accounting and finance personnel and included an additional level of management review to the financial close process. The Company plans on performing an additional detailed evaluation of the internal controls surrounding financial reporting as of December 31, 2013 in connection with the year end financial close process.
 
2)  The documentation surrounding equity transactions for employees and consultants needs to be strengthened to comply with procedures outlined by the Company to ensure that all equity related transactions are properly recorded in the appropriate periods. In 2013, the Company improved the approval process for grants of equity securities.  The approval process includes approval by the Compensation Committee or the Board of Directors, review by our Human Resources department on all stock option vestings and cancellations and additional review by in house legal counsel on all stock option and equity grants. We anticipate that all of the above initiatives will be implemented by December 31, 2013 when we re-evaluate our internal review of financial controls.  
 
 
24

 
PART II - OTHER INFORMATION
Item 1.   Legal Proceedings
 
On January 29, 2013, we received two warning letters from the Food and Drug Administration (“FDA”): one related to our procedures to ensure compliance with regulatory requirements regarding the production of medical devices; and one related to our procedures to ensure compliance with regulatory requirements regarding the production of human tissue cellular products (H/TCP). We responded to both warning letters and, on April 17, 2013, we received two letters from FDA in which the agency stated that it was in receipt of our response letters and found that the corrective actions in those letters appeared to be adequate. The letters also stated, however, that the corrections would be further evaluated in conjunction with our operations during the next inspection of our facilities.  FDA conducted two follow-up inspections as a result of the warning letters of our facilities in July 2013: one inspection focused on our production of medical devices and one inspection focused on our production of H/TCPs.  At the conclusion of the inspection focused on medical devices, no Form 483 was issued.  At the conclusion of the inspection focused on H/TCPs, FDA issued a one-item Form 483, to which we responded, and we are in the process of providing further updates to FDA.  FDA also conducted a routine inspection focused on H/TCPs in July 2013 and issued two observations on a Form 483, to which we have fully responded. On September 19, 2013, we received a letter from FDA indicating that, based on a review of our corrective actions, it appears we have addressed the violations contained in the warning letter regarding our production of medical devices.
 
Item 1A Risk Factors
 
Our business and an investment in our securities are subject to a variety of risks. The following risk factors describe some of the most significant events, facts or circumstances that could have a material adverse effect upon our business, financial condition, results of operations, ability to implement our business plan and the market price for our securities. Many of these events are outside of our control. If any of these risks actually occurs, our business, financial condition or results of operations may be materially adversely affected. In such case, the trading price of our common stock could decline and investors in our common stock could lose all or part of their investment.
 
We may not be able to meet financial or other covenant requirements in our current credit facility, and we may not be able to successfully negotiate waivers or a new credit agreement to cure any covenant violations.
 
We failed to achieve the revenue required by a covenant in our Credit Agreement with ROS Acquisition Offshore LP (“ROS”) and we may fail to meet additional financial or other covenant requirements in the future. Our debt agreements with ROS also contain representations, warranties, fees, affirmative and negative covenants, including a minimum cash balance and minimum revenue amounts by quarter, and default provisions, which include departures in key management, if not remedied within 90 days. A breach of any of these covenants could result in a default under these agreements. Upon the occurrence of an event of default under our debt agreements, our lender could elect to declare all amounts outstanding to be immediately due and payable and terminate all commitments to extend further credit. If our lender accelerates the repayment of borrowings, we may not have sufficient assets to repay our indebtedness. Also, should there be an event of default, or should we need to obtain waivers following an event of default, we may be subject to higher borrowing costs and/or more restrictive covenants in future periods. In addition, to secure the performance of our obligations under the ROS facility, we pledged substantially all of our assets, including our intellectual property, to ROS. Our failure to comply with the covenants under the ROS facility could result in an event of default, the acceleration of our debt and the loss of our assets.
 
We are not currently profitable and we will need to raise additional funds in the future; however, additional funds may not be available on acceptable terms, or at all.
 
We have substantial operating expenses associated with the sales and marketing of our products. The sales and marketing expenses are anticipated to be funded from operating cash flow. An increase of these expenses may impact our operating results and there can be no assurance of their effectiveness. There can be no assurance that we will have sufficient access to liquidity or cash flow in the future to meet our operating expenses and other obligations. If we do not increase our revenue or reduce our expenses, we will need to raise additional capital, which would result in dilution to our stockholders, or seek additional loans. The incurrence of indebtedness would result in increased debt service obligations and could require us to agree to operating and financial covenants that would restrict our operations. Financing may not be available in amounts or on terms acceptable to us, if at all. Any failure by us to raise additional funds on terms favorable to us, or at all, could limit our ability to expand our business operations and could harm our overall business prospects.
 
We may not be able to raise such capital or, if we can, it may not be on favorable terms. We may seek to raise additional capital through public or private equity financings, partnerships, joint ventures, dispositions of assets, debt financings or restructurings, bank borrowings or other sources. To obtain additional funding, we may need to enter into arrangements that require us to relinquish rights to certain technologies, products and/or potential markets. If adequate funds are not otherwise available, we would be forced to further curtail operations significantly, including reducing our sales and marketing expenses which could negatively impact product sales and we could even be forced to cease operations, liquidate our assets and possibly even seek bankruptcy protection.
 
We may not continue to satisfy the continued listing requirements of the NYSE MKT exchange.
 
We are currently listed on the NYSE MKT exchange, which imposes both objective and subjective requirements for continued listing. Continued listing criteria include the financial condition of the company, market capitalization, shareholder equity, total assets, annual revenue, and low selling price. Our common stock is currently trading at less than $1.00 per share, we are operating at a loss, we have negative shareholder equity, and our market capitalization, total assets and annual revenue are all currently less than $50 million, so our continued listing is at risk. If the NYSE MKT determines that we fail to satisfy the requirements for continued listing, we could be de-listed from the exchange, which could result in reduced liquidity for our shareholders. There can be no assurance that we will satisfy the continued listing requirements of the NYSE MKT or that we will continue to be listed on any exchange.
 
On May 13, 2013, we received a deficiency notice from the NYSE MKT exchange notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders’ equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders’ equity of less than $4,000,000 and net losses in three of our four most recent fiscal years. On June 12, 2013 we submitted a plan to regain compliance with the continued listing requirements, and on June 21, 2013 the NYSE MKT informed us of the acceptance of our plan and gave us an extension until November 13, 2014 to regain compliance with the continued listing standards. We will be subject to periodic review by Exchange staff during the extension period and failure to make progress consistent with our Plan or to regain compliance with the continued listing standards by the end of the extension period could result in our delisting from the Exchange.
 
 
25

 
The impact of United States healthcare reform legislation remains uncertain.
 
  In 2010 federal legislation to reform the United States healthcare system was enacted into law. The law was upheld by a Supreme Court decision announced in June 2012. The legislation is far-reaching and is intended to expand access to health insurance coverage, improve quality and reduce costs over time. Among other things, the new law imposes a 2.3 percent excise tax on medical devices beginning January 2013, which applies to United States sales of our medical device products, including our wound drains and OsteoSelect® DBM putty. Due to multi-year pricing agreements and competitive pricing pressure in our industry, there can be no assurance that we will be able to pass the cost of the device tax on to our customers. Other provisions of this legislation, including Medicare provisions aimed at improving quality and decreasing costs, comparative effectiveness research, an independent payment advisory board, and pilot programs to evaluate alternative payment methodologies, could meaningfully change the way healthcare is developed and delivered. We cannot predict the impact of this legislation or other healthcare programs and regulations that may ultimately be implemented at the federal or state level, the effect of any future legislation or regulation in the United States or internationally or whether any changes will have the effect of lowering prices for our products or reducing medical procedure volumes.
 
We face risks and uncertainties relating to FDA warning letters and an OIG subpoena.
 
On January 29, 2013, we received two warning letters from the Food and Drug Administration (“FDA”): one related to our procedures to ensure compliance with regulatory requirements regarding the production of medical devices; and one related to our procedures to ensure compliance with regulatory requirements regarding the production of human tissue cellular products (H/TCP). We responded to both warning letters and, on April 17, 2013, we received two letters from FDA in which the agency stated that it was in receipt of our response letters and found that the corrective actions in those letters appeared to be adequate. The letters also stated, however, that the corrections would be further evaluated in conjunction with our operations during the next inspection of our facilities.  FDA conducted two follow-up inspections as a result of the warning letters of our facilities in July 2013: one inspection focused on our production of medical devices and one inspection focused on our production of H/TCPs.  At the conclusion of the inspection focused on medical devices, no Form 483 was issued.  At the conclusion of the inspection focused on H/TCPs, FDA issued a one-item Form 483, to which we responded, and we are in the process of providing further updates to FDA.  FDA also conducted a routine inspection focused on H/TCPs in July 2013 and issued two observations on a Form 483, to which we have fully responded. On September 19, 2013, we received a letter from FDA indicating that, based on a review of our corrective actions, it appears we have addressed the violations contained in the warning letter regarding our production of medical devices.  We are committed to working with the FDA to address their concerns; however, there can be no assurance that the FDA will be satisfied with our corrective actions or that the FDA will not have additional concerns.
 
 
26

 
 
 
In February 2013, we received a subpoena from the Office of the Inspector General of the U.S. Department of Health and Human Services (“OIG”) seeking documents in connection with an investigation into possible false or otherwise improper claims submitted to Medicare. The subpoena requested documents related to physician referral programs operated by the Company, which we believe refers to the Company’s prior practice of compensating physicians for performing certain educational and promotional services on behalf of the Company. This program was discontinued in 2010. We provided an initial response to the OIG subpoena and have not received any further correspondence or requests from the OIG. The extent and nature of information requested in the OIG subpoena could divert management’s attention from business demands and subject us to significant legal expenses. 
 
We cannot assure you that the government will find our efforts to resolve the FDA warning letter or the investigation initiated by the OIG subpoena to be satisfactory. We may be unable to implement corrective actions within a timeframe or in a manner satisfactory to the FDA. Failure to do so could result in enforcement proceedings by the government, which could potentially include civil or criminal fines and penalties, including disgorgement of amounts earned on any legally-adulterated products; injunctive relief, which could limit, modify or constrain our ability to manufacture, market and sell our products; and exclusion from participation in government healthcare programs, such as Medicare and Medicaid. The investigation initiated by the OIG subpoena could result in civil or criminal fines or penalties, increased supervision of our business operations by the OIG, or exclusion from participation in government healthcare programs, such as Medicare and Medicaid. We are unable to predict when these matters will be resolved or what action, if any, the government will take in connection with these matters. The issues arising out of the FDA inspection and OIG subpoena may be expanded to cover other matters. We could also face product liability, third-party payer, shareholder, or other litigation. Any of these risks and uncertainties could adversely affect our revenues, results of operations, cash flows and financial condition.
 
Pricing pressure and cost containment measures could have a negative impact on our future operating results.
 
Pricing pressure has increased in our industry due to continued consolidation among healthcare providers, trends toward managed care, the shift towards government becoming the primary payer of healthcare expenses, and government laws and regulations relating to reimbursement and pricing generally. Pricing pressure, reductions in reimbursement levels or coverage or other cost containment measures could unfavorably affect our future operating results and financial condition.
 
Future regulatory action remains uncertain.
 
We operate in a highly regulated environment, and any legal or regulatory action could be time-consuming and costly. If we fail to comply with all applicable laws, standards and regulations, action by the FDA or other regulatory agencies could result in significant restrictions, including restrictions on the marketing or use of our products or the withdrawal of products from the market. Any such restrictions or withdrawals could materially affect our business and operations. In addition, governmental authorities could impose fines, seize our inventory of products, or force us to recall any product already in the market if we fail to comply with governmental regulations.
 
Competition from former Chief Executive Officer
 
We believe our former Chief Executive Officer, Guy Cook, has acquired an ownership interest in a tissue bank that sells competitive products. Because our former CEO has in depth knowledge about our customers, employees, consultants, products, policies, practices and prospects, we may be adversely affected by increased competition with that business.
 
Many competitive products exist and more will be developed, and we may not be able to successfully compete because we are smaller and have fewer financial resources.
 
Our business is in a very competitive and evolving field. Rapid new developments in this field have occurred over the past few years, and are expected to continue to occur. Other companies already have competing products available or may develop products to compete with ours. Many of these products have short regulatory timeframes and our competitors, many with more substantial development resources, may be able to develop competing products that are equal to or better than ours. This may make our products obsolete or undesirable by comparison and reduce our revenue. Our success will depend, in large part, on our ability to maintain a competitive position concerning our intellectual property, and to develop new technologies and new applications for our technologies. Many of our competitors have substantially greater financial and technical resources, as well as greater production and marketing capabilities, and our ability to compete remains uncertain.
 
The medical community and the general public may perceive synthetic materials and growth factors as safer, which could have a material adverse effect on our business.
 
Members of the medical community and the general public may perceive synthetic materials and growth factors as safer than our allograft-based bone tissue products. Our products may be incapable of competing successfully with synthetic bone graft substitutes and growth factors developed and commercialized by others, which could have a material adverse effect on our business, financial condition and results of operations.
 
Negative publicity concerning methods of human tissue recovery and screening of donor tissue in the industry in which we operate may reduce demand for our allografts and impact the supply of available donor tissue.
 
Media reports or other negative publicity concerning both improper methods of tissue recovery from donors and disease transmission from donated tissue may limit widespread acceptance of our allografts. Unfavorable reports of improper or illegal tissue recovery practices, both in the United States and internationally, as well as incidents of improperly processed tissue leading to transmission of disease, may broadly affect the rate of future tissue donation and market acceptance of allograft technologies. Potential patients may not be able to distinguish our allografts, technologies and the tissue recovery and the processing procedures from those of our competitors or others engaged in tissue recovery. In addition, families of potential donors may become reluctant to agree to donate tissue to for-profit tissue processors.
 
We are highly dependent on the availability of human donors; any disruptions could cause our customers to seek alternative providers or technologies.
 
We are highly dependent on our ability to obtain donor cadavers as the raw material for many of our products. The availability of acceptable donors is relatively limited and we compete with many other companies for this limited availability. The availability of donors is also impacted by regulatory changes, general public opinion of the donor process and our reputation for our handling of the donor process. In addition, due to seasonal changes in the mortality rates, some scarce tissues are at times in short supply. Any disruption in the supply of this crucial raw material could have significant consequences for our revenue, operating results and continued operations.
 
Our success is dependent on our ability to remain accredited with the AATB.
 
Our success is dependent on our ability to remain accredited with the American Association of Tissue Banks (“AATB”).  Although AATB accreditation is voluntary, many participants in our industry would not do business with us if we lost our AATB accreditation.  Although we make every effort to meet and exceed AATB standards, the AATB has broad discretionary power when reviewing members for accreditation, and there can be no assurance that we will continue to remain accredited with the AATB.
 
 
27

 
We will need to continue to innovate and develop new products to be desirable to our customers.
 
The markets for our products and services are characterized by rapid technological change, frequent new introductions, changes in customers’ demands and evolving industry standards. Accordingly, we will need to continue to innovate and develop additional products. These efforts can be costly, subject to long development and regulatory delays and may not result in products approved for sale. These costs may hurt operating results and may require additional capital. If additional capital is not available, we may be forced to curtail development activities. In addition, any failure on our behalf to react to changing market conditions could create an opportunity for other market participants to capture a critical share of the market within a short period of time.
 
Our success will depend on our ability to engage and retain qualified technical personnel who are difficult to attract.
 
Our success will depend on our ability to attract and retain qualified technical personnel to assist in research and development, testing, product implementation, low-scale production and technical support. Competition for qualified technical personnel is intense, and we may encounter difficulty in engaging and retaining qualified personnel needed to implement our growth plan. The demand for such personnel is high and the supply of qualified technical personnel is limited. A significant increase in the wages paid by competing employers could result in a reduction of our technical work force and increases in the wage rates that we must pay or both. If either of these events were to occur, our cost structure could increase and our growth potential could be impaired.
 
Loss of key members of our management who we need to succeed could adversely affect our business.
 
We are highly dependent on the services of key members of our management team, and the loss of any of their services could have an adverse effect on our future operations. We do not currently maintain key-man life insurance policies insuring the life of any member of our management team.
 
We are highly dependent on the continued availability of our facilities and would be harmed if they were unavailable for any prolonged period of time.
 
Any failure in the physical infrastructure of our facilities or services could lead to significant costs and disruptions that could reduce our revenues and harm our business reputation and financial results. We are highly reliant on our Belgrade, Montana facilities. Any natural or man-made event that impacts our ability to utilize these facilities could have a significant impact on our operating results, reputation and ability to continue operations. The regulatory process for approval of facilities is time-consuming and our ability to rebuild facilities would take a considerable amount of time and expense and cause a significant disruption in service to our customers. Further, the FDA or some other regulatory agency could identify deficiencies in future inspections of our facilities or our supplies that could disrupt our business, reducing profitability. 
 
We will be required to invest in facilities and equipment on a continuing basis, which will put pressure on us to finance these investments.
 
We have invested, and intend to continue to invest, in facilities and state-of-the-art equipment in order to increase, expand or update our capabilities and facilities. Changes in technology or sales growth beyond currently established production capabilities, which we anticipate, will require further investment. We currently anticipate that we will need to spend between $4 and $5 million over the next five years in order to increase, expand or update our existing facilities to meet our expected growth over that period. However, there can be no assurance that we will generate sufficient funds from operations to maintain our existing facilities and equipment or to finance any required capital investments or that other sources of funding will be available. Additionally, there can be no guarantee that any future expansion will not negatively affect earnings.
 
Future revenue will depend on our ability to increase sales.
 
We currently sell our products through direct sales by our employees and indirectly through distributor relationships. We incurred increased sales and marketing expenses in building and expanding our direct sales force, and there can be no assurance that we will generate increased sales as a result of this effort.
 
There may be fluctuations in our operating results, which will impact our stock price.
 
Significant annual and quarterly fluctuations in our results of operations may be caused by, among other factors, our volume of revenues, the timing of new product or service announcements, releases by us and our competitors in the marketplace of new products or services, and general economic conditions. There can be no assurance that the level of revenues and profits, if any, achieved by us in any particular fiscal period will not be significantly lower than in other comparable fiscal periods. Our expense levels are based, in part, on our expectations as to future revenues. As a result, if future revenues are below expectations, net income or loss may be disproportionately affected by a reduction in revenues, as any corresponding reduction in expenses may not be proportionate to the reduction in revenues.
 
 
28

 
We are dependent on the ability of our licensees and development partners for obtaining regulatory approvals and market acceptance of their products, for which we may have no control.
 
Our success may depend on our ability, or that of our licensees, to obtain timely regulatory approval for products employing our technology. Moreover, our success may also depend on whether, and how quickly, our licensees gain market acceptance of products incorporating our technology, compared to competitors using competing technologies.
 
Our revenues will depend upon prompt and adequate reimbursement from public and private insurers and national health systems.
 
Political, economic and regulatory influences are subjecting the healthcare industry in the United States to fundamental change. The ability of hospitals to pay fees for allograft bone tissue products depends in part on the extent to which reimbursement for the costs of such materials and related treatments will continue to be available from governmental health administration authorities, private health coverage insurers and other organizations. We may have difficulty gaining market acceptance for our products if government and third-party payors do not provide adequate coverage and reimbursement to hospitals. Major third-party payors of hospital services and hospital outpatient services, including Medicare, Medicaid and private healthcare insurers, annually revise their payment methodologies, which can result in stricter standards for reimbursement of hospital charges for certain medical procedures or the elimination of reimbursement. Further, Medicare, Medicaid and private healthcare insurer cutbacks could create downward price pressure on our products.
 
Our operating results will be harmed if we are unable to effectively manage and sustain our future growth.
 
We might not be able to manage our future growth efficiently or profitably. Our business is unproven on a large scale and actual revenue and operating margins, or revenue and margin growth, may be less than expected. If we are unable to scale our production capabilities efficiently, we may fail to achieve expected operating margins, which would have a material and adverse effect on our operating results. Growth may also stress our ability to adequately manage our operations, quality of products, safety and regulatory compliance. In order to grow, we may be required to obtain additional financing, which may increase our indebtedness or result in dilution to our stockholders. Further, there can be no assurance that we would be able to obtain any additional financing.
 
Future business combinations or acquisitions may be difficult to integrate and cause our attention to be diverted.
 
We may pursue various business combinations with other companies or strategic acquisitions of complementary businesses, product lines or technologies. There can be no assurance that such acquisitions will be available at all, or on terms acceptable to us. These transactions may require additional financing which may increase our indebtedness or outstanding shares, resulting in dilution to stockholders. The inability to obtain such future financing may inhibit our growth and operating results. Integration of acquisitions or additional products can be time consuming, difficult and expensive and may significantly impact operating results. Furthermore, the integration of any acquisition may divert management’s time and resources from our core business. We may sell some or all of our product lines to other companies or may agree to combine with another company. Selling some of our product lines may inhibit our ability to generate positive operating results going forward.
 
We may be subject to future product liability litigation that could be expensive and our insurance coverage may not be adequate in a catastrophic situation.
 
Although we are not currently subject to any product liability proceedings, and we have no reserves for product liability disbursements, we may incur material liabilities relating to product liability claims in the future, including product liability claims arising out of the usage of our products. We currently carry product liability insurance, however, our insurance coverage and any reserves we may maintain in the future for product related liabilities may not be adequate and our business could suffer material adverse consequences.
 
We may implement a product recall or voluntary market withdrawal due to product defects or product enhancements and modifications, which would significantly increase our costs.
 
The manufacturing and marketing of our biologic products, medical devices and coating technologies involves an inherent risk that our products may prove to be defective. In that event, we may voluntarily implement a recall or market withdrawal or may be required to do so by a regulatory authority. A recall or withdrawal of one of our products, or a similar product manufactured by another manufacturer, could impair sales of the products we market as a result of confusion concerning the scope of the recall or withdrawal, or as a result of the damage to our reputation for quality and safety.
 
U.S. governmental regulation could restrict the use of our products or our procurement of tissue.
 
In the United States, the procurement and transplantation of allograft bone tissue is subject to federal law pursuant to the National Organ Transplant Act, or NOTA, a criminal statute which prohibits the purchase and sale of human organs used in human transplantation, including bone and related tissue, for “valuable consideration.” NOTA permits reasonable payments associated with the removal, transportation, processing, preservation, quality control, implantation and storage of human bone tissue. We provide services in all of these areas in the United States, with the exception of removal and implantation, and receive payments for all such services. We make payments to certain of our clients and tissue banks for their services related to recovering allograft bone tissue on our behalf. If NOTA is interpreted or enforced in a manner which prevents us from receiving payment for services we render or which prevents us from paying tissue banks or certain of our clients for the services they render for us, our business could be materially and adversely affected.
 
 
29

 
We are engaged through our marketing employees, independent sales agents and sales representatives in ongoing efforts designed to educate the medical community as to the benefits of our products, and we intend to continue our educational activities. Although we believe that NOTA permits payments in connection with these educational efforts as reasonable payments associated with the processing, transportation and implantation of our products, payments in connection with such education efforts are not exempt from NOTA’s restrictions and our inability to make such payments in connection with our education efforts may prevent us from paying our sales representatives for their education efforts and could adversely affect our business and prospects. No federal agency or court has determined whether NOTA is, or will be, applicable to every allograft bone tissue-based material which our processing technologies may generate. Assuming that NOTA applies to our processing of allograft bone tissue, we believe that we comply with NOTA, but there can be no assurance that more restrictive interpretations of, or amendments to, NOTA will not be adopted in the future which would call into question one or more aspects of our method of operations.
 
Our business is subject to continuing regulatory compliance by the FDA and other authorities which is costly and could result in delays in the commercialization of our products.
 
As a manufacturer and marketer of medical devices, we are subject to extensive regulation by the FDA and the Center for Medicare Services of the U.S. Department of Health and Human Services and other federal governmental agencies and, in some jurisdictions, by state and foreign governmental authorities. These regulations govern the introduction of new medical devices, the observance of certain standards with respect to the design, manufacture, testing, labeling, promotion and sales of the devices, the maintenance of certain records, the ability to track devices, the reporting of potential product defects, the import and export of devices and other matters. We are facing an increasing amount of scrutiny and compliance costs as more states are implementing regulations governing medical devices, pharmaceuticals and/or biologics which affect many of our products.
 
Medical devices that incorporate coatings technology are subject to FDA regulation and compliance. Generally, any medical device manufacturer that wishes to incorporate our coatings technology into its products will be responsible for obtaining FDA approval for the medical devices it intends to market though we will assist in the 510(k) filing submitted by licensees. The FDA process can take several months to several years in the United States. The time required to obtain approval for international sales may be longer or shorter, depending on the laws of the particular country. There can be no assurance that our licensees will be able to obtain FDA or international approval on a timely basis. The FDA may also require the more extensive Premarket Approval Application, or PMA, process for certain products, which results, in effect, in a private license being granted to the applicant for marketing a particular medical device and requires an additional level of FDA scientific review to ensure the safety and effectiveness of such devices. Approval or clearance may place substantial restrictions on the indications for which the product may be marketed or to whom it may be marketed, warnings that may be required to accompany the product or additional restrictions placed on the sale and/or use of the product. Changes in regulations or adoption of new regulations could also cause delays in obtaining product approval. In addition, regulatory approval is subject to continuing compliance with regulatory standards, and product approval is subject to withdrawal if a licensee fails to comply with standards, or if an unforeseen event should occur concerning a product. Significant delays in obtaining product approval could have a significantly detrimental impact on our business.
 
Human tissues intended for transplantation have been regulated by the FDA since 1993. In May 2005, three new comprehensive regulations went into effect that address manufacturing activities associated with human cells, tissues and cellular and tissue-based products, or HCT/Ps. The first requires that companies that produce and distribute HCT/Ps register with the FDA. The second provides criteria that must be met for donors to be eligible to donate tissues and is referred to as the “Donor Eligibility” rule. The third rule governs the processing and distribution of the tissues and is often referred to as the “Current Good Tissue Practices” rule. The “Current Good Tissue Practices” rule covers all stages of allograft processing, from procurement of tissue to distribution of final allografts. Together they are designed to ensure that sound, high quality practices are followed to reduce the risk of tissue contamination and of communicable disease transmission to recipients. These regulations increased regulatory scrutiny within the industry in which we operate and have lead to increased enforcement action which affects the conduct of our business. In addition, these regulations can increase the cost of tissue recovery activities.
 
Other regulatory entities include state agencies with statutes covering tissue banking. Regulations issued by Florida, New York, California and Maryland will be particularly relevant to our business. Most states do not currently have tissue banking regulations. However, recent incidents of allograft related infections in the industry may stimulate the development of regulation in other states. It is possible that others may make allegations against us or against donor recovery groups or tissue banks about non-compliance with applicable FDA regulations or other relevant statutes or regulations. Allegations like these could cause regulators or other authorities to take investigative or other action, or could cause negative publicity for our business and the industry in which we operate.
 
Our products may be subject to regulation in the EU as well should we enter that market. In the European Union, or EU, regulations, if applicable, differ from one EU member state to the next. Because of the absence of a harmonized regulatory framework and the proposed regulation for advanced therapy medicinal products in the EU, as well as for other countries, the approval process for human derived cell or tissue based medical products may be extensive, lengthy, expensive and unpredictable. Some of our products may be subject to European Union member states’ regulations that govern the donation, procurement, testing, coding, traceability, processing, preservation, storage, and distribution of human tissues and cells and cellular or tissue-based products. Some EU member states have their own tissue banking regulations.
 
 
30

 
Clinical trials can be long, expensive and ultimately uncertain which could jeopardize our ability to obtain regulatory approval and market our products.
 
Clinical trials are required to develop products, gain market acceptance and obtain 510(k) certifications from the FDA. These trials often take several years to execute and are subject to factors within and outside of our control. The outcome of any trial is uncertain and may have a significant impact on the success of our current and future products and future profits.
 
The commencement or completion of any clinical trial may be delayed or halted for numerous reasons, including, but not limited to, a regulatory body placing clinical trials on hold, patients not enrolling in clinical trials at the rate we expect, patients experiencing adverse side effects, third party contractors failing to perform in accordance with our anticipated schedule or consistent with good clinical practices, inclusive or negative interim trial results or our inability to obtain sufficient quantities of raw materials to produce our products. Our development costs may increase if we have material delays in clinical trials or if we need to perform more or larger clinical trials than planned. If this occurs, our financial results and the commercial prospects for our products may be harmed.
 
Product pricing (and, therefore, profitability) is subject to regulatory control which could impact our revenue and financial performance.
 
The pricing and profitability of our products may become subject to control by the government and other third-party payors. The continuing efforts of governmental and other third-party payors to contain or reduce the cost of healthcare through various means may adversely affect our ability to successfully commercialize our products. In most foreign markets, the pricing and/or profitability of certain diagnostics and prescription pharmaceuticals are subject to governmental control. In the United States, we expect that there will continue to be federal and state proposals to implement similar governmental control though it is unclear which proposals will ultimately become law, if any. Changes in prices, including any mandated pricing, could impact our revenue and financial performance.
 
Failure to protect our intellectual property rights could result in costly and time consuming litigation and our loss of any potential competitive advantage.
 
Our success will depend, to a large extent, on our ability to successfully obtain and maintain patents, prevent misappropriation or infringement of intellectual property, maintain trade secret protection, and conduct operations without violating or infringing on the intellectual property rights of third parties. There can be no assurance that our patented and patent-pending technologies will provide us with a competitive advantage, that we will be able to develop or acquire additional technology that is patentable, or that third parties will not develop and offer technologies which are similar to ours. Moreover, we can provide no assurance that confidentiality agreements, trade secrecy agreements or similar agreements intended to protect unpatented technology will provide the intended protection. Intellectual property litigation is extremely expensive and time-consuming, and it is often difficult, if not impossible, to predict the outcome of such litigation. A failure by us to protect our intellectual property could have a materially adverse effect on our business and operating results and our ability to successfully compete in this industry.
 
We may not be able to obtain or protect our proprietary rights relating to our products without resorting to costly and time consuming litigation.
 
We may not be able to obtain, maintain and protect certain proprietary rights necessary for the development and commercialization of our products or product candidates. Our commercial success will depend in part on obtaining and maintaining patent protection on our products and successfully defending these patents against third-party challenges. Our ability to commercialize our products will also depend in part on the patent positions of third parties, including those of our competitors. The patent positions of pharmaceutical and biotechnology companies can be highly uncertain and involve complex legal and factual questions. Accordingly, we cannot predict with certainty the scope and breadth of patent claims that may be afforded to other companies’ patents. We could incur substantial costs in litigation if we are required to defend against patent suits brought by third parties, or if we initiate suits to protect our patent rights.
 
In addition to the risks involved with patent protection, we also face the risk that our competitors will infringe on our trademarks.  Any infringement could lead to a likelihood of confusion and could result in lost sales.
 
There can be no assurance that we will prevail in any claims we make to protect our intellectual property.
 
Future protection for our proprietary rights is uncertain which may impact our ability to successfully compete in our industry.
 
The degree of future protection for our proprietary rights is uncertain. We cannot ensure that:
 
 
·
we were the first to make the inventions covered by each of our patent applications;
 
 
·
we were the first to file patent applications for these inventions;
 
 
·
others will not independently develop similar or alternative technologies or duplicate any of our technologies;
 
 
31

 
 
¨
any of our pending patent applications will result in issued patents;
 
 
¨
any of our issued patents or those of our licensors will be valid and enforceable;
 
 
¨
any patents issued to us or our collaborators will provide a basis for commercially viable products or will provide us with any competitive advantages or will not be challenged by third parties;
 
 
¨
we will develop additional proprietary technologies that are patentable;
 
 
¨
the patents of others will not have a material adverse effect on our business rights; or
 
 
¨
the measures we rely on to protect the intellectual property underlying our products may not be adequate to prevent third parties from using our technology, all of which could harm our ability to compete in the market.
 
Our success depends on our ability to avoid infringing on the intellectual property rights of third parties which could expose us to litigation or commercially unfavorable licensing arrangements.
 
Our commercial success depends in part on our ability and the ability of our collaborators to avoid infringing patents and proprietary rights of third parties. Third parties may accuse us or our collaborators of employing their proprietary technology in our products, or in the materials or processes used to research or develop our products, without authorization. Any legal action against our collaborators or us claiming damages and/or seeking to stop our commercial activities relating to the affected products, materials and processes could, in addition to subjecting us to potential liability for damages, require our collaborators or us to obtain a license to continue to utilize the affected materials or processes or to manufacture or market the affected products. We cannot predict whether we or our collaborators would prevail in any of these actions or whether any license required under any of these patents would be made available on commercially reasonable terms, if at all. If we are unable to obtain such a license, we or our collaborators may be unable to continue to utilize the affected materials or processes or manufacture or market the affected products or we may be obligated by a court to pay substantial royalties and/or other damages to the patent holder. Even if we are able to obtain such a license, the terms of such a license could substantially reduce the commercial value of the affected product or products and impair our prospects for profitability. Accordingly, we cannot predict whether or to what extent the commercial value of the affected product or products or our prospects for profitability may be harmed as a result of any of the liabilities discussed above. Furthermore, infringement and other intellectual property claims, with or without merit, can be expensive and time-consuming to litigate and can divert management’s attention from our core business. We may be unable to obtain and enforce intellectual property rights to adequately protect our products and related intellectual property.
 
Others may claim an ownership interest in our intellectual property which could expose us to litigation and have a significant adverse effect on our prospects.
 
A third-party may claim an ownership interest in our intellectual property. While we believe we own 100% of the right, title and interest in the patents for which we have applied and our other intellectual property, including that which we license from third parties, we cannot guarantee that a third-party will not, at some time, assert a claim or an interest in any of such patents or intellectual property. A successful challenge or claim by a third party to our patents or intellectual property could have a significant adverse effect on our prospects.
 
The result of litigation may result in financial loss and/or impact our ability to sell our products going forward.
 
We intend to vigorously defend any future intellectual property litigation that may arise but there can be no assurance that we will prevail in these matters. An unfavorable judgment may result in a financial burden on us. An unfavorable judgment may also result in restrictions on our ability to sell certain products and therefore may impact future operating results.
 
We have found material weaknesses in our system of internal controls over financial reporting that have not been fully remediated as of September 30, 2013, which could adversely affect our ability to record, process, summarize and report certain financial data.
 
In connection with the evaluation of the effectiveness of our internal controls over financial reporting as of September 30, 2013, management discovered the following deficiencies: (i) insufficient number of personnel with the appropriate level of experience and technical expertise to appropriately resolve account reconciliations, while completing the financial statement close process; and (ii) the documentation surrounding equity transactions for employees and consultants needs to be strengthened to comply with procedures outlined by the Company to ensure that all equity transactions are properly recorded in the appropriate periods.  In light of these material weaknesses, management has concluded that we did not maintain effective internal control over our disclosure controls and procedures as of September 30, 2013, which constituted a material weakness in our internal controls over financial reporting because they resulted in a reasonable possibility that a material misstatement could occur in our annual or interim financial statements which could not be prevented or detected.  Although we are working to remediate these deficiencies as outlined in Item 4 of this Quarterly Report on Form 10-Q, there can be no assurance that our remediation efforts will resolve all of our internal control deficiencies or that we will not discover additional material weaknesses or significant deficiencies as we evaluate and test such controls in the future. Such material weaknesses or deficiencies could adversely affect our ability to record, process, summarize and report our financial information, which could cause current and potential stockholders to lose confidence in our financial reporting which could have a negative effect on the trading price of our common stock.
 
 
32

 
Because we became public through a reverse merger, and our stock is currently trading below $1.00 per share, we may not be able to attract the attention of major brokerage firms or certain investors.
 
There are coverage risks associated with our becoming public through a reverse merger, including, among other things, security analysts of major brokerage firms may not provide coverage of us since there is no incentive to brokerage firms to recommend the purchase of our common stock. In addition, we may not attract the attention of major brokerage firms and certain investors due to our low stock price. We cannot assure you that brokerage firms would want to conduct any public offerings on our behalf in the future.
 
The market price of our common stock is extremely volatile, which may affect our ability to raise capital in the future and may subject the value of your investment to sudden decreases.
 
The market price for securities of biotechnology companies, including ours, historically has been highly volatile, and the market from time to time has experienced significant price and volume fluctuations that are unrelated to the operating performance of such companies. Fluctuations in the trading price or liquidity of our common stock may harm the value of your investment in our common stock.
 
Factors that may have a significant impact on the market price and marketability of our securities include:
 
 
¨
announcements of technological innovations or new commercial products by us, our collaborative partners or our present or potential competitors;
 
 
¨
our issuance of debt, equity or other securities, which we need to pursue to generate additional funds to cover our operating expenses;
 
 
¨
our quarterly operating results;
 
 
¨
developments or disputes concerning patent or other proprietary rights;
 
 
¨
developments in our relationships with employees, suppliers or collaborative partners;
 
 
¨
acquisitions or divestitures;
 
 
¨
litigation and government proceedings;
 
 
¨
adverse legislation, including changes in governmental regulation;
 
 
¨
third-party reimbursement policies;
 
 
¨
changes in securities analysts’ recommendations;
 
 
¨
short selling;
 
 
33

 
 
¨
changes in health care policies and practices;
 
 
¨
halting or suspension of trading in our common stock by NYSE MKT;
 
 
¨
economic and other external factors; and
 
 
¨
general market conditions.
 
In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been instituted. These lawsuits often seek unspecified damages, and as with any litigation proceeding, one cannot predict with certainty the eventual outcome of pending litigation. Furthermore, we may have to incur substantial expenses in connection with any such lawsuits and our management’s attention and resources could be diverted from operating our business as we respond to any such litigation. We maintain insurance to cover these risks for us and our directors and officers, but our insurance is subject to high deductibles to reduce premium expense, and there is no guarantee that the insurance will cover any specific claim that we currently face or may face in the future, or that it will be adequate to cover all potential liabilities and damages.
 
Shares of common stock are equity securities and are subordinate to any indebtedness.
 
Shares of our common stock are common equity interests. This means that our common stock will rank junior to any outstanding shares of our preferred stock that we may issue in the future or to our current credit agreement and any future indebtedness we may incur and to all creditor claims and other non-equity claims against us and our assets available to satisfy claims on us, including claims in a bankruptcy or similar proceeding.
 
Additionally, unlike indebtedness, where principal and interest customarily are payable on specified due dates, in the case of our common stock, (i) dividends are payable only when and if declared by our board of directors or a duly authorized committee of our board of directors, and (ii) as a corporation, we are restricted to making dividend payments and redemption payments out of legally available assets. We have never paid a dividend on our common stock and have no current intention to pay dividends in the future. Furthermore, our common stock places no restrictions on our business or operations or on our ability to incur indebtedness or engage in any transactions, subject only to the voting rights available to shareholders generally.
 
Our stockholders may experience significant dilution if future equity offerings are used to fund operations or acquire complementary businesses.
 
If our future operations or acquisitions are financed through the issuance of equity securities, our stockholders could experience significant dilution. In addition, securities issued in connection with future financing activities or potential acquisitions may have rights and preferences senior to the rights and preferences of our common stock. We also have established an equity incentive plan for our management and employees. We expect to grant options to purchase shares of our common stock to our directors, employees and consultants and we will grant additional options in the future. The issuance of shares of our common stock upon the exercise of these options may result in dilution to our stockholders.
 
 
34

 
We do not anticipate paying dividends in the foreseeable future; you should not buy our stock if you expect dividends.
 
We currently intend to retain our future earnings to support operations and to finance expansion and, therefore, we do not anticipate paying any cash dividends on our common stock in the foreseeable future.
 
We could issue “blank check” preferred stock without stockholder approval with the effect of diluting then current stockholder interests and impairing their voting rights, and provisions in our charter documents and under Delaware law could discourage a takeover that stockholders may consider favorable.
 
Our certificate of incorporation provides for the authorization to issue up to 5,000,000 shares of “blank check” preferred stock with designations, rights and preferences as may be determined from time to time by our board of directors. Our board of directors is empowered, without stockholder approval, to issue one or more series of preferred stock with dividend, liquidation, conversion, voting or other rights which could dilute the interest of, or impair the voting power of, our common stockholders. The issuance of a series of preferred stock could be used as a method of discouraging, delaying or preventing a change in control. For example, it would be possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of our company. In addition, we have a staggered board of directors and advanced notice is required prior to stockholder proposals, which might further delay a change of control.
 
 
35

 
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds
 
Nothing to report for the quarterly period ended September 30, 2013.
 
Item 3.   Defaults Upon Senior Securities
 
On November 14, 2013, we entered into a Waiver and Fifth Amendment to our Credit Agreement with ROS Acquisition Offshore LP (“ROS”) whereby ROS (i) waived our failure to achieve the revenue required by Section 8.4.1 of the Credit Agreement for the quarter ended September 30, 2013, and (ii) agreed to revise our future revenue requirements as follows:
 
December 31, 2013
 
$
7,500,000
 
March 31, 2014
 
$
7,500,000
 
June 30, 2014
 
$
8,000,000
 
September 30, 2014
 
$
8,000,000
 
December 31, 2014
 
$
8,000,000
 
March 31, 2015 and thereafter
 
$
9,500,000
 
 
In exchange, we agreed to issue 1,500,000 shares (the “Shares”) of our common stock to ROS.  If we do not issue the Shares by December 2, 2013, we will be required to pay an additional fee in the amount of 3.5% of any principal payment required to be paid pursuant to the Credit Agreement or other loan documents.
 
The foregoing description of the amendment to our Credit Agreement is qualified in its entirety by reference to the full text of the amendment, which is attached hereto as Exhibit 10.27 and incorporated by reference herein. 
 
Item 4    Mine Safety Disclosures
 
Not Applicable
 
Item 5.   Other Information
 
None
 
Item 6.   Exhibits
 
 3.1
 
Certificate of Incorporation (filed as Exhibit 3.1 to Form 10-Q filed November 14, 2011, incorporated by reference herein)
 
 
 
3.2
 
Amended and Restated Bylaws (filed as Exhibit 3.2 to Form 8-K filed July 11, 2013, incorporated by reference herein)
 
 
 
10.26
*
Indemnification Agreement with Daniel Goldberger
 
 
 
 10.27
Waiver and Fifth Amendment to Credit Agreement 
 
 
 
31.1
*
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer
 
 
 
31.2
*
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
 
 
 
32.1
Section 1350 Certification of Chief Executive Officer
 
 
 
32.2
*
Section 1350 Certification of Chief Financial Officer
 
 
 
101.INS
**
XBRL INSTANCE DOCUMENT
 
101.SCH
**
XBRL TAXONOMY EXTENSION SCHEMA
 
 
 
101.CAL
**
XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
 
 
 
101.DEF
**
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
 
 
 
101.LAB
**
XBRL TAXONOMY EXTENSION LABEL LINKBASE
 
 
 
101.PRE
**
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
 
 
*
Filed herewith
 
 
**
Furnished herewith
 
 
XBRL (eXtensible Business Reporting Language) information is furnished and not filed as part of any registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these Sections.
 
 
36

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
BACTERIN INTERNATIONAL HOLDINGS, INC.
 
 
 
Date:  November 14, 2013   
By:
/s/ John P. Gandolfo
 
 
Name: John P. Gandolfo 
 
 
Title:  Chief Financial Officer
 
 
 
37

 
EX-10.26 2 v359011_ex10-26.htm EXHIBIT 10.26

 

INDEMNIFICATION AGREEMENT

 

This Indemnification Agreement ("Agreement") is made as of August 14, 2013 by and between Bacterin International Holdings, Inc., a Delaware corporation (the "Company"), and Daniel S. Goldberger, a resident of the State of Colorado ("Indemnitee"). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.

 

RECITALS

 

WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors and officers unless they are provided with adequate protection through insurance or adequate indemnification or both against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation;

 

WHEREAS, the Board of Directors of the Company (the "Board") has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The By-laws of the Company (the "By-laws") require indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the "DGCL"). The By-laws and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification;

 

WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

 

WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;

 

WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified;

 

 
 

 

WHEREAS, this Agreement is a supplement to and in furtherance of the By-laws, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

WHEREAS, Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she be so indemnified; and

 

NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

 

Section 1.          Survival. This Agreement shall continue in force after Indemnitee has ceased to serve as an officer or director of the Company, as provided in Section 16 hereof.

 

Section 2.          Definitions. As used in this Agreement:

 

(a)          References to "agent" shall mean any person who is or was a director, officer, or employee of the Company or a subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, fiduciary or other official of another corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.

 

(b)          A "Change in Control" shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:

 

i.            Acquisition of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company's then outstanding securities unless the change in relative Beneficial Ownership of the Company's securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors;

 

ii.         Change in Board of Directors. During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in Sections 2(b)(i), 2(b)(iii) or 2(b)(iv)) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board;

 

-2-
 

 

iii.         Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity;

 

iv.         Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets; and

 

v.           Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement.

 

For purposes of this Section 2(b), the following terms shall have the following meanings:

 

(A)         "Exchange Act" shall mean the Securities Exchange Act of 1934, as amended from time to time.

 

(B)         "Person" shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided, however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.

 

(C)         "Beneficial Owner" shall have the meaning given to such term in Rule 13d-3 under the Exchange Act; provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity.

 

(c)          "Corporate Status" describes the status of a person who is or was a director, officer, employee or agent of the Company or of any other corporation, limited liability company, partnership or joint venture, trust or other enterprise which such person is or was serving at the request of the Company.

 

(d)          "Disinterested Director" shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.

 

-3-
 

 

(e)          "Enterprise" shall mean the Company and any other corporation, limited liability company, partnership, joint venture, trust or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, employee, agent or fiduciary.

 

(f)          "Expenses" shall include all reasonable attorneys' fees, retainers, court costs, transcript costs, fees of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also shall include (i) Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of Section 14(d) only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement, by litigation or otherwise. The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance with this Agreement, all Expenses included in such demand that are certified by affidavit of Indemnitee's counsel as being reasonable shall be presumed conclusively to be reasonable. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

 

(g)          "Independent Counsel" shall mean a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than as Independent Counsel with respect to other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term "Independent Counsel" shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee's rights under this Agreement. The Company agrees to pay the reasonable fees and expenses of the Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto.

 

(h)          The term "Proceeding" shall include any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, legislative, or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or failure to act) while acting pursuant to Indemnitee’s Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under this Agreement. If the Indemnitee believes in good faith that a given situation may lead to or culminate in the institution of a Proceeding, this shall be considered a Proceeding under this paragraph.

 

-4-
 

 

(i)          Reference to "other enterprise" shall include employee benefit plans; references to "fines" shall include any excise tax assessed with respect to any employee benefit plan; references to "serving at the request of the Company" shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in manner "not opposed to the best interests of the Company" as referred to in this Agreement.

 

Section 3.          Indemnity in Third-Party Proceedings. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe that his or her conduct was unlawful. The parties hereto intend that this Agreement shall provide to the fullest extent permitted by law for indemnification in excess of that expressly permitted by statute, including, without limitation, any indemnification provided by the Certificate of Incorporation, the By-laws, vote of its stockholders or disinterested directors or applicable law.

 

Section 4.          Indemnity in Proceedings by or in the Right of the Company. The Company shall indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 4, Indemnitee shall be indemnified to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by him or on his behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the Company. No indemnification for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court to be liable to the Company, unless and only to the extent that the Delaware Court (as hereinafter defined) or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.

 

-5-
 

 

Section 5.          Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or on his behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

 

Section 6.          Indemnification For Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of his Corporate Status, a witness or otherwise asked to participate in any Proceeding to which Indemnitee is not a party, Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith.

 

Section 7.          Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.

 

Section 8.          Additional Indemnification.

 

(a)          Notwithstanding any limitation in Sections 3, 4, or 5, the Company shall indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding.

 

(b)          For purposes of Section 8(a), the meaning of the phrase "to the fullest extent permitted by applicable law" shall include, but not be limited to:

 

i.            to the fullest extent permitted by the provision of the DGCL that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and

 

-6-
 

 

ii.         to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors.

 

Section 9.          Exclusions. Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnification payment in connection with any claim made against Indemnitee:

 

(a)          for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; or

 

(b)          for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as defined in Section 2(b) hereof) or similar provisions of state statutory law or common law, or (ii) any reimbursement of the Company by the Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the "Sarbanes-Oxley Act"), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act); or

 

(c)          except as provided in Section 14(d) of this Agreement, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.

 

Section 10.         Advances of Expenses. Notwithstanding any provision of this Agreement to the contrary (other than Section 14(d)), the Company shall advance, to the extent not prohibited by law, the Expenses incurred by Indemnitee in connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee, and such advancement shall be made within thirty (30) days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding. Advances shall be unsecured and interest free. Advances shall be made without regard to Indemnitee's ability to repay the Expenses and without regard to Indemnitee's ultimate entitlement to indemnification under the other provisions of this Agreement. In accordance with Section 14(d), advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. The Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement, which shall constitute an undertaking providing that the Indemnitee undertakes to repay the amounts advanced (without interest) to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company. No other form of undertaking shall be required other than the execution of this Agreement. This Section 10 shall not apply to any claim made by Indemnitee for which indemnity is excluded pursuant to Section 9.

 

-7-
 

 

Section 11.         Procedure for Notification and Defense of Claim.

 

(a)          Indemnitee shall notify the Company in writing of any matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof. The written notification to the Company shall include a description of the nature of the Proceeding and the facts underlying the Proceeding. To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding. The omission by Indemnitee to notify the Company hereunder will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise than under this Agreement, and any delay in so notifying the Company shall not constitute a waiver by Indemnitee of any rights under this Agreement, unless, and only to the extent that, the Company did not otherwise learn of such action or request, as the case may be, and such failure results in forfeiture by the Company of substantial defenses, rights or insurance. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.

 

(b)          The Company will be entitled to participate in the Proceeding at its own expense, provided that Indemnitee provides signed, written consent to such participation, which shall not be unreasonably withheld.

 

(c)          Except as otherwise provided below, the Company may, at its option and jointly with any other indemnifying party similarly notified and electing to assume such defense, assume defense of the Proceeding, with counsel reasonably satisfactory to Indemnitee, provided that Indemnitee provides signed, written consent to such assumption, which shall not be unreasonably withheld. Upon the Company delivering to Indemnitee written notice of its election to assume such defense, and Indemnitee providing signed, written consent thereto, the Company will not be liable to Indemnitee under this Agreement for any legal or other expenses subsequently incurred by Indemnitee in connection with the defense thereof, except as provided in subsections 11(b)(i)-(iv) below. Indemnitee shall have the right to employ separate counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof, and Indemnitee’s signed, written consent thereto, shall be at the expense of Indemnitee unless (i)  the employment of counsel by Indemnitee has been authorized by the Company, (ii)  it is reasonably determined at any time before or during the course of the Proceeding that the use of counsel chosen by the Company to represent Indemnitee would present or presents, as the case may be, such counsel with an actual or potential conflict, (iii) it is reasonably determined at any time before or during the course of the Proceeding that the use of counsel chosen by the Company to represent Indemnitee would be or is, as the case may be, precluded under the applicable standards of professional conduct then prevailing, or (iv)  the Company shall not in fact have employed counsel to assume the defense of such Proceeding, or fails to continue to retain such counsel to assume the defense of such Proceeding, in each of which cases the fees and expenses of Indemnitee’s separate counsel shall be at the expense of the Company.

 

-8-
 

 

(d)          The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any action or claim effected without its prior written consent, which shall not be unreasonably withheld. The Company shall be permitted to settle any action except that it shall not settle any action or claim in any manner that would impose any expenses, losses, liabilities, judgments, fines, or penalties (whether civil or criminal,) on Indemnitee, including without limitation a prohibition against Indemnitee serving as an officer or a director of a listed company, without Indemnitee’s prior written consent.

 

Section 12.         Procedure Upon Application for Indemnification.

 

(a)          Upon written request by Indemnitee for indemnification pursuant to Section 11(a), a determination, if required by applicable law, with respect to Indemnitee's entitlement thereto shall be made in the specific case: (i) if a Change in Control shall have occurred, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (ii) if a Change in Control shall not have occurred, (A) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (B) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C) if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee or (D) if so directed by the Board, by the stockholders of the Company; and, if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee's entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or Expenses (including attorneys' fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee's entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. The Company promptly will advise Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied.

 

-9-
 

 

(b)          In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section 12(b). If a Change in Control shall not have occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising him of the identity of the Independent Counsel so selected. If a Change in Control shall have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been given, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of "Independent Counsel" as defined in Section 2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or the Delaware Court has determined that such objection is without merit. If, within twenty (20) days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section 11(a) hereof and the final disposition of the Proceeding, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any objection which shall have been made by the Company or Indemnitee to the other's selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by such court or by such other person as such court shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

 

Section 13.         Presumptions and Effect of Certain Proceedings.

 

(a)          In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(a) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

 

-10-
 

 

(b)          Subject to Section 14(e), if the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, or if the determination is to be made by Independent Counsel pursuant to Section 12(a) of this Agreement, within sixty (60) days after (i) the Independent Counsel shall have been selected and not objected to or (ii) all objections to the appointment of a selected Independent Counsel have been resolved by the Delaware Court or agreement between the Company and Indemnitee, or (iii) the Independent Counsel has been appointed by the Delaware Court or a person designated to do so by the Delaware Court, the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee shall be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee's statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 13(b) shall not apply if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section 12(a) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat.

 

(c)          The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.

 

(d)          For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee's action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert selected with the reasonable care by the Enterprise. The provisions of this Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.

 

-11-
 

 

(e)          The knowledge and/or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

 

Section 14.         Remedies of Indemnitee.

 

(a)          Subject to Section 14(e), in the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Section 5, 6 or 7 or the last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by the Company of a written request therefor, (v) payment of indemnification pursuant to Section 3, 4 or 8 of this Agreement is not made within ten (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) in the event that the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by the Delaware Court of his entitlement to such indemnification or advancement of Expenses. Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association and in such event the Company and Indemnitee agree to fully and finally resolve by such arbitration the matter subject to the demand for arbitration, and the award of the arbitrator shall be final and binding on both parties and may be enforced in any court having jurisdiction over the parties hereto. Indemnitee shall commence such proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such proceeding pursuant to this Section 14(a); provided, however, that the immediately preceding clause in this sentence shall not apply in respect of a proceeding brought by Indemnitee to enforce his rights under Section 5 of this Agreement. The Company shall not oppose Indemnitee's right to seek any such adjudication or award in arbitration.

 

(b)          In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 14 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be.

 

-12-
 

 

(c)          If a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee's statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

 

(d)          The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement. It is the intent of the Company that, to the fullest extent permitted by law, the Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee's rights under this Agreement by litigation, arbitration or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to the Indemnitee hereunder. The Company shall, to the fullest extent permitted by law, indemnify Indemnitee against any and all Expenses and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefor) advance, to the extent not prohibited by law, such Expenses to Indemnitee, which are incurred by Indemnitee in connection with any action brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors' and officers' liability insurance policies maintained by the Company if, in the case of indemnification, Indemnitee is wholly successful on the underlying claims; if Indemnitee is not wholly successful on the underlying claims, then such indemnification shall be only to the extent Indemnitee is successful on such underlying claims or otherwise as permitted by law, whichever is greater.

 

(e)          Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement of Indemnitee to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding.

 

Section 15.         Non-exclusivity; Survival of Rights; Insurance; Subrogation.

 

(a)          The rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Certificate of Incorporation, the By-laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

 

-13-
 

 

(b)          To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Enterprise, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director, officer, employee or agent under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. Nothing in this Section 15 shall be construed to permit the Company to delay advancement of Expenses or payment of amounts in indemnification, to which Indemnitee is otherwise entitled under this Agreement, because such insurance coverage is in place and a claim has been made and is pending under such policies of insurance.

 

(c)          In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

(d)          The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement is provided hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.         

 

(e)          The Company's obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such other corporation, limited liability company, partnership, joint venture, trust or other enterprise.

 

Section 16.         Duration of Agreement. All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is a director, officer, employee or agent of the Company and thereafter so long as Indemnitee shall be subject to any possible Proceeding or any possible action to interpret, enforce or defend Indemnitee's rights under this Agreement by litigation, arbitration or otherwise. The indemnification and advancement of Expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and shall inure to the benefit of Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.

 

-14-
 

 

Section 17.         Injunctive Relief. The Company, and the Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause the Indemnitee and the Company irreparable harm. Accordingly, the parties hereto agree that the parties may enforce this Agreement by seeking injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, they shall not be precluded from seeking or obtaining any other relief to which they may be entitled. The Company and the Indemnitee further agree that they shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection herewith. The Company and the Indemnitee acknowledge that in the absence of a waiver, a bond or undertaking may be required by the Chancery Court of the State of Delaware, and they hereby waive any such requirement of such a bond or undertaking.

 

Section 18.         Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.

 

Section 19.         Enforcement.

 

(a)          The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the Company.

 

(b)          This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in furtherance of the Certificate of Incorporation, the By-laws and applicable law, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.

 

-15-
 

 

Section 20.         Modification and Waiver. No supplement, modification or amendment of this Agreement shall be binding unless expressed in writing stating the express intent to amend, modify or supplement this Agreement and executed by the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.

 

Section 21.         Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise, unless, and only to the extent that, the Company did not otherwise learn of such action or request, as the case may be, and such failure results in forfeiture by the Company of substantial defenses, rights or insurance.

 

Section 22.         Notices. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given if (a) delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, on the date so delivered and receipted for, (b) mailed by certified or registered mail with postage prepaid, on the third business day after the date on which it is so mailed, (c) dispatched by reputable overnight courier and receipted for by the party to whom said notice or other communication shall have been directed, on the date receipted for or (d) sent by facsimile transmission, with receipt of oral confirmation that such transmission has been received, on the date of such transmission:

 

(a)          If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide to the Company.

 

(b)          If to the Company to

 

Bacterin International Holdings, Inc.

664 Cruiser Lane

Belgrade, MT 59714

Attn: General Counsel

 

or to any other address as may have been furnished to Indemnitee by the Company.

 

Section 23.         Contribution. To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

 

-16-
 

 

Section 24.         Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations between the parties hereto shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules, except the provisions of Section 14(a) providing for arbitration of disputes which shall be governed by, and construed and enforced in accordance with, the Federal Arbitration Act. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the "Delaware Court"), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii) appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware, irrevocably RL&F Service Corp., 920 North King Street, 2nd Floor, Wilmington, New Castle County, Delaware 19801 as its agent in the State of Delaware for acceptance of legal process in connection with any such action or proceeding against such party with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum. The parties hereto, for purposes only of enforcement of any arbitration award resulting from arbitration under the provisions of Section 14(a), (a) consent to the personal jurisdiction of the state and federal courts sitting in the State of Delaware, provided such court then also would have subject matter jurisdiction over such enforcement action, (b) appoint, to the extent such party is not otherwise subject to service of process in the State of Delaware, irrevocably RL&F Service Corp., 920 North King Street, 2nd Floor, Wilmington, New Castle County, Delaware 19801 as its agent in the State of Delaware for acceptance of legal process in connection with any such action to enforce such arbitration award with the same legal force and validity as if served upon such party personally within the State of Delaware, (iv) waive any objection to the laying of venue of any such action or proceeding in any such federal or Delaware state court, and (v) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in any such federal or Delaware state court has been brought in an improper or inconvenient forum.

 

Section 25.         Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

 

-17-
 

 

Section 26.         Miscellaneous. Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. The headings of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written.

 

Bacterin International Holdings, Inc.   INDEMNITEE
     
By: /s/ John P. Gandolfo   /s/ Daniel S. Goldberger
Name: John P. Gandolfo   Name:   Daniel S. Goldberger
Office: CFO   Address:

644 College Ave

Boulder, CO 80302

 

-18-

 

EX-10.27 3 v359011_ex10-27.htm EXHIBIT 10.27

Waiver AND FIFTH AMENDMENT TO CREDIT AGREEMENT

 

This WAIVER AND FIFTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into as of November 14, 2013 by and among Bacterin International, Inc., a Nevada corporation (the “Borrower”), Bacterin International HOLDINGS, Inc., a Delaware corporation (“Holdings”), and ROS Acquisition Offshore LP, a Cayman Islands Exempted Limited Partnership (the “Lender”).

 

WHEREAS, the Borrower and the Lender are party to that certain Credit Agreement, dated as of August 24, 2012 (as amended by that certain First Amendment to Credit Agreement, dated as of May 16, 2013, as further amended by that certain Waiver and Second Amendment to Credit Agreement, dated as of August 12, 2013, as further amended by that certain Waiver and Third Amendment to Credit Agreement, dated as of August 12, 2013, and as further amended by that certain Fourth Amendment to Credit Agreement, dated as of August 30, 2013, the “Credit Agreement”), pursuant to which the Lenders have extended credit to the Borrower on the terms set forth therein;

 

WHEREAS, the Borrower has advised the Lender that the Revenue Base for the Fiscal Quarter ended September 30, 2013 was less than the Minimum Revenue Base required for such Fiscal Quarter under Section 8.4.1 of the Credit Agreement, and therefore an Event of Default has occurred under Section 9.1.3 of the Credit Agreement (the “Existing Default”);

 

WHEREAS, the Borrower has requested that the Lender waive the Existing Default and amend the Credit Agreement, as more fully described herein; and

 

WHEREAS, the Lender is willing to waive the Existing Default and agree to such amendment, but only upon the terms and subject to the conditions set forth herein.

 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

1.          Definitions; Loan Document. Capitalized terms used herein without definition shall have the meanings assigned to such terms in the Credit Agreement. This Amendment shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents.

 

2.          Amendment to Section 8.4.1. Section 8.4.1 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:

 

SECTION 8.4.1 Minimum Revenue Base. 

The Revenue Base for any Fiscal Quarter shall not be less than the amount set forth below for such Fiscal Quarter:

 

 
 

 

Fiscal Quarter Ending  Minimum Revenue Base 
September 30, 2012  $7,500,000 
December 31, 2012  $7,500,000 
March 31, 2013  $8,500,000 
June 30, 2013  $8,500,000 
September 30, 2013  $10,500,000 
December 31, 2013  $7,500,000 
March 31, 2014  $7,500,000 
June 30, 2014  $8,000,000 
September 30, 2014  $8,000,000 
December 31, 2014  $8,000,000 
March 31, 2015 and thereafter  $9,500,000 

 

3.          Waiver. The Lender hereby waives the Existing Default and agrees not to exercise any rights or remedies that may be available to it as a result of the occurrence thereof.

 

4.          Restricted Stock Grant. Holdings hereby agrees to grant and issue to the Lender, and the Lender hereby accepts, as consideration for the Lender agreeing to execute this Amendment, and for no additional consideration, 1,500,000 shares of the common stock of Holdings (the “Shares”), which shall be issued by Holdings to the Lender in certificated form as soon as reasonably practicable, but in any event on or prior to December 2, 2013, subject to the last sentence of this Section 4. The Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and will not be able to be transferred by the Lender, other than pursuant to an effective registration statement, or exemption from registration requirements under the Securities Act and other applicable securities laws, and will contain a legend to that effect. Issuance of the Shares requires additional listing approval by the NYSE MKT exchange, and Holdings shall use its reasonable best efforts to obtain such approval as soon as reasonably practicable. If such approval is not received prior to November 29, 2013, then in lieu of issuing the Shares to the Lender, the last two sentences of Section 3.2 of the Credit Agreement shall hereby automatically be amended and restated in their entirety to read as follows:

 

At such time as the Borrower pays, prepays or repays, or is required to pay, prepay or repay, any principal amount of the Loans, whether on the Maturity Date or otherwise, whether voluntarily or involuntarily (if involuntarily, whether required by this Agreement, the Royalty Agreement or any other Loan Document) and whether before or after acceleration of the Obligations, including without limitation any payment pursuant to any provision of this Section 3.2, the Borrower shall pay to the Lender a fee in the amount equal to 7.0% of the aggregate principal amount of such payment, prepayment or repayment. For the avoidance of doubt, any such fees paid by the Borrower to the Lender shall not be included in clause (ii) of the definition of “Recovered Amount” for purposes of the Royalty Agreement.

 

5.          Conditions to Effectiveness of Amendment. This Amendment, including the Lender’s consent to the Waiver in Section 3 of this Amendment, shall become effective upon receipt (i) by the Lender of a Secretary’s Certificate, in the form attached as Exhibit A hereto, duly executed and delivered by the signatories thereto, and (ii) by the Lender of a counterpart signature to this Amendment duly executed and delivered by each of the Borrower and Holdings.

 

-2-
 

 

6.          Expenses. The Borrower agrees to pay on demand all expenses of the Lender (including, without limitation, the fees and out-of-pocket expenses of Covington & Burling LLP, counsel to the Lender, and of local counsel, if any, who may be retained by or on behalf of the Lender) incurred in connection with the negotiation, preparation, execution and delivery of this Amendment.

 

7.          Representations and Warranties. The Borrower and Holdings each represents and warrants to the Lender as follows:

 

(a)          After giving effect to this Amendment, the representations and warranties of the Borrower and the Guarantors contained in the Credit Agreement or any other Loan Document shall, (i) with respect to representations and warranties that contain a materiality qualification, be true and correct in all respects on and as of the date hereof, and (ii) with respect to representations and warranties that do not contain a materiality qualification, be true and correct in all material respects on and as of the date hereof, and except that the representations and warranties limited by their terms to a specific date shall be true and correct as of such date.

 

(b)          After giving effect to this Amendment, no Default or Event of Default under the Credit Agreement will occur or be continuing.

 

(c)          The authorized capital stock of Holdings, as of immediately prior to the date hereof, consists of (i) 95,000,000 shares of common stock, par value $0.000001 per share, 51,744,136 of which are issued and outstanding as of November 13, 2013, and (ii) 5,000,000 shares of preferred stock, par value $0.000001 per share, none of which are issued and outstanding as of the date of this Amendment.

 

(d)          Other than (i) up to 9,000,000 shares of common stock reserved for issuance pursuant to the Equity Incentive Plan of Holdings, (ii) an option to purchase 2,000,000 shares of common stock granted outside of the Equity Incentive Plan, and (iii) warrants to purchase 11,140,709 shares of common stock, except as granted pursuant to this Amendment, as of the date of this Amendment, there are no outstanding options, warrants, phantom equity, rights (including conversion or preemptive rights and rights of first refusal), proxy or stockholder agreements, or agreements of any kind for the purchase or acquisition from Holdings of any of its securities.

 

(e)          All issued and outstanding shares of Holdings’ common stock and preferred stock (i) have been duly authorized and validly issued and are fully paid and nonassessable, and (ii) were issued in compliance with all applicable state and federal laws concerning the issuance of securities.

 

-3-
 

 

(f)          The rights, preferences, privileges and restrictions of the Shares are as stated in the Certificate of Incorporation of Holdings (the “Charter”). When issued in compliance with the provisions of this Amendment, the Charter and applicable law, the Shares will be validly issued, fully paid and nonassessable, and will be free of any liens or encumbrances other than liens and encumbrances created by or imposed upon the Lender; provided, however, that the Shares may be subject to restrictions on transfer under state and/or federal securities laws or as otherwise required by such laws at the time a transfer is proposed. The issuance of the Shares is not and will not be subject to any preemptive rights or rights of first refusal that have not been properly waived or complied with. Holdings has no obligation (contingent or otherwise) to purchase or redeem any of its capital stock. Except for (i) the warrants issued in connection with Holdings’ issuance of common stock on June 10, 2013, and (ii) the warrants issued in connection with bridge financings in 2009 and 2010, the issuance of the Shares pursuant to this Amendment will not result in any change to the exercise price, conversion price, conversion rate, or number of shares of Holdings’ capital stock issuable upon the exercise or conversion of any of Holdings’ capital stock, options, warrants or other rights to acquire the Holdings’ capital stock.

 

8.          No Implied Amendment or Waiver. Except as expressly set forth in this Amendment, this Amendment shall not, by implication or otherwise, limit, impair, constitute a waiver of or otherwise affect any rights or remedies of the Lender under the Credit Agreement or the other Loan Documents, or alter, modify, amend or in any way affect any of the terms, obligations or covenants contained in the Credit Agreement or the other Loan Documents, all of which shall continue in full force and effect. Nothing in this Amendment shall be construed to imply any willingness on the part of the Lender to agree to or grant any similar or future amendment, consent or waiver of any of the terms and conditions of the Credit Agreement or the other Loan Documents.

 

9.          Waiver and Release. TO INDUCE THE LENDER TO AGREE TO THE TERMS OF THIS AMENDMENT, THE BORROWER AND HOLDINGS EACH REPRESENTS AND WARRANTS THAT AS OF THE DATE HEREOF THERE ARE NO CLAIMS OR OFFSETS AGAINST OR RIGHTS OF RECOUPMENT WITH RESPECT TO OR DEFENSES OR COUNTERCLAIMS TO ITS OBLIGATIONS UNDER THE LOAN DOCUMENTS AND IN ACCORDANCE THEREWITH IT:

 

(a)          WAIVES ANY AND ALL SUCH CLAIMS, OFFSETS, RIGHTS OF RECOUPMENT, DEFENSES OR COUNTERCLAIMS, WHETHER KNOWN OR UNKNOWN, ARISING PRIOR TO THE DATE HEREOF; AND

 

(b)          RELEASES AND DISCHARGES THE LENDER, ITS AFFILIATES AND ITS AND THEIR OFFICERS, DIRECTORS, EMPLOYEES, AGENTS, SHAREHOLDERS AND ATTORNEYS (COLLECTIVELY THE “RELEASED PARTIES”) FROM ANY AND ALL OBLIGATIONS, INDEBTEDNESS, LIABILITIES, CLAIMS, RIGHTS, CAUSES OF ACTION OR DEMANDS WHATSOEVER, WHETHER KNOWN OR UNKNOWN, SUSPECTED OR UNSUSPECTED, IN LAW OR EQUITY, WHICH THE BORROWER EVER HAD, NOW HAS, CLAIMS TO HAVE OR MAY HAVE AGAINST ANY RELEASED PARTY ARISING PRIOR TO THE DATE HEREOF AND FROM OR IN CONNECTION WITH THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY.

 

-4-
 

 

10.         Counterparts; Governing Law. This Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of such when so executed and delivered shall be an original, but all of such counterparts shall together constitute but one and the same agreement. Delivery of an executed counterpart of a signature page of this Amendment by fax transmission or other electronic mail transmission (e.g., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this Amendment. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW OF THE STATE OF NEW YORK).

 

[Remainder of Page Intentionally Left Blank]

 

-5-
 

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized as of the day and year first above written.

 

  BACTERIN INTERNATIONAL, INC.,
  as the Borrower
   
  By: /s/ John P. Gandolfo
  Name:  John P. Gandolfo
  Title:    Chief Financial Officer
   
  BACTERIN INTERNATIONAL HOLDINGS, INC.,
  as Holdings and a Guarantor
   
  By: /s/ John P. Gandolfo
  Name:  John P. Gandolfo
  Title:    Chief Financial Officer
   
  ROS Acquisition Offshore LP,
  as the Lender
  By ROS Acquisition Offshore GP Ltd.,
  its General Partner
  By OrbiMed Advisors LLC,
  its investment manager
   
  By: /s/ Samuel D. Isaly
  Name:  Samuel D. Isaly
  Title:    Managing Member

 

Signature Page to Waiver and Fifth Amendment to Credit Agreement

 

 

 

EX-31.1 4 v359011_ex31-1.htm EXHIBIT 31.1
Exhibit 31.1  
 
Certification of Chief Executive Officer
 
I, Daniel Goldberger, certify that:
 
1.         I have reviewed this Quarterly Report on Form 10-Q of Bacterin International Holdings, Inc.;
 
2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.         The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting standards;
 
c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.         The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:  November 14, 2013   
 
 
/s/ Daniel Goldberger
 
Daniel Goldberger
 
Chief Executive Officer
 
 
 
EX-31.2 5 v359011_ex31-2.htm EXHIBIT 31.2
Exhibit 31.2  
 
Certification of Chief Financial Officer
 
I, John P. Gandolfo, certify that:
 
1.         I have reviewed this Quarterly Report on Form 10-Q of Bacterin International Holdings, Inc.;
 
2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.         The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)         Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b)         Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting standards;
 
c)         Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)         Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.         The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
 
a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date:  November 14, 2013   
 
 
/s/ John P. Gandolfo
 
John P. Gandolfo
 
Chief Financial Officer
 
 
 
EX-32.1 6 v359011_ex32-1.htm EXHIBIT 32.1
Exhibit 32.1
 
Section 1350 Certification of Chief Executive Officer
 
In connection with the Quarterly Report on Form 10-Q of Bacterin International Holdings, Inc. (the "Company") for the quarterly period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Daniel Goldberger, Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Daniel Goldberger  
 
Daniel Goldberger
 
Chief Executive Officer
 
Date:  November 14, 2013   
 
 
 
 
EX-32.2 7 v359011_ex32-2.htm EXHIBIT 32.2
Exhibit 32.2
 
Section 1350  Certification of Chief Financial Officer
 
In connection with the Quarterly Report on Form 10-Q of Bacterin International Holdings, Inc. (the "Company") for the quarterly period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Gandolfo, Chief Financial Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange  Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition  and results of operations of the Company.
 
/s/ John P. Gandolfo
 
John P. Gandolfo
 
Chief Financial Officer
 
Date:  November 14, 2013   
 
 
 
 
EX-101.INS 8 bone-20130930.xml XBRL INSTANCE DOCUMENT 0001453593 2012-01-01 2012-03-31 0001453593 2012-01-01 2012-09-30 0001453593 2012-01-01 2012-12-31 0001453593 2013-01-01 2013-09-30 0001453593 2012-04-01 2012-04-23 0001453593 2013-04-01 2013-06-30 0001453593 2013-06-01 2013-06-10 0001453593 2012-07-01 2012-09-30 0001453593 2013-07-01 2013-09-30 0001453593 2012-08-01 2012-08-24 0001453593 2013-08-14 2013-09-30 0001453593 2013-09-30 0001453593 2013-11-13 0001453593 2012-12-31 0001453593 2011-12-31 0001453593 2012-09-30 0001453593 us-gaap:GeographicConcentrationRiskMember 2013-01-01 2013-09-30 0001453593 us-gaap:GeographicConcentrationRiskMember 2012-01-01 2012-09-30 0001453593 us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-09-30 0001453593 us-gaap:CustomerConcentrationRiskMember 2012-01-01 2012-09-30 0001453593 us-gaap:OtherIntangibleAssetsMember 2013-01-01 2013-09-30 0001453593 us-gaap:BuildingMember 2013-01-01 2013-09-30 0001453593 bone:ComputersAndEquipmentMember us-gaap:MaximumMember 2013-01-01 2013-09-30 0001453593 bone:ComputersAndEquipmentMember us-gaap:MinimumMember 2013-01-01 2013-09-30 0001453593 bone:UnitedStatesMember 2013-01-01 2013-09-30 0001453593 bone:RestOfWorldMember 2013-01-01 2013-09-30 0001453593 bone:UnitedStatesMember 2012-01-01 2012-09-30 0001453593 bone:RestOfWorldMember 2012-01-01 2012-09-30 0001453593 us-gaap:FairValueInputsLevel1Member 2013-09-30 0001453593 us-gaap:FairValueInputsLevel2Member 2013-09-30 0001453593 us-gaap:FairValueInputsLevel3Member 2013-09-30 0001453593 us-gaap:FairValueInputsLevel1Member 2012-12-31 0001453593 us-gaap:FairValueInputsLevel2Member 2012-12-31 0001453593 us-gaap:FairValueInputsLevel3Member 2012-12-31 0001453593 bone:WarrantDerivativeLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2012-12-31 0001453593 bone:WarrantDerivativeLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2013-01-01 2013-09-30 0001453593 bone:WarrantDerivativeLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0001453593 bone:AcquisitionContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2012-12-31 0001453593 bone:AcquisitionContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2013-01-01 2013-09-30 0001453593 bone:AcquisitionContingentConsiderationLiabilityMember us-gaap:FairValueInputsLevel3Member 2013-09-30 0001453593 bone:LincolnParkCapitalFundLlcMember 2012-01-01 2012-03-31 0001453593 us-gaap:InvestorMember 2013-06-01 2013-06-10 0001453593 bone:GrossRevenueEqualsOrExceedsOneMillionMember 2013-09-30 0001453593 bone:GrossRevenueEqualsOrExceedsOneMillionMember 2013-01-01 2013-09-30 0001453593 bone:GrossRevenueEqualsOrExceedsTwoMillionMember 2013-09-30 0001453593 bone:GrossRevenueEqualsOrExceedsTwoMillionMember 2013-01-01 2013-09-30 0001453593 us-gaap:EquipmentMember 2013-09-30 0001453593 us-gaap:BuildingMember 2013-09-30 0001453593 us-gaap:ComputerEquipmentMember 2013-09-30 0001453593 us-gaap:ComputerSoftwareIntangibleAssetMember 2013-09-30 0001453593 us-gaap:FurnitureAndFixturesMember 2013-09-30 0001453593 us-gaap:LeaseholdImprovementsMember 2013-09-30 0001453593 us-gaap:VehiclesMember 2013-09-30 0001453593 us-gaap:BuildingMember 2012-12-31 0001453593 us-gaap:EquipmentMember 2012-12-31 0001453593 us-gaap:ComputerEquipmentMember 2012-12-31 0001453593 us-gaap:ComputerSoftwareIntangibleAssetMember 2012-12-31 0001453593 us-gaap:FurnitureAndFixturesMember 2012-12-31 0001453593 us-gaap:LeaseholdImprovementsMember 2012-12-31 0001453593 us-gaap:VehiclesMember 2012-12-31 0001453593 bone:RosAcquisitionOffshoreMember 2012-08-01 2012-08-24 0001453593 bone:RosAcquisitionOffshoreMember 2013-01-01 2013-09-30 0001453593 bone:MidcapAndSiliconValleyBankMember 2012-04-23 0001453593 bone:RosAcquisitionOffshoreMember 2012-08-24 0001453593 bone:MidcapAndSiliconValleyBankMember 2013-01-01 2013-09-30 0001453593 bone:ValleyBankOfBelgradeMember 2013-01-01 2013-09-30 0001453593 bone:ValleyBankOfBelgradeMember 2013-09-30 0001453593 bone:RosAcquisitionOffshoreMember 2013-09-30 0001453593 bone:RosAcquisitionOffshoreMember 2012-12-31 0001453593 bone:MidcapAndSiliconValleyBankMember 2013-09-30 0001453593 bone:MidcapAndSiliconValleyBankMember 2012-12-31 0001453593 us-gaap:MinimumMember 2013-01-01 2013-09-30 0001453593 us-gaap:MaximumMember 2013-01-01 2013-09-30 0001453593 us-gaap:EmployeeStockOptionMember 2013-09-30 0001453593 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-09-30 0001453593 us-gaap:RestrictedStockMember 2013-01-01 2013-09-30 0001453593 us-gaap:RestrictedStockMember 2012-01-01 2012-09-30 0001453593 us-gaap:RestrictedStockMember 2013-09-30 0001453593 us-gaap:RestrictedStockMember 2013-05-01 2013-05-24 0001453593 us-gaap:RestrictedStockMember 2013-05-24 0001453593 bone:BrokerMember 2012-10-01 2012-12-31 0001453593 bone:BrokerMember 2012-12-31 0001453593 us-gaap:PrivatePlacementMember 2012-07-01 2012-07-23 0001453593 us-gaap:PrivatePlacementMember 2012-07-23 0001453593 us-gaap:BridgeLoanMember 2010-12-31 0001453593 bone:DebtFinancingMember 2010-12-31 0001453593 bone:EquityFinancingMember 2013-09-30 0001453593 bone:LincolnParkCapitalFundLlcMember 2013-06-30 0001453593 bone:LincolnParkCapitalFundLlcMember 2012-03-31 0001453593 bone:WarrantDerivativeLiabilityMember 2012-12-31 0001453593 bone:WarrantDerivativeLiabilityMember 2011-12-31 0001453593 bone:WarrantDerivativeLiabilityMember 2013-01-01 2013-09-30 0001453593 bone:WarrantDerivativeLiabilityMember 2012-01-01 2012-09-30 0001453593 bone:WarrantDerivativeLiabilityMember 2013-09-30 0001453593 bone:WarrantDerivativeLiabilityMember 2012-09-30 0001453593 bone:RosAcquisitionOffshoreMember 2013-01-01 2013-09-30 0001453593 bone:RosAcquisitionOffshoreMember 2012-01-01 2012-09-30 0001453593 bone:SeaarkCapitalLlcMember 2013-01-01 2013-09-30 0001453593 bone:SeaarkCapitalLlcMember 2012-01-01 2012-09-30 0001453593 bone:AmericanDonorServicesMember 2013-09-30 0001453593 bone:MrGodfreyMember 2013-01-01 2013-09-30 0001453593 bone:WestCoastTissueServicesMember 2013-01-01 2013-09-30 0001453593 bone:WestCoastTissueServicesMember 2012-01-01 2012-09-30 0001453593 bone:AmericanDonorServicesMember 2013-01-01 2013-09-30 0001453593 bone:AmericanDonorServicesMember 2012-01-01 2012-09-30 0001453593 bone:MrCookMember 2013-01-01 2013-09-30 0001453593 bone:FortySevenEqualMonthlyInstallmentMember 2013-01-01 2013-09-30 0001453593 bone:OneFinalInstallmentMember 2013-01-01 2013-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:USD bone:Warrant xbrli:pure 10-Q false 2013-09-30 2013 Q3 BONE 51744136 Bacterin International Holdings, Inc. 0001453593 --12-31 Smaller Reporting Company 1297335 1576955 0.000001 0.000001 5000000 5000000 0 0 0 0 0.000001 0.000001 95000000 95000000 51781044 51781044 42877770 42877770 4926066 3437549 4633067 7154065 13228383 13141421 486685 353271 21785684 25574823 1238225 1238225 5320992 5234867 563524 592378 728618 728618 1401854 1126643 31038897 34495554 3225377 3997789 555361 418922 1814472 2400090 2223332 984356 165844 149729 820500 698408 47018 45135 8851904 8694429 119543 245703 6639435 6839935 16064064 14483102 31674946 30263169 0 0 52 43 55558330 51897890 -56194431 -47665548 -636049 4232385 31038897 34495554 7710256 8643299 24430158 24427853 219727 236466 385480 430185 7929983 8879765 24815638 24858038 3318327 2600452 10011687 6788606 4611656 6279313 14803951 18069432 2764328 2439229 7877697 7349852 4053679 3352394 12057389 11333946 97923 88112 304771 302392 43153 186867 11924 491051 6959083 6066602 20251781 19477241 -2347427 212711 -5447830 -1407809 1197370 867894 3436006 1276946 -849288 -125972 246337 1393155 17551 -1738202 108616 -1544035 -2029107 -2732068 -3081053 -1427826 -4376534 -2519357 -8528883 -2835635 0 0 0 0 0 0 0 0 -4376534 -2519357 -8528883 -2835635 -0.08 -0.06 -0.18 -0.07 -0.08 -0.06 -0.18 -0.07 51616319 42796244 46611358 42341796 51616319 42796244 46611358 42341796 586771 577145 917153 228505 603058 1114846 1197669 136637 500 -7902 246337 1393155 91740 358426 -970971 237841 -265396 5092496 -291375 957628 -635973 1316973 -428751 -848488 -5178199 -7809289 1216723 633393 10149 0 -643542 -1216723 0 22741719 34308 9773075 110045 21085 4450002 3899996 27575 43334 4333224 16890889 -1488517 7864877 751111 8615988 0 139228 -78408 50659 0 342485 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Business Description</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements include the accounts of Bacterin International Holdings, Inc., a Delaware corporation, and its wholly owned subsidiary, Bacterin International, Inc., a Nevada corporation, (collectively, the &#8220;Company&#8221; or &#8220;Bacterin&#8221;). All intercompany balances and transactions have been eliminated in consolidation. Bacterin&#8217;s biologics division develops, manufactures and markets biologics products to domestic and international markets.&#160;&#160;Bacterin&#8217;s proprietary methods are used in human allografts to create cell scaffolds and promote bone and other tissue growth.&#160;&#160;These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and regeneration in knee and other joint surgeries.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Bacterin&#8217;s device division develops and licenses coatings for various medical device applications.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">An operating segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise&#8217;s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The primary performance measure used by management is net income or loss. The Company operates in two distinct lines of business consisting of the biologics and devices divisions. However, due to the immaterial revenue from devices to date, the Company reports as one segment.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company's revenue is derived principally from the sale or license of its medical products, coatings and device implants. The markets in which the Company competes are highly competitive and rapidly changing. Significant technological advances, changes in customer requirements, or the emergence of competitive products with new capabilities or technologies could adversely affect the Company's operating results. The Company's business could be harmed by a decline in demand for, or in the prices of, its products or as a result of, among other factors, any change in pricing or distribution model, increased price competition, changes in government regulations or a failure by the Company to keep up with technological change.&#160;&#160;Further, a decline in available tissue donors could have an adverse impact on our business.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying interim condensed consolidated financial statements of Bacterin for the three and nine months ended September 30, 2013 and 2012 are unaudited and are prepared in accordance with accounting principles generally accepted in the United States of America. They do not include all disclosures required by generally accepted accounting principles for annual financial statements, but in the opinion of management, include all adjustments, consisting only of normal recurring items, necessary for a fair presentation. Interim results are not necessarily indicative of results which may be achieved in the future for the full year ending December 31, 2013.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in" align="justify"><font style="FONT-SIZE: 10pt">These financial statements should be read in conjunction with the financial statements and notes thereto which are included in Bacterin&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Concentrations</font></strong><font style="FONT-SIZE: 10pt">&#160;<strong>and Credit Risk</strong></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s accounts receivable are due from a variety of health care organizations and distributors throughout the world. Approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 98</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 97</font>% of sales were in the United States for the nine months ended September 30, 2013 and 2012, respectively. One customer accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6</font>% of the Company&#8217;s revenue for the nine months ended September 30, 2013 and 2012, respectively.&#160;&#160;One customer represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 19</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21</font>% of gross accounts receivable at September 30, 2013 and 2012, respectively. The Company provides for uncollectible amounts when specific credit issues arise. Management believes its estimate for uncollectible amounts have been adequate during prior periods, and management believes that all significant credit risks have been identified at September 30, 2013.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenue by geographical region is as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>United States</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,285,028</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,084,836</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>Rest of World</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>530,610</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>773,202</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,815,638</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,858,038<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Use of Estimates</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period; the carrying amount of property and equipment and intangible assets; valuation allowances for trade receivables and deferred income tax assets; valuation of the warrant derivative liability; inventory reserve; contingent consideration from acquisitions; royalty liability; and estimates for the fair value of stock options grants and other equity awards upon which the Company determines stock-based compensation expense. Actual results could differ from those estimates.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Cash and Cash Equivalents</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company considers all highly liquid investments purchased with an original maturity date of three months or less to be cash equivalents.&#160;&#160;Cash equivalents are recorded at cost, which approximates market value. At times the Company maintains deposits in financial institutions in excess of federally insured limits.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounts Receivable</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts receivable represents amounts due from customers for which revenue has been recognized. Normal terms on trade accounts receivable are net 30 days and some customers are offered discounts for early pay.&#160;&#160; The Company performs credit evaluations when considered necessary, but generally does not require collateral to extend credit.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables. The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance, general economic conditions that may affect a customer's ability to pay and management judgment. Actual customer collections could differ from estimates. Account balances are charged to the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Provisions to the allowance for doubtful accounts are charged to expense. The Company does not have any off-balance sheet credit exposure related to its customers.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounts Payable - Related Party</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts payable to a related party includes amounts due to American Donor Services, a supplier of donors to the Company. See Note 14, &#8220;Related Party Transactions&#8221; below.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"> Inventories</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">&#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Inventories are stated at the lower of cost or market.&#160;&#160;Cost is determined using the specific identification method and includes materials, labor and overhead. The Company calculates an inventory reserve for estimated obsolescence or excess inventory based on historical usage and sales, as well as assumptions about future demand for its products. These estimates for excess and obsolete inventory are reviewed and updated on a quarterly basis. Increases in the inventory reserves result in a corresponding expense, which is generally recorded to cost of tissue and medical devices sales. Inventories where the sales cycle is estimated to be beyond twelve months are classified as Non-current inventories.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Property and Equipment</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to seven years for computers and equipment, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> years for buildings. Leasehold improvements are depreciated over the shorter of their estimated useful life or the remaining term of the lease. Repairs and maintenance are expensed as incurred.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <i><font style="FONT-SIZE: 10pt">&#160;</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Warrant derivative liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(246,337)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>New warrants issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,485,313</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(91,740)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.98 0.97 0.05 0.06 0.19 0.21 0.01 P15Y 0.01 16800000 0.167 13800000 50000 P30Y P7Y 0 P3Y <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Goodwill</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in" align="justify"><font style="FONT-SIZE: 10pt">Goodwill represents the excess of costs over fair value of assets of businesses acquired. Goodwill and intangible assets acquired in a purchase business combination and determined to have indefinite useful lives are not amortized, instead are tested for impairment at least annually and whenever events or circumstances indicate the carrying amount of the asset may not be recoverable. In its evaluation of goodwill, the Company performs an assessment of qualitative factors to determine if it is more-likely-than-not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment. The Company conducts its annual impairment test on December 31 of each year.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Derivative Instruments</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company accounts for its derivative instruments in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 815 &#8220;Accounting for Derivative Instruments and Hedging Activities&#8221;. The only derivative instruments presented in the accompanying consolidated financial statements relates to warrants issued in connection with certain debt financings. The Company has not designated its warrant derivative liability as a hedging instrument as described in ASC 815 and any changes in the fair market value of the warrant derivative liability are recognized in the consolidated statement of operations during the period of change. See Note 10, &#8220;Warrants&#8221; below.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Intangible Assets</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Intangible assets with estimable useful lives must be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment whenever events or circumstances indicate their carrying amount may not be recoverable. Intangible assets include trademarks, customer lists and patents and include costs to acquire and protect Company patents. Intangible assets are carried at cost less accumulated amortization. The Company amortizes these assets on a straight-line basis over their estimated useful lives of five years for customer lists and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> years for all other intangible assets.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Revenue Recognition</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Revenue is recognized when all of the following criteria are met: a) the Company has entered into a legally binding agreement with the customer; b) the products or services have been delivered; c) the Company's fee for providing the products and services is fixed or determinable; and d) collection of the Company&#8217;s fee is probable.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s policy is to record revenue net of any applicable sales, use, or excise taxes.&#160;&#160;If an arrangement includes a right of acceptance or a right to cancel, revenue is recognized when acceptance is received or the right to cancel has expired.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company ships to certain customers under consignment arrangements whereby the Company&#8217;s product is stored by the customer.&#160;&#160;The customer is required to report the use to the Company and upon such notice, the Company invoices the customer and revenue is recognized when above criteria has been met.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company also receives royalty revenue from third parties related to licensing agreements. The Company has royalty agreements with Nufix, RyMed and Bard Access Systems. Revenue under these agreements represented less than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1</font></font></font></font>% of total revenue for the three and nine months ended September 30, 2013 and 2012.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Non-Cash Consulting Expense</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in"> <font style="FONT-SIZE: 10pt">From time to time, the Company issues restricted stock awards to consultants and advisors to the Company. These awards are measured at fair value at each reporting date, recognized ratably over the vesting period and are recorded in non-cash consulting expense.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Research and Development</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Research and development costs, which are principally related to internal costs for the development of new technologies and processes for tissue and coatings, are expensed as incurred and included in general and administrative expenses.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Income Taxes</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company accounts for income taxes under the asset and liability method of accounting for deferred taxes as prescribed under FASB ASC 740, Accounting for Income Taxes.&#160;&#160;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When applicable, a valuation allowance is established to reduce any deferred tax asset when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the statement of operations or accrued on the balance sheet. See Note 12, &#8220;Income Taxes&#8221; below.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Long-Lived Assets</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. No impairment was recorded during the nine months ended September 30, 2013 or 2012.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Net Loss Per Share</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in"> <font style="FONT-SIZE: 10pt">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Diluted net income (loss) per share is computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares outstanding during the period, which include the assumed exercise of stock options and warrants using the treasury stock method.&#160; Diluted net loss per share was the same as basic net loss per share for the nine months ended September 30, 2013 and 2012 and the three months ended September 30, 2013 and 2012 as shares issuable upon the exercise of stock options and warrants were anti-dilutive as a result of the net losses incurred for those periods.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Stock-Based Compensation</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company records stock-compensation expense according to the provisions of ASC 718.&#160;&#160;Under ASC 718, stock-based compensation costs are recognized based on the estimated fair value at the grant date for all stock-based awards.&#160;&#160;The Company estimates grant date fair values using the Black-Scholes-Merton option pricing model, which requires assumptions of the life of the award and the stock price volatility over the term of the award.&#160;&#160;The Company records compensation cost of stock-based awards using the straight line method, which is recorded into earnings over the vesting period of the award. Pursuant to the income tax provisions included in ASC 718-740, the Company has elected the &#8220;short cut method&#8221; of computing its hypothetical pool of additional paid-in capital that is available to absorb future tax benefit shortfalls.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Recent Accounting Pronouncements</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"></font></strong>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">There are no recently issued accounting standards for which the Company expects a material impact to its consolidated financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.01 0.01 0 0 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Business Description and Summary of Significant Accounting Policies</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Business Description</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements include the accounts of Bacterin International Holdings, Inc., a Delaware corporation, and its wholly owned subsidiary, Bacterin International, Inc., a Nevada corporation, (collectively, the &#8220;Company&#8221; or &#8220;Bacterin&#8221;). All intercompany balances and transactions have been eliminated in consolidation. Bacterin&#8217;s biologics division develops, manufactures and markets biologics products to domestic and international markets.&#160;&#160;Bacterin&#8217;s proprietary methods are used in human allografts to create cell scaffolds and promote bone and other tissue growth.&#160;&#160;These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and regeneration in knee and other joint surgeries.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Bacterin&#8217;s device division develops and licenses coatings for various medical device applications.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">An operating segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise&#8217;s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The primary performance measure used by management is net income or loss. The Company operates in two distinct lines of business consisting of the biologics and devices divisions. However, due to the immaterial revenue from devices to date, the Company reports as one segment.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company's revenue is derived principally from the sale or license of its medical products, coatings and device implants. The markets in which the Company competes are highly competitive and rapidly changing. Significant technological advances, changes in customer requirements, or the emergence of competitive products with new capabilities or technologies could adversely affect the Company's operating results. The Company's business could be harmed by a decline in demand for, or in the prices of, its products or as a result of, among other factors, any change in pricing or distribution model, increased price competition, changes in government regulations or a failure by the Company to keep up with technological change.&#160;&#160;Further, a decline in available tissue donors could have an adverse impact on our business.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying interim condensed consolidated financial statements of Bacterin for the three and nine months ended September 30, 2013 and 2012 are unaudited and are prepared in accordance with accounting principles generally accepted in the United States of America. They do not include all disclosures required by generally accepted accounting principles for annual financial statements, but in the opinion of management, include all adjustments, consisting only of normal recurring items, necessary for a fair presentation. Interim results are not necessarily indicative of results which may be achieved in the future for the full year ending December 31, 2013.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in" align="justify"><font style="FONT-SIZE: 10pt">These financial statements should be read in conjunction with the financial statements and notes thereto which are included in Bacterin&#8217;s Annual Report on Form 10-K for the year ended December 31, 2012. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Concentrations</font></strong><font style="FONT-SIZE: 10pt">&#160;<strong>and Credit Risk</strong></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s accounts receivable are due from a variety of health care organizations and distributors throughout the world. Approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 98</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 97</font>% of sales were in the United States for the nine months ended September 30, 2013 and 2012, respectively. One customer accounted for approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">6</font>% of the Company&#8217;s revenue for the nine months ended September 30, 2013 and 2012, respectively.&#160;&#160;One customer represented <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 19</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21</font>% of gross accounts receivable at September 30, 2013 and 2012, respectively. The Company provides for uncollectible amounts when specific credit issues arise. Management believes its estimate for uncollectible amounts have been adequate during prior periods, and management believes that all significant credit risks have been identified at September 30, 2013.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenue by geographical region is as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>United States</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,285,028</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,084,836</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>Rest of World</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>530,610</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>773,202</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,815,638</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,858,038<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period; the carrying amount of property and equipment and intangible assets; valuation allowances for trade receivables and deferred income tax assets; valuation of the warrant derivative liability; inventory reserve; contingent consideration from acquisitions; royalty liability; and estimates for the fair value of stock options grants and other equity awards upon which the Company determines stock-based compensation expense. Actual results could differ from those estimates.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Cash and Cash Equivalents</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company considers all highly liquid investments purchased with an original maturity date of three months or less to be cash equivalents.&#160;&#160;Cash equivalents are recorded at cost, which approximates market value. At times the Company maintains deposits in financial institutions in excess of federally insured limits.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounts Receivable</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts receivable represents amounts due from customers for which revenue has been recognized. Normal terms on trade accounts receivable are net 30 days and some customers are offered discounts for early pay.&#160;&#160; The Company performs credit evaluations when considered necessary, but generally does not require collateral to extend credit.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables. The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance, general economic conditions that may affect a customer's ability to pay and management judgment. Actual customer collections could differ from estimates. Account balances are charged to the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Provisions to the allowance for doubtful accounts are charged to expense. The Company does not have any off-balance sheet credit exposure related to its customers.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounts Payable - Related Party</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accounts payable to a related party includes amounts due to American Donor Services, a supplier of donors to the Company. See Note 14, &#8220;Related Party Transactions&#8221; below.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"> Inventories</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">&#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Inventories are stated at the lower of cost or market.&#160;&#160;Cost is determined using the specific identification method and includes materials, labor and overhead. The Company calculates an inventory reserve for estimated obsolescence or excess inventory based on historical usage and sales, as well as assumptions about future demand for its products. These estimates for excess and obsolete inventory are reviewed and updated on a quarterly basis. Increases in the inventory reserves result in a corresponding expense, which is generally recorded to cost of tissue and medical devices sales. Inventories where the sales cycle is estimated to be beyond twelve months are classified as Non-current inventories.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Property and Equipment</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to seven years for computers and equipment, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> years for buildings. Leasehold improvements are depreciated over the shorter of their estimated useful life or the remaining term of the lease. Repairs and maintenance are expensed as incurred.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Goodwill</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in" align="justify"><font style="FONT-SIZE: 10pt">Goodwill represents the excess of costs over fair value of assets of businesses acquired. Goodwill and intangible assets acquired in a purchase business combination and determined to have indefinite useful lives are not amortized, instead are tested for impairment at least annually and whenever events or circumstances indicate the carrying amount of the asset may not be recoverable. In its evaluation of goodwill, the Company performs an assessment of qualitative factors to determine if it is more-likely-than-not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment. The Company conducts its annual impairment test on December 31 of each year.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Derivative Instruments</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company accounts for its derivative instruments in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 815 &#8220;Accounting for Derivative Instruments and Hedging Activities&#8221;. The only derivative instruments presented in the accompanying consolidated financial statements relates to warrants issued in connection with certain debt financings. The Company has not designated its warrant derivative liability as a hedging instrument as described in ASC 815 and any changes in the fair market value of the warrant derivative liability are recognized in the consolidated statement of operations during the period of change. See Note 10, &#8220;Warrants&#8221; below.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Intangible Assets</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Intangible assets with estimable useful lives must be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment whenever events or circumstances indicate their carrying amount may not be recoverable. Intangible assets include trademarks, customer lists and patents and include costs to acquire and protect Company patents. Intangible assets are carried at cost less accumulated amortization. The Company amortizes these assets on a straight-line basis over their estimated useful lives of five years for customer lists and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">15</font> years for all other intangible assets.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 27.5pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenue Recognition</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Revenue is recognized when all of the following criteria are met: a) the Company has entered into a legally binding agreement with the customer; b) the products or services have been delivered; c) the Company's fee for providing the products and services is fixed or determinable; and d) collection of the Company&#8217;s fee is probable.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s policy is to record revenue net of any applicable sales, use, or excise taxes.&#160;&#160;If an arrangement includes a right of acceptance or a right to cancel, revenue is recognized when acceptance is received or the right to cancel has expired.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company ships to certain customers under consignment arrangements whereby the Company&#8217;s product is stored by the customer.&#160;&#160;The customer is required to report the use to the Company and upon such notice, the Company invoices the customer and revenue is recognized when above criteria has been met.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company also receives royalty revenue from third parties related to licensing agreements. The Company has royalty agreements with Nufix, RyMed and Bard Access Systems. Revenue under these agreements represented less than <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1</font></font></font></font>% of total revenue for the three and nine months ended September 30, 2013 and 2012.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Non-Cash Consulting Expense</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in"> <font style="FONT-SIZE: 10pt">From time to time, the Company issues restricted stock awards to consultants and advisors to the Company. These awards are measured at fair value at each reporting date, recognized ratably over the vesting period and are recorded in non-cash consulting expense.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Advertising Costs</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company expenses advertising costs as incurred. The Company had no Advertising expense in the nine months ended September 30, 2013 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> for the nine months ended September 30, 2012.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Research and Development</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Research and development costs, which are principally related to internal costs for the development of new technologies and processes for tissue and coatings, are expensed as incurred and included in general and administrative expenses.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Income Taxes</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company accounts for income taxes under the asset and liability method of accounting for deferred taxes as prescribed under FASB ASC 740, Accounting for Income Taxes.&#160;&#160;Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When applicable, a valuation allowance is established to reduce any deferred tax asset when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the statement of operations or accrued on the balance sheet. See Note 12, &#8220;Income Taxes&#8221; below.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Long-Lived Assets</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. No impairment was recorded during the nine months ended September 30, 2013 or 2012.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Net Loss Per Share</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0in"> <font style="FONT-SIZE: 10pt">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Diluted net income (loss) per share is computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares outstanding during the period, which include the assumed exercise of stock options and warrants using the treasury stock method.&#160; Diluted net loss per share was the same as basic net loss per share for the nine months ended September 30, 2013 and 2012 and the three months ended September 30, 2013 and 2012 as shares issuable upon the exercise of stock options and warrants were anti-dilutive as a result of the net losses incurred for those periods.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Stock-Based Compensation</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company records stock-compensation expense according to the provisions of ASC 718.&#160;&#160;Under ASC 718, stock-based compensation costs are recognized based on the estimated fair value at the grant date for all stock-based awards.&#160;&#160;The Company estimates grant date fair values using the Black-Scholes-Merton option pricing model, which requires assumptions of the life of the award and the stock price volatility over the term of the award.&#160;&#160;The Company records compensation cost of stock-based awards using the straight line method, which is recorded into earnings over the vesting period of the award. Pursuant to the income tax provisions included in ASC 718-740, the Company has elected the &#8220;short cut method&#8221; of computing its hypothetical pool of additional paid-in capital that is available to absorb future tax benefit shortfalls.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Fair Value of Financial Instruments</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The carrying values of financial instruments, including trade accounts receivable, accounts payable, other accrued expenses and long-term debt, approximate their fair values based on terms and related interest rates.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We follow a framework for measuring fair value. The framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 2: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the nine months ended September 30, 2013 and 2012, there was no reclassification in financial assets or liabilities between Level 1, 2 or 3 categories.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accrued stock compensation</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>171,174</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>218,850</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Warrant derivative liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The valuation technique used to measure fair value of the warrant liability is based on a lattice model and significant assumptions and inputs determined by the Company.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 3 Changes</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <i><font style="FONT-SIZE: 10pt">&#160;</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Warrant derivative liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(246,337)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>New warrants issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,485,313</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(91,740)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the nine months ended September 30, 2013, the Company did not change any of the valuation techniques used to measure its liabilities at fair value.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Items measured at fair value on a non-recurring basis:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s royalty liability is carried at its estimated fair value based upon the discounted present value of the payments using an estimated discount rate.&#160; The Company did not have access to a readily traded market for similar credit risks and the estimated interest rate was based upon the Company&#8217;s estimate of a market interest rate to obtain similar financing.&#160; The Company originally discounted the $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">16.8</font> million of estimated payments at an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16.7</font>%. This was adjusted to an estimated royalty total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13.8</font> million as of December 31, 2012 and was not adjusted in the first nine months of 2013.&#160; Accordingly, these inputs are classified as Level 3 inputs.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Recent Accounting Pronouncements</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt"></font></strong>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">There are no recently issued accounting standards for which the Company expects a material impact to its consolidated financial statements.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Fair Value of Financial Instruments</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The carrying values of financial instruments, including trade accounts receivable, accounts payable, other accrued expenses and long-term debt, approximate their fair values based on terms and related interest rates.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We follow a framework for measuring fair value. The framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 2: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the nine months ended September 30, 2013 and 2012, there was no reclassification in financial assets or liabilities between Level 1, 2 or 3 categories.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accrued stock compensation</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>171,174</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>218,850</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt">&#160;</font></div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Warrant derivative liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The valuation technique used to measure fair value of the warrant liability is based on a lattice model and significant assumptions and inputs determined by the Company.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Level 3 Changes</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <i><font style="FONT-SIZE: 10pt">&#160;</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Warrant derivative liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(246,337)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>New warrants issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,485,313</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></i></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Gain recognized in earnings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(91,740)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="70%"> <div>Balance at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the nine months ended September 30, 2013, the Company did not change any of the valuation techniques used to measure its liabilities at fair value.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Items measured at fair value on a non-recurring basis:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s royalty liability is carried at its estimated fair value based upon the discounted present value of the payments using an estimated discount rate.&#160; The Company did not have access to a readily traded market for similar credit risks and the estimated interest rate was based upon the Company&#8217;s estimate of a market interest rate to obtain similar financing.&#160; The Company originally discounted the $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">16.8</font> million of estimated payments at an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16.7</font>%. This was adjusted to an estimated royalty total of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13.8</font> million as of December 31, 2012 and was not adjusted in the first nine months of 2013.&#160; Accordingly, these inputs are classified as Level 3 inputs.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Accrued stock compensation</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>171,174</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>218,850</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"></font><font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Warrant derivative liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>984,356</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Acquisition contingent consideration liability</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 85%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>As&#160;of</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 2</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="56%"> <div>Level 3</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> </tr> </table> </div> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Revenue by geographical region is as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="23%" colspan="5"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="11%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>United States</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,285,028</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,084,836</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>Rest of World</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>530,610</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>773,202</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="65%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,815,638</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 3px double; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="10%"> <div>24,858,038</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Advertising Costs</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company expenses advertising costs as incurred. The Company had no Advertising expense in the nine months ended September 30, 2013 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">50,000</font> for the nine months ended September 30, 2012.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 24285028 530610 24084836 773202 171174 0 0 218850 0 0 0 0 2223332 0 0 984356 0 0 0 0 0 91740 984356 -246337 1485313 2223332 91740 -91740 0 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Equity</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">During the first quarter of 2012, we issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,475,037</font> shares of our common stock to Lincoln Park Capital for aggregate proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,899,996</font>. We used the proceeds for working capital and general corporate purposes.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On June 10, 2013, the Company issued approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 8.51</font> million shares of common stock to new and existing investors at a price per share of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.57</font>, which represented a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% discount to the closing price on June 4, 2013. For each common share purchased in the offering, investors received a warrant providing the right to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.5</font> shares of Bacterin common stock at an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.72</font>, a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15</font>% premium to the June 4, 2013 closing price. The warrants will be exercisable for seven years beginning 6 months from the date of issuance. The transaction resulted in net proceeds to Bacterin International of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.45</font> million, after deducting approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">400,000</font> of placement agent&#8217;s fees and offering expenses. Proceeds from the transaction will be used to fund the Company's operations and working capital requirements.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1475037 3899996 8510000 0.57 0.1 0.5 0.72 0.15 4450000 400000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Acquisition</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In 2011, the Company acquired the assets of a medical devices company. As part of the purchase agreement, we agreed to pay an additional $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font> in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1</font> million, and an additional $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">500,000</font> in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2</font> million, provided that such gross revenue thresholds were achieved within <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2</font> years. The revenue thresholds were not achieved within 2 years of the asset acquisition, so no additional stock issuances were required.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The initial valuation of the contingent consideration was based upon management&#8217;s estimates of the probability of reaching the milestones that would trigger the requirement to pay the contingent amounts. During 2013, management reviewed and adjusted the assumptions associated with the contingent liability which resulted in an elimination of the contingent liability as of June 30, 2013.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> P2Y 500000 1000000 500000 2000000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Inventories</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 27.5pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Inventories consist of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Current inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Raw materials</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,978</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,919,250</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Work in process</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,176,764</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,991,032</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Finished goods</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>8,004,314</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,350,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,405,056</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,260,614</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Reserve</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(1,176,673)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(1,119,193)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-LEFT: 11px" width="71%"> <div>Current inventories, total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>13,228,383</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>13,141,421</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Non-current inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Finished goods</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-LEFT: 11px" width="71%"> <div>Non-current inventories, total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,466,608</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,379,646</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Inventories consist of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Current inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Raw materials</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,223,978</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,919,250</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Work in process</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,176,764</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,991,032</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Finished goods</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>8,004,314</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,350,332</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,405,056</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,260,614</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Reserve</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(1,176,673)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(1,119,193)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-LEFT: 11px" width="71%"> <div>Current inventories, total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>13,228,383</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>13,141,421</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Non-current inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Finished goods</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left; PADDING-LEFT: 11px" width="71%"> <div>Non-current inventories, total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,238,225</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total inventories</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,466,608</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>14,379,646</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 2223978 1919250 4176764 4991032 8004314 7350332 14405056 14260614 1176673 1119193 1238225 1238225 14466608 14379646 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Property and Equipment, Net</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Property and equipment, net are as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Buildings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,653,263</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,653,263</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Equipment</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,761,079</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,172,523</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Computer equipment</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>312,650</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>312,650</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Computer software</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>395,146</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>392,206</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Furniture and fixtures</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>170,118</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>170,118</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Leasehold improvements</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,808,461</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,793,756</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Vehicles</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>41,099</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>78,306</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total cost</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>10,141,816</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>9,572,822</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Less: accumulated depreciation</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(4,820,824)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(4,337,955)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,320,992</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,234,867</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company leases certain equipment under capital leases. For financial reporting purposes, minimum lease payments relating to the assets have been capitalized. As of September 30, 2013, the Company has recorded $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">549,603</font> gross assets in Equipment, and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">142,307</font> of accumulated depreciation relating to assets under capital leases.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Maintenance and repairs expense for the first nine months of 2013 and 2012 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">198,986</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">204,947</font>, respectively.&#160;&#160;Depreciation expense related to property and equipment, including property under capital lease for the first nine months of 2013 and 2012 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">530,020</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">516,162</font> respectively.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Property and equipment, net are as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Buildings</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,653,263</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,653,263</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Equipment</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,761,079</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,172,523</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Computer equipment</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>312,650</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>312,650</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Computer software</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>395,146</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>392,206</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Furniture and fixtures</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>170,118</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>170,118</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Leasehold improvements</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,808,461</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,793,756</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Vehicles</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>41,099</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>78,306</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total cost</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>10,141,816</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>9,572,822</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Less: accumulated depreciation</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(4,820,824)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(4,337,955)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,320,992</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>5,234,867</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 198986 204947 530020 516162 549603 142307 10141816 9572822 1653263 5761079 312650 395146 170118 1808461 41099 1653263 5172523 312650 392206 170118 1793756 78306 4820824 4337955 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Intangible Assets</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Bacterin has applied for various patents with regards to processes for its products.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table sets forth information regarding intangible assets:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Intellectual Property</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Gross carrying value</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>848,675</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>820,778</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Accumulated amortization</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(285,151)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(228,400)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Net carrying value</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>563,524</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>592,378</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Aggregate amortization expense:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>56,750</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Estimated amortization expense:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Remainder of 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>18,729</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2016</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2017</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Thereafter</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>245,123</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>563,524</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table sets forth information regarding intangible assets:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Intellectual Property</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Gross carrying value</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>848,675</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>820,778</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Accumulated amortization</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(285,151)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(228,400)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Net carrying value</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>563,524</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>592,378</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Aggregate amortization expense:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>56,750</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Estimated amortization expense:</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Remainder of 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>18,729</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2014</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2015</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2016</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>2017</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>74,918</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Thereafter</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>245,123</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Total</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>563,524</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 848675 820778 285151 228400 56750 74918 18729 74918 74918 74918 74918 245123 563524 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Accrued Liabilities</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Accrued liabilities consist of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Acquisition contingent liability</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Accrued stock compensation</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>171,174</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>218,850</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Wages/commissions payable</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,129,555</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,013,909</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Other accrued expenses</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>513,743</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,075,591</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,814,472</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,400,090</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Accrued liabilities consist of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 100%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Acquisition contingent liability</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>91,740</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Accrued stock compensation</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>171,174</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>218,850</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Wages/commissions payable</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,129,555</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,013,909</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>Other accrued expenses</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>513,743</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,075,591</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="71%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,814,472</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2,400,090</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0 91740 171174 218850 1129555 1013909 513743 1075591 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Long-term debt consists of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Loan payable to ROS Acquisition Offshore, LIBOR plus 12.13% maturing August 2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,000,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,000,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Adjustment fee payable to ROS Acquisition Offshore August 2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>700,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>6.00% loan payable to Valley Bank of Belgrade, $10,746 monthly payments including interest, maturing December 24, 2030; secured by building</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,387,112</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,421,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>22,087,112</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>21,421,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Less: Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(47,018)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(45,135)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Debt discount</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(5,976,030)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(6,893,183)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Long-term debt</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>16,064,064</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>14,483,102</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following is a summary of maturities due on the debt as of September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>11,357</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>47,727</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>50,670</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,720,463</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>6,723,781</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>13,533,114</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>22,087,112</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following is a summary of estimated future royalty payments as of September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>197,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>853,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,050,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,289,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,384,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>8,477,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>13,250,000 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> The facility allowed borrowings based upon a predetermined formula of up to 80% of Bacterin's eligible accounts receivable, as defined in the credit and security agreement. The Company also amended its existing Loan and Security Agreement with MidCap to allow the Company to borrow up to an additional $3 million in connection with a permitted acquisition. The credit facility carried an interest rate of LIBOR plus 4%, subject to a LIBOR floor rate of 2.5%. The Company also agreed to pay a 0.5% collateral management fee on the average outstanding balance of the facility and 1% of the average unused portion of the facility, as well as a 1% origination fee. LIBOR plus 12.13%, subject to a LIBOR floor rate of 1.0%. LIBOR plus 12.13% maturing August 2019 The Company did not achieve the $8.5 million revenue in the second quarter of 2013 for which we received a waiver, in exchange, the Company agreed to pay a fee of $400,000 when the Company pays, prepays or is required to pay any principal amount of the loan. In addition, the Company did not hire a Chief Executive Officer within 90 days of the resignation of the prior Chief Executive Officer for which we received a waiver in exchange for Board observer rights. 7341520 13800000 1500000 750000 300000 5000000 20000000 5000000 10000000 45000000 royalty of 1.75% on the first $45,000,000 of net sales, plus 1.0% of net sales in excess of $45,000,000 for each of the next ten years 3000000 10746 0.0600 2030-12-24 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> (8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Long-term Debt</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On April 2<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font>, 2012, the Company secured an accounts receivable credit facility with Midcap Financial LLC and Silicon Valley Bank. The revolving loan credit facility allowed Bacterin to borrow up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> million through January 1, 2015. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The facility allowed borrowings based upon a predetermined formula of up to 80% of Bacterin's eligible accounts receivable, as defined in the credit and security agreement. The Company also amended its existing Loan and Security Agreement with MidCap to allow the Company to borrow up to an additional $3 million in connection with a permitted acquisition. The credit facility carried an interest rate of LIBOR plus 4%, subject to a LIBOR floor rate of 2.5%. The Company also agreed to pay a 0.5% collateral management fee on the average outstanding balance of the facility and 1% of the average unused portion of the facility, as well as a 1% origination fee.</font> We repaid the outstanding balance owed on this credit facility in full with the proceeds from our credit facility with ROS Acquisition Offshore LP (&#8220;ROS&#8221;) on August 24, 2012.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On August 24, 2012, the Company entered into a Credit Agreement with ROS, whereby ROS agreed to provide an initial $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">20</font> million term loan and Bacterin may also borrow an additional $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5</font> million upon achievement of certain revenue objectives prior to December 31, 2013. The loan carries an interest rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> LIBOR plus 12.13%, subject to a LIBOR floor rate of 1.0%.</font> Bacterin also agreed to pay a <font style=" ">royalty of 1.75% on the first $45,000,000 of net sales, plus 1.0% of net sales in excess of $45,000,000 for each of the next ten years</font>. Bacterin has the right to repay the loan and royalty interest at amounts to be determined based on the date of repayment and the amount of prior principal, interest and royalty payments. The loan is secured by substantially all of our assets. The estimate of the royalty component of the facility over the life of the agreement resulted in a debt discount and a royalty liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7,341,520</font>. The debt discount will be amortized to interest expense over the seven year term of the loan using the effective interest method. The royalty liability will be accreted to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">13.8</font> million through interest expense over the ten year term of the royalty agreement using the effective interest method. Payments made under the royalty agreement, per the table below, will directly reduce the royalty liability.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company received net proceeds of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10</font> million following repayment of the existing term loan and accounts receivable credit facility with MidCap Financial, including prepayment penalties. The Company used the net proceeds for working capital and general corporate purposes.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On May 16, 2013, we entered into an amendment to our Credit Agreement with ROS, whereby ROS agreed to reduce our minimum liquidity requirement from $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,500,000</font> to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">750,000</font> until September 30, 2013. In exchange, we agreed to pay a fee of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font> required to be paid pursuant to the Credit Agreement or other loan documents which is recorded in Long-term debt and in Other long term assets which will be amortized to interest expense over the term of the debt.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">There were two compliance violations of covenants in the ROS Credit Agreement in the second quarter of 2013. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company did not achieve the $8.5 million revenue in the second quarter of 2013 for which we received a waiver, in exchange, the Company agreed to pay a fee of $400,000 when the Company pays, prepays or is required to pay any principal amount of the loan. In addition, the Company did not hire a Chief Executive Officer within 90 days of the resignation of the prior Chief Executive Officer for which we received a waiver in exchange for Board observer rights.</font></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Long-term debt consists of the following:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Loan payable to ROS Acquisition Offshore, LIBOR plus 12.13% maturing August 2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,000,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>20,000,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Adjustment fee payable to ROS Acquisition Offshore August 2019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>700,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>6.00% loan payable to Valley Bank of Belgrade, $10,746 monthly payments including interest, maturing December 24, 2030; secured by building</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,387,112</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,421,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>22,087,112</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>21,421,420</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Less: Current portion</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(47,018)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(45,135)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Debt discount</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(5,976,030)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(6,893,183)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="71%"> <div>Long-term debt</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>16,064,064</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>14,483,102 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following is a summary of maturities due on the debt as of September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>11,357</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>47,727</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>50,670</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,720,463</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>6,723,781</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>13,533,114</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>22,087,112 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following is a summary of estimated future royalty payments as of September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>197,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>853,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,050,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,289,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>1,384,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>8,477,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="85%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>13,250,000 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 700000 0 20000000 20000000 1387112 1421420 22087112 21421420 5976030 6893183 11357 47727 50670 1720463 6723781 13533114 22087112 197000 853000 1050000 1289000 1384000 8477000 13250000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Activity under our stock option plans was as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%" colspan="8"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%" colspan="8"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average&#160;Fair</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average&#160;Fair</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value&#160;at&#160;Grant</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value&#160;at&#160;Grant</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Date</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Date</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Outstanding at January 1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>5,266,535</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>4,828,910</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.14</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>3,331,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.63</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>1,105,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(230,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.06</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(39,375)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.87</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Cancelled or expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(729,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(1,152,250)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Outstanding at September 30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>7,638,785</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.49</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>4,742,285</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Exercisable at September 30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>2,531,534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.98</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>2,242,118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The following table summarizes restricted stock award activity during the period ended September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 75%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Outstanding at Jan. 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>733,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Awarded</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Cancelled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(112,500)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(164,500)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>456,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 622648 0.0168 P6Y4M24D 0.626 0 0.1700 0.200 667175 799941 132766 5107251 0.80 11924 491051 160021 P3Y P5Y P1Y 335000 227800 0.68 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Stock-Based Compensation</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Our Equity Incentive Plan ("The Plan") provides for stock awards, including options and performance stock awards, to be granted to employees, consultants, independent contractors, officers and directors. The purpose of the Plan is to enable us to attract, retain and motivate key employees, directors and consultants, by providing them with stock options and restricted stock grants. Stock options granted under the Plan may be either incentive stock options to employees, as defined in Section 422A of the Internal Revenue Code of 1986, or non-qualified stock options. The Plan is administered by the compensation committee of our Board of Directors. The administrator of the Plan has the power to determine the terms of any stock options granted under the Plan, including the exercise price, the number of shares subject to the stock option and conditions of exercise. Stock options granted under the Plan are generally not transferable, vest in installments over the requisite service period and are exercisable during the stated contractual term of the option only by such optionee. The exercise price of all incentive stock options granted under the Plan must be at least equal to the fair market value of the shares of common stock on the date of the grant. Nine million shares are authorized under the Plan and at September 30, 2013, we had approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 622,648</font> shares available for issuance. Shares issued under the Plan may be authorized, but unissued, or reacquired shares.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Stock compensation expense recognized in the statement of operations for the nine months ended September 30, 2013 and 2012 is based on awards ultimately expected to vest and reflects an estimate of awards that will be forfeited. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The estimated fair value of stock options granted is done using the Black-Sholes-Merton method applied to individual grants. The Company utilizes historical employee termination behavior to determine the estimated forfeiture rates. If the actual forfeitures differ from those estimated by management, adjustments to compensation expense will be made in future periods. Assumed forfeiture rates range from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 17.00</font>% to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20.00</font>% for the first nine months of 2013.</font></div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Key assumptions used to estimate the fair value of stock awards are as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="8%"> <div style="clear:both;MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt">&#8901;</font></div> </td> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 92%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="92%"> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Risk-Free Rate: The risk-free rate is determined by reference to U.S. Treasury yields at or near the time of grant for time periods similar to the expected term of the award. We used a weighted-average rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.68</font>% for the nine months ended September 30, 2013.</font></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="8%"> <div style="clear:both;MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt">&#8901;</font></div> </td> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 92%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="92%"> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Expected Term: We do not have adequate history to estimate an expected term of stock-based awards, and accordingly, we use the short-cut method as prescribed by Staff Accounting Bulletin 107 to determine an expected term. We used a weighted-average expected term of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 6.4</font> years for the nine months ended September 30, 2013.</font></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="8%"> <div style="clear:both;MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt">&#8901;</font></div> </td> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 92%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="92%"> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Volatility: We estimate expected volatility based on peer-companies as prescribed by ASC 718. We used a weighted-average volatility rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 62.6</font>% for the nine months ended September 30, 2013.</font></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="8%"> <div style="clear:both;MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt">&#8901;</font></div> </td> <td style="BORDER-BOTTOM: #ece9d8; BORDER-LEFT: #ece9d8; PADDING-BOTTOM: 0in; BACKGROUND-COLOR: transparent; PADDING-LEFT: 0in; WIDTH: 92%; PADDING-RIGHT: 0in; BORDER-TOP: #ece9d8; BORDER-RIGHT: #ece9d8; PADDING-TOP: 0in" valign="top" width="92%"> <div style="clear:both;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Dividend Yield: The dividend yield assumption is based on our history and expectation of dividend payouts and was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0</font>% for the nine months ended September 30, 2013.</font></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Activity under our stock option plans was as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%" colspan="8"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="33%" colspan="8"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average&#160;Fair</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average&#160;Fair</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value&#160;at&#160;Grant</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Value&#160;at&#160;Grant</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Date</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="9%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Date</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Outstanding at January 1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>5,266,535</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.02</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>4,828,910</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.14</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>3,331,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.63</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.53</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>1,105,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(230,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.06</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(39,375)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.87</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.37</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Cancelled or expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(729,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.90</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>(1,152,250)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.01</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Outstanding at September 30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>7,638,785</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.49</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="8%"> <div>4,742,285</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.11</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="31%"> <div>Exercisable at September 30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>2,531,534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.98</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="8%"> <div>2,242,118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.77</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0.76</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 27.5pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The aggregate intrinsic value of options outstanding as of September 30, 2013 is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">799,941</font>. The aggregate intrinsic value of exercisable options as of September 30, 2013 is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">132,766</font>. As of September 30, 2013, there were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,107,251</font> unvested options with a weighted average fair value at the grant date of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.80</font> per option. As of September 30, 2013, compensation expense related to nonvested awards not yet recognized was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">667,175</font>.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In addition, on May 24, 2013, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 335,000</font> restricted stock awards to certain employees. These restricted shares vest after one year and were issued when the stock price was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.68</font> per share. The total expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">227,800</font> is recognized ratably over the vesting period in General and Administrative and Sales and Marketing Expenses.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">From time to time we may grant stock options and restricted stock grants to consultants. We account for consultant stock options in accordance with ASC 505-50. Consulting expense for the grant of stock options to consultants is determined based on the estimated fair value of the stock options at the measurement date as defined in ASC 505-50 and is recognized over the vesting period.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes restricted stock award activity during the period ended September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 75%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Outstanding at Jan. 1, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>733,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Awarded</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Cancelled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(112,500)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Vested</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>(164,500)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="60%"> <div>Outstanding at September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>456,900</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The restricted stock awards generally vest over three to five year periods. The Company recognized reduction of non-cash consulting expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11,924</font> for the first nine months of 2013 and expense of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">491,051</font> for the nine months ended September 30, 2012. As of September 30, 2013, the total expense related to nonvested restricted stock awards not yet recognized is $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">160,021</font> and is expected to be recognized over three years.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 5266535 4828910 3331250 1105000 230000 39375 729000 1152250 7638785 4742285 2531534 2242118 2.02 2.14 0.63 2.00 0.10 0.87 1.78 2.01 1.49 2.11 2.03 1.77 1.03 1.01 0.53 1.19 0.06 0.37 0.90 0.78 0.86 1.04 0.98 0.76 733900 0 112500 164500 456900 1485313 297991 2.30 300895 1.03 342485 1570565 375000 4254387 246337 97828 143700 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table summarizes our warrant activities for the nine months ended September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Weighted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Average</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Exercise</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Shares</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Price</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Outstanding at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,321,667</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2.20</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,352,215</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>0.72</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Exercised</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Expired</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(533,173)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2.00</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Outstanding at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,140,709</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1.63</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The estimated fair value was derived using the lattice model with the following weighted-average assumptions:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 76%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="26%" colspan="6"> <div>Nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="26%" colspan="6"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Value of underlying common stock (per share)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.68</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>1.55</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Risk free interest rate</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.72</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.38</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Term to expiration/implied expected life</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>5.96 years</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>4.15 years</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Dividend yield</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Volatility</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>63</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>62</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The following table summarizes our activities related to number of warrants used in the derivative liability for the nine months ended September 30, 2013 and 2012:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Balance at January 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,649,707</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,506,007</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Derivative warrants issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,352,215</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>143,700</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Derivative warrants exercised</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Balance at September 30</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,001,922</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,649,707</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (10)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In the fourth quarter of 2012, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 297,991</font> warrants with an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.30</font> to a broker in conjunction with the August 24, 2012 financing arrangement with ROS. These were recorded in &#8220;Other Assets&#8221; and will be amortized over the life of the financing term. In addition, on July 23, 2012 the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 300,895</font> warrants with an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.03</font> to a private party resulting in $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">342,485</font> recorded in &#8220;Other Expense&#8221;.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes our warrant activities for the nine months ended September 30, 2013:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Weighted</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Average</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Exercise</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Shares</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>Price</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Outstanding at January 1, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>7,321,667</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2.20</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,352,215</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>0.72</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Exercised</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Expired</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right" width="12%"> <div>(533,173)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>2.00</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Outstanding at September 30, 2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>11,140,709</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1.63</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We utilize a lattice model to determine the fair market value of the warrants accounted for as liabilities. The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,570,565</font> warrants issued in connection with a 2010 bridge financing, the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 375,000</font> warrants issued in connection with a 2010 debt financing and the <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,254,387</font> warrants issued in connection with the second quarter 2013 equity financing were accounted for as derivative liabilities in connection with the price protection provisions of the warrants in compliance with ASC 815. The warrants issued in the second quarter of 2013 resulted in a warrant derivative liability of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,485,313</font> as of the issuance on June 5, 2013. There were an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 143,700</font> warrants in the first quarter of 2012 as a result of the LPC share issuance triggering the anti-dilution clause in the original warrant agreement and an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 97,828</font> related to the second quarter of 2013 equity financing. The lattice model accommodates the probability of exercise price adjustment features as outlined in the warrant agreements. We recorded an unrealized gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">246,337</font> resulting from the change in the fair value of the warrant derivative liability for the first nine months of 2013. Under the terms of the warrant agreement, at any time while the warrant is outstanding, the exercise price per share can be reduced to the price per share of future subsequent equity sales of our common stock or common stock equivalents that is lower than the exercise price per share as stated in the warrant agreement.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The estimated fair value was derived using the lattice model with the following weighted-average assumptions:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 76%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="26%" colspan="6"> <div>Nine&#160;months&#160;ended</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="26%" colspan="6"> <div>September&#160;30,</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="12%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Value of underlying common stock (per share)</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.68</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>$</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>1.55</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Risk free interest rate</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.72</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0.38</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Term to expiration/implied expected life</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>5.96 years</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>4.15 years</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Dividend yield</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>0</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="48%"> <div>Volatility</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>63</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="11%"> <div>62</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>%</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes our activities related to number of warrants used in the derivative liability for the nine months ended September 30, 2013 and 2012:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT-SIZE: 10pt; MARGIN: 0in 0in 0pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; WIDTH: 100%; TEXT-INDENT: 0in"> <table style="OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: #9eb6ce 0px solid; MARGIN: 0in; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2013</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: center" width="13%" colspan="2"> <div>2012</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Balance at January 1</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,649,707</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,506,007</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Derivative warrants issued</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>4,352,215</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>143,700</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Derivative warrants exercised</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ccffcc; BORDER-BOTTOM: #000000 1px solid; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>-</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ccffcc; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="61%"> <div>Balance at September 30</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>6,001,922</div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160;</div> </td> <td style="FONT-SIZE: 10pt; BORDER-TOP: #000000 1px solid; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: bottom; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: right; PADDING-RIGHT: 5px" width="12%"> <div>1,649,707 <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; VERTICAL-ALIGN: middle; BACKGROUND: #ffffff; FONT-WEIGHT: 400; FONT-STYLE: normal; TEXT-ALIGN: left" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 4352215 7321667 0 533173 11140709 2.20 1.63 0.72 0 2.00 0.68 1.55 0.0072 0.0038 0 0 0.63 0.62 P5Y11M16D P4Y1M24D 1649707 1506007 4352215 143700 0 0 6001922 1649707 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (11)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Commitments and Contingencies</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Operating Leases</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We lease two office facilities under non-cancelable operating lease agreements with expiration dates in 2019 and 2023. We have the option to extend both the leases for another ten year term and for one facility, we have the right of first refusal on any sale. We lease an additional office facility under a month-to-month arrangement. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Future minimum payments for the next five years and thereafter as of September 30, 2013, under these leases, are as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>61,599</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>269,400</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>823,730</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,944,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Rent expense was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">204,180</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">234,316</font> for the nine months ended September 30, 2013 and 2012, respectively. Rent expense is determined using the straight-line method of the minimum expected rent paid over the term of the agreement. We have no contingent rent agreements.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Indemnifications</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Our arrangements generally include limited warranties and certain provisions for indemnifying customers against liabilities if our products or services infringe a third-party's intellectual property rights. To date, we have not incurred any material costs as a result of such warranties or indemnifications and have not accrued any liabilities related to such obligations in the accompanying financial statements.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We have also agreed to indemnify our directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person's service as a director or officer, including any action by us, arising out of that person's services as our director or officer or that person's services provided to any other company or enterprise at our request.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> Litigation</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On January 29, 2013, we received two warning letters from the Food and Drug Administration (&#8220;FDA&#8221;): one related to our procedures to ensure compliance with regulatory requirements regarding the production of medical devices; and one related to our procedures to ensure compliance with regulatory requirements regarding the production of human tissue cellular products (H/TCP). We responded to both warning letters and, on April 17, 2013, we received two letters from FDA in which the agency stated that it was in receipt of our response letters and found that the corrective actions in those letters appeared to be adequate. The letters also stated, however, that the corrections would be further evaluated in conjunction with our operations during the next inspection of our facilities. FDA conducted two follow-up inspections as a result of the warning letters of our facilities in July 2013: one inspection focused on our production of medical devices and one inspection focused on our production of H/TCPs. At the conclusion of the inspection focused on medical devices, no Form 483 was issued. At the conclusion of the inspection focused on H/TCPs, FDA issued a one-item Form 483, to which we responded, and we are in the process of providing further updates to FDA. FDA also conducted a routine inspection focused on H/TCPs in July 2013 and issued two observations on a Form 483. We have fully responded to that Form 483. On September 19, 2013, we received a letter from FDA indicating that, based on a review of our corrective actions, it appears we have addressed the violations contained in the warning letter regarding our production of medical devices.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Market Exchange Notification</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style=" ">On May 13, 2013, we received a deficiency notice from the New York Stock Exchange (&#8220;Exchange&#8221;) notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders&#8217; equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders&#8217; equity of less than $4,000,000 and net losses in three of our four most recent fiscal years.</font> On June 12, 2013 we submitted a plan to regain compliance with the continued listing requirements, and on June 21, 2013 the Exchange informed us of the acceptance of our plan and gave us an extension until November 13, 2014 to regain compliance with the continued listing standards. We will be subject to periodic review by Exchange staff during the extension period and failure to make progress consistent with our Plan or to regain compliance with the continued listing standards by the end of the extension period could result in our delisting from the Exchange.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 204180 234316 On May 13, 2013, we received a deficiency notice from the New York Stock Exchange (Exchange) notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders equity of less than $4,000,000 and net losses in three of our four most recent fiscal years. <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Future minimum payments for the next five years and thereafter as of September 30, 2013, under these leases, are as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Remainder of 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>61,599</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>269,400</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>263,136</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Thereafter</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>823,730</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>1,944,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 61599 269400 263136 263136 263136 823730 1944137 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> (12)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income Taxes</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In evaluating the realizability of the net deferred tax assets, we take into account a number of factors, primarily relating to the ability to generate taxable income. Where it is determined that it is likely that we will be unable to realize deferred tax assets, a valuation allowance is established against the portion of the deferred tax asset. Because it cannot be accurately determined when or if we will become profitable, a valuation allowance was provided against the entire deferred income tax asset balance.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The 2008 through 2012 tax years remain open to examination by the Internal Revenue Service and the 2006 to 2012 tax years remain open to the Montana Department of Revenue.&#160; These taxing authorities have the authority to examine those tax years until the applicable statute of limitations expire.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company did not recognize any interest or penalties related to income taxes for the nine months ended September 30, 2013 and 2012.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Supplemental cash flow information is as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Supplemental disclosure of cash flow information</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Cash paid during the period for:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,436,006</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>815,031</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Non-cash activities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>ROS adjustment fee</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>700,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Settlement of SeaArk accounts receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,829,647</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Inventory received in SeaArk settlement</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>409,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Write-off of SeaArk allowance for doubtful accounts</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,419,809</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Net shares issued for non-cash consulting expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>157,561</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Capital lease acquisition</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>408,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Issuance of warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>220,872</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Non-cash accrued compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>304,680</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Debt discount related to financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,341,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Royalty liability related to financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,341,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160; <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (13)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Supplemental Disclosure of Cash Flow Information</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 31.9pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Supplemental cash flow information is as follows:</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>Nine&#160;months&#160;ended</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%" colspan="5"> <div>September&#160;30,</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Supplemental disclosure of cash flow information</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Cash paid during the period for:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,436,006</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>815,031</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Income taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Non-cash activities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>ROS adjustment fee</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>700,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Settlement of SeaArk accounts receivable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,829,647</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Inventory received in SeaArk settlement</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>409,838</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Write-off of SeaArk allowance for doubtful accounts</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,419,809</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Net shares issued for non-cash consulting expense</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>157,561</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Capital lease acquisition</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>408,257</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Issuance of warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>220,872</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Non-cash accrued compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>304,680</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Debt discount related to financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,341,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="75%"> <div>Royalty liability related to financing</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>7,341,520</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 3436006 815031 0 0 700000 0 1829647 0 409838 0 0 157561 0 408257 0 0 220872 0 7341520 0 304680 0 7341520 1419809 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (14)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 31.9pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Guy Cook, our former President and Chief Executive Officer, formerly served as a board member of West Coast Tissue Services (&#8220;WCTS&#8221;) and American Donor Services (&#8220;ADS&#8221;). Mr. Cook did not received any compensation for his board service for either entity as of the date of his resignation. Mitchell Godfrey, a director, is on the board of ADS and also serves as secretary and treasurer for ADS. Mr. Godfrey receives $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5,000</font> annually for his service to ADS.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">ADS and WCTS recover tissue from donors.&#160; We reimburse them for their recovery fees, which are comprised primarily of labor costs.&#160;The approximate aggregate amount of all transactions with WCTS for the first nine months of 2013 and 2012 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">577,200</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">389,500</font>, respectively, and the approximate aggregate amount of all transactions with ADS for the first nine months of 2013 and 2012 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,558,360</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,004,036</font>, respectively. These relationships benefit us as these entities provide us with donors, thus insuring that we have a pipeline of current and future donors, which is necessary to our success. As of September 30, 2013, we had an accounts payable balance of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">555,361</font> to American Donor Services.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 29.7pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On June 27, 2012, the Board of Directors granted a waiver of certain provisions of the Company&#8217;s Code of Conduct to allow an entity controlled by two of our former CEO&#8217;s adult children to become a distributor of the Company&#8217;s products.&#160; This entity acquired inventory from Allograft Tissue Management, a non-affiliated distributor that had previously acquired inventory from the Company.&#160; The affiliated distributor, Silver Forest Fund, LP, exchanged products initially purchased from the non-affiliated distributor with Bacterin for different Bacterin products of equivalent value. Other than product exchanges and payment of amounts owed by the non-affiliated distributor, there have been no other direct transactions between Bacterin and the affiliated distributor. Mr. Cook pledged <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,850,000</font> of his shares of Bacterin stock as collateral for loans made to the affiliated distributor by independent third parties.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On April 5, 2013, Guy Cook resigned from his roles of Chief Executive Officer, President and Chairman of the Board effective immediately. The Board unanimously voted to have Kent Swanson, an existing independent director, serve as Acting Chairman of the Board. Our current Chief Financial Officer, John Gandolfo, and our Chief Operating Officer, Darrel Holmes, served as interim Co-Chief Executive Officers until the Board appointed Daniel Goldberger as the new Chief Executive Officer on August 14, 2013. Mr. Goldberger received inducement grant stock options to purchase up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2,000,000</font> shares of the Company's common stock, with a per share exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.60</font>, which was the closing price of the Company&#8217;s common stock on the August 14, 2013 grant date. The option will vest over five years, with <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 20</font>% of the underlying shares vesting after one year and the remaining eighty percent (<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80</font>%) vesting in forty-seven (47) equal monthly installments as to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 33,334</font> underlying shares, beginning September 15, 2014, and one final installment as to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 33,302</font> underlying shares.</font></div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 555361 5000 577200 389500 1558360 1004036 1850000 2000000 0.60 0.2 0.8 33334 33302 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> (15)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsequent Events</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.1pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.1pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> On November 5, 2013, the United States Patent and Trademark Office issued US Patent No. 8,574,825 entitled &#8220;Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors&#8221; to the Company.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The issued claims in the patent are for a method to produce a demineralized cancellous bone matrix, such as</font> <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; COLOR: #323133; FONT-SIZE: 10pt"> Bacterin&#8217;s OsteoSponge&#174; product line.</font> <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font> Bacterin has a pending divisional application in the United States to pursue protection on other aspects of its bone demineralization technology and is pursuing protection on related applications in Canada, Europe, and Korea.</font></font>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.1pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> </font></font>&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 1.1pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> </font></font> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0in 0in 0pt"> <font style="FONT-FAMILY:times new roman,times,serif"><font style="FONT-SIZE: 8pt"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 29mpokbjhzodtek; COLOR: black">On November 14, 2013, the Company received a waiver from ROS for failure to achieve $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10.5</font> million of revenue in the third quarter of 2013. In exchange for the waiver and reduction of future quarterly minimum revenue thresholds, the Company agreed to issue <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,500,000</font> shares of restricted stock to ROS by December 2, 2013. If the Company does not or is unable to issue the restricted shares by December 2, 2013, the Company</font> <font style="FONT-FAMILY: 38rryoynknfsajr; COLOR: black">agreed to pay an additional exit fee in the amount equal to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3.5</font>% of the aggregate principal amount of the loan.</font></font></font></font></div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 10500000 0.035 1500000 EX-101.SCH 9 bone-20130930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - Business Description and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Acquisition link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Property and Equipment, Net link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Intangible Assets link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Long-term Debt link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Supplemental Disclosure of Cash Flow Information link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Business Description and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Business Description and Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Accrued Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Long-term Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Warrants (Tables) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 1) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 2) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 3) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 4) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Equity (Details Textual) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Acquisition (Details Textual) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Property and Equipment, Net (Details) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Property and Equipment, Net (Details Textual) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Accrued Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Long-term Debt (Details) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Long-term Debt (Details 1) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Long-term Debt (Details 2) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Long-term Debt (Details Textual) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Stock-Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 151 - Disclosure - Stock-Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 152 - Disclosure - Warrants (Details) link:presentationLink link:definitionLink link:calculationLink 153 - Disclosure - Warrants (Details 1) link:presentationLink link:definitionLink link:calculationLink 154 - Disclosure - Warrants (Details 2) link:presentationLink link:definitionLink link:calculationLink 155 - Disclosure - Warrants (Details Textual) link:presentationLink link:definitionLink link:calculationLink 156 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 157 - Disclosure - Commitments and Contingencies (Details Textual) link:presentationLink link:definitionLink link:calculationLink 158 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) link:presentationLink link:definitionLink link:calculationLink 159 - Disclosure - Related Party Transactions (Details Textual) link:presentationLink link:definitionLink link:calculationLink 160 - Disclosure - Subsequent Events (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 bone-20130930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 bone-20130930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 bone-20130930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 bone-20130930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2013
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
(12)           Income Taxes
 
In evaluating the realizability of the net deferred tax assets, we take into account a number of factors, primarily relating to the ability to generate taxable income. Where it is determined that it is likely that we will be unable to realize deferred tax assets, a valuation allowance is established against the portion of the deferred tax asset. Because it cannot be accurately determined when or if we will become profitable, a valuation allowance was provided against the entire deferred income tax asset balance.
 
The 2008 through 2012 tax years remain open to examination by the Internal Revenue Service and the 2006 to 2012 tax years remain open to the Montana Department of Revenue.  These taxing authorities have the authority to examine those tax years until the applicable statute of limitations expire.
 
The Company did not recognize any interest or penalties related to income taxes for the nine months ended September 30, 2013 and 2012.
XML 15 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details 1) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Value of underlying common stock (per share) $ 0.68 $ 1.55
Risk free interest rate 0.72% 0.38%
Term to expiration/implied expected life 5 years 11 months 16 days 4 years 1 month 24 days
Dividend yield 0.00% 0.00%
Volatility 63.00% 62.00%
EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!'07DC,`(``!LD```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VLMNVS`0!=!]@?Z#P&UA MT7RY:6$[BSZ6;8"F'\!*8UNP1`HDD]I_7TI.@B!P'1@UT+N1((N;B;#3S MZUW7%O<48N/=@HERR@IRE:\;MUZPG[=?)U>LB,FZVK;>T8+M*;+KY=LW\]M] M3['(NUU8^T7]<'/EX$Q<.,OR_L?"9 M.21(#@620X/D,"`Y9B`YWH/DN`+)\0$DAYBB!$$15:"0*E!,%2BH"A15!0JK M`L55@0*K0)%5HL@J4625*+)*%%DEBJP215:)(JM$D56BR"I19%4HLBH4616* MK`I%5H4BJT*15:'(JE!D52BR*A19-8JL&D56C2*K1I%5H\BJ4635*+)J%%DU MBJP:15:#(JM!D=6@R&I09#4HLAH460V*K`9%5H,BJT&1=?:_9$UY](+X>/UW M4\4CEX@&>USZ5(X]PW`3?QSS,$NC\ M4WB<5AEV3_IY=C;%]XI)2;8M?[J+*+BQJZE/PC8C0= M3Q0+\>QRI9$P4P>J/OH\^;*W-$UO M>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O M;VLN>&UL+G)E;',@H@0!**```0`````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````"\FLMNVS`01?<%^@\"][7,&5))BLC9!`6R;=,/$&SZ@=B2(#)M_?#[W M^:W_OWFWW1[6X;%;OYY"F_[R'N7/;GB)^Q!2WK09=B'59ER*Y>45JXN[8?G#0#X[M!P?]X&?U MPSBB3VX8E]ZF=@^G=L^>VCVF8+I?EY2=$GV6+P6(Q ML$EL(8F%36*!)!8VB0626-DD5DAB97>WPO9V;!([2&+')K'#)&;/QQ[.Q^R; M@^_-K&(8A3W)85QZ=SA4!+N.81E;-I$M)+)E$]E"(@L;@0(1J/32@;6C["Y7 MV.:.C4`'$>C9DZ"'DZ"PAPN!PX5C,]E!)GOVG.SAG%S-2N68SL?\;=?T<>3E M>.R3X<>#;LMH9=;=E&L-`(PC:"0",(VP@"C:#LTE%8.XYM!`>-X-FSEH>S MEF4+RD)!*9N!"B'HV()R4%!^5D&-ST^3H\:E]T&PO=V]R:V)O;VLN>&ULE)A;;^)($(7?5]K_@/R^`_@")$HR(H'5(F4RT<). M'JV.W4`KOHV[/9!_O]40S&FWXTF>H#!]NNKT5V7#U==]FO1^\5**/+MVAE\& M3H]G41Z+;'/M_+?Z^Z^)TY.*93%+\HQ?.Z]<.E]O_OSC:I>7+\]Y_M(C@4Q> M.UNEBLM^7T9;GC+Y)2]X1E?6>9DR16&YZ,$7IRZTHI'-SM18)_W&LJ,>*XH&EE/<^<7H) MDVH>"\7C:R>@,-]QXX.R*FXKD=#5"V_@.?V;NLC'LA?S-:L2M:+R3NKDE^N[ M[DA_4UOQ0_"=/"_286__)+(XW^FODK6O=>11`KO#I2<1JRU='PP&]6?_<+'9 MJM.')-\'_8.#M,_AM9<=RCLY$DZS.)QG2JC7<)$=W1>2GH M3;F(ASIQ5+G[_C";/RSGLY#>+;_?+V;3%06WT_OIP]T<5%Q0<3^G0@G4R7@@ M<_#[`\DL5Y33-TS&!Q7_@\F\J6`R9'[M3-"4N:VDR+B4X8S+J!2%YBVDK@B7 M59HR*&F$!A_(P)KF/RLZ&?PZ.CEN[CJ-Z/M2Z,UP#=HV::Y99+^H,_)24*.> MG1ZA21?--8\EM6M)R.B*=(Z%[J[P@2N40(.&@Z;&(J,IL1'/"0^G4G)E[#X" M;X<6=M,H*BL>A_>"/8N$RC53'^-BB[;[/-LH7J9T,L]&NC2XZO,<6G0M51Z] MW#))V][E*0TK>9@A6.\%"EA@/;&R9)E1YI@Z_+REQ1#MDPJEG94'H^]RZM-L M0^/6+'B,"`TMAA8TGE,>KMC>L&F,)`TME)95420TNNB4DG`F9)3DLBIYF*_# M.X9G-4:ZAA9>_^IA2Z8],LW+BBR0+#I,7[!NC+0-+=R6U;/D/RN-V%S#:FR/ ME-'(;$RH[C[$=AXC5D/J3'RYUK\0;_1F1#^1C4(H6M!^'[?:2G, M`5ET+1:MWK,SF2";KL5F2PNV:""8Q]L>#C>C$UM6(Z"N#6A[0[;H(*"N!>BI M+UL6(I6N165G>X9P&!-$U+,0[>XT1'2"B'J?1)1H#RXNENI)A(9+CB>U4Q>O@\K\>9X%G\PCV_2P0'@F>QC$/I+1/(P,=90$&C M@HZI1%JH@_/`M_CMUL%&\)%?"AH)V>.MI28DU[?(;9MO+2)(K6]1:PZXEN7( MJF^QVKH\-'Q`1GV+T78!\JYFRT]N$&R"@%OUEIG&N`<%+PN[5&QLAD8#'9 MS+AEX$P0BL#"LON^9YP"XAE8>'8+&349&5F8=M]!#2$$-;!`??]A5;,*H`8( M*@6-`[(>6(W)##HCY)0"TND?FI-^KDA_!/VB?X@?+Y[^1;GY'P``__\# M`%!+`P04``8`"````"$`K!X@Q2$'```J'```&````'AL+W=O;.JSL4)KNRK^IBW\+-^63?GNLAWW4W'PUHP%JZ/>7GRK(6' M^D=L5/M]N2W2:OMV+$ZM-5(7A[R%^3>OY;FY6#MN?\3<,:^_O)V7V^IX!A// MY:%LOW=&O<5Q^_#YY535^?,!='_C?KZ]V.Y^3,P?RVU=-=6^78&YM9WH5'.T MCM9@Z>EQ5X("L^R+NMAOO(_\(9/<6S\]=@OT3UF\-\[_%\UK]?Y+7>Y^*T\% MK#;XR7C@N:J^&/3SS@S!S>O)W9\Z#_Q1+W;%/G\[M']6[[\6Y[]G7CR7`5*":Y"+S%<]&TGTISK[?8OC5M=?S7 M0MW4!R.B-P)W]$:X6`D=\""\;V5M9]0I2?,V?WJLJ_<%A`<\LSGG)MCX`UCN M)?3S&$3!VFX-_='@&T]Y"YAN`Z-?GY1\7'^%1=KV2#R#^!A)+HA9*6,VO0R, M9CF^);L0QA\P]6'^L"K._"_3-*-FFI<'Q'8`C`SS%O@!R910`4;2*4*,9%/" M,8+F+6?G;48A.)QIJA!/(K:([R!DFLE=(KU+9+<(I`,F,K/^9G3CP6H,RZT4 MT6$1;6-(<28"HC1Q"1WZ4D01MI&ZA/!]R7B@,9(11"@=C`&+E$#TSR@QHT0) M>41LD:!3(GBD!)&:($"&?DB4IBX@=>!K1E2X@)&I1Y\C#>&L!C-*-)"5C"UB M-:@(5EJ/J]2E:.(26JM(A>,<;!*[A/`UU"5)EBHC2*"9@R`E4&(<;W1U2;*A M#)FK6!%=LM@B5I&47,N)6UQ"A(SY`4GGU"4X8YR'FO@VLPG71&AVVP2`>91,PM M8W6$41"Q27?!"`O#D(WK:=L+0@3L%[C2$Z^X3^(1^$WX(X/UF)XZH\>V6J2' MI'8,>WQ3ZZR>I9"^\B?-!3&""\7'>?1ZD)7`]Y66M.\C*TON,Z79F%-8C^FM M,WILRX5(&HHNSBI$8 M,HV86\;F#E>!4V[ZFN8"2PY-!'*=:G$9SG3(QU7OK&3H,4L.V<7D%3%B?AO0 M#>-M0$3Z2-PSET+`!-1/LJH)8904+"3N2S$CF88R3)Z5889#Q=%B5(W<(_!6 M@&Z>N\M$&6D+<<_TRGP)NWU)F`0S4(\C&1#U*69@\Z(UK?T99H26\.)PS5<0 M6S.!)\PPWGQ&HX4N(N*>N57D[B/I?22[B6`_S6\-Q'1K$(V>[M58QN]>.FEU MZPW,7DQO7]7R[-U_. MR`M81+(S[AG[J6)Y)1>LG9ZYD@N(N9(+B+F="_,-7TP;/OUN$O?,S5RXNR=( M[UO);B+8/_,-7TP;/KR(XW80]U#4)<.2K1CQ8#(!2#JE%.#$0H8!M6+XC\J6 M8X_"NN;[OICV?D,\<]9'MEP&$S(OFX2;>[&L1`[XY" M^%Z)ER7%3`B?>N3D&UL MC)9=;YLP%(;O)^T_(-\W8+Y"HI"J2=5MTB9-TSZN'3#!*F"$W:;]]SNVTQ`# MHJVB)AQ>OWY\?#AF<_M25\XS[03C38KPPD,.;3*>L^:8HC^_'VX2Y`A)FIQ4 MO*$I>J4"W6X_?]J<>/`CM>\QP@=[O1"?K+Z$E<_79$R4]? M.I9_9PV%;,,^J1TX1%?Y]8+LL4!?$B6GH!]B/D'*B0#TR-14[V)"2O_QD1 M/EL9$_]L$@#F^;Z_\),(1_'[+JXATBNY)Y)L-QT_.5`>,*=HB2HVO`X@A9D* MWJFHO@=4`J+/VRA<;=QG2$9VUNS&&M]6["<4RXO$!8`+!:QM@D)%(57(Z2DB M[V*@27=&$UYK;,5^3F%!P$03$"J:(C"Y@L#V%#NC272B?-]+EA@/8Q*,0=-J*Y#9J5V$"JVXWK!)LF M"$VHK\11*SV+9D&,S[3$!E$-;P+$]$$[(\-B@3-;;:#IISB8:J>V9+*=FF/; M''8M.=(?I#NR1C@5+2`)WF()C:@SA[:YD+S59]Z!2SB#]<\27JXH'(C>`L0% MY_+M0KT67%[7MO\!``#__P,`4$L#!!0`!@`(````(0"`^;N=H@(``'P&```9 M````>&PO=V]R:W-H965T7:,"58!(]MINF^_8YQ0/QYLY1M;QKN2-[F2!_TB+;]]F!I]*FY0X^S9;8WDA>#HO:AK`XSDC+58<#86G> MP]!5I81\T&+7RLX%B)$-=Y"_K55OC[16O`?7/B[PK1)&6UVY"'`D)'I9\X(L")#6JU)!!;[MR,BJ MP'=T>;_`9+T:^O-+R;V=O"-;Z_TGH\HOJI/0;!B3'\!&ZV?Y9J6SN8=NJ7"-V`$ORB5ODM`)7SU^&Y5Z6K"YQD49K' M"64I1AMIW:/R:S$2.^MT^SL$T0,J0-@!`L\#A+*(S5.:9O^GD)#14,D#=WR] M,GJ/8'>`INVYWVMTR:"#PAOOO'7P0586K"_K-$U7Y`6:(0XQ]Y.F&? M3R&X`SN-LSP>M4_RSJZRO77"/F][<`S.:E@<57#6\\US@<08L+& M82R>YY2>GX-P@81CU_.M_,K-5G46-;*"'1E'.0S1A.LC?#C=#Z=OHQW\A*,91Q!<:>V.'_Z"&O\WUG\!``#__P,`4$L#!!0`!@`(````(0!16[Z0 MD`(``'\&```9````>&PO=V]R:W-H965TA-;)/7] M%$DKJ_M7T:(#4YK+KL1Q$&'$.BHKWNU*_/O7YJ[`2!O25:25'2OQ&]/X?OWY MT^HHU8MN&#,(")TN<6-,OPQ#31LFB`YDSSKPU%()8F"I=J'N%2.5VR3:,(FB M>2@([[`G+-5'&+*N.65/DNX%ZXR'*-82`_GKAO?Z1!/T(SA!U,N^OZ-2](#8 M\I:;-P?%2-#E\ZZ3BFQ;./=K/"/TQ':+"[S@5$DM:Q,`+O2)7IYY$2Y"(*U7 M%8<3V+(CQ>H2/\3+QP4.URM7GS^<'?7D'>E&'K\H7GWC'8-B0YML`[92OMC0 MY\J:8'-XL7OC&O!#H8K59-^:G_+XE?%=8Z#;F=U"90M*\(L$MR,`)R>O[GGD ME6E*G,Z#+(_2.,DPVC)M-MSNQ8CNM9'BKP^*!Y2')`,$G@,D3H*DR.)L_G]* MZ#-R)WDBAJQ72AX13`=HZI[868N7"5206N.#M3H?9*7!>EAG6;X*#U`,.L0\ M7L8D8T0(]%$"$IY((%NE-!JEK!<,&$VDBA'DTGGT,;-IS!CQ3@HP$ZG3::RU MQ``9)9(\'0%>PL<4[JSQ(H^B:`QXIP!)7%&P5JM@*Y5$\6SG3EWD:4W MX3`,5^#6.H%G9W#O]O`XR@!^(_7Y5;JU3NCS,[IW#_2D6-RDYU?IUCJAG\^0 M=P_TM)C=I-L;\W),K=72IXT]K[V/&6H_RV]W=G%5PEK/)&PO=V]R:W-H965T-V`2 M((F2K(:8:5=JI:KJY9DA)$$3<`3,9?]]CSE<<@RU=Q^R$_/EV)]OQW%V7S^+ MF_6>574NRKW-%JYM964J3GEYV=M___7\96U;=9.4I^0FRFQO?\]J^^OAYY]V M'Z)ZK:]9UE@0H:SW]K5I[EO'J=-K5B3U0MRS$IZ<154D#;RM+DY]K[+DU'ZH MN#F>ZP9.D>2EC1&VU8_$$.=SGF9ZC%>F/A"N2 MZO7M_B45Q1U"O.2WO/G>!K6M(MU^NY2B2EYNX/W)5DG:QV[?3,(7>5J)6IR; M!81SL*%3YXVS<2#287?*P4!VNU5EY[W]Q+:QM[:=PZ[MH'_R[*-^^-NJK^+C MERH__9:7&?0VC),<@1O67ZY M-C#II)\DOK=#VX+FUE#Z?O#]S> MD7TE`W,L@-8-?+QWH9^&5L;+&E[(V1T1C-$L*)1^`Q#B5A'$"=8#:I3,"K)IZJ2 M,@01,D0I"&ASCC,,);B1B'4$40J(4K]49"E566W4^88,4:'-/!H)CL2ZW378 M$C$[%2'`D_%8E7*Z8[ZDFNAA$1!X& ME`UX)0/C?BN?4B$_&#>3EHF0T0D9"8X$"C%_;FAT,8C09BJT'->-?*H*K>DL MB)#1"1D)CD0W0JT0K236A2`^#,X%Z@@]"+6/%2-?W=PZ2*=D1GB'H-1R;I"T M0:B53*?*O&.;<>(Q3+=TSYYD>H2T6D:$=U61**&ZGN:@842IF&%Z M)F*^DD8BAA!ITE`;YE"^ILPL;HX2:Q&J)7/Q M.$H3+4S59/*%:H*"KQ#27:N%R.-.,-$R1HFU%5$MF9A'K6'R8;ZF.I.]#R&M MCA'A#!$T9NW>-SD]=,Q\3=1'IN<9'\S:U&>R-^A2>[$=TB^A<*54$VMC4!EZ>AAD M9@X-H7I<]8PG@J,9X1T2M$?P5;A>*/XQQ$C^C"MA#7F0*8;2X?>! M)T_>$"OE$=O"!;6\9QX>P&W^/;EDOR?5)2]KZY:=(:2["&'I5'CQCV\:<6_O MU%]$`_?X[9]7^($F@RMN=P'P68BF?R,K&'[R.?P'``#__P,`4$L#!!0`!@`( M````(0`NA]ALY00``,L1```9````>&PO=V]R:W-H965T88 MC)V4S/2A;>Q_#K]S\3EQUE\^ZLIZ9VU7\F9C$\>S+=84?%\VQXW]S]_/#[%M M=7W>[/.*-VQC?V>=_67[ZR_K"V]?NQ-CO046FFYCG_K^_.BZ77%B==XY_,P: MV#GPMLY[>-D>W>[E^"!"+O5LL/&?B*/&26V MNUT/`?JW9)=N]K_5G?CEM[;<_U$V#*(->1(9>.'\54B_[L42O-F]>O?SD($_ M6VO/#OE;U?_%+[^S\GCJ(=V!>$O!*W@2_+;J4M0`N)Y_#'\OY;X_;6P_=(+( M\PD-;.N%=?US*=YK6\5;U_/Z/Q0-Z),1*HW`7VF$!,Z*!E'\,U9\:66EK%"' MQ@$)POLL+OHUQ"/+^WR[;OG%@B(#\NZ,P,=XRA6-W8X+1"B)6_B(F:)4Q4!%@;-`P#W["1S16KF,8) M\297-4PX83!-3 MK)J8D0ZQ0\U2-%&!CCQ0_]J13%/XB?]9B<*9O1%,L6I2Q@8E:I8H42$I(YK, M0S4D)-,4A`1T'F\MFF+$JH8TUJ98-3D3@Q,U2!&%?AR9U9O>561SQ2I:4>BO MTU,TS.0FIE@U,!.CKG:HD;49^"3PC5Z0WE5DFH*N*"$J:1HF@=$X"Z?9F89M M$]CHQ#LI6BH`*4F&4T\=S^BUF;%/E,JP>AQ M%9-A`18'APZK4H0ME2Q-ET&22@G2$"=2-8E-0-N'*O&2^8]2Z^P0GB5VL6U6 ML#JSDAU%(]C*Z!PI6=[/M'WJ$)4&'56,C(4PXT31PVQ.+O@4*OQ!5'&2YB%* M5(QDQ']&G6FV(3^?58L8*0MNX,31W5"F9,11!'%5'R:F@R3943(FQ3-.1T:, M_<^"+D;+`BU.'IW6"...H&B1%B5(ZSG!%>U\GSA$E9A>(F+`+-#B_-%IE2D9 M6Q0MTJ)DI/6,*LN(ON^K].FT8LXLT.(8FM.&Y@>M'4'1(BU*1EK#WTQ:&+=G M;46#I3=&W4J,V2%J3\.VWBA"3]44AE:*QD?%1MS2._N9M@_?'Z@FJJ,NSSEZ M/>="'`$;>O`>3^^$/?$Z6N8[?\```#__P,`4$L#!!0` M!@`(````(0!9Y5-(J0(``*L&```9````>&PO=V]R:W-H965TFT.WZ\Z?54Y(>&M=J92%93#?RJXIUZ M=VORC]@U5#X?NIM<-!U8['C-]9LU15Z3+Q_WK9!T5T/=KSBB^;NW'5S9-SR7 M0HE2S\#.=Z#7-:=^ZH/3>E5PJ,"TW9.LS-`=7FYCY*]7MC^_.3NJBV=/5>+X M1?+B&V\9-!NVR6S`3HAG(WTL3`@6^U>K'^P&?)=>P4IZJ/4/Z"I#\W"6$!(MDI@@;\>4?N!F,?+R@]*B^>-4 M^.3E7,*3RQPX3_/A+$P()HOPORZ^0[*EW%--URLICAX<#\BI.FH.&U[.H86Y M"=Z9J)T#*@71ES7`KOP7Z$9^TFRN->%0L9U0Q+W$!X">`FJ;H#!1Z!7R+BC. M!I9TXS31I:9/817;?RD&$)!H`L)$,P0F/428X&&*C=,DME'!<&Y[.9?B.#K/ M#Y)#!1/)3724/#@;N`XX#;')<8PAQ8C@4A#B)"%GAP$"'*()!!,=(22CC=XX MS0D!ARDA9,0P4`1XG@9IKQA`+"8A3'0,,>\-7!^->TD[NF=/ M5.YYJ[R:E7`$@YFY,J2[;=Q`B\Z^JSNAX>ZPCQ5\%!B\R,$,Q*40^GU@[K/^ M,[/^"P``__\#`%!+`P04``8`"````"$`P.F_TH<#```_"P``&0```'AL+W=O MI\7#O$25`!(^PT[;_?,9,XP7!H;T(87EX>SPR#%U_>RL)[%8W*9;4D M=!(03U29W.7584E^?']^2(FG-*]VO)"56))WH5%'(;0'#I5: MDJ/6]=SW5784)5<368L*KNQE4W(-I\W!5W4C^*Z]J2Q\%@2Q7_*\(N@P;S[C M(??[/!-/,CN5HM)HTHB":^!7Q[Q65[Y/J]-25> MF9?IQ06.5Y?XTRX^+JQ-R!/7?+5HY-F#+@-R57/3LW0^A4ID)OAHHDN2$`_6 MIB#ZNHK"<.&_0DZSBV:-&OBU&MI5;/J**(RLQ@<"BP&I&<`P48-ADFFXUABX M?R:S?JUB,Z!(K*3S2,CCP"--%*I\MRH6WPR0`C7AG>:V*J084W0@P&0`PD27 M!)9B4\OBU*X"(5"3ML5)PS1.7(:.@`5);CF#&IK_+`W3[0!Y, MU$5P5KE&S14AB1S$S?WU))S1WQ3"?%WZKZ*).@V9.$V_1@T4W/:+VPQCBDXA M9H,0)NIF86HKB85`S1@$*C!/-$W8K9\Z"!3F^4`BVK"!,..(!=2I\_IR?0S@ M(D&"D4I0,[GZI6C#=P1.DM>7ZZ,$.!,_)C!S;(``QYO-0>S4@.+U40*4?$Q@ M9M@``8XV2^#.1CHV^G`X7B0?$\`RA@A,V&W&7C.@:#01*$$,%D:4W3JZVX_# M$Q(V#'V.7DN@:)0#)3C)G0F&'+B/P<]V*9J#V(BB4%XF3Q6\\!1>"!NU^Z=' MUNZ`[`78U=3\(+[QYI!7RBO$'FX-)F87T^`&"$^TK-M-P59JV,ZT?X^P417P M]0TF(-Y+J:\G9HMEM[ZK_P$``/__`P!02P,$%``&``@````A`.3)%:X"`P`` M(0@``!D```!X;"]W;W)K&ULC%7;CILP$'VOU'^P M_+[A3D(4LDI8;5NIE:JJEV<'3+`6,+*=S>[?=XR!`%EE]R6!F>,S9RZ,-_J9",US%V%C9&M$YYQNICC/_\?KQ;8205J3-2\IK&^)5*?+_]_&ESYN)) M%I0J!`RUC'&A5+.V+)D6M")RP1M:@R?GHB(*7L71DHV@)&L/5:7EVG9H5835 MV#"LQ4)ZSE#[P]%316AD204NB0+\L6"-[MBK]"%U%Q-.IN4MYU0#%@95, MO;:D&%7I^MNQYH(<2LC[Q?%)VG.W+U?T%4L%ESQ7"Z"SC-#KG",KLH!IN\D8 M9*#+C@3-8[QSUDF$K>VFK<]?1L]R](QDP<]?!,N^LYI"L:%-N@$'SI\T]%NF M37#8NCK]V#;@IT`9S6G_SRQ3 M18R]R.S\[L)=!4X0OL]B M&45M)@]$D>U&\#."Z8"8LB%ZUIPU,'TM5>:-8H4N#-8NT-QA]CAE"MWN068B(&2&Z(T=X80VI# MVH%O3T/M#6;5=L:)5M$JG`*2,<"U_?!C,+3&W$!,Q^MZX?*Q]4[1U5A'_4E)3$8/IFN)'H3TK66(`;ZN<:(@F M&MJ"^)JWC;/3WKF66:B]P70SZKN>?1E!\[T8P"TM9B6;1591<:0)+4N)4GZJ MH>4NR!FLPTVP<_4&F=GW<$.T:]8:'+"X&W*D/X@XLEJBDN9`:2^6,+;"['CS MHGC3KL\#5["RV\<"KF(*&\I>`#CG7/4O>M$-E_OV/P```/__`P!02P,$%``& M``@````A`+L0^9*Y!0``OAT``!D```!X;"]W;W)K&ULC)E=CZLV$(;O*_4_(.Y/^$C(EY(<+1BW1VJEJNK'-4M(@C9`!.QFS[_O M&`.)C3MS]B*;V`]COYZ)>8EW7S^+J_61U4U>E7O;F[FVE95I=_IXU]M?#SS_M[E7]UERRK+4@0MGL[4O;WK:.TZ27K$B: M677+2N@Y5761M/"Q/CO-KKZ#[TULDZ1"[^S`)7^1I7375J9U!.$=.=*IYXVP6\VENO]2Y\??\C*#U88\B0R\5M6;0+\=11-< M[$RNYET&_JBM8W9*WJ_MG]7]URP_7UI(=R`N2:LKC`2O5I&+&@#IR6?W_YX? MV\O>GB]GPWY@6Z]9T_)<7&M;Z7O35L6_$O+Z4#*(WP=9PC3[?G_FKP,O M6-)1'#FC3@E+VN2PJZN[!>4!8S:W1!2;MX7(0L(<%D+.8Q0%:YL*^D7@>WME M6\`UT/IQ6*SG.^<#5BGMF7#*K!8J$@V(6"H1EPT-C[B>>DD\$,,E7#9T:^2` MF%$1K-.3HF'BHE5,?+@\E`T09%3BJR-&4V(5J`B;(EJ0>$KH0?@4\5?C.(JT MN5&::(6L/2E9K+4%#R6S>&(T*1%),)*(28)CA"(5IFK(HFC=V[!@8](6:TU( M*!E,*DDP2:R[`G?'7'2E&C_W!2[\J?T=)5DD$X1BA:84-\TCKLHL/>(WIUS6LMI9+!-),$DT30E^W,6ZXZV<.+OJ.2 M`3E&*/J%HWG<10;=HE77O=%T2V:A)"Y$0TP@S(8J/9R=@`:7<[CB*J9F%`#)JE+U$UZQ[*P\Q+]RV- M:(312$PC'$54Q9`CDV+13+E&3T)HEDF$T5%B&N$HHBH6%N618_UN#$]HTSU; MJZBPAU#EF!.2F[8ARF*CF;G8`&FSX2BB:A>6!=$N'8U:Y[K]\C#;T]YG]ZY23"#%$6&\WAQ@9(FPU'$56[L#*(=NET5.VZ]?1(PQ31"*.1 MF$8XBBC*?;,SZYJI_;R'D`J-:(312$PC'$54Q:HST^OHL(=0[3(.@C`Z2DPC'$54Y6:G MYDL3AN_G/83(B6B$T4A,(QQ%5,4PWZ=<#W`^ABF4D4\BC$9B&N$HHBHV>S-?>JKGG3MP)Y5-&J^HCX.4`>N1L;)=[0813P#- MIG-T$%6MZLO&_$[]6.#JSYAP7"7*'I$2T0CKD5&MIUF?6`=\[3<<<6SV__.0 M:N6QF#Q,*K+ZG$79]=I8:?5>PD\E<_CE=6P=C^->?'$`H[6'WA8.A*;MS-O" MJ0^T.^,%<*AV2\[9[TE]SLO&NF8G&,J=K6"SJ.7YF_S05K?N:.NU:N$XK7M[ M@7/2#(Z:W!G`IZIJAP]B@/'D]?`?````__\#`%!+`P04``8`"````"$`;[=: M'+D#``!]#```&0```'AL+W=OT(2FUP*#RSQ M_#W^><:>S*X_?12Y]\YJR46Y(702$(^5F3CP\K0AW_]]?5H03ZJT/*2Y*-F& M_&22?-K^^69,>>"AE!MR5JI:^;[,SJQ(Y414K`3+4=1%JN"Q/OFR MJEEZ,).*W)\&P=PO4EX2]+"J'_$ACD>>L1>170I6*G12LSQ5P"_/O)(W;T7V MB+LBK=\NU5,FB@I<['G.U4_CE'A%MOIR*D6=[G/8]P<-T^SFVSSF7@QZ"R?[=[%>3@6^U=V#'])*K?\3U,^.GLX)T M1WI*)G)8";Z]@NLS`%M//\S?*S^H\X;,YI,H#F9T&A%OSZ1ZY7HN\;*+5*+X M#T6T<85.IHV3&6`V]F@23J-X\8`7'XG,3EY2E6[7M;AZ<#Q@35FE^K#1U0Q" MF.G!9SVZ(3'Q@$K"Z/LV"J*U_P[!R!K-#C7PW=/,;4URKXG#5N(#0LL!NQO@ MT*.:0X=4@^UPP%XT;CT:33*D6;0::U6(96]53R=P%K11T%88L':X;!TA$&K" MOL96)&,*"P:<]&!NJ="C&P)[ZL),`WN)'6K&(%`1F532,(Z"61L(4X.:90,2.^8$S<-! MLTC@&K@A"74DS2K/VNJ2S!P2U$2+!H6Z04'[`RCZS='=5C<[VNJB=-<-@X(: M)`G#*("/#9N@X@&8I05SBX<>=2&<_>Y0@Z8*!0M'L1N4&889?" M*4Z[1C2\BHE6,BJQ#@G5I>[_4V/,OZLEC6@4""OJL,0&TF6P`VHC@]71KB== M++)7RZ^-H@N@`.@&!=M$&Z,MV`C!7/!F1,8H/`?GH@ M[NVAVOS;%*%H-#)C$AO(+K9MBH:J[%V*4(07>1'1@4L$K8C>T#"K#3)>;.E0 MM75?A(WH5FZCN3X2W<( MO5/!ZA-+6)Y++Q.7$M[,%$I[.]IVG\]3TS^V!N@)J_3$OJ;UB9?2R]D1I@:3 M&!)58_N(#TI4IC/;"P7=H/EYAC:?00<$;U3B'850MP?=H+;_.&Q_`0``__\# M`%!+`P04``8`"````"$`DJBE?N0"```/"```&0```'AL+W=O.!R_/G[SHWCSJI@8^54%TJSC-NDUU1>(P7)":B@8[AK6ZA$/FN6#\7K)]S1OC2!2OJ`'_ M=2E:?62KV25T-55/^_:*R;H%BIVHA'GM2#&JV?JQ:*2BNPKB?HGFE!VYNX\3 M^EHP);7,30!TQ#EZ&O,UN2;`M-UD`B*P:4>*YRF^C=9W48S)=M,EZ+?@!SUX M1[J4A\]*9%]%PR';4"=;@9V43Q;ZF%D3;"8GNQ^Z"GQ7*.,YW5?FASQ\X:(H M#90[L5N8K$`)[J@6M@<@=/K2/0\B,V6*9XL@68:S*$XPVG%M'H3=BQ';:R/K M/PX4]52.).Y)X-F31$DPCY/EZ@(6XCSJ(KFGAFXW2AX0M`=HZI;:9HO6,:20 M6>.MM:9XB1%XI<'ZO$WB:$.>(1FLQ]PY#-P]Y@U!@-U+@,-G)*S52MAL6MD->!.TG\1N`D'&8^Q)R7`,C`960+.PM]=NQJBL%?'WD2 MSSR1DW*8D50\]YA1/-`"_Q&SJU.QQ!,Y,8<9B7G$2&HQDCI6VUK?2YW#7"`! M33.-9I[XU-G5:30+[ZN+QF'L'FB[T%X>,`K&CM'3UK76J<+2$S@%AW$*4:?P M#XGKD<2T#^SJ5&HUD7*8"_(6P?@Y$TYG?J\X/>@2%?O7OB6MBVA0GLC]U./6 MGM:G![U?()B]0[%CNW7F:=ZF)>I!3@3.-7OYU+HV<'/93;.:JX)_XE6E$9/[ M!G[,"/K'6_UY<-L=!\0OP)1N:<&_456(1J.*Y[`U#);P1RDWT-V'D6TW*W?2 MP'SN7DLX>#D,KC``<"ZE.7[8(\,?Y=N_````__\#`%!+`P04``8`"````"$` M=RV>J#0#``!A"0``&0```'AL+W=O/8HCI=(!#XU8NTQ-EO1QSYZ4O' MBN^LH9!MJ).JP)[S1R7]5B@3+/8N5C_T%?C9.04MR5,E?_'35\H.1PGECM22 MG%>P$WPZ-5,]`*&3E_[[Q`IY7+LX7:#0CW'D.GLJY`-32UTG?Q*2U_^T!@V> MM`\\^`B`HUM`P@@[DRWBEK M_PZH!%B?-Q'.5MXSY"(?--M+#385NQE%,DH\`!@I(+89"F5=NQ#O2(&#R4%/ MNM6:\$P3C5OTBMTUA0$!&\U`*"N4ZVP#'*3F%ENM2?M$88R#++$4NW,%RE"& M(W_T84!`)#,0RFI#V/70FJB'"%$2)W$X;J$S82BR#/G!5#$#`IIR!D)9+8AP MBD*70VLT1.K[88!LB'-%$D1^\!Y$/`NAK"9$%-@06J,A4!CZD1_%5BI,"8[] M^`S4R$4RBZ&L)@8.D;G'5FLTQ@V"BL1)8$IVED1UQB0Q,-3(N#RGRFIC3#75 M)=&:(1L!QFF03GOHQC`E*$0AGH(Q,+)9#&4U#VI@E7VK)="!XUFVS^DUA<&` MX)Z>R45OMI-AM\8@&K(!)QECF^.JQ`1YY_+4]YYQ9816RK=(BZZ"7).8(.J. MN^P.&'V7[6$79A#IRPM.2QS'OGU[69H@R>)P.E$:10])/5M:&PO=V]R:W-H M965T`1O,)4HRFF34NR/M2*O5 M7IYIXB2H`XZ`[O3\_98I!U*`G'Y)0OE0/E7'/N"LOGR49^==UDVAJK7+%K[K MR"I7^Z(ZKMU__GY^2ERG:;-JGYU5)=?N3]FX7S:__K*ZJOJU.4G9.I"A:M;N MJ6TO2\]K\I,LLV:A+K*"D8.JRZR%R_KH-9=:9OONIO+L<=^/O#(K*AGXM+4AT6G/JI1YDVJSV M!52@V^[4\K!VO[+ECD>NMUEU#?JWD-?F[K?3G-3UM[K8_U%4$KH-.FD%7I1Z MU=#O>QV"F[W)W<^=`G_6SEX>LK=S^Y>Z_BZ+XZD%N86^)5=GF`D^G;+0:P!* MSSZZ[VNQ;T]K-X@6(O8#QH7KO,BF?2[TO:Z3OS6M*O]#$#.I,`DW20*@:<;Y M@B>"B>AQ%@\9=95\R]ILLZK5U8'E`7,VETPO-K:$S+J$P(=6YGKPJQ[M,!!N M(/J^$0%;>>_0E-Q@ME,,IXC=#"+N(1X0Z=E`C18V>A3HNA)<#-5T4VP1DW0-8SX+6<*B$8M[2"IBGO"A M$L("2IEAH:-C%@F=8HL8T;%X"A/N)SRDD!V%!$&<"M%#"`U8IS,T=)32"(;[ ML1<(018BX'Z:#H6B(`3!@S")AGX2#M$L!QVE',)T5.<6,5!M+]J(YLZ&("1B M0F*\8?3HHR6*&!L9&X*0T4^28??>EJB.THY,ERAB4!86@3!1T`N/LM@0A$0Z M2T)'*0D1C*;8(L;6"1N"D&#@WG>M&.O2#3\2QH!L?*P02H@ZZTT;AF9H]P\# M,ILFCI@?IR-U*(3%7/"ANY2(-KSI(F'H@_=$1##>-P9D[0CFF8=0(M10)Q*A M)<+GL$F#D5=L&8+F9\-U:X500I!FKC,Z3)?N=/\P!*%$\!R/A#]6R(*@-.:] M%=XDQC3$Q%T-"*8:FC;F@7GF(90(-=B)0.B1#P2R&:D1R`:AA*C9]GL(_?%^ MZZ;?F">>0@E0JUV M(A"ZY0.!;)9J"-D@A!"GKGL3J`L_VD$&9!Y!L<_8Z`5F9T-0&O->RZ=>*X+A MW0(%,J#Y[F,_K!!*1)OAX+5C@3AZI5T@`[(2^K3G(!U^*!""C$") MGX31Z-U_UZ5?NS<-TR`6PP:@G8%ZYHCH,"4B@M$ZV'($63MB@U`BU&TG$J%; M/I#(9JEFS=@@E!!UW5XB=$F[R<'I5K"2_9 M4?[(ZF-1-M.K2G0A?5`LGU>[G"?Z"D'!<]!<`/BC5 MWB[TX;G_4V/S/P```/__`P!02P,$%``&``@````A``@]':>7`@``608``!D` M``!X;"]W;W)K&ULC)5=;]L@%(;O)^T_(.[K;SL? MBE.UJ[I5VJ1IVL0_G`-EG&B"?@0GB'[<]U=4B1X0.]YQ^S)`,1)T_=!( MI4AR1'"+R/D#@/LB1?+#]`"7U&PTKNB"7;C58' M!+L#/$U/W%Z+UPE4D+K@C8N6>($19&4@^K0MHG03/D$QZ%%SZS7P'#7QJ`B! M/EI`PC,6+NHL7+65[ZAH=V0F?Q>=6BPG%EYSLBBR=RW<;?FZ1:?] M=E^G5JN)E==XJRPO+IOAC[@_&(+IAGUA76<057L)/8ZAQF-TO%ENDN%R&#_` M@>])PWX0W7!I4,=JF!H%"^B3]G>#'UC5#\=NIRP<]>%G"U&PO=V]R:W-H965T8YC!8#N* MLPJ>IEVIE:JJ?YX)QC:*`0M(LOOM>X<[!N[`7N_N0[)FCL_\N%SF3.#ATY?B M[+QG=9-7Y=85"]]ULC*M]GEYW+K__/U\MW:=IDW*?7*NRFSK?LT:]]/CSS\] M?%3U:W/*LM8!A[+9NJ>VO=Q[7I.>LB)I%M4E*V'D4-5%TL+'^N@UESI+]MV7 MBK,G?3_RBB0O772XK[_'HSH<\C135?I69&6+)G5V3EK@;T[YI;FZ%>GWV!5) M_?IVN4NKX@(6+_DY;[]VIJY3I/>?CV55)R]G..\O8IFD5^_NP\2^R-.Z:JI# MNP`[#T&GY[SQ-AXX/3[L'KD#_YME',_J_TYRJ MCU_K?/][7F90;;A.^@J\5-6KEG[>ZT/P96_R[>?N"OQ9._OLD+R=V[^JC]^R M_'AJX7*'^BMI=8:9X*=3Y+H'X-23+]WOCWS?GK9N$"W"E1\(&;K.2]:TS[G^ MKNND;TU;%?^A2!@K-)'&!'X;$Q$NEC)1" MKD,11K?/R,/J=%5529L\/M35AP.M"N??7!+=^.(>G$TY34WZ`L-U3K7Z2A M^T;UB(1UMC%JX`(,->NGZDYH=U.A.`7!A6ELW,COXO0NOTU7A8+,2FKPX!A7N:*;,>I:"1 M6/9&>,NAA@-%!58YBE9B=#]U%HJS(+0ZSJUE:]3">M2F'6Y=I$4-1SM51"*B MYZRFFF$>`KQA@?6H#;RB4\6HX8!18;K87T32IN4L"*V`7&;JVPW;O';?&A$' M;"178GK"BC6@N#HLOMT.`K.$+FG#;8#]8$0L+OHLNU7"2C3%?I_2ZF`9:*\1 M)C!O"*6T9HF-B*5$'T:B6!?*JD-E8+6C36#FP,]16-C99D0,T.ZV1+$2R@PS MC9C[^NK#5M/*"2N*6%:47)MV84>#X"PHJ$Z1H;@]*(8+;01KEACVO/IL6-"; M$L6Z4%:=(@/KI!$P9&XT`HI8YIL2)3@)9=9Q,C#W]<64H?6=-`(71=V*L1,H MZ1M!6"NV,H+Y\Z6D.D=F2#%>**D5[['@,LB0WI0HUH6RZA096">=@"%SHQ.X M)#+,-R5*WAC1_-5$9B/!7:_>0RZMME*L"47F,TW.9)H< M]AX=3VQ$+#+Z(+((Y"JR-PVL"476R?/MSI!ZV*ZR-5ML1"PR^B!R*/R5#"=E M1LF\"V76"68QCS;H4@]3YND.W8CF9S.=@3[7/;JU5U*L`^6%64:\US5-ZL.4 M,Y+6>A0;$:;O5+HIQ;`S*\41L0`[6Y+%"NAS#I=F'[`\('V M&C8\TKJ:L>02RO0#2LQM)S;26FV4\4#!JZ!X6=$6,4@"'W?:J"=48S/:X*,,\U+*+*.'*LW5GKR MCN8IP$0BO1%8-WUL1/B`1,K5>HJ,-O,\W4S*F,Q+*/),]HW:&1[C3S(EL`H4 M&]$UV")K+=R9\7D:`XSSS$L0&%\'X(/K(JN/V2X[GQLGK=Y*6()+Z:;!U?`>O)[I'_%X_`"\-+LDQ^R.ICWG9..?L`);^`JZ=4^/[!?S05I?N M?/ZT/DCUJ"O.C0,,K(U,^"_KD2G M7]F:_"-T#5./^^XJETT'%%M1"_/2DQ*GR5>DL/F#;K0D`$-NV.XF5&;NCJEH;$VZS[!/T5_*!/GAU= MR<-7)8KOHN60;=@GNP-;*1\M]*&P)ECL7:R^[W?@IW(*7K)];7[)PSV+7$R??:R.8? M@NB1"DF"(PG2B!&)2@ ME$9^ZH]9G(2QG&@XMH5#?^@#^_5<:ZQ*U$(,YBIP802?_D;P1)7"K#D)[5RV M_WRN.R8)=8^@)6Z2F[XE9?MTS.*%%+;Q:5''RPLI!"W>JP=J^_<='6SO4YTD MBH9]/X:$(-1Y*YYI^U_$@ST^U1G[XZCS.@CL9*-N,L:+NX03'^=DP]6.?^%U MK9U<[ENH#PII&*S#27,3]&?%\`'F?\=V_`=3.]%JI^8E+/7=%+I7X5&!+T9V M_13>2@.3OW^LX$CG,!)]%\"EE.;UQ1Y&PY^$S7\```#__P,`4$L#!!0`!@`( M````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_; M-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7 M`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA M0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD M$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G; M`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG M6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;G MUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQ MC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"LY1ZMAUC_J" M2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$ M'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?7 M85;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&Q MMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@! MKTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5 MA@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[P MX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0U MG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO M]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_ M7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'` MB\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R` MY+<\-&^>^I:K]58VRWH:%G#MT.&+KJJ:>JJZO;;?OZAV?? MT[XZT=H-@['>>]O5-2>8APLW>!CK?[^W+H:ZMH[M8&%[8>",]:VSUG^X^>UO MKM?QUG,^/SI.K(&(8#W6'^-X]:[36<\?'=]>OPU73@#?+,/(MV/X&#UTUJO( ML1=K;.1[':/;O>SXMAOHB81W_EQ$B&]'3YO5Q3ST5W;LSES/C;=,EJ[Y\W0'WNF?8\D\T^E,3[[CP*U^$R?@OB.N%RZ>F&DQ>!0,(4="6S?27XQM3UW%KGXLZ7MN]XV.6S@`18# MZ>]\%SR"!SN)AO/JF2&:S*8APN!LZN,1:I,/)MEXL-XF^\L>FSA=@V9=Q_#' MZ6)6U-LE355A:]SQ,F9![33>(Q)Y9(^ZWI%;KQW?6>M?7)^U7X*?3M`8NF@QG[-CHU)74/LN)Z7E[Y]5C'"D9MKJ,)C M)PHL^*"E[^^W*Z@7`Y@P)+#8[[!]S:\?(GO;,UC5U$E^VM!@'7KN`NO6ARFK M4E-?3R_OK.D=TTN0(3DB*"J$6M;TZ@1"[R:CJ7RDT]%(ME##@I=DH>\'^)(L MU(+_IM(X3<<)4Q;(7)X6NSB![+Z]&HU&P][E<#@:3*29VE$N\'">79P M3BF-IC*"`2`8]8>C2P.`=,TA4W56!'T`<#48#`>]D6'"_VQ@.CT"V9P.=-5> M)0@4>94@4.15-K'I2,C\:4^!Y1S%?94@4.15@D"15Z\D9^`KY5XE"!1YE2!0 MY%6V'">QK\(RJ>*^2A`H\BI!H,BKTHK/-`./E'N5(%#D58+@W%[-IE73K+`N M5V;2ZN-4%Q;Q%EL(:J.+3?!@GCH+HP6 M\6\F0/C,IFP25+M.PMWXY>MRW7OC4N@$;EM-IQP&.1* MTG`HU@4[Z(74?8(MF*N9IP4;0$QD(2'80H:-Q1JYJ(VDA9B-I(&@C:2%J(W0 M=?9UKHS)1;B!4[.[#K:L8;>;+$>*ZJD72(#OB9C]($B;,I^-3?8PVMBFK:V0 M7TI]8V+@BU7'>RQM:%&VLZ'!'BL;6HC:R,=-YEU.>+YT@>EY#Y(=OKF?'P8# M%"4-,SP[23#-3\5RJG"ZVV]NH_@]5C>V.]M/&GSF1Q7;*,!7LJ`5ZBD\35M84G]][[D/@.VP944_$_!B% ML3./V4X>=A*D"D^_`D\O%22"YQC]9H5^X$F8CV/TPS+57B<"+TKU0W`)ZY<9 M#[AG*0UJ<`$-ZCH\,A'`8D2&`)R@`@'NL4HY@/!4@0`F>1D""-`"`<"IB8IC M^D&/9#.(@4(EZ#^52L@QF961;"/2"9OA0`^`H ME54I5E6*(6Z'GE90`!]J*+!@U)4SY/6JH(; M(15A`#Q*>D51)_2X$>.,-!`(JC(DB09#58JD&%3ER,(5AJH422"HRI#4$ZI2 M),6@*D<25ZA*D00",*(D0U)/J$J1%(.J'%FXHJ\J11((JC(D\43_Q"FR0Y=- MDT54LGYZV3UH_51[7C8NI/:J)DW@]ZQY,GM*9H[@"S:7(E/I'H"SL[53[3&, MW&\PR<1+WN:PF.I$.EX-&;MS>N37R%[=.\\P%4W.4CTOJ]=Z`4FVOK$;C#S" M2DR%?EARYJFF"05(Y!NHJQ).N.<-AKH;@0QU\'G3R M`I+'VQ0`/)U'A$,CO62`QD6<+-DUP=T_1O-)4((1;/_+X6FJOSL#K^MT/-S* MVJ_XK"6$N"_?@T\LFO0'NZR!=2JE' M$X7;BWF1[C*?-9F>G"\MJ+<;[\T3>9_];;R>5V*Y3TX-25& M]`F4XWE[9 M#5"X9V(+2@_*,66*]_(J5+&4X;[*Q/[B2>?'H1+PNM_1LM3R`)_&O5'>^?(2'!MQ>)[>I\JH' MTC/,]HZ=*/&YLH%#OD0Y)NDT\DL&5`,R>%;.\2\"H#LVQ'=+B/A2R'M9'BQ&ENS(/OK85BO87$4N5>4O M5,VW8FEXYT^X*7GW]]J%]GZ.0O-:`^<_LXWKP>UQ<'J)V^3F,("$_B0YF&YL MJI.5SY\QE*@LJ-7;R@()R=3#P*V3!!?,$=O*`O6)K#Y82V3!5;RM9<%VUE06 M;FPM<)FP>:4M+FB2RN*Y'PAR;^[S(]L"7N!"DT5P45F%'W&2162!R6UE%7X$ MQU%98');684?`2&198*2MK(*/X(7J"P(M[:R5>/_*QBOLU M17!1684?^5CM"\8JE57XD8]5-+DMKL*/()7P9<(7;645?N3SA"F8)ZB-A1]Y M[@>"W.]F5#[B#<&(3Z04OH-WA",L)T0X2J047N.CO"\8Y8F4PE]\?)N"\9U( M*3P%\HA%)GPA;E'NHS[/KBG([L1>9%F7#Q@<9T1@P#,MYAL/'BL2XD-)V'YD M7"4A!N'5)T*2'IWYDS:%VTOD@OC^@,.HB*"[YY5G!W8<1EL-]R#GXGBG#P3% M_3D,$H;X&,:*JHV8O"_P].`%B6W$0.L$#1]_ M.!EJ(P9:)V+XI(KUDXB8#\%JDWN(SZ4X=(N(^.@&3\Z"CQR>80-`BDCZY&SB MR,[CC^]2AB`QG_"F)+D,/D4D-UK/[J"2UI^?X!XD&8E8:9.^@]6_"/"_;6)" M([8B0G#Z)2+DWHWA3E-9)^9$("PA$2%<%Y"+V,DH@C+^848WS($;MU33X?`*(6SM+>>/%]_N58+][_E=W##8(I_=6/ M[MO'^(]X<#WHQ+"Q#NOFXAANNP5]M$[EC_;]WDZO1[9UE7`R[D^&% MV7<&%Z/!Y/9B8$XGM[?6J&MTI_\#RO")4._@F4M'/'&)/1D*KK/HF>_6'CR7 M*4J-3<%_+HZ-=?(A@<_NB`6PX:1#9D1GG3^QZN;_````__\#`%!+`P04``8` M"````"$`..8FU"Y@``"G,@$`%````'AL+W-H87)E9%-T&ULQ)W; M;EQ'EJ;O!YAWV!#DL0PD:1Y$4;)=;E"49+-+EE0D74:AT!?)S$TRRWFJ/$AB M714&,U?S!`/,`$9?SU-XWL1/,M^_5D3LV(=,T]7=&,QT6SZ>\>[._N/2C*Z6`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`/]H_SK>O2^ M/T826TO5OI9%?V!V8UDLRD')HU?CLE=,RU4QNRZ0J]F'_G10%MB'8CA;7ZVN MU^/J%1YYN-\[>';<.SP\LCGY\^CX2>_9T5&/`9?S^/AC;F;'6+=`^"/O67R[)C+;,52K;]F3>SZ4Y\8E3-WYX: MH[O`*HJ'8M]<8ME))2:E/[T9P;+"R>I\ZIO9;/AA-&YISEM;U[;UG'2N]?79 MR?.SUV>79R\OBO_2G\R_+"XNWY[^_MNWKU^\/+_XM'CTXN6KL].SR\^*EW_X M_NSR3\T%GL0=G_?OM-V_]GVQPU:.L3[#8MZ',1W/+]9\.1[UKT;CT8H];3[R M0W]A%GJ(HK['!+\OT].MX:+A-&.&G4+(!OWY2/L[+OO+LIA=C4M63SLB9K<=R.5;].P[RN6/-%DS>G&Q;7 M8[G+99+IP([FVYJC,%);"[W_`-5:[_>.+$V-3L$0N!#0 M4`>;/OWYIY]_:HY@WND6)PV<^K1XB1JV!0\C<5WB98>@*O-E#W?QQWADR6F! MU5N77Q9'/3[1_Q5+]W3]]>H6P_.W/N\F!/)/?`*+'2%]8L8RPA\?-![>GS<.SY.:^JF/HR" M#PF#;/(CPR%::[!(1G<'L!0TKKDKF([U9.VV8%A>CP:C#=J1;]___==?_NO_ M^>6__2N&R5_!,'7N9TNLHGG3[@99N/=@]W.[?WX'^@'?EJL1*.U?-KGA+:[R MUWSD([@YG(W'_<7RLR8[6P*Q75]/Y>/=2PJ,FF+VH?=O6T0W;+BY!;]^]?`-D>_NJ>/ONY?G)Y1FX M;I/D'-X[?FK!N_,2C+1NN>=+6U^Q!-2U_-^Y.3MLK!LR`8SFEKJ2;1C[=$8D MBN%9^1RRAI-R*-7`$[X?#1BX<]YO%C-$#'W&BJ.AO M]D%S/(.$@LF#V72Y'AN5I5/9?-3Y]NN+>?0:5GRFJ'(V`32G=E`VNDM*+0L,#0??@/.\KE'3N>C,'1K[K!L@ZJ!ON8B MWA`L:-'%\Y(PH2P>(0?O1TJ"?,9'4VS^RN*'L,S+_L>V"/PC[P2PUR0')V.@ MH/EY)+/K\['(3V:V!=&>]Y>CP3U-\HO1>&T`]WX6_,)!R7H)^&`#X3.R.)FO M5R:O6RAQV]C:K]KT&Y[9X!KKINWTY.+;XM7KMS]L-&V5+I!B&;TWX-\B6%R/ M,B8NMPA&!2U0[0__LEXZ9&P-? MW*+]GQO$*V9SX:)->A>BFF7A'L>$?%DNS$XVJ4ISC92&0IF;#R2EL6'$*BP= M;0&((6N5I&@N.\LH-+\" M9C62"=V,D*R:+$9MS.A,$MX<7/,NS7%LT8)WZ\7@EMC54/U\H7&;"8;VN/7< M`I[147K+B;3(EF@T26H._VHT);$CK[R-[,5L4);#I;LQV29)NB6$V/3M4?*[ M_IW'?TC(_9^L1?J=*X5[&4TY/::RS76B5MGCY<=R,1@IAX!U,-WNG,.$@(G> MC\AY%U=WQ74'MYHSV38D3^PV#4!C_]B2A3O=E*XK^JOBBN3V=*I=@F"$ABQG M<]JM[Y-3W?SF\_62=#N.[T6Y'"Q&;NJ$P2[6$^#5G=Z\&-U,1\1Y2J^'O)&H M>3<;$_NUW7C'(\6?3ZZ4GQ^L6BG]MXN;_C0@LQY)Z^F288<5GB]0(W@*U;`SR,]NT$%W^^+#^NBN=C(LH6/8_V/U,JHOW__@,X MU35D3YX!U]ZJ"](H^ MLC#N8_N%0A:DG(SW?(Y4C,CE?"`*'R,8'Z80L%Q?+4?#$9+2VS"^%U__NR#GS`>1=#[Y;+%66^._QB*C",IAXGXJ+/+:;2/_E[_]S M65R-9N/9S6BPQ&\ZAE7@4XYG\V6OF/2GZVM&1];R("1_"Z,AM[@L5C.B_HG, M\,"Y5ZL^>?2RW)6H5>MC?MZ?DQ1?2?TF)8DJC*]V(WJDVS5$6%[^9M&_]GD& MU`-7;%@):Z@U75^3-7/Z&&TRXZLKRHU&A:?20W1WLYA]6-T:#4@:1C$1G\_8 M)Y$FBLP<].=S%-^$0HYF/).#33+5WEC^NX$\\GJV7C6B[R/G=FO,D!U++ M\D;V$`<-1Z4;;#E_HOK("_\J%\@5>XP&R_TE`(8H$_>ZD,$##P\;#.##;QB(OL[9`+"-4A2:1)D= MV=P@H5JTN!\30-$Z]"K)K99;C"9S[#`M"K9!P;Z)FQ]N1X/;VB(DG>4*KLK, MW(YN;B'"/R.$Q&1KU`5%D:$^%Z!"2W9K2&15#FZG;JAA7W_XWCP`A%4A!J7= M%?9WP>K)-2\<+/2T/"V5/[%+*FRRR'SNN$BW3=/R@S+AJ:QEKZ>Y60$!Z%@Y M*S5]4.4L,+XXM'RU\+^E;#71XX%,M#0?:E11)"\7)(3PC,01EL M)9)5%L-F2J=FUSW7ENB"6"MRTI?:H>+V?9_J!6++6PN970JPN#6\;>"K.?._?HN^]Z:MWJU7F@%PA49<_KO&5;US)B]',ZF MK"_LD8$!3&'8*\DKZU>`C4E*.]"I234(9MAC-&%4>D)(9@+P?Q64(6/1/YBQ MUZ)7MXO@8(#W)=RU)AOP.B-N*/O07'#@8&#:Q^_*;DH:I$5S1;@JA+&!(GIO0/54#7# MSP2@B0F1G`0(+F-CZF:RVS%'P*0-8M1=T)].URAS%ZKML3^:T:1E-B<_K&V[ MSDR\R:4!7]&3I9)DK"IS/66YO(=8T#(#J0-Z"D0*"YZ@"%,*9'=RFV*'?'5$3.,ILJ8FRECLOBDV\%)_\X\GSSH^XKGUVN! MRB0<-%F,BSMU#"$0(O!%HX1WV"6H^/4N[E'K,"N%65'CF/@(3_ZRQKN)CR8C MVO?.=R5@K`^!D<:5J*BO0T(71,!&C/)M\.#$M_+U&VPY MVF0H5^+":QM8VR,S*.71X-A'`F4&,=F9XTC0-N'R:#$Z^%L7KGKXMU"SWBG) M4;"7TQ)2%7RA__^._UG^355N6@WW'GS^]5>$4^@1U$[H+=S7)XM7F!5_Y')$ M,$(8]J$XG^%$].UU?R)Q]1'TP>VBW>XB(2H@FKST4M$7?DM#TQTC1MSK8(!/\]2%+D6J,*G7%+ M"5W[SYR,@WVC@Y@-)-^Y::MMSJ[)A4P,T!S+SGGTA"T+J01KQ9JH+*!D!:&_ M6M"4P"J`+1(Q2]4+>A(,[1;?54'"E0)4\J:&H12W:[M-F;M'K[(+_2$^3P\/ MU^9-T'OVG-B$;)W!*XJH'?.L;DGPR5TMLY15H!+J?LP3&.0A2;";>>&E-CYH MN8/S@/F!6#?EC%S!'!AN/N]&1E]1HEBG<+B=;7\#(OGY)XTPOW[T,&])*UTHFVO:ZVYD% M;(*MKK;#[7M4$V%0"UW[Q71MC3=\'X7![06E@_7$4\?XT['%\#&F0P<(SU`` M<#8B*,*["QQF0*2>%732P_AEI038ZXWON6%29*@7-$2'7W%*]66#(L-ST0S( M^H6R+Y&ARZ[><H>S.I MZRQ.;2CZ8M.ITTQ3D7=T`2Y4/U_U/P96Y$.%E<<:E46U#KAB$>GN2ZRQMY@J MFZ&J'+U@&7_Y)\G+F/!QIS$`NBZM$VKY9=%JI_O2EE@)0[2BAA*U3-N1O&X( MRE;7HZ_,@RZA8U5^('VX)-(1`&L%R$.BXP4)2XR1#;=S90$7#)D32A\#4.R#]R^&!'00S'V%9F#&94P*R0*D1`6U-H?44B` MZZ#1RFQAH-$KA@9Z#0(@4$0_4D%J>72S]")@K7RX]%_-(R:;.($3=,K0D80_ M+E!'*E;\GW(FU$^5"`%S5KK&-ZO1RD)C^T9`$">'9%Z7$BM%5CP#JE=C+,V0 M[9SA22QJGBD)H0S\ MH-_8-LY21)'1(8='G.X.FD)!L!C!@T=-9=`899%/5D18Q9?#&;HR)0X+)IZM MI^..52%G2!`E'U7"?(:6`ERR[62XB MK"K4\T,,&];.,.7'D$JL-KB1FW)D"29O.)D)?I$O46#"C_*WT,K:`=62?ZD<^3!,@LASS\/#I"5Y;%>-PEU:\K-LU&!(2 M4-/BA3)ZP%]OL5'^;[E618H]8F="OB]P,'"!Q#%.Y8VJ8/N/>ZHGUL@L+K.* MH6J.5]3Z/K1,A)H\PG$5,X16<34?H[WF#:=`#D>)4_U'A(+4^` M2B^FX"3B>R^M(6RJ_`5(%7@2JP5H)EE.)I&D2:@(;S'D^<:C^0,*.99B5RVN M@8-,(J-*,,;51YIMN$- MQ,ZW_]>[9T5/)4^$J2S&Q,&Z6P=W`W+83%)M$6-?J91]!T&4I\HQ59*`D\P0 MC&%YB`[)\70?X6KU7T MT!D$50XPUUY0,CX`$'V=$K](+4E7B:#L$N211^X@_]KT3=3C",":9A9TZLA? M\N-.N]A5JN6!6H.EI5JW6#)B$T036R'1-F<^;.UT/(#&-%"J;+:CF0JS:@-A MI8BOAS,A?(6@6*2"Y7T%2J"UW2*-+-:UHK_T(%^A5#$62$.A,),K]658>,@( MF9%DW\QMD4RG@5@E"?5`5-NNQ0OP`;G4W5T.50+``Y/@UE?8/LF6G*>RC_S#,M0(B>A6G@@188NDE+"!PX:C!7*,E8?/8JPE]%U).R+B)'\& M:T05VAIHDWX6$5JZP&;J3S/%:-TW4>YT;,!YL2 MTXJ1"K;2+7A2HD0_DJ[<`6Y-=T23X:XX9S&1HHE.9P^\"JQ@,?#,ADEPV^"8 M%^%-%:F0[\#?>5I"QN2&*\)B63^,T$3(U6<;HFV2R%"'"8% MI2[&`7Y%[\]G_*=X!*1X=7+Q7.U)W<^=6F4@N'8]?G)Q:D\_W3\2(,D&%XW= M2[3M^;8_(:F,@>%ADU#R@6=\/-R M#`B>15"J6M*`Y!#&#&)HT@X!,VTN=;E0,"JA');*?IKGEH1LR^C(Q/5IY7$6 M5%NGSQF&#L8K7R'L+<1:"715VTZNWPQ8-Z\H2M\:\ M-D`Y.F4Y5;765IC)X&Z^@1MV#0&\UJ964*>#$ZA0];UB8$]AMMQ\RTB?A^+# MN>N+3$/30L='<%:95EG%QF8*J6TK4,CBH=TK[';?6`DR_*+H?V:N*)IY&13V MS7)/4*C@,!8Q@/PW8_1OR"^:?J::=USUE\65#P>TGZN`;LD'&"-^X[=02&LZ4TZ/ M*60H0[>A3$2(ZK`4UFD$4E3S(-EX>A]5^CNSOD*S5;')+@7O!1E>L(4&M=82 M`ZLLE$XD^P(:Z">G757U/2>B2PRJ=_U;+J=PAHD;C9'8(N72YH9*F[*6<8.L MQVANCBQZJ2@!).-!FM@796=NO'$I6Y[E(A=EO6/)>>L2H_U0V@T2PT-Q9..7 M:(@?Z-'4)F,;,@?#VB;#[Y@!BH(MN;$Z@:7W,'4T>]41(['LS#K`Q)@T23"Z MML==[+T"[5=JE9+#Z-8V<2(7MC01TFZPC'"Y0MS'T$LX0K[FA.`ZB.K@P3)* MWEA84\4.6!#'3.H*[]4H_&:-RO2*\[OO9$7ARG/!+\"3\NX7=^#1":-%P^*[ M"4=D+Z/BBYJY1T",X?4%X'&Q_XEIF=WKD):"Q(JA_V"C5HN)"LNM8G&*A(6C MIB^[CYJ^LHY,2A(F"_RWL=^"7EJ*NO,&\LA6)8I%):F73Y%J3S2]C9;6W^#9 MQ2!;YF7$'Y`/>%9Q4^BB-3>518(X+8_%3AZC8U#V$Q:\K>/%@]:"SQ'=/L?&3-9? M8"@YA"#OU5QW[3FZA^-S2`%.Y6_GQ-N#B*>6LXJWC5:9$JC^H08 M)&Y4R*ZJ5"[%)Z&E5"Z/K[Q[-Z;;O2+BWUV5I!')BDDZJZ)F%<$T8+:EV5*M M*N!/"4!DE9''WXQ7#QM$54C"WG>)R09Y9I!LEQDYC82186$2)_\(F$?^GUP? M=JW_T18:=C=$N@Y@^2-6V54+QU-@QM3GF;,D"FH<^2KE<#!6;#G-AZNQDEX2 MK-(;O8%GN21$9-[DC.0G:[&N5E)WS)!9ISZ83LO<\(T:7$/F3CPQ*"L[O%O\ MH%:G"KZA=5V-%P(>.`W8-*+Z8RX9O+(>X`%`?^V%6&8LY((B2M5K*N!5B29D M0(DF?2R+OO+OEU(QUJ[GP2/MZ48Q%VHO(\&Z[JS:I:: MI[$VD/[".B_J2E8IF`3#=C_Y49?+H3=5&\D48+4"S(FEFUWI/>$J.0]BZ3T. MLE^9#];05W[C`E"HQD4LM4ZS4KJ@1<,1>3P]@)_)#EEJ#&I-N`0W\6)$F,)R M//"^JFV>G5\@LHJZ+*F*0T!;N4:#**'F6P>Q0J'#/'K",Z_IU>AH:UXI6NFZ MD1%544U$:WC5YF,/Q2[=ZI3UU*59Q/U$8%Q4UO=;F3\6F25P4'XB&;OC#&$6 M0VI%U+S$>&!)G-RZ;T[DV/5@KRVJZ4[DV`,*..4X=>M=;'.7%V)5]2R#NUK@ MJQ?%S--5J>^N/$MV6F93OCMH0L,=>,`8/.:F#,PYV!#(%BOZLH&VB"#$MZ5. MSK`CQ#SX?]2+S/PZQ$]^A$U-FI7UV$8#>A&\H,)9@Y37:FVLN0HTQS&&(',( MTHPD4C;T\7KWA-AL0B17J@8Q&3S3NI@H=S">)[&34L;D8'TQF2EAUNB("+Z( M+QN]=?:HB7A(S M$DLE)>-9#922S1>J&JBS2G5#.R096(R$D<&Y@;.8B0!4$&'EU9+EQE\/XT4U M&]G8YD>,)@(8B0)(%4:MI-7="AZ0AAL63,M#)DA/UTE_\SP'O2'$GOYZX>RR/U4 M`F;#&9(6`?[:1]8:G9X3VC*RX4/\X6J'7+:YQ$*>!:%\1VE'2A M^_-VT$V>/LV:2)O:>PFY^EYHT(V'Y;1X%Q'!<=9;3^43221*R)`N+=4PALX! M6[A@\&/_J44WWUMN+7S"[6M&$'L'0;6A0XB.^@3((>_LSP7/VVD*@Y>R;EMO M)]7V2^#SF3S-D=)Q<:5QQ-"M&][7T2^O7V02^WS,V?6=BP'`K%SN?$<^0N[) M+\X@N+9SD^&J_P2OJ%W`B_G%`MITA9CP[+=WF,!PVR/6<$91`URR\?Y+QD:V\%G9X5(L M*?U(BZN(.#+0C14@0KE&\-I*^$H2](&(,1$2VO#([L.."M\&-"V037"?[J]5+9>7YVR3'S42TUE/!4?R6,R: MB35`A/,)@5O\WL(5/ZAPHM,!V+OK!8?U:$/]T=(LC@FU>=5,'EE4SZ7(Q@X6 M!ZVE"1:T0/;,XM(5\L69'!I0_Q8"Z-$4H<"5S+(XV;);NC5?3DIRQ5D0QZ2M MV:O1<;-A2#7!*PP*4UE28CWULZB,]ML?]9,A5J/6S-24"?Y4M?4K]4:V[N8*-'U!DTODJ<:3O'IGCZNCCNL3]3'@1J98R#($ MZ%COB*0J>^."%G2M,]E&'$G3!^J6YS;&XAZ(/%1KF0V MM-9L*R(BL74)8\>=I9N]I,"!%@ZI7PU62J(K2QG_ZIDJZ+8=(CZU%%NRA1W3 M*>'<%W09A@WL.;P?>WR[LD5HC7EL'2QYI9U1992<:LU]TFF[J)V:*!J\97\W M2B-VN(8%@O#[R[+CX!;;@&2V[T]J\6)MA_V,"0ZP@- M/RRHVI=NF8[)V*!)7/8O`3@D0+1??%`VI0NJ5;?9**6'4:F.1Q,[&5?PW$C6 M%IYB_]<;99P5P=5TU*]^"776LN6_3N!,E\2D2!XER"0#K"0\*]@JB\Y6CMIG M#\F36Z+%,5".7YHL.%G^_-/LNOEI)(MSB?NMR*#P,\%U4Y,N(N.O%/!XS?(>4#8 M^:+7T\RN!K^1_'0>>C?,D4AJZV3++3\/YSS0P7_FWC)5._SZ]Y;\ZKY0XT=, M7W%8*`#[)B-U?T"*Y#VYTGPDF[=-9?/AWVATZW7P(6<-I]0;!K;I9OV#7E78 M(VEC&],I',AWLV:L6A)VIO:"K3NN8O:O63>9BB##UCP2>QTB'7Y`J.H4$XTQ M/B723T%IL`TIR1!/VQG`M'R^!Z_1T(#VY9!C]H4,>C5J?->*:TJ_9$2"2)S' M?H3(>RWP^=(??A1(0$0'!G7`W4Y4YL`IG'SSH^Q2)RE8-6TM)C#OZ?8NK2GG M4WQ-ZU%BS":KCP!5LRMK/(W(+;A=+H]J+"H>0;4DV-+JLBQ!Y#W"FGT)&\>?R)XC7D1%DC`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`C>(EF(7!!_& M2-KP`#?[*&D6K\Y$U>;D`NB`H'1$&ZH$P$Q6N(RB:@@U^VGMH3`^'CG/\\%T M\GDK'YZ68:W<*!>@LU9^K5'J%XT[K-9IS8A@>BNY2ZP$*XEY5%@Y7:LXT[3% M:]9GY(5?_OTP&3C/+8$BLDSU_U?*#BKE<9,$N98JMRIZG3&IE05<9'`@WGT7 M4A,'?LK`-3URL_F2<#Z'POS2O/J+<7>-DRXD?HD+=2:UU>1,\Q`Z&I=`4.S% M;BG0)7*FHXEBV",NQ_L9@.Z^FYNR!;JB^[.#7O$W\ MQ;/6KL2STWO$%UK\].9S]:WY\0!W(G4G+"# M)HRP(I7FDQN.F6]XVG]&:,M*WW6>1N]Q8V&KX3D^VBO>D9C!+N`8!9_G)LZ; M?VY@^WOW]69'&Z0CCEXG9^L"[%$L?_8+HQ8LH04N->WTZ/-X(KVY'8D!S2_D M/77:O3KHOO&)Y>QZ!9)K"07W[6(%U^!6L9I3&/IW2Z*Z3\@W)_MCR7576+7F MYRX@JO\WOWE-@SG'O;*3:D\;1^1ON+Y1R4]KL'\>R49L8RZAC8%!Y*V\%0]4;,4L.0`/://D)M3(.YF4\8\#RZ,\W'_VM/?LZ1/[].'!WN/> ML\>$9^QM.)DZ]DNE:O=+=/23SG,#D[8X[ZA,3W0L\S=3?83_VCO8>*\S^W3%F>W[;5M3N_)!K/6(J1)=HJY)(G6@@Y$ M4,@7?](@G(MUV*`$@\X:"6S7SHXHB\,GAIA;(B5E37Z4!FH[H:A&3>:QRX#Y M+YDAH0N?0&*+%$86NOBV'#!KX\H:*JXZK/PNR$=S?=_8Y:7U-HSF,R3$.H_Q M-I_#F55=G];0T7SB).5@\N/`,:)LK>#ETN\I)8[(?R(MB'_K\7.[9D0Z'%2M M.3V,!H`J'&Y]TX4!6+<5ZUY7A?'F>^_\NB>/D.UY3A!NB31Y1%E!>DS#/5$R M(1WSU,#?-L$^WB#8'6,V:8^/1'"KFL^]T5T6W>9P/([5^CVU'\#CR\\58Q*> M(,D*7>VFK"95;S&>[8:=YE/6.\X^3KA/HOT3UOJLQL&-%J4^SO9`_VDGJ^LC M-.DD]7=""FI<'!"5R.C7W=M2Y6(,BF+?*!F>%S,C$&H,W(;B`92%)M^-AKBH M[->B7K\^-3M\P4/LG[JPQK3I/N>'8U+4.1N_E]$8SYBI.2J/TV:C`Z?TFY&E MD_7B!BY^/D>_5<`?#U,RB:#,;I!NU-R.?)Y$9QS11V'B6LBHM"272&KW:,(S M:ZH?79;2^GQ/R4/R1Z2'/!$!5O@=^C:7\/FZ(0/(PEBB'FL:EBCE,A;;I:3Q MF*P3&]&1G?BE*MAZI&Q`R'+@TR;VD,%XTWY!3YE/"GP?I,Q!Q64K0STW)`,54 M$"`T":=96#,:TH.HD,3LM+KII'PP$PWAKLR%53M#8LO"5S8^QB$Q%S8SH;0^ M0RPETLA*FO7!0Y=]-U\F\/*X6C6+@G]1@#.!YX#'_N%]A'Y_=P^A3VOKE/A8 MU(3\_=UCI#_(N(/\AX\I3%59=*7MPP43IGJ:0/8L?2Z=KRXGR]\6L+23Z$%! MIOHU/Z*-F$-,5`J-2J93C41RKF907=>H[6"[(M&)2RJ-A"MU99[4^YB,<.K& MT1"Q3&&#VKYI/'WC[VLUOE?\KY^Y5J01-B.?&Z+T_C+;/Q0MNCW$L=[WAQW5 MV%73EK_'%OM]]8$M<67`B3GI0Y(DX8NDAZECN]:&GLPW0I.J+/J5'>!"*GR) M?!H`PM4/"=!HBH?'OOEJ7HVU? M=8K$#[B@'15_PTD2:V1HDYFH`+RRO6:VZR7XZ,,WDQ8EKD98G,J,APG%O:@$ MZ)H$8#2&:HX=@NY,<@.#TW#\'%[XRB,@:\?%;JF*%'M%B7_L0&\^0-JASK@J M^N-4;906)CO.GC:J8?N5\:M"LDH/@IREL^+2GTKC?@N&$W(@ATD>@?Q[/4Z7 M*AN#TVE.%[>X%B^HH8VUMNHN\/X^)^RAWDV9)+M:71`KS_A;/>DA^A9L*Q,^/`YW3ZQIT."'4O73 M3O9#!BF?3I^VC*LU3775OQRBJ/`?1HWU$?D=;"+9'+IA&D,PW[EH_=M0H2!BW8[2T.<0\H@5?R2V6SE M9UX+F#$T9/A.)6)O(,](N:]_6?-8/O$^L;,-ND*L7O, ME/!WQVA/=O?V/G';GHV4!=="!,_+,6#)@S><9/@9S!" MRL[@JNJ3834)Z'H$<+CW90Z.X@6]S85ZS2`6LT)\U'SH18YJFE_6][#Y[25R MG+91"J";R-./9COQ=ON5?IDA0&$W;1N2^BU1V#Y#Q'OD!OR7XR+V2$P%_L+] MMOEO393EE7E!2IX.>IZ'"]U/_2*A"[4NA=\B>19P M)#_E#$#C4<)]_$;]>?>==D+5(2=WT(QG=Z7NQY2!`&W+JVA@REM*M@#:^8)^ MH8'_3"?M1;)\BNOT\QKX3WWNP">4GB+*MY4@E4R*LU*VG`0'?^A&((93]<0Z M9362?E^9&W5+?GOSCM]%342E&6R^&HE$))1O2\X9X="S]H59?Y[ M.!S/MQZ:^&CD2H5];0$*HL$;X6P45B+L4WT>K;&BNI[I(B]EB9''!P^,M599@@"FP MPH!#4J"!LKEDJ6Q\P;G@/Z[)O=;V+XY$F"[@Y,D?FR;&L7/[C0$6FT)2FT[` MR#1=9Y]JI/IO#R%K=:[FDBMZZWV`[HJK&Q9"8V66%],[^3Q1.N*O>T!['/*> MVZQ^R`#!\0I372"D'CGZ(26YO4+MD'+$.NQ*^.L^(P6)ACQ((T&5_RQ$.`5O M=&GHO!-QZ![2UV"]+%'#5`$RD!EX'PYUVZW*%H1S#YM_IK3998MQVC/%YIND M=).(KUD;,D[B0=54;MF3X$E51:/U^X=F=ZL61V]O"VF--?%3PX.>D\>/XW=I]5Y:9G. MV'#5O)>C+IJ6-1,S$E'^,S]K^EC4X6S*J?ZH@#5]'2TD?V&V!=6K'%E,+2CF MJ`ZY)#$P0,0&9LV6HEK?Y^5I&67ENIL1E?'*ZM68W)0F"INB5S=AHA%CJ!06HA%C'8BZQAKJ#K)P,#X";ZN$ZKLU M)E?B`QOC:.P4*L5:]"-7&MIDPHA6ZQ M?L$OQZRDN-&UW4%'S!)M[GGZY7_\]R;^/N?W,7=>Z>?BSM&M+SS3I\^N]9DE MNR4Z6?96B1-8+'4!S=V(RZA00=*DN'\.OW7HB[%%&A3U M(1XS8C2MK])N9;R0:!,!:7%U;H)&_G";T4XL_L3$_/[N$WY7-O+^/F:GM0TO MHWVYA((O=%ACZ-?*^>&M^"NE'%`"9-CU!&F#`+XM^DTC`]R/J%<62SD\N_9% MYXF(FMEM6ZO=?;%3W;^AJN,<<8"_I,>)@Q;%V M)6T8UJE.T%8>MDA_LOLXN[I<&_$/,?2/Z>X5XV;B5IKO?7J@LOOSLES8?3G\ MSC"VN,6$>"U..DS3(139N%$^GASL/ODWRL<+F42<6/$GB;LKC9E)?68JD&FQ M3&_R98*N46PD`LZ`='(V#4+TJ1JB^1:U06?6Y!_:@!/@^WL%:0X41$;N)W0< M8QI.VVTV'S\$E6O:D!/R8O1<_/S3*QS1AB^;'Y/<6/-&?_7S3]]@0UN]BA=V M"U3S+;)7"]V?_O-/[W3[1_/K%YBPYF=OLU(L9BF=X&T^9U24P^;'<<;6%Z<* M35$Z:KH4TOS"].;+C;ESP--\-,QC(29D;GOT4AXQ=3>1J24]J`O,$K"-T6!> MA4:&L*3YL)YXEW0^/-:QM,?[#L>W#IW'`'&:K4/O'Q[TCI]PXNUD`P$6*.'Q M+6%\U,-^]0XXD+:VPUOB;OB%8*N,5QJ>:OZ9-PSHS%%9+"QR".WIGM5[?*1M ME'1"`^O>A!"L*O&LX"9_!'\[)<:ZH\J3P6%IZ\,G3XY[^\='+<=R5K5F@,&G M_&KV72S('WK$&(&5`_7B\-#JO4S0B/\#`1`5B]P1=CE"PY7D[_B=:HZ5[8R6 ML*"N]'4+@SNWT(*5I2RUVP>2OOAY6]0>CM48:>&""XL?O9454T,J$O;P_S%W M[C]Q'5D>_U=:(T=V)&P##39>92)A,!EF_)(ACD;1_M`V8)-@&G7323S:OVG_ MB/W+]O,]IZINW;JW;G=;GNRN9B,#MUZGSOM5V]N/-_8V-X57&51@OJ!VUGE+ M6Y$FZCJ`%.4?:+)47Q'$C9WT^9PXKLWKLPZ`O)I^2R3,-HW'FM-AIZ$HDZ6X.+,-= MB:O=S=W[NT1T#]Q/I3-$V$6%Q7?8T>-UT8US2]!-(GZ5OFY!BRH.[M9,:+Y@ MMIM1#1B<)3DU^[9[:-]K\AZT[[.#^.)9C9O7HZ[NY[5&4AWP&WI+[W>IE;D; M`L+43,B.5[;@P?#_![7V#?O2,;LB(''ZDF>_-5Y0_K98L,MRRP&"33\`,-^< M**`"9JTDZ3D87DY.<5F7`<$$%>NC%TB.@KTM]YLK6Q">^.J+R"IK(]Q(ZE;K893"\OKL&NASE+V&T]4C[Y5D1F M'2#Z$M[I(I)C(P.V-3_O(/5/I`?)U5Q>J(=;@U?\5"XX(;(24>L^_H$Q0^[[ MK6F2,!A&T_>0Q->M;L7(:+5%OB)A9$=J4NHP0 M!FP_X-5',',R>C>;_GJNWEMB6[_0U\#(U],1]`-6<]NYJ99H0,.^YPL=C4JE*R(UGR3'I/X5)ZD$TI/6%0.RR*2 M"JW\?0'=Q6Q:`ULDK2B=B>SN/=E="32D9HT=-(#+P@0JJ)4QK8B%)`'GN3.F MG&1G;]?0L'/((.XX90<5Q4,&^*OT?9B;L#4R59E4:Q#JN,-8HV9<8G^O9EXP MQ:2%NQ):3G%L7LKRMQP?7W]'$<GK(^/W``#LJ` MV]0H0@(.DC#F_``O9Z\DB3S>W-A]E%U[0`=']B*_%G?F)M1P>?:!&_(D'#4G M$!&,U64"52DMOG0>BWRF60S7-=$.*O/.QGCO\2I3:4"13L$>QU;5!CXVLQNU M=>!Q1MYV>#'WN[&V/53)FAHIEU'::_ M&2]`8=YU=+7M1),%1AC3+U!>MW;&&X];5QKX;5_/$2VE_C]B`-J$UGS^^L`] M_\WJH4I9+$)?0,.QM3'[HNN,W$8!%K$?3SIO2GDS7&GO%;Z^M[W'^A`-<()8 M!L")"UON@X0=?B6,S)N103L4]DN'1'-FJUQV7I$=C,>(%8U?EE0992FXDP>K M51US[>(T2;RZ=!3H$)I/8H!#Z>D&?S9B]$$MN$P4[3S:&-/"I>&OJ6?`>V]S M%6"6&9#A#N**O<@2>695+7HP^C%E'DJN)'2*TZ:#X)J&'1-NM'@".4>$E_,3 MHZT`#&OIP^4[SRA@B#8'EXF<-P-M`3$/WS"'8J0H[Y.UE&SI#=9_@O#43JM]OKW"3N:CH M3RO:(;/4+HE?-X&--E(FE:,1CQW7<>9R[X@Y/+(W;7E7W8>Q#K.4=#:)DY?6CBIL$P:6C& M:@O,%0,V/`EHL3TVZ6&!'/$I=PHZL9&+CB]EBG6CO]CTKB-/KOFEN%LHCS![ MP2:4-)`K+58#A)@^/BM-X243XKDF_HF;+6"R(M9R2]H[D,5G&_ABM6J=[;'Z*M;C]:R M0&RD"+NH61^UUD(4)9T_EPIR)NK]$UYSY[Y"H)NKT3U%B"7F2G23<+W2LY/A M>"N>'+Y/.-?@$MUQ,'2=6.4/EJ$5:T"Z_LEC-(1/UY>DH1EW[WH0Q#UEKKDA MG/N!/,>3>Z"KML1AX%*B%T$V>H,S/5O7KUPX+>CB:X%8_V0)<%*72)9I:?*N M`#"!-UUB=$@($BU=$&S`DID`-]XFO6\V+%63DF^I`)RA$+YL6P%\CJJ('8;< M:X@#>F((I8ZH*VS[L[)48;S01GBWHJT86R^D[*#9@2($[?!&U9H;J\7*J35U M?K9,#-F<4QYPHT^?^6:"_)'!8TVOQ+:"NLN^3&2F3[63`)$3(0L[Y2+JEN+AVPV"=`B2C.50EEAPMOC0"I@`Z'LXQHX.]U7Z^1\F MGS+$UV;MDG&J@SB<$![-/^UX$(OR.DQII@$$M=*6X1"J$EPQ:1I#B'O<$M`_ED;^+@@]0>#2BX"F.'5%4>P\SHSN_>WAZ<'KWF\`:+E M]#<4E02LE=@O@0UX+4SG=?5;-$N1:\'8&.9G!M(D\92\-N M;@CN18+$0P%V0J*P8B9('XEA^;8V1A^QWZR^I;..V(3W2\.^O)#?&%HX5[29 M&U)>(`RG/;M`[FY=+M))HYF2=7CTFS6U+Z>2.FH;[0FS5QUOF,?Q M]F^Y2MVBGB&5)RRRQ?Z)"HK:('RCODF?1CM[8TCDSCF;CQY[XYQ0OQF>VCJ8CWQ:#QS!).*J^@`*,L*I+ MOH@Y5!:C6"@M:A-G9S`H>ST'X&:E0)\&^E9[0-A3!>,B?/UL^>. ML/+0.G'UX")[24E#5%)[Q)=5<,(/NUQ1E97!ZGT\!"?K MFRT5KO43I3W&S='\+^CG.KD*B7,:UMW8MRYC5]K"SL`6I'NEH@A%];`0^S=B MB&T-(65!ZZ`:N!8Z30HY:C4<.Q217#9PM0'BV MS'9X)<&X0[Q7P(:FJU1:KC1<#2HWJ>#N:0_&APJ(!+@/9'?J2WZD/P&*BA!Y M@9UU1;/PW[P>5Q*9X^RLO75$G[U=#%/^22CA/82S$@T4P\LI=,TAC8)1/-,Y M&$P*9B;9FOWY,-L_SN4KZ59`]=/D5V.26(4@%U2LWI:R$TW9TLU9F8J4TC6O M()TCOL4J/T:`;6=7I(SR7"Q[4-"!6];"9S2]\=M,-!K/V6$1Q^FA^-7\497O M!YU/M=;NS5Q=7](Q&.(ZB;!2N.HQ@:PCK'XI`NZ^GCTWG>Y6-X0EB\[O44!H MHO%6HJ*H3$P%NWBB:;0D*8)^;,N%-H2A^RPS>.(&Q30\:F=^*RPQ;&XP30X7 M,?RVH\)DD/^V>04^5']FR&'!COYSK/1>^238_8+(3;OG31]_X[KG1D.SGPZRGG*^[.RR.TD%$>).PE\3/](8X=GUILZY[98!]F2I'D_T0SE[U(K61/"] MH8W4_`7HR(KF.0I.#_.6GO?"+0K,6$:.S>$E/S`VO0Z&`8R]*R,:Z/E3Y4X0 M7![P:.X(62GGAC:TEO^^LZN3Q-\] MO/W^NX?SR^^_T__??M\:WXQXYG,.9>>DCS=&K4F:33!ZD*756K=7IM,]I457 M/M-[04'/=0-]25G'9!@-A%5SU+8V<-8THF<#O=.50+5=FJLTDX5!`K*'3A#& M"`K$*><)O!TT[O+VES%CK8DH=>:U9E.ITD<.LW*%D\8]QN%.SB?[J*"!TUNR M*@:]:*4<%UM2B]\'HQ^Y&<8W/K=RV$_T<3N_CR=+=QE74_,V4W1$$6?3Q;M; M[)&TB7**E[`V2[9%V_22^MM5H"Y'PA91"46WC3:8.4^8SJHR2"X3BOS=68)]MUYJ]^ M.9"6]Z8^J*']):1?ZX)>G[O<^@^+SX0"I[_BC$);$V6?HRW"?NV94U,T*VTY M[,5+OD9(R]DJN0HW(,B%B4@0Q/K9@)X_B9,?3%4W>VJ8!L+.?L-HFYLK\:># M4V\C)Z&WSW28NM>C0QXLFK4_W#^T[QZ,7LR4Y#S]E?)Z?_8JD8Z$1XXX)ALH MB0E[BBYA(7JH5Y?T)YC`QMFII(A<"?JW1@D('UQDL^KE[?N/^/Q&/TS/"+M3 M584=&NK#,;*9P%T5?GQF8+\&/7-%&(",5Y(>I;K^F7SF"#-YKU'B#?(:XL<+ M:T2F0&:I9W.A(%$M"SS)`FHIDL<#=QU1YD"8E M\-X9[SVQODLE$[::D;CNKCD8IQ'JRAY66;4M077=79/;M[FV,'X5]D!0J6&N`K,!:56?S28^8TJ MH8??X/9;**C&3X024)H]F#2ZN;S!+,,=!NC1M#VD"+Q"_DZ(<*D0>2C#VE:#)V!LN\63>N5&E5JKW]G=)37NT98FKE!_!ZMQHKD3P)WF M(;6XV[7!*S+$EY`[:K!DQR5Z*+W MTV33^>*&'FH7<"-OQ'0QA\6D"OYB%=%-V&4P+'B:J6]6]-G+*T']B*:AB`2'MIVLV[RZDQP&`SLWG$_])$657NL.J)IFF&D5$*[) M+_.B-EQ7G$BK>G7/[ M.-@]W<-%1YOGQ1>&TW%,0HA-]<(WDX28+N0`TWQV8R\TEN.D)A^\.(N?TJ3F M%I3$RUK?"F[J^,7;F6IO"+;K8/W+"ML5?T8].Q.4+5AOX5A%6$H)!*UZA"OD MMV[@)'6%0XP/\#EQ\Q M+ECN$RR#S?9N"`R#8T8VZT<[BBT3U54776BV,?K[]".%:AQK>G4Q=1$E3NO? M-]E.Z?M#5.GSJ]'?IC1;P7-D6S$5S,SGRT\0Z?T*')7^)#=G`S,$X53C"/FJ M(EI:SM79N_/9!RB#XQF:XUFOS"?=)U1=;'G5Q3CJ,6F6I*0!R45XGJVO8HZK MB!P@]-'>3B[J8*^$VPY,B%@_[#2]^86WS6I(%*X/Z:LQ=%6VAZ]P@H4VI$273>R?-3?4_$H,YI4FWI`TU6 MUY83.2@@ZM1&95M=Y1,;-OF\F]O=>3O\XZ1))7Y&)ZAN053G@P&+J^?;0<=* M[16ASCQMKC?#(=3_Q`W<,(46$D/4'?[(TST0WPF>-#C@:_[+_0F(6)UD5^D1 M4"?\:*S_>!*_>CE],-JC;F2'C/M=5Q&DDQ#O>NUO=YBN>LA+D58#>_DO]]Q` M!4]U0R\FJ"!_.-&(NV*;I0]>*G.>^^-UC=])83AR+[4JH8*$*/2`X$B@;N"2 MU'003D>["8=!#DK,D&9XCE?1_'@N;DT3:K;'WK$`E5X!A\9R8X\XF]BC.K_3 MX`G$='`#9OWO-?^9_TO"_*]_V=K\R\/OOT.PL=#LP[N__N7H:+Q-X<58OYX= MH;'Y=Z>T")GS:M7OHS=3Y(?^>H%[%AKP:?2+AS;S[?=1$5897IR0[?3 M\__Y[Z0N2)4.F+MD4P#D$X\>;7WY?OH1:X0%%S>**),=+ODLNC\C"5MZ+O<8 M?+:64!-NIXUXSGR5WL+5Q+(:F+OK+!,SH4Q`ZX4!NQJ0LXU7C/IXS05\<`,7 MK=6ZT&HG[3G-QN&RLTT9SAR@M)Y--D;/%DKU07>M]_G M9!4%D.E>45&%1V:OM)HI8$J'''M"RBR4-GEO[Q>J$6;6WA5J03.V3G0!<*[V MM(L>Q&(9A8%!.-#Y&PE%#&A*5A;80Z0+^:*QJ44@*5A"UUOVJ?) M$@$M%ZGI+=Q(2$9"-);FXAH?=ZOCHKTUW3H]5IMZ(05RQGD(=5P3BN$`7&`3 M'7+/@F`9U,WQ?P6)CO=FL\_3S]>_7E_, M)[_,<@[17`>6@K3&K&@+!9*8O55I&"X$WX)2IM"_$(1ZA"(H-(T'`D7%^]'W M=>5-1TE$`)-:D*ZHV.^AM?*QOA8F/TZ:AJ37%3YFB>YK03@ M7OQ7I];DU>P#6J$+C@UH*C[CK8"YL/JUY`8!J(C8C79K`LU3^^IE!;V;_]EV M\WDT(*#9B/0-94[^TSB1OC$$I1+#6VN$>I3)X/^*VXW?U0Z1`Q#J;1L%`U[S%%ZKT`E=8 M='Y[XW&=B89?5<-F)"%5*O0Z1?L;R&,R(4T/ZKF^U==\YJG2T!E6 MY8D$WCH[M@&A29MD;`QL;8Q>-9R:G7(D,,F(B97$ES^/5KC/(U6>OU73*V%W MPWR/L>=FWM%_G=U*+<[EPXP8`4T6+/E_+>;4R]>%-NL(I5/CB1V1=$(P!L?J M.6:1!%(F!_B%N'],?A@])2_O7'[1&SK(3]11^(/DUL\V\9!X24L(J`G$&P&U M#/^?-T_JC5YX)$=VK^@:K[JDZ],)J5@K+)8OL.*L&UB-WN3>LC".KWE!5BL# M#?/QKG;*R/@52[BW`K#C]V#F4@A&^6"PR@2#8L^UM>(8,+8K4U98LT/FU96Z M7RX_$711OJ58G3_'G[YQRU=KVMM;R+L&LGPA^W#YS/D0/``$B2P9"$POUEQC M*A%>B+.CC02E;RF.G"A/MZ<9_$I@K3-6FS:P5YB6_+,NYY=O*'(6@%&?_TUC M7OE2,J3Q`Y/@H)&/J-.X:6&@H4%X%^4.1Z@NT,CWL_$8V MR9548Y]4]GCC2']N9<,K<)3_3Z6OK8PJ5!_YK)4##*Z:]5&FJ2U'JWSD8`:: M"9D!:^RK2/M#/7EP-?]V=._'D\/1G8[8S\5D6^QS#A/[/S_'$!X=4V@R_T^W ME)LD/7^^/"C?G1RDMBOLYQ>6P=*90X0OI>.GZ8QJC]G^@C'CZIBO"K[M*OB^ MZC+C/V>9'9:I7T,#4K3#7@J*,J2'28N'UQ`Z?^`(PG/&K+PN2@W.K!,#")AQ M^PKU?%6(BQGA1JO"/3=BHI-KB")RNSB8TR4',;-RE%F@!]B"/`E=?B?6K/[9 MXA31J:1$0I=$ZWV-2+WU?.@WN*;*L5'EBBX%#%090^1]E%\&.18'I,LJO_-\ MB![MN'*G?C[5#RSF=*&X(@D2^( M>K/`AZAXTXH;/LY'SU1/7=XDB6#T7"663P+@N/PC)85..M-^IC MH2X6QF%1Y:0&PTO-]'!_4QA?'F!PVF=_<`%J(?!:.0^5H:.^#34W)^:%:__3 M);B*'P/E_M7U:"?DWJG&[P#M4Y3;NP9DJV8/5`14>_C.:TYBWW3!A M@\.CII=;C+Q2'SJ@TQ3FLRR_1],A[GL-CR56'G/3E7(V>G[UOHJZ^166,SH: M8#/4Z+39%J`Y]$1+H$=9'\X+2S7A)[_(\`,@8(1D69M.\Q57/9.H!*>-S=KK"\UCR0*=G4HU<\"_>'X]8K93"$ M%Y-JU]2[P?WF%?M`_$G*!J)@%<,X"39WKB+\+6&MW'SO`BT(E"-:?Q3W*8YU M2F."9<>*CCASW"VSF^+'A&IL[7)#4<;V>NJ631X'5UQV`S:(0._1@]KE14EM M+'K%3^?3B]O?)[/SVIQ'"_J>X/,B\03V<'2)%DD`LTKFYBA0%%YZ'V\-NB.\ M^OG;<_S,RF.L+1_!-03KI5)1/%"L,4U&A`MCT!-67TPN41GU*'.'\U,@B)%( M3B3>X1()(M>T`^/%"B&47H1I?6N6(U^3@3G!:4N.W#%Y!N/>+3PLOKAG:4%<'C6RLJO-3@JE:R)JZT.>'73IGWZ`ACMCW_8%G MV9<@+[RM2[=B[MTFKC-HX-L[M8A1.6[*==],E;,*]?$HG^($Z"-Z&>B\BK3D MYH?WLE%5.B\I9T_6'H$%E45?7)Z]Y[EPBP`1H7C/NC#6*]ZE>CJY_K6Z=`5& M`VZ17+4CG!^]V^&9US.]*#MT?[4%ZXZ$QL0+.3VSX`B_B;['+UEOF7V[-8SJ MBP\/X@,@'>5W_P;-.+8?+Y'#&#:\)5PS:7_;N*4E!%^%+KY5` M*:(,B-1!5$2RQ4R!7)`ZI]PTLC2:9[_PRXH;B)W1AH>D&/)6]4-,:"/#EVJ5 M#Y>2Q)-82P(7"[8&*6+JRT>J*2NBA2L]B1HKI8$(U2BX$@*0F!-[YGEFKB2+ M"L:L/FLB]-9P?/@IY]L(R+`U3K$?I_!\21`:/J@=>W&(5H[3\DL_?3A3.RWH MSCB]',Z.H816=VLE[\UBZXR&2GW?X6@)UN^)(*A[*PN(ZR/)Z!6"HT`0?'[\ M]-4;>F\LYJ.=;Y0_^>X7NCO9AL/?J.B%+\?OM\E&ZH..CNT9FTIP&I$9]TU> M/D`*9:@SL50GKEB0B(^G97V&\\H??9(.(2AOV:7G(Q?7>!2HOVAW$8B#[-Y_ M5TF>Y3MJ.$T!8XT].5>=9.+H^DBVQ1!"1Q(&C%L/'BM+RX_E=6AW=JPB3ZGI M`K1:/Y"$H%03?^[[@:-P^KT0D\1`I6CQ>3Y:40F>R^3E4L\XMRY62.]^A7B0 M#V^@-+K7XODEO!T*^(P.SK\PXO`)46`EGU1)NE\R1EA^Y?W2^D:&$I,E8,NA9I^&`CSKDX7=&QITEMA6:#!*8C`B?QI% MA8QWY(CD33^^%C/0GQ!$1XF97)'1'N0-KFCX9[DVRG+FDG`_IV8KO\NU$G#Z MZ?D5Z2/41=4T^F)'RCK*/+:D,N/M44@8S2C9]N6:G3G<4*9!4.!62P>$.#[Y MO3UNXF+Z#%(1W!5HW\UDR-;V@ZWQ*G*$!TF^Z7#?[DQ*['>W27RSA6;*Y3FE M[2)>!QB8.5-Z4PB66:[#QD*N1E+ZX`D$>)1`[KGWKO?LK1ML'LR]`3OW5=-J M7ST]8VM./)/NYBO/_(->4U%*8?^?HW.O^@$Y])T'!&N3%7MKJGG&>%4'U[>( M,,=994BQ2@:!^/+C*#SU*$8TX+I,H%ES7)P5F*TYLA^8:TY2G+\-LC7G"D?I M!_^:KSK'BK:TZ70&G)?>WZJSKW>2J MLR[EAYC.)<=16D.K7*1X)6\][I:>P:MQD/`<7NW/Z?)J'[QENW7^.'A9"A35 MIET.N64VN3',WE1?9Z74R5+]-N-E0KH4FBBQ-6,BL'(>42`C`80PPAM["'SH M"FK+CO:;3N\J_6N-/?2,4Q)B,3Q:BZQ)I\.JG`,;%Y MC65SI&ZRT107(X?7'@]O*5/E#IYAATP_HY:?A-YIM2UQP/3"JF$?8/9\H-;& MS:_ZDM(G/;U*/-/;DDG0FL3W?.U.<+NVZ%>`@Q(1K(KK%)=`>?J[X4D6HG)6 MQ#O'X6,Z?_GAG['!M^D]%WOO_?]B"X?QP9F^3`F'@8?16G>>TPC9XOEW!8VD M4%%*K`_=(T[5/2(@AT(L9@%CQO5'NUXL20`XFLXN:%"D"$7?0:+!7C-'&IK( M<+9JO'P%U$@'SQBO&4&$N/5ZM(7/_@WXD-;-Y.AJZX9X=@T-YJH:,,"$#UMX M$"\:TU6)`G#R"EO(A*JSC]J-[5/L3(=G9JK>1B4A*=]D[33#AUD)IY-C28+7 M0OX6Y^Z]TR6P_2J["00TO)N[N_T^M#\+9DMVMV6[*T'8$.\7"+06!KSLDV+* M4`GJB4O!O/U-!8W_+'A9X#VH/*_HA0(753^2;LY;RGQ9&B\C#"Q>3-@@9N1_ MD94^I#-ZND!-HX1L\=55#?6,8?JH,%`2+!1,S?@3UF0&C2;+FXL%:NIG$MERW)&RK' M,'`OCUTA;;>[G65VD.7E150NH4`#@I27MUG^\:F_9VO!MYJ\?.HO0-?^;,[. M<)L#B:5!\BW_D%<]ZM%2,KV`HU5MAK9&M6U5+ZQC\#67:D$$N]4.+@U,EU%9 M"=X?F_=,?R!-1"E]X7;5&**+$^5X7Q6O>$2D5Q'KG).T$^'Z53_$U%"ESS*O M;>Z7#?'V3R'N=1/C[=BZJDTGSP4$\!:U0U2QVHY&R[`^W]G[=$@+0Q.8\J1Y MZ[4PM)>R1$G5ZXBPH`!BQYYW`A8DNOZ*O4I6G'<>>9F]K3$8M>?VO_9#&W$3 MWZJ#R)_UQ,;_]?L:_>M_I<P^KY M2#0RRF-V-6GHM^EI05\(+)N"'/D%_2@FRA21H](@6,)'<).,C]GOJF-0[S&Z%W4K0,I-#+*06/M9*3KP MT_+^28[),A6?J"Z4KE@+6ANW#^?SV^_\5```` M__\#`%!+`P04``8`"````"$`'"<=:]L"``"%"```&````'AL+W=O28V MCM':Q@*RV?W[#I`;Q$WC!\?,',Z<&0;(_/ZM;;Q7P@5E78XB/T0>Z0I6TFZ3 MHU\_G^ZFR!,2=R5N6$=R]$X$NE]\_##?,?XB:D*D!PR=R%$M93\+`E'4I,7" M9SWIP%,QWF()0[X)1,\)+O6DM@GB,)P$+:8=,@PS?@L'JRI:D$=6;%O224/" M28,EZ!Z!8TX;*=TV*O+:8/6\ZQO&Z@;S?HC$N M#MQZ<$'?TH(SP2KI`UU@A%[FG`59`$R+>4DA`U5VCY,J1P_1;!6%*%C,=8%^ M4[(39]^>J-GN,Z?E5]H1J#:LDUJ!-6,O"OI<*A-,#BYF/^D5^,Z]DE1XV\@? M;/>%T$TM8;D3-:5@#42"M]=2U0.0.G[3OSM:RCI'HXF?I.$HBA/DK8F03U3- M15ZQ%9*U?PPHVE,9DGA/,@*9>W_LQ],D2B;_9PF,(IW)(Y9X,>=LYT%[0$S1 M8]5LT0R850JC$$I9*.>#\FH,F`587Q>3T3QXA9H4>\CR$A+;B-4`(CU"`M!Q M%`,I7A&CO#F"]TG,^,BC]2X-9*J51G&6CD:)C5A9B"2=9,D)86F!8ES1HKR. MEA./T6(@F=:2^9G]))_N3C70^-7M>$OGV-)Y6#AE=?1-[$HL#231^I)0/S9B M=0UA:8`F/JO508.R.AJJB.6WNP[HHJZTO=6J_-!#3&]EP-XFL)SRL52`1?!4#&TV='A'&#+/>:J M$`OS#R7F(C'';X\WY!OF&]H)KR$5'&FAGT++&PO=V]R:W-H965T&ULC)C;;J-($(;O5]IW M0-S'IH]`%'LT,,KN2+O2:K6':X)QC&*,!229>?NMIMINJB'>N]J$;!6%074JVUU]>MZ$?__U>)>$03\4IUUQ;$_5)OQ> M]>&G[<\_/;RWW4M_J*HA@`BG?A,>AN%\OU[WY:%JBG[5GJL37-FW75,,\+-[ M7O?GKBIVXTW-<YRO;(\P$?X.F-CT`CUY\&_]]KW?#81,*O5)Q)!A7 M8?!4]<-C;>X-@_*U']KF7Q0Q,_LU"+=!!&#:ZWS%$\64_O\H:R0:G^1+,13; MAZY]#Z`]8,[^7)AF8_<0V3R"B""5I;GXV5P=-3#)2`25Y%3" M))/<12$4>I'"C'H4G$Z1H<1F(M$Z<8^)B9@*A!(\_H`@7B0PHQZ!]Y`92I"` MLSA1.I$4,B<2I6*9%Y,&\.MQRO53#C'H4WA092FPUN$@X]Q-Q2T$8TD4& M,^HQ>#-D*$$&R'24IEZUS\AE)0][R4@Z'C3=U">.LOLQJDB'FBF9L#&_.6@E(8;YLW!4/+(Q3> M')G5V+:0$4O4+!D8QDH8UUI^T)MLV3K'8:\FGC-F5H.3"!:))$F]C.54(V6J MU`269F3!0*=O-30_P+VZN?0=E*$&_EXU7COG-R649]E$8:_@KQGIW,=VZ]0C MP465B&>)(9(TC>/$Y9=R+-LHF_NH]%9F9C58()8#28EX9&*7.*Q-D2A(2F1,R22$[YLK..P1^&MALQJD$+&8&G>RY8*%!,N MFY1AV5;YW%:E-T5F-383L$5/(Z^#A'93&X#69&,M89]J\LH9:$>>V69>ZN__/J&9U;G MXKGZO>B>ZU,?'*L]%"9:Q3!/AV=O^&-HS^.1U5,[P%':^-\#G)%6<)X5K4"\ M;]OA\L.<[EU/7;?_`0``__\#`%!+`P04``8`"````"$`):W\+G\"``!V*>V_W['-5T*%RD7`/J]?/^?XQ,SO7V6- M7K@V0C4Y3J(8(]XP58AFD^,_OY\&=Q@92YN"UJKA.7[C!M\O/G^:[Y7>FHIS MB\"A,3FNK&UGA!A6<4E-I%K>0*146E(+0[TAIM6<%GZ1K,DPCL=$4M'@X##3 M'_%092D8?U1L)WEC@XGF-;7`;RK1FJ.;9!^QDU1O=^V`*=F"Q5K4PKYY4XPD MFSUO&J7INH:\7Y,194=O/[BREX)I951I([`C`?0ZYRF9$G!:S`L!&;BR(\W+ M'#\DL]48D\7OX'MS\1N92NV_:E%\%PV'8L,QN0-8*[5UTN?"3<%B2`K7`I`Y??7?>U'8*L?I.,HF M<9H,,XS6W-@GX=9BQ';&*ODOB)*#53`9'DQ2P#S$LV@TS"9W'W`A@A"DW45JUN*#@28O`/A9G,,F5Q`](J^#)JI/[4DCOH$(0S/D\59T2&` M#KT@Z'>(B_9)SD:^BY9!\_Y67K$*BBRP9K'[G`K6@1G?A''1/LSX9!1@@N86 M3%!D=YXFC0*.9W*/],O@W%&!+5P0X;5JZ8;_H'HC&H-J7D)QXV@"Z>EP/82! M5:WOX[6R\+;[GQ7.3@HC$JE[''@+J#3_\+B/P```/__`P!02P,$%``& M``@````A`.:NP^U\!0``3!D``!D```!X;"]W;W)K&ULE)E=;ZLX$(;O5]K_@+@_`9-`2)3DJ&!W]TB[TFJU']>4D`0UX`AHT_/O M=\PX%!MDG^U%VIB'\;R>P3.XNZ\?U=5Y+YJVY/7>)0O?=8HZY\>R/N_=O_]Z M_A*[3MME]3&[\KK8N]^+UOUZ^/FGW9TWK^VE*#H'+-3MWKUTW6WK>6U^*:JL M7?!;4<.5$V^JK(.OS=EK;TV1'?N;JJL7^'[D55E9NVAAV_R(#7XZE7E!>?Y6 M%76'1IKBFG7@?WLI;^W#6I7_B+DJ:U[?;E]R7MW`Q$MY+;OOO5'7J?+MMW/- MF^SE"KH_R"K+'[;[+Q/S59DWO.6G;@'F/'1TJGGC;3RP=-@=2U`@EMUIBM/> M?2);%JQ=[[#K%^B?LKBWH[^=]L+OOS3E\;>R+F"U(4XB`B^ MY.[G/@)_-,ZQ.&5OU^Y/?O^U*,^7#L(=BEMR?H69X-.I2I$#(#W[Z'_?RV-W MV;O+:!&N_24)0M=Y*=KNN13WND[^UG:\^A*BK7P^:==EAU_"[`TD&GK>W3*0LV8)EN1!2S;`T M$*%8:USR23(P.?`A/%29=*I':(2]$&(F(BI MV<.LB"LX/RB`51TI>#@J1H6CC]L3'!A[%:@SIE:"3@E=/)LBP7J81_$;XCGC MMQB%)!LM7K2.!@/]2B3(K$:,%H+42E`KP4R$(@00!2MMP1-$ MXCZ-PC!<1EH.I#:`(@"?PR3:2K"QB16)-\&G$XH(R/V1B/XY6(5#VHNKJIAH M_1E6C`HRXI[W`VSGXD>-6SHFEDNQA6@$'1.$^.'$!D-B7K$B*%($/1X+,:H+ MB54W$V0VO1!_H25?:KQ*\>J\>_@8FPA%`&PR>D0B?XB(N*H+V6A"D#$XDR(1 M8@KZB\_@[;,C->*JIB;6E=H1:D>8 M$5'EP-J.Y.@5E(C+^J8P23F$C%%"9$@Y7[-!Y40&&\R(J*)$N9V)$59A->6T MW$_@?4(H-CB2VA%J1Y@14>6(XCLC!VNR)>5,A5NFG!6AQ(HP(Z+*$=5W1@X6 MY7%T)JTG00;3:+;WM!)4$H8`,R.B:A&U=T8+EN2QEBC6>MR$F.JV#`TBJ)>$ M\$(6:?T%E58DXOLK?ZGU?LPXD2I'5-X9.5B053G:+`DQ56TIQXI0NQ5F1!0Y MP7Q[T`_;V@,)&=(DM2/4CC`CHLI1VX-')0WFV@+]-4="1CGCMF#Z#D/M)I@1 M4;5`,LUD6B"&]7JC=<2)A(Q:T(X!H78KS(BH@WOW5H'*HW(?B'>0#JJ!#-.HXJ9 M[P;$Z=M$C/XN*B&C&&O#0.U6F!%1Y8A:/)-J6*(MJ6:MXVE@1:@=849$E:-V M`WT#.GHIA>/D290V6BXD$C)&:=PYD%AL;YH5:K%-_,3H2P\O,;#VJIH MSD5:7*^MD_.W&MX,`C@)&4:'0_.G0!QX:N,IV<)IJC@V'2[`$?_9\VY MK%OG6IS`I+]80P8V>!J.7SI^ZX^(7W@'A]O]GQ?XKT4!Y['^`N`3Y]WCBYA@ M^#_(X3\```#__P,`4$L#!!0`!@`(````(0#@TA-HF@0``,`0```9````>&PO M=V]R:W-H965TZ0>J:KZ<4V(DZ`%'`'9[/GW'3-@L*'.=B]V$_ME>/QZF,&[^?I1%L8[K9N< M55N3K&S3H%7&3GEUV9I__?GZ)3*-IDVK4UJPBF[-'[0QO^Y^_FGS8/5;UI;59%=:ILV*W6@%,V=6EVD+7^N+U=QJFIZZB\K"_Q2YZ??\HJ"V[!/ M?`>.C+UQZ;<3'X*+K=G5K]T._%X;)WI.[T7[!WO\2O/+M87M]ODE&2O@3O#; M*'.>`[#T]*/[^\A/[75KNL'*#VV7.+YI'&G3ON;\6M/([DW+RG]01/I0&,3I M@\#?/@CQ5Y[CA]'_B>+V4;PQBK-R(I_XP7,6"]?5^9&D;;K;U.QA0)(!>7-+ M>A7(ZR!'U(F#:EKR6=7)4&P% M.HD:'2XJ_&Z_B1_Z@;(9R1!"MEKBY'UUK$)#/O)1E4]];%"CXQL4\NV[U24X MA^R>'4%)%LN7^.)%/CZJ\L4B`/J'FMX=+_)=HI3+`RJ\SC\U$Z=7.XX=A6,V M27P$.N""@=VP3.C9RCWVO4AGH9`L>=A/XA)=VPNB\0XR)*_I\UTF6.JG9<>S ME1S:]R(M),99-K*_'B%#UR.^\U^4O.@O4&(OD"G'W<#-)BC24@Z212MQ\C.4 MO-0O4&('F%(&:O/=$UV;Z!9R>"Y)M!)YW\&/)58^_*Q:$A1I'7TJ2;119%9> M^T=?U8H)[XCS1UYYK]CW(BTSQNG+0N3$@3=6'BQ-(HJ<*#(M;P0:6NP3TVQP M8^6M8D]TS:3/!I0@K6?'D:M4X40$T<'R/J"!Q38APRIO#GLR])+Q%459SZ&7 M]-9Z)(YLI28G(HJ.EK>&D79H200[QI32]V=E8&@Y&LJGDJ2_U7(:R6G`V\0" M*W8/>-HG[W,SUJ']C**9HT\E"=%))%8XU2VQ=L-RIW)CI5/N>]&R(YBJO03? M/D.;_\@-F1\K^2.,BG$2(?'`B`>DDM87>J!%T1@9NU?@H0,]6HR*@^J+PX\= MRO@!#K#=(=`2$W"LO*47^CVM+WG5&`4]0TA[%4(IJ/$$BE]:=NN.94?6PH&R M^WB%_Q10.-;8*Q"?&6N'+_QT)/[WL/L7``#__P,`4$L#!!0`!@`(````(0!X M?I/O]@(``-X'```9````>&PO=V]R:W-H965T,P0&RK;9Y"#`^ M/G/FC!DVM\]UA9ZHD(PW*?8=#R/:9#QGS3'%/W\\W"PQDHHT.:EX0U/\0B6^ MW;Y_MSES\2A+2A4"AD:FN%2J7;NNS$I:$^GPEC:P4G!1$P6/XNC*5E"2=YOJ MR@T\+W%KPAIL&-;B+1R\*%A&[WEVJFFC#(F@%5&@7Y:LE0-;G;V%KB;B\=3> M9+QN@>+`*J9>.E*,ZFS]^=AP00X5U/WL1R0;N+N'*_J:98)+7B@'Z%PC]+KF ME;MR@6F[R1E4H&U'@A8IOO/7^R5VMYO.GU^,GN7H'LF2GS\*EG]A#06SH4VZ M`0?.'S7T";0#DMR*E2W_GY$V7'4D&W8[TEXQ5D@G]4,WT$ MH'+RW%W/+%=EBL/$B1=>Z`S'*3E+Q^K.O)K_EAYMP)FBR(70FB(FF9**IZ]/(&KTZ MUQ9-4^T,!ARP]B71W)_7,"O+,Q$$[\`K)NGH7,C\P!A,;Y)GVV:$_.CI//:MO9S!#:B>9MV.^?NFO$6#FJ1D@-15'NJ=5)5'&3PVX&D#; M;=2.\;M`O[FS^`[&>SLX`C(LR`-@^*M]W8 M.G`%\[:[+>$[2F$R>`Z`"\[5\*`'C/TR;_\```#__P,`4$L#!!0`!@`(```` M(0"<'&PO=V]R:W-H965T@+DF44C5I.I6:9.F:9=G!TRP"AC93M/^^QUC0L)E:5Y( M?/C\G>]<[,/J_JTLK%[N;(DHI4*2EX16/T M3B6Z7W_^M#IR\2)S2I4%#)6,4:Y4O;1MF>2T)'+&:UK!FXR+DBA8BKTM:T%) MVFPJ"]MUG-`N":N085B*6SAXEK&$/O+D4-)*&1)!"Z)`O\Q9+4]L97(+74G$ MRZ&^2WA9`\6.%4R]-Z3(*I/E\[[B@NP*B/L-^R0Y<3>+$7W)$L$ES]0,Z&PC M=!SSPE[8P+1>I0PBT&FW!,UB]("76^PB>[UJ$O2'T:.\^&_)G!^_")9^8Q6% M;$.==`5VG+]HZ'.J3;#9'NU^:BKP0U@IS$%>(*G M53+=`Q`Z>6M^CRQ5>8R\8.:[033';H"L'97JB>G-R$H.4O'RKT'AELNPN"V+ M!SK;]^[,G0BXAY@F7V@I5NO`0!H,@-@;C7V#.+AJ=VVN(G@@@ MF1"AK3&"4+HP0V_>16%283!!4XG(C3@_(,P8-Z&2%F$)KI45*QIUM:%-)*^*&"N\6%R#IK-X`?FOD[ ML&_T8&Y&:_<"QF5-]O0[$7M62:N@&5`ZLP@N#F$FJUDH7CDT.2GV;J/W\'/\:J4E91?HA2DN.9^@N7ZL_Y M[[]-KZ1X*\\85PHHY.5,/5?59:)I97S&652.R`7G<.=(BBRJX&]QTLI+@:-# M_5"6:H:N.UH6);G*%";%=S3(\9C$V"?Q>X;SBHD4.(TJJ']Y3BXE5\OB[\AE M4?'V?OD1D^P"$J])FE2_:E%5R>))>,I)$;VFT.Y/9$4QUZ[_#.2S)"Y(28[5 M".0T5M%AFSW-TT!I/CTDT`*:=J7`QYGZ@B9[3]7FTSH__R;X6G9^*^697-=% MU`7\6R@$?H_>T^HM<-S@YG2MPVZ:/ MQ"2%DN!;R1+:!:#ET6=]O2:'ZCQ336=DN[J)#%M57G%9!0E]5E7B][(BV7\, M0HT4$S$:$;@V(L@>68;MCI]1,1L5*)>K&"-C;"/;>:(N3J,"UT;%0"-DZ<]H MN(T&7'E-GD\*C*0ZLW#E%;&>K8C7:"#:`5I[GFP-:CV&'[PJ]M,F(^XR_<%E MW&\;I+&.5W=8/ZJB^;0@5P4F`:A4>8GHE((F5+KIJDU_:SLO#*&8XB^4GZE@ M#73+$J(?<\^6<:T^LAS*H#[A3=DA-3LAX3SR#.8".]Y1L,]S\3`4@SX8F`E!@(6Z.?:Z3=N?8\1/-O< M8X0DA4/&1D)9VV\PNR'CV%Z_SOL[C',;X+TA8MU/-PW#:MCKA3>%NK\O&`/? M;4\5^NE22OA28B4E`BFQEA(;*1%*B:V4V$F)_5=$SS?8)W2'2;UPF'J[3M#; M,Q6&7>N-XPB#TZP).JW)/;\A!U;UT^^5-&PZ.--@8U# MQGSE(R/L>K^`$.R@7%V8,GRIR*HKXIH&O;1XWYG\\W''`WW;3,]8;@L&/.5;5+"EQ(K*1%(B34CV-@W/-?SA&5\(Y4( MI<162NRDQ)X1K**FKH^]V^31&PO=V]R:W-H965T#.CQ%C6EJQ1+<_I.S?T=OGYTV*K](NI.;<$"*W):6UM-_=]4]1<,N.ICK?@ MJ926S,)2KWW3:<[*/DDV?A0$J2^9:"D2YOHC#%55HN`/JMA(WEJ$:-XP"_LW MM>C,GB:+C^`DTR^;[J90L@/$2C3"OO=02F0Q?UJW2K-5`W6_A1-6[-G]X@PO M1:&5497U`.?C1L]KSOS,!])R40JHP+6=:%[E]"ZL4UC?ZCM5R[6M85I M)RZE4`THP2^1PAT!J)R]]<^M*&V=TSCUDFD0AU%"R8H;^RA<+B7%QE@E_V!0 MN$,A)-I!X+F#A)$7S9(P2:]3?-Q17\D#LVRYT&I+X'2`INF8.VOA',BNA#B` M3A;.>>>\?0R8#5A?EVF:+OQ7:$JQB[D_CXF&"!]4!BG`_T?*>4&;DI'4=`#U MV[G'F,DH)ADBCJ0`,Y+:5^.L.07((!%-XP&`$A@SPUK#),L&_Y$`[.&"@+,Z M`=>H*`@G0RZRT9V@.\TF03`$','A3%R`.^L(?J@C>P^,P/LSI")Y>A#OK M"'[(13BZK\.G%^'..H*?3A7=U^'NUCP'/8_D7``#__P,`4$L#!!0` M!@`(````(0!&MRT6D@(```0&```9````>&PO=V]R:W-H965TB&,8.`H=,%;HSIEW&L:<,$T9'L60<[E52"&%BJ M.M:]8J1TAT0;9TF2QX+P#GN&I?H(AZPJ3MF#I'O!.N-)%&N)`?VZX;T^L0GZ M$3I!U,N^OZ%2]$"QXRTW[XX4(T&73W4G%=FUX/LMG1)ZXG:+*WK!J9):5B8" MNM@+O?9\&]_&P+1>E1P#4IL]D$R. M)/!_)$FS*%O,TEG^?Y;8*W).'H@AZY62!P33`3EU3^RLI4M@/EHXZ@BFH+34 MHN\MO,!SC$"NANCK.L\7J_@5JD2/F,TU)KU$;$\(6US0$<1`?09B3CEMU.:T MQ;`B-CX`)$%$-DIPC9C/`N0B)7@>I'3^)TFP:W>A68-,>7X;B+P:CYD.,.=4 M#K']%^)"#)`,Q)S\VZB;G6`WGR%"`LSC M0(*?A\6Y('9[K&74W8W'0,*!WG&#KC'GHGD]_M;Y615,U6S+VE8C*O<=\&;@ M-$3#9;_/[)",XAMX!-Q-BL,&W,V>U.R9J)IW&K6L`LHDFH,JY:^Q7QC9NQNR MDP9NI?MLX+5E,(1)!.!*2G-:V%D.[_?Z+P```/__`P!02P,$%``&``@````A M`$)>'BZ$`P``^@H``!@```!X;"]W;W)K'.(E5P,QVFO:_WQD3P(9,?4G@ M^/KNX_.=[?7=:Y%[+U1(QLL8X;3,^(Z5AQC]^OEXLT2>5*39?2!9Z>"ELHX$30G"OCED57RXJW(WN.N M(.+Y5-UDO*C`Q9;E3+W53I%79*NG0\D%V>8P[U<S4! M=[X!'<[YUK_UP=-FO6,P`YUV3]!]C.[Q*L4A\C?K.D&_&3W+WK,GC_S\2;#= M%U92R#:LDR+;'S2GF:([6#GDZ1793?2YC[0$?QVS#] MYTO(QWK9O@EO1_?DE*OO_/R9LL-10:1(#\]X#EKX]0JF"P?R15X-!MNI8XQF M\TFTF,YP$"%O2Z5Z9'HL\K*35+SX8T2X<669X-8.\9MIXKZTQ6L!2Q$B" M]64S7?LOD,^L421&`;^M`MN*]*+02P+!VHB0A)&(VJHCZA70"(DQ]`,$3H"A M8M8JK(B0L)&(V@JKV9M!V`XW"$81]A21K4C_I[`0P,D(@K;&".;1)G%N!TB, MHH^PL!7I4-%!6@A0:",(VFHC+.T`B5'T$6YM13I47$&8CR)HJXV`W6HSDCX# M=LMM*+D"`54]D@=M=2"<>DN,Q(+H"JZNF'0HN0*A#Y^N[3R]_+WZ(H]!)6=H(^J37*/0>-T)AMCZ+ MPFT8/-P>`[=C1C370`!V#$2;[0()W&:!ZX?6]&<;=%%,H8YH.HFI5'.S,,=G M0<6!IC3/I9?Q4PG]BR'9K;6]^C1WDO8#W"TJ*^O$(=TP*1^-T`N(]Y^KRHD_8]M:Z^0<``/__`P!02P,$ M%``&``@````A`+VW5D@7`P``?`@``!D```!X;"]W;W)K&ULC%;;CILP$'VOU']`?M^`N20D"JEV6VV[4BM552_/#IA@+6!D.YO= MO^^8(=P2M7F!,#X^9V[V9/OAM2J=%ZZTD'5"Z,(C#J]3F8GZD)!?/Q_O8N)H MP^J,E;+F"7GCFGS8O7^W/4GUK`O.C0,,M4Y(84RS<5V=%KQB>B$;7L-*+E7% M#'RJ@ZL;Q5G6;JI*U_>\I5LQ41-DV*A;.&2>BY1_DNFQXK5!$L5+9L!_78A& MG]FJ]!:ZBJGG8W.7RJH!BKTHA7EK28E3I9NG0RT5VY<0]RL-67KF;C\NZ"N1 M*JEE;A9`YZ*CES&OW;4+3+MM)B`"FW9'\3PA]W3S0`/B[K9M@GX+?M*CWXXN MY.FS$ME747/(-M3)5F`OY;.%/F76!)O=B]V/;06^*R?C.3N6YH<\?>'B4!@H M=V2WI+($)7@ZE;`]`*&SU_9]$IDI$A(L%]'*"Z@?$6?/M7D4=B]QTJ,VLOJ# M(-I1(8G?D<"[(Z'1(O2C57P#BXL>M9%\8H;MMDJ>'&@/T-0-L\U&-\!L0PC! M)_2C#PIRFUKTO84G9$4/8;V"!=D>VW0&VF? M):S52M@T6LT'-(SY_.M\P82OC27P>M?M:D*`K'V8ODT?Q*(_/S&67=2!,WYJNPN$^F"2/VG-\10./]U1C M*#&FK=V;D*[1_B4RO0/.70!38%X;G\[;H`/A>9D'@4,`K\Z*JP/_R,M2.ZD\ MUG"?4#@!O;4?/O=^.S[Z!1@)#3OP;TP=1*V=DN>PU5NLX)PJG![X86337LQ[ M:6`8M#\+F/(<+D-O`>!<2G/^L/.I_]^P^PL``/__`P!02P,$%``&``@````A M`.!Z)P7Y`@``90D``!D```!X;"]W;W)K&ULC%;; M;N(P$'U?:?\A\GMS#P$$5"U5=RMMI=5J+\\F<8C5)(YL4]J_W[$-(0Y1VA<@ M,\=GSLPX,ZQNW^K*>25<4-:L4>#ZR"%-QG+:[-?HS^_'FSERA,1-CBO6D#5Z M)P+=;KY^61T9?Q$E(=(!AD:L42EEN_0\D96DQL)E+6G`4S!>8PF/?.^)EA.< MZT-UY86^/_-J3!MD&);\,QRL*&A&'EAVJ$DC#0DG%9:@7Y2T%6>V.OL,78WY MRZ&]R5C=`L6.5E2^:U+DU-GR:=\PCG<5Y/T6Q#@[<^N'*_J:9IP)5D@7Z#PC M]#KGA;?P@&FSRBEDH,KN<%*LT5VPW`8A\C8K7:"_E!Q%[[2 M"&2>_*$;SI,@F7W,XAE%.I,'+/%FQ=G1@>L!,46+U64+EL"L4H@3*&6FG'?* MJS%@%F!]W<3I?.6]0E&R$^;^&A/:B.T((NT@'@CIU$".0S61WZE17B@=(Q*4=2`A'61Y;S!3=9A"6"+@BO9$Z"O2:XKR?M04@YD2,X6P MQ,PL,>>F*.N@(L.F&$BLF^)WU=:79CONL^*FHW&5=1`WO;32W$B#F4I^"F&) M4(MC\++V.J&\'W7"8*;$3"$L,0M+S+D3RCJHR+`3!C+>B7&?%3>`.=VKPCFP M-@\BIY%MYR;-6D> M)&OU=MDQ"5M/_RSA[PR!U>.[`"X8D^<'M8B[/TB;_P```/__`P!02P,$%``& M``@````A`)QV7EP*"P``1#$``!D```!X;"]W;W)K&ULE)M;;QL[#H#?%]C_8/B]\=Q\19*#9N[`+K!8[.79=2:)4=L3V&[3\^^7 MDDA)%+5NVX>F^8:D15(4.>/I_1\_CH?)]^%\V8^GAVEZETPGPVDW/N]/KP_3 M?_^K^;2:3B[7[>EY>QA/P\/TS^$R_>/QKW^Y_QC/7R]OPW"=@(73Y6'Z=KV^ M;V:SR^YM.&XO=^/[<((K+^/YN+W"K^?7V>7]/&R?M=+Q,,N29#$[;O>GJ;&P M.?^*C?'E9;\;JG'W[3B3ALK[#^R]O^_4+6CKM?,7?_^T&X_O M8.++_K"__JF-3B?'W:9_/8WG[9<#^/TC+;8[LJU_$>:/^]UYO(POUSLP-S,+ ME3ZO9^L96'J\?]Z#!RKLD_/P\C#]G&[Z>3*=/=[K`/UG/WQ M/_]M?QH@VI`GE8$OX_A5B?;/"H'R3&@W.@/_.$^>AY?MM\/UG^-'-^Q?WZZ0 M[KE2V8T'^"3X>W+3+<+DV>Z4\ MG>R^7:[C\;]&*D5;QDJ&5N`G6LD7=_-EDJ>_821'(_"3EC*_2XM$+^3&AQ>H M!S]1#Q9^0QZN:I?A)WT.J-Y06*#"TBK<_@`H(OT!\//7/F"-"O"3%&YY/C,Y MU+FOMM?MX_UY_)A`04&2+N];59[I!FQATM$UNPU@-^Z4]&"W@,S\-:Z##ON=UQ6 MXLIE6NP3`2\&@7\D02I5".H0-"%H0]"%H/<`\P^*X7?\4^(/4_C;2^F<._2$ M,G[>`Y'2BEBG!:D%:01I!>D$Z7W"7(>B_!W7E3BX#D7G^;X(?$>A6[Y;$>N[ M(+4@C2"M()T@O4^8[W#`>+Y3P2JJ7:2E/2&!8O><7G*G2RM$:I4@M2"-(*T@ MG2"]3YA'<(A&/%*4>X1D;4NT%*02I!:D$:05I!.D]PE;/NP8;_GZ:%U"BZ.^ M(0]7I<`]0\)SM0IR985LK@2I!6D$:07I!.E]PIQ54Z#K([3[%.4>(?%R)4@E M2"U((T@K2"=([Q.V?(BPMWR=J]7Z3DTBILG+9"D-[AH2GJQUD"PK9),E2"U( M(T@K2"=([Q/F;0K#H>"$&XW(FX3H+$.2E2K"2J)6HD:B7J).H9XFZKUN_(>ZWZN+.;YM`;.Z^;XC<>LI4H$JB6J)&HE:B3J*> M(>Z(:M[.D5]*(/9[WTE$/(%96(%6RB50H!IN6?7![`+62-1*U$G4,\3]5EW? M^6T3B,.`[YL_'^B[G3(5J)*HEJB1J)6HDZAGB#NB.GK$$6STOB.V]_O'9!XF MR4JY)`E4IP(U$K42=1+U#''?5+N/^(93@.^;/QA@D@2J4H%JB1J)6HDZB7J& MN".JDT<<43CHUP9!ZZ#PERFBS*(*D1IO;,=+YT&]U4Z*;#725NNDG*TL"6QU M3HIL]GG(4D:.N\$R$S/S'#G^4A#)TLFYQ9$T%W);"E11:BP M4C6BPA5`0U+.5DO(*792L2,H/4P6MW M9K8.GC"5)+6P/E6$?,5T'BC6*)6M,..)_L./L(9,.>LMH9O6NU^QWI,I;9T' M3$TCMP.&\XH?,(-4,7D!"Q_.9$8*=AUME0H1*!*J$>6JM+X_+J.Q$89:::BC MCV.+2H)%]21E'DNS)W1\/-);9YZIL3Y:_W)JR@P*ME'P9*:DM MU5$/4FP#H**K[QJEONE"0_,T%V7LKX@G4?]G$!*"<>YVA4LWVC+55^-4KFIOD_S]7*1Y$'Y-=)42WK. M5$<(32U6ZSQ=!<-#STSQN*B)[#?B8@8X_[8^,RC8*^&S)I1B>\4H%G`^VG81 M:9,H98HW720+^$HMZ*6-M-XBNFV](RFT7A2K/`T'QIY99]'+^71(%:4Q/P<) MN1972E1)5$O42-1*U$G4,\0=B4]Z4+3A&4<(TF*SEB?!WBV=%)T#E42U1(U$ MK42=1#U#W#<^_-DDR8D/6JUVUT^20)64JB5J)&HEZB3J&>*.J(''U:IUQ,Q! M?DW"P:)/(>AI-DG9,C@52I)R+:8BY%I,C0B.$-6(4SAT@S[0D)+L.#D?GNR* MY92D)>'<7)MVGZ1!B9-0%$PFL& M`Q9>@Z`5Z-DD28,^5,+4$G8!0GYDC11&=IXLED$9-:04B6Q\*,GE4(+(138< M/5&`118'&5<(-5DVD4V765(L@@W5,$L\MJHQ1V)K^C6++4X0-K9!`LL1K61T-"\@XF5QW4.6.+T#16%GN#^(BS%)L;I?P$((*@ MV_-&MG*]$*AQO..-C_0D)+=\$6^V&O-F2\AMWU*B2J):HD:B5J).HIXAMKN* M>+/5.'`$^R^$U\8U3X)]7)*B<[>2J):HD:B5J).H9XC[%F^VA6RVA-RJ2XDJ MB6J)&HE:B3J)>H:X(_%F6\AFBRBHFN!L+$G*JQI"7DM`1,UVK1Y\!(^$2"M2 M(/%NJT;@X*XL)X<&$`O[!Y'3L(4N634]8S6$.%*O]O^VV4-U/'DL:!U7P MLW:+.OY-%R$_MJS=ILE%F MJW5DN4;-6.+;5_6_2'1-6_0/_<(@-\R$#9<$_)UK==Q>,(AV;KXJ(LM%M4AT M5==SR_U9PX7'Q6)+&P11=T>E;+BHR$(O&RY)F8:[@C$RX@NJR7Y;J&9(OJCG M^>9U18V#C8UM$S:=/=XST6]1D>UN5(1X6D79;TD1)_<\B^YX-`4[R9K*YN[V MG>TJ>.]C4O?!Z'\^M0#H?#9;(;OYW@@^'6]/'>8O.6 M\5,!KQE#JX$])JYD<$4_!0FOI,N-^AHNHI.NX(I^H!/JY,E&W1M'=')8`=Q, MQ*[`"N!6+7*E`&O0_"-74K!FO@<*5Y""-?/EB;B2PY4\:JV`*SK`0F<.5_3) M)ZXLX(HNO_`*J$0U0"$J#V&.1AF"'(WQ>@/O`,5B`M&"EVKD%?AF<*.^]Y-7 MX'N^C?H63UZILF2COBF35^";L4T7O0+OLG^.YE$E*V+I"5(5E8=$Q?+TN=A\ M-N_*AR&'_)GZL!?@U?;W[>OP]^WY=7^Z3`[#"Y1&HK]M/)NWX,TOU_%=?>LX M^3)>X9UV_<\W^-\*`[R_G*BO)E[&\4J_0"QF]O\_//X/``#__P,`4$L#!!0` M!@`(````(0#)PP1JL!$``(M?```9````>&PO=V]R:W-H965T/I\Z9[/3D\W+P^[; M]N7'Y].N]?^X.CW9'^Y?OMT_[5XVGT__N]F?_N?VW__Z]'OW]N?^<;,YG%"& ME_WGT\?#X?7F_'S_\+AYOM^?[5XW+[3D^^[M^?Y`_WS[<;Y_?=OGXZ M=V>SB_/G^^W+Z9#AYNTC.7;?OV\?-NO=P\_GS;H_4/OWC]O7/6=[ M?OA(NN?[MS]_OO[QL'M^I11?MT_;PW_[I*F?MP]ON_WN^^&,TIT/#<5MOCZ_/J=,MY^^;6D+Q&X_>=M\_WSZQ;GI MEO/3\]M/_0[ZO^WF]U[[_63_N/L=O&V_I=N7#>UMJI.HP-?=[D\1>31"N? MP]I^7X'R[>3;YOO]SZ=#O?L=;K8_'@]4[J58Y6'W1)]$_S]YWHH^0)M^_U?_ M\_?VV^'Q\^G\XFQY.9L[[O+TY.MF?_"W8MW3DX>?^\/N^?^'($>F&I*X,@G] MG$AR9,6Y7)%^3JSXP4]?R"3T4R9QK\\NG=GU_)(VX^A?13QCN+LX6[O+SJRW-DS6NY)OW\ M9TUTJ*\-/4)TNJ':QQOIC'V(?OF'S72XZSBJ"WRP>@[77?S"VWCYL;U#AX+< M2*WV'RNAP\47OWQL_W#5'57VCY;1X1X@?N&-_&!#N0LXJ@\<+Z3+I1>__,-" MNMP)Q"_'=LOY<`+J3USK^\/][:>WW>\3NAK0>OO7>W%M<6Y$$GG*DH?'>!*C M<^F#"/\BXC^?TBZET].>]->M@T,(I%9ULHUF(Y'EMB,=T):,?6?&85XT[&Z`?@TJK7&#(6#,0#\4$"D!`D M`HE!$I`4)`/)00J0$J0"J4$:D!:DT\4H(5WUH(3BNC;<%.#Y4L133>DZ,IXP MY[.Y6;$[&72LJ&/(6%00#\0'"4!"D`@D!DE`4I`,)`.]_F=%+JT:]5ET,>I"YRZ]+OU]Y/SJ3`QGWSLUBE7,FDDQ#R_[ M\C8&C8<7B`?B@P0@(4@$$H,D("E(!I*#%"`E2`52@S0@+4BGBU%&ND[I9>0S MH6"S5%*TPPMD#>*!^"`!2`@2@<0@"4@*DH'D(`5("5*!U"`-2`O2Z6+4A0Z) MJ;H(-NLBQ3R$+JPKU!@T'D(@'H@/$H"$(!%(#)*`I"`92`Y2@)0@%4@-TH"T M()TN1JG$5,Y4K7HWB\6D'45(:R0/R4<*D$*D""E&2I!2I`PI1RJ02J0*J49J MD%JDSB"S6F)@K4V`\!E/3*]9AQ8355Z[^[NTCBT5-1Y<2!Z2CQ0@A4@14HR4 M(*5(&5*.5""52!52C=0@M4B=068!Q6![JH##()Q&7ER'.S'M*6JJ'VY`:XSR MD'RD`"E$BI!BI`0I1H,,@LH M!M%3!92#:[V``PT/W/IIWI5X:$"ET6B-Y"'Y2`%2B!0AQ4@)4HJ4(>5(!5*) M5"'52`U2B]099%9+C*.U:O7#LJMK,2P;+W1RJ*T7;J"%>>1=VT?>$+6DVQUU M.734LP"S(6+@J#5D_'0YH-0_71]CRFX#M!;/@>R#',C'J``I1(J08J0$*47* MD'*D`JE$JI!JI`:I1>H,,JLEQH=:M8:G0C-7=1HY@-3+-M#?=9HARNHTSMBU MS&:(X9#6C+'3R&&2_NGZR$EV&J"U>)QG=QH@'Z,"I!`I0HJ1$J04*4/*D0JD M$JE"JI$:I!:I,\BLEA@1:=7J.\W%_(Q>!Q@+)T*L(=!`?]=MABBKVZAG(T9# MQ'-4O2'\Z;V;G\ZDW1$BK9$\)!\I0`J1(J08*4%*D3*D'*E`*I$JI!JI06J1 M.H/,:ED#L(EN(YY+6]U&TM]T&QEE=1OU],5LR#L#"1<'$DQZM\&!!$9Y2#Y2 M@!0B14@Q4H*4(F5(.5*!5")52#52@]0B=0:9U1(W^=K99CS(Y-``LE#\I$"I!`I0HJ1$J04*4/*D0JD$JE"JI$:I!:I,\@LX#L# M"1<'$DSZX2:C%*TQRD/RD0*D$"E"BI$2I!0I0\J1"J02J4*JD1JD%JDSR*S6 MU$#"68J+^\GA*47SWWL4_9`-)/#!]A*1M%T`=-:DGM!J7[= MNC-'G:W[VSI/!?`Z/E*`%")%2#%2@I1*TAJ>J2C9<'5WTC<\5P'<\`*I1*J0 M:J0&J47J)`T--RLL1D]3)U0YJM)/J`,9E92D5W*@I:JW1U45O4(C7Q(-87FO M!!@5(D6X8LQ1="G61J36\\-$1?$GIIQ+M3[C*-7Z'*G@%57K2XRJD&I&H MHZUO512WON-O-FEKCN/$BB<,W=R"CII+47EES5/\.M3P>990BGZ/4BH$D MT?W>+TVHHGCC(LP5JR@]E_6,*U%1G"O%7!F3:GV.5#"I#2HE'=^@2D5Q(VK, MU:BH(QO4JBC.U1FYS,J+8>W4T2R'N_K1/)!1>4EJ>]>N)+6C/"2?2:T82+)V ME/74)%11O'$1YHI5E+ZCK"GA1$5QKA1S94QJ@W*D@DEM4"GI^`95*HH;46.N M1D4=V:!617&NSLAE5GYJ&'[L2HUCFYU!13GRM149PKQ5R9BM)R.=8VYBJ* MC=G322)UQY5 MY5WK?F?%41?CE7W-I%X_]IBN^ON]I7MQL9Q;5VR?8U2F@(DN/F,3G*4UI@ME MU%S>3)[9;]-&G$9ECIF.9D[,S/25+NLV->4T*G/&I+8^9QJV?G'E7EUK,^A] M3RTX1F4JF8ZVL9)1X]8[UNZI.8W*W#`=S=R:F6GKK9[7<9H^L]G-K.D>OB69 MXQR/)/%%BK'&<]?:T2L911-,W,G7:D4FC].+$99F<75H,B#E`-BC%-PE&<9FFE23E`I*HH4'6P5SS4M6:!G.T'#7D<,[L,V7'`7T:LU^(^;.)&Y:YG%?3;E@D6:PL,^NV-N5U5)J,2:7))?%FS<67\L9G+/*T,NQ8>@C$!TF) MB2I)XU9=63=N-:^CTC1,JCVMG69NI>EXG3Z-V3&LB;[A6=3[,P]SG`"49)U( MK!VRDE'&B63(1=/(O(\\CA+/PJC#7+K7$QU&KJ8.ED`U@3.%G(D/EDOK/C;B M`)4FQC0)1_&)Q+HY27FYRI(QJ1F.<[2A1-DP4$J52F)=BUO5\51\D1R M-IM=Z_]96UESN$K:8-*6HW@K[9W5<4"?QNQ`[TPTSG&B49)U9K$.P15'J2Z_ M9E*7=H]I.+-<7LRO+J^L+N=SC,H4,.GW5A,W-K+MP\G&.5M858\XCO:6U]PC,I4,AUM8R6C9!O=,\=.>4`=9+(5&;>%[DDWA?NPG4;,?BCG6J1NI8>Y5?Q^21@9]UU0G[Q72 M&LE#\I$"I!`I0HJ1$J04*4/*D0JD$JE"JI$:I!:I,\BL%@VT)JLEW#IK2#*' M0U;_7LW'*#XLUD@>DH\4((5($5*,E""E2!E2CE0@E4@54HW4(+5(G4%F`<6\ MZ-3A-LR7&H>;)/UP`UK3&M9!Z2'Y2`%2B!0AQ4@)4HJ4(>5(!5*)5"'52`U2 MB]099%9+3&-.56N8WJ05^:BYH[?$91W456'NJI-N/XI:J2A><8WD(?E(`5*( M%"'%2`E2BI0AY4@%4HE4(=5(#5*+U!ED%'#QSBQE[^;YDDD[W)#62!Z2CQ0@ MA4@14HR4(*5(&5*.5""52!52C=0@M4B=06:UWIGL6^!D'Y-Q=9M;4S$K%34> M;D@>DH\4((5($5*,E""E2!E2CE0@E4@54HW4(+5(G4%F`=^9E5O@K!R3?KC) M*$5KC/*0?*0`*42*D&*D!"E%RI!RI`*I1*J0:J0&J47J##*K94V5\=SZ`J?$ MF,S#S1I'KU24.MQD+E53#Z-\I``I1(J08J0$*47*D'*D`JE$JI!JI`:I1>H, M,@OXSE35`J>JF%0=5DAK)`_)1PJ00J0(*49*D%*D#"E'*I!*I`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`KV03]FFEM!;\K0]4TOHG7?ZG'[)^=AIZ"^D MO][_V&3W;S^V+_N3I\UW.JW.^N\8O0U_3'WXQV'WVO_AXJ^[`_UM]/[71_JC M]QMZH6MV1O?4WW>[`_^#=O+Y^&?T;_\G`````/__`P!02P,$%``&``@````A M`"-,GAWA"@``VR\``!D```!X;"]W;W)K&ULE)I; M;^,Z#H#?%]C_$.1]DMC.I0G:'DQ]-W:!Q6(OSYG4;8-IXB+)3.?\^T-9I"F* M:J<]#\?3SR0E7B31CJ__^'5X'OUL3^=]=[P91Y/9>-0>=]W]_OAX,_[O?XHO M5^/1^;(]WF^?NV-[,_ZS/8__N/W[WZY?N]/W\U/;7D9@X7B^&3]=+B^;Z?2\ M>VH/V_.D>VF/<.>A.QVV%_CS]#@]OYS:[7VO='B>QK/98/[GI_W+F:P==A\Q=]B>OO]X^;+K#B]@XMO^ M>7_YLSS\^_1^:E[+4_[^W_L MCRU$&_)D,O"MZ[X;T?K>(%">*NVBS\"_3J/[]F'[X_GR[^ZU:O>/3Q=(]\*H M[+IG&`G^/SKL30V`Z]M?_?5U?W]YNADGBTE\M8@6RW@Q'GUKSY=B;Y3'H]V/ M\Z4[_-]*]7,?K,1H!:YD93E9K&9)]`DC"1J!*QJ)K]C(.Z//41&NJ+B8K*+9 M.EF!!^_HP=W>=[C2@*M)-)_UGK^CMT0]N*(>+)MWY%!B>H11A1>R,^%K;F,U\D/N@\$'I@\H'M0\:!TS!_R$(L`P^%00C;X)`T[\CP%&)/8])@E0R M'^0^*'Q0^J#R0>V#Q@'"8UBSG_+8R,-6(]*^EB[>H8Q;&PLID@XB0Q@4R14I M%"D5J12I%6E<(J(!&]&GHF'D(1JPTG@5S&?2USL4>B\<@\@0#D5R10I%2D4J M16I%&I>(<,#^ZH:#EK[!O=C?BN/%Q.(@#WK M]&9N-*2S2&1&_;UL$!HRJDBN2*%(J4BE2*U(XQ+A/RQ'UW\J6X.EDTB62P]`B)3%LB-Z1T$!K2IDBN2*%(J4BE2*U( MXQ+AI.DZ0E[V7+I)R,F<1IE&N4:%1J5&E4:U1HU`TCG3(X$(H)10/*".4#"C7J"#$BB4BT]_S9AUY!W3%4C2)6MB2SIGN(N2<[3J$ MF[#HHDXJX?>P77:8N$TXAX[EED40R'EE-U7N>8LQ3-O4`$^2%4LI1C:ZXJ M>!B1%&MA2\;!M`=.'(;E:;BW]U@$#^7NZ$N9A=3>^[(W'$WB3X_[G'>8U&>W'D<$QG48H M.-B!N,5@402;_#"S9.ZYE$)43'#B_E4(/O<-BI2M'*424WT_;^?)(H[];:K0 MEDI$,`6R5)'4NK^QE)8U0BM.9$>(5 MFR-*X$@<;,4SK\0+4F1;)2&V57W(5DV*@?2;ML0)P6_W"&QCW-!8Y)6%][H@ MC:R4*`M$?%SD)!7WR?RR2))HY74X!<0B60NO%=!:3Q(<3(5RK54H5&I4:51K5$CD/37M$PA M?VTK)?Q%Q)E+8X4RC7*-"HU*C2J-:HT:@:1SIAT*.8=MDK-KFX5LFC<^*U)" MW(9FB,QE6+_1PGOKE;,4I;S0J-2HTJC6J$%DIRK]-3V-X^_OCFW3FGNM+B(1 M!ROEM.,92HG6/EIX+5;.4AP':PON$"JU5*51K5&#*!0'TW!])@ZV01/%CCV; M6P^(W'JP*%[9=F(6>2=H#G?ZMI?/]`+1@BV7B.!9A:)2L:+IA.-9Y`6W9@'2 M:NL)IF`==S"O`DLRPX-5K$B#U21% M@_F_ZS6L$QY,1,P\PX0BUG/9"B+R:LPKE92D..T9(2Z.G,R[3U")G^A"*Y:$ MV'Q%B,W78?->8]\(11D5KX>D.H*G77\71N35D?],C5)N';$BI38G*4RMK,6" M%<)Y[3O2DFPX1<2*-%)-4L&1&E8(CR1C]4:/F>@>$Y%70=Y>DI(4IS@CQ"G. MR?RLW\_]YZ&"-<(N8+#L'.$-!$6F8D5"M3>4MT2D;+-)2!'2K!1M/9 MH0CQ1I-JE&F4:U1H5&I4:51KU`@DG7NC0TUTATI(;K_^XQ5+43(RC7*-"HU* MC2J-:HT:@:2_;S2MB6Y:";G)1"E&F9;*-2HT*C6J-*HU:@22SGVR0X7F0.V- MV(YR_Y2BE-NA(H(>$?LG[US,68"JH-!F2I8*MV$5"Y"96IB1WIMN,+1.;9?H M]EZ)17)76_H/ER3%6TU&B#O.G!"^15K.UZN9=Y84),.62D)LJ2*$EA:SYFZW.2_[N'L\1VB6"0QK]#Y!6%=W2D),6IS,@6/[KD MB!;NHZQ^W:QME=I6]2%;M;`E0C-_HU_LN>P7$7F%X2WN%*7P%L]"62E)C2Q4A:RD*K;":+?&)_N;+5/C>5!0++96>>Q&Q[6,_ M&QM5^Z6I_=3OT)X>V[1]?CZ/=MV/(SR5].M@P/83U[LDV9@C&"I-W9G#G=ZX MNK.`.WWSY-^)9AOSNWC`6@QW;%9\G1B^LH5WCB&=&.[TE:MT8-;P:BND`[.& M]T*!.W`CR,&9H"_+#7QU$["SVL#7*`%^M8%O.@)\O8'/(#2'5RD;\W(C=&>U M,>\/]!UX.0`ZH3M9LMR8DTWKP$FV,8>5O@.?-W\-1A<2$LX'A#9@Y\Z44(!_ MG6^^VL^GO?3!9PD;\]&!GA+\I@]W0H/`#^)P)S0,_-R\,3\FAZS-02=T!][G M02#[M$^'R<$7UR_;Q_:?V]/C_G@>/;B?&9)#6_>?OYU/T==V&+O^\A"GLWDFWW>7EX?X[[_8 MITTG_M(^Q-_;,?[\^/-/]^_]\#H>VW:*P,-E?(B/TW2]2Y*Q.;;G M>ISUU_8"(X=^.-<3_#F\).-U:.N]F'0^)=E\ODK.=7>)I8>[X4=\](=#U[1E MW[R=V\LDG0SMJ9Y`_WCLKJ/V=FY^Q-VY'E[?KI^:_GP%%\_=J9N^"Z=Q=&[N MOKQ<^J%^/D''J\WW<0`4][ M-+2'A_@IO6/Y(DX>[T6"_NG:]]'Y?S0>^_=?AF[_6W=I(=M0)UZ!Y[Y_Y:9? M]AS!Y(3,9J("?PS1OCW4;Z?IS_[]U[9[.4Y0[B6?TO0G>!+\&YT[O@8@]/J; M^'SO]M/Q(VW%B'9\;1\W;./7G?Z51JEQ))YER`I\!)SV62#Y:HDE[I31K2B,B8F"D(H0 MYA(4!2AVHM"+F5,A5C]DI\@6R5]A^84QTM-*0BI"F$N0-MAU`6V<8FV*;,WB M+0@I":D(82Y!0J`>`2&<8B&2+.#T=VJ\]I)DC$R2"*D(82Y!VO@-P!Y3NH"< M8FV*.$DBI"2D(H2Y!`F!I>$($>=EOIGQKB1/:WID\AE8I")XE6V\!!HCDT!" M*D*82Y#N%,KE"-<9%!BKT\C)(44E115%#"&LAY_HM**I/.CA`-%A[Q3BIXY9 M;]DZ]]*EK59F8JF1.S'UVU6EK+*-Z&:K=+G=8M=,^Q&N<1#\I`\$(1L`"D*B M="N>DLU3[V0O4FF0B0N4ZHIFC@T\H%\]+)6>5]O%?.X'X/K&`?!S/Q"`:@=N M%22"*O"F#P%XAWJ1*@.W`&;.S0"DE2I`MLK3W#MQ&?*-`^!'?B``U0G<`"2R M%?`>4J32`%7`S+D9@'J8KD`H`-\[GK8M3PUZ@*IVH];&8F@,E9DMB8; M1%JA\B@$9X8Y&0(;1%EE8N5NLGR=DPWB^L;1\8YDHS-1R$:%=KA$WC%%=HFR MXM`):ZSG$8O)\%PE!MSBV&V_E$R8J4H)*BBB*& M$-;#^Y35(Q9-MIS!FOFHB_+5X6\(T^QLXO*5=WH7>J)M9R5%%44,(:0>UJ"K M7B\*@?&>U<@^O*"HI*BBB"&$]81[:49[J4+X[K;VMD-AK703+BFJ*&((88F\ M!=F"FY2IYN4LP$PA-V4$E=2JHH@AA/7PIF/U_,@]+I-]RMWS&KDG5[[VO^Y: M*YM.YL(-):<-12%O"?JW'FNE5T%)4441 M0PA+##>4G#84A5#*I)6#2FI54<00PGH"#66SO;D"<]I0-,(KT/^F8JUL.FE# MH58,(2P_W%#@98"_HQ42;PFD"_ESO_Q5^=P.+VW1GDYCU/1O%[C0PJY]O#=8 MOF?899L[OIU!/AG9PHC86OY(/H>7$^(<(2/\M87X[9^,9#"2A9Z3YS"2AT8R MF`,7AY`VF`,].32R@!&1$E]!MH01\8J#C*Q@1'P/("-K&!$_4OLCD)Q@;E+( M#?S6$E"60J;A'AX:`6=PQPV,9.`-;INA$<@T7/+H"+PY>@KF#":$['<\R0$_ M.UZ6`']:W#W)-U-^2B#SP<1#WH-IAZP'DPXY#Z8<\B?2EY@'PXNJ:_W2_EX/ M+]UEC$[M`9;Y7'SC'>0[+?G'U%_%^Y7G?H)75.*_1WCWV,(;CSG_JG/H^TG_ M`1E-S-O,Q_\```#__P,`4$L#!!0`!@`(````(0#0MRQ>T`(``%D'```9```` M>&PO=V]R:W-H965T9IBB)B"0*)!TG?]\E:3.2K:*YZ#$:SLXNEZO-[4M3HV>NM)!M MAI,HQHBW3.:B+3/\Z^?#S1(C;6B;TUJV/,.O7./;[<DX:*%GN%M7J/ABP* MP?B]9(>&M\:+*%Y3`_YU)3I]5FO8>^0:JIX.W0V330<2>U$+\^I$,6K8^K%L MI:+[&O)^2::4G;7=RY5\(YB26A8F`CGBC5[GO"(K`DK;32X@`UMVI'B1X5VR MODM23+8;5Z#?@A]U[QGI2AX_*Y%_%2V':L,^V1W82_EDJ8^YA6`QN5K]X';@ MNT(Y+^BA-C_D\0L7965@NV=V"9,U1((K:H3M`4B=OKC[4>2FRO`DC9)I/$]G M&.VY-@_"+L6(';21S1_/24Y*7B,]:<#]K#&/9HMXDOQ?A'@_+H][:NAVH^01 M07-`2-U1VVK).H4",@ON+)KA!49@2@/ZO$V6TPUYAE*P$^?.<^#ZQ@D,`NHA M!/@="6%1&\+6RL:\\T!?+QW7FXSJ612JVK,S62R"@`_A.=,>9Q88`\M`&;%L M40@!AS>D/%DL@X*/X4GOB`$;/Q+#HBY&J(M'$NC-7M15B#KP/1_5M.A0TR.@ M:9N[OU>PY3U3R/?S)%K,0FM8QE#,(T.#RWC/F+&O$G8.'JB<(;I<%3.RQ>,O0&9PE_0(ZQH7=:/$(ZL/S_0G:%S'#/#TS>3?I#Y`=!P5?)/O*XU8O+00G/9\Q_0,$!W M;GY>XM/US@]6$K[`O.MHR;]158I6HYH7H!G;U)'RH]&_&-FYN;.7!D:=>ZS@ M%\9A",01D`LIS?G%EC?\%+=_`0``__\#`%!+`P04``8`"````"$`E'>;XY`% M```E%```&0```'AL+W=O&8)2=`&B(#=W/OO.\8VL3U1NONR+"?'ASF> ML3VP^OZCOA@?9==7;;,VR\.>27MBG7YL^R M-[]O?OUE=6N[M_YWJ?(#;[F3U MUZ[,#^.@^F(YMKVPZKQJ3*80=I_1:(_'JBCW;?%>E\W`1+KRD@\0?W^NKKU0 MJXO/R-5Y]_9^_5:T]14D7JM+-?P<14VC+L+LU+1=_GH!WS^(FQ=">[Q!\G55 M=&W?'H<9R%DL4.PYL`(+E#:K0P4.Z+0;77EJ*6&V(4\T`Z]M^T:IV8%",-A"H^,Q`W]TQJ$\YN^7X<_VEI;5 MZ3Q`NCTZI&@O\"3X:]05K0&PGO\8K[?J,)S7YGPQ\Y;VG#B>:;R6_1!7=*QI M%._]T-;_,A+A4DS$X2)PY2*.-R.NO?B"ALLUX"HT)HDGCX8@Q_CARH<%GQFV MY,/@*I[VU"&LB_$Q<.5\?^9[GKOPE_#D)_$%?"!<^4`B#7P^OQ;+U9CC?3[D MFU77W@Q8.)"-_IK394A"$.;)Y6%,Z8:J*RC[A=+7)EB%1/:`?FRQ6`-(< M:/X$0PS9ZT"D`[$.)#J0ZD`F`8J_^=?\43HL526E2]70EG/DO'LJ93=1)M,( MB1`2(R1!2(J03$84Z[#BOY):2@?KL!*EN9]HDS>$1(A)$9(@I`4 M(9F,*-YA\Y"\BP5+T=&B"&W+$5CLDNE`-;V;2&+8'B$10F*$)`A)$9+)B.)H M\=`1155''`FF);I#R!XA$4)BA"0(21&2R8@2/E3,@X105`V?(TI"?%M+R$2: M$H*0""$Q0A*$I`C)9$1Q1%NZ^V$A2HRBJB..2`E!R!XA$4)BA"0(21&2R8@2 M/LSP@_`IJH;/$,(:$WH^[3CB3!6V9PAM2J951#Q'35HTD4328B243)R[D&-K M0NE$$D*9+*28)-#@22[YB3ZCO<5PKHJW;0L!D_N!3NFJ_5$!.))_`4D3P"%G MP;H`F\PU\W>""#K&,LF=-383-M&MWPE")E-D5//TS,<5"E:0209!(RO-NX\: M%JG`(%HF4>5(]@T/YHBU$W`8BGG>$@81J#7)A/:D'6>. M<)9<']-`$7+$60[+%B%.X'FH%)!2(L39NQ;=AU)-"19=8&M'=R:&/<@\[1WN M[O]W:^"MACPK#%(KPM=6_HXPEE(1'+KO*9%@.6-%>&2^=#6A6%#NI94(Z"Z4 M"H@)$7OI>8&VD#/!8:^Z\ML`S?!7)H72M?V20?R=>#PO1E'80N6Z8"Q7WA&( MIZV!B`]TEVR9^,1UEUK1Q5@\$<.>BJ>"Q<0=U[;M`*T=;D96*&V=$-[S\!.V\Q#>@C#^XH8OK.KT![@AO#K``&OZ`;[= M7/-3^7O>G:JF-R[E$2;>'CN%CGWF83=#>Z4=@_':#O#59OSW#)_C2MB0[!F4 MR[%M!W%#'S!]X-O\!P``__\#`%!+`P04``8`"````"$`*,']V.<'```!(``` M&0```'AL+W=O2GZE+<#_\KFN'7 MAU]_N?NHZM?F6!3M`")J_J M&XIVWO],N'->O[Y=O^RK\Q5"/)6GLOVO"SH;[.52U?G3"71_"V;YGF)W M?[#PYW)?5TWUW(X@W%@ERC6OQ^LQ1'JX.Y2@0`[[H"Z>[X>/P283Z^'XX:X; MH'_*XJ,Q_C]HCM5'4I>'W\I+`:,-=9(5>*JJ5VF:'20"YS'SCKL*_%$/#L5S M_G9J_ZP^TJ)\.;90[KETV5*,A*K M>3!?R%1NW!Y^[33`%1W7-^V7:`_7_D;!;/*CV\#:Z&X#5W1;C9;!9#U=>M,; MJY'N*A3F;?YP5U+*-A`HE@:%-@7"^;,7EH_2O/[(>0*96B` MOC\$R^!N_`[5WZ/-UF-C6^S(0LX`&39T0>2"V`6)"U(79`88@]I>,DR,STB6 MYE(R);LEH,=`./K(@EQ"%T0NB%V0N"!U068`2]^4ZYM.^@K*7V%=&144"R?_ M+=J899X[$GN37B,C$2,Q(PDC*2.922REL#@_4TEI#M)AR?2S5RRFMK`M&MW2 MWIOTVAF)&(D921A)&14MLB@;5MB)[9HG>]$;F%C$2, MQ(PDC*2,9":Q%"V\BB2U%2'I#JQN^]@Q$C(2,1(SDC"2,I*9Q$H?9HRG()+: MZ2.Q"^(NK]ZH+P@C$2,Q(PDC*2.922Q%LO_29P--,4EM14B,@C`2,A(Q$C.2 M,)(RDIG$2A]&V).^I';Z2.R"+)P5TAOU!6$D8B1F)&$D920SB:4H@-;+(ZG# MMB9"1DTX"CF*.(HY2CA*.(H(+H1TAT:,0D6S- M^ETNF#O'6J2M*%;,8R7:2L<2$R=6JJTH5F;%LN7*HUK+Q2YK)%NU]ECN7[<5 M9!WT1W2@3G9K&!2"6]#M=F@%%T(A(K'H.C,Q"9S#+=(&Y!/S,(FVD@T>A&'B M539P'PJ366%L\?+XUN)I&PGP5#=KK1`\&A@COU@Z*Q$=`WWSD)!NTB(*KZUB MLM(H(:0=4^Z8D57G:&N3Q[-'&Y[:IC:%`EC;_0P5BY6K35F)[GD*6V./8S!W M#O`HP#O*2?3^L)JM%DOG2(G1Q(B=(+*28K%3)[:8+)=.WID5VQXA>=SK$?KA MU)?FSE:FD#,KUN[(H94N;B@]9"R8K/V0,W4164V[D?O2/>,Y3S0QVAA3+B&W MF\%3LJ+@8C6;3.S,,RNX/7:RU_C$V&%K8LXZA:P"BZ63P0YTR8$R9D:(:`;3 MZM;8*=F;<]S=<"V%S-KN]"R M5_*,#[90YO@H9!4:D2YA*%.%I6!818C@$9IF2$Q6VC$AI.=1RATSLN*%AHKX MA'38W@\1R5#]TA1+YXC>H15<*.M0.Q**R$JWB3$A[9APQY2LM&-&J'.TBB3\ MW5Z''6VJ`32&?X=6L!U0UB$A/=81Q=)9QV2E'1-"VC'ECAE9>8HD^QX^VX1J MA\Q^#9%3)*<=VZ$5C)S6IF*!(Z&(K#2*"6G'Q'='OM;0"M=:L%H*YR#-K-!V M&?V-G."-'"(H(S:0SJFP(P-=FY"0KDU$D;7*F*RT8T((3OM^/7B$JRS%JDO) MM\E0'$_997/E*3OV7,8F(Q2"ZJ%PIPG;H8%5\=Y'5UPA]4Z^:P-C[ICHF]T4 MCEE^?W>U0ML5EQV41S@V5J9PA73%W>=G^6@F-U9=N)"067&,;%:<.2;:\:9P MY7BKXF9H6[CL+#S"5<-A+72%=,7=QQ5X2'*;*T36&DJ+K`'!5@G&ME^.8LDV`+0RIT/OJ-G`W-,*(G; MK3A9J59EBHGX2Y)6MKR5<(:FO*9]N`V="HYSR, M94T*M#(G!7-,*`E8Y_V`>_8_Y3C]?JN>82"U-]GR95?DD:^:)4N^0C-Y>JD0 MZJN@^N9T+NJ78E><3LU@7[U=(%T8ZX>['JO/D=OY!EX20P"7+S;P]M7#EQMX MA^GAJPV\'/3P]09>L7EX,-G(=U;\%WB_M)%OC_@O\+9H(]\%\5_@90SX="]G M'!WP?@5\?+_`A]A'']_"!UK?/;8"/MQZ[KV=;N"C"<_I<0;QO=)G&_C2``[C M/E?X+GO-7XK?\_JEO#2#4_$,Y9IT[ZQJ]0E7_=%65_GN:O!4M?!%MOOO$3ZU M%_!9;S*"3>"YJEKZ0]Z@_WC_\#\```#__P,`4$L#!!0`!@`(````(0#7,KF, M5@<``&P=```9````>&PO=V]R:W-H965T%5F.A=B6(2G)[K?O4"3%8]0<+ZO-3S-_ M<3A#J[:KF^O]G"R<^:RZELVAOC[=S__^*_FVGL^ZOK@>BG-S MK>[G/ZMN_GWWZR]W;TW[W)VJJI^!PK6[GY_Z_K9=+KOR5%V*;M'CAS_9IV=W:JC@,3I?SDCI.L+P4]77.%;;M9S2:X[$NJZ@I7R[5M>AA_=ZIOG52[E)^1NQ3M\\OM6]E<;B#Q6)_K_N<@.I]=RFW^=&W:XO$,$/)'^IR[;IFF._`+DE'RB.>;/<+$%I=W>H(0(V[;.V.M[/'\@VI_Y\ MN;L;)NB?NGKKM/_/NE/SEK;UX;?Z6L%L0YY8!AZ;YIF9Y@>&P'F)O),A`W^T MLT-U+%[._9_-6U;53Z<>TCT\KVS.\"3X=W:I60U`Z,6/X?I6'_K3_=P-%O[* M<0D,;_98=7U2,]_YK'SI^N;R+SN*25\1025'1%[N[MGF;P?*$G'>W@BUVL@4Q44(B M+6-106V7S/J!F=_/(4XHEP[HZXYZ_MWR%:JT%#9[;$-,BU!:L/)BLI$-8ALD M-DAMD-D@U\`2HAU#A@+^2LC,G(4L![N70)L#*SYI(5TB&\0V2&R0VB"S0:X! M(SY89W9\KC-FD-V%]6]D,##'OQIJM)(>CR1@C(C$B"2(I(ADBN4Z,2&%G ML".%_>]_BY>90^BPV+3J75FQ"Z/W8A]-QM@1B1%)$$D1R1#)=6+$#G%JL@0HAS:7A!8VUK0:S/H<#22;A$B,2()(BDB&2*Y3HR(8->=B(A1,R)!-N.* M#!&)$(D121!)$$=SOL M.`H%H6.%19RPAF5<1<2G9M+BT4@F+4%"Z6BCA*AC"66CD13*=2$C2`)=HQ:E M.,`7K-'I3W7YO&]@P&3<_0=S,WR!]/@ETB9`(!KP0]\AKA6\,I"#3K!,JJR& MWL$A=NC*0,KDAHP9/#OB<85"*':.!6*GPYA`ZCMF#*&T"E3B)8)%,CH2WS,= M8VFU'F:'!+Y+`VN"$FFCQ%.)WA7/I-4[XKFT&<3-.6)MPL0<\>X!#D,YSWO" M$8%:&T.E/NK=N!4=?IJ([FUTE%JQT')9Y;WN_%5`G)6UQR7"1E-*U1"D4F8I MD17UJ36UN:%D1L]ZAXGH14NA1\^152%6>89$6*DD1A+Q'UYL_X@%HCQC\"LK ML$LMD5Y**)5("64?"^72:R+SK'>8B%VT%'KL'%F9MV8Y)-Q*RU69R<@BQ.JU$>BFA5"(EE'TLE$NOB;RS%F4B=M&YZ'GGR,J[W>I# MT"QV(^^CH\J[D.T>"E5*!M`K*!!(51%;L9SO*O#XF,_.LG5'1 M?W@@BNY'GQ6.V`1K^Z`U@I`(*Y7(2"!7'9NQ1.ZP#WKP#@+M@D@GE4Y*)Y.( MZZS6+EX+NHXY(ZQ#4C,B^S@B&B<]K!^(87"T:@'H>5I^X!`/C\2'>*1 M-;$F,<%2J1R6DLHDXE(;?T77U-J8W3H'@$7(7"`6"BT210!Z<'N-RPAV4M.(YAOX)5HJ5XP2+I]+M7?%, M6@EQZGKKP*KJ7(FK85)?K59S[J8;3XH;3XGT.1)6"D78*L8HP2C%*,,H-Y`9 M"&O=K,5!_054.G\QB]\`4M[LZ>M#(JCV,<,TL)MK9:5*0VBIF8BQ58)1BE&& M46X@,^SIMI#BME`B-<00HPBC&*,$HQ2C#*/<0&8@K"?[6OYX%V?D3R`S?];A M'=+12N4/H1A;)1BE&&48Y08RPV;MF`I;'FGL][G5W@DTG"9<@G].X2_!+U7[ M5(75^=S-RN;E"M4+Y\CN;L3\.\Z>NO`AQV5;&KKCP9U!W+[C;^%-UX1'L(57 M2!-\M847,1-\O84W'!.^`[_CM]GD'?CF]3#U[#T,=WJT,-B))^QARJ=F_,$#_P6_%4_5ZT3_6UFYVK(R38&=Z-M/QK&?^C;V[L'GAX]?PWQ-\U:S@ MIYS#ML)CT_3R#YB+Y?B==/[:O2^V@>]5;=D=Z_:\]__^Z^,F];UA+-IC<>W::N]_ MJP;_W=///SV^=OWGX5)5HP<1VF'O7\;Q]K#;#>6E:HIAV]VJ%IZ#BOW=T^,D MT#]U]3HL_O>&2_?Z2U\??ZO;"M2&==(K\-QUGS7TTU$/P. MU:EXN8Y_=J^_5O7Y,L)R1_J5LKM")OCM-;6N`9AZ\77Z^UH?Q\O>5_$V2@(E M9.1[S]4P?JSUN[Y7O@QCU_R+($&A,(BD(`IHTG.YE6DDHOC_H^R0T323#\58 M/#WVW:L'Y0$YAUNABTT\0&2:`O&8)P7:EAK]7L/W?N)[0'>`T2]/(H@>=U]` MI9(PN0/#$8<[0HL+/&8R,,4%F7M./:IS:ETUB1P'(,A,0EH)UHC$L&0I8AZG,TQ1!8I%`3#JMQ":- M9)JFBD,.#")3%<7*$&4TH!8=-/2HK47*<^2(@4PS59,"M7@+P4C$3A)ZE&N1 M6AERA$23%%$:)XG@)`\,`(]#$X$Q@.IVR*!'.0,19#Q#CABDD(E$1/9:+`$2 M>G?1.XR"WB%,5]X;08]:%$1@44!,.*E@/3O@,Z0G5`8$YI=9]HQEGSQ!!1`1 M+4`_M5E84N>(P4QQH(+(9,)R6`*$$&$:FO9B7`2XLD.*:=AF8;E`3B"W&/00 M.:I0AHN"X@RT6ZT70Z")L?84UGKG!,(DFR0-`UL(AHB".#(UQ5EH2S,L[$41 MZ'B<33@O[R1Z3B`J`)$E<6RRX;IPB(IC91R'\]'F9OCIL^(Q]T8 M]?ZQB0*[3BD(\DRRP*PKIZ"=S4$!#8]3,-5%%!!$"R/#6"TF2E(P"/2+$I&9 M"6?B=DXX"ZQ;Q>A)3!!$3,`UPI4<#*&B-)1F.IP'-\]5D:`#@OJS30MA%60N M$`23GT%FUJ3,6Q!.R.VEPF&FPBK%G$`H3)8$VI2C,7JI2E::EZ*XX9P(MH`'9KH85L3>ZN1")J+1(%] M\MWHP"%"BCA9S(^E>B$ M;*]9F#/5!X+N6H0J"JT2.E"<.\DWM7!;JD1+Y>5A[S4$[.1+F\UW4?2(,B6GJ@L;57*)(03M5D[SL5MJ])EJR8$<6"FJ4*U.J-1&%J= M+$E4L+!>1@3.R:Z>F8:MGE'V1D.@>Q&((%A\0T%).$2*X'N'5N7VU6G8YF&Y M9DX@Y!&&<#Y;G,"(!QY^$:+2#'[,IL@%<1NK4)AO1P3@($7&:!>GW3%YI?WR# M$=HG9V2ERZ<8>Q_3;>`[%-P%61U_8)@DC<,T,1"N$??8E48.KUW<(TP"Y`I! MI%$FXR`V94$:+2&P8\//O"]P/MQQ5WP6C@B2_AB/(_.]X[OI;ZNLL9SN(^<[O1V M\P.X);P5Y^KWHC_7[>!=JQ.$#+8)J-3CA2)^&+O;=%?WW(UP/SC]>X&+WPJN MPX(M@$]=-]X_Z%NU^2KYZ3\```#__P,`4$L#!!0`!@`(````(0"_JK4@O"`` M`#>U```8````>&PO=V]R:W-H965T&ULE)U+;QO)DH7W`\Q_ M$+1OB\6W#-L7-NL)S`"#P9V9M5JF;:$MT9#4[;[_?DY4951&Y`D]O&FUOXI, MUHFHK#R5))/O_O'W[?>SOX[W#S>GN_?GU9O%^=GQ[OKT^>;NZ_OS__EG^]O^ M_.SA\>KN\]7WT]WQ_?F_C@_G__CP[__V[N?I_H^';\?CXQEZN'MX?_[M\?'' MVXN+A^MOQ]NKAS>G'\<['/ERNK^]>L0_[[]>//RX/UY]'AO=?K]8+A;;B]NK MF[OSJ8>W]Z_IX_3ER\WUL3Y=_WE[O'N<.KD_?K]ZQ/D_?+OY\:"]W5Z_IKO; MJ_L__OSQV_7I]@>Z^/WF^\WCO\9.S\]NK]\.7^].]U>_?X?NOZOUU;7V/?Z# MNK^]N;X_/9R^/+Y!=Q?3B;+FRXO+"_3TX=WG&RB0M)_='[^\/_]8O1VJ?75^ M\>'=F*'_O3G^?##_?_;P[?2SN[_Y_!\W=T>D&X62$OQ^.OTAH<-G06A\0:W; ML03_=7_V^?CEZL_OC_]]^MD?;[Y^>T2]-]+D^O0=KX3_GMW>R$4`[5=_CW]_ MWGQ^_/;^?+5]L]DM5M5R[_.K/-%RGAOB;&FY>U0Z:1KGXJR^X?;/<;ZK-5O0^\XK; MU!)_M>7K3G67&N+O+YTJQN)XJOBK+_C*4[U,+?%76SY[JA?3-3%>2_75X]6' M=_>GGV<8H:CZPX\K&>_56W26+J*4I?FRPN5]+=$?)?S].73B@GD`_>M#M=J] MN_@+U^EUBOD4Q/B(@T;(M2K=UB5H2M"6H"M!7X+!@`NHG27C$OX5R1(NDO5D M/RG(.5@6^C1"F]0E:$K0EJ`K05^"P0"G#R/M5_1).&X)KJ1[+^A3BK%UW_B0 MPQPRBR;2$&F)=$1Z(H,E3CKN%;\B7<(A'F)#)8X M1;@/!XJ$>D6)7,Y#]$"D)M(0:8ET1'HB@R7N]''%!*UPM5DM&JI M1NPU*3+%8E0S:ABUC#I&/:/!(2]$9G&^YJIIM6[/\21%R8L;1JAA'.4H; MUHP:1BVCCE'/:'#(:Y,9/-`V3>Q.6T*V2(3JBE##J&74,>H9#0YY(3(A9R'C MR%KMWV2[S8.K2G.X+6!"OH#KLH!S5"X@H4:[SPEK&76,>D:#0UZW3,99]SS* MTAQMM264S^=0$:H9-8Q:1AVCGM'@D!Z1)S5*Z> MG?_'QX&&HUI&':.>T>"0%RTS=Q8]5R]-Z+9Z$\(4K6=]J`C5C!I&+:..4<]H M<,@+D0D["WG5\)OF>'>/2<@7<%L.OSE*4U%7A!I&+:..4<]H<,CKEID^ZYX+ MF`R`+:#U!.,U=J@(U8P:1BVCCE'/"*M!TZ`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`5FS`$O*/ M!IMB)!YRE!:J9M0P:AEUC'I&@T->FQBF/#WH=+\27(SQA&R1"-7:,$T>"0%^(-V(N/!BMV9HK\7:Q\^LY1N7KDWQJ.:AEUC'I&@T->M/BMH'J3 M#;,K0ZL)V>4O1C6CAE'+J&/4,QH<\D+$^`1")C_DA$RH&&+%O?"`%G+]&KDU MHX91RZACU#,:'/+:Q/@$VB8_A'9Z'7U:)90'SX%1S:AAU#+J&/6,!H><$,FY M$3(.L>>7N,86_C:BR`^R\OD[1VER:D8-HY91QZAG-#CD97M[I+?(-:\,*3+U M8U0S:ABUC#I&/:/!(2_$>YI9"'N7]80D)]F5;`L;=LA1N4AS0T4-1[6,.D8] MH\$AK\V;D%D;FXUU0K9(A&J.:ABUC#I&/:/!(2_$FXW7##+V(>N$W"#;%@_= MAQREQ:H9-8Q:1AVCGM'@D)<=^Y`U^Q!%MG[L0SBJ8=0RZACUC`:'O)!?]"%K M]B&*?/6*9Y=#CLK58Q_"42VCCE'/:'#(BXY]R)I]B");O1254H M9S0XY(7$/F3-/B2AXA99+ACDJ%PDLB8-1[6,.D8]H\$AKTW!BCDXH M5^2@41G5C!I&+:..4<]H<,@)V7@?HO?Z$7LABOQ(*IZN#SEJ+A*CAE'+J&/4 M,QH<\MIBLR&?<2J*I"A7Y,"H9M0P:AEUC'I&@T->2&PV-FPV$O(C:5F:C1R5 MB\1F@Z-:1AVCGM'@D-<6FXT-FXV$H$W/^L"H9M0P:AEUC'I&@T->2&`V7OC0 MSX;=AB(_RLK5OQREJ:@9-8Q:1AVCGM'@D-<=NXT-NPU%=I2QV^"HAE'+J&/4 M,QH<\D*\VYAOA6PJ-A/RHVQ;+DWEJ%RDN:&BAJ-:1AVCGM'@D-<6FXH-FPI% MMDAL*CBJ8=0RZACUC`:'O!!O*EYAZ3?L-Q3Y058N3N4H+5;-J&'4,NH8]8P& MA[QL<1'L-S:"BVDZ(5L_0K4VS%$-HY91QZAG-#CDA&QCOS%B+R0A-\C*[]8< M\$&\WQC'V MPDRV92NB"!>?6?H7,"Y MH:*&HUI&':.>T>"0UQU;D2U;$46V@&Q%.*IAU#+J&/6,!H>\$&]%YE'&?F,[ M(3_*=N428H[2BM2,&D8MHXY1SVAPR&L3R\!^8YN1'6;F*F*/F`C)J&+6,.D8]H\$AKSLV(SLV M(XIRM0Z,:D8-HY91QZAG-#CDA7@SHJ-LQX8CH6*4E:N(.2H7:>K+SF4\MMAP[-AP*+)%2E$9U1S5,&H9=8QZ1H-#7H@W'*]X*MNQ%U'D!UFY MP)BCUC#I&/:/!(2\[]B+R&2&!%WG^W>@=6Q%%OG[ETE6.RO5C*\)1+:..4<]H<,C+CJW(CJV((EL_MB(< MU3!J&76,>D:#0UZ(MR*O&7_L4G8)^?J5JUHY*M=O;JBHX:B64<>H9S0XY&7C M5`.7LA-<3.`)V?H1JK5ACFH8M8PZ1CVCP2$G9!^XE.?'W]C":U0$7?F!>U>N M:N4H+5;-J&'4,NH8]8P&A[SLV*1@EZ"R?HIR90Z,:D8-HY91QZAG-#CDA<0F M9<\F):'"I)2K(CDJ%XE-"D>UC#I&/:/!(:\M-BE[-BD)&1]U8%0S:ABUC#I& M/:/!(2_DETW*GDV*(C_(R@63')7KQR:%HUI&':.>T>"0EQV;E#V;%$5VD*6H MC&J.:ABUC#I&/:/!(2_$FQ1]$MBS$TG(#[)]N2B2HW*1IK[,%=QP5,NH8]0S M&ASRVF(GLFB'.THK4C!I&+:..4<]H<,AKBSW%)7L*1;DB!T8U MHX91RZACU#,:'/)"8D]QR9Y"D9N3]N7"1X[*14I]Y0PT'-4RZACUC`:'O+;8 M4URRIU"43_'`J&;4,&H9=8QZ1H-#7HCW%/-(8N-P.:%B))6K&SDJ%VENJ*CA MJ)91QZAG-#CDM<7&X9*-0T)FVCPPJADUC%I&':.>T>"0%^*-P_ATO+]\=CN> M2S85BOPH*YT>"0UR:^@$W%9;(+ MQE0HRA4Y,*H9-8Q:1AVCGM'@D!-2+;RK>,U;+5,;;SEFY@=:N8YAPN8B!@S; MLLEIX25RVK`O&S%LS$8,.[,1P]9LEA49B+U'M6#S,;-\6H>`8:.YU#;'01(Q M2"(&2<0@B1@D659(BEU(M6`;HJP8?.7:A@DSA9NZL\,OB(-*BH-*8E!)#"HM M*U3&?J1:L"&962X("I?B,D/AB*%PQ"")&"01@R1BD&19(,G]K= ML5JP9YF9'XKE:H<),Q5-W>640#XQR"<&^<0@GQCD6U;(C\U+M6#W,K-\JJAH MBLL,%24&2<0@B1@D$8,D8I!D62')VQCUFM6"O8HR/Q0ORQ40$V8*-W7GAR(Q MJ"0&E<2@DAA46E:HC$U+M6#7,K-<)!2.?4O`4#B*@R1BD$0,DHA!DF6%)&]? M7C$4V=A4B\3<4+PLETM,F*GHW%09Y!.#?&*03PSRB4&^985\L3+L<*J%\'+N M3\Q5E!B&(C%((@9)Q"")&"01@R3+O*1Q?]9`DN[;:EQ;E5@Q%,LE%!.F1<)& MK)/5<$.1&;9BI3CLQ4H,F[$2PVZLEA4JQ19$*I-=<"JMA4@["KJ=7M/&]LRP MN2RUA21BD$0,DHA!DF6%)/$`D:3)&]@OD%=Y?U>S0'E9+JN8,%.XU%V^C*&2 M&%02@TIB4$D,*BTK5(HMB%0FN^`*9RV$%HX8KD5BD$0,DHA!$C%((@9)EA62 M9*K/DL9[Z//OD%:ZO:M3.SL&6]-R%69NFNN'!,Q-M5,Y-3>&(024QJ"0&E<2@TK)"I1B#2&4R#*YP MUD1HX8A!$C$4CA@D$8,D8I!$#)(L*R3)9)\EO6HP)G_@U,Z>P=:T7*RIW#ZQ M.HW,34U-B2$!Q)``8D@`,23`LB(!8@UR`O)@3);!J;0V0FM*##4EAIH2@R1B MD$0,DHA!DF5>TKB;:R!)=WFUDI2A-S,8:84FAVF1L"7[9#?,`,6>[,2P*3LQ M[,I.#-NR$\.^[)85*L4:1"J397`JK8U(A4O[PIK3AR2*@R1BD$0,DHA!$C%( MLJR0)#X@2WK-8-1-89W:V4[8FM+BC3:U,R,S)&#N3FN/!!!#`H@A`<20`,N* M!(AKR`F8!Z/N`NM46H>A-26&FA*#)&*01`R2B$$2,4BRK)`D/B"2E/R!DS1[ M!ELX6J-Q6\FFNR@SJ)R[,X4C!I7$H)(85%I6J!1K$*E,EL&IM#9""T<,A2,& M2<10.&*01`R2B$&2984D\0&1I.0/G*39,^3"X4<#RPWFW?:R6KBYJ18)*HE! M)3&H)`:5Q*#2LD*E6(-(9;(,3J6U$5HX8B@<,4@B!DG$((D8)!&#),L*23+9 M1Y*2"7"2)H;'3,W^H7*;QFJ5ICBY7.9I$INY^@)#Y1RFW4%E>HF\*2Q4SG'/ M=`?A+(*3OC$O/#$\IFBEA-SPJM-L>0!X7.8GBF$4W<0 M/L=9X45W$#Z':7<0;KOSPL<]7`/A:6]7]_2A^[W:BBNSPA.#\"&7V*96.Z)Y.8(;85?9K$]%7+%041RD[.P=4Y;N5# MP_(FJ76ES#:M-L4#-GZ.9GI57)>2J&J'IXTB!FF98O!HI0*1EL2>[1X_6N.Z M7U9[;!'LAQUR9;LO7ND!OJ#HEX37?(A>VNR(6XE"@7R;VX7$RLN&[H@2[M#FL* MBUS,34TNTDO@HGXV%ZFINTZH.^3B-=TA%[:[(A?B9:)<)(_C,X2;/OR85;\RUJCC)U(P:1Q""2&$02@TAB$&E9(5)\2R1R\C-^ MCDXL7V*XZQ)#W8A!$C%((@9)Q"")&"195D@21Q))FIP*6FKV/U6X4<@@='Y+ M638+D#3%.;\5&,TDE% M<#$:0<5U!ISUH"\-`1E/#\@R/TD_=H:F>%7X;,+T$:O&<8="FN3ND@;I# MG5_3'7*1FH[=%;D0+Q'E(ED15_KD.S""S,G373KM=HLU3M6-7,Q-E2$7$WO) M2&I8[@ZYH.Z0B]=TAURDL+&[(A=B0J)<)'/B9%C&Q!NNRN$BYF)A$\FQ\]DR?C8%:*TZZY9UT$MIS@G/'(L*29K&-)3-;MYMEJN:#E'FV:NT,:J#O\W&\ZXV>[0RY2T\"QC!OU M1KE(7LB5/AD?7$CFY,FQI+U_G6-)#*MF6B'\R/'4W4N.1<.L8^'ND(O7=(=< MI+#`L8Q[_4:YF$R.ORZ29\+\9W)!CB5M'^P]=G:8L2D$W&7 M2G!R]`K(V!2FG@5+LK1HZGHO1I&XF2A;D\OQV4HLE_^`\T%[]ST-#!EBR`,Q MB":&\4$,"HGA`K"LD"1N)I*47(X;#(GYP4!OP[KMAY-E80:5$H#I*(01(Q2"(&2<0@R;)" MDKB92%)R.4[2['S,R"U_)@^7YQQF5!*#2F)020PJB4$E,:BTK%`IUB52.5D: M/^(2RT6")&(H'#%((@9)Q"")&"01@R3+"DEB2B))DUGQDA)S(ZXJWEZ%RCG, M%(X85!*#2F)020PJB4&E95[EN(=PH#+M+>Q4ZG[#UE@RJRMF3<#:@'4!ZP,V M>%9($DL124J.Q(ZXM/.PK"'-H7#=F$#F]`GK3.(@D!I'$()(81%I6 MB!2O$(FKLJ=_;&J=O.BCK(E)U/??S(F_V5S.*WAZNTF["OSS3M%_4ID@Q)*2S; M*4A*CB$_WD!28JOI#>WU?K,J\P-)MK-"DLS/6=+\(3;=/]A58YK+_5O.5?'0 M@%.?PISOUNYP(G,AHTMK:HIWU,9'K'AUS/5?J)&I.5*3IFRGQD[CR5*XW8.3 M2V*&K%-;))D8QCXQC'UB&/N6%9)D'HXDI?G929J8N\$%RU=I:V%SY\*U-3EGE'^[Y$KN,;()6!NP+F!]P`;/_$4W;O8;20HL0MH8 M6-XSS0FL:,T@A^F%!)6INVSGH9(85!*#2F)020PJ+2M4RMPJC<3L+I_LX,DJ@M)!&#)&*01`R2+"LDR=P<24H3NY.4F"\F M6DRH)`:5Q*"2&%02@TK+"I5/V`S=&MBI3";`%8X8KD5BD$0,DHA!$C%((@9) MEA629,[.A1MO\R_\6DFE6P([N?/<;T>D37-6D(&YJ2DJ,62`&#)`#!D@ MA@Q85F1`YO.<@3PM3/.\OXTFED\?HY$8)!%#48E!$C%((@9)Q"#)LD*23.N1 MI&FZ]Y(F)I_`,+=16GE+VP@C3(L$E7-395!)#"J)024QJ"0&E985*F6JCU1. M%L"K3,P5CA@D$8,D8I!$#)*(01(Q2++,2QHW^PTDZ2;`=L0I0V^YRF7BX>OAV/C_75X]6'=[?' M^Z_'P_'[]X>SZ].?=\B#3%*&G]T?O[P__X278>`E0NZUHP")6I&%; MR;'12',[.1<\MX7MY%SPM!,=VTF?,(OAL:4<&Q_OZ?4VDC.\9Q"UVTC.L-(> M'I/SQ))U>$S.$PN]X3')&59,PV-R36"=,3JVE+KC*V;A,=&`+V:%QT3#](8[ M:5^*!GPO*&PG&O`%F^C82EX/'T*.CE72#M\U#H^)=GP--SPFVJ?W#_D\Y5J: M'L;XF-1]>BCC8U)W?-,P?#UI-[W+3>TJ:3>]S<_'I`[8V"#L4_*"[_R'QZ0. M>'H+CTD=IB5#>KV%M,,N0E&[A;3#WCOA,:D#-K$)CTD=L,-+>$SJ@*U2HF.5 MU`$;C`3'+M$,>\D%1[#!FO08ML).97(L'K4+J0(V^0K[E"I@MZSPF%0!6TD% MQR[1#)M_1D?0"%MG1D=0`.Q%&1U!^K%;8W0$R[3!O!<=01OL-1\= M0:ZQ>7MT!+G&_N;1$>0:&X9'1Y!K;+<=')&)+9[7=F@3SVH[Y#J>TW;(=3RC MR80-HQ2<@4S7\6R]11NL_P1M=FB#E93H"'(=SV,[Y#J>Q<04Q)Y@AUS'CF"+ M-EB3#\Y@BS98VHZ.(-=8)HZ.(-?QK+U%KN,Y>XM<8[TOZ&V#-O'\N4&;>/;< M(-?QW"E6)'8B8D1B'[)%KO%F2W1N:(,/W$1'T`8?/XF.(-?XJ$5T!+F.W8>8 MC]A[;)#KV'FLT08?V0Q>9XTV^)AC=`2YQJ<%HR/(-3Y.%QU!KO%YL^#(!KG& M1[."(RNTF3Y34,YQ:[29'N/H"'(]+:?3$>0:']0.7F>-7.-CR]$1Y!J?T0V. MB+F*O=42;6)GM42N8U\EMBIV52N\#KZ/%IR!6*HG'!7J\X2?0GV><%/(=>RE MELAU[*26R'7LHY;(]5,N"J\3CH710H7UJ9"#)_P3T*NG_!.R'7LG&3X M1)E&@W`<(,WA*$"2PS&`%(.*GQ\88%VX;&/U=N/<060LB@S4N:(RT4;\(_KMQ^KV!7(0`M:(`.B)!SK MR(`H"8^A727MHK-&NTK:1$QT8YO,8;'1#N^_!<>DUO5M/Y5W,GKY>YM'SYGUDL4 M".\5)#(\@_W(MA/W)7@R2_^BU/DDZXFRLD(PX%RND(L[$"HF8 M\G`Q)^+AP[L?5U^/_WEU__7F[N'L^_$+EHT6;V2-_/[FZ[?Y'X^G'UA..C_[ M_?3X>+H=__?;\>KS\5ZB$?SE='K4?R!I%S]/]W^,2U,?_E\`````__\#`%!+ M`P04``8`"````"$`O&]9!I@"``!R!@``&````'AL+W=O&07MV]J(8\"V.E;G.:1@DEHN6ZD&V5T]^_'F\^ M46(=:PO6Z%;D]%58>K?^^&%UT&9G:R$<`4)KZ0I?@U.,;/;=S=):2OC>.JW^AJ#4 MNP>6S^&!.;9>&7T@L+$0;3N&8Y(N,RB>H[A!-:<+2H!G07U>9UFZBI^A#/X6 M/.47$0.\M(-\1"U31`NM$S_L@G/.RWG'`FXSR4(6.G*6392=`L`@Q MT[.8V;@%A(RDC"I8P,'K2\ZR24\('B'H"@_8LQ$/5+U'WY>@P`2>NTY[UT%K MYJ-,5(?,H(2I'@!@R\^2(CB+BT4$\W6<#`P8LH+R+K__]!7OK,MI0W7(#,I( M?K<#@,\OF\VBQ2E!C!C"@O(NP?EX`S%J)$,O#ZEOTM2?+C_NX82'TZ6$J<1G MT326<+UOH8UXN'JUOUDV&:Y_KT^7&\##A[C_`A=!QRKQG9E*MI8TH@1F@H43 M$^Z,\.)TYP_U5CNX`OQC#7>[@!.61!!<:NV.+VC0_UNL_P$``/__`P!02P,$ M%``&``@````A`&TULQV7`@``;P8``!@```!X;"]W;W)KXA=N\?7F\Z?U09M'VW+N$!"4+7'K7+\BQ+*62VHGNN<*9FIM)'4P M-`VQO>&T"HMD1XHLNR22"H4C864^PM!U+1B_U6PON7(18GA''>1O6]';(TVR MC^`D-8_[_H)IV0-B)SKA7@(4(\E6]XW2ANXZJ/LYGU%V9(?!&5X*9K35M9L` MCL1$SVM>DB4!TF9=":C`;SLRO"[Q-E_=Y!DFFW78H#^"'^S)-[*M/GPUHOHN M%(?=AG/R)[#3^M&'WE=>@L7D;/5=.($?!E6\IOO._=2';UPTK8/CGOLE3'?@ M!+]("M\#4#I]+G$!#J)R;8FGEY/Y(IOFQ1RC';?N3OBU&+&]=5K^C4%Y<(^L MD,,M=72S-OJ`X&`AVO;4MTF^*J!XYL6M5TN\P`AX%M2G35$LUN0)RF"O,30[8N%5;^'K])XW43CE%>.\Z2C/J[`C)^D4Q54"1(L8,SN) MF:>(0 MEZ-,KPZ948E=/0#`D9\DA4(O+O_WA9\>DJ+R)KMW&L&_6.>]YM4A,RHCV2T' M@)A=/I_,4]_Z@"$K*F_R>Z>Q?-1(@D$>4E^E6;A:H=?C]8Y72W+3\"^\ZRQB M>J^@6?P.)C4]*]O"KW^KSU9;P,,$23/P"O2TX0_4-$)9U/$:F-ED`:UAXH,1 M!T[WX4;OM(/['SY;>-@Y7*\,=@G56KOCP!NDOXK-/P```/__`P!02P,$%``& M``@````A`/IO97#?!@``/AH``!@```!X;"]W;W)KZU37?7.HKR\/[M]_I=^6 MKM/UY?50GIMK]>#^5W7N]\=??UF_-^UK=ZJJW@&%:_?@GOK^MIK/N_VINI3= MK+E55_CFV+27LH>/[1B,+N>R7Q4O MUZ8MG\_@]T\2E'O4'CY8\I=ZWS9=<^QG(#?G`[5]CN?Q')0>UX<:/&!A=]KJ M^.`^D55!J3M_7`\!^J>NWCOE?Z<[->]96Q]^JZ\51!ORQ#+PW#2OC%H<&`3& M<\LZ'3+P1^L_AR>[_6A M/SVXOC=;$"_V%Z'K/%==G];,UG7V;UW?7/[E)"*DN`@5(O`4(C25AZ/`4_%AYZ9WA+H0A/(4AF2W#,(B6S.<[AC`[AC?"$]\X MQ9_S&`^YV95]^;ANFW<'"AZBV-U*-GW(*G8=D13QQC%-4"U[QGYB]`<71@D) MZ`#]\4BHMY[_@+SO!67H22^ MXC*C,Y=QL!L$9`RHX1\RT&1G`HD)I":0F4!N`H4":/[Y7_./T6&**2FEOJ\[ MM!$<->^A3MF.E-%I"TDL)+60S$)R"RE41',=YNE74LOHX#K,G;&<-K,YDM!L M9R&)A:06DEE(;B&%BF@>19,>,53W2"#Q.$6W%K*SD,1"4@O)+"2WD$)%M.%# MQ4PDA*'Z\`6B)R32JW`[DL:$6$AB(:F%9!:26TBA(II'K!63FP66&$-UCP2B M),1"=A:26$AJ(9F%Y!92J(@V?(CPQ/`9J@^?(X0W%&Q_V@IDZ([XCL41UDJ, MLXB$QCZ0C"1,6FH)92-'"E'/$,I'$@H5JI#F)('&3/%2[.@SUD;TIWK_NFE@ MP$1NZ(RNNS\H`$?Q'R$E``*BT=`%4(\8>T8B"3CHU);))(LU$R!CNBX)*%-H M,KKS;,^W*Q1>;T=%5=)K@O47,BJX:[',FPL?A\2A=%CX!4M;``1+SN,$6;P` M2!!XH1<:.WB*)+4"+*D<62A%(R\RPU8@::($6#UCI-1$ET5&J4.*15B7ERVA). MTHIDM).KIV#);C&U#3,!P0O1,$>6A`J$)@J`-4S2M0\G!N^OM%U5M%PP9\?\ M4GMM%"R9NAT+$EMIU(J:*`S!\H>Y0F"_IM0XE:5"2:FZ[%/B.;+NB!>:N+:" M0@*_$KN!KK>4`@I@[U1B9Y3]5K#@@3G>H2&L[J.A'3MDA7=B9XMG:'97/$?6 M'?%"$]=CIW>D']4=M3M5`;$U?PP!#8R==(LLI>X$%,`B/!I.Q(Z_,5CPV`5! M%$6>V<[9ZMFGU'-DH;J_B*/`V!D+35V/'FM(Y:S%91LV%'/O%E#`2H=+\(MH M?MEYJ=J7:EN=SYVS;]ZN$`[H*1[7(\QOP#?A"BXC0,#$HQ6<\B?PQ0K.RA/X M<@6'4!O?Q2LX$MIX%J_@A&?C.^*MV#'*_@:.3:M\\ANXQ7\:3FFF#W"[/VRG M)D[AUG_B#1M_!==L]IN?`M"?-`A6<#<%!O/Q#7"I?RM?JM_+]J6^=LZY.D+@ MX2H?*KGE]__\0]_6YZN,X?_CW![S05=,3>#,C'INGQ`WO!^,O/X_\` M``#__P,`4$L#!!0`!@`(````(0![#J.,[0(``'L)```9````>&PO=V]R:W-H M965T'Y][CW,OJ_O7JG1>"!>4U0GR)QYR2)VR MC-;[!/W^]70W1XZ0N,YPR6J2H#.1[5S2* MU%*3<%)B"?I%01MQ9JO2C]!5F!^.S5W*J@8H=K2D\JTE14Z5+I_W->-X5T+> MKWZ(TS-W^W!%7]&4,\%R.0$Z5PN]SGGA+EQ@6J\R"AFHLCNM46Z`\E)S'X[8B"G;YPFGVC-8%J@T_*@1UC!P5]SM02;':O=C^U#OS@3D9R M?"SE3W;Z2NB^D&!WI+:DK(23X-.IJ+H#D#I^;;]/-)-%@J:S211[4S^(D+,C M0CY1M1L"9HL'JLOE+8%8IA!&4,E7!!Q5M,;`L8/5E'<:+E?L"14D[S.8:$YB([0@B M[B$N".G50(Z7:J9>KT9%H73(&:@)>Z)6\49CP@$F,A%;&\(0`P=9Q*AH@H"L M%Q-X<_.HC<;,V\)Y9FP[C"W\.'R/&R(@DX&(LR]JU3P\C"_RW&B,K1(VA"$" M+NE`1'M)!K:HZ"U;-,8FQH8PQ,RL8E34K,RU+1H3CMHR'C,$Q(:`LR5JU3PX MC&>FYQN-L57!AC!$J!ER\=X.+%'16Y9HC$V,#6&(65C%J*A9F6M+-&;-,+YL81W( M*DCSC$-,0:K=_?^BP'B\;4X'&N]C1G"LD>GQJ8=.@_?D.^9[6@NG)#D4P9O$ M\.9S/3SU@V1-.W-V3,(L;'\6\">'P$#R)@#.&9/G!S6>^[]-ZW\```#__P,` M4$L#!!0`!@`(````(0#"DG!<>0<``*D>```9````>&PO=V]R:W-H965TXPNVC]6T.P]#\_&=#Y^+[8-Y^/[CZJYOVNO&=F>.;=77JCTT MU^>-_?=?Z;?0MOJAO![*_;W_]Y>&][5[Z4UT/%BA<^XU]&H;; M>C[OJU-]*?M9>ZNO<.?8=I=R@)_=\[R_=75Y&(TNY[GG.,OYI6RN-E58=Y_1 M:(_'IJKW;?5ZJ:\#%>GJ;]^J]G(#B:?FW`P_ M1U';NE3KXOG:=N73&?S^X09EQ;7''TC^TE1=V[?'809R-_>BN"V]IS[KW7OK;ZD_M>]8UA]^::PW1ACR1##RU M[0NA%@<"@?$<6:=C!O[HK$-]+%_/PY_M>UXWSZPK:>Z']*&V-I6]=H/[>5?2G*9%!4)F`A< MF8@["Q>+8!FN/B\"S'$D<&4BJZ^+K)@(7/__2&`2C".!ZY=',J?Q'?.R+X=R M^]"U[Q84.T2POY5DZKCKR+980EA418J@4BK"?B3TC0UN0/![0-^V?N@_S-\@ MYQ7C[##'51DQ9Y"\$]F]#B0ZD.I`I@.Y#A02,`=OA$)`A) M$9(A)$=((2.*[[`>2;[S^4G0T44^M!U#8&Y+3B^U;`H2-]LC)$%(BI`,(3E" M"AE1/%H:/2*HZA%#(C$C8X3L$9(@)$5(AI`<(86,*,.'BC$DA*#J\!FB)F2E M)4201$(0DB`D14B&D!PAA8PH'I&N:]H;>(D15/6((B[=?,EZ'C/$$RG:4X1L MWJ(,W86V+R2"Q+U.$9(A)$=(01%W?+SB$01=\HCM=C/2#0RGIGK9M3`X5RR5 MA*UZ2A'94X9(GE($NBC94VV'2`1)>(J0#"$Y0@J*&#QUH3?[@JLC7?650;*S M')*\99"W&IL!SW&U;B"9",)5+A.(\L@F%NDI0$8+6#X1N$S!97":86\Y M@^KC13PR-']IOP#MZ)0X/PRUB*AV(Q-*&\I%3#\_C'3?J*$W]O#,-PJ!(==*F)8W M02F')L-L>B(WS#EK,BPX1-\:Y";-)9L^7GQ&6,L;;0_4O$6.[AMC31G9,RW% MT%UHO5#"6%XX%K@?^$MX953%4ZXTB6<>J>.@NX`5'U2ZXD"']I#

%+N4I:1?&/(L)IPEEY+G:%U4REER12"MG+,^U"HXRU`D M$%U3!`BL%0F%E%S[D;;(Q.0V&"J36QA.$6#RDV\I-LPX1-]NR:Z8,PB:<:Y5 M<)8ANZ31,&27]1]R=BFD95=;AV-PBOBF9-=@B&HT888^V1??MBN'_%-K-,7: M&8.402'MG!O>*0!YZ.H*2'H70Y!82R,'B4(DWM,*&&F3/789:YK(>P[)ALB1 MA+'8*N&&7K0,M)XNY4J3>,:A#\5SQH*ZF<:.IES!M0RE1/HA0Y1HFZ3L$ZQS MDO/A1]KDCEW*4DK)8&B($GLB+:7`B4)?VU]3K)TQZ%XIL4')0S<$21ZZ6DI@ M*`5I[`VUGH$PM&6%0EI5:=M#3$:N+RL&0T.\*&NQ'*>>&[A1Z&B;=HK%,P[= MJ2HJ?J^JY+$K`8/TWPG8R%`#QB`EEWZDS928L>#"%\J]R1`'C+'86N4N5HNE MMLNE6#O[E';.#2$@8@7!!<99>+/RU*:4=VLCK`7)U(E&VDR)F2$LH5.0#(:& M(%'6QXE/L7S&H8_KBK'84A@XH;?0\EMP(;Q4>>:6=H2U((G.=$J''VFS(V:& MD)4I2`9#0Y`H"[K<21YE.\7R&8.4"D?R.7>(KH2>YX0KK1DI%&UUYIE[8X^V MN/)ZSB!E?0KT[3OF++F2#$TU\B+A3_QP8TJQ?,:A.Y5$!\%;;P<.[K7.H^!" MADHB[2;>]#S:A2I!$HWIE.K`T=:-F!DJE60P-`2)LNY5$F--A9JQ)]ZK)&K( MVS,_BI(LKI829,`4)0)K\XU"6BEI11N3`QYMJ^,0W!'KIB%*[(EW2@G) M9Y^2SQF+E=+*'"597(T2:4`-M43[4J66*#2>;%`)^BV,?G.YU-US'=?GL5P@%O=]L'`=./<+O%&@Y)8;W2\>4:3A\-^&H-9W@8WX=K.!LSX-$:3I(, MN.NLR7$-O@/',VMR`H/OP`?#Q_'\11\K?$@#-9R-@\%OHIT;Z8VAOY)3/>FH' M^'(X_GF"3\(UO*(Y,ZB!8]L._`=Y@/C(O/T/``#__P,`4$L#!!0`!@`(```` M(0"^$[,3J`(``+8&```9````>&PO=V]R:W-H965TN./UX?G/1P.>'WS+%OTQ+41JBMP$L48\8ZI4G1U@7_]O+^ZQLA8VI6T51TO M\`LW^&;S\$XD%1T.A)5^#T-5E6#\3K&]Y)T-$,U;:B%_TXC>G&B2O0J@[I>FNA7D_)QEE)[9_NYACMN+'WP@W&B.V-5?)/B$J.K$!)CQ2X'RFS M>90OXEGR?P@)&?F9W%%+-VNM#@C:`RQ-3UVS):L42LB8VQ`#UR'F-8(`?;"`?"R-$0"6_"PIY#MZ^=H7[O.8%)0WV?VCJN[UOP;U;7H#&IY M!K>K^E=\K"*>(?&_@_<-A?<03!E5+V]`+.9/CC;/X"``#_ M_P,`4$L#!!0`!@`(````(0`WQL$P#`H``&8J```9````>&PO=V]R:W-H965T M)[\8NL%CLY3E- MW3:8)"Z2=#KGVQ]*(BV)]+2=\W`R_86B1(JF_HY]^\?/XV'THSU?]MWI;AQ. M@O&H/>VZQ_WI^6[\W_\4WV[&H\MU>WK<'KI3>S?^L[V,_[C_^]]NW[OS]\M+ MVUY'X.%TN1N_7*^OR71ZV;VTQ^UETKVV)_CFJ3L?MU?X\_P\O;R>V^VC'G0\ M3*,@6$R/V_UI;#PDYZ_XZ)Z>]KLVZW9OQ_9T-4[.[6%[A?5?7O:O%_)VW'W% MW7%[_O[V^FW7'5_!Q[F\?]Q"!2OOHW#[=C==ATL3+\?3^5B?H?_OV M_>+\>W1YZ=[+\_[Q'_M3"]F&?5([\-!UWY5I_:@0#)Z*T87>@7^=1X_MT_;M M7*VSW7`W9=0>8"?X_.NY5#4#HVY]WXPAFV#]>7^[&\6(R7P9Q M&,W'HX?V>3]6/BD>69VL1],M,"!\(D#9U]9WQ*'P>>7U@=7CUX??-+Z("4?K&N% M`^"3!GQI82$4A)Y)_>,+$4W-KNMJR;;7[?WMN7L?P24(^WIYW:H+.DR4+ZP3 M7'-?.5#`.V6^5O9W8\@'U,0%Z(_[V7QU._T!I;A#FXVT"7V+E"Q4.2JW&0>WLJ'L(1MPE=NK8!'XL6[0Z*-T]"9].@3)!2D$*06I!*D%:5SBI0.Z MJYL.NO05UE'3:C=(H'GU>8AGL9^'M#>B89D@N2"%(*4@E2"U((U+O"#A)!@* M4F$_2"2K_FI/!&B_XJS`A9\9$3NM%R;!E'X6+!"K0@&^NI)`077Y_,<,[+`*WBA78> M3>`VSOV/R9R:G.IY_.0H*3*4'"-1X#"E#&]"@T(HN'YE\8R%E*)5I.^#4$7V M`\E7CE:QJC[0JO$\BGA#*J2GTBZ!/%5DM=*>@LE2Q&YF-POR8U?*8RAV5"1N M[`;YA1&Q74E#M++;F1$R]WBJJ^>(8KC<^CQ&`2OQ@@9:7R4AZZOZDJ^:!@YL MOU(;3@H^[1&H3MS4&,3*XH9?,\;**PM$MKGD(:)(;^:W>1R'2R9<"K*Q!582 MLIXJ1/.9N4#\U=0TP-RLN_<<:H?=A-#9ICEKCLH4FJ/7+&+1+-#*[F.&OD*W M6:"5:19A"#?IRX!UT(+&65?L[B8->RL;KT"YM"HD*B6J)*HE:CSD MQZO$RE"\1L1X\2)R!+YJ,4J@6)1)E$M42%1*5$E42]1XR`L.>MM@<)K[K0,1 M',NT32DA1U706ZMR% M4(*Y>3#(TY?AG)WS.?H"*YN'?B"A4EI5$M42-8B&\J`$AE/4G^;!"!*WV"-4 M2&X]('+S8%"T-&=:$+(VGJ,;,*!X"T1SZ[FDR72CU@JML@.5'(N"D"6WM@;D MN2$WVK-?&$Q7Z81$BPD4,C6X2$HL1.HHZF51S*L])2N[RQDA]QP0BCFG&8UB M#B8+IE`*R>J/B-41O[%#*S@/:!\S.Y!03E:XM;[N+NR` MX7W5W:@D'W:FR@ZDF6JR&IRIL0.&9_)SI93D4`4ISDYN@UB78O6;0@?6=6:W M."-DMSA'!!6DNBX7Y84=,1P")DM,5=F!-ED8"4[%>D1C1PQ/Y6=+"84"1V%\*L1ORP)V1,ME2B3*)>HD*B4J)*HEJCQD!^<$G-. M<)^IQMB(/_?\1^2J9T*.:D0$#1&U'3NS ME8BJ@^MFMHZE+$3D-US^5"\E*Z?A$K)B.">$O[(L9JMEP(ZY@FRLIY*0]501 M0D_S8!%P3S79:$]^]*[&DG@+=@N8HI5[--N!M!LY(BA)M8/#O[E* M3Z7T5/F>PEF\#-@/$;7GR`_>E6O0G\RK#;]\*A%+%8>(E00["U*RLAN9D2][ M=>2(YC!+?V+('V.EKU+ZJK[DJ_9\^9EQ)9M3%E*QP2]Y6E]X[9T+B!2MO+)` M7_;>+T9UF6-[?F[3]G"XC';=VPFV$*3,_6V/\:VN:)6LS6M=[!M0#(DZ MC.$BX=_$`;P*IB6H^$:])*9O>_DWLP0>WP_XFB?PQ'N`+Q)X;BSY.EPFZT@G M@<\`WZC?$^6837@#WPR/@1C-O1[SED5AHG[KD-ZR*$K4SPGR&_BM`,8,?9/% M,`9:OAP#AT>BS@?Y#;QOMQ[B&TCQT+HV$6S7@)]-#%LRP->S9&V>T['0RV4" M3[SE@LJ;!!X;#_!54@V5218&B7JT.3`"OJD&O\FB`%*HQTS[9<'+?Z_;Y_:? MV_/S_G09'=HG*&9XG`6-Z6S>$S1_7+M7]=!V]-!=X;4__<\7>)^SA2=+@1*) M3UUWI3]@4=/^#='[OP```/__`P!02P,$%``&``@````A`(/(#!1D!```=`X` M`!D```!X;"]W;W)K&ULE%?;CJLV%'VOU']`O)^` M@9"`DASE1GND5JJJ7IX)<1(T@"-,)G/^OMOX@FUH.GT9)HN]E]>^V-ZLOG[4 ME?..6UJ29NVBF>\ZN"G(N6RN:_?//[(O2]>A7=Z<\XHT>.U^Q]3]NOGQA]63 MM&_TAG'G`$-#U^ZMZ^ZIY]'BANN_7HO<7YN7>J*R_P M_=BK\[)Q.4/:?H:#7"YE@0^D>-2XZ3A)BZN\`_WT5MZI9*N+S]#5>?OVN'\I M2'T'BE-9E=WWGM1UZB+]=FU(FY\JB/L#17DAN?L?(_JZ+%I"R:6;`9W'A8YC M3KS$`Z;-ZEQ"!"SM3HLO:W>+T@Q%KK=9]0GZJ\1/JOWOT!MY_M26YU_*!D.V MH4ZL`B="WICIMS.#P-D;>6=]!7YKG3.^Y(^J^YT\?\;E]=9!N>?,I2`5K`1_ MG;ID/0"AYQ_]\UF>N]O:#>/9?.&'*)B[S@G3+BN9K^L4#]J1^F]NA`05)PD$ M"3PE23A;SN=1O%P`RPO/4'C"4W@&_FR!_"3\#\=(.,)3.$8S%/DQ4_UB/7C; MAPM/X886GUHO%H[P_)10C^>YK\\A[_+-JB5/!YH>,DGO.=M"*`4R41BA694* M.J9@UEMFOG87K@-%H("^;Z(X7'GO4/M"V.S&-LBTV$L+5G]&>["!HPUD&N"! M=*4?:OQ_]#-SIE^NO)/`$%!@B946TN5@`T<;R#3`$`MM98L-?95;]A;Z7FF)VPT0LP-TWVRD0)'B''$9+IB*$9.MK6##OW7QN$F4,0<'!K'6)'(8Q> M1:%,5!0CY#A",ATQH@#%6A2RFQG:BY6+[`22&/+M#"LCZ788(<<1DNF(H0VV MW80VAIK:!)*HYMV/D,,(.8Z03$<,(5"/"2$,-85PA'6!JG&PL$Z!O3"*E=K# MA!N:6ZUQY$;!LC];8C1/$K.],YW74,]FA>$DDR5FJ*F>(RCI5PA\9"G8\_=! M?Z'QTTEY#/&.A8N%$*>-D\CW+>4ZL:$:RE7 M'J^4@^;V@4TI-U:8R\,]+P//J_DR\5DYB?T M&]QF`.Q>&7<-XM<-'&-RB^\$-&1_829I+PVT]$M(WRGCSA%6KPH@B7IN,P!V MUPP!B`M\QL:5[E86;SO2CTMR.R!^-1F!<0@J,V0Y6-B[0C@:Y>&.`>1*G0,3 MT0FKH._:91`N0GMC&-QF=.Q:&J)348C;2B\/AZQ#R=XA2%CI-1(0G"NOHA!6 M_%Q"212AT&J`S"`WPV#WTD08XKK2P^!0/XIS"CY3\YFMQNT5[W%54:<@CP;T M,CT*5;/\-F!]:^$[-N-/X4$*`\N$?9C"5##&MU&ZY=\*]@)1"A?PV&$W3^'R MF\#C%.XBP#U%!)\"]_R*?\W;:]E0I\(7B!$F<.CFEG\U\!\=N?>CZXET\!'0 M_WN#KSL,LZ0_`^,+(9W\P190WXN;?P```/__`P!02P,$%``&``@````A`/BG M*+],!P``*!T``!D```!X;"]W;W)K&ULG%G;CN)& M$'V/E']`?E_P%0P"5HOQ34JD*,KEV6,,6`,8V9Z9W;]/M;NZW;J[>KFMK&XO#;_6M@FA#GD@&GIKFF9CF!P*!\TSS3H8,_-%. M#M6Q>+GT?S9O656?SCVD.R`N97.!.\'_DVM-:@"D%]\WE@MWJ`_]>6-Y\VFP ML#W'#:S)4]7U24U\K4GYTO7-]5]JY"`5)?&1!#Z1Q)F&0>#/P\7'2X7"*=%FI]LXLD7$ M+$CQ$-J]"L0JD*A`J@*9"N0",`.U7#(4YFB!0=I'A(C+]^B>(N3`X:J=0&E#,3=BJA,-234DTY"<(LYP>TD1 M%)&0(VRN4W*"]>>Z?-XUL#B'[TQB+2NEB*@4$4$I15Q8@Z!4:4@Q-^)*-235 MD$Q#.''IR84>IDMWY%$J.[45B(*ND"$Q-8ZZ\,)1E1&@T M'XL9D?$(BI%ZM$DTKU3SRC2O7/22*M>!^5!0QR0-L*P)(0>H>`%ZX5(1A5;N M,&/BF4]N`?6_Y$)C9C5""8-&QW2\(TM2QJQ&QYQ!=*H5SW^H,J,V.B_`\''[2R.0)8QK)4P:)J]+( M,YD\=`(8P&7NG!$-W'+ZR6PQ[F>>?CIR2"&BD)S^I7*G"#H&R;64?N[(PATS M*[&47%N9/!)F)5:$QI4QJX=<.;,R%`D9.@P1P%E$+!(**46B-);(0:LQCWL& MT1]1Y""+$8)QC04E85:C8\J@T3'3'7-F9<@N&2H,VG#6$+512,FNTG@CAUI) MV34X:C4:HZ-'SL#7[<(F_^0:373N%"%I41IWQAS?*0!QZ?(6@.UE"A*!E0Y( M(:4`E,T>DW5#9W!.'1&H7!T1`EO",M)=]>AIYR ML"8Z=XK0>Z6$BQ*7;@B2N'2YE,C8-`9IF`/E4<&A@Y44+YRUQ/QY2^5XB-!1 MJBJ#HR%>U"J8#UO/\9UE:"N'=J*3IPP25Z619TS..U6%"S54%1FZ'@>,CF52 MP'!2$[/D+96=$CG42NI5!D=-4XR.V*N<8!',E5,NT;E3A-XK,%R4N'1#@8E+ MEPL,'(5X\>.:P$JOHA#9T+SE>$MEIT1DN6JO,C@:@H1W?)CX1*=/&22N2Z// MT`I;H6^';J#D-V=$>E%!RDU!&F`Y2`@1*B%(RNZ(T`H^V%F]-SEJ*F+F*-)K MV4Z8U4B??H@^0RLL5->UPX4RC.02MU1)KGDV'F`E2#CUBAGSU>,[0D>Q/S%( M=#0$":?QQY7$N(1SCT$/Z3.T8J.W#0^6EV'9SZ10J]B2$ MI$KR;:5O1&@%61DKB4^T8PD:@D2MW':!>LX)$<%)Z"[^-1EP!#!DP,,5/('1\31'S5TC==]$O?W"&(\!*KZ>'%U?#G&=Y(5O#3S9Y"$1Z; MIF=?R`WX.\[M?P```/__`P!02P,$%``&``@````A`&`=LQ9G`P``7@L``!D` M``!X;"]W;W)K&ULC);;CMHP$(;O*_4=(M^7G`\@ MH%I(MJW42E75P[4)!JQ-XL@VR_;M.XY)%IM5TIM=,OG\>_[Q8&;Y\:6NG&?" M!67-"ODS#SFD*=F>-L<5^O7S\4.&'"%QL\<5:\@*_24"?5R_?[>\,/XD3H1( M!Q0:L4(G*=N%ZXKR1&HL9JPE#;PY,%YC"8_\Z(J6$[SO%M65&WA>XM:8-D@K M+/C_:+##@98D9^6Y)HW4(IQ46$+^XD1;T:O5Y?_(U9@_G=L/):M;D-C1BLJ_ MG2ARZG+QY=@PCG<5^'[Q(USVVMW#G7Q-2\X$.\@9R+DZT7O/2P0@_^HO`]Y*Z778%^4W(1-Y\=<6*73YSNO]*&0+7AG-0)[!A[4NB7 MO0K!8O=N]6-W`M^YLR<'?*[D#W;Y3.CQ).&X8[6D9!7L!'^=FJH>`.OXI?M_ MH7MY6J$PF<6I%_I!C)P=$?*1JK7(*<]"LOJ/AORKE!8)KB*PXBKB![,@B_TX MF59Q=4:=DQQ+O%YR=G&@/6!/T6+5;/X"E)6%$`JA\QA,06U+13\H?(52Y``G M(/J\CI)LZ3Y#E4`<"N0\&H"PW!OH\ M553EV6^PT0$0&1(/S`VV]T0:FTA^CU@BQ3UQ(V+D'1IY]X7O\U=OX21NTHV2 MN9G-1C/1#6/ENYTD\DFB&",,0Y#(&P>AHBL$91GJ'J6>940S6==.Z3R8S[/0 M)+:W1):E\S2QK.:W1!!E\*4(K;XL+"3.O!O$L`)?A#>LJ*AMQ>K2C69@I\&N ME>AVDL@GB6*,,(PDAA&[R=3;J2;3S)BA22*?)(HQPC`$-\\;)Z.B]LG83::9 M,2.31*Z)N&O4((*[UPOL)C,1+XNR,!F:V;"BIH#7F[?_XJNH;<6Z9#::&;,R M2>231#%&&$;FAA&[R=3;J2;3S)BA22*?)(HQPC`$,\-;1].%[;.QV^P*C7F9 M1O(KHJ_$./02W]I'S36JKM=+,PT#[[5+M!D]MN@?^YKP(]F2JA).R*[&*Q5WAP4P]+3X2+YA?J2-<"IR@*V\60H7 M%M?SD7Z0K.U&CQV3,.YT'T\PQQ(8!;P9P`?&9/^@-A@FX_4_````__\#`%!+ M`P04``8`"````"$`,/_M&P,#``!G"0``&0```'AL+W=OTD<$@((J`I5MTJ;-$W[\6P2AUA-XL@V MT/[W.]L08LC2OD!R]_GS=W?V71;WKU7I':B0C-=+A$OI M;HH\J4B=D9+7=(G>J$3WJ\^?%DYRRECSS=5[16ED30DBC0 M+PO6R#-;E7Z$KB+B9=_#"GRJG3^O*NY(-L2XG[%$4G/W.;E MAKYBJ>"2YVH$=+X5>AOSS)_YP+1:9`PBT&GW!,V7Z`'/-SA$_FIA$O2'T:/L M/'NRX,>E> M*E[]M2!\HK(DX8ED##)/_G`43F,<3]YG\:TB$\DC462U$/SHP?&`/65#]&'# M5E$R7O@'2$IZPJQO,:&+V/0@DA;B@Y!6#<1X MK68D417O?*XK%#(D90CAB)HZ8]XIB,4-BAA".F)DCYEP4;74SF#;`N': MMUTCNFX*ZQ-H4)#EZ8>X@G2;NQR0-C.V^PVW+YB9NG*V?UU7Y3].N[D=E7;` M-&1'OQ.Q8[7T2II#X,$H@7LN[*"T+XHW9KYLN8*Y9QX+^*"A,'R"$8!SSM7Y M18_B]A-I]0\``/__`P!02P,$%``&``@````A`')H(CCB`@``O`<``!D```!X M;"]W;W)K&ULC%5=;YLP%'V?M/]@^;V`"4F:**1* M5W6KM$G3M(]GQQBP"AC93M/^^UW;J0L)E?I"XL/UN>=^LKEY;AOTQ)46LLLQ MB1*,>,=D(;HJQW]^WU]=8Z0-[0K:R([G^(5K?+/]_&ESE.I1UYP;!`R=SG%M M3+^.8\UJWE(=R9YW\*:4JJ4&CJJ*=:\X+=REMHG3)%G$+14=]@QK]1$.69:" M\3O)#BWOC"=1O*$&].M:]/J5K64?H6NI>CST5TRV/5#L12/,BR/%J&7KAZJ3 MBNX;B/N99)2]*[Z#AD&^ID*["7\M&:/A06@LOQQ>U[5X&? M"A6\I(?&_)+';UQ4M8%RS^T5)AOP!$_4"ML#$#I]SG$*'D1AZAS/%M%\F2/BO'LNI^&.&KK=*'E$4%BPUCVU;4+6*03/++BS M:(Z7&`&?!O1IFR6S3?P$8;"3S:VW@6>P(<$B!O;@`O1.N+"H=6'CM#YO/3#D M2Z?Y9I-\%H6,#.1D218(O`MODPULYL%B)!E,)B1;%%S`X(60L^2-P?OP1A_P M`36;\&%1YR/DQ2,$^FK@=3&M>S'):=$QIT>`TS;FL%90\H$HY'HQ(Z$O[.LQ MDT?.U"VGU=F-==EK%AUS>F1"W6I$X-2E9!G-@SYK,.;RR)F^ZVE]UFI"H(/' MK"<(?LX32.Q8O`7I-5Z3"$8T#)>?'.BC4&-W"T9P7.35.S*G!XKX`1K1GF9J M0N9XB)S,&5D-4DE.`S54Z:&Q2I*\HW)ZAF"3GI?H!+D5ZYO1[TJ_IUJN*OZ% M-XU&3!XZF`&[I@(:=O0NM>D\Q[/USN_N.+R!E=K3BO^@JA*=1@TO@3.)EC!G MRF]??S"R=^MQ+PTL4_>WAJ\DAUV50)Y0*:5Y/=@N"-_=[7\```#__P,`4$L# M!!0`!@`(````(0!Q$W0TJ0L``%DT```9````>&PO=V]R:W-H965T:HJJ(+G`%T,O] M]Y.RE9:4QTU73S]TP>>C8TFIS9+Y]/?/TUOA^^%R/<;GAZ)7JA0+A_,^?CJ> M7QZ*VTWT5[-8N-YVYZ?=6WP^/!3_.5R+?S_^^U^??L27K]?7P^%6((?S]:'X M>KN]A^7R=?]Z..VNI?C]<*8KS_'EM+O1U\M+^?I^.>R>DD2GM[)?J=3+I]WQ M7$P=PLM'/.+GY^/^T(WWWTZ'\RTUN1S>=C?*__7U^'YEM]/^(W:GW>7KM_>_ M]O'IG2R^'-^.MW\2TV+AM`^'+^?XLOOR1N7^Z55W>_9.OH#]Z;B_Q-?X^58B MNW*:42QSJ]PJD]/CIZ^%R>'XH?O;"K=\LEA\_)17TG^/AQ]7Z7+B^ MQC_ZE^/3Y'@^4&U3G%0$OL3Q5R4=/BE$B*-PUE60?O]&=Z/_"Z:C:`!5]]S/Y^^/X='M]*`;U4JU1"3R_5BQ\.5QO MT5&E+1;VWZZW^/3?5.1IJ]3$UR;T5YOXC5*S5JO6FXV/NY`RR0K]U2[_ATE# MF]!?+D_)JU;JJC1W2D#M/KDW_"G@21!'T) M!A(,)1A),)9@(L%4@ID$+$A<8N.RYZ'5E23SRWU^/^:SM. M'IRX:RFY&Z^4T(,`]YJ.)GY&NBGQZ\FZTZ]X@=OS>MEU]HB`]($,@`R!C(", M@4Q2XIG\3C.-6B=3?L5D/LNN5%3V$W M>BFQHZ>)J8BN)D$6F1Z0"%+U4Z)V&7X=AT$FXB(-P6B4:6PC\;@YSD1L-`&C MJ2:F'#,@TE-IC& M1L5>$_2:&I7EY8DRSHR*O>;HM3`JRTN6<6E4[+5"K[51V5ZBC!NC8J^MX^6V M&[4G8;4;GM0IY-`^4D0[Y/;=Q=JEHQ/2OBG?O,[CJ/76>-ZTRE%RUO MRS:)L]O,U,9)7C/3&RK)*4^RY=OV4N31))?%./!%17>TBC:Z33/+$C+J:57@ M)5ZE5JF(<5736[6Z+%A5>KAE>1(N65!8N.V"[7W MDM3U6^6F#:?BMG`8#3GV=C++`36_`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`"*S;TL@+B)I][5 M4OW/K#@[B+J(>H@B1'U$`T1#1"-$8T031%-$,T1S1`M$2T0K1&M$&T1;![G1 M^L66FH];:AK1]AQWI`XCLTW:U4AL/8NU7\^HV"MRO-P\_F(_QL?]&(W6KYWAKQLIZ0?I\;\]ZB91V M`=QA3.RU=+2*^AW76-WE5\2<%K$*)VL5MMQL*RY&WQ2)JA;KNDYB MZ&YQ,+*K.O7BO0!/[7Q!7>O[Y=2U>M*PZOIWC]_J.$`61C\CD[H MQ"!-2!W,Q$`C?DZM5W,*HS4Y$5#K6:LP6<-)U[E.PTF1B(!8F75\K;(;NT;F M8:C'*OTP5*OG-';;R.V@OUCB43RAHF&)E[[QGK[/>SI<7@Z=P]O;M;"/OYUI M498LE#.5"E?4^_E)E,05&K%"-1ZA&[W2_SF/ MM\DJSZGMTRUR?-I!2._BY?A7P\^TY,4+[6I([WGE\%I(+Q7E\'I(+[4@_TP5 M]9F"@%?HR#-4!YIXA0XP0W4\B5?H5#%49X9XA\*]U&2"_`H->T$=*+)LA' MS9#>NT"^;H;T:@/R?BND]P.0CUHA'?F2_C0D_7*+WVGLI5]]Q#?ZI4?R\95^PG.@S>!* MB<;3YSB^\1=U@^Q'08__`P``__\#`%!+`P04``8`"````"$`\X(?M3$%``#T M$0``&0```'AL+W=O?O9QO;X$NG:E]*66PO>^V+O9W- M]Q_-S7K#75^3=FNCA6M;N*W(J6XO6_OOO])OD6WU0]F>RAMI\=;^B7O[^^[7 M7S8/TKWT5XP'"QC:?FM?A^$>.TY?77%3]@MRQRU\.9.N*0=X[2Y.?^]P>1H' M-3?'<]V5TY1U:S.&N/L,!SF?ZPH?2?7:X'9@)!V^E0.LO[_6]UZP-=5GZ)JR M>WF]?ZM(

*Y_I6#S]'4MMJJKBXM*0KGV^@^P?RRTIPCR\&?5-7'>G)>5@` MG<,6:FI>.VL'F':;4PT*J-NM#I^W]A.*"^3;SFXS.NB?&C]ZZ7^KOY)'UM6G MW^H6@[E8VZI>^X$T_S(C MQ*D8B<=)X,E)O&"!?'?U!0Z?<\!3<$P4'TP-BQS7#T\^;/V982$?!D\QVX<* MH2[&:>#)[:-%%`3^*@IA9G-]#G/S&)YC.92[34<>%N0\.+*_E[2"4+RV+1X7 MSC!%"A*FHM9/U'QKPRHA!CV@;SL_<#?.&X2^XC9[TP:I%@=A0<-/:8\ZD.A` MJ@.9#N0Z4$B``VHGR9`57Y%,S:EDL=B]`&8?>)H^82&&''4@T8%4!S(=R'6@ MD`!%W_)K^J@Y5)D44B\,54%[;B/'/5!-#I/))-I`$@-)#20SD-Q`"AE1I$.Q M?B6TU!RD0Q%)Z:PEZYX;?:1],IFT&TAB(*F!9`:2&T@A(XIVJ'M)NRA8BHX2 MQ=+V'(%BGT1[D5;#A\E(##L:2&(@J8%D!I(;2"$CBJ+5NXHHJBKBR'HJT8.! M'`TD,9#40#(#R0VDD!%E^9`Q[P2$HNKR&8+8$4:WPP-'O$G0D2'T^)J"A@)M MVTDF(Q&TU"#*)IN9R',UHGPR$D2%3*2(I`V:<7XLZ"$T7.OJ94]@O6@Z/JBU M*IXALGB.2.(9XJW&\\9ST5+=>I+INUAN:G!DDPT]LX!#ESQ]%QR%S*%(ALJ1 M)(M"HZ@JC2'0Y4BNCK3=Y<"-5G.H.0(>ET+M:Y+Y;)![DY'G:EMR:G!GG^'. MN5$TNGN-0E_;'`J95_$,@K[P'=>,L.H;#B&@D@1H$QVXE3?VEKQ3H%-`2LW% MG@AZFF9O.Q0B6++JKM0DRN85B(CG*I&'HDCO;0J%2-5.VXVY$D1:0&;K><$A M+3&TA#P(*RDS!,3Z9KI3)!SR6+`0\M9!H*>!S90*:F7*-":IL[:Y5-Q9B MV,BDJJ?-R*R>]Y'_NP\@UKO`R2N0FA&15NH';J5D!./RYOTS$5;>F!$! M6H:^1I0*DSFU,@'-1+F`&!%RPR!8:Q5<"!MV`9(;343[E"\XA;M M57.AD*O90YN:V5%3[?!>1W8(@\:;*J-@5TYVIVEP=\$'?+OU5D5>6WKTT,A- M,+OK[H,8>@Y(/!U?Q7"8F_@QC.%H-?$LC.&D-/%C%,.19.)9%.?OX7#W?AI/ M.WT]]$[^#L_>BZ'W-_GWRQ@Z8Q-_\N,G=K?7)_!C:"=A@#-]@*OXO;S@W\ON M4K>]=<-G<*([UG'';NWL92!W>JY;SV2`2_CX[Q5^7<&P)[D+./'.A`SBA4XP M_5ZS^P\``/__`P!02P,$%``&``@````A`%D,@_KA(P``Z\```!D```!X;"]W M;W)K&ULE)U;;QM)DH7?%]C_(.B]+17O-&P/1-85 MV`46B]G=9[4LVT);EB&IIV?^_9ZHO$7D"5'R2ZO]962R3D1F1E213'[XVS_O MOY_]X_;QZ>[AQ\?SYMWE^=GMCYN'SW<_OGX\_Y^_][_MSL^>GJ]_?+[^_O#C M]N/YOVZ?SO_VZ=__[<-?#X]_/'V[O7T^PP@_GCZ>?WM^_OG^XN+IYMOM_?73 MNX>?MS_0\N7A\?[Z&?]\_'KQ]//Q]OKSW.G^^\7B\G)S<7]]]^,\C/#^\2UC M/'SY?/WVX> M[G]BB-_OOM\]_VL>]/SL_N;]]/7'P^/U[]^A^Y_-ZOHFC3W_@X:_O[MY?'AZ M^/+\#L-=A`MES?N+_05&^O3A\QT4B-O/'F^_?#R_:MY/<,GYQ:?; M+]=_?G_^[X>_QMN[K]^>$>^U=+EY^(Y7PG_/[N]D$D#[]3_GOW_=?7[^]O%\ MN7FWWEXNF\7Z_.SWVZ?G_D[ZGI_=_/GT_'#_?\&HB4.%019Q$/QU!CG1<1D[ MXF_LN-B65S_1<14[XF_LN'Y3/VB:Y>)O>L'-N\5NW:PWHO?$*VYB3_Q-/=]V MJ=O8$7]_Z5*Q%N=+Q=_T@F^\U'WLB;^IY\E+O0AS8IY+[?7S]:5IA>M^(]968?SR'3DR8)]!_?%HUVP\7_\`\O8DV M![9IK,4Q6AK,-1@K,&D@-&'E5;K6ZUS!*45.X")X,Y>_R':Z#"OKLFBFU6](+-1ZM82Z8CT1`8B(Y%)$Z,( MVZZC2*A5%,D^K\@CD99(1Z0G,A`9B4R:F,O'C%&7/^^D:VQ!(=_P3BKF5EF)#$1& M(I,FYO+A8>?RA=K+C\0&9&GWBV,VR@$ATA'IB0Q$1B*3)D91@^7M2)JQU920 MB@FCEE''J&9%=UI23D8#HY'1 M9)`5(LFZ"'EU&VQBBL&74,>H9#8Q&1I-!5K1DZ2(Z1R\F M;ZTM(*3C-.>.#:&64<>H9S0P&AE-!EDADIR+D#_7(DPGS4OW6B/V<6XN35HM+.\D/R0H> MS9F(=K(X4KG%;$NWM#8Z1CVC@='(:#+(>&'A%Q(SMH5$1-6-174G>2Q624C+ MJ&/4,QH8C8SPS&V.2]AAK39;6Z1)LN#Z(:$RM8^,6D8=HY[1P&AD-!EDA=AB MX=4UP^+7#^DJSXR M:AEUC'I&`Z.1T620%>(7"PLN%A(R05I76\RQ6"6Y+:..4<]H8#0RF@RRVB2! METTT!RGF=;4/2T5O4_V14%W1Q&!@D;7T:>:Y)9M<-Q2H.4WEM+`9I MF"D-XP1<"@QG5<:Z0Z_*@*3N42&K-!P7T:K$ITT(D5,=JSON+EGM@G=6>%?F M]$*=4H*79M0V4.ZA!:SJ];+RTU3;?Q],BD##0F5@<:$PD#;[7)Q64VF M*9F$]QOU6R5+6S*]ZA,NI>81L)V$-R;ES9YC0B7`;422-)7GZNF3K%9Q^NSP MEMZRGCX\^I#ZG1Q]3%9Y]/7NLAY],J/;Z>,497I7_?O#3[VK+KDFBXAO3992 MT)3U&Z/P\JW);$^W)E6R.20KO:AHKL92JNQ6;>F6IF_'J&MGSX4JQ*].%;Q0\=6/:.! MTH9#8Q&1I-!5HA3$YQ^Q+CBLB`A MN\CKYP_%*L>/4<>H9S0P&AE-!EG9-K^GN;GB/!X1+_+5+^;QV7Z>&Z4J6BVJ M:OR0K$XM\F)3'$FIO6.KGM'`:&0T&60=Z>?Q%>?QB&0JEJIP4Y7!QV)5M(6Q MT#&ACJUZ1@.CD=%DD-7FYW%\_*;.!`GI14ZIO66KCE'/:&`T,IH,LD*OJD./Q2H%JV74,>H9#8Q&1I-!5K;D9TY`JY"V=0)*2,H9#8Q&1I-!QI%2L3N.G+&M52*JMN@J11V+5=$6:@*]1;-5SVA@-#*:#++: M_#R^YCR>4)G'1T8MHXY1SVA@-#*:#+)";#619OLZYG6UDA.R*[F:I,=B58(4 MQRH>Z-BJ9S0P&AE-!EEM?HVPYAHA(FB!R6$>KDRLY MVQ1'$NK*2,FJ9S0P&AE-!EE'VCR>)PDGZW5`=B77[VTK:G?%T] M&CPDJU.KO-AD1S+J&/6,!D8CH\D@X\B-GZ]G;/-U1':5;RK]QV)5M'&^9JN> MTT3UP^UB50+(F9RM>D8#HY'19)#5+?G9"6!(VR:``?$BW_YB)I_M M*9-73CHDJU.+O-AD1S+J&/6,!D8CH\D@X\BMG\EG;#-Y1&:1-YOZ"7JQ*MHX MD[-5SVA@-#*:#++:_$R^Y4R>4%G21T8MHXY1SVA@-#*:#+)"G$S^2KV^Y52> MD%GEV_KI=K$J`>14SE8]HX'1R&@RR.KV4_F64WE$SBK_Q50N'TH+[Z'J5%[- M\D.R.KG*.967;LFW':.>T";4;7*ZZ?HQ:IHXUS.5CVC M@='(:#+(:O-S^8YS>4)E21\9M8PZ1CVC@='(:#+("G%R^>F[\AVG\H3L(J\? ML!>K$C].Y6S5,QH8C8PF@ZQL/Y7O.)4GI.,7K0IJV:ICU#,:&(V,)H.L$*>@ M>"5^N:1(83CL(K+QJQ^=%JO4L674,>H9#8Q&1I-!5K9?0>RX@DBH!.O(J&74 M,>H9#8Q&1I-!5H@M%][P5&S'E41"-G[U4\UB5>)']4;'5CVC@='(:#+(RK;% M17KBL>,"(B$=/RH-6K;J&/6,!D8CH\D@*T1J@%(MO"5^TJ/*?Q'9^-5/K';9 MJL2/4,=6/:.!TBJ3J5N"0K$X5 M2<4F.Y)1QZAG-#`:&4T&64?ZA<2>"XF(JB*I>N!S+%9%6Q@+'1/JV*IG-#`: M&4T&66VVMLB3A`N(?4#J$H^,6D8=HY[1P&AD-!EDA=AJX0V+?,^%1$)VD5>W M\L=BE8+5,NH8]8P&1B.CR2`KV]86.7Y<0.P#N,!MPDZ,%W-S^8LI M.W2@G%W=V!^RV:GUK(RR/QV&?OYI(3>&+>HI>L6?;%5U-X)V0V!IV[L:C8$8O``,7B` M&#Q`#!X@!@]H9CTPGSM8/)"WO70>H589F;,AS*?XE5%>WQ#F#E0%5`[#H84Y MT9[8$(I162K,<&IA'BS9X=A"8CBWD!@.+B2&DPLUJ[PJJ;/XHW@UI%3]CE$3 M#PZL-H3Z29TR2U>/HQEUAIZ/R8!*8E!)#"J)024QJ-2L4BG9U%,9LZR9.SKS MQD/BS.F!X8"4AADD45]((@9)Q"")&"1I5DF2U%DDS1/YE<\Q-/'L0!O4G(++ MQ&UV]>.[W%5O"&FXPN"!/%P*/CQ`#!X@!@\0@P$X_^4ZD3*G-7I9(85!*#2F)0 M20PJ-:M42J;U5(8,;%5&5J8Y`D<,DH@A<,0@B1@D$8,D8I"D625)4F>1-&\( M\DVJ%\]`3`<)FG62\Z^.:/VC` M(C_/VWBDH(EH.F90;K*K4213EE%>+P_207^(B]H-JNWST"0SS,AL1KM!,4H> MQ%'`.G7'Q,D,AP&3'4X#)H;C@(GA/&#-*G](3BW^*%X-N=9Z->??HK'9UX__ MFGA*H-D-F.'$XSQ<\@94$H-*8E!)#"HUJU1*FO54QO2K5X@Y&S"6!\P0.)VZ M4^"(01(Q2"(&2<0@2;-*DN3-(NGUW2"="VBTYN2K(UH_*VQ25[T;,$-$\W`J MHL0@GQCD$X-\S2KY+]0&Z=!`H_+%VF`^AJ]RXLG:()[;AV51'+:JSZ'";I#3 M;S'CW2`;)6]A4AXEA4AXG!J\3@5&\2P^JS)W3`V_]BAV/IB>%< M>F(XF)X83J8GAJ/I-:LD26HNDN9M_/0GI)IXRIU5&S,\?)?+CV9/C_)2UR(6 M#LA=2TR9P0%D!P<0@P.(P0&:50Z0K%T MM!A#;6$78V0VIM4#!,S<;*9B2@P.(`8'$(,#B,$!Q.``S2H'2&G@Q326#":F MD9G%2`S3E!@D$8,D8I!$#)*(09)FE22I`SQ)H3ZP@8O,!JZZUT/@LID*'#&H M)`:5Q*"2&%02@TK-*I52&G@J8\E@`J?+B+08B2%PQ"")&"01@R1BD$0,DC2K M)"$*2M*;%J-TJ3XO@/TEYG>=&>D15C%3,0RO')`SX\PKE8GIQ<@,/UVC*Y&8,YCAQVO(#K]>0PP_7T,,OU^C625)Z@!G MFJ:#_?0T30P.4B4-/:DJ9BE(4*G+C:22&%02@TIB4$D,*C6K5$IIX*F,)8-1 MJ'5S=)P$*Z'JX1+E>`)C]6#$1Z8%1Z9$1X8A+_P MPPE-/.S0!IM&@N9Z)):;+91+CE+<-C*ICA%W@KKO[! M&4P-/7SE*RDV/%_%(L3X*C!Y0T;YJA*#_2&8Z=]+2`Q=D__@F&AGAZON<^$; M&@Z^"4P-!T>\93CX0@]G?3&?K^CX(IV[J'T1635OZ(8NF97`XC?S0C&$KL47 MZ270I%Q+ODA=RW#X)3T:#C^E%^NMD\/AY_5BUWFXRA=2RWB^B#6.\86N>V+> MB^))BC6,DY;I'QX-N^\QA MC[-RJ,Q=DW*H)`:5Q*"2&%02@TK-*I52RW@J8XUC5.JZ)P6.&"01@R1BD$0, MDHA!$C%(TJR2)+6,)RG6.$:2KGN2)&*01`R2B$$2,4@B!DG$($FS2I)4*9ZD M4+W@'CA-GD.3#HO$QI7WAA7MNL4J]83(.%I9A!!)#"*)020QB"0&D9I5(J4B M\42&2L6*C*Q&!&>'8VNJ;AG@>I15.PT&X,QS]=A*$9S,E7`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`C\7B+3QGWN,I<_7^&KP5 M3$+%5.IC%6.4:DK MGUBRI,-@2S!;3)TP60M#X(A!$C%((@9)Q"!)LTJ25#.>I%CE&$F1F7VB_N5E M3,]LEH($E<2@DAA4$H-*8E!)#"HUJU1*Z>*I#"6-77&1E8!`$C%((@9)Q"") M&"01@R1BD*19)4F*$D]2*%:LI,ALX*JB#RJSF0H<,:@D!I7$H)(85!*#2LTJ ME5*+>"I#C6)5!H9/AJ3+AR1B"!PQ2"(&2<0@B1@D$8,DS2I)B((K27CUN:)T MB"QR24[T_#BZ6"7A$!E&4\Z`2&(020PBB4$D,8C4S(J<#WYUXI8.A-7;2F0F MYRZ:JE0]-LFLI.LV,ZS\[!]*UUTR._&(H4\V7KZ>3WKUQ,0ZPXB):1^NR5>T M:.@Y73P\UE1ZD9EG4Y'A`]QR+_#;8K59UC]6@4L/KQD&J^(@*;M<^OPI/OW# MZX<'7*4,/F>HJR:=!6LDA;1?Q:=Z3H3X1#,3GU@QE)L2!".RY2P)[Y>OE[5_ M($D/5DF2_%PDE4N/>=M<>F"V[FZJFP9<>C"ST8C#(77F0'I3*YK%FS7_Z9@9 MOU(CJ=E3$U.V4:/3>"PIS.&OL4IB!J]37SB9V."PT6&3994DR<.>I)B?C:3` MY--\VTZT$E,:@D!I7$H)(85&I6J934[*F,*=NH#*Q: M0;S#13.S@IRNWC0,9FF'0\57W9#`#WKT2HLDX*+E]5TB)FRC,;!JJ?'&%\SL M4HNL)&Y$,K)%V/CVKB(]5J5(\F]15#:)D)=-W1#/;ZVBPYM$Z&H>H:>NN)`\ M?;WHQ%=%!+*9\PY#&FV.?Z5'4JVG)Z1@JR%>$2MV49?/+:VF<]R+:/$='GB M))!T^"O20-Z^5LOJB=)P:O$X%5B M\*IFE5RIC0&W/,;"PTF$%E'BX%&"J)024QJ"0&E9H9E?CNBZLR<%MH)*8.MKMX M^G9[^]Q>/U]_^G!_^_CU]GC[_?O3V/OEXSE6\N(]+FF^ MZ\U]]?OM+M*&Z<]L: M:9OO'6C,K?@:#_2]?ENY3CP9=]OD.O$\V6T37^/!K-LFOL;C3+=-?(WG@E[; M6EX/G^YTV^3U\#%)KVTC^O!)$K=-].'S%VZ;O!X^R."U;67NXJT>KVTI,0I5 M&OEZ)3'"ON[U6TF,PMT[]Y/7PW??W'ZB#]\8<]M$'[YZY;4MI1^^/.^V23]\ M"]UM$[_@"]INF\0!WW1VVR3N(?V2OJ7$/>3`JNT*)T.]QW_\UT,;3N/PY_5" M?(8#E[QK68AVG%SDMHEV'.O#;;@,["\-BAYNDP-UI)^O?2':<=R+VT^TXZ&$ MVR9S"1^ZX[8K'*B):\$-.;?)2:#H%SX]4OD3;>*7\&$*;A._X,!'=TSQ"XY" MY#9CXGK%+_@K#FW3?P2'@)78U[AN'%<"TYH M]OJA#>>[^O/E4OR"4[S=?N(7'(?MMHE?<(@TM^$RQ"\X");;#M*&?OY\N12_ MX'!AMY_X!:?TNFWB%YQ?RVU7>[C%G[EHD=]7X3X'2=%^AM[#(7Y^WL,=?G:6 MY"QGXWLO!%_XJ5DRLY^8]_"#GY;W\(*;E*]VEW"">P5HD5_B[!0WBO!>[!`VVO!>[Q$_\.^ZJ?]G?P#IY,>J/!.W@*Z+7`.WA6QBU76_C` M3^EHD5\6YCZ'+7R`#VMX+?"!GPBEKG#+BJOM&E?@35+\#BOZN$MW"Q_X!<46 M/O#+B2U\X!835QOXP$_[:)GP$6Q'Z08^P`>2O1;X`)^^]5K@`[?TN-K`!_C@ ME-<'/O#+C@U\@`\8>GW@`WP"SVN!#_!A-6ZY6L,'^$80MQS0,N&K>%X+?(!O MM'DM\`&^!>:UP`?X,A6W7*&BN\+7`;CE(+6>7^JMX0._T%O#!_C"B#<:?(!O M67#+U6KY_@I?P.26`UHFOZA:807[)=4*5XVO>WNCX:KQ?6BO!5>-+QQ[+;AJ M?%&66ZY0N5WYA934='Y)M\15^P7=$E?MEW-+7+5;S%VA7KORRU&IY-Q"[B!U ML5\62U7L%\52$[]0$L-O;N&`^@S><6 M2G7I%Y<+1,$M+0\+1.&%(A=7\$(IARMXH9##%;Q0QN$*W"(.W^M#BSM[4=WA M3LCS&[JX/=#!M4?0W+F.2>/-](,DWP0UGL5?,AU^QZ? M:O7:T&\G_;RK0+^=]//:KE!5^7,-%^A=N4P:C\O"=?C5"C63]\('V86<#OA& MH@AQMSOY2AJ$N&WHMY=^GKOE:UW2SVN#XS;B."_<<-Q&'.>UX;@"Z>=NBG+L M!/JY;>@G`7:W3#FZ0?KY`49^@#ZO#?JDG]N&92'KST]Z^*B]M+D!Q1>(I@FWQ:WD:-[%]GB)G)T[R';!4+NWD$.:!G=%OAQ+7[TEB_\N!8_>FT' M>03UPA.HI:Q*?**84]8!QRM*F[LD<$ZAM,U>O,BW/7^]^ M/)U]O_V"1XF7[^0#C(]W7[_E?SP__)1/YYS]_O#\_'`__^^WV^O/MX]B#>,O M#P_/Z1^XL(N_'A[_F!]7?OI_`0```/__`P!02P,$%``&``@````A``+R(@(B M#0``)ST``!D```!X;"]W;W)K&ULE)M;;R.Y$87? M`^0_"'H?2WWS1;"]L/H.)$`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`:2`.D!=(!Z7VB MFD\S)M)\0W7S+4GL&6MVOY)).FXQE27FD/0&+9BI]1@D@]8`:8%T0'I+DN'K ME2)C%^%LN+@RK7K9KK\M]]2X9-Q83+16:HFOE(FGU)*4>M53&NRG]1@T*@72 M`NF`])9$E-+J^`6E)EHKM<17RL13:DEZ-9R:Z3S)](Y:C^6C2,Z1C_.B'6/, MR4LY@H[JQG+)T7,.'-R$7*>G63:0`6MQC,S.ZHU1T/Q2HB['UE:":()Y%?-` MMT1=VX[)R2#.T^!$:B3(96\%G291DGU_GU]FE;D(O04-VM01H2/U>8G_T MX1H8PH/>LS8DH8'P.B$\3KEB.OA^]D2V8NHVBEJBTJ&KBFQ^F00[>2,A+E$K MR"7J!-E$5U=9.@^F4B\A]DK$]T^T?GZI3ZQ/H6-7)N5RR$![A[UD&?9`06Z` M*T8I'?]>S\'TL>G3G*?/-5U=9#!];%#BLK>?RMY)U)B]N)Y[V?5<,3[ES'[Y M^_[=WR\3MC5^OU@T+'B=VM@`2/VQTTG8-M"&-W9=G@=#O)0H?P7!Q/0-"$], M0+7+)&/<(&H1=8AZA70O&.O@>F'AN;O2R+\V.9BHZ)U$AJA$U MB%I$':)>(:W-^(J(-K8;_B3Q'8CU/S2O00B@&J,:1"VB#E&OD!9B[$1$B,'! M(#'R!XEN)(6#-$;)U*H20#6B!E&+J$/4*Z2U&0,1T69]A=KA&+FI52:`*D0U MH@91BZA#U"NDA1A;$!%B<#!(%M%I(-U?FJ.,HFAK%%0Q4H:5[(D>RMI%2<4& M<[4NRNU=D*MS49*K5[F47#I68W('K.4R\N4*\N0R4G*3(MA>:QY=)RM6F1?9*<1#BZC)1<]BN^7'8BYB;"8#L#[U=S&NH/:5TC MF5V:UD5]X%Y=@*3I51HM4KN0422ZC90/?]KMQ\,PG0<:2HER%J$2Y%=,BM"` M<%1J'69RE21704@CB5SN5M#9W)W.G2;7Y(WUHNHET9!;]Y#V(V,/H>\P%LNL M:%K87@\%*DJ.HGDGPU.YBH)JB=*Y`EO12)3+U6*N3J+.YNHE"ITJF<+HNA_= MD;1Z.40.CM3O@>`ZH90H-XZ5(#?U:T89;3I>;T(/V$;002J-:#%7]ZEH5TI/9^)F($+8YGC\R]Q*,-CUI MKO2R*5V4='^%J$;4(&H1=8AZA;0VXV9J7=297)V+DER]RJ7EQKU0AEZ(D9*+7HBCE%RT?BY*FMA(>M=UK8OR MY8;6ST5)KE[ETG+CKBA#5\1(R66CY)I8<13)_<#ZN0!I72.979K617U@_5R` MI.E5&BTR;FPR-#:,S&6W-SE#ZR=1[BBN!'G'NJ0_?ZQ+19>K%>1R=9_*U4M% M/-:SN+$9<+"(V6;0#N3U0+C3 MHM#:97%C,^"@!ZS7">9`:.VXHF?'*D'^Y$'[SU%T<@Q3.TVS+`N6<".9_$D1 M:14D[W3RF^L\*X*&]RJW7B9QRY2A91+DQKI$5"&J$36(6D0=HEXA+<3X&?1' M&=LH5TMJ,H8EH8Y_C:P/K4YJ?LJW5 M=4(`U1C5(&H1=8AZA;00ZO.8$(.#!6F1.GD8N2.C,OZ=*JJ#%FX#U2Y*>J!A MY-V>:EV4OPD&'J5S49*K5[F4W#QNHP:LY3+RY0KRY#)2Y=)RXS8J1QO%2,E%&\51'_L*%R"M:R2SZ[7617W@*UR`I.E5 M&BTR;IYR-$^,@C,E]!42Y;;]2I#S`K6D/^\KI*++U0IRN;I/Y>JE(OJ*/.ZL M!AS,ZD_=,N**OJ]@Y/L*B:(5[WF4T%=(E.D[3L^VY8;N6;H;BWI1 M&*."!Q0]41;NZXSPU\M<&Y&_?,APB!\ZV\V'/`]6UU*BR`6,LR:8,Z6+D>5? M(:H1-8A:1!VB7B'=D=K%#+V0%A?4C_9!6'S8,D>#(TA-[R0XR4H7Y61S+F?Q M:HQJ$+6(.D2]0EJV,221^<,^Q3,XN46T/TNK2T05HAI1@ZA%U"'J%=)"C"&) M"#$XV!DL,@?-.#/AYE8^!HG:"E&-J$'4(NH0]0HI:47N=1A+AX57$/R2J[H'UZ,_,-+ MTIL'X7[6TY_NKYH@*M"*-@1,(+?(GR1X1S.3M52_IL MT)+DUT46]DJC,FDM"W)Y:(JH0U8@:1"VB#E&OD!82/[D+/+D9J0TK MG8>7S2Y*>J!"5"-J$+6(.D2]0EJ;MA3RVV:!]S88!>LCN!@J)0HM9!L+OIY7<:REBC[ M3.`7;0E9"M="VUS$3_D!!WNO/>55MZ:X]CG*'P]&U(9S:]]&F9M)8U0Z#[:6 MAMME7;D>$W,L1U:_/:W5ZN<#W/2@36'?U[*OU^PVA^=-N7E]/4[6^^]OU!8Z M!.YO1\POBN67BP?[IEA00O9V82*RH9WD>!DFLJ&38H*+FADF&?"DN* MG-Y5&SP[E!14,EQ<0@D5Q%I&38ZU^"')%P]T=1#10B7F@;]8"7T[39)8"7V- M';FP70GU##V]%:M#/4./0T5*4OH>N@T1*Z'OH1]ML:3*YXN:[I5@"=UZ69@; M*UA2Y0G5&99;T&JZB4%U8B7T&N'#<#H'-9;T>F$L?IE2@R/?O0L6")8U*;%"JC$30CT]8@W[+6G31$OH)B>K$FD6_"E&=6`G=_*,ZL>E* MM_*H3JQDF=%PT;+'MBTSFA9T!S960M/"KNF@BZN4AMANF$$)/;"U,(]C8;8J MI=ZQ.RK4H=Z)EM#/IZ0TEHU^#"6EL9)E2GKH1WALP3(E/704Q4IH`Z`?A;&D MNEK0.R$1?KV@-R@BG(8FEJ>E@8EQ>C9P89[\PTSTI-_"/,=');.QP^CMU??5 M\^:?J\/S]NTX>=T\T=8Y'\[$@WW1U?YQL@]33[[N3_3>JGFN>O)"+R1OZ'V: MN;FF?MKO3_*'^8+Q%>?[_P,``/__`P!02P,$%``&``@````A`"$540AH"0`` M3R8``!D```!X;"]W;W)K&ULE%IK;]M*#OV^P/X' MP]]K:R39EHTD%['>P%U@L=C'9]=18J&V%5A*T_OOEZ/A/#A4TK8HFN:(/"8Y MG#F4K+L_?ES.L^_-K6^[Z_U<+(+YK+D>NZ?V^G(__\^_BR_)?-8/A^O3X=Q= MF_OY7TT__^/A[W^[>^]NW_I3TPPS8+CV]_/3,+SNELO^>&HNAW[1O397N/+< MW2Z'`7Z]O2S[UUMS>!J=+N=E&`3KY>707N>*87?[%8[N^;D]-EEW?+LTUT&1 MW)KS88#X^U/[VFNVR_%7Z"Z'V[>WUR_'[O(*%%_;.OZ[GE8`-U2!;Z? M/XI='0?SY;1>K#9!),+5?/:UZ8>BE;[SV?&M'[K+_Y210"I%$B,)_$02H/O$ M'IC'#X6?:+]=A,E*K-;R0S]Q7*,C_$1'L4A6JWB=;'X]V@V2P,\)DD\^'3;' M&#;\U&%/1;M4)1Z7)CL,AX>[6_<^@WZ'(O:O![E[Q&X[G^&:8+YFE:!9CM+Z M49K?SR%*J'\/Z/>'>!7>+;_#LA_19L]M!+5(M85<>DF;^4#N`X4/E#Y0^4#M M`$O(UJ0,??`[*4MSF;(.=J\!6P.O`JFVT"Z9#^0^4/A`Z0.5#]0.0/*+?B\_ M:0X[S%E2:'NZ8'NT<=?=,TF-B4F:(3E#"H:4#*D84KL(21TV^^\LK32'U&'O M..T<>;FCT6>Y&Q.3.T-RAA0,*1E2,:1V$9(['#9.[GK#2G1,48>V1P0VNTDZ MW'I)I\9(NV4,R1E2,*1D2,60VD5(1G"B3F0D49H1(ENS15.&9`S)&5(PI&1( MQ9#:14CXT#$3X4N4AJ\0H>1+'H'-CI!>M8$2EL;%$ M8>"=7Y4QTD2U2T22E,,9TX^%5+[AU!Z_[3N(5QCYD-8T>86XR2/B)*^0<#WJ M31@(KUES:!*EJ2E$V$12AF2( MQ&:EZFA3]FK7V&O-=7(3@LF!PFO MQ[V"J5$#A$1WSQXZ6O:#@&4P.S;<^J*)5N$X..,H9!PU5XY6D=Q'WQ\VD[51 M7@Y1:2/01)7^.!)4X`55:RLUS;N3$_0RJ\0J7'RPV4=KKXW4S.*UT9HN=(J. MPBYTIKGL9LHU%(U5$5&R$?ZN+CA3J=TL4Z4A9(I#$883"9*Z,JM9^EJC2$5)#I5+(N M%4U6CA\3R>)4XB:K(+S!&V5-(.2N*[/*T2JR>Z+@CJ6&U/VCI*^X8ZVM)C8U M-.U4(A+V>E9!WD[>T/Y(94N#(UE(XZB7.T2`W6[I M$J="69%>45`,V\$4=$(FT4IM7K$.UC'\I>P%9R\1^IR]TE;('L=)))S1D)9* M3D>V5.;04T,3*8F"QB.(4L@)Q5+\_-&#M!^WIBU1[$\2>[E-I154RA32VQFI MM=$;,^-0SJ&"0R6'*@[5!")5@"9PJZ`+.<+T'-*0VUM1X&V4U%J9W#B4,"!NMO[9$* MQFZWLL;'!JL@K.PJ6&^\;500'MH+4E8G@E5J2X)5D*VL/^?*VWEO9D"(5!:9 MU?0O-F$0K[V&*@@3#9=JO6E=KNEP?RVC`4W'VGH+F&H#M[;&Q]9605C;]2:, M-HGW_+<@3#1-S@Z;'VVO_ M_H&N@!10NP(F:-159\(/%<25'49WE^*GRC[:,V7WLM]K*S=5SR:U-GH-,P[E M'"HX5'*HXE!-(%)(.`K=*NA"CC!5=@VY+1L%WJ9)K97-C.W%I1T>#-B^A:/E^`SJ`VE'`_<4 MM#ZZRW*$H!LD3;*"H9-%BX+*S\!(JI<^3IQH4=2B M2$JO(._D8-V-5F[]$8)Z?B+N$5HI<1=1.-GQAMU2A2O[8((L$[P$,I7:"%/E M0L@9`=3;'^H5@TMS>VG2YGSN9\?N[0HYP(H\W!D87SN)@MVC>N_$NP*2OY," M"]W'KL"[*K!GIJZ$<&5\)N3[K';P5>.$QWH'W^%Q_%%L=X\PX_`K\)!A)V_I M)ZZ$$+%J.__30XA8=9]W)=OLX)L[SE5N=O!%',>S9`??>'&\3';5%`ZO]3Q. MU@,"FJP@%'#2/H+"3GSN8[Q[%%,?O(_A?2+IL#09PUL^KX>7YA^'VTM[[6?G MYAF:(A@/@)MZ(4C],G2O37#<]=-^A?Y`>8 M5\$>_@\``/__`P!02P,$%``&``@````A`*C<>SE(!@``ZA8``!D```!X;"]W M;W)K&ULE%C9CJLX$'T?:?X!\7X#-FM0)U>=A$V: MD4:C69YI0A+4`2*@N^_]^REC&[QD>GEI.B=5!Y^J?$ZEI-&64G]NN+YZNH/L'BKT\9\1%&.UJ:U?9@"]$]=O0W"_\9PZ=[2OC[^5K<51!OR M1#+PU'7/Q#0_$@B<+R:?ZD18E24!#,2 M>#(2[*UPZ"'/_P*+RUC@R5G>?2NL;UHZ/)G]6GCI.\L-F",\F2-:A9[G^F$` M7.\XPNZ8W@A/_L9[]A:-\92;0S$6VX>^>S.@X"&*PZT@VP=%:]-@26%OG-,$ MU5(2ZT=BOC%AE9"``=#7K>OZ#]8KY+UD-CO=!LD6>VY!\X@^19VE)!!K&60V8AI]A2)L\FL44-B#4DT)-603$-R$9&4PK;\2B:) M.4B'K2)4;R`+VS&C][3/)K-V#8DU)-&05$,R#)?&D[ MAL#>GD5C=RV+WL]&W.V@(;&&)!J2:DBF(;F(2(K\NXH(*BMBR'143>UCKR$' M#8DU)-&05$,R#9`$7)0S4E#GM)E MXMF()RW1B-+99B'"MD*4S4:<*!>)))%D&-..BQ4YH\9+73[O.E@OFGL-L9;% M4T04SQ!!/$6P/QTOV$:.7*SQ_#U?;J)QI+,-.:*`0Y4\?\\YRP8!"="Z=H)C3DS)[ MW7J!C^Q`Z6<)LQ&8TF4)/.69PH0"[&$EK+G$)*LG\\6R%WAA0&VKE<$@I324 MDMQS*Z$V.$2G9-(K8@9A6@HP$OMJC27<:R%*.;0091\3Y=QK(I*UD]GCCG8Z MDL`)RV.\0Q12,J]$><^LA'P=%D?.%3/(H9EWUAY2)Y=$)TIUHDPEPMA6AMA< M(I*UDW'DCG8VI8C:*:3D7=G;>\2LEG0=.+2D*V80RSL*;(1"N4DDW&LA2CFT M$&4?$^7R3AR1SN;4D3M%%+RKDZ1B%I)>9\=E[PS>IIW%-JAZRN](]&9 M4@8)O2-C$*L@%*R=P-,R+ZY)SCP971;U[,?2_YY^)._*&<$@I2*4%>RYU9+( M`^=:CLF80\[4!UUDK[4N2!>`%IZ4.RT\&8>2(D&EHBYC15?Z[VU?4Z&&7WTI(A',/FF&%ZP[?S M(OCU!6U5Q?T(?M;H^"&(X$>&CJ=!!+\9=/P01C"B4]=# M;B+O\.QP!)<>.O_.B>".0,B1=G_U!6X$/ZS!P9J_@`O(6W&N?B_Z<]T. MQK4Z01#MJ;?W]*Z2?AB[VW1I]M2-,-]2 M;_\#``#__P,`4$L#!!0`!@`(````(0`!.;?*2P<``$T<```9````>&PO=V]R M:W-H965T79,298`8QL9S+S]UOMKNJKPTY>ALFAZG2=JNKNPG[X^OUR'GTKF[:JKX]C M;S(;C\IK41^JZ\OC^.^_XB_K\:CM\NLA/]?7\G'\HVS'7W>__O+P7C>O[:DL MNQ$P7-O'\:GK;MOIM"U.Y25O)_6MO,(WQ[JYY!W\V;Q,VUM3YH?>Z7*>LMEL M-;WDU74L&+;-SW#4QV-5E&%=O%W*:R=(FO*<=Q!_>ZIN+;%=BI^AN^3-Z]OM M2U%?;D#Q7)VK[D=/.AY=BFWV3/=3(%I]W"H0`%/^Z@ICX_C)V^;L>5XNGOH$_1/5;ZWVO]'[:E^3YKJ M\%MU+2';4"=>@>>Z?N6FV8%#X#QUO..^`G\THT-YS-_.W9_U>UI6+Z<.RMVO M5]1G6`G^'5TJW@,@/?_>?[Y7A^[T.)ZO)DM_-O<@O-%SV79QQ7W'H^*M[>K+ MO\+(XZM+$H8D\(DD;#59L*6__@S+`EG@DU@F;+WTEBL>RIWEX=M>`WRBX^:N MO8_V\"D7\A:S_UL&]D:_#'RBVWKB>[/-W!\,;RHRW5\AE M>\OY)O*V$"B6!@7*8D'/%-SZB9L_CB%6*$,+Z+?=8K%^F'Z#ZA=HLW=M/-,B M(`M>-DX;VD!D`[$-)#:0VD"F`5-0*R5#8WQ&,C?GDBG8/0$J!\S21Q;D$MI` M9`.Q#20VD-I`I@&&OKFK;SZ3%>3?PK[2*LA65OQ[M-'+O+0D2A.IT4$B!XD= M)'&0U$$R'3&4PN;\3"6Y.4B'+:-U[\84MD>C>]JEB=3N()&#Q`Z2.$CJ()F. M&-IAFVO::7]RM)=(H>T1@;TM1;/5RA0=2"-R"QTD M]S7$Z\FSAEN;X@6BBT=$$R\0MNJO%S;SYF:S1O)["C=V.!)IPZ\HX+`ER^^) M(],Y#,FP3#!#4CJ85,30AY0R49D*^O"#]"*]5,@7NA\"6@%W=%;+LQL1+0B[YAO MN_5BO?*M>R9VN9.AH!SNU.)F,]^WXLX,;C-#?';X^3Z'?K:[`2&K':S+)B`K M5>N0N.!VEREWU$5D->\S]Z6?3*TI*W;)$W*[2YZ2%9&S]6(V,TN7&>1F[OA< M\HG" MT'WNE*R0>\/F;M>)Y47<9N;XH*,R1T>-A_./GB$!X8^H_A)!*T]O);32SA;B M4E:QZY@0I!Q3US$CJY[+%,*GE@$A.,SH0@1DE=KJY,`35D:I!QP'M@FN*`Z8 M)1PO5A?%+G6"D!&30YVBU5Q0^XN-YQPO>M1F?O@,-)`?#EL'L(",0B.D2ACR M4X:?MN(W-6^'""$8_&E;Q62E'!."E&/J.F9D-5!H/@T-",$A22^T@(RD,M^Z ME@/H7B[$*+1T)"$16:D),"9(R4T0@A7),24K!64$B2<8^L]$CP]!`]K$;&2< M5S@NJ2P&O3-41.4Z)$A910@914(NY9BXCJGKF)'50)'X:#,@1$P\AA`<@O1; MF_G6_!5XPLHHDG2D7$=DI7(=$Z0723K>.;%3=,2]YJU]9EVDF4%M[C4^!@VH MY["UUP0$W8Y#HW4K!+QY^393M0D)THN*S$IE3%;*,2$(=N['5U6*5FS=AS1X MR.@Q&<*A/D/">]@4CA`LAL*M(2Q``_B@\H;*AZ"(K+2*$Z0<$^5X3SA:W3E= M#6I3N#F\T37*W"$-(55Q^W@`229RALJ'X(BLM(KKD\W_6^!1#G>K3A&^?%] M2JOU,9G"S<$)GV)^^+.4N0,50ORFD]N1^?8!0%:JJB%!>CL@O+I<>LXS@SN,VT\`%DH!]P*-)N9R8@?MS(8)C]6RQ`*Z,I MI*-J"@$QO2D04AE)D&L.W\@5!^0+Q_G'HWIF!&7*YU/1@'P.6P>@@!:\V06% M>)&;EXZ&_A M"8Z+)_X6'LBX>+C>PI,/%T_6VW0(AY>-G3/WNR<08O@0;X]_,M M/(!UUWU:`/^@X,46GEJ"PU2N`.]X;OE+^7O>O%37=G0NCY#$6;\_&_$Z2/S1 MU3=(+KSIJ3MXN]/_]P2O[4H8:&<3J-&QKCOZ@R\@7P3N_@,``/__`P!02P,$ M%``&``@````A`)'4YER,!@``91@``!D```!X;"]W;W)K&ULE%G9CJ,X%'T?:?X!\=X!LV51*JU*PB;-2*/1+,\4(0FJ$"*@NKK_ M?JZQK_&225>]="HGYQY\-_N:7G_]WERL;U77U^WUR28SU[:J:]D>ZNOIR?[[ MK^3+PK;ZH;@>BDM[K9[L'U5O?]W\^LOZO>U>^W-5#18H7/LG^SP,MY7C].6Y M:HI^UMZJ*_QR;+NF&.!K=W+Z6U<5A]&HN3B>ZT9.4]17FRFLNH]HM,=C75;[ MMGQKJNO`1+KJ4@RP_OYNWGOI;ZL_M^]I5Q]^JZ\51!OR1#/PTK:OE)H?*`3& MCF&=C!GXH[,.U;%XNPQ_MN]959_.`Z0[I"9E>X$GP;]64],:`->+[^/G>WT8 MSD^V'\W"N>L3+[2MEZH?DIK:VE;YU@]M\R\C$2[%1#PN`I]J/'PJK&]<.GQR_E)ZZ(/ESKDA?')#,EN$81`MYJ#UP!"Z8WPB?.(3 M[_$=%N,Q-_MB*#;KKGVWH.`ABOVMH.U#5DO;XDGA3Q1I@FHI*?N9TI]L6"4D MH`?TVR8(@K7S#?)>M`K`.)#J0ZD.E`+@$.>"MJI2=H`BG#20VD,1`4@/)#"27$<5UZ-//I);2P77H':F<-<>VG/3( M=T$1OAM(;"")@:0&DAE(+B.*[[!/2+YCPU)T=!&7MN4(-+MPVO,C+9N"A&9[ M`XD-)#&0U$`R`\EE1/$HNNL1156/.+(4+;HSD+V!Q`:2&$AJ()F!Y#*B+!\J MYDY"**HNGR&$G5]T.]QQQ!,.[1E"3RZ1-!)JVTXL2)BTQ!!*!6<2\EQ-*!,D M%,IE(<5).IT9Y\>,'EK#N2Y?MRVLEXCC@[)5YQDB.\\1R7F&>-%XWG@NT7:G M6/R.RTT,C51PZ)D%&KK+XG?4R&4-Q67H',EE;#2*JJXQ!$8<*=3^7<3HJF M5'-D.G!B+CUQ$L,J-:PRPRJ7K12/"`QS=UP:8=4G#A&0$H7H^0O-*DCH!1D0Q)JHT.,3Z05`VGR/'\YU\034SR]MRI#/%/%R9(LO=!55YXKXFJ, MZ#@Q53JF'2I7SSN'M,0OU2?MD#5E=8\0&XKI3A!SR%NP68O,HWFD!2U!LTDI M16A2RC2EY9*XOM8$.9J-2JKW=-B8O.=SXO_V.6&S"9RLV$Y;#BD%X`5:_'>< MI50.T_*F_3%&EC=&9>&Z@4^,J'"S\5(RUF"*9I-2AA!3FONAZYM1D974J-!! M9(J*J`D^G\C>,XC?=\9-GG!H2ML>(:GW$6(%0(+`#=U0.ZT3)$U2*4*35(80 M2GF1&^EARY%TIP3HY#$Y^],2X(.*'`0&:25@7`X82RD!#DV)BPF'6.*^$.B, M:*X=#`F2Y!HPI#)D"2FZ-6A2.9+8'5>^3M`^E^(BBH#"VN;)H`#J:=H\`ZT) M=Z,>[)13,O<(P2DL#(W]+486SZ_O>0M_H?F1(&E23Q%ZJ)XA"]5)0`)/RUV. MI#O50\>DJ7I$E/CT)%<)@Y0J\;7NWD%T:'25(A%VN.?$R)HFPP0AN20,PPQ9 MDV&.T)T"H,/1Y-I/&X/-4LK>R"`:/9'?.WLC9TVIVQ.N)5?4G<+@+'_<+@F< MUYZGW7(2K@1>8O32#XEGR'H@GBOBZ@Y*IZQ/Q(X-94KL&!3`;BK%3BO['6$L MI5ZX(6P(PO!.[#@K?!0[0SSESPL>BF?(>B">*RM78T?GN4_$CHU_2NP8I-6= MT6N<-97&GC8GM%\`G?,H=IPU9[$+@BB*7&.<,]33#ZEGR$)U?[Z,`NUDS#F) ME;42/2@%.7JX(8VPNFUS**"=P238.T[V'JVINE.UJRZ7WBK;MRN$`V:*S5K` M[.7J-ES!/1<$=#Q:P072Q/?S%5SG3#R=K^!V9N+[Q0JN02:>+E;9/1Q>]CZ/ M-RQ]/?`2>#QE==R#E\-W]+?^"M[&F,]]#D!_W"IUH6`%KS#`P!$_P+O?6W&J M?B^Z4WWMK4MUA""ZXVS9L=?$[,O0WNA=TGII!WCK._YYAM?Y%EHOTVN4 M^,"-Y&UGH$8[\&C!SL\J8:GH'#RXSH(+"GP22<9386O4A&`IQEXTH+G/8L/$ M<-,YS4,\NBVV7+SS+>`BSZ^PAL`E#QSO@:F=B6A"2C$C[8=K1X`4&%K08(+' M)"/XNQO`:?_GA3$Y:6H5=C;.-.F>LJ4XA'-[\&HN]GV?]>6H$?T)?EG=/XZC MILKL=R4`L?U^6N[#*JYRHT#>[-CPYMK$^Z;"O[-*BM&."@<\@$SB>_1@=TR> MR]N[]1*Q(B=E2DA*+M8%H9>$EL5KA8^MZ3Z;@7H2^#?Q"&"C]\\_9U\```#_ M_P,`4$L#!!0`!@`(````(0"1ROX_:0,``*T-```0``@!9&]C4')O<',O87!P M+GAM;""B!`$HH``!```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````````````````````````````)Q7 M;6_:,!#^/FG_`>5[&_JRKJI"*@I,0V)MM63;1\LX!UA-[-1V4-FOWYD4&JAC MK?GF^-Z>.S]W=J+;ER+OK4%I+L4@.#OM!ST03&9<+`?!K_3;R770TX:*C.92 MP"#8@`YNX\^?HD`,QI)5!0@3GO?[5R&\&!`99"?EWF%0>[Q9FZY.,\DL/OT[W90(.(Z&99ES M1@UF&?_@3$DM%Z8W>6&01V%3&"&Z!%BEN-G$_2AL?D8)HSF,T'&\H+F&*'S; MB+X#M45[I%SI.%J;FS4P(U5/\[]8MO.@-Z<:+)Q!L*:*4V$0EE6K/[;KO-1& MQ7^D>M(K`*.C$!7JS>VRJ=M<\\OX"K&B,JX.->UFC00%AQA3;G+0#XM'JHP# M\A52X0WS%D6-N`:T.T4R%!F9"(/U(E-1GS:73>3['$8/]^/)?3(9$UPE#[/I M>)CBQ]UP-KP?33J8G'W$)DDQVH\/A7DU<8>YJS07H#49@V:*EY9;!!N%)%51 M4">RR7.%97**A@QEFELG3OE4K+%EI,)^<\I?VW&S16#CE+;%R#T8I_I48$\O M^3P',M3ZB&K[`QLRIBK(R(S3.<\17$OPF11+`ZK`4LS=\1(CV=,==D!&1K+` MR:"WO>C$]HWASA.M"VYL;GJ;ZD@B]<029U8;N"F.LP)(2E]:T"<5#@>P M+FE.QERS7.I*`9$+,J)N%#\AIP9SL:VS(2G"U939LW.K)]5.^O;H!)6!2G@AM/.*&O5XOF(53[_#G+YU`\XYE-LH9K/9,,19#C^QNASHA3..GSB7'6R^=+"YZF#SM8/-M=.F'JTX@`SEN28I/BLJBG?[ M?I;9N[:^N1JC]K_TF_WRZM_IU],P:-;!Q,V0=Z-[EX0S@JO+?$D:N M@]_&#L9;S[6(\OVEUO;(O0-#EX%Q^]A&=,GOGOJ' MFU&RH@HR?`3OY&\;T7=\Y:O<.AFM\)4%V4[GO<#^F/RN_[[BL\O3_D4?W_&- MO2A\G2KXNHG_`0``__\#`%!+`0(M`!0`!@`(````(0!'07DC,`(``!LD```3 M``````````````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``& M``@````A`+55,"/U````3`(```L`````````````````:00``%]R96QS+RYR M96QS4$L!`BT`%``&``@````A`"XU8N&``@``HB,``!H````````````````` MCP<``'AL+U]R96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`%%;OI"0`@``?P8``!D`````````````````HQT``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+L0^9*Y!0``OAT``!D````````` M````````/#4``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`'&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`').H<@)!@``GAH``!D`````````````````#4T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"J[.)C@"P``]VH```T````` M````````````95T``'AL+W-T>6QE&PO&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*RK M^5_L!0``NA4``!@`````````````````X&UL4$L!`BT`%``&``@` M```A`.:NP^U\!0``3!D``!D`````````````````N=4``'AL+W=O&UL4$L!`BT`%``&``@````A`)P=S7Q%`P`` MF`D``!D`````````````````:N,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$:W+1:2`@``!`8``!D````````` M````````W>X``'AL+W=O+H0#``#Z"@``&`````````````````"F\0``>&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`+VW5D@7`P``?`@``!D` M````````````````8/4``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,G#!&JP$0``BU\``!D````````````````` M'P'>$*``#;+P``&0`````````````````&&0$`>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`-"W+%[0`@``60<``!D`````````````````:BL!`'AL+W=O;XY`%```E%``` M&0````````````````!Q+@$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`+^JM2"\(```-[4``!@`````````````````8TH!`'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`/IO97#?!@``/AH``!@` M````````````````\'`!`'AL+W=O&UL4$L!`BT`%``&``@````A`,*2<%QY!P`` MJ1X``!D`````````````````*7L!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(/(#!1D!```=`X``!D````````` M````````^X\!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`##_[1L#`P``9PD``!D`````````````````MY\!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`/."'[4Q!0``]!$``!D`````````````````ZK$!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"$540AH"0``3R8` M`!D`````````````````P^@!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)'4YER,!@``91@``!D````````````` M````8P`"`'AL+W=O XML 17 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue        
Tissue sales $ 7,710,256 $ 8,643,299 $ 24,430,158 $ 24,427,853
Royalties and other 219,727 236,466 385,480 430,185
Total Revenue 7,929,983 8,879,765 24,815,638 24,858,038
Cost of tissue and medical devices sales 3,318,327 2,600,452 10,011,687 6,788,606
Gross Profit 4,611,656 6,279,313 14,803,951 18,069,432
Operating Expenses        
General and administrative 2,764,328 2,439,229 7,877,697 7,349,852
Sales and marketing 4,053,679 3,352,394 12,057,389 11,333,946
Depreciation and amortization 97,923 88,112 304,771 302,392
Non-cash consulting expense 43,153 186,867 11,924 491,051
Total Operating Expenses 6,959,083 6,066,602 20,251,781 19,477,241
(Loss) Income from Operations (2,347,427) 212,711 (5,447,830) (1,407,809)
Other Income (Expense)        
Interest expense (1,197,370) (867,894) (3,436,006) (1,276,946)
Change in warrant derivative liability (849,288) (125,972) 246,337 1,393,155
Other income (expense) 17,551 (1,738,202) 108,616 (1,544,035)
Total Other Expense (2,029,107) (2,732,068) (3,081,053) (1,427,826)
Net Loss Before (Provision) Benefit for Income Taxes (4,376,534) (2,519,357) (8,528,883) (2,835,635)
(Provision) Benefit for Income Taxes        
Current 0 0 0 0
Deferred 0 0 0 0
Net Loss $ (4,376,534) $ (2,519,357) $ (8,528,883) $ (2,835,635)
Net loss per share:        
Basic (in dollars per share) $ (0.08) $ (0.06) $ (0.18) $ (0.07)
Dilutive (in dollars per share) $ (0.08) $ (0.06) $ (0.18) $ (0.07)
Shares used in the computation:        
Basic (in shares) 51,616,319 42,796,244 46,611,358 42,341,796
Dilutive (in shares) 51,616,319 42,796,244 46,611,358 42,341,796

XML 18 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment, Net
9 Months Ended
Sep. 30, 2013
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment Disclosure [Text Block]
(5)           Property and Equipment, Net
 
Property and equipment, net are as follows:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Buildings
 
$
1,653,263
 
$
1,653,263
 
Equipment
 
 
5,761,079
 
 
5,172,523
 
Computer equipment
 
 
312,650
 
 
312,650
 
Computer software
 
 
395,146
 
 
392,206
 
Furniture and fixtures
 
 
170,118
 
 
170,118
 
Leasehold improvements
 
 
1,808,461
 
 
1,793,756
 
Vehicles
 
 
41,099
 
 
78,306
 
Total cost
 
 
10,141,816
 
 
9,572,822
 
Less: accumulated depreciation
 
 
(4,820,824)
 
 
(4,337,955)
 
 
 
$
5,320,992
 
$
5,234,867
 
 
The Company leases certain equipment under capital leases. For financial reporting purposes, minimum lease payments relating to the assets have been capitalized. As of September 30, 2013, the Company has recorded $549,603 gross assets in Equipment, and $142,307 of accumulated depreciation relating to assets under capital leases.
 
Maintenance and repairs expense for the first nine months of 2013 and 2012 was $198,986 and $204,947, respectively.  Depreciation expense related to property and equipment, including property under capital lease for the first nine months of 2013 and 2012 was $530,020 and $516,162 respectively.
XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 20 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment, Net (Tables)
9 Months Ended
Sep. 30, 2013
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment [Table Text Block]
Property and equipment, net are as follows:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Buildings
 
$
1,653,263
 
$
1,653,263
 
Equipment
 
 
5,761,079
 
 
5,172,523
 
Computer equipment
 
 
312,650
 
 
312,650
 
Computer software
 
 
395,146
 
 
392,206
 
Furniture and fixtures
 
 
170,118
 
 
170,118
 
Leasehold improvements
 
 
1,808,461
 
 
1,793,756
 
Vehicles
 
 
41,099
 
 
78,306
 
Total cost
 
 
10,141,816
 
 
9,572,822
 
Less: accumulated depreciation
 
 
(4,820,824)
 
 
(4,337,955)
 
 
 
$
5,320,992
 
$
5,234,867
 
XML 21 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details) (USD $)
Sep. 30, 2013
Schedule of future minimum payments by operating lease [Line Items]  
Remainder of 2013 $ 61,599
2014 269,400
2015 263,136
2016 263,136
2017 263,136
Thereafter 823,730
Total $ 1,944,137
XML 22 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Disclosure of Cash Flow Information
9 Months Ended
Sep. 30, 2013
Supplemental Cash Flow Elements [Abstract]  
Cash Flow, Supplemental Disclosures [Text Block]
(13)           Supplemental Disclosure of Cash Flow Information
 
Supplemental cash flow information is as follows:
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
Supplemental disclosure of cash flow information
 
 
 
 
 
 
 
Cash paid during the period for:
 
 
 
 
 
 
 
Interest
 
$
3,436,006
 
$
815,031
 
Income taxes
 
 
-
 
 
-
 
Non-cash activities:
 
 
 
 
 
 
 
ROS adjustment fee
 
$
700,000
 
$
-
 
Settlement of SeaArk accounts receivable
 
$
1,829,647
 
$
-
 
Inventory received in SeaArk settlement
 
$
409,838
 
$
-
 
Write-off of SeaArk allowance for doubtful accounts
 
$
1,419,809
 
$
-
 
Net shares issued for non-cash consulting expense
 
$
157,561
 
$
-
 
Capital lease acquisition
 
$
-
 
$
408,257
 
Issuance of warrants
 
$
-
 
$
220,872
 
Non-cash accrued compensation
 
$
-
 
$
304,680
 
Debt discount related to financing
 
$
-
 
$
7,341,520
 
Royalty liability related to financing
 
$
-
 
$
7,341,520
 
XML 23 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt (Details Textual) (USD $)
1 Months Ended 9 Months Ended
Aug. 24, 2012
Apr. 23, 2012
Sep. 30, 2013
Dec. 31, 2012
Debt Instrument [Line Items]        
Line of Credit Facility, Description   The facility allowed borrowings based upon a predetermined formula of up to 80% of Bacterin's eligible accounts receivable, as defined in the credit and security agreement. The Company also amended its existing Loan and Security Agreement with MidCap to allow the Company to borrow up to an additional $3 million in connection with a permitted acquisition. The credit facility carried an interest rate of LIBOR plus 4%, subject to a LIBOR floor rate of 2.5%. The Company also agreed to pay a 0.5% collateral management fee on the average outstanding balance of the facility and 1% of the average unused portion of the facility, as well as a 1% origination fee.    
Royalty Payments Description royalty of 1.75% on the first $45,000,000 of net sales, plus 1.0% of net sales in excess of $45,000,000 for each of the next ten years      
Future Royalty Liability     $ 13,800,000 $ 13,800,000
Royalty liability related to financing     7,341,520  
Amendment To Credit Agreement, Minimum Liquidity Requirement Amount     1,500,000  
Minimum Liquidity Requirement Amount     750,000  
Amendment To Credit Agreement Adjustment Fee Payable     300,000  
Compliance Violations Of Covenants Related To Credit Agreement Description     The Company did not achieve the $8.5 million revenue in the second quarter of 2013 for which we received a waiver, in exchange, the Company agreed to pay a fee of $400,000 when the Company pays, prepays or is required to pay any principal amount of the loan. In addition, the Company did not hire a Chief Executive Officer within 90 days of the resignation of the prior Chief Executive Officer for which we received a waiver in exchange for Board observer rights.  
Midcap and Silicon Valley Bank [Member]
       
Debt Instrument [Line Items]        
Debt Instrument, Unused Borrowing Capacity, Amount   5,000,000    
Debt Instrument Additional Borrowing Limit   3,000,000    
Proceeds from Other Debt     10,000,000  
Valley Bank Of Belgrade [Member]
       
Debt Instrument [Line Items]        
Debt Instrument, Interest Rate, Effective Percentage     6.00%  
Debt Instrument, Periodic Payment     10,746  
Debt Instrument, Maturity Date     Dec. 24, 2030  
Ros Acquisition Offshore [Member]
       
Debt Instrument [Line Items]        
Debt Instrument Borrowing Capacity Amount 20,000,000      
Debt Instrument, Unused Borrowing Capacity, Amount 5,000,000      
Line of Credit Facility, Description LIBOR plus 12.13%, subject to a LIBOR floor rate of 1.0%.      
Royalty Payments Description     LIBOR plus 12.13% maturing August 2019  
Installment Amount $ 45,000,000      
XML 24 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Schedule of commitment and contingencies [Line Items]    
Operating Leases, Rent Expense, Net $ 204,180 $ 234,316
Market Exchange Notification Description On May 13, 2013, we received a deficiency notice from the New York Stock Exchange (Exchange) notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders equity of less than $4,000,000 and net losses in three of our four most recent fiscal years.  
XML 25 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity (Details Textual) (USD $)
0 Months Ended 3 Months Ended
Jun. 10, 2013
Mar. 31, 2012
Schedule of Equity Method Investments [Line Items]    
Stock issued (in shares)   1,475,037
Warrants Issued In Offering, Right To Acquire Common Shares Per Warrant 0.5  
Warrants Issued In Offering, Exercise Price $ 0.72  
Warrant Issued In Offering, Percentage Of Premium Based On 4 June 2013 Closing Price 15.00%  
Proceeds from Issuance or Sale of Equity, Total $ 4,450,000  
Payments of Stock Issuance Costs 400,000  
Lincoln Park Capital Fund Llc [Member]
   
Schedule of Equity Method Investments [Line Items]    
Stock issued   3,899,996
Investor [Member]
   
Schedule of Equity Method Investments [Line Items]    
Stock issued $ 8,510,000  
Stock Issued During Period, Price Per Share $ 0.57  
Stock Issued During Period, Percentage Of Discount Based On 4 June 2013 Closing Price 10.00%  
XML 26 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt (Tables)
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Schedule of Debt [Table Text Block]
Long-term debt consists of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Loan payable to ROS Acquisition Offshore, LIBOR plus 12.13% maturing August 2019
 
$
20,000,000
 
$
20,000,000
 
Adjustment fee payable to ROS Acquisition Offshore August 2019
 
 
700,000
 
 
-
 
6.00% loan payable to Valley Bank of Belgrade, $10,746 monthly payments including interest, maturing December 24, 2030; secured by building
 
 
1,387,112
 
 
1,421,420
 
 
 
 
22,087,112
 
 
21,421,420
 
 
 
 
 
 
 
 
 
Less: Current portion
 
 
(47,018)
 
 
(45,135)
 
Debt discount
 
 
(5,976,030)
 
 
(6,893,183)
 
Long-term debt
 
$
16,064,064
 
$
14,483,102
Schedule of Maturities of Long-term Debt [Table Text Block]
The following is a summary of maturities due on the debt as of September 30, 2013:
 
Remainder of 2013
 
 
11,357
 
2014
 
 
47,727
 
2015
 
 
50,670
 
2016
 
 
1,720,463
 
2017
 
 
6,723,781
 
Thereafter
 
 
13,533,114
 
Total
 
$
22,087,112
Schedule Of Royalty Payments [Table Text Block]
The following is a summary of estimated future royalty payments as of September 30, 2013:
 
Remainder of 2013
 
 
197,000
 
2014
 
 
853,000
 
2015
 
 
1,050,000
 
2016
 
 
1,289,000
 
2017
 
 
1,384,000
 
Thereafter
 
 
8,477,000
 
Total
 
$
13,250,000
 
XML 27 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2013
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
Accrued liabilities consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Acquisition contingent liability
 
$
-
 
$
91,740
 
Accrued stock compensation
 
 
171,174
 
 
218,850
 
Wages/commissions payable
 
 
1,129,555
 
 
1,013,909
 
Other accrued expenses
 
 
513,743
 
 
1,075,591
 
 
 
$
1,814,472
 
$
2,400,090
 
XML 28 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt (Details 1) (USD $)
Sep. 30, 2013
Schedule of maturities due on debt [Line Items]  
Remainder of 2013 $ 11,357
2014 47,727
2015 50,670
2016 1,720,463
2017 6,723,781
Thereafter 13,533,114
Total $ 22,087,112
XML 29 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details 2) (USD $)
Sep. 30, 2013
Dec. 31, 2012
fair value on a recurring basis [Line Items]    
Warrant derivative liability $ 2,223,332 $ 984,356
Fair Value, Inputs, Level 1 [Member]
   
fair value on a recurring basis [Line Items]    
Warrant derivative liability 0 0
Fair Value, Inputs, Level 2 [Member]
   
fair value on a recurring basis [Line Items]    
Warrant derivative liability 0 0
Fair Value, Inputs, Level 3 [Member]
   
fair value on a recurring basis [Line Items]    
Warrant derivative liability $ 2,223,332 $ 984,356
XML 30 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current inventories    
Raw materials $ 2,223,978 $ 1,919,250
Work in process 4,176,764 4,991,032
Finished goods 8,004,314 7,350,332
Inventory, Gross 14,405,056 14,260,614
Reserve (1,176,673) (1,119,193)
Current inventories, total 13,228,383 13,141,421
Non-current inventories    
Finished goods 1,238,225 1,238,225
Non-current inventories, total 1,238,225 1,238,225
Total inventories $ 14,466,608 $ 14,379,646
XML 31 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
2 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Sep. 30, 2012
Schedule of activity under stock option plans [Line Items]      
Outstanding at January 1, Shares   5,266,535 4,828,910
Granted, Shares 2,000,000 3,331,250 1,105,000
Exercised, Shares   (230,000) (39,375)
Cancelled or expired, Shares   (729,000) (1,152,250)
Outstanding at September 30, Shares 7,638,785 7,638,785 4,742,285
Exercisable at September 30, Shares 2,531,534 2,531,534 2,242,118
Outstanding at January 1, Weighted Average Exercise Price   $ 2.02 $ 2.14
Granted, Weighted Average Exercise Price   $ 0.63 $ 2.00
Exercised, Weighted Average Exercise Price   $ 0.10 $ 0.87
Cancelled or expired, Weighted Average Exercise Price   $ 1.78 $ 2.01
Outstanding at September 30, Weighted Average Exercise Price $ 1.49 $ 1.49 $ 2.11
Exercisable at September 30, Weighted Average Exercise Price $ 2.03 $ 2.03 $ 1.77
Outstanding at January 1, Weighted Average Fair Value At Grant Date   $ 1.03 $ 1.01
Granted, Weighted Average Fair Value At Grant Date   $ 0.53 $ 1.19
Exercised, Weighted Average Fair Value At Grant Date   $ 0.06 $ 0.37
Cancelled or expired, Weighted Average Fair Value At Grant Date   $ 0.90 $ 0.78
Outstanding at September 30, Weighted Average Fair Value At Grant Date $ 0.86 $ 0.86 $ 1.04
Exercisable at September 30, Weighted Average Fair Value At Grant Date $ 0.98 $ 0.98 $ 0.76
XML 32 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Disclosure of Cash Flow Information (Tables)
9 Months Ended
Sep. 30, 2013
Supplemental Cash Flow Elements [Abstract]  
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]
Supplemental cash flow information is as follows:
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
Supplemental disclosure of cash flow information
 
 
 
 
 
 
 
Cash paid during the period for:
 
 
 
 
 
 
 
Interest
 
$
3,436,006
 
$
815,031
 
Income taxes
 
 
-
 
 
-
 
Non-cash activities:
 
 
 
 
 
 
 
ROS adjustment fee
 
$
700,000
 
$
-
 
Settlement of SeaArk accounts receivable
 
$
1,829,647
 
$
-
 
Inventory received in SeaArk settlement
 
$
409,838
 
$
-
 
Write-off of SeaArk allowance for doubtful accounts
 
$
1,419,809
 
$
-
 
Net shares issued for non-cash consulting expense
 
$
157,561
 
$
-
 
Capital lease acquisition
 
$
-
 
$
408,257
 
Issuance of warrants
 
$
-
 
$
220,872
 
Non-cash accrued compensation
 
$
-
 
$
304,680
 
Debt discount related to financing
 
$
-
 
$
7,341,520
 
Royalty liability related to financing
 
$
-
 
$
7,341,520
 
XML 33 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Details) (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Intellectual Property    
Gross carrying value $ 848,675 $ 820,778
Accumulated amortization (285,151) (228,400)
Net carrying value 563,524 592,378
Aggregate amortization expense: 56,750 74,918
Estimated amortization expense:    
Remainder of 2013   18,729
2014   74,918
2015   74,918
2016   74,918
2017   74,918
Thereafter   245,123
Total   $ 563,524
XML 34 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets [Table Text Block]
The following table sets forth information regarding intangible assets:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Intellectual Property
 
 
 
 
 
 
 
Gross carrying value
 
$
848,675
 
$
820,778
 
Accumulated amortization
 
$
(285,151)
 
$
(228,400)
 
Net carrying value
 
$
563,524
 
$
592,378
 
 
 
 
 
 
 
 
 
Aggregate amortization expense:
 
$
56,750
 
$
74,918
 
 
 
 
 
 
 
 
 
Estimated amortization expense:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remainder of 2013
 
 
 
 
$
18,729
 
2014
 
 
 
 
$
74,918
 
2015
 
 
 
 
$
74,918
 
2016
 
 
 
 
$
74,918
 
2017
 
 
 
 
$
74,918
 
Thereafter
 
 
 
 
$
245,123
 
Total
 
 
 
 
$
563,524
 
XML 35 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2013
Accounting Policies [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
(1)           Business Description and Summary of Significant Accounting Policies
 
Business Description
 
The accompanying consolidated financial statements include the accounts of Bacterin International Holdings, Inc., a Delaware corporation, and its wholly owned subsidiary, Bacterin International, Inc., a Nevada corporation, (collectively, the “Company” or “Bacterin”). All intercompany balances and transactions have been eliminated in consolidation. Bacterin’s biologics division develops, manufactures and markets biologics products to domestic and international markets.  Bacterin’s proprietary methods are used in human allografts to create cell scaffolds and promote bone and other tissue growth.  These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and regeneration in knee and other joint surgeries.
 
Bacterin’s device division develops and licenses coatings for various medical device applications.
 
An operating segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The primary performance measure used by management is net income or loss. The Company operates in two distinct lines of business consisting of the biologics and devices divisions. However, due to the immaterial revenue from devices to date, the Company reports as one segment.
 
The Company's revenue is derived principally from the sale or license of its medical products, coatings and device implants. The markets in which the Company competes are highly competitive and rapidly changing. Significant technological advances, changes in customer requirements, or the emergence of competitive products with new capabilities or technologies could adversely affect the Company's operating results. The Company's business could be harmed by a decline in demand for, or in the prices of, its products or as a result of, among other factors, any change in pricing or distribution model, increased price competition, changes in government regulations or a failure by the Company to keep up with technological change.  Further, a decline in available tissue donors could have an adverse impact on our business.
 
The accompanying interim condensed consolidated financial statements of Bacterin for the three and nine months ended September 30, 2013 and 2012 are unaudited and are prepared in accordance with accounting principles generally accepted in the United States of America. They do not include all disclosures required by generally accepted accounting principles for annual financial statements, but in the opinion of management, include all adjustments, consisting only of normal recurring items, necessary for a fair presentation. Interim results are not necessarily indicative of results which may be achieved in the future for the full year ending December 31, 2013.
 
These financial statements should be read in conjunction with the financial statements and notes thereto which are included in Bacterin’s Annual Report on Form 10-K for the year ended December 31, 2012. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.
 
Concentrations and Credit Risk
 
The Company’s accounts receivable are due from a variety of health care organizations and distributors throughout the world. Approximately 98% and 97% of sales were in the United States for the nine months ended September 30, 2013 and 2012, respectively. One customer accounted for approximately 5% and 6% of the Company’s revenue for the nine months ended September 30, 2013 and 2012, respectively.  One customer represented 19% and 21% of gross accounts receivable at September 30, 2013 and 2012, respectively. The Company provides for uncollectible amounts when specific credit issues arise. Management believes its estimate for uncollectible amounts have been adequate during prior periods, and management believes that all significant credit risks have been identified at September 30, 2013.
 
Revenue by geographical region is as follows:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
United States
 
$
24,285,028
 
$
24,084,836
 
Rest of World
 
 
530,610
 
 
773,202
 
 
 
$
24,815,638
 
$
24,858,038
 
 
Use of Estimates
 
The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period; the carrying amount of property and equipment and intangible assets; valuation allowances for trade receivables and deferred income tax assets; valuation of the warrant derivative liability; inventory reserve; contingent consideration from acquisitions; royalty liability; and estimates for the fair value of stock options grants and other equity awards upon which the Company determines stock-based compensation expense. Actual results could differ from those estimates.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments purchased with an original maturity date of three months or less to be cash equivalents.  Cash equivalents are recorded at cost, which approximates market value. At times the Company maintains deposits in financial institutions in excess of federally insured limits.
 
Accounts Receivable
 
Accounts receivable represents amounts due from customers for which revenue has been recognized. Normal terms on trade accounts receivable are net 30 days and some customers are offered discounts for early pay.   The Company performs credit evaluations when considered necessary, but generally does not require collateral to extend credit.
 
The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables. The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance, general economic conditions that may affect a customer's ability to pay and management judgment. Actual customer collections could differ from estimates. Account balances are charged to the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Provisions to the allowance for doubtful accounts are charged to expense. The Company does not have any off-balance sheet credit exposure related to its customers.
 
Accounts Payable - Related Party
 
Accounts payable to a related party includes amounts due to American Donor Services, a supplier of donors to the Company. See Note 14, “Related Party Transactions” below.
 
Inventories
 
Inventories are stated at the lower of cost or market.  Cost is determined using the specific identification method and includes materials, labor and overhead. The Company calculates an inventory reserve for estimated obsolescence or excess inventory based on historical usage and sales, as well as assumptions about future demand for its products. These estimates for excess and obsolete inventory are reviewed and updated on a quarterly basis. Increases in the inventory reserves result in a corresponding expense, which is generally recorded to cost of tissue and medical devices sales. Inventories where the sales cycle is estimated to be beyond twelve months are classified as Non-current inventories.
 
Property and Equipment
 
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to seven years for computers and equipment, and 30 years for buildings. Leasehold improvements are depreciated over the shorter of their estimated useful life or the remaining term of the lease. Repairs and maintenance are expensed as incurred.
 
Goodwill
 
Goodwill represents the excess of costs over fair value of assets of businesses acquired. Goodwill and intangible assets acquired in a purchase business combination and determined to have indefinite useful lives are not amortized, instead are tested for impairment at least annually and whenever events or circumstances indicate the carrying amount of the asset may not be recoverable. In its evaluation of goodwill, the Company performs an assessment of qualitative factors to determine if it is more-likely-than-not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment. The Company conducts its annual impairment test on December 31 of each year.
 
Derivative Instruments
 
The Company accounts for its derivative instruments in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815 “Accounting for Derivative Instruments and Hedging Activities”. The only derivative instruments presented in the accompanying consolidated financial statements relates to warrants issued in connection with certain debt financings. The Company has not designated its warrant derivative liability as a hedging instrument as described in ASC 815 and any changes in the fair market value of the warrant derivative liability are recognized in the consolidated statement of operations during the period of change. See Note 10, “Warrants” below.
 
Intangible Assets
 
Intangible assets with estimable useful lives must be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment whenever events or circumstances indicate their carrying amount may not be recoverable. Intangible assets include trademarks, customer lists and patents and include costs to acquire and protect Company patents. Intangible assets are carried at cost less accumulated amortization. The Company amortizes these assets on a straight-line basis over their estimated useful lives of five years for customer lists and 15 years for all other intangible assets.
 
Revenue Recognition
 
Revenue is recognized when all of the following criteria are met: a) the Company has entered into a legally binding agreement with the customer; b) the products or services have been delivered; c) the Company's fee for providing the products and services is fixed or determinable; and d) collection of the Company’s fee is probable.
 
The Company’s policy is to record revenue net of any applicable sales, use, or excise taxes.  If an arrangement includes a right of acceptance or a right to cancel, revenue is recognized when acceptance is received or the right to cancel has expired.
 
The Company ships to certain customers under consignment arrangements whereby the Company’s product is stored by the customer.  The customer is required to report the use to the Company and upon such notice, the Company invoices the customer and revenue is recognized when above criteria has been met.
 
The Company also receives royalty revenue from third parties related to licensing agreements. The Company has royalty agreements with Nufix, RyMed and Bard Access Systems. Revenue under these agreements represented less than 1% of total revenue for the three and nine months ended September 30, 2013 and 2012.
 
Non-Cash Consulting Expense
 
From time to time, the Company issues restricted stock awards to consultants and advisors to the Company. These awards are measured at fair value at each reporting date, recognized ratably over the vesting period and are recorded in non-cash consulting expense.
 
Advertising Costs
 
The Company expenses advertising costs as incurred. The Company had no Advertising expense in the nine months ended September 30, 2013 and $50,000 for the nine months ended September 30, 2012.
 
Research and Development
 
Research and development costs, which are principally related to internal costs for the development of new technologies and processes for tissue and coatings, are expensed as incurred and included in general and administrative expenses.
 
Income Taxes
 
The Company accounts for income taxes under the asset and liability method of accounting for deferred taxes as prescribed under FASB ASC 740, Accounting for Income Taxes.  Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When applicable, a valuation allowance is established to reduce any deferred tax asset when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the statement of operations or accrued on the balance sheet. See Note 12, “Income Taxes” below.
 
Long-Lived Assets
 
Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. No impairment was recorded during the nine months ended September 30, 2013 or 2012.
 
Net Loss Per Share
 
Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Diluted net income (loss) per share is computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares outstanding during the period, which include the assumed exercise of stock options and warrants using the treasury stock method.  Diluted net loss per share was the same as basic net loss per share for the nine months ended September 30, 2013 and 2012 and the three months ended September 30, 2013 and 2012 as shares issuable upon the exercise of stock options and warrants were anti-dilutive as a result of the net losses incurred for those periods.
 
Stock-Based Compensation
 
The Company records stock-compensation expense according to the provisions of ASC 718.  Under ASC 718, stock-based compensation costs are recognized based on the estimated fair value at the grant date for all stock-based awards.  The Company estimates grant date fair values using the Black-Scholes-Merton option pricing model, which requires assumptions of the life of the award and the stock price volatility over the term of the award.  The Company records compensation cost of stock-based awards using the straight line method, which is recorded into earnings over the vesting period of the award. Pursuant to the income tax provisions included in ASC 718-740, the Company has elected the “short cut method” of computing its hypothetical pool of additional paid-in capital that is available to absorb future tax benefit shortfalls.
 
Fair Value of Financial Instruments
 
The carrying values of financial instruments, including trade accounts receivable, accounts payable, other accrued expenses and long-term debt, approximate their fair values based on terms and related interest rates.
 
We follow a framework for measuring fair value. The framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
 
Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.
 
Level 2: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
 
Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the nine months ended September 30, 2013 and 2012, there was no reclassification in financial assets or liabilities between Level 1, 2 or 3 categories.
 
The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:
 
Accrued stock compensation
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
$
171,174
 
$
218,850
 
Level 2
 
 
-
 
 
-
 
Level 3
 
 
-
 
 
-
 
 
The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.
 
Warrant derivative liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
2,223,332
 
$
984,356
 
 
Acquisition contingent consideration liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
-
 
$
91,740
 
 
The valuation technique used to measure fair value of the warrant liability is based on a lattice model and significant assumptions and inputs determined by the Company.
 
Level 3 Changes
 
The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:
 
Warrant derivative liability
Balance at January 1, 2013
 
$
984,356
 
Gain recognized in earnings
 
 
(246,337)
 
New warrants issued
 
 
1,485,313
 
Balance at September 30, 2013
 
$
2,223,332
 
 
Acquisition contingent consideration liability
Balance at January 1, 2013
 
$
91,740
 
Gain recognized in earnings
 
 
(91,740)
 
Balance at September 30, 2013
 
$
-
 
 
During the nine months ended September 30, 2013, the Company did not change any of the valuation techniques used to measure its liabilities at fair value.
 
Items measured at fair value on a non-recurring basis:
 
The Company’s royalty liability is carried at its estimated fair value based upon the discounted present value of the payments using an estimated discount rate.  The Company did not have access to a readily traded market for similar credit risks and the estimated interest rate was based upon the Company’s estimate of a market interest rate to obtain similar financing.  The Company originally discounted the $16.8 million of estimated payments at an interest rate of 16.7%. This was adjusted to an estimated royalty total of $13.8 million as of December 31, 2012 and was not adjusted in the first nine months of 2013.  Accordingly, these inputs are classified as Level 3 inputs.
 
Recent Accounting Pronouncements
 
There are no recently issued accounting standards for which the Company expects a material impact to its consolidated financial statements.
XML 36 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition
9 Months Ended
Sep. 30, 2013
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block]
(3)           Acquisition
 
In 2011, the Company acquired the assets of a medical devices company. As part of the purchase agreement, we agreed to pay an additional $500,000 in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $1 million, and an additional $500,000 in common stock if gross revenue from the sale of products resulting from the purchased assets equaled or exceeded $2 million, provided that such gross revenue thresholds were achieved within 2 years. The revenue thresholds were not achieved within 2 years of the asset acquisition, so no additional stock issuances were required.
 
The initial valuation of the contingent consideration was based upon management’s estimates of the probability of reaching the milestones that would trigger the requirement to pay the contingent amounts. During 2013, management reviewed and adjusted the assumptions associated with the contingent liability which resulted in an elimination of the contingent liability as of June 30, 2013.
XML 37 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets
9 Months Ended
Sep. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets Disclosure [Text Block]
(6)           Intangible Assets
 
Bacterin has applied for various patents with regards to processes for its products.
 
The following table sets forth information regarding intangible assets:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Intellectual Property
 
 
 
 
 
 
 
Gross carrying value
 
$
848,675
 
$
820,778
 
Accumulated amortization
 
$
(285,151)
 
$
(228,400)
 
Net carrying value
 
$
563,524
 
$
592,378
 
 
 
 
 
 
 
 
 
Aggregate amortization expense:
 
$
56,750
 
$
74,918
 
 
 
 
 
 
 
 
 
Estimated amortization expense:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Remainder of 2013
 
 
 
 
$
18,729
 
2014
 
 
 
 
$
74,918
 
2015
 
 
 
 
$
74,918
 
2016
 
 
 
 
$
74,918
 
2017
 
 
 
 
$
74,918
 
Thereafter
 
 
 
 
$
245,123
 
Total
 
 
 
 
$
563,524
 
XML 38 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories
9 Months Ended
Sep. 30, 2013
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
(4)           Inventories
 
Inventories consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Current inventories
 
 
 
 
 
 
 
Raw materials
 
$
2,223,978
 
$
1,919,250
 
Work in process
 
 
4,176,764
 
 
4,991,032
 
Finished goods
 
 
8,004,314
 
 
7,350,332
 
 
 
 
14,405,056
 
 
14,260,614
 
Reserve
 
 
(1,176,673)
 
 
(1,119,193)
 
Current inventories, total
 
$
13,228,383
 
$
13,141,421
 
Non-current inventories
 
 
 
 
 
 
 
Finished goods
 
$
1,238,225
 
$
1,238,225
 
Non-current inventories, total
 
$
1,238,225
 
$
1,238,225
 
Total inventories
 
$
14,466,608
 
$
14,379,646
 
XML 39 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment, Net (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Property, Plant and Equipment [Line Items]    
Total cost $ 10,141,816 $ 9,572,822
Less: accumulated depreciation (4,820,824) (4,337,955)
Property and equipment, net 5,320,992 5,234,867
Building [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 1,653,263 1,653,263
Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 5,761,079 5,172,523
Computer Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 312,650 312,650
Computer software[Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 395,146 392,206
Furniture and Fixtures [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 170,118 170,118
Leasehold Improvements [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost 1,808,461 1,793,756
Vehicles [Member]
   
Property, Plant and Equipment [Line Items]    
Total cost $ 41,099 $ 78,306
XML 40 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Activity under our stock option plans was as follows:
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
 
 
Average
 
Value at Grant
 
 
 
 
Average
 
Value at Grant
 
 
 
Shares
 
Exercise Price
 
Date
 
Shares
 
Exercise Price
 
Date
 
Outstanding at January 1
 
 
5,266,535
 
$
2.02
 
$
1.03
 
 
4,828,910
 
$
2.14
 
$
1.01
 
Granted
 
 
3,331,250
 
 
0.63
 
 
0.53
 
 
1,105,000
 
 
2.00
 
 
1.19
 
Exercised
 
 
(230,000)
 
 
0.10
 
 
0.06
 
 
(39,375)
 
 
0.87
 
 
0.37
 
Cancelled or expired
 
 
(729,000)
 
 
1.78
 
 
0.90
 
 
(1,152,250)
 
 
2.01
 
 
0.78
 
Outstanding at September 30
 
 
7,638,785
 
$
1.49
 
$
0.86
 
 
4,742,285
 
$
2.11
 
$
1.04
 
Exercisable at September 30
 
 
2,531,534
 
$
2.03
 
$
0.98
 
 
2,242,118
 
$
1.77
 
$
0.76
 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
The following table summarizes restricted stock award activity during the period ended September 30, 2013:
 
 
 
Shares
 
Outstanding at Jan. 1, 2013
 
 
733,900
 
Awarded
 
 
-
 
Cancelled
 
 
(112,500)
 
Vested
 
 
(164,500)
 
Outstanding at September 30, 2013
 
 
456,900
 
XML 41 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Fair Value, Concentration of Risk [Line Items]        
Total Revenues $ 7,929,983 $ 8,879,765 $ 24,815,638 $ 24,858,038
United States [Member]
       
Fair Value, Concentration of Risk [Line Items]        
Total Revenues     24,285,028 24,084,836
Rest Of World [Member]
       
Fair Value, Concentration of Risk [Line Items]        
Total Revenues     $ 530,610 $ 773,202
XML 42 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details Textual) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Accounting Policies [Line Items]          
Advertising Expense     $ 0 $ 50,000  
Asset Impairment Charges     0 0  
Discount Of Estimated Payments     16,800,000    
Discount Of Estimated Payments Interest Rate     16.70%    
Royalty Revenue Percentage 1.00% 1.00% 1.00% 1.00%  
Future Royalty Liability $ 13,800,000   $ 13,800,000   $ 13,800,000
Other Intangible Assets [Member]
         
Accounting Policies [Line Items]          
Estimable useful lives     15 years    
Building [Member]
         
Accounting Policies [Line Items]          
Property, Plant and Equipment, Useful Life     30 years    
Computers and Equipment [Member] | Minimum [Member]
         
Accounting Policies [Line Items]          
Property, Plant and Equipment, Useful Life     3 years    
Computers and Equipment [Member] | Maximum [Member]
         
Accounting Policies [Line Items]          
Property, Plant and Equipment, Useful Life     7 years    
Geographic Concentration Risk [Member]
         
Accounting Policies [Line Items]          
Concentration Risk, Percentage     98.00% 97.00%  
Customer Concentration Risk [Member]
         
Accounting Policies [Line Items]          
Concentration Risk, Percentage     5.00% 6.00%  
Accounts Receivable Percentage     19.00% 21.00%  
XML 43 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details Textual) (USD $)
3 Months Ended 9 Months Ended 3 Months Ended 1 Months Ended
Jun. 30, 2013
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2010
Bridge Loan [Member]
Dec. 31, 2012
Broker [Member]
Dec. 31, 2010
Debt Financing [Member]
Jun. 30, 2013
Lincoln Park Capital Fund Llc [Member]
Mar. 31, 2012
Lincoln Park Capital Fund Llc [Member]
Sep. 30, 2013
Equity Financing [Member]
Jul. 23, 2012
Private Placement [Member]
Class of Warrant or Right [Line Items]                      
Class of Warrant or Right, Exercise Price of Warrants or Rights   1.63   2.20   2.30         1.03
Class of Warrant or Right, Outstanding   11,140,709   7,321,667 1,570,565   375,000 97,828 143,700 4,254,387  
Unrealized Gain On Warranty Derivative Liability   $ 246,337                  
Issuance of warrants           297,991         300,895
Class Of Warrant Or Right Issued During Period Value $ 1,485,313 $ 0 $ 220,872               $ 342,485
EXCEL 44 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C M8S`Y-V)F-3DB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DEN=F5N=&]R:65S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8W)U961?3&EA8FEL:71I97,\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X.DYA M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O5]4#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D)U#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E=A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U<'!L96UE;G1A;%]$:7-C;&]S=7)E7V]F M7T-A#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D)U#I7;W)K#I%>&-E;%=O#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I% M>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E!R;W!E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R M;W!E#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DQO;F=T97)M7T1E8G1?1&5T86EL#I%>&-E;%=O M#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-T;V-K0F%S961?0V]M<&5N#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S M7S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O5]4#I%>&-E;%=O M#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV M95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!296=I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^4V5P(#,P+`T*"0DR,#$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)U$S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!L:6%B:6QI='D\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO2P@;&5S'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA MF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XU+#`P,"PP,#`\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M6%L=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A M96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU.#8L-SF%T:6]N(&]F(&1E8G0@9&ES8V]U;G0\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6UE;G1S(&]N(&-A<&ET86P@ M;&5A3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO M9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P="<^(#QS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!A8V-O;7!A M;GEI;F<@8V]N3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D)A8W1E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^06X@;W!E2!M86YA9V5M96YT(&ES M(&YE="!I;F-O;64@;W(@;&]S3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO M9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0G/E1H92!#;VUP86YY)W,@2!C;VUP971I=&EV92!A;F0@2!C:&%N9VEN M9RX@4VEG;FEF:6-A;G0@=&5C:&YO;&]G:6-A;"!A9'9A;F-E2!C:&%N9V4@ M:6X@<')I8VEN9R!O2!T:&4@0V]M<&%N>2!T;R!K965P('5P M('=I=&@@=&5C:&YO;&]G:6-A;"!C:&%N9V4N)B,Q-C`[)B,Q-C`[1G5R=&AE M3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("8C M,38P.SPO9F]N=#X\+W-T3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!A8V-O;7!A;GEI M;F<@:6YT97)I;2!C;VYD96YS960@8V]N2!D;R!N;W0@:6YC M;'5D92!A;&P@9&ES8VQO65A6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#(Y+C=P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#!I;B<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^5&AE6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQS M=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!#;VUP86YY)B,X,C$W.W,@86-C M;W5N=',@2`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2X@ M5&AE($-O;7!A;GD@<')O=FED97,@9F]R('5N8V]L;&5C=&EB;&4@86UO=6YT M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2!G96]G6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P M:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED M=&@],T0Q,"4^(#QD:78^,C0L,C@U+#`R.#PO9&EV/B`\+W1D/B`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`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E. M1RU224=(5#H@-7!X)R!W:61T:#TS1#$P)3X@/&1I=CXU,S`L-C$P/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,"4^(#QD:78^-S6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#8U)3X@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI M9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(&QE9G0G('=I9'1H/3-$,24^ M(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S M<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M M86P[(%1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+5))1TA4.B`U<'@G('=I M9'1H/3-$,3`E/B`\9&EV/C(T+#@Q-2PV,S@\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE M.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M M04Q)1TXZ(&QE9G0G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=( M5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(')I9VAT M.R!0041$24Y'+5))1TA4.B`U<'@G('=I9'1H/3-$,3`E/B`\9&EV/C(T+#@U M."PP,S@\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2 M;VUA;B#L@1D].5#H@,3!P="!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^57-E(&]F($5S=&EM871E3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!P2!A;F0@97%U M:7!M96YT(&%N9"!I;G1A;F=I8FQE(&%S2!D971E'!E;G-E+B!!8W1U86P@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^5&AE($-O;7!A;GD@8V]N3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S M='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P="<^06-C;W5N=',@ M4F5C96EV86)L93PO9F]N=#X\+W-T3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS M1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D%C8V]U;G1S M(')E8V5I=F%B;&4@F5D+B!. M;W)M86P@=&5R;7,@;VX@=')A9&4@86-C;W5N=',@7,@86YD('-O;64@8W5S=&]M97)S(&%R92!O9F9E2!P97)F;W)M2P@8G5T(&=E;F5R86QL>2!D;V5S(&YO="!R97%U:7)E(&-O M;&QA=&5R86P@=&\@97AT96YD(&-R961I="X\+V9O;G0^/"]D:78^(#QD:78@ M2=S(&)E2!A;F0@;6%N86=E;65N="!J=61G;65N="X@06-T=6%L(&-U&AA=7-T M960@86YD('1H92!P;W1E;G1I86P@9F]R(')E8V]V97)Y(&ES(&-O;G-I9&5R M960@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@3PO9F]N=#X\ M+W-T3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/D%C8V]U;G1S('!A>6%B;&4@=&\@82!R96QA=&5D('!A2X@4V5E($YO=&4@ M,30L("8C.#(R,#M296QA=&5D(%!A6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO M9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P="<^(#QS=')O;F<^/&9O;G0@3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/DEN=F5N=&]R:65S(&%R92!S=&%T960@ M870@=&AE(&QO=V5R(&]F(&-O&-E M6-L92!I6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z M(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q M-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@2!A;F0@17%U:7!M96YT/"]F;VYT/CPO M6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^4')O<&5R='D@86YD(&5Q=6EP;65N="!A65A'!E;G-E9"!A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG&-EF5D+"!I;G-T96%D(&%R92!T97-T960@9F]R(&EM<&%I6EN9R!A;6]U;G0@;V8@=&AE(&%S M2!N;W0@8F4@2!P97)F;W)M2!A8V-O=6YT6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T M:69Y/CQS=')O;F<^/&9O;G0@6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q M+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[ M/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^26YT86YG:6)L92!AF5D(&]V97(@=&AE M:7(@65A65A6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\ M+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^/&9O;G0@6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`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`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE($-O;7!A;GD@86QS;R!R96-E M:79E6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/&9O;G0@2X@5&AE2!O=F5R('1H92!V97-T:6YG('!E6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG2!E>'!E;G-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\ M+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^/&9O;G0@2!R96QA=&5D M('1O(&EN=&5R;F%L(&-O6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@ M5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y M/CQS=')O;F<^/&9O;G0@3X\6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^("8C,38P.SPO9F]N=#X\+W-T3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H M92!#;VUP86YY(&%C8V]U;G1S(&9O&5S(&%S('!R97-C2!D:69F97)E;F-E2UT:&%N+6YO="!S=&%N9&%R9"!A;F0@=&AA="!AF5D+B!$:69F97)E;F-EF5D('1A>"!B96YE9FET2!A;F0@:6YT97)E"!E>'!E;G-E+B!4:&5R M92!AF5D(&EN('1H92!S=&%T96UE;G0@;V8@;W!E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/DQO;F2!O9B!A2!A(&-O;7!A2!W:&EC:"!T:&4@8V%R6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I M=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M5&AE($-O;7!A;GD@2!O=F5R('1H92!T97)M(&]F('1H M92!A=V%R9"XF(S$V,#LF(S$V,#M4:&4@0V]M<&%N>2!R96-O"!P2!H87,@96QE8W1E9"!T M:&4@)B,X,C(P.W-H;W)T(&-U="!M971H;V0F(S@R,C$[(&]F(&-O;7!U=&EN M9R!I=',@:'EP;W1H971I8V%L('!O;VP@;V8@861D:71I;VYA;"!P86ED+6EN M(&-A<&ET86P@=&AA="!I6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6%B M;&4L(&]T:&5R(&%C8W)U960@97AP96YS97,@86YD(&QO;F6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$58 M5"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^3&5V96P@,3H@26YP=71S('1O('1H92!V86QU871I M;VX@;65T:&]D;VQO9WD@87)E('5N861J=7-T960@<75O=&5D('!R:6-E2!I;F-L M=61E('%U;W1E9"!P2P@9F]R('-U8G-T86YT:6%L;'D@ M=&AE(&9U;&P@=&5R;2!O9B!T:&4@9FEN86YC:6%L(&EN6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3&5V96P@,SH@26YP=71S M('1O('1H92!V86QU871I;VX@;65T:&]D;VQO9WD@87)E('5N;V)S97)V86)L M92!A;F0@6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV M/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P M="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^02!F:6YA;F-I M86P@:6YS=')U;65N="=S(&QE=F5L('=I=&AI;B!T:&4@9F%I2!L979E;"P@=VET:&EN('1H92!F86ER('9A;'5E(&AI97)A2P@;W5R M(&%S3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D%C8W)U960@ M6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z M(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q M-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D]. M5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL M93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D%S M)B,Q-C`[;V8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P M86X],T0R/B`\9&EV/E-E<'1E;6)E6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#4V)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M+W1A8FQE/B`\+V1I=CX@/"]D:78^(#QD:78@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q M+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[ M/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U3 M25I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS M1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D%S)B,Q M-C`[;V8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X] M,T0R/B`\9&EV/E-E<'1E;6)E6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#4V)3X@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^ M.3@T+#,U-CPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1( M.B`Q,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]6 M15)&3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI M9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/ M3$Q!4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@ M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X] M,T0R/B`\9&EV/D%S)B,Q-C`[;V8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#4V)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X] M,T0R/B`\9&EV/D1E8V5M8F5R)B,Q-C`[,S$L/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C M96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/C(P,3(\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE"<@=VED=&@],T0Q,B4^(#QD:78^ M+3PO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,B4^(#QD:78^.3$L-S0P(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$58 M5"U)3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^3&5V96P@,R!#:&%N9V5S/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@ M5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^5&AE(&9O;&QO=VEN9R!I6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#(Y+C=P="<^(#QI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO:3X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A M6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S M='EL93TS1"=C;&5A2`Q+"`R,#$S/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS M1#$R)3X@/&1I=CXQ+#0X-2PS,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,BPR,C,L,S,R/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QI M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^06-Q=6ES:71I;VX@ M8V]N=&EN9V5N="!C;VYS:61E3PO9F]N=#X\+VD^ M/"]D:78^(#QD:78@6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE M('-T>6QE/3-$)T]615)&3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B M-F-E(#!P>"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI M9#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@ M(SEE8C9C92`P<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^*#DQ M+#6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@"<@ M=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@2!D:60@;F]T(&-H86YG92!A;GD@;V8@ M=&AE('9A;'5A=&EO;B!T96-H;FEQ=65S('5S960@=&\@;65A28C.#(Q-SMS M(')O>6%L='D@;&EA8FEL:71Y(&ES(&-A2!D:7-C;W5N M=&5D('1H92`D/&9O;G0@2!T;W1A;"!O9B`D/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2!I6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$58 M5"U)3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^1'5R:6YG('1H92!F:7)S M="!Q=6%R=&5R(&]F(#(P,3(L('=E(&ES2!I2`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B&5R8VES92!P&EM871E;'D@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U M9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B M9C4Y+U=O'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG(#QD:78@3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/DEN(#(P,3$L('1H92!# M;VUP86YY(&%C<75I2X@07,@<&%R="!O9B!T:&4@<'5R8VAA6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG&-E961E9"`D/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG&-E961E9"`D/&9O;G0@6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE(&EN:71I86P@=F%L=6%T:6]N M(&]F('1H92!C;VYT:6YG96YT(&-O;G-I9&5R871I;VX@=V%S(&)A3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N M/CPO'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"!S;VQI9#L@34%21TE..B`P:6X[($)/4D1%4BU,1494 M.B`C.65B-F-E(#!P>"!S;VQI9#L@5TE$5$@Z(#$P,"4G(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1L969T/B`\='(^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H M/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/E-E<'1E;6)E6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X] M,T0R/B`\9&EV/C(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\ M9&EV/C(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-"PY.3$L M,#,R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@ M"<@=VED=&@] M,T0Q,B4^(#QD:78^."PP,#0L,S$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P M,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-RPS-3`L,S,R/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU2 M24=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ-"PR-C`L-C$T/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H M="<@=VED=&@],T0Q,B4^(#QD:78^*#$L,36QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@] M,T0Q,B4^(#QD:78^*#$L,3$Y+#$Y,RD\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R M)3X@/&1I=CXQ,RPR,C@L,S@S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T M:#TS1#$R)3X@/&1I=CXQ+#(S."PR,C4\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$ M1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#(S."PR,C4\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`Q<'@@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS M1#$R)3X@/&1I=CXQ+#(S."PR,C4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@ M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ M-"PT-C8L-C`X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q M<'@@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P M,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,30L,S&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\ M='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!A;F0@17%U:7!M96YT+"!.970\8G(^/"]S=')O;F<^ M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L2P@ M4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@4&QA;G0@ M86YD($5Q=6EP;65N="!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z M(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q M-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^/&9O;G0@2!A;F0@97%U:7!M96YT+"!N970@87)E(&%S(&9O;&QO=W,Z/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T M>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I M9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D1E8V5M8F5R)B,Q-C`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q M,B4^(#QD:78^,2PV-3,L,C8S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-2PW M-C$L,#6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,S$R+#8U,#PO9&EV/B`\+W1D M/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,SDR+#(P-CPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#'1U6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,36QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X M)R!W:61T:#TS1#$R)3X@/&1I=CXT,2PP.3D\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=( M5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXW."PS,#8\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P M,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^36%I;G1E;F%N8V4@86YD(')E<&%I6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2!A;F0@97%U:7!M96YT+"!I;F-L=61I;F<@ M<')O<&5R='D@=6YD97(@8V%P:71A;"!L96%S92!F;W(@=&AE(&9I6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2X\ M+V9O;G0^/"]D:78^(#PO9&EV/B`\=&%B;&4@8F]R9&5R/3-$,"`@&5D.R<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@ M6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G M('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D1E8V5M8F5R)B,Q-C`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`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q M,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#6EN9R!V86QU93PO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^.#0X+#8W-3PO9&EV/B`\+W1D M/B`\=&0@"<@=VED=&@],T0Q,B4^ M(#QD:78^.#(P+#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`Q<'@@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^*#(R."PT,#`I M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6EN9R!V86QU93PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@ M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXU M.3(L,S6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-S0L.3$X/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q M,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`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`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W M:61T:#TS1#$R)3X@/&1I=CXW-"PY,3@\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED M=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X M)R!W:61T:#TS1#$R)3X@/&1I=CXU-C,L-3(T/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)W=I9'1H.C$P,"4[('1A M8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6%B;&5S(&%N M9"!!8V-R=6%L'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP M="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q,#`E M.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)&3$]7 M.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]2 M1$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q!4%-% M.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]2 M1$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@"<@ M=VED=&@],T0Q,B4^(#QD:78^.3$L-S0P/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^ M(#QD:78^,C$X+#@U,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H M=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#`Q M,RPY,#D\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE'!E;G-E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU2 M24=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#`W-2PU.3$\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^ M(#QD:78^,2PX,30L-#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@"!S;VQI M9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,BPT,#`L,#DP/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("@X*28C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.TQO M;F6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#(W+C5P=#L@34%21TE..B`P:6X@,&EN(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3VX@07!R:6P@,CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!S96-U6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG2!A;&QO=V5D(&)O2!!9W)E96UE;G0@=VET:"!-:61#87`@=&\@86QL;W<@=&AE($-O;7!A;GD@ M=&\@8F]R2!A(#`N-24@ M8V]L;&%T97)A;"!M86YA9V5M96YT(&9E92!O;B!T:&4@879E2!A;F0@,24@;V8@=&AE M(&%V97)A9V4@=6YU6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z(#,Q+CEP=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^3VX@075G=7-T(#(T+"`R,#$R+"!T:&4@0V]M<&%N M>2!E;G1E2!A;'-O(&)O6%L M='D@:6YT97)E6UE;G1S M+B!4:&4@;&]A;B!I2!L:6%B:6QI='D@;V8@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPGF5D('1O(&EN=&5R97-T(&5X<&5N65A2!L:6%B:6QI='D@=VEL;"!B92!A M8V-R971E9"!T;R`D/&9O;G0@2!A9W)E96UE;G0@=7-I M;F<@=&AE(&5F9F5C=&EV92!I;G1E6UE;G1S(&UA M9&4@=6YD97(@=&AE(')O>6%L='D@86=R965M96YT+"!P97(@=&AE('1A8FQE M(&)E;&]W+"!W:6QL(&1I2!L:6%B M:6QI='DN/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^5&AE($-O;7!A;GD@&EM871E;'D@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6UE;G0@;V8@=&AE(&5X:7-T:6YG M('1E6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H97)E('=E2!D:60@;F]T M(&%C:&EE=F4@=&AE("0X+C4@;6EL;&EO;B!R979E;G5E(&EN('1H92!S96-O M;F0@<75A2!P87ES+"!P2!A;GD@<')I;F-I<&%L(&%M;W5N M="!O9B!T:&4@;&]A;BX@26X@861D:71I;VXL('1H92!#;VUP86YY(&1I9"!N M;W0@:&ER92!A($-H:65F($5X96-U=&EV92!/9F9I8V5R('=I=&AI;B`Y,"!D M87ES(&]F('1H92!R97-I9VYA=&EO;B!O9B!T:&4@<')I;W(@0VAI968@17AE M8W5T:79E($]F9FEC97(@9F]R('=H:6-H('=E(')E8V5I=F5D(&$@=V%I=F5R M(&EN(&5X8VAA;F=E(&9O3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/CPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS M1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO M9F]N=#X@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4 M+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z M(",Y96(V8V4@,'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[ M($)/4D1%4BU#3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4 M.B`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`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`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$R)3X@/&1I=CXW,#`L,#`P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO2!"86YK(&]F($)E;&=R861E M+"`D,3`L-S0V(&UO;G1H;'D@<&%Y;65N=',@:6YC;'5D:6YG(&EN=&5R97-T M+"!M871U2!B=6EL M9&EN9SPO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q,B4^(#QD:78^,C$L-#(Q+#0R,#PO9&EV/B`\+W1D/B`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`C,#`P,#`P M(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,30L-#@S+#$P,B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O M;&ED.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^/&9O;G0@2!O9B!E6%L='D@<&%Y;65N=',@87,@;V8@4V5P=&5M8F5R(#,P+"`R M,#$S.CPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@ M,'!X('-O;&ED.R!"3U)$15(M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXX-3,L,#`P/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXX+#0W-RPP M,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,3,L,C4P+#`P M,"`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA M;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^("@Y*28C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.U-T M;V-K+4)A3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D]U65E M2!T:&4@8V]M M<&5N&5R8VES M92!P2!N;W0@=')A;G-F97)A8FQE+"!V97-T(&EN(&EN&5R8VES M86)L92!D=7)I;F<@=&AE('-T871E9"!C;VYT2!B>2!S=6-H(&]P=&EO;F5E+B!4:&4@97AEF5D('5N9&5R('1H92!0;&%N(&%N9"!A="!397!T M96UB97(@,S`L(#(P,3,L('=E(&AA9"!A<'!R;WAI;6%T96QY(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF5D(&EN('1H92!S=&%T96UE;G0@;V8@ M;W!E2!E>'!E8W1E9"!T;R!V97-T(&%N9"!R969L96-T2P@:6X@6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE(&5S M=&EM871E9"!F86ER('9A;'5E(&]F('-T;V-K(&]P=&EO;G,@9W)A;G1E9"!I M2!U=&EL M:7IE65E('1E'!E;G-E('=I;&P@8F4@;6%D92!I;B!F=71U6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/"]F;VYT M/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CH@:G5S=&EF M>3L@34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\=&%B;&4@6QE/3-$)V-L96%R.F)O=&@[5$585"U!3$E'3CH@:G5S M=&EF>3L@34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^4FES:RU&6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,X.3`Q.SPO9F]N=#X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ("-E8V4Y9#@[($)/4D1%4BU,1494.B`C96-E.60X M.R!0041$24Y'+4)/5%1/33H@,&EN.R!"04-+1U)/54Y$+4-/3$]2.B!T'!E8W1E9"!497)M.B!792!D;R!N M;W0@:&%V92!A9&5Q=6%T92!H:7-T;W)Y('1O(&5S=&EM871E(&%N(&5X<&5C M=&5D('1E'!E8W1E9"!T97)M+B!792!U'!E8W1E9"!T97)M(&]F(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)U=)1%1(.B`Q,#`E M.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4+5-)6D4Z(#$P<'0G M(&)O6QE/3-$)T)/4D1%4BU"3U143TTZ M("-E8V4Y9#@[($)/4D1%4BU,1494.B`C96-E.60X.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!"04-+1U)/54Y$+4-/3$]2.B!T6QE/3-$)V-L96%R.F)O=&@[34%21TE..B`P:6X@,&EN(#!P="<^/&9O M;G0@2!!4T,@ M-S$X+B!792!U6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)B,X.3`Q.SPO9F]N=#X\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ("-E8V4Y9#@[($)/4D1%4BU,1494.B`C M96-E.60X.R!0041$24Y'+4)/5%1/33H@,&EN.R!"04-+1U)/54Y$+4-/3$]2 M.B!T6]U=',@ M86YD('=A6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E' M3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L M92!S='EL93TS1"="3U)$15(M0D]45$]-.B`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`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M M4U193$4Z(&YO&5R8VES928C,38P.U!R:6-E/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`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`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#@E M/B`\9&EV/C,L,S,Q+#(U,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C8S/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXQ+C$Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXP+C`V/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+C6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0X)3X@/&1I=CXW+#8S."PW.#4\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO&5R8VES86)L92!A="!3 M97!T96UB97(@,S`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPGF5D('=A6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%2 M1TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M26X@861D:71I;VXL(&]N($UA>2`R-"P@,C`Q,RP@=&AE($-O;7!A;GD@:7-S M=65D(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG65E M65A M'!E;G-E(&]F("0\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@)U1I;65S($YE=R!2;VUA;BF5D(')A=&%B;'D@ M;W9E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/"]F;VYT M/B8C,38P.SPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^1G)O;2!T:6UE('1O('1I;64@=V4@;6%Y(&=R M86YT('-T;V-K(&]P=&EO;G,@86YD(')EF5D(&]V97(@=&AE('9E3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO M9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPGF5S(')E6QE/3-$)T)/4D1% M4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M3$5&5#H@(SEE M8C9C92`P<'@@"!S;VQI9#L@ M0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R M)3X@/&1I=CXW,S,L.3`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!R97-T65A2!R96-O9VYI>F5D(')E9'5C=&EO;B!O9B!N M;VXM8V%S:"!C;VYS=6QT:6YG(&5X<&5N6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG'!E;G-E(&]F("0\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B65T(')E8V]G;FEZ M960@:7,@)#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG'!E8W1E9"!T;R!B92!R96-O9VYI>F5D(&]V97(@=&AR M964@>65A6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!4'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/"]F;VYT/B`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5.5#H@ M,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)&3$]7.B!V:7-I8FQE.R!"3U)$ M15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B M-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@0D]2 M1$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT M97(G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!C96YT97(G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#8Q)3X@/&1I=CXF(S$V,#L\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!C96YT97(G('=I9'1H/3-$,3(E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@&5R8VES M93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#8Q)3X@/&1I=CXF M(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/E-H87)E M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-RPS,C$L M-C8W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@ M/&1I=CXR+C`P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,2XV,SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E=E('5T:6QI>F4@82!L871T M:6-E(&UO9&5L('1O(&1E=&5R;6EN92!T:&4@9F%I6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!O9B!E>&5R8VES92!P2!F;W(@=&AE(&9I2!T:6UE('=H:6QE('1H92!W87)R86YT(&ES(&]U='-T86YD:6YG+"!T M:&4@97AE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^/&9O;G0@6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z M(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q M-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D]. M5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL M93TS1"=C;&5A6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q M<'@@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!C96YT97(G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!615)424-!3"U!3$E'3CH@;6ED9&QE.R!&3TY4+5=%24=(5#H@ M-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(&QE9G0G('=I M9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!"3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!C96YT97(G('=I9'1H/3-$,3(E(&-O;'-P86X],T0R/B`\9&EV M/C(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6EN9R!C M;VUM;VX@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@] M,T0Q,24^(#QD:78^,"XV.#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,24^(#QD:78^,"XW,CPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@65A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED M=&@],T0Q,24^(#QD:78^,#PO9&EV/B`\+W1D/B`\=&0@3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@ M4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$Q)3X@/&1I=CXV,SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU2 M24=(5#H@-7!X)R!W:61T:#TS1#$Q)3X@/&1I=CXV,CPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y M+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[ M/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,30S+#6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#8Q)3X@/&1I=CY$97)I=F%T:79E('=A6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R M)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-BPP,#$L.3(R/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,2PV-#DL-S`W(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X M-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA M'0^)R`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q M+CEP=#L@34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^ M/&9O;G0@6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%21TE..B`P:6X@,&EN(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5V4@;&5A65A2!S86QE+B!792!L96%S92!A;B!A9&1I=&EO;F%L(&]F M9FEC92!F86-I;&ET>2!U;F1E6UE;G1S(&9O6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M24Y$14Y4.B`P:6X[(%=)1%1(.B`Q,#`E)SX@/'1A8FQE('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M3$5& M5#H@(SEE8C9C92`P<'@@"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P M>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X@/'1R M/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXV,2PU.3D\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXR-C,L,3,V/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,2PY-#0L M,3,W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M1D%-24Q9.B`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`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQS=')O;F<^/&9O;G0@6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3VX@2F%N=6%R M>2`R.2P@,C`Q,RP@=V4@2!R97%U:7)E;65N M=',@2!R97%U:7)E;65N=',@2!S M=&%T960@=&AA="!I="!W87,@:6X@2!R97-P;VYD960@=&\@=&AA="!&;W)M(#0X,RX@3VX@4V5P=&5M M8F5R(#$Y+"`R,#$S+"!W92!R96-E:79E9"!A(&QE='1E3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("8C,38P.SPO9F]N=#X\+W-T M3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^36%R:V5T($5X8VAA;F=E($YO=&EF M:6-A=&EO;CPO9F]N=#X\+W-T3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("8C M,38P.SPO9F]N=#X\+W-T3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)R`G/D]N($UA>2`Q,RP@,C`Q,RP@=V4@&-H86YG92`H)B,X M,C(P.T5X8VAA;F=E)B,X,C(Q.RD@;F]T:69Y:6YG('5S('1H870@=V4@87)E M(&YO="!I;B!C;VUP;&EA;F-E('=I=&@@4V5C=&EO;B`Q,#`S*&$I*&EI:2D@ M;V8@=&AE($-O;7!A;GD@1W5I9&4@=VET:"!S=&]C:VAO;&1E2!O9B!L97-S('1H86X@)#8L,#`P+#`P,"!A;F0@;F5T(&QO2!O9B!L97-S('1H86X@)#0L,#`P+#`P,"!A;F0@;F5T(&QO65A M2!%>&-H86YG92!S=&%F9B!D=7)I;F<@=&AE M(&5X=&5N6QE/3-$)W=I9'1H M.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S/&)R/CPO"!$:7-C;&]S=7)E(%M!8G-T#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M("@Q,BDF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M);F-O;64@5&%X97,\+V9O;G0^ M/"]D:78^(#QD:78@&%B;&4@:6YC;VUE+B!7:&5R92!I="!I6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z M(#(Y+C=P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE(#(P,#@@ M=&AR;W5G:"`R,#$R('1A>"!Y96%R&%M:6YA M=&EO;B!B>2!T:&4@26YT97)N86P@4F5V96YU92!397)V:6-E(&%N9"!T:&4@ M,C`P-B!T;R`R,#$R('1A>"!Y96%R&EN M9R!A=71H;W)I=&EE65A'!I6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1% M3E0Z(#(Y+C=P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE($-O M;7!A;GD@9&ED(&YO="!R96-O9VYI>F4@86YY(&EN=&5R97-T(&]R('!E;F%L M=&EE&5D.R<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE M/3-$)T)/4D1%4BU"3U143TTZ(",Y96(V8V4@,'!X('-O;&ED.R!"3U)$15(M M3$5&5#H@(SEE8C9C92`P<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([ M($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,"<@=VED=&@],T0Q,24@8V]L6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX,34L,#,Q/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`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`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@ M/&1I=CXQ+#@R.2PV-#<\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT,#DL.#,X M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`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`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$P)3X@/&1I=CXT,#@L,C4W/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR,C`L.#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P M)3X@/&1I=CXS,#0L-C@P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO2!R96QA=&5D('1O(&9I;F%N8VEN9SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$)W=I9'1H.C$P,"4[ M('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)R`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO M9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^1W5Y($-O;VLL(&]U&5C=71I=F4@3V9F:6-E2!C;VUP96YS871I;VX@9F]R(&AI2P@82!D:7)E8W1O6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M2!F;W(@:&ES('-E3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S M='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D%$ M4R!A;F0@5T-44R!R96-O=F5R('1I6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2X@5&AE6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@ M/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/D]N($IU;F4@,C&-H86YG960@<')O9'5C=',@:6YI M=&EA;&QY('!U&5C=71I=F4@3V9F:6-E&5C=71I=F4@3V9F:6-E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG65A6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^("@Q-2DF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#M3=6)S97%U M96YT($5V96YT6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z M(#$N,7!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1&IU2!A;F0@:7,@<'5R M3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)TQ)3D4M2$5)1TA4.B`Q,34E.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N+'-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z(#$N,7!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M4TE:13H@.'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`R.6UP;VMB M:FAZ;V1T96L[($-/3$]2.B!B;&%C:R<^3VX@3F]V96UB97(@,30L(#(P,3,L M('1H92!#;VUP86YY(')E8V5I=F5D(&$@=V%I=F5R(&9R;VT@4D]3(&9O6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG&-H86YG92!F;W(@=&AE('=A:79E2!$96-E;6)E3PO9F]N=#X@/&9O;G0@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0G/E1H92!A8V-O;7!A;GEI;F<@8V]N3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I M=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/D)A8W1E6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q M+CEP="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^06X@;W!E2!M86YA9V5M96YT(&ES(&YE="!I;F-O;64@;W(@;&]S3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS M1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!#;VUP M86YY)W,@2!C;VUP971I=&EV M92!A;F0@2!C:&%N9VEN9RX@4VEG;FEF:6-A;G0@=&5C:&YO;&]G M:6-A;"!A9'9A;F-E2!C:&%N9V4@:6X@<')I8VEN9R!O2!T M:&4@0V]M<&%N>2!T;R!K965P('5P('=I=&@@=&5C:&YO;&]G:6-A;"!C:&%N M9V4N)B,Q-C`[)B,Q-C`[1G5R=&AE3X\6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^("8C,38P.SPO9F]N=#X\+W-T3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0G/E1H92!A8V-O;7!A;GEI;F<@:6YT97)I;2!C;VYD96YS960@8V]N M2!D;R!N;W0@:6YC;'5D92!A;&P@9&ES8VQO65A6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#!I;B<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE&5D.R<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T#L@ M1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL M93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!# M;VUP86YY)B,X,C$W.W,@86-C;W5N=',@2`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG2X@5&AE($-O;7!A;GD@<')O=FED97,@9F]R('5N M8V]L;&5C=&EB;&4@86UO=6YT6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2!G96]G6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^ M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q M,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,"4^(#QD:78^,C0L,C@U+#`R.#PO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E. M1RU224=(5#H@-7!X)R!W:61T:#TS1#$P)3X@/&1I=CXR-"PP.#0L.#,V/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$P)3X@ M/&1I=CXU,S`L-C$P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4 M+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ M(&QE9G0G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P M.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(')I9VAT.R!0041$ M24Y'+5))1TA4.B`U<'@G('=I9'1H/3-$,3`E/B`\9&EV/C(T+#@Q-2PV,S@\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(&QE9G0G('=I9'1H/3-$,24^(#QD M:78^)#PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@ M9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+5))1TA4.B`U<'@G('=I9'1H M/3-$,3`E/B`\9&EV/C(T+#@U."PP,S@\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE M9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\ M+W1D/CPO='(^/"]T86)L93X\2!; M4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M/&9O;G0@6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y M+C=P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE('!R97!A2!R97-E M6%L='D@;&EA8FEL:71Y.R!A;F0@97-T:6UA=&5S(&9O&5D.R<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T#L@1D]. M5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^5&AE($-O;7!A;GD@8V]N#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^06-C;W5N=',@2!P87DN)B,Q M-C`[)B,Q-C`[(%1H92!#;VUP86YY('!E'1E;F0@8W)E9&ET M+CPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L M(&%C8V]U;G1S(&ES('1H92!#;VUP86YY)W,@8F5S="!E&ES=&EN9R!R96-E:79A8FQE2!A9F9E8W0@82!C M=7-T;VUE&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D M/CPO=&0^/"]T6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^06-C;W5N=',@4&%Y86)L92`M(%)E;&%T960@4&%R M='D\+V9O;G0^/"]S=')O;F<^/"]D:78^(#QD:78@2!I;F-L=61E2!42!;4&]L M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^($EN M=F5N=&]R:65S/"]F;VYT/CPO6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O M;G0@2!B87-E9"!O;B!H:7-T;W)I8V%L('5S86=E(&%N9"!S86QE2!R97-E2!R96-O6]N M9"!T=V5L=F4@;6]N=&AS(&%R92!C;&%S2P@4&QA;G0@86YD($5Q=6EP M;65N="P@4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@ M("`\=&0@8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QS=')O;F<^/&9O;G0@2!A;F0@17%U:7!M96YT/"]F;VYT/CPO M6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@ M86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^4')O<&5R='D@86YD(&5Q=6EP;65N="!A65A'!E;G-E9"!A&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,#X\='(^/'1D/CPO=&0^/"]T#L@1D].5#H@ M,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX] M,T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@&-EF5D+"!I;G-T96%D(&%R92!T97-T960@9F]R(&EM M<&%I6EN9R!A;6]U M;G0@;V8@=&AE(&%S2!N;W0@8F4@2!P97)F;W)M M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)W=I9'1H.C$P,"4[('1A M8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E M>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD M:78@3X\6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^/&9O;G0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$58 M5"U)3D1%3E0Z(#,Q+CEP="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M5&AE($-O;7!A;GD@86-C;W5N=',@9F]R(&ET2!D97)I=F%T:79E(&EN2!A MF5D(&EN('1H92!C;VYS;VQI9&%T960@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T#L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J M=7-T:69Y/CQS=')O;F<^/&9O;G0@3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/DEN=&%N9VEB;&4@87-S M971S('=I=&@@97-T:6UA8FQE('5S969U;"!L:79E2!N;W0@8F4@6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF M:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT M9#X\+W1D/CPO='(^/"]T86)L93X\2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^4F5V96YU92!296-O9VYI=&EO;CPO9F]N=#X\+W-T&5D(&]R(&1E=&5R;6EN86)L93L@86YD(&0I(&-O;&QE M8W1I;VX@;V8@=&AE($-O;7!A;GDF(S@R,3<[6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`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`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG2!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E3X\6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("8C,38P.SPO9F]N M=#X\+W-T2!I'!E;G-E+CPO9F]N=#X\+V1I=CX@/"]D:78^(#QT86)L92!B M;W)D97(],T0P("!S='EL93TS1"=W:61T:#HQ,#`E.R!T86)L92UL87EO=70Z M9FEX960[)R!C96QL#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!#;VUP86YY(&5X<&5N2!H860@;F\@ M061V97)T:7-I;F<@97AP96YS92!I;B!T:&4@;FEN92!M;VYT:',@96YD960@ M4V5P=&5M8F5R(#,P+"`R,#$S(&%N9"`D/&9O;G0@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\ M='(^/'1D/CPO=&0^/"]T2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4F5S96%R8V@@86YD($1E=F5L;W!M M96YT/"]F;VYT/CPO6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP M="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^4F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,#X\='(^/'1D/CPO=&0^/"]T"P@ M4&]L:6-Y(%M0;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@ M8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`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`@("`@(#QT M9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6EN9R!A;6]U;G0@;V8@86X@87-S970@;6%Y(&YO="!B92!R96-O M=F5R86)L92X@4F5C;W9E6EN9R!A;6]U;G0@;V8@86X@87-S970@=&\@9G5T=7)E(&YE="!C87-H M(&9L;W=S(&5X<&5C=&5D('1O(&)E(&=E;F5R871E9"!B>2!T:&4@87-S970N M($EF('-U8V@@87-S971S(&%R92!C;VYS:61E6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P M="<^(#QS=')O;F<^/&9O;G0@&5D.R<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T2!497AT($)L;V-K73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0G/E1H92!#;VUP86YY(')E8V]R9',@F5D(&)A&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T2!;4&]L:6-Y(%1E M>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD M:78@6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^1F%I6%B;&4L(&]T:&5R(&%C8W)U M960@97AP96YS97,@86YD(&QO;F6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP M="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M3&5V96P@,3H@26YP=71S('1O('1H92!V86QU871I;VX@;65T:&]D;VQO9WD@ M87)E('5N861J=7-T960@<75O=&5D('!R:6-E2!I;F-L=61E('%U;W1E9"!P2P@9F]R('-U8G-T86YT:6%L;'D@=&AE(&9U;&P@=&5R;2!O M9B!T:&4@9FEN86YC:6%L(&EN6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$58 M5"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^3&5V96P@,SH@26YP=71S('1O('1H92!V86QU871I M;VX@;65T:&]D;VQO9WD@87)E('5N;V)S97)V86)L92!A;F0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P M=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^02!F:6YA;F-I86P@:6YS=')U;65N="=S M(&QE=F5L('=I=&AI;B!T:&4@9F%I2!L979E;"P@=VET:&EN M('1H92!F86ER('9A;'5E(&AI97)A2P@;W5R(&%S3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D%C8W)U960@6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV M/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I M9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D%S)B,Q-C`[;V8\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/E-E M<'1E;6)E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#4V)3X@/&1I=CXF(S$V,#L\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@ M/"]D:78^(#QD:78@6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV M('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ M(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$ M,3,E(&-O;'-P86X],T0R/B`\9&EV/D%S)B,Q-C`[;V8\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C M96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/E-E<'1E;6)E M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#4V)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^ M+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD M:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=( M5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^.3@T+#,U-CPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q,#`E.R!415A4+4E.1$5. M5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)&3$]7.B!V:7-I8FQE.R!" M3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+5))1TA4.B`C M.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q!4%-%.B!C;VQL87!S93L@ M0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C M96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D%S)B,Q-C`[ M;V8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#4V)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C M96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D1E8V5M8F5R M)B,Q-C`[,S$L/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E M(&-O;'-P86X],T0R/B`\9&EV/C(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@ M"<@=VED=&@],T0Q,B4^(#QD:78^ M.3$L-S0P(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^ M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3&5V M96P@,R!#:&%N9V5S/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP M="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M5&AE(&9O;&QO=VEN9R!I6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^(#QI/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO M:3X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!- M05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A2`Q+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`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`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@ M4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#0X-2PS M,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED M=&@],T0Q,B4^(#QD:78^,BPR,C,L,S,R/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U) M3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QI/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^06-Q=6ES:71I;VX@8V]N=&EN9V5N="!C;VYS:61E M3PO9F]N=#X\+VD^/"]D:78^(#QD:78@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q,#`E M.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)&3$]7 M.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]2 M1$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q!4%-% M.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H="<@=VED=&@],T0Q,B4^(#QD:78^*#DQ+#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q M<'@@"<@=VED=&@],T0Q,B4^(#QD:78^ M+3PO9&EV/B`\+W1D/B`\=&0@2!D:60@;F]T(&-H86YG92!A;GD@;V8@=&AE('9A;'5A=&EO;B!T96-H M;FEQ=65S('5S960@=&\@;65A28C.#(Q-SMS(')O>6%L='D@;&EA8FEL:71Y M(&ES(&-A2!D:7-C;W5N=&5D('1H92`D/&9O;G0@2!T;W1A;"!O9B`D/&9O M;G0@&5D.R<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^ M/"]T6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\+V9O M;G0^/"]S=')O;F<^/"]D:78^(#QD:78@2!I6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG&5D.R<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT M:6YG(%!O;&EC:65S("A486)L97,I/&)R/CPOF%T:6]N+"!#;VYS;VQI M9&%T:6]N(&%N9"!0'0^)SQS<&%N/CPO#L@1D].5#H@,3!P M="!4:6UE6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4F5V96YU92!B>2!G96]G6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U) M3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I M=B!S='EL93TS1"=C;&5A6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P M,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/ M5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P M,"`Q<'@@"<@=VED=&@],T0Q,"4^(#QD M:78^,C0L,C@U+#`R.#PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X M)R!W:61T:#TS1#$P)3X@/&1I=CXU,S`L-C$P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P M,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`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`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S M<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M M86P[(%1%6%0M04Q)1TXZ(&QE9G0G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!& M3TY4+5=%24=(5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q) M1TXZ(')I9VAT.R!0041$24Y'+5))1TA4.B`U<'@G('=I9'1H/3-$,3`E/B`\ M9&EV/C(T+#@Q-2PV,S@\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=( M5#H@-#`P.R!&3TY4+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(&QE9G0G M('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@"!S;VQI M9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`S<'@@9&]U8FQE.R!&3TY4+5=%24=(5#H@-#`P.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+5)) M1TA4.B`U<'@G('=I9'1H/3-$,3`E/B`\9&EV/C(T+#@U."PP,S@\+V1I=CX@ M/"]T9#X@/"]T6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA M>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^ M/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E"!S;VQI9#L@34%21TE..B`P:6X[($)/4D1%4BU,1494 M.B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV M/C(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#4V)3X@/&1I=CY,979E;"`Q/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`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`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXM M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@ M5$585"U)3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"!S;VQI9#L@34%21TE..B`P:6X[($)/4D1%4BU,1494.B`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`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\ M='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT M97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/C(P,3,\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#4V)3X@/&1I=CY,979E;"`Q/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#4V)3X@/&1I=CY,979E;"`R/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#4V)3X@/&1I=CY,979E;"`S/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"]D M:78^(#QD:78@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U) M3D1%3E0Z(#,Q+CEP="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I;B`P:6X@,'!T)SX@/&1I M=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\ M9&EV/D%S)B,Q-C`[;V8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E M(&-O;'-P86X],T0R/B`\9&EV/E-E<'1E;6)E6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#4V M)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L M93X\'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@ M,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P M="<^(#QI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^5V%R6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1( M.B`Q,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]6 M15)&3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI M9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/ M3$Q!4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@ M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF5D(&EN(&5A M6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"]D:78^(#QD:78@"!S;VQI9#L@34%21TE. M.B`P:6X[($)/4D1%4BU,1494.B`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`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q M,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)& M3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@ M0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD M:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q M<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P M,"`Q<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`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`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-"PQ-S8L-S8T M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R M)3X@/&1I=CXQ-"PT,#4L,#4V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@] M,T0Q,B4^(#QD:78^,30L,C8P+#8Q-#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P M,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@"<@=VED=&@],T0W,24^(#QD:78^0W5R6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI M9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,3,L,C(X+#,X M,SPO9&EV/B`\+W1D/B`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`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,2PR M,S@L,C(U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE"<@=VED=&@],T0W,24^(#QD:78^3F]N+6-U6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@ M"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P M,"`Q<'@@"<@ M=VED=&@],T0Q,B4^(#QD:78^,2PR,S@L,C(U/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,2PR,S@L M,C(U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@"!S;VQI M9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,30L-#8V+#8P.#PO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"]D:78^(#PO9&EV/B`\=&%B;&4@8F]R M9&5R/3-$,"`@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D M/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!A;F0@17%U:7!M96YT+"!.970@*%1A8FQE2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1=/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@4&QA M;G0@86YD($5Q=6EP;65N="!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@ M("`@("`\=&0@8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<^4')O<&5R='D@86YD(&5Q=6EP;65N="P@;F5T(&%R92!A"!S;VQI9#L@34%21TE..B`P:6X[($)/4D1%4BU,1494.B`C M.65B-F-E(#!P>"!S;VQI9#L@5TE$5$@Z(#$P,"4G(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`@86QI9VX],T1L969T/B`\='(^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$ M,3,E(&-O;'-P86X],T0R/B`\9&EV/E-E<'1E;6)E6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R M/B`\9&EV/C(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV M/C(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+51/4#H@(S`P,#`P,"`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`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,S$R+#8U,#PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@ M/&1I=CXQ-S`L,3$X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^,2PW.3,L-S4V/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-#$L,#DY/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-S@L,S`V M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S M;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R M:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXQ M,"PQ-#$L.#$V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q M<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P M,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD M:78^.2PU-S(L.#(R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E. M1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXU+#,R,"PY.3(\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@(S`P M,#`P,"`Q<'@@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R M)3X@/&1I=CXU+#(S-"PX-C<\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"]D:78^(#PO9&EV/B`\=&%B;&4@ M8F]R9&5R/3-$,"`@&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^ M/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E"!S;VQI9#L@34%21TE. M.B`P:6X[($)/4D1%4BU,1494.B`C.65B-F-E(#!P>"!S;VQI9#L@5TE$5$@Z M(#$P,"4G(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@86QI9VX] M,T1L969T/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/E-E M<'1E;6)E6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I M9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/C(P,3,\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$ M,3,E(&-O;'-P86X],T0R/B`\9&EV/C(P,3(\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52 M+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`Q<'@@"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS M1#$R)3X@/&1I=CXU-C,L-3(T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@"!S M;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/ M5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^-3DR+#,W.#PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@] M,T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#F%T:6]N(&5X<&5N6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H M=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXU-BPW M-3`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!R:6=H="<@=VED=&@],T0Q,B4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R M/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD M:78^,3@L-S(Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-S0L.3$X/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,B4^(#QD:78^-S0L.3$X/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD M:78^-S0L.3$X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-S0L.3$X/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I M=CXR-#4L,3(S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P M,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^ M(#QD:78^-38S+#4R-#PO9&EV/B`\+W1D/B`\=&0@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^06-C6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@ M,&EN(#!P=#L@5$585"U)3D1%3E0Z(#(Y+C=P="<^(#QF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T M>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[1D].5"U325I%.B`Q,'!T.R!-05)'24XZ(#!I M;B`P:6X@,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I M9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/D1E8V5M8F5R)B,Q-C`[,S$L M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#3PO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E. M1RU224=(5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@0D]21$52+51/4#H@(S`P,#`P,"`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\+W1R/B`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`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^ M,2PP,3,L.3`Y/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=( M5#H@-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXU,3,L-S0S/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52+4)/5%1/ M33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD:78^,2PP-S4L-3DQ/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@ M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C M-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P M8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG(#QD:78@6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q M+CEP=#L@34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@1D].5"U325I% M.B`Q,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A"!S;VQI9#L@34%21TE..B`P:6X[(%=) M1%1(.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/ M5SH@=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`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`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6UE;G1S(&EN8VQU9&EN M9R!I;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$R)3X@/&1I=CXQ+#,X-RPQ,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXQ+#0R,2PT,C`\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I M=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^,C(L,#@W+#$Q,CPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F M9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@U+#DW-BPP M,S`I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,3(E/B`\9&EV/B@V+#@Y,RPQ.#,I/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,B4^(#QD:78^,38L,#8T+#`V-#PO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y' M+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)W=I9'1H.C$P,"4[ M('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@ M,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@ M,'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[($)/4D1%4BU# M3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E M(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A M;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$R)3X@/&1I=CXQ,2PS-3<\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXT-RPW,C<\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$R)3X@/&1I=CXU,"PV-S`\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I M=CXQ+#6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXV+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U! M3$E'3CH@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^(#QD:78^ M,C(L,#@W+#$Q,CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@ M/"]D:78^(#PO9&EV/B`\=&%B;&4@8F]R9&5R/3-$,"`@&5D.R<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T2!087EM96YT#L@1D].5#H@,3!P="!4 M:6UE6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<^5&AE(&9O;&QO=VEN9R!I6UE;G1S(&%S(&]F M(%-E<'1E;6)E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5. M5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V M8V4@,'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[($)/4D1% M4BU#3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B M-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$R)3X@/&1I=CXQ.36QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$ M24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)W=I9'1H.C$P M,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@ M8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M06-T:79I='D@=6YD97(@;W5R('-T;V-K(&]P=&EO;B!P;&%N6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!72414 M2#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]-.B`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`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!C96YT97([($9/3E0M4U193$4Z(&YO&5R8VES928C,38P.U!R:6-E/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!4 M15A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!C96YT97([($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@ M8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$ M24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#@E/B`\9&EV/C,L,S,Q+#(U,#PO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P M)3X@/&1I=CXP+C8S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+C$Y/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXP+C`V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$ M,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXQ+C6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR M+C`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`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0X)3X@/&1I=CXW M+#8S."PW.#4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M&5R8VES86)L92!A="!397!T96UB97(@,S`\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T'0^)R`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%21TE..B`P:6X@,&EN(#!P="<^(#QF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO M9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I M;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN M(#!P=#L@1D].5"U325I%.B`Q,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A"!S;VQI9#L@ M34%21TE..B`P:6X[(%=)1%1(.B`W-24[($)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,B4^ M(#QD:78^-#4V+#DP,#PO9&EV/B`\+W1D/B`\=&0@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)R`\ M9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE M=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4 M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[(%=)1%1(.B`Q M,#`E.R!415A4+4E.1$5.5#H@,&EN)SX@/'1A8FQE('-T>6QE/3-$)T]615)& M3$]7.B!V:7-I8FQE.R!"3U)$15(M5$]0.B`C.65B-F-E(#!P>"!S;VQI9#L@ M0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4-/3$Q! M4%-%.B!C;VQL87!S93L@0D]21$52+4)/5%1/33H@(SEE8C9C92`P<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#8Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3(E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@&5R8VES93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z M(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W M:61T:#TS1#8Q)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P M,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T M:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P M86X],T0R/B`\9&EV/E-H87)E6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@ M(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@"<@=VED=&@] M,T0Q,B4^(#QD:78^-RPS,C$L-C8W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@ M;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C M,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@ M-7!X)R!W:61T:#TS1#$R)3X@/&1I=CXR+C`P/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P M,"`Q<'@@"<@=VED=&@],T0Q,B4^(#QD M:78^,2XV,SPO9&EV/B`\+W1D/B`\=&0@#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^5&AE(&5S=&EM871E9"!F86ER('9A;'5E('=A"!S;VQI9#L@34%21TE..B`P:6X[ M($)/4D1%4BU,1494.B`C.65B-F-E(#!P>"!S;VQI9#L@5TE$5$@Z(#6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%, M24=..B!L969T)R!W:61T:#TS1#0X)3X@/&1I=CXF(S$V,#L\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!C96YT97(G('=I9'1H/3-$,3(E(&-O;'-P86X] M,T0R/B`\9&EV/C(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E' M2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T M)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@ M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@0D]2 M1$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=( M5#H@-7!X)R!W:61T:#TS1#$Q)3X@/&1I=CXQ+C4U/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L M93L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"<@ M=VED=&@],T0Q,24^(#QD:78^,"XS.#PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"<@=VED=&@],T0Q,24^(#QD:78^-"XQ-2!Y96%R6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#0X)3X@/&1I=CY$:79I9&5N M9"!Y:65L9#PO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B4\+V1I=CX@/"]T9#X@ M/"]T6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"<@=VED=&@],T0Q,24^(#QD:78^-C,\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U7 M14E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L M969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@ M"<@=VED=&@],T0Q,24^(#QD:78^-C(\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%# M2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)W=I9'1H.C$P,"4[ M('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\2!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@ M8VQA#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P M:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^5&AE(&9O;&QO=VEN9R!T86)L92!S=6UM87)I>F5S M(&]U"!S;VQI9#L@34%21TE..B`P:6X[($)/4D1%4BU,1494.B`C.65B-F-E(#!P M>"!S;VQI9#L@5TE$5$@Z(#DP)2<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#8Q)3X@ M/&1I=CXF(S$V,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E# M04PM04Q)1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV M/C(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q) M1TXZ(&UI9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R M;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!C96YT97(G('=I9'1H/3-$,3,E(&-O;'-P86X],T0R/B`\9&EV/C(P,3(\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI M9&1L93L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O M;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@1D]. M5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!S;VQI9#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"<@=VED=&@],T0Q,B4^(#QD:78^-"PS M-3(L,C$U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!4 M15A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&UI9&1L93L@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E, M13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D52 M5$E#04PM04Q)1TXZ(&UI9&1L93L@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D]. M5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=. M.B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L.R!415A4 M+4%,24=..B!L969T)R!W:61T:#TS1#$E/B`\9&EV/B8C,38P.SPO9&EV/B`\ M+W1D/B`\=&0@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,#L@1D].5"U35%E,13H@;F]R;6%L M.R!415A4+4%,24=..B!R:6=H=#L@4$%$1$E.1RU224=(5#H@-7!X)R!W:61T M:#TS1#$R)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q<'@@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@0D]21$52+4)/5%1/33H@(S`P,#`P,"`Q M<'@@"<@=VED M=&@],T0Q,B4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@5D525$E#04PM04Q)1TXZ(&)O M='1O;3L@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U714E'2%0Z(#0P,#L@ M1D].5"U35%E,13H@;F]R;6%L.R!415A4+4%,24=..B!L969T)R!W:61T:#TS M1#8Q)3X@/&1I=CY"86QA;F-E(&%T(%-E<'1E;6)E&5D.R<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO6UE;G1S(&9O'0^)R`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0@9FEV92!Y96%R6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#,Q+CEP=#L@34%21TE. M.B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T M>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA M;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P=#L@1D].5"U3 M25I%.B`Q,'!T)SX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R M)3X@/&1I=CXR-C,L,3,V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$R)3X@/&1I=CXX,C,L-S,P M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5)) M1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5? M-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG(#QD:78@6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!415A4+4E.1$5.5#H@,&EN.R!7 M24142#H@,3`P)2<^(#QT86)L92!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q%1E0Z(",Y96(V8V4@,'!X('-O M;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P,"4[($)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P"!S;VQI9#L@0D]21$52+5))1TA4.B`C.65B-F-E(#!P>"!S M;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS M1&QE9G0^(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S M;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXF(S$V M,#L\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,24@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=( M5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXM/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4 M:6UE2!R96-E:79E9"!I;B!396%!6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T M=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXM/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$P)3X@/&1I=CXW+#,T,2PU,C`\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO2!L:6%B:6QI='D@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U M9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B M9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P M.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E M9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P M.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%? M8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@ M8VAA2`Q+"`R,#$S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XY,2PW-#`\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!2979E M;G5E(%!E'0^)SQS<&%N/CPO6%L='D@3&EA8FEL M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#@P,"PP M,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@ M4&QA;G0@86YD($5Q=6EP;65N="P@57-E9G5L($QI9F4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)S<@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A M7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@ M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L6UE;G1S(&]F(%-T;V-K M($ES'0^)SQS<&%N/CPO2!-971H;V0@26YV97-T;65N=',@6TQI M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'1U M86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L M87-S/3-$=&@@8V]L'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C M8S`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`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y M+U=O'0O M:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4&QA;G0@86YD($5Q=6EP;65N M="!;3&EN92!)=&5M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA6EN9R!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N(&5X<&5N'!E;G-E.CPO'0^)SQS<&%N/CPO3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A M96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O M'0O:'1M M;#L@8VAA3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%? M8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@ M8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%L='D@<&%Y;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V M,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q M8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)U1H92!F86-I;&ET>2!A;&QO M=V5D(&)O2!!9W)E96UE;G0@=VET M:"!-:61#87`@=&\@86QL;W<@=&AE($-O;7!A;GD@=&\@8F]R2!A(#`N-24@8V]L;&%T97)A;"!M86YA M9V5M96YT(&9E92!O;B!T:&4@879E2!A;F0@,24@;V8@=&AE(&%V97)A9V4@=6YU6UE;G1S($1E2!O9B`Q M+C'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%L='D@;&EA8FEL M:71Y(')E;&%T960@=&\@9FEN86YC:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO2!297%U:7)E;65N="!!;6]U M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A9W)E960@=&\@<&%Y(&$@9F5E(&]F M("0T,#`L,#`P('=H96X@=&AE($-O;7!A;GD@<&%Y2!D:60@;F]T(&AI&5C=71I=F4@3V9F:6-E&-H M86YG92!F;W(@0F]A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@06UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XU+#`P,"PP,#`\'0^)SQS<&%N/CPO'0^ M)TQ)0D]2('!L=7,@,3(N,3,E+"!S=6)J96-T('1O(&$@3$E"3U(@9FQO;W(@ M'0^)SQS<&%N/CPO2!087EM96YT'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P M.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&5R8VES86)L92!A="!397!T96UB97(@,S`L M(%-H87)E&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V M,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q M8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D('5N9&5R(%-T;V-K($]P=&EO;B!0;&%N'0^)SQS<&%N/CPO2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!. M=6UB97(@;V8@4VAA'0^)SQS<&%N/CPO6UE M;G0@07=A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3:&%R92UB M87-E9"!087EM96YT($%W87)D+"!&86ER(%9A;'5E($%S'!E8W1E9"!497)M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)S8@>65A2!3:&%R92UB87-E9"!087EM96YT($%W M87)D+"!&86ER(%9A;'5E($%S'!E8W1E9"!6;VQA=&EL M:71Y(%)A=&4\+W1D/@T*("`@("`@("`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`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S2!3:&%R92!"87-E9"!087EM96YT($%W87)D($5Q M=6ET>2!);G-T'0^ M)SQS<&%N/CPO6UE;G0@07=A2!);G-T'0^)SQS<&%N/CPO65T(%)E8V]G;FEZ960L(%-H87)E+6)A M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y M-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969? M-68R,E\T865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO2`Q+"`R,#$S+"!3 M:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!0'!I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6EN9R!C;VUM;VX@'0^)S0@>65A3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U M9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P.3=B M9C4Y+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M2`Q+"`R,#$S+"!3:&%R97,\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO2`Q+"`R,#$S+"!3:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'1U86PI("A54T0@ M)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@ M8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D($=A:6X@3VX@5V%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E M9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T865A7V(P.#5?-C,P8V,P M.3=B9C4Y+U=O'0O:'1M;#L@8VAA2!O<&5R871I;F<@;&5A M'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO2!N;W1I8V4@9G)O;2!T:&4@3F5W(%EO2!'=6ED92!W:71H('-T;V-K:&]L9&5R2!O M9B!L97-S('1H86X@)#0L,#`P+#`P,"!A;F0@;F5T(&QO65A'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO2!L:6%B:6QI='D@'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2!R96-E:79E9"!I;B!396%!'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3:&%R92U"87-E9"!087EM96YT($%W87)D M+"!/<'1I;VYS+"!''0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3:&%R92UB87-E9"!0 M87EM96YT($%W87)D+"!!=V%R9"!697-T:6YG(%!E'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6UE;G0@07=A'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!O9B!$:7)E8W0@0V]S=',\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2!4'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X-5\V,S!C8S`Y-V)F-3D- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S,Q8S4U969?-68R,E\T M865A7V(P.#5?-C,P8V,P.3=B9C4Y+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M M;6EC&UL/@T*+2TM+2TM/5].97AT4&%R=%\W,S%C-35E9E\U9C(R7S1A96%?8C`X 2-5\V,S!C8S`Y-V)F-3DM+0T* ` end XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 108 319 1 false 43 0 false 5 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.bacterin.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.bacterin.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.bacterin.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.bacterin.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.bacterin.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 106 - Disclosure - Business Description and Summary of Significant Accounting Policies Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPolicies Business Description and Summary of Significant Accounting Policies false false R7.htm 107 - Disclosure - Equity Sheet http://www.bacterin.com/role/Equity Equity false false R8.htm 108 - Disclosure - Acquisition Sheet http://www.bacterin.com/role/Acquisition Acquisition false false R9.htm 109 - Disclosure - Inventories Sheet http://www.bacterin.com/role/Inventories Inventories false false R10.htm 110 - Disclosure - Property and Equipment, Net Sheet http://www.bacterin.com/role/PropertyAndEquipmentNet Property and Equipment, Net false false R11.htm 111 - Disclosure - Intangible Assets Sheet http://www.bacterin.com/role/IntangibleAssets Intangible Assets false false R12.htm 112 - Disclosure - Accrued Liabilities Sheet http://www.bacterin.com/role/AccruedLiabilities Accrued Liabilities false false R13.htm 113 - Disclosure - Long-term Debt Sheet http://www.bacterin.com/role/LongtermDebt Long-term Debt false false R14.htm 114 - Disclosure - Stock-Based Compensation Sheet http://www.bacterin.com/role/StockbasedCompensation Stock-Based Compensation false false R15.htm 115 - Disclosure - Warrants Sheet http://www.bacterin.com/role/Warrants Warrants false false R16.htm 116 - Disclosure - Commitments and Contingencies Sheet http://www.bacterin.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R17.htm 117 - Disclosure - Income Taxes Sheet http://www.bacterin.com/role/IncomeTaxes Income Taxes false false R18.htm 118 - Disclosure - Supplemental Disclosure of Cash Flow Information Sheet http://www.bacterin.com/role/SupplementalDisclosureOfCashFlowInformation Supplemental Disclosure of Cash Flow Information false false R19.htm 119 - Disclosure - Related Party Transactions Sheet http://www.bacterin.com/role/RelatedPartyTransactions Related Party Transactions false false R20.htm 120 - Disclosure - Subsequent Events Sheet http://www.bacterin.com/role/SubsequentEvents Subsequent Events false false R21.htm 121 - Disclosure - Business Description and Summary of Significant Accounting Policies (Policies) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies Business Description and Summary of Significant Accounting Policies (Policies) false false R22.htm 122 - Disclosure - Business Description and Summary of Significant Accounting Policies (Tables) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables Business Description and Summary of Significant Accounting Policies (Tables) false false R23.htm 123 - Disclosure - Inventories (Tables) Sheet http://www.bacterin.com/role/InventoriesTables Inventories (Tables) false false R24.htm 124 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.bacterin.com/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) false false R25.htm 125 - Disclosure - Intangible Assets (Tables) Sheet http://www.bacterin.com/role/IntangibleAssetsTables Intangible Assets (Tables) false false R26.htm 126 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.bacterin.com/role/AccruedLiabilitiesTables Accrued Liabilities (Tables) false false R27.htm 127 - Disclosure - Long-term Debt (Tables) Sheet http://www.bacterin.com/role/LongtermDebtTables Long-term Debt (Tables) false false R28.htm 128 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.bacterin.com/role/StockbasedCompensationTables Stock-Based Compensation (Tables) false false R29.htm 129 - Disclosure - Warrants (Tables) Sheet http://www.bacterin.com/role/WarrantsTables Warrants (Tables) false false R30.htm 130 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.bacterin.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R31.htm 131 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) Sheet http://www.bacterin.com/role/SupplementalDisclosureOfCashFlowInformationTables Supplemental Disclosure of Cash Flow Information (Tables) false false R32.htm 132 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetails Business Description and Summary of Significant Accounting Policies (Details) false false R33.htm 133 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 1) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetails1 Business Description and Summary of Significant Accounting Policies (Details 1) false false R34.htm 134 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 2) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetails2 Business Description and Summary of Significant Accounting Policies (Details 2) false false R35.htm 135 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 3) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetails3 Business Description and Summary of Significant Accounting Policies (Details 3) false false R36.htm 136 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details 4) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetails4 Business Description and Summary of Significant Accounting Policies (Details 4) false false R37.htm 137 - Disclosure - Business Description and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.bacterin.com/role/BusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual Business Description and Summary of Significant Accounting Policies (Details Textual) false false R38.htm 138 - Disclosure - Equity (Details Textual) Sheet http://www.bacterin.com/role/EquityDetailsTextual Equity (Details Textual) false false R39.htm 139 - Disclosure - Acquisition (Details Textual) Sheet http://www.bacterin.com/role/AcquisitionDetailsTextual Acquisition (Details Textual) false false R40.htm 140 - Disclosure - Inventories (Details) Sheet http://www.bacterin.com/role/InventoriesDetails Inventories (Details) false false R41.htm 141 - Disclosure - Property and Equipment, Net (Details) Sheet http://www.bacterin.com/role/PropertyAndEquipmentNetDetails Property and Equipment, Net (Details) false false R42.htm 142 - Disclosure - Property and Equipment, Net (Details Textual) Sheet http://www.bacterin.com/role/PropertyAndEquipmentNetDetailsTextual Property and Equipment, Net (Details Textual) false false R43.htm 143 - Disclosure - Intangible Assets (Details) Sheet http://www.bacterin.com/role/IntangibleAssetsDetails Intangible Assets (Details) false false R44.htm 144 - Disclosure - Accrued Liabilities (Details) Sheet http://www.bacterin.com/role/AccruedLiabilitiesDetails Accrued Liabilities (Details) false false R45.htm 145 - Disclosure - Long-term Debt (Details) Sheet http://www.bacterin.com/role/LongtermDebtDetails Long-term Debt (Details) false false R46.htm 146 - Disclosure - Long-term Debt (Details 1) Sheet http://www.bacterin.com/role/LongtermDebtDetails1 Long-term Debt (Details 1) false false R47.htm 147 - Disclosure - Long-term Debt (Details 2) Sheet http://www.bacterin.com/role/LongtermDebtDetails2 Long-term Debt (Details 2) false false R48.htm 148 - Disclosure - Long-term Debt (Details Textual) Sheet http://www.bacterin.com/role/LongtermDebtDetailsTextual Long-term Debt (Details Textual) false false R49.htm 149 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.bacterin.com/role/StockbasedCompensationDetails Stock-Based Compensation (Details) false false R50.htm 150 - Disclosure - Stock-Based Compensation (Details 1) Sheet http://www.bacterin.com/role/StockbasedCompensationDetails1 Stock-Based Compensation (Details 1) false false R51.htm 151 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://www.bacterin.com/role/StockbasedCompensationDetailsTextual Stock-Based Compensation (Details Textual) false false R52.htm 152 - Disclosure - Warrants (Details) Sheet http://www.bacterin.com/role/WarrantsDetails Warrants (Details) false false R53.htm 153 - Disclosure - Warrants (Details 1) Sheet http://www.bacterin.com/role/WarrantsDetails1 Warrants (Details 1) false false R54.htm 154 - Disclosure - Warrants (Details 2) Sheet http://www.bacterin.com/role/WarrantsDetails2 Warrants (Details 2) false false R55.htm 155 - Disclosure - Warrants (Details Textual) Sheet http://www.bacterin.com/role/WarrantsDetailsTextual Warrants (Details Textual) false false R56.htm 156 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.bacterin.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R57.htm 157 - Disclosure - Commitments and Contingencies (Details Textual) Sheet http://www.bacterin.com/role/CommitmentsAndContingenciesDetailsTextual Commitments and Contingencies (Details Textual) false false R58.htm 158 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) Sheet http://www.bacterin.com/role/SupplementalDisclosureOfCashFlowInformationDetails Supplemental Disclosure of Cash Flow Information (Details) false false R59.htm 159 - Disclosure - Related Party Transactions (Details Textual) Sheet http://www.bacterin.com/role/RelatedPartyTransactionsDetailsTextual Related Party Transactions (Details Textual) false false R60.htm 160 - Disclosure - Subsequent Events (Details Textual) Sheet http://www.bacterin.com/role/SubsequentEventsDetailsTextual Subsequent Events (Details Textual) false false All Reports Book All Reports Element bone_ForfeitureRate had a mix of decimals attribute values: 3 4. 'Monetary' elements on report '138 - Disclosure - Equity (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '148 - Disclosure - Long-term Debt (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Process Flow-Through: 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS bone-20130930.xml bone-20130930.xsd bone-20130930_cal.xml bone-20130930_def.xml bone-20130930_lab.xml bone-20130930_pre.xml true true XML 46 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details 1)
9 Months Ended
Sep. 30, 2013
Restricted stock award activity [Line Items]  
Outstanding at Jan. 1, 2013, Shares 733,900
Awarded, Shares 0
Cancelled, Shares (112,500)
Vested, Shares (164,500)
Outstanding at September 30, 2013, Shares 456,900
XML 47 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Debt Instrument [Line Items]    
Loan Payable $ 22,087,112 $ 21,421,420
Less: Current portion (47,018) (45,135)
Debt discount (5,976,030) (6,893,183)
Long-term debt 16,064,064 14,483,102
Ros Acquisition Offshore [Member]
   
Debt Instrument [Line Items]    
Loan Payable 20,000,000 20,000,000
Amendment To Credit Agreement Adjustment Fee Payable 700,000 0
Midcap and Silicon Valley Bank [Member]
   
Debt Instrument [Line Items]    
Loan Payable $ 1,387,112 $ 1,421,420
XML 48 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] (USD $)
Sep. 30, 2013
Dec. 31, 2012
Trade accounts receivable, allowance for doubtful accounts (in dollars) $ 1,297,335 $ 1,576,955
Preferred stock, par value (in dollars per share) $ 0.000001 $ 0.000001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in dollars per share) $ 0.000001 $ 0.000001
Common stock, shares authorized 95,000,000 95,000,000
Common stock, shares issued 51,781,044 42,877,770
Common Stock, shares outstanding 51,781,044 42,877,770
XML 49 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
(9)           Stock-Based Compensation
 
Our Equity Incentive Plan ("The Plan") provides for stock awards, including options and performance stock awards, to be granted to employees, consultants, independent contractors, officers and directors. The purpose of the Plan is to enable us to attract, retain and motivate key employees, directors and consultants, by providing them with stock options and restricted stock grants. Stock options granted under the Plan may be either incentive stock options to employees, as defined in Section 422A of the Internal Revenue Code of 1986, or non-qualified stock options. The Plan is administered by the compensation committee of our Board of Directors. The administrator of the Plan has the power to determine the terms of any stock options granted under the Plan, including the exercise price, the number of shares subject to the stock option and conditions of exercise. Stock options granted under the Plan are generally not transferable, vest in installments over the requisite service period and are exercisable during the stated contractual term of the option only by such optionee. The exercise price of all incentive stock options granted under the Plan must be at least equal to the fair market value of the shares of common stock on the date of the grant. Nine million shares are authorized under the Plan and at September 30, 2013, we had approximately 622,648 shares available for issuance. Shares issued under the Plan may be authorized, but unissued, or reacquired shares.
 
Stock compensation expense recognized in the statement of operations for the nine months ended September 30, 2013 and 2012 is based on awards ultimately expected to vest and reflects an estimate of awards that will be forfeited. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
The estimated fair value of stock options granted is done using the Black-Sholes-Merton method applied to individual grants. The Company utilizes historical employee termination behavior to determine the estimated forfeiture rates. If the actual forfeitures differ from those estimated by management, adjustments to compensation expense will be made in future periods. Assumed forfeiture rates range from 17.00% to 20.00% for the first nine months of 2013.
 
Key assumptions used to estimate the fair value of stock awards are as follows:
 
Risk-Free Rate: The risk-free rate is determined by reference to U.S. Treasury yields at or near the time of grant for time periods similar to the expected term of the award. We used a weighted-average rate of 1.68% for the nine months ended September 30, 2013.
 
Expected Term: We do not have adequate history to estimate an expected term of stock-based awards, and accordingly, we use the short-cut method as prescribed by Staff Accounting Bulletin 107 to determine an expected term. We used a weighted-average expected term of 6.4 years for the nine months ended September 30, 2013.
 
Volatility: We estimate expected volatility based on peer-companies as prescribed by ASC 718. We used a weighted-average volatility rate of 62.6% for the nine months ended September 30, 2013.
 
Dividend Yield: The dividend yield assumption is based on our history and expectation of dividend payouts and was 0% for the nine months ended September 30, 2013.
 
Activity under our stock option plans was as follows:
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
Weighted
 
Average Fair
 
 
 
 
 
 
Average
 
Value at Grant
 
 
 
 
Average
 
Value at Grant
 
 
 
Shares
 
Exercise Price
 
Date
 
Shares
 
Exercise Price
 
Date
 
Outstanding at January 1
 
 
5,266,535
 
$
2.02
 
$
1.03
 
 
4,828,910
 
$
2.14
 
$
1.01
 
Granted
 
 
3,331,250
 
 
0.63
 
 
0.53
 
 
1,105,000
 
 
2.00
 
 
1.19
 
Exercised
 
 
(230,000)
 
 
0.10
 
 
0.06
 
 
(39,375)
 
 
0.87
 
 
0.37
 
Cancelled or expired
 
 
(729,000)
 
 
1.78
 
 
0.90
 
 
(1,152,250)
 
 
2.01
 
 
0.78
 
Outstanding at September 30
 
 
7,638,785
 
$
1.49
 
$
0.86
 
 
4,742,285
 
$
2.11
 
$
1.04
 
Exercisable at September 30
 
 
2,531,534
 
$
2.03
 
$
0.98
 
 
2,242,118
 
$
1.77
 
$
0.76
 
 
The aggregate intrinsic value of options outstanding as of September 30, 2013 is $799,941. The aggregate intrinsic value of exercisable options as of September 30, 2013 is $132,766. As of September 30, 2013, there were 5,107,251 unvested options with a weighted average fair value at the grant date of $0.80 per option. As of September 30, 2013, compensation expense related to nonvested awards not yet recognized was $667,175.
 
In addition, on May 24, 2013, the Company issued 335,000 restricted stock awards to certain employees. These restricted shares vest after one year and were issued when the stock price was $0.68 per share. The total expense of $227,800 is recognized ratably over the vesting period in General and Administrative and Sales and Marketing Expenses.
 
From time to time we may grant stock options and restricted stock grants to consultants. We account for consultant stock options in accordance with ASC 505-50. Consulting expense for the grant of stock options to consultants is determined based on the estimated fair value of the stock options at the measurement date as defined in ASC 505-50 and is recognized over the vesting period.
 
The following table summarizes restricted stock award activity during the period ended September 30, 2013:
 
 
 
Shares
 
Outstanding at Jan. 1, 2013
 
 
733,900
 
Awarded
 
 
-
 
Cancelled
 
 
(112,500)
 
Vested
 
 
(164,500)
 
Outstanding at September 30, 2013
 
 
456,900
 
 
The restricted stock awards generally vest over three to five year periods. The Company recognized reduction of non-cash consulting expense of $11,924 for the first nine months of 2013 and expense of $491,051 for the nine months ended September 30, 2012. As of September 30, 2013, the total expense related to nonvested restricted stock awards not yet recognized is $160,021 and is expected to be recognized over three years.
XML 50 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net income (loss) $ (8,528,883) $ (2,835,635)
Noncash adjustments:    
Depreciation and amortization 586,771 577,145
Amortization of debt discount 917,153 228,505
Write-off of debt discount 0 139,228
Non-cash consulting expense/stock option expense 603,058 1,114,846
Warrants issued for services 0 342,485
Non-cash interest (78,408) 50,659
Provision for losses on accounts receivable and inventory 1,197,669 136,637
(Gain) loss on disposal of assets (500) 7,902
Change in derivative warrant liability (246,337) (1,393,155)
Reduction of contingent liability (91,740) (358,426)
Changes in operating assets and liabilities:    
Accounts receivable 970,971 (237,841)
Inventories 265,396 (5,092,496)
Prepaid and other assets 291,375 (957,628)
Accounts payable (635,973) 1,316,973
Accrued liabilities (428,751) (848,488)
Net cash used in operating activities (5,178,199) (7,809,289)
Investing activities:    
Purchases of property and equipment (633,393) (1,216,723)
Intangible asset additions (10,149) 0
Net cash used in investing activities (643,542) (1,216,723)
Financing activities:    
Proceeds from the issuance of long-term debt 0 22,741,719
Payments on long-term debt (34,308) (9,773,075)
Payments on capital leases (110,045) (21,085)
Net proceeds from issuance of stock 4,450,002 3,899,996
Proceeds from exercise of options 27,575 43,334
Net cash provided by financing activities 4,333,224 16,890,889
Net change in cash and cash equivalents (1,488,517) 7,864,877
Cash and cash equivalents at beginning of period 4,926,066 751,111
Cash and cash equivalents at end of period $ 3,437,549 $ 8,615,988
XML 51 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Disclosure of Cash Flow Information (Details) (USD $)
3 Months Ended 9 Months Ended
Jun. 30, 2013
Sep. 30, 2013
Sep. 30, 2012
Supplemental disclosure of cash flow information      
Interest   $ 3,436,006 $ 815,031
Income taxes   0 0
Non-cash activities:      
Net shares issued for non-cash consulting expense   157,561 0
Capital lease acquisition   0 408,257
Issuance of warrants 1,485,313 0 220,872
Non-cash accrued compensation   0 304,680
Debt discount related to financing   0 7,341,520
Royalty liability related to financing   0 7,341,520
SeaArk Capital, LLC [Member]
     
Non-cash activities:      
Settlement of SeaArk accounts receivable   1,829,647 0
Inventory received in SeaArk settlement   409,838 0
Write-off of SeaArk allowance for doubtful accounts   1,419,809 0
Ros Acquisition Offshore [Member]
     
Non-cash activities:      
ROS adjustment fee   $ 700,000 $ 0
XML 52 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 3,437,549 $ 4,926,066
Trade accounts receivable, net of allowance for doubtful accounts of $1,297,335 and $1,576,955, respectively 4,633,067 7,154,065
Inventories, net 13,228,383 13,141,421
Prepaid and other current assets 486,685 353,271
Total current assets 21,785,684 25,574,823
Non-current inventories 1,238,225 1,238,225
Property and equipment, net 5,320,992 5,234,867
Intangible assets, net 563,524 592,378
Goodwill 728,618 728,618
Other assets 1,401,854 1,126,643
Total Assets 31,038,897 34,495,554
LIABILITIES & STOCKHOLDERS' (DEFICIT) EQUITY    
Accounts payable 3,225,377 3,997,789
Accounts payable - related party 555,361 418,922
Accrued liabilities 1,814,472 2,400,090
Warrant derivative liability 2,223,332 984,356
Current portion of capital lease obligations 165,844 149,729
Current portion of royalty liability 820,500 698,408
Current portion of long-term debt 47,018 45,135
Total current liabilities 8,851,904 8,694,429
Long-term Liabilities:    
Capital lease obligation, less current portion 119,543 245,703
Long term royalty liability, less current portion 6,639,435 6,839,935
Long-term debt, less current portion 16,064,064 14,483,102
Total Liabilities 31,674,946 30,263,169
Commitments and Contingencies      
Stockholders' Equity    
Preferred stock, $.000001 par value; 5,000,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $.000001 par value; 95,000,000 shares authorized; 51,781,044 shares issued and outstanding as of September 30, 2013 and 42,877,770 shares issued and outstanding as of December 31, 2012 52 43
Additional paid-in capital 55,558,330 51,897,890
Accumulated deficit (56,194,431) (47,665,548)
Total Stockholders’ (Deficit) Equity (636,049) 4,232,385
Total Liabilities & Stockholders’ (Deficit) Equity $ 31,038,897 $ 34,495,554
XML 53 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details Textual) (USD $)
1 Months Ended 9 Months Ended
May 24, 2013
Sep. 30, 2013
Sep. 30, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant   622,648  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   1.68%  
Granted, Weighted Average Fair Value At Grant Date   $ 0.53 $ 1.19
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options   $ 667,175  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   6 years 4 months 24 days  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate   62.60%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%  
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period   0  
Maximum [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Forfeiture Rate   20.00%  
Minimum [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Forfeiture Rate   17.00%  
Employee Stock Option [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value   799,941  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value   132,766  
Share Based Compensation Arrangements By Share Based Payment Award Options Unvested Options   5,107,251  
Granted, Weighted Average Fair Value At Grant Date   $ 0.80  
Restricted Stock [Member]
     
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]      
Allocated Share-based Compensation Expense   11,924 491,051
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Minimum Vesting Period   3 years  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Maximum Vesting Period   5 years  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options   160,021  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vesting Period 1 year    
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Grants In Period 335,000    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options $ 227,800    
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issue Price On Grand Date $ 0.68    
XML 54 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Tables)
9 Months Ended
Sep. 30, 2013
Other Equity Transactions [Abstract]  
Schedule Of Warrant Activity [Table Text Block]
The following table summarizes our warrant activities for the nine months ended September 30, 2013:
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Average
 
 
 
 
 
 
Exercise
 
 
 
Shares
 
Price
 
Outstanding at January 1, 2013
 
 
7,321,667
 
$
2.20
 
Issued
 
 
4,352,215
 
 
0.72
 
Exercised
 
 
-
 
 
-
 
Expired
 
 
(533,173)
 
 
2.00
 
Outstanding at September 30, 2013
 
 
11,140,709
 
$
1.63
 
Schedule Of Warrant Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following weighted-average assumptions:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
 
2012
 
Value of underlying common stock (per share)
 
$
0.68
 
 
$
1.55
 
Risk free interest rate
 
 
0.72
%
 
 
0.38
%
Term to expiration/implied expected life
 
 
5.96 years
 
 
 
4.15 years
 
Dividend yield
 
 
0
%
 
 
0
%
Volatility
 
 
63
%
 
 
62
%
Schedule Of Warrants Activities Used In Derivative Liability [Table Text Block]
The following table summarizes our activities related to number of warrants used in the derivative liability for the nine months ended September 30, 2013 and 2012:
 
 
 
2013
 
2012
 
Balance at January 1
 
 
1,649,707
 
 
1,506,007
 
Derivative warrants issued
 
 
4,352,215
 
 
143,700
 
Derivative warrants exercised
 
 
-
 
 
-
 
Balance at September 30
 
 
6,001,922
 
 
1,649,707
XML 55 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventories (Tables)
9 Months Ended
Sep. 30, 2013
Inventory Disclosure [Abstract]  
Schedule Of Inventory [Table Text Block]
Inventories consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Current inventories
 
 
 
 
 
 
 
Raw materials
 
$
2,223,978
 
$
1,919,250
 
Work in process
 
 
4,176,764
 
 
4,991,032
 
Finished goods
 
 
8,004,314
 
 
7,350,332
 
 
 
 
14,405,056
 
 
14,260,614
 
Reserve
 
 
(1,176,673)
 
 
(1,119,193)
 
Current inventories, total
 
$
13,228,383
 
$
13,141,421
 
Non-current inventories
 
 
 
 
 
 
 
Finished goods
 
$
1,238,225
 
$
1,238,225
 
Non-current inventories, total
 
$
1,238,225
 
$
1,238,225
 
Total inventories
 
$
14,466,608
 
$
14,379,646
 
XML 56 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Liabilities (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Accrued Liabilities [Line Items]    
Acquisition contingent liability $ 0 $ 91,740
Accrued stock compensation 171,174 218,850
Wages/commissions payable 1,129,555 1,013,909
Other accrued expenses 513,743 1,075,591
Accrued Liabilities Current $ 1,814,472 $ 2,400,090
XML 57 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details 2)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Class of Warrant or Right [Line Items]    
Outstanding at January 1, 2013, Shares 7,321,667  
Derivative warrants issued 4,352,215  
Outstanding at Sep 30, 2013, Shares 11,140,709  
Warrant Derivative Liability [Member]
   
Class of Warrant or Right [Line Items]    
Outstanding at January 1, 2013, Shares 1,649,707 1,506,007
Derivative warrants issued 4,352,215 143,700
Derivative warrants exercised 0 0
Outstanding at Sep 30, 2013, Shares 6,001,922 1,649,707
XML 58 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisition (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2013
Business Acquisition [Line Items]  
Business Acquisition Gross Revenue Achievement Period 2 years
Gross Revenue Equals Or Exceeds One Million [Member]
 
Business Acquisition [Line Items]  
Business Acquisition Additional Equity Interest Issued Or Issuable Value Assigned $ 500,000
Business Acquisition Gross Revenue 1,000,000
Gross Revenue Equals Or Exceeds Two Million [Member]
 
Business Acquisition [Line Items]  
Business Acquisition Additional Equity Interest Issued Or Issuable Value Assigned 500,000
Business Acquisition Gross Revenue $ 2,000,000
XML 59 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details 3) (USD $)
Sep. 30, 2013
Dec. 31, 2012
fair value on a recurring basis [Line Items]    
Acquisition contingent consideration liability $ 0 $ 91,740
Fair Value, Inputs, Level 1 [Member]
   
fair value on a recurring basis [Line Items]    
Acquisition contingent consideration liability 0 0
Fair Value, Inputs, Level 2 [Member]
   
fair value on a recurring basis [Line Items]    
Acquisition contingent consideration liability 0 0
Fair Value, Inputs, Level 3 [Member]
   
fair value on a recurring basis [Line Items]    
Acquisition contingent consideration liability $ 0 $ 91,740
XML 60 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details 4) (Fair Value, Inputs, Level 3 [Member], USD $)
9 Months Ended
Sep. 30, 2013
Warrant Derivative Liabilities [Member]
 
fair value on a recurring basis [Line Items]  
Balance at January 1, 2013 $ 984,356
Gain recognized in earnings (246,337)
New warrants issued 1,485,313
Balance at September 30, 2013 2,223,332
Acquisition Contingent Consideration Liability [Member]
 
fair value on a recurring basis [Line Items]  
Balance at January 1, 2013 91,740
Gain recognized in earnings (91,740)
Balance at September 30, 2013 $ 0
XML 61 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Long-term Debt [Text Block]
(8)          Long-term Debt
 
On April 23, 2012, the Company secured an accounts receivable credit facility with Midcap Financial LLC and Silicon Valley Bank. The revolving loan credit facility allowed Bacterin to borrow up to $5 million through January 1, 2015. The facility allowed borrowings based upon a predetermined formula of up to 80% of Bacterin's eligible accounts receivable, as defined in the credit and security agreement. The Company also amended its existing Loan and Security Agreement with MidCap to allow the Company to borrow up to an additional $3 million in connection with a permitted acquisition. The credit facility carried an interest rate of LIBOR plus 4%, subject to a LIBOR floor rate of 2.5%. The Company also agreed to pay a 0.5% collateral management fee on the average outstanding balance of the facility and 1% of the average unused portion of the facility, as well as a 1% origination fee. We repaid the outstanding balance owed on this credit facility in full with the proceeds from our credit facility with ROS Acquisition Offshore LP (“ROS”) on August 24, 2012.
 
On August 24, 2012, the Company entered into a Credit Agreement with ROS, whereby ROS agreed to provide an initial $20 million term loan and Bacterin may also borrow an additional $5 million upon achievement of certain revenue objectives prior to December 31, 2013. The loan carries an interest rate of LIBOR plus 12.13%, subject to a LIBOR floor rate of 1.0%. Bacterin also agreed to pay a royalty of 1.75% on the first $45,000,000 of net sales, plus 1.0% of net sales in excess of $45,000,000 for each of the next ten years. Bacterin has the right to repay the loan and royalty interest at amounts to be determined based on the date of repayment and the amount of prior principal, interest and royalty payments. The loan is secured by substantially all of our assets. The estimate of the royalty component of the facility over the life of the agreement resulted in a debt discount and a royalty liability of $7,341,520. The debt discount will be amortized to interest expense over the seven year term of the loan using the effective interest method. The royalty liability will be accreted to $13.8 million through interest expense over the ten year term of the royalty agreement using the effective interest method. Payments made under the royalty agreement, per the table below, will directly reduce the royalty liability.
 
The Company received net proceeds of approximately $10 million following repayment of the existing term loan and accounts receivable credit facility with MidCap Financial, including prepayment penalties. The Company used the net proceeds for working capital and general corporate purposes.
 
On May 16, 2013, we entered into an amendment to our Credit Agreement with ROS, whereby ROS agreed to reduce our minimum liquidity requirement from $1,500,000 to $750,000 until September 30, 2013. In exchange, we agreed to pay a fee of $300,000 required to be paid pursuant to the Credit Agreement or other loan documents which is recorded in Long-term debt and in Other long term assets which will be amortized to interest expense over the term of the debt.
 
There were two compliance violations of covenants in the ROS Credit Agreement in the second quarter of 2013. The Company did not achieve the $8.5 million revenue in the second quarter of 2013 for which we received a waiver, in exchange, the Company agreed to pay a fee of $400,000 when the Company pays, prepays or is required to pay any principal amount of the loan. In addition, the Company did not hire a Chief Executive Officer within 90 days of the resignation of the prior Chief Executive Officer for which we received a waiver in exchange for Board observer rights.
 
Long-term debt consists of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
 
 
 
 
 
 
 
 
Loan payable to ROS Acquisition Offshore, LIBOR plus 12.13% maturing August 2019
 
$
20,000,000
 
$
20,000,000
 
Adjustment fee payable to ROS Acquisition Offshore August 2019
 
 
700,000
 
 
-
 
6.00% loan payable to Valley Bank of Belgrade, $10,746 monthly payments including interest, maturing December 24, 2030; secured by building
 
 
1,387,112
 
 
1,421,420
 
 
 
 
22,087,112
 
 
21,421,420
 
 
 
 
 
 
 
 
 
Less: Current portion
 
 
(47,018)
 
 
(45,135)
 
Debt discount
 
 
(5,976,030)
 
 
(6,893,183)
 
Long-term debt
 
$
16,064,064
 
$
14,483,102
 
 
The following is a summary of maturities due on the debt as of September 30, 2013:
 
Remainder of 2013
 
 
11,357
 
2014
 
 
47,727
 
2015
 
 
50,670
 
2016
 
 
1,720,463
 
2017
 
 
6,723,781
 
Thereafter
 
 
13,533,114
 
Total
 
$
22,087,112
 
 
The following is a summary of estimated future royalty payments as of September 30, 2013:
 
Remainder of 2013
 
 
197,000
 
2014
 
 
853,000
 
2015
 
 
1,050,000
 
2016
 
 
1,289,000
 
2017
 
 
1,384,000
 
Thereafter
 
 
8,477,000
 
Total
 
$
13,250,000
 
XML 62 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Future minimum payments for the next five years and thereafter as of September 30, 2013, under these leases, are as follows:
 
Remainder of 2013
 
$
61,599
 
2014
 
$
269,400
 
2015
 
$
263,136
 
2016
 
$
263,136
 
2017
 
$
263,136
 
Thereafter
 
$
823,730
 
Total
 
$
1,944,137
 
XML 63 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Property and Equipment, Net (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Property, Plant and Equipment [Line Items]    
Cost of Property Repairs and Maintenance $ 198,986 $ 204,947
Depreciation 530,020 516,162
Equipment [Member]
   
Property, Plant and Equipment [Line Items]    
Capital Leased Assets, Gross 549,603  
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation $ 142,307  
XML 64 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies
9 Months Ended
Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
(11)           Commitments and Contingencies
 
Operating Leases
 
We lease two office facilities under non-cancelable operating lease agreements with expiration dates in 2019 and 2023. We have the option to extend both the leases for another ten year term and for one facility, we have the right of first refusal on any sale. We lease an additional office facility under a month-to-month arrangement. Future minimum payments for the next five years and thereafter as of September 30, 2013, under these leases, are as follows:
 
Remainder of 2013
 
$
61,599
 
2014
 
$
269,400
 
2015
 
$
263,136
 
2016
 
$
263,136
 
2017
 
$
263,136
 
Thereafter
 
$
823,730
 
Total
 
$
1,944,137
 
 
Rent expense was $204,180 and $234,316 for the nine months ended September 30, 2013 and 2012, respectively. Rent expense is determined using the straight-line method of the minimum expected rent paid over the term of the agreement. We have no contingent rent agreements.
 
Indemnifications
 
Our arrangements generally include limited warranties and certain provisions for indemnifying customers against liabilities if our products or services infringe a third-party's intellectual property rights. To date, we have not incurred any material costs as a result of such warranties or indemnifications and have not accrued any liabilities related to such obligations in the accompanying financial statements.
 
We have also agreed to indemnify our directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by any of these persons in any action or proceeding to which any of those persons is, or is threatened to be, made a party by reason of the person's service as a director or officer, including any action by us, arising out of that person's services as our director or officer or that person's services provided to any other company or enterprise at our request.
 
Litigation
 
On January 29, 2013, we received two warning letters from the Food and Drug Administration (“FDA”): one related to our procedures to ensure compliance with regulatory requirements regarding the production of medical devices; and one related to our procedures to ensure compliance with regulatory requirements regarding the production of human tissue cellular products (H/TCP). We responded to both warning letters and, on April 17, 2013, we received two letters from FDA in which the agency stated that it was in receipt of our response letters and found that the corrective actions in those letters appeared to be adequate. The letters also stated, however, that the corrections would be further evaluated in conjunction with our operations during the next inspection of our facilities. FDA conducted two follow-up inspections as a result of the warning letters of our facilities in July 2013: one inspection focused on our production of medical devices and one inspection focused on our production of H/TCPs. At the conclusion of the inspection focused on medical devices, no Form 483 was issued. At the conclusion of the inspection focused on H/TCPs, FDA issued a one-item Form 483, to which we responded, and we are in the process of providing further updates to FDA. FDA also conducted a routine inspection focused on H/TCPs in July 2013 and issued two observations on a Form 483. We have fully responded to that Form 483. On September 19, 2013, we received a letter from FDA indicating that, based on a review of our corrective actions, it appears we have addressed the violations contained in the warning letter regarding our production of medical devices.
 
Market Exchange Notification
 
On May 13, 2013, we received a deficiency notice from the New York Stock Exchange (“Exchange”) notifying us that we are not in compliance with Section 1003(a)(iii) of the Company Guide with stockholders’ equity of less than $6,000,000 and net losses in five of our most recent fiscal years and Section 1003(a)(ii) with stockholders’ equity of less than $4,000,000 and net losses in three of our four most recent fiscal years. On June 12, 2013 we submitted a plan to regain compliance with the continued listing requirements, and on June 21, 2013 the Exchange informed us of the acceptance of our plan and gave us an extension until November 13, 2014 to regain compliance with the continued listing standards. We will be subject to periodic review by Exchange staff during the extension period and failure to make progress consistent with our Plan or to regain compliance with the continued listing standards by the end of the extension period could result in our delisting from the Exchange.
XML 65 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accrued Liabilities
9 Months Ended
Sep. 30, 2013
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
(7)           Accrued Liabilities
 
Accrued liabilities consist of the following:
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Acquisition contingent liability
 
$
-
 
$
91,740
 
Accrued stock compensation
 
 
171,174
 
 
218,850
 
Wages/commissions payable
 
 
1,129,555
 
 
1,013,909
 
Other accrued expenses
 
 
513,743
 
 
1,075,591
 
 
 
$
1,814,472
 
$
2,400,090
 
XML 66 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity
9 Months Ended
Sep. 30, 2013
Equity [Abstract]  
Stockholders Equity Note Disclosure [Text Block]
(2)           Equity
 
During the first quarter of 2012, we issued 1,475,037 shares of our common stock to Lincoln Park Capital for aggregate proceeds of $3,899,996. We used the proceeds for working capital and general corporate purposes.
 
On June 10, 2013, the Company issued approximately 8.51 million shares of common stock to new and existing investors at a price per share of $0.57, which represented a 10% discount to the closing price on June 4, 2013. For each common share purchased in the offering, investors received a warrant providing the right to purchase 0.5 shares of Bacterin common stock at an exercise price of $0.72, a 15% premium to the June 4, 2013 closing price. The warrants will be exercisable for seven years beginning 6 months from the date of issuance. The transaction resulted in net proceeds to Bacterin International of approximately $4.45 million, after deducting approximately $400,000 of placement agent’s fees and offering expenses. Proceeds from the transaction will be used to fund the Company's operations and working capital requirements.
XML 67 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Details) (USD $)
9 Months Ended
Sep. 30, 2013
warrant activity [Line Items]  
Outstanding at January 1, 2013, Shares 7,321,667
Issued, Shares 4,352,215
Exercised, Shares 0
Expired, Shares (533,173)
Outstanding at Sep 30, 2013, Shares 11,140,709
Outstanding at January 1, 2013, Weighted Average Exercise Price 2.20
Issued, Weighted Average Exercise Price $ 0.72
Exercised, Weighted Average Exercise Price $ 0
Expired, Weighted Average Exercise Price $ 2.00
Outstanding at Sep 30, 2013, Weighted Average Exercise Price 1.63
ZIP 68 0001144204-13-061887-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-13-061887-xbrl.zip M4$L#!!0````(`."";D,"(>>A6_P``'\9$``1`!P`8F]N92TR,#$S,#DS,"YX M;6Q55`D``S,_A5(S/X52=7@+``$$)0X```0Y`0``[%UK'`(-MLD9`-I,LY&_O?5R(?%B1(`I+,)$L3 M'=/N1'"/#D=7]PH]/OWU?10,WE"<^%'X^0`<*@<#%+J1YX[@<6@># MOW[Y]W_[])?A@CFU]Z?XL`_)O\_P+##Y/@I"M'G@]KYRQOHPL;1[.*R MZ,JC?\*L++!M^RB[NBR:^&4%\4/!T3^_7=^[KVCD#/TP29W0S6'Q&=B+Y?TD MTE1@LNZ8E5C)JG+4'NX4OT=C2_F+V9H0*&$"QOF\0Q%E[5??.KY$8U?Z.'_/)[\(42 M.^C=?2TO3ZZ4W."';RA)RV^972NY*71\-RF_)[M$;@'Y6Q+?+;\!7R@KGH[C MBO+X2LD-DV3XXCCCY3W/3O*4O=GYA9):O`<,_?SSFA+U)(T9LL%7#W#S'0P^ MD89PG&02OT//@ZQA'*?3,6[$B3\:!T2_V6^O,7K^?$":]W#1B@_?$^]@<(0? M-/,29U&8HO=T<(_<%#N?S$-@$S,?XC;H+XK7X8]^:WT)`HXXN? MYAS.G\TEUGZ$RB]'K#V$2L?$`O475"S^IUO%0DJQL(_$PB;$PNX4JU&N0'M4 M89\5JS5Q!=I0A5T22Q1K]%RQ]8G%-QD=*=;($0MZ3:S1C%C0";'F'D4%YBY% M!>8>=5[UB>VP\[(HQ5J/JM9GQ5I-%&L-5:T;8H&V+XJUAD#;%<6>)#=A[PB= M#5*E)`>PM,P`,`>R*F;XEDQ0SA:RP*V9`_Y@!G3+3NQ@NIYGV M?H8,-I[[(Q1FWSAJ##?F.KW'KRAZB9WQJ^^>1:&+ZQ,[Y$%W?O+C&QH]H7B2 MD''8E8NGTX?I&)V\^\F&Z2]VA^@%!C(^SCP73^=56/@+;CZ?#`? M6SYF5FI1B$O0IZ-2@Q\,')4AW;N1EM)!5RFOOLIK5X>>\][K;)*DT0C%4ERE MXN+0(ST7PW-):?506OWP6C?I*XJO0ASSO?A/`3I)$I0FM*PN_=!/T;7_AKQB ML=/I-^=_HO@L<)*DWS*K5?(#/_514O&X18GI/DQC8%V#A'J4HS#X>_@92<754ER1L5_>:4D)]4="/7):35=^]E=8M9;."Z_I M[*47*FA![J*PB[LH;$,)BV7-TCLP)5%!TZ^AC?OH.?WIQ*BP78U4"DLI3-+V M6S>7DSCTTTF,,%>7_COY*Y%B*1-+-5/[K9!KY"3H-0J\J]$XCMX0J8*42*E$ M&%3MMT9^1Z^^&TC/42Z+/#M[J`1J5IK,5G8\6]G84@^9I>S\&,;&M"`SU]YE MKAO7ALQ<]R)SW=Q20IFY]C-SW9A"9.;:V\QU8QJ1F>N.9ZX=KA8I/>KP\2Y* MJ-G5-\_/R6L4(UH?UU'X@OO>T3EZ2OLOB/+:S/9S8U"QI>_VNW:J8\7.I%)# M.ZRA79S[L3PG_/&;[[G.&'OF>Q]S$H6_.T&`IJ=.^..7U`^/CBUU2KDSSM<] ML"X[HYUU)'D1T+U*]_,0I6?84<^PR[U+A98^R+IY/D7!2^QXOZ9;J29"ZJ?L M2Z_4S>[H9AN?^F5$LKL1R<:^\DL1[*X(NATZE>'H[H>CV_`(4@R[+X:-;[RT MG^?0R4/?VDAB+T_AE$=>-EGD.!H'T12A^S1R?]R,T\(BVI.?3NSUOY,H5&,Y M_:^J\GL6)E2X`?GNM_ON=]E-,$Y[C'TW.Z`.\_;KR*6TXE(JG(/YI%2V+)7= M/H1/2F0[$ME,T*%3/8@^_Y@NW_E.N`7\UO4F/8C>S02NS"U(B6Q;(GFWH'J'+4<#0&D0#>0&+-?<[*4$ M]F3PV:22`',YC_(V.[`$W0:.BXI+#N\G3XGO^4X\O7<"=/.<^;Q^ONZ%`V=4 MZ6/J?QDCVTL/S";I@4G-NUQW'"#%L[OBR4^\-+N;?;OL%A3<+?C>"[J.G-S@ MY/UK%*_,5LZ(ZRRT+"AQLY8TKFUD.ICP2#B[]T`G=PAX6II1+[^32 MPUD:4F7]5MEN3_"0ZNJ=NC:_G%$ZH7[+1-WTO&7^PD>9HY?DZ+NQ2+*',9+4 MV[[H;<>BI0K_=H^7%30D^:)+>BZ&GRP@3=X_>4'CQY\0)ON%;7H/I%5K%\W^[/Z]XN)]$F@K,8URB^;,?<84? M[PG`@A7/?\-"*[X%+(BOOQ+)06$%/[I+\/A19`MI!W>*_W_00;ODD1JWB,X^`*4X3\^'16?M*@5^1WG M!*%'+EP&SDMM$^K!EV@I M"FI;,PZ^G-Y\OYC9RSV*MG&1]8)GT6@4A=D2\3E'R@(??D#6>K$,`C M@*L&S8,!:0Q9N7G'-/"0ZX^PK#X?7'V_//BB`U/3`#1FH/BV5Y'>H1<_28F7 M^.Z,Z@O/PJ3@OS#?X>`*WQJ'V=0X)QC\+_XZFM3'9^3BK\L&TY;-)'.=DV[0E`N7@RW"Q&('UY-5Z7_H!BL_PI9!">N&TW"-+E#+O+?G*<`S>NTJN0J;"HE91(#43K&?`'5-B'4/QTU0K'F M*GRL',M7`;*KH)N&K:^K"KD;XRFRCJ5LGOHGO4S*N\+L33!#V;EG#%J=? MRV.GPD2J%MB_*8<*^1_XJ(88DG7AK^)>WRK^F1<]F:2O4>S_"WGBO!L"'CQ# MK%0A+MINB[2*89&^9OU(K\B7I!I\6GR4''PSBVVP53%H;Q`;,YJHBD>5U@!+ M`HG&*"MH5$&7**G0J+535=7&3DD`QEJ05W$,MX2\L2-5-;XJ[!7_Q+#<"F05 MK?JF0=9TGZI(=P1,"RB:Q@!8[J;J93Q5",52'AY",0_0R,VK`EV0IEHF_A_K M):^#PRJ$`AV1`$(6AT[R>A)ZY%]D\YHW)\`A;'*2GCEQ/,7E,W<@C!OOLM,H$NJ88>C.`5^$;_A4GN;B(.&,:.\^#JFI!"WX@HJW40U!%BW9F\"YC2,<7Z?3V\`)4ZPKT@.,R5!U':^D ML?TXUK)BVRJMYFJC[0!6$X&$Q*; M?(TB[Z@7S+>]'KQ5Q+)[`]U6H6FUPUN?0W9'8*J6`2A, M]>U6<<%VZ:)V*<_>Q&.Q_3?0%&#IE()*K36$5,4+VYT#H!J&!FM"FET7ID5G M.W((%&A9MEGL4D2M5M1V3H?"7,-K0%K% M(F<01M--I0G2V7JF0EO%Q>I*SF0[?<.`MD8:`,=>8U@5M)EL/V]8.+*M`:NL M^3:0GHT:MFOHH+MS*&B&AA#N=-B3W:H]^W(9#ORRKD-I=^(A(!4$<)VXO6`4)\/ M:]+!=MU?AW&E3MPDS8['=+TZ3 M=0M".FCDVEX'V@H.+;97UG'B;%IV*[1W*'7\$'D73AR2B<78MT]&DRSW/D?/ M9+F2.+=L;SW4#8!#&$B-0O"-KP-N%;EL-S[43,/0=C_#4*/!0GLR-I MQ-EDN_:A`0V%_AR^:JH)F"JN.$&["E5(?Z7D@Z$Z@I/0:\,3V_6O#I'R++=' M6D4BY]OIRK!J7:2DF?OI*)L&$7K+_77=.A&%M=)UO"?^<>@'GP]2'/0=#(Y: M6:VB9J6SX%DEQP4F=V3M[@213Q+)RG>UY>F&-OQ6X8&5=M>.S"!52!L'Z]B_ZX`W>H,&8,RMCO'R%33TF$]9+,49SHO M55]?;!^N`MM4*<^4M]8("X,?M@M7H:'1$\):8!%0$<=G6[C;5=:*A<$+VRL3 M/=,]&QL+K:E&#HD=N)LV;O56A88Y#:N1&V+'\)9EVB8]CZP5')%58&Q_K6H6 MT`U8X7T:`ZKF!RAL/XT!Z992`]!9E*0WSYDW(CW^?,><>]SIUY82[KK8C0P" M"]+>I]IV:Y0L!CENVU`4+9^OKAVEB/`X\Q<5!0##ZI9,$3FR?;QA6I:A&$U0 M?HVC)+F-H^=B@B6D1,X41P.31X=9E+'Z.%CTL%V]H9HV!+`E#A$U\2:[8)]A MZV!-0%B$<*:X6(IA:_177!80%*+8";".3KR1'V9KD:;=$] M14V\]R@(<.**BW]SXA^()+'-ID5T(_I7]9P-I MLOL>&Z<85`_(,-T>)8M-7N*!O5?'*`6DJ7)F9RJ:22^&Z!0F@TR5,YU3PR.Q+!U6Z'' M5E9,-L7$HHJ3D2B&8=`S"5IC$A$69V:GHF:+A3L`Q2**DZG8V-6J6B-05Z$; MC=`U3FSJ:XJSS':H0LW4Z$&6$JO-@3'XXBRF5;'R0!E;;6`):(NS`G.V/`Y'=U'><39VCIS%N\#4Z1%4MO6U8&61R^M=3&BIN3BO M.[@B\N5][;`,8&P4+(M;=J@YBM&LW(/SCI*+]S1VHMCS0R>>7J5HE"UQP'?&438,N8A%ZJN: MLT1YJ$'3T&$N+.P,_?:)8NB!LZIZB--J&^KFGA,ET+HY"[^'EHZ#U/QF07M, M%$M1G+!"M2#9>6,K1,T7!"V?-'=EIRA$C>80<-:WTYNN,2VO!2?KG;##DL1!FM MP;"8X22Q*STY$\QB?=)B\^!3)_'=!MHI=!'E.QJK&)YR2.]H4&J^#486<68- MC$8'&$649HEC!%WP*")`NP:/9DN,YWXP28O;`XLHLKAXOJDBYP#:X62P65Q- MWU25K7`**+.XOKZI,M>"D\6GT-[J?'56X/P#^2^O^/>3-YP&O2Q/+5S9LKFA M'S4%]EG7<01A0$!]8*P%JHL:L=Z'P*;LFFK:ADIO8+2U&HFT!(%=W#7#``#2 MB]NV7B/6.Q+8]5U3H0;P:^JV1O-6Q]E\7:@E">P3+]R2JF!U4RO6FQ+:6UZP M-6VF5@(MRA(X&46X16VV5HQW90FB643E[ MM0K$&H&SW@%G5V0,6]/;`:>OX?>$GM)S/\EV\KR-TO/)P=2744SR?^P\PM4C'+#$EQNI-^"4N^.;:9"-G1H" MZJ8^K-?`F4`*#0.:K:NS>(G4G!@_&4>)/VL3Q7W$Z[\6SHX5N?TN!4&L%SOC M%7`VM1B:-CT%ICWZY6PDU5GBZU@TL5&-@W\$&<+#=QM:LJ\V;)-MT?)HI:S ME$ZW-#+3HP9,ZI-M3#:G/$>S?_\_>__:W+:1+([#[[OEPMT$0[4'5-*M*@IPUZA6$XZZ$H$?)5E%[3%;O5Z[=+!SS1\W,MC3:B M]9ID):/;:0VZJT#.O;X,6%=1=[65[&@#HUTBK'P\4'(DMG!,T-8$-]9T"3DU M!GJKUUF%Q"9P58K=<]2)@PL[ZY3F#!0E0KZ*X&O.1?NP=^JOE/;U MD..H.S,<4:??)O:[Z9\AGLZG!3[G`,K3KI1?8V=I)5V^D=OFP)2.QBHVK$D* MQM(HHU\*&K`PJ'=Y[Y];_\1.0.`9U%]ZVG7?8:QKMV+HW5Z^Z'TM"&7!O$IP M5AOB+G83*!7D%V]-C37]6G1-S[%>06]UW6/Z0_@/]V28*87W$PH/]Y_ M)X'EA#OD-1EK&LH8O4ZOLQCBA0"4!?$J*J^VAFWP]]HO@'B)[?S@>,">%[HC M:QK1(.B&T5YKQQ?`4CH6JQBP9CYXMS_0^AML<39`8_'@^L\D<'Q[=@.[`SO6 M;#GU-HZURK:<\@V=B1_(2J46>_BT/%(&%Z2T`H*!]N/MV??CC_>'7]G]?WSABL_"?RK-SZ M8]-[0_]V=_7_?_]:T;5)].;C^>WO5Y]>*_`9_GUG-[._*3/WJNP'50&$G:%R M\O\>HS>E@^%X[-\DRIX?1@'L2/`K?AL"N9+7S3R&WI)07,F1'._[!6],'O)+ M\9F_``H5H_-&N7___[L_O?IT^1X)W-+/!GD`JD^$/E'4@_")ZG4,7GF6Q\E_*'[V(J*(@E>"YGJF(" MWUWSV0S0H@<3G]5KP^^>K3CPI.>1[[I3Q7_V`(`P?@@=VS&#J;KD^=EC/Y$G MTS:+#WUEP<,(#1^[\`@$F3&J#UO8-Q<,[?07_8WB!_D+DE?FKOCY3#EW72`" M_(&337DP750^(<4A`K43FA8+"HS,)Z(\$.(IQ'7&0$VDJN/EJ`R7G2FS[]%[ M;T+EP?%=_]&Q0@5DAF9Q@0X$//P)T!+D(A["77'`7SNFO7?S=TU8Y#Q4(E^Q M_3'&%BU&Y0)_^(UG.0%./RV$"YX["1P2`5.4,8E&O@T0`#?CD.$VB@$XD$<` M(S"'[/WHJD;`<`*D"RUS.`2A8'##T\8^_`F5,?W!Q\-;)7)`HQ/E,?"?H]%" MV$!RP15/D&29R<:P?.!]"12_O8=NKKHB=Q_N<@QA/")>"-B MQ9#`%PQ]/Z)(FMXW-_>FPCWAMQBH-"*F2Z$#`?:?\9-'XL#GM]"'!.21=@:/ M./C?/)(G(8>.W@";M[-#Z*7%2G579553';MP%<%2!I]D?FE3!H+`)NU%Z2EC M"&(04*'VXQ`6G0T"[2:/R`NX9/*AF'P.:SNUR9P>J.73,`4Q@`G\DSJ+:'*;5@V0,*$F6- MJ+9*'X8.,Q6ML?D--:I//Z0_PUL>_#C"=_IQ@-8+KG@@5'%;U$[!=WQ=@@S5 M6YA#'%([#>\!H1RCX3M3T(T`B,9H$W)_`%$U00%QS0S@PZ_F(TEHXX$.=6CQ M-]I=UP]#]B1NESDN!-6V$CV#%7/P?,R*8'V``TGU:^)+HD&E?WW$GQ'LS!`B MX&RM9*84WO2'_PQK+E`5&PP-Q]49CTUTJ?EO/DI3/GHH,X-P!%$GP.DR)F8Z&=2]E(Q-UTFADSW MHABAF"?*-G$TU$PG9W(%.C;^/\&S>>SQ3[H`2SA`@`=0C8HT\)MP`F&D_4>=395>SU6(! MR6!9!8`]/>6GGKN*Z%$%`G_!P984R?R[4V^*NCD><,LR)UG6$]Z>OIM:I]BU M$0`2A.!?*^#7@:^=QQ;H/Z?="FL<+LBM87P%J1Z1L,D;B M@'*AF*!28&K'HLI`96HI00&N,%']LK?2OYMC'_4#]8[0>?:#$/<=G,[T'?@T MJD0"JFT"YR&F[M78MPGL-1P>?+79:S/BH>>7H_^C#S3QJ)YC>IRYGP@3O-EQ M42=R;9[(!:B6;X1,E'C"J%_D,GOV0D?X0QP@1FJ16.83O(8F!W)7VO8]P)<3 MF>Y+T$MGO$/Y!7HHZ(#&0(0WF;=KJC"A&L%RB40C^A@T/N2,3N/4!EDY+4Q4,>M$+,73'-E^> M"3LK?!UU%`)?:V`7RL?T,JF7X.[[/3E;Y MGQY]]%U$_0&`_1QT&*P,JDRF(-R*YT=I:`(>@%P/9%A%0A642)>#YL'/DV[?,Q5$+\)@VLIG?FG=7/)?N4SWTF=#ML.(@ MH$S%'G4J:&%0;R$Z5L-$?01(VA">Q,,'5YS]>?<1R9'"83.!$($?6$,SGJU M=7EF<(%?7Z(C0*\O7/GA*#&T8,N2<-3?L4=C5MSXC);<2W6#CVL0;0X!H\5$ M"$6.2SM]XL(][SE;3;?47T9C\P%D'D`^_;]4R!+Y@J?,BI?!'(?\8L5`/3HB M(6PDX`DLR!+13=6*E4N!92X?[#S,,!_)+#P63+_K_#=;$$RAF4F@)EI*8E4A MWU&WX,/!+8F%+Q&U^`^@:DF`!R5*(B+/ MCAV-7NN:]N,;A5YTZII3V/Z]'CK?B?WFA(;F0G`"@`#T1OP^,6V;?T]>'07I M)SL%)_\QR#[B:_`;/Q9;?](R=R[L@[WP(D;Q6R?\=@$ZW(GPTPZ',KU&',J4 MY"@52!^N M,8(-&MG"*_S@T?1XB)QOG)/=%6Y*P._TX\<1AJ-0SS[[@6N?*>>H++\[&)$! M!V8AX)PXRD\SY/E)_2G$]?83)^*L>`_Z!8;\2$$J]PV]F3=@9!]G9BO/A-K* M!6YM8@2W-V)1!S MT7:[0-^`<$M-2A8??5"U@!KZ/$T?<2KRXF4>;2.#^2#NA.45,ND&)Y,?R-*' MCME[GD<$#]^(A1$N/"M$@T"C%NBK.2$Y4SYF@>,'/)9[(BP*C:>:*,\KGIZ= MP9HV[`/Q8CL.^&8/[IK0M+I0Y<>H\^^)1H`];N'"7!".0PG0?PM))M`6J2ZI#9O#6>;R**!ZRW4*#1_@L?9D1*-R`7FD9Z\T]L].:L/7DL.K M@)_]KJQD>0DO5+Y<7=[_@5]P[S.WOY[9.O&7W?SU_O;#]%\$?WBCO M;FXOW]^>WM]\?JW\SX`\="V"OK]"PVSIGV^O?O_C?M4%%S?7U^>?[P`ZU%7F M),P>_>[F_O[FX\*;X:/ M;DR^Y_YN+Q&F(F=FMT)O%*#J_=7%^?7I^?75[X`.@_I?RJQWK=88^X/E2]XDGU`;I>$HDB!D47H5>%_ M-YX`NRFY3DM3N[HF9;Z.+&\\`7:3^5ZOI1K:GK??8LF\.%:]PCWYH8*H8CEP M0OCL2Q9_"UYF^_%#-?&I&NQE*J'+SMN=OMY1NRVYK3]*J9"KI>S5TNFK&ELM M9:6Q4:HO+QUISC+,^R=998HR?T_=2FLVJ)69+:OY,R0WP_<\<7:7#G/]1E32 MI,_?LM:EQ.6K%-;OGZPK0;&8(6W4 M8BH>':^+?R?I:N5=6.(Q:Y2,3:I8=P7>P80U(\'T3+=F'$&>]L\LU9MM#PD M,&V2JW)(6GJP>5)):QH<43C_*([Y,VLSR5J+L/+JA%;3-_"$9,PG5HD$3V`6 M<_2E1>!VTL"+%5#A4`XV(1+>%OA3TP4L'9MHL!P/FU/1V<"T?5!F3^$OD1/% M2?=*VE<@I"9T2&S>QP2NB=%>88?1Z)B4ZT;JI;5MJ+.>_2P(>;3P&/*=]^W*;1N+!>^YK5-4`)1MH7"KQWH/*F&,'D,( M?DZ(@Z9IGS]>P,ZW5X&#;1K5=*T``-@>C*0%Z,_8]8BVUS;;A[+Z=^P1QOL[FGEPDDGSL#HFYG2VAO[O MV&;-4),]8@[&!-%%&\9LJZAP599KLH[+._?O(!%!XMSH:'M&;*,R/.6(*^&(D+3O`-S/0C8T_L.>B MJ;E,&3/AC`%=8::*8X*\27KW%5U#N(ZWV?242VP?JR2C=+#9;!ACXWD6G^;- M9;DNY/KL#"XGX"F"N=7;:GZN1D$NE/O2KHWL6D:?+H-/U;B^C&9#P""[)H/M$4P^/3@ M*HZ(:1?=.?#G+6S]3<^5YL^"V`:7.[KPC(?0!P_'8GW9@R32E]V6;A]RVX4X M1.>>;JFQMYR*NXEG'+*#K<]SIX1LU`-OZ)OU42]T3*?`YX]I&(`,#(HEA9!V M+DU@8J%0/IX"KXDGK.4T'K8I_\2@W@CNX`%V)\1&Q:Q]>KJOFB-*F/1KIV-\ M+#_`QF(^ZS?,?>8DU.KD^T6G\5@<-N2SX@O>^)QN20HC4T)&K;/\6L<80=H6 M%H\"K2FL`'Q)QB(6-'X@4Q_W#$#GIS2N3-U[%TC.>W_!"O&]TV2OYF3O.0)[ MMLXD+9@R3$]K/^.(A'//?I\DK10 ML&M4=]$3*M.RXG',_&0;0[>6P]N]7^:^L?C$>!)'18L6!2:F(9[2<1#)B=%BSPZ'ET.=.DS#RV-T0[I(*4L9XS/ M`:,J+I^LY+'G\XD7U$OD6BS?:S7.L1^6$/`_5%Y=X\`\I?5S/FULIM@RN,= M/\L!-?B_IA?C5!\^.V?>!VA.<48MV%EFA=-!L=J@/LF8QW70;ZNMCNQ<(H2& M*JG<>Y&&^AVG7&>9/C3GT`S0T3MD%[*#U[?7@I_'AQ[552OUTBNCW55;K=[/ M399.<313A;X3@L++;4(V'>20G94.;HWVP\?&=IFID@"[>6"ZVNYWU%:SMPKB M:+H*?;#<+G$^?-5D.W?0IA'582]PIXP7NFY;*SE#-8P6^'.RF5;Z><-F%?*H MMHP@]7E6@+V\5%N&K6786H:M#^V-'-P7K04[FQZVUM5>^Y#=:`\NI8W8,B7AUY)OI-AGX%D*Y[!]]S](J4H#G6K#-]D7]3`+\P7PD^B;IPE]_3P>^SSWJ(U7%<8@OFOOCN^G] M=$+.OSOA3,9QYT2)/8>]=`*HGB@VL1P0HA#G^KW5S@;]%6U=<^"7@*J10]4H M']7N6E1[>T.UR-4+WB>A)$1[ZQ#5.@?B:XZE3G_26I]K+/791-1NL(GJS"/"/`^6ORE\-_UH_NT' M%U@HNH`G@-EGO?.?G('<`.B7L*`@83/`M$IC`;WHDO?URKJEVI_-*:O0VEX^ MVCG@_KR[S,-VVCEYJW?[U/OE`*YX=P'&*YRX2\+H%JZX&98+\2JKWZ(JI=OC MX&X,1@'X#[2XF_,B<:BF14C/PQL/5$E+7\3P[AJ:M@HT7?RZV55W;C^1('*P MHN<]*X/;01)[RP'33MYV&%#+W[AQ.?*6BN`=KSS,K_VESUZJA_NPYEO:?S:H MIYM?\F5C=)&4<^:?L25Z7S^:WYUQ/,[?=@N::Q'N`\"]]S+4-Q:P%6NSJZT4 ML(,(5SFL`/.Q&2NZ.HKARUCQN^_;SX[KPM6S=B_Y$RL)W8%#S6A94T[#:R6A M]GQV@B"5_O5L5[D@"6)71!(.Y7NRTL+\M+LS]@$(6:EZL;D_'\H`GQZP4);0 M+I5T;`"6E:>\7SP+(;V0M5=)NFBGC\*"_@?'X\,2Z"R$M%U.Y+.VA(YGDR'U M2XO=`VB?5S_"!F*@(O]+;)4VKR:F3?\4$=IMD3:=&6.Q/&M^$-$*>AS=X,6T MUP"^%=NU$D0=/?6@8)E,[_@&0G8B5LB8]/8%,*=$44!H. M;3L$-"&GKO.-N-/3:&1ZIP@3[:N9O%,98X`4X63DX?UT@!1T:`-[3-JWEK;; M9'!16*-G_Q3H.\D>EQ%YIBF1[]%N/Q1]1O4\0R(ZN-A3+N%-[)Q!I_-'3&M$ MFRZL:5RPG[E5@HKAC;1SGG*B),BPP]_A\=8@?/```*R4U+3 M@5QH6$>XM4H[VU&O+3\`9).)4>EHD2R-B7HX>=JE%,,'XB:-][B?FYY%W4@* M5+X1JU9HQ,I[I\Q]6B[QS:CVU`Y9CBCO\(8(*R=7.[^ M'H=AO)K;1U(5S-JEX:^%C>`8GH[[F'0CF'9<<["O/C9;I5IO2156FT=XS>SVNV7>!S7YS@2H[BTH*5Q8I-B>^$ M>7^:SH&B^H'/K4T['8)?3_MZ4\TZ)M%KQ?RY$`7$K02A![,TKHH3%%SR2$.6 M#PYK-6@^!H1YYM0\4L^=*T'PJMGCDF;;:)9"/DPA-Y;&)JA.X1UO%*OP_I]` MMQ'6,AQ;FSIVZNLG#Z1-P),G`MI4&^%KDG"D2 ML%$*`!AY')YE&Q425]MDM/HDMO.\39WW77!D:VTMH+!PY$RI^20@F&^07 M>S8;/X;A%M[=.I4CWF+_8;I4W7!=AE*!$PY`)OC%R1L6"NQ][@(F4/R,BZX0 MW/#39\0AF9E/PP<6@`JD@]C`Z7=P%%K^"L=[\JE"S4.1;#^6RO<#^,N914GG M)XZ)G!DHA`2;;N@G>B=,IZPG'.43RYV`S49R2)@?L@9JE7AAP=PO"#HFS\RN M83[!IQC,LJK<3C_R\[UW&`P^M^BQ[]TTC,@XQ&[B#!*VG/@6+7M2>FB,,W_I M,.,1:.RRC]]*/0$1$C!]7H#7?_F1^DM^1.?=NSO2A!C[-%V[1 M"S';[8@VI6OWF(6,Q4^^AZ.=+\!S.)4YKVDQ,NFNC'1D3Q&]E>>6%G?_A&\K!29J MD&DVC^.)L,FZ_/B*PL'/P^AH)Z"3AT.54%BM3%B34:KU5Z/;:,7Y\%X(HFB- MSCW[$B:/ MYBW8B-^;WU_N*O8;H>'*.I%'LBOW&#L45LD=HV]804H;8R4-`V=Q!IXTC7HG MRTE*IL<-DR`?[VP.) MGC%.1^^?SU";S12@A][DN\.QQ>P.L4)YX?AH%+,6D&%%UO!GH^>Z`)L^G M)Q.T>`)I0AF%6XTSY0N-Q:8'(3BR/,OV-_'@+SF"@'T'7.&$HR1H;,?8;L>; M+D"$A7B=V6'"#)PTUU]AN?XL,I?F^H>(!MT/9<=NB]Z`^?MI"@JL_/\BA?DJ M2H*7-,8=YO97^#RZ#M,YP?C$B<^:F88,@C'!Y;VX'"'DJ:9<9LUH;G]'-03+ MDF'X+BML\(N@7RY89-D"HZ]#[J>H,+FT?4H$"G(TPA.O$6!,YSNR19^%^1]R MNT03]5E.@.AB`X=JZ&"@MD!%=I(*0#W&#DO@];F,L?AJ-O`.GC$&U9%,NF3S M(-,@%UXR\3%9!_&YNKUCCB0)F2H%1\9T4>9G*C&2<<$AOV*:%.VP6[FK5_1/ M$ZU=5!!\P'3ZQV1+C.\+""_-*8S46PS@@MS39>FF>.IG64',10TG`O(V5;", M2)1/.34**:<%)V++M%-97K+"^9USDM.:)<32AJZH M!@7X9O.)V,-?[E\/I'\M0.$)<<"DGDD'+3K(&YQ,656[J M-D]US:H0EF:]A`O16*,&EF3K#)8LCNAV%IYTQ24AK M`>?KW&CF*[L&]IQ)AX,%UP4Y"))`T&CLIKY!@BC)G0@Q3#$NQWAU3.<]:XSJK`VF MU[S#F!8&3H@7T@#$#:4W[;"`W>:`M-BI*-SUH+NG2[N\W!+29( MZRS`L0[;$81,#YU:.?:D$436H8"J:C\I&L'Y3#2.-V0Q4;V_\`CF3WJ,PZ]0 M^4M8A+GP*G9@/G,8DT6BE^UW^%;TD57$X_8TJ>#+OXFE&RU-_DXHD;PA+#PO M?5G>7+US37CZG37R71*>?B1!A"X`U2F8&X`*$"R%C84,S$BF`7=J(;FRYPK< MQ:9NR<[M.8N@$VX;\(%$>?)=(!7;-B<93WA\4+AS+8X)M^>(GYJB`LUR*"=U MG0JMZV0&.G4!PGR6%0A)ZHDL2\XJ`*U\C@,PD6S;3#?262@Z)VKY%`8RV_%$8<^'SUF'B0X7#2,`J(XFDZP"#1R+!-=)9_6 M?*$I0XKA3Z9CGV*4Q)PXF,R;'&B83Z;C)J>#YD/H!P_YPT1^DJ!06(8@J,=D MF75>,WH![IR3ACS*G[07F2"`R=X5M96@ M+Y^H<.A*U,(17$#9XTZ3S6PNHR),._V@""Z"1Y-CW3%[CZ+LMAR$D]2KA#PI=X%0LRW47S#@0!8QTE34FO"2VM&7GQL()0I)E#.OK'2:I!@#/%:NKX%OO/WPZ-P'4%.PHSS`O\Y*X M&$E`XQY@%BI>R+I\T7:-(Q_/./QG3+0,XX?0L1U8P>J2YV>/_42>3-LL/O15 MTOGDB;A3=3;$,-.5@$86@OP%R2OS'3?/E'-LN(PP<+(EN7`\6S"`[;)IL9A1 MUNN%N`YV98G2_I:963Q39M]#^R,\.+3BQ`KI41L&59+2%*`ER$6,3:CC@+^6 M-9_,WY7VBL'$9W^,$1TKRSE,^<-O7!B+6@@7/'<2."1"M('AG]@37SXB4UCX'_'(V6 MQEJ?-)TR*/Q('/;^%-*7@R#`?_FT?R).30T1N8O6?:7E9#1*@$+MQYB99-,X)W]$7L`EDP_% MY',OR9?&Z`YY9+V40IX'!VH@S7>C?<5`@X9XWH^'OME][*@X.5EYC%TSH"6+ M/"&0YU5D#RA(E#6BVBI]&&[BJ&B-S6^H47WZ(?TYQ,XU<83O]./`(DE6'RIN M*TE!IT<)'!FJM^A$!&JG^4`"-'PLTQT@HJYV[@])$AW3S``^_&HF?:;"?$X% MB#>>BA=SYADNO,OR,Y;OX*F$Q0XU"E,QDE2+I#0"$]130\CK0VEGGV2]P9O^ M\)\QG5)5[#CM%>2,TW!;H4%,L0X;JP>I#F7' MPR`WF/K$9,@B&?'0\\O1_Q%/4EE/-*;'LS(:/*-V42<66Z.A:OE&R$2))SQ9 MK,!EWMI]D2/\(0X0([5(K-S))G.E;=_#%A^,R'1?@EXZXUURMH`.:!RD'*F! M"FMLG6]ATTYW=,Z8COMA#0?6;^/S._87]K1BFR_/A)U51+)6+A,PC&8R?FIF M;$;N*(QK8QO31-$[,TEA`A\'*H,IDFE0/)J$)3"FQ MTT!RKDD@K+D%[U@,#,U-82.3%A%0A642)>#YL'/DV[?,Q5$+\)@VLIG?FG=7 M<,@&]IF@H^7QS)#-00=M1L9P:38%:IBHCZ!0LGC&`B+`_KS[B.1(;G7P"))5 MA*"6AYGQ*%S+#RR<.6'H\30!CBOC86C_HZ]W+R5)47QS.\Y6TUL+@<:FP\XT4S73O\O%;)$OH@])UX&%/P+,"%.I."D]44> M@U1\XG3.3@\F@G2./5WV=K*C+\2(,=B*4Z;P"C]W>LWW>,E&@+;(&P5^_#C" MR`FMB#/H%AOQ8^FP-9=";>0,&H;&/."MI6.B! M[52;:HKC3,^7&R[=99AS+*\I*"-JIF)S=>6(NZX`]VU+V)<1#\& M8_!8RZ9M8&C'32QV)F?*QRS&^8`G2-AUFDZ?Y0GK*YZ>'1>:-FQ9\&)>R`4^ M`PZ#8.5!*C_QFW\/:^2"AVRY>!&'$J#[EG\%8`K^SI`/%9HGF4#>?%U.X3>' ML\SE44`UZ29.=[IX`CL9T0!20![I,2$-4[-#Q?"UY/`JX&>_*RM97L(+E2]7 ME_=_X!=,,EU>R\MR5/G+;OYZ?_OA^N;+:P5/-NC4EW?OW^P^(W<80'VH]K\V<3#]$EPQS5HR"APQ_O&3ZZ,?F>^[N]1)B*G)E- MK7NC`%7OKR[.KT_/KZ]^!W2`FV!'^5U?^+O:FI:LR?O_7,.361"'\X[?20%6 M:/KP;R?=SH\%D5D@TH749)887"XJ8\>V44Q>B(I^>$QV9XI%#U%37(P6"J"/ M\@:?G*EV?J MO&8T`"^V(0R5*[+F#%R!2<&36[*P1%RPNIY?L,8<97!_*01-)/,/PGRC(4O[ MH+KYW?G%__U^>_/GITO@LV4-AY95B<(N1(;WR]@J4*S16MX/]O\^1J3IX-$W MRN?SR\NK3[\GP9`.+,B4$MH\*8RV:O0[JF;TI9S7CN52SK>1E7XWXTGP&Y*KM/2U*ZN29FO M(\L;3X#=9+[7:ZF&MN?MMU@R+XY5KW!/?J@@JE@.G!`^^Y+%WX*7V7[\4$U\ MJ@9[F4KHLO-VIZ]WU&Y+;NN/4BKD:BE[M73ZJL96RWZF=#5H&>;]DZP%H#)_ MS](O92;N[=J&['`M.K>K]_B3E7J_3[I)SXOAH3M1-;>P8[[>:G$]5]JN.Y<2 M74R[3[M?F+DA)%D'<=[:(FWU38O22:'SP\">;-L+!JNRJM"`M,FN7S\I$\"'WR::Q8^_RB..1^IP?HUL)K5=$#Q&W@" MSC_S`VR\`0;E"11XCK[)T"_V0%;J@T-B^-TK`NG[FGT@13H4AK7_#CJ-#YEL_I!-DD_[]"UKKI\,\SZTHIGG;K%*7U>VS M:;U)TPJLE`S?8Y..(3H)(ACKD"N9"WH"&*2_0)&!;*%GS MNFALHE)W/.R*0\=&T[XEFJ\I57)2;5F?BQ`XM;AK!1: MN)?-W,&9H;1K"/H5(9V]0[VO9=7/V'"MI8&"FC+?A8ZHS]Y)RY_I\'9:],R? M@9`0VHAN8BZN,RT64;+V;V%2=DA2]XY73^;&LJ:]35@SE:PUB^T#BSP_2EQ[ M5H$4X5]1@Y+O$0'PV1NDWCFD`4V]?RHG&(J*AK&;2:!3,#O8[HM.NT]J89/) M0OE=R`.55RX^Z:R\F<>0[[Q_3FZG4:SFS7G;40'0=%`5[P&6#`X&LP\K(6#] MMGAU+O?(`P?;I:GI6@$`Z.R^M+KV&;N/T*99V44HZ5EG"E7!>0:X8F&QX5HZDN;;(WT]93-V$P51T"P:?`9CKM)YDW-@;!8'F>@3K=;!EO-MWDOR(5RGVO@GF\-_T!`LPBT MG.LB)SNN7^6*Q_D6SN:HSQRS6D2VUF&1XP6UH#0B;2=1:U@7R5AOS"4->/QA M<5`#+Z&]>+EW9N>G5B:-59+>)*RM.1\SP$/17#,DC9IA\;OF`^W5:-,!EB-B MVD5[#@Z=A3U8:2QZ/G[,=CCIP%+_(<0YH19KD!LDD8_LMM1_S/F+<8C>'=U3 M8>V[RS8M;0MM"ZE@*?#^TR`!D8%$L*(6TAE\#$0D.\ M3SA>$T]8[T\,T"O_Q*#9"&[A<-IVB!TC61_;U+&>(TJ8-,ZE\Q0L/\"V.3YK M_,B=IMP\T6SGEL:G<.H#GU3*.]!2G[30NSYDU#K+KW7<)*;]^?#XP)K""L"7 M9"QB0;0',O71:00Z/Z5Q-NK?N4!RWMD&5HCOG2;.NI.]1VKR?:G`S_F#I??) MP9(`ZK#>W-A5EW]>R6P]O.7N:^L?T9CN0M M*G0^AO@T-X8XFS*<+>@X)+A+#:DZWL(`Z+/X00V*T5RC3C?S- M05C$22V]%5E+*[`Z!\)#[+`Y1V?*-6K6D0];:6>,+<5R74=3`I(<&>AT869` MX:L3+*++D"3-VV'K:SH>)7!NGK2+[SS#UJJF$R03@;##J,>VX_!NKK6I3@0K MBAK1%D@)UG1W6LY989DRJA3H\+OOV\^.ZPJK;NO)]Q([-2<%*AT@-%;#=-FR^3,>Z:331-'LH!J+ M>.]FEUDH/#/`.2T*ZGPVU\%R`K!).$+9HAXL[6Q.EN6UI+:$QDX1J@>2Q!4Q M_H#>)VO06$A$>>3$*\YZ24\W<'@"'8:39!N!C^TZ$J8S1:"*\RL4I/YS?O:OYA[+M,P=*K%$E)D?8AY\&'+`:0L5$RU*\\4 M#%D+WF26@4=RHPPLV.N8='K00Y0\C[KI>2[BV3IJ89M@XUPVI1.[_:Y(1&33 MA4:<%!E^^+M-)]L^,("`[)34;.[C-#\F*$TSS"?L;)(%F:8"L3R`Y%D%VF73 M!/QT+!R&H.8R0JF+P>8+Y4+D6B%$_H43>MN`>"75`2+J!$%5F2C;D*O,^Z1# MY,6U9<<>_KF:VP=0-,VL^[_H*O3B4(?=BS"!A&?9S^][Y1. M.@??F9[M4LTX)M%KQ?RY$(5!=YWVG*2N+\T?<*%;A_3^!;B+LV)B-#$G]Z70:/1X$ M)T\$M(?.=S2=01H.,FG%+HVJ_9S/C%LQ+09?Z81I@J1`H?NZ"&S90Z;HH#B: MF@@BR`Z^TVQM3+6F\[ZGR8!V.K.!)0?$>'C.SO1Q#'AD?B>+2T"NZ,1PNO=* MQF:GF5&L>IMGE)()=8C8A%GV!SR`Q]]<-3\#>6X!9O./#H20QR5<.1,J/@E88XLFS_V;):#C"$-?L2;RA%/LRC.("X*-]-E*!68 MY9*-GT_>L%!@[W,7,('B9PQTA="YC_B,."0SV7D\:054(,W&!J?=L6;FK#O> MD\^FL.=?PK5V^I&?K[S#@.NY18_=[J8ASM_% M(W4&"5M.?(N5/2D_5HT5^(U`8Y>]`2G5*181,'U>?M=_8TX MR?JX]Y3'J6Q$V6)BGB$MV;T`DQN[]"#E/8SE^ZLFIZW#Y`,U-\Z8 M>2?P_S,>"!OT"`H_"AR+';)@6PC>]H&FO%+>I]TA3/O)"1?5(K`47WXCV^>: MK)K:C/)9'O"-GK9XM?15$V;R97=8LHQ\\,JT31RSW=\ MH?T0L+-8KYU+V`>XOBPP.*12*S#$SAC"E%G:L";`>#FH-6?""X>R`FH,[7NT M"C^,LH9<^4?!QL\#9")BC3S?]1^3WFN3P+=8&BR]*RL\LGS:T0W/FY?DPN?/ M=*F/E-3B,S]N['A.2&OYG]+[C_P,\DCD511%=<5:W]UCM%]8Y72,.\(*$CW3 M+H8DS"*#/,T\W]MQFA8]I8T_D@3+M"4B>XK)$B-YWB![)B9\TOS!7ALL+3O9#&/,.U]R`I4\4;<())_8L)Z?D2P\7V(HZ1NG_4*87][ M(-$S1M:7]*Z3ZN'/%%'.;>Y1L^04)VOPB&T8`4?8GV,R?IXDB:FQLJ)5GH;$ MCM@`WLA-?'K"NKKX7D$REF&%\L2S-BE@*2;%,Q#'FX&>QP1HN4%ZEDC+39`F ME%$88#A3OM#3D_3H$ELL+.CYR>MRX0HG'"7'/'9LL;8I\XBP0QEGM@2<@9-6 M1RBL.H+%TKVD.H)VJZ)1D.R@?-$;L.(A3?J"E4\;9?%5E!PW\(:Q650%GT?7 M85K=C4^DG?%RS7>P\XNYN(`CY`G87&;-:"ZJDVMTQ/!=5@KB%T&_7+#(L@5& M7X?<3U%A[:@('A;@/2/^:9``>^WR1?F'&8UG$P-CXC+VW>@$4(#D=B/AREMPP&P!TZ8V;]5,,`C MN1^'R4@TVC\$)1'.NB1LGQME&1[T]C/E:IATQLO2E+,6;.S>I#Z1G9/D:P=3 MLY(HQ"(R.6,(W[)>V:L*.$-:$TOL<*9[0+$H-KL6V+4?ALIG$)J[$2P6:2$.=X[[#K:'%E5[W*U[A7U$?\;= M#SA8J,GR_4H><-?&TWCG[^'*ZIE@+B1:'=3?L.O*!DG`U6-,7,,'@Q&)([H7 M@*>=,4E(RQ/G2^]HHC"[!AS^I"!_P75!#H)DESZS%\IO[>`[:%7T7@O@7#HN MQ7A3RM#.`,`O+\DD#*-<2K5)U?,#I36P'9N2A+D'@5('._P(E,4M-]O=XO8: MMF>INX]5H@@3[NN7DG&>'FGKJ:1JA^G\>$QP]`4):%KMW-0&6D.?5(QF36JB M@-JE*;^:!6QR$94"U9!:>1S-D+>J&B,$G!@++MSB]"M+1TIW2X56\AO<%B94 M1,%C55T3OL_8D#Q4=N"3;3)D-E%HV3X;T'& MD?^DH6A^A:HLG5S#4Q6*`>4LFK;,8^>;J4=6ZXX;K*3N+_\FEBBU-.4\S:%( M6R;FGY>^+*_UW[DF//W.&F&SQ]./)(C0DE)5B.>2V"0`%*Z-Y1-)'WX>-,SW MC&IN2ZL>6:..;RP[`S=F+0EZ65%8!6/LK7*). MZ=G&7'67RW>H\'LN^D5;I2E6'''H\Q$PYHB!WT(#`2"*H^D$2TW>>N;>0.$]5"ST^.9 M]$0E.-@PNZ/2>[N"_24IQ(:]WC"`7>VS'WRC+AF+WM+L@Y2E[$@NNRX]$C3S M+M[((0$FA$V9B05GR`^Y;"S:S*/'H[0WQY'*$S\5?0T/_9,^V\V:^2?V*>S!@)6GXU5L'2'R]HP\10/VH(<78>D MH490.#5\=8WI:(K^<^KJ81OTN7?Z#U@'SM,(*)[\QM;/#'RVM7?QM]2=7$@[ MUC\V21"AYWVOQ5DF=5&T&\/)V?L:S%PBGM0)3D64>:"8?,AXLU2^-I&F.1D4 M2`,>*6N-S5B;A!CG>1HZ8]@G!,LR=.98JO($!?;.)$,DIR"2&"$[OLM)R%15 MB$.-L`T[4"O"8I^`GDBR;RJ#)W[`B"D/J[(T+M4Y=G)(0&,N_`3#HQ7X/*&*=PYU"DEF"XU6DHS&326\`*]H M*9@F\2B';%0LE-6%*.X+W9@B-L4=3=(0IQSB@2@5776=X,/.,5YJ'DWJ[2X1 MT%S':580MCBC,I_XX='#*3R#0J!I?K!TC_>V;3SGP0$6[K96GA!)'F3`SWY7 M5JJ$$EZH?+FZO/\#OV@_KLJP8"G^_&4W?[V__7!]\^6U@H%\VKKLW*15PWG)AXN//;B<:^3_!(@'_GTN^2 M88[J49#0X8_W#!_=F'S/_=U>(DQ%SLSFQ[Y1@*KW5Q?GUZ?GUU>_`SK`S<@? M\[N^\'>U-2W1V??_N88G>W3D,^<=OY,"#.K8CD:_G72Z/Q9$9H%(YZ7XE\@N M'Y6Q8]LH)B]$13\\)KLSQ:(M"C-<6BB`/LH?B)@QA]AYF*'F#R6;))O$8=,O M42#589T9*`!3MEQGZJE4RFIXK'RR-&3DEICVUGYCG// M$1ZQ?*1:\.[XT*N?1I*L;"9Z4E)?9#M_H1E>V=?"/3)%KU+@%UU36N;N@B*Z M%35T:1G_T@3.0OHZKX+AG7)H70LOB9&])X7,Y2[SR84'?V&=@A0;;GAB7?'3 MHF"-S?H_N!%;F_(K.N^-#3YYK'0TKCQP]*:DUMITR\[>^2U:B M=S0:2;*RF>A)2:VQ[929O_5=LK*(KY0B/M4P6FJK=4@G3PJJ%-2U@CKHM]56 MI]MD,959OWOO%XV#/$.'3^;R<"(5CLU,IB>SM%J9+2FS)66VY+Z.\^0!>.5V MOO(SUD:FX4DVU8)-,A^HY@P4@"DR6_*8V26S):5VK"T#!6"*S)8\*N;(;,FC M.[62V9*B\^[XT*O?.;ID93/1DY):8]LILR7KNV0E>D>CD20KFXF>E-0:VTZ9 M+5G?)2N3T.JNB*2`2@%=GR6IJ[VV1G^IK@UA4Q?`3OF7E?1L3(!O=$+ABS([ M=V^P^LS[9:9IGX6^JJ;BFE'D6$09^S:X-*8':\)Y])RA8^%=9AC&XPF^-*1_ M<[Q)'(6*32(2C!T/'O(PI:^Y\,<3TYONL1OK4ADP!F>]8Y0![G0J%R/3>R2A M`)0^YM4V]%W7?W:\1UPOIA(0R_'<_#BW!Q$`_356%QN:9G M`71#/TB7G0/?^2*U%3,J+%2//3\.`G9["&^,0_R<7XJQYS^`QGVBZ;]\';[B M,O&S8L?T9@0*X,'E[$6C,`$I3=E16IJJX!'U:P'$9W:A.@DH+Y$CYR`2M3'H MV[4OK@R9.8='9K?+[/8JW->>-N^_OF,*$M7@_YI>;`9316=:JBW8V?3] MJJSJ$R>^6U*H>Y&&^MT$$X@N'[A?_R6X[5'`[*&C%S8YME\+?AX?>E17K=1+ MKXQV5VVU>C\W63K%T4P5^DX("@_IA+`S#6-B-]D:[8>/LSL#C?Y'T3-G7Q)@ M3QZ8KK;[';75[*V".)JN0A\LMTN<#U\UV)G[2)&1KF^7 MHX.+N6P?<[`@]4O[R,BPM0Q;']_62X:MZQ3@E6'K7-B:IEDU64H;L6.24>L# MAG4;&R.JD@`;1+Z9;I.!;R&4VWZ\+Z'"00-C`CHGXF,M"SC.*(PT+'F M&5\N324%GW)>]ZKY_&_%=FR0ADBQ:)*R@C_Q7-D%Z>OA7/ZZ$X6%E-E"IJQ, M+J^.Z5?`U=49RI[OG MA$K@3TTWFA;+.RP3F,2XB`N*P*O&9@0_Y'C*2D#B":Y'>+;MA)8?>WC1)"`A MAGL+9203J1(&)"F9L!M](1'/G0V?LN&:@6""1#CS=";^Q*A0$*'N]@RW`X"M]O?)L MAK.X+:);8(B#/]> MR.0=BZOT[EF_(+U@NUV7UR5DA$EY!G(`#"MB!U>6"9(",/4*,/UX!J0!842& MF#;*.U/U!=%)Q#?R(]-%F,JE4VL9G0`F>%G2&E-IL4"N0:4+`49)38%VF!@- MG0"(ES>)\`BT@'EI.+ M2D7(!2?:4M"7[SX.[8J!00%5@>K"\S&<"UQPISS7#RUGPJ M.=:HX(J3[Q-BH>)14-<&#BA8!_YB1:B%T2_`\US<%#/7@-DVN`B>&S'>GU6J M>%84:>>_L*/5!]"J)*"GC@DP=&OYFIW,THM.77/JQ]'KH?.=V&_6'E\FKV8; M3+:53L')?PRRC\G^\]=?XO#TT30GKV^"1]-S_DMW-A'+N6=_9IX4_7HS M_)!0^"XE\"4X":Z/+C=O;VQ_^]<._%.77 MY/T?P*7["SVUW`NN/!#TF+Z!WC^EI_CPA%LR_.WDLZ9_A?^BY;KWM<'7ED8_ MGRB.#1P&^7#LKT:O?_)V=C6D4CV)\,28L9EQ>#:ZH+(?5-@O@D0HI9[)BP;& MRQ45\E#Y*W&W4S8J.3X*H(;K;7A?LO'"_=0452[=$E&_+U.73L8D%;Y8;DQ+ M;NEV)E'7(=7C#JW=5;,?P4%GOP"&X(7"[P'J>%3<7DC87L<%)I]BM;UBDX<( M;IY,`O\[V[O`72`XV:8N5]B/=[`'!,2=WR:M\S;W*4&[7V77`_"?'1MG(;^9'#@G,P!IA+P;8[$T"!W:B MD?-?N`X]`KX#`;._41!N]NW9TQ^=)_[(D?,X0F'BK\(=G!)[Z9;IG]AGH00' M"^&!8FA68.//-MK,8P$TP,19L(1@4X0_SI3+\^)V_>=TSP]$FW_GBJIX!GXT M"@CW0Y0+26H'S@(TM"+Q.A`A7S13MQG!R]KX&,Y>(9S%./";1 MR+=]UW]DO%DJ7YM(TYP,"J0!CY2UQF:L93:3+.!I$G?C'*7F32A0OGIY"9;>49UF82 MA5UDN?,MK7*.`KL9(_S>E*D%IA7@\LVYKFQY'DJ%"H/)-/X;$!Y/QAT`C_Y: M3#(!H0SIQ4;K@43/A'@\4HQ!:KRB!1N2B#R"#R24'W]T0EE=T+788(I&E4`D MV;%7-,*>:E1TU76"#SO'>*EY9&<<2P1T_N@CM9=;M*F2[O'>MHWG/#@01K[U M3;'\,<8(J"*1/)`E0[)D2([F$R?O=%],D0.")9N.A$UR4FG-&2@`4^0C8HZKNJ]MA13 M\1@JQ31G'?6^VN_(?B]"6$TYP;F^ZDBB5ZI>:O1<7%%9>>3H24FML>V4$YSK MNV0E>D>CD20KFXF>E-07V4ZQNE4)G*)7`?"+KBDMW0H^)CL*=&72O6NYNKB=*K8;9BN^UI!9R3(K668EU_JX M7`"FR'17R:8C89/,NZLY`P5@BLQ*/F9VR:QDJ1UKRT`!F"*SDH^*.3(K^>C. MB&56LNB\.S[TY,G;T;#RR-&3DEICVRESD^N[9"5Z1Z.1)"N;B9Z4U!K;3IF; M7-\E*\L,2RDS5`VCI;9:AW3RI*!*05TKJ(-^6VUUNDT64YF7O/>.UM8_L1,Z M-+\7IR\YWB/.6<.96XY-`I;X*[,E9;:DS);/`"OW,Y7?L;:R#0\R:9: ML$GF`]6<@0(P169+'C.[9+:DU(ZU9:``3)'9DD?%')DM>72G5C);4G3>'1]Z M]3M'EZQL)GI24FML.V6V9'V7K$3O:#229&4ST9.26F/;*;,EZ[MD91):W161 M%%`IH.NS)'6UU];H+]6TSFSR`M@I_[)I'3UKDMFY>PO89]XO,TW[+'1^-177 MC"+'(LK8M\&E,3U8$\ZCYPP="^\RPS`>3_"E(?V;XTWB*%1L$I%@['CPD((PD%H/0QK[:A[[K^L^,]XGHQ ME8!8OF?!`F(KD"^N!_+H>!Y>A(N#>)BN"HO+-3T+H!OZ0;KL'/C.%ZFMF%%A MH7KL^7$0L-M#>&,?_U'5.0J`;_U_1B,Y@J.M-*37;7:\'.IN]7956?./'=DD+=BS34[R:8 M0'3YP/WZ+\%MCP)F#QV]L,FQ_5KP\_C0H[IJI5YZ9;2[:JO5^[G)TBF.9JK0 M=T)0>$@GA)UI&!.[R=9H/WR)\^*K)=FX%>H7HR))%*@3#R]Q'BHQT?;L<'5S,9?N8@P6I7]I'1H:M M9=CZ^+9>,FQ=IP"O#%OGPM8TS:K)4MJ('9.,6A\PK-O8&%&5!-@@\LUTFPQ\ M"Z'<]N-]"14..KAI.VAD1$#_3&2D91G'$86!CC7/^')I*BGXE/.Z5\WG?RNV M8X,T1(I%DY05_(GGRBY(7P_G\M>=*"RDS!8R965R>75,OP*NKLY0]GSO="9+ M6<0D8L$9DL3,_H[#R!E.TUJ935+2^1IC&/0-O?89G`),9% M7%`$7C4V(_@AQU-6`A)/<#W"LVTGM/S8PXLF`0DQW%LH(YF8TS'!G`.6F&YZ MN:L=;`$&7^GKE6."#`O[+D/3!P,,UKCO-$Q1A^/=")N]87*5WS_H%Z07;[;J\ M+B$C3,HSD`-@6!$[N+),D!2`J5>`Z<F:HOB$XBOI$?F2[" M5"Z=6LOH!##!RY+6F$J+!7(-*ET(,$IJ"K3#Q&CH!$"\O$F$1Z`%S$O#N67Y M`0;(W2DUC&%:JV&">;-<,PR=(5V;H9(4]+`+UEBWPA=VW/``;R(!C<0GU*+N MUFMV6D$O.G7-J1]'KX?.=V*_61O23U[-G"[F7J;@Y#\&VL/H&;^0NUQ,_S`EHSI7GEA%,14'C^#)VY-W_[PKQ_^I2B_)C?=62-BQR[> MD]Q^'H8D"L\]^SIS"3YR$W7CW2;&Z!W:HGL$XYY\C]ZYOO6-'EO!EULR_.WD MLZ9_A?\BJ^Y];?"UI='/)XIC@WR95N387XW>X.1MZ8I_$N'1"KN9_6W6#5?9 M#RHX5B#'2JF'5R760%$FATK(-',TPK(_%\57!0\_&B4K)#,O(X<$9F"-8!7X M<8!UA"1BRKO@WM$U-.]3T@OG5V.&JEI_I$<-;*?12AZ*M%!L=JQ/K:GJWJO+<54 M/(9*,A)2:VQ[91#1NJ[9"5Z M1Z.1)"N;B9Z4U!?93K$*J@1.T:L`^$77E#+S9O=9(>;2!,["T)!_8C]*K^*E M$Y/`L9)499`ET)'8^`05O7@NT)3!&T0OWD9KM1&>(K?)E0+A/* M94)YK3,=!&"*S%26;#H2-LF4R9HS4`"FR(3R8V:73"B7VK&V#!2`*3*A_*B8 M(Q/*C^YX7R:4B\Z[XT-/'IH>#2N/'#TIJ36VG3*MO+Y+5J)W-!I)LK*9Z$E) MK;'ME&GE]5VRLD+T6&9@2D&5@KI^N%J_K;8ZW2:+J4PIWW>>Z$LGM$I&R&Q) MF2TI#\#KY;U4?L;:R#0\R:9:L$GF`]6<@0(P169+'C.[9+:DU(ZU9:``3)'9 MDD?%')DM>72G5C);4G3>'1]Z]3M'EZQL)GI24FML.V6V9'V7K$3O:#229&4S MT9.26F/;*;,EZ[MD91):W161%%`IH.NS)'6UUUX][V6G+,+E7UCVU(,?V"2@ MB44).2F4KUGR%;WHU#6G?AR]'CK?B?UF;882E4QJ\])/=O+IE_S'(/N88//K M+W%X^FB:D]=WUHC8L4MNAA],)_@+V[">AR&)PG//ON:)>PX)/[)FK?:-=TNL M.`@`AG=FZ(3W^,1[\CUZY_K6M[<__.N'?RG*KP^^1W)/OO`]#)NS=,";X:T3 M?KL%>^;%Y-WT=^(_!N9DY%BF>TL>X8+B(VE:(7RY)93^HRATVEE1* MS=1[48XF)[7R,%4><\16`DIM[*AKALK0=UW_.7Q-Q>2P*9I;=T^5*9K'EZ(Y MT)J2HMGM'-[A./C9H0!,F3G8-0H'NYTYQ#XY'LF0&X/2&>6R`8EG$[LAO*MS MRHM^/!N=,BA79,T9N`*3@B>W9&&)N&!UO;HLME)I M(IE_$.;+++F:GE8L4MA_>@Y.YKF+S(B$,B2\Q[4L>,189*0W""AK"_I#M%6C MWU$UHR_EO'8LEW*^C9QK_;;:;\D.$T)8[Y+2+A99[UL21CB*[XL?N'L.8HF5 M6;(?#E;A?S>>`+LIN4Y+4[OZZN-A*?."LKSQ!-A-YGN]EFIHC<[*%L>J5[@G M/U0052P'3@B??62EH,F6)^8Y)"F62GWEN/Y$@SO.(R8?%O;WS*COD+)3SE?2#$L/O!@'2V7X2M0]N0V M;%H']OV(`$/&$].;*N3[A'@AO-K,<45A>ET+3N90TIT1I::J"*TLQ/5OY]T)X$QV_Y>3YCJ:"$B^P M0AGZP:80&6>KN5@'9;JAYIM5E'>F2T*N9C^1:!/%^)6=4[)CRH^4D*C),Q5= M4.2HQL^_.^&,.C5.E!@>0]_SY]WEB6(3RP&[&B(EWAIMH]_1C'XNX;X(9QEH M8,#V9DC#M;MBT5J)1:>E=76M9!R,'`Y&*:QHKV&%UF_W6]U*T2B!%9V56/1Z M+4,S-L;AW+*"F-COQQ/7GQ+RCGADZ$3A!:I$;P:E\_#&RTE56@]RY4WB**05 MB#I#*@[QX>D%[Z;IQS\<$IB!-9K2RQ=@UUV)G=[3]5X[IP-6@E\QLL:+D>VM M1%83!,_6B_'LBX$GK+\66Y,5">]@M8+1^Z#K!4'VQ<([T&K!U!<+[T"O!L]+ M\/*>0,\_D5P9W<'T[F"UFY+#+XF M52O;P6H_:"_!Y]=ECLR9&^:F_T^_K%#`+3BQ8:[R6/2Z&\ M<,TP7,"%U9[NK-]0">W*8M"2=_QN.MZU'X97GN7&-K&OO/=FX,%EX49A7Y&9 MM]IY/S7:W5:K]W+N;4W8@F+Z1)XY[N%5&,+6OO9D7Q-=;?<[+;W%==<<]@=2 M1S4A[>IMS-S&6VA]M+O!R`U\7&?H-B9T159\]7Z+6_%:L*L:\U$C5J[>&)Z6 MQ,N=C*AO?)RPEZ5X%_G6MY'O`IG"]T##:/K)C\BE$UJNCR_=/<&J MI365\7,NRV@/GQA##Y'/5)]6=F4F8UW&N.IHCM+0"<)(^2QU5:_6*"5/AR`S@,?!V/PY@`8_'O@?O MP]4<^";Q;1-QIN4+?/^OH M17D?.ZZ+K3PSN9^5>0\>CJ)#P"ZCEZ`XWA.!OP:A8D:*"3+G6"!&L&3I,TJ7 M>^VL4URCH!)&CC52`C(!D+%;#-"L9.503*/\4;'!NOLQ/!T(@BQ#4X^T8,C[ MG*UMQM4SY0,L/V("C`DQ*65@J5DC$]6>&Y2!<8R<>)QS/,[C(?I8=S)D5*L^PHI0'DE"$)LJB.@XQT4Z9@A(* MX<^/CH?[`*6;9.4.`W],7V2C5@;ZH38PO>3Q$3P\1"\1Z`[LB-V(B9%'HDSK M`Z@ICZZPBQ(+*X.^A^<5U4JIW&F?M3L+U0IP:8C&'+8^L4651Y50:`L2H`'Q MB6M:="<`5AK^EYF.OJ'WW@#5">9^@W9+EF*:$7ZF?$Z-:<*:/!,2-C/;ZRO# MV+/SVOPG6#(3OI%BKYBUQP$!7Y/M4=99WSKE7F^\/5JXKV+A1.85?@:.^/8= MU3\@!/1/R^(3F$K;2D)-,YNJ_*D5TV;Y'>35IP\8WNQUM'Q4>3-@-D2!;B.W MPN`K]S31T>1^Y@<0L&O7RF^F;XD+Z\B&BZ+I?2:;X;MI_B\+-M2K3ZE:X&B" MG[F6&$6TRJ!%-[=%[G[5>:3BBAO'4E!?<31TVCYYV^_H6`JW(^ZLF&OQ'9_1 M5L!'*D+[QWOF5.4KZ*:O%)0\!8R3M^AN)55I&R"R$>9@"$')@?:]&5YR1^H= M^D$W7OMO,*N([`6SJ/39^R=._NP#W*H"372DB;Z&)%MB6*!:\23ERKOAIN@6 M';U[G\;I`G)!?2ZF?^!U_*9-2#6#:V^]-@09X/B^!+:-D'S/_<:-&3^#37]C ML>X9:W`J@+((^-D;\ES_S+S%EXKU#':#%7))D=)G&/5"$&=U>.("?0`/Z(K[ MHS'5> M4%N;`7?%RV'V7"]& MU4QFH]CFS*3SB>AV6!D3FPZSL7V&/@AQH_8R)YTTQJ"HJ3; MX,#'37C(PP>X$TVOR2)3G$"P-87;8%L`)?`2KP9<>S83S8"=*0 M8BH8(/H/_`P??PHP&)\$T&%]X,X1_"ZV,)[]V(4U$CB/CX1U2\A%YA+]/@.D M.<8M'@@P/[]DASD9="C4#GE&)8`*S4:F9B8H'D]X6#`,? M0GKBD05^,>;N.F/N-2Z@8W:S2_WJ=9A M6_D=G.W6R=O/QG_X1FS5LQ>FMN<\Q?-4:[%]#8WA@ZRR7=U-0/<20(!DU"+H MB]G$TYDDGSPT[]$.A3?!>VJ$X#KRD5F*?`AEKLO`N^D[XEFCL1G,-QQH&:L3 MK3M\:U0JONN(F$=YHV2VJFFT(I_YM'OR5M?64"D/GU`2=/_LOYPZJ]..:R]! MI=!H1?XP2I"QBP0EZA/CJ%[D!]-R`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`D7],%',6QLU;2,EMG(&?KY*5*3DJ1DU+DI!0Y"T#(;N0",$5.2CEF=LE)*5([UI:!1SIJ M0TY*J37[Y*24(SI(D)-2Q(L#2NR/,I=:LE=B+X7[^*UUE=UNY*24&G%0L,3H M%Q8KR4DI4E!%QTI.2CD"^RDGI=1?,4GT2M50`G)320*8WG@!R4LH1F'8Y*44>'$GLY:24QK.\V=C+22G' M8,RK/#N6DU+JZZDWG@!R4LK1L[CQ!)"34FIGK^6D%`'EU-2\5[@=EY-2#N2Y2_3J66$B^==,]*1XULUJRDDIM5^NM>S4 M*#C>]>WI+(5="KL4]N89\I?Y-')2RG%$_@YYYB=P;%"\Q%P1M*=<*G*IR*52 MCZ4BCJ,A)Z4T0#G6EB#(II78#338;4I*,-)D;?W)K M/G],VK45)YFL@DF+<`B]AQVY9]WER>*32P'>!OT%TU;R MK]L1)MWXVJ(35HP9F/25,.D#?6!TM%UAPKX\5]YGUI5G"T(9*X%JZ[UNK]M> M`%3A?;M"M914K=50#0:ZUC)VABHY`OL=3\"VH%5[)51]36NW]$6T*KQO5ZB6 MTJJS$JI>JZ.U%M)J,ZA^#_RMY*F[6LC;;:VC=;H+P*$OVA:,I43IK0'#Z&K= MA;Q:#<:Y_7<<1F/XL@U-^JN!@376[;46P))[VVX0+27/8`U$J(PVA(CJ]\5" M]IGWMV=N4GL@T= M5RMV6(C=+FQ/9H%<\MX7`KF4D*OUO-X&QQ#\PBV!3*06S,"$!-'TLVO2B]__ M$SL3E-T%(]6V'Y+6;LLA:>]SP\245YV?<[[N'CXE_%5,SU92YJJ`8$2=4#F, MK0H^+[QFQW&-2@'5`C])QD\/5(H9$,4,^;B]4`[;D\/VY+`].4Y*I(CFOI@B MA^T=,[ODL#VI'6O+P".=UB:'[=6:?7+8WA'EHKR+'1?]:IF#FN\O MN:[;::E&5S9KJ!_'I9A+,:^GW:ZP5T,:GC\@IP^>+5P+[AT?>KOIIH[:Z^JJ MUAM(B16/I4>.WJX2J_<,M6,G*7B6-,J1\[[XTDKLIJ99N@--_R#FADJ'-1$_*:^U-:H4;U-2DAOXP>C8#V>5?="X>'WH[:J@! M./X'+9Z2#&TF>KO*JZ$:6J/E51R+6F6CP3CPG"C&Q%W/5H;.=_PLSVU%9^7Q MH;?CV51/4W5=UN\+R-`C1T_*:^W-:H4;U6MBAF3DN[;BC">!_T1H-6:3O:E: ML/+XT-LUY:.O]=5V]Y#C.21+FXG>KA+;&[34WD$'&A^*8U@IWK'^1D6.Y M''->X4Z9]:VU M_%`F'1^Z;;7$?B\[%8W.ONSKC=ZJU)3ES<9^-X$?J)V>H?:-/9?XBL5Q<6QY MA5OS:Q*&KQ73LN)Q[)H1L16;3`)B.6;D^%Z37;GZ.N^-)\#ZN9ROVJ#=-/C7 M_EG*>!U9W'@";"3CK59/'70ZC99Q<M^59BSR:!8ID3!P\ZV&5GR@<_4(:.9WJ6`[\&9.(' MD>,]*I,XF/@AMHX?.YXSCL?L#F5B3MGXB("X)KTR\I5HA/VV0P(_C\PGHCP0 MXB5OD4`@"3+@E0%^G(0%W+P$)(YLZQ: M^MG@&)?51UA`$<&UP:I28'683A`JY/N$>+`6AK!V4'R'\&.D>(Y'E#$\2I=:0VNK@W91:E6@0S@A5N0\$7=ZMFC6 MPF5>D!-J48$&*0=YGBSIW>]XEAO;5/TD5RR0^8/2O0.:2S.TBNG>T;NJWC6* M;RF2?;4YSG\1=-3;+H-7-A[:\I)1+1TYJB4OBW+01DG`S^TCY*`-.6CCF.*F M(L9]]L44.6CCF-DE!VU([5A;!A[II`8Y:*/6[).#-HXHX4X.VCCT,9N<0"`G M$$@QEV(NQ?SH[':%&79RT$9=N'=\Z,E!&T?'TB-'3P[:.`)K*@=M',4JENB5 MJJ3DX`)A&7KDZ$EYK;U)K7"#*@=MU,`O/G+TY*"-(V/HD:,G!VW4WJ+*01M' MLXXE>N6>3[-:X495#MJHBWM\Y.C)01M'Q](C1T\.VC@" MTRH';=1X[AL)-'9"#-NK+\<830`[:J+LYKW"G+`=MK$%/Y,[[S<9>#MIH M',N;C;T>`'+0QM&SN/$$D(,V:F?&*]R2RT$;POCH M??G;"(14=; MC45[T-5:.78O@7051B$&Y0AY9[HH#78@*\`+&-YP:LE8,9;(S5V&AZ6^_KW0V4Y4*V;@NF;GQM MZ0O63J>U$LQ!IV?T#6-?4.9D*ND;^3*1:J]F0K?3,KJM`V!7THKIK%89O:ZN M]08'0"^IS2X)S=7VNZ4;W8YV0"SO>`'ZE1>9WB,.1J#*YV4XKS;^K4%';^]- M>>1P3FL$X;8/O$+P98BN]B+TGJ;K_0,@FE9M7.6*-EZ&Z6HW1>]K_797/P"J M21;MB[#KKG9?VKHVV)LFRHQ=.6:DN\8SV:\9R6%7CG[MKG95.GK/Z!B'0*]< M,])=[>KLUXPLP+(*,])=[0"U!H:A'<`'+=^,=%>[0OLU(SE$RSL<@J?EF)'5?D^OW]I=7N=C''+Z7_K[TH=OO@GLKG9N MVGU#ZQOM#)^R(-P?YLOVE=W5SDZ[U>H-.IWJ,9]1IN&"R8';1[YZFIP#^#XW M*4]YU?UYT;#/ZCYE;%487VD(6LZZK8*[[T#J0>`\.H/9G$Q,2NU86P8>Z9!*.6.TUNR3,T:/J-;P"KCONL2* M8M-5DM#@`3-+#UZ:4M.9A,W&?GWAE1#%.)*]$GLIW,=OKRLL*N1GR6803#&2 M^V2ZL9S>(CHCRRQY.BA6NU4L]=M]M=OK2#$5CZ%23'-B:FAJKW?(IO('%U-Q M3&B%6]YJ,[C=27P5*PEPNVT5?A M68T6;'%,=86[W4\DDGM=,>)7LC](7?J#=%MJQVC+A7*$$B$72ID+96"H+;G? M%\.)J'"_+T]'#K[X)?;RZ$^R5V(OA;O61KK"G?[YXR/6)T6D$))7R/<)\4+R MNLE.6BUX*EB`4T@S77EL=''1J^L&E5!Q;*C>\M59( M$CWIU1\E_XX=3.4%6XZWX>1,Y[+`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`KSZ=/D>R=[2SP;;8#ZS(JL$?DY5 MK619"2]4OEQ=WO^!7W"U%\@$KSN941;\93>@(C]?[P`Z"T3-G(1D?H,W?W..2.GEU^\_+'Y3#N&U MFDPQ7>?1^^V$ZNS#;6PJV,,AG(!; M+T8*EJ.S[W/!?KNO=GNR'EU`ADHQS8FIH:D].?U5#!-:X9;WW++B<>S.=?EO MLN]4WZ10D358Y9)%9N'*AR(52W4(9&&I+[O?%<"+D5*)CUHD2>WGT M)]DKL9?"76LC7>%.__SQ$>N3(B('[];EE$WD`.7^2U_57D>34BH>/Z649KC* M]F/BV%*YX:VU0I+H2:_^*/EWY.A)\:R;H:QPT_D^C)SQ7!Z8W'36A:?'AUY- MU)/D7S/1D^)9-^LIMYFU7JH2O7IK(LF_9J(GQ;-NAK+";>8M&9N.9Y-`\8?* M_OO?B.4:U8*+QX=>3122Y)\\QEQ[C*GWU9XQ:+*4BF,VJYW,>\@JAH/[1K5@ MW/&A5Q-+*?E70TLI)_,VUU)6N,$$2RF[ZXC.N.-#KR:64O*OAI92IL8VUU)6 MNZ?L-MD=J@7CC@^]FEA*R;\:6DJYIVRNI:QV3]EKLCM4"\8='WHUL922?S6T ME')/V5Q+6>&>\GY$`F(.(Q(TV2FJ!?N.#[V:V,N&\*]6/?\$QWLWFVNT.ZIN M'#+#\N"B+H[1K7![>N]'IMMDUZH6G#L^]&IB;T7FW_YZS0ID;$5&6O:9+L'2 M_A*9#R[)OA;N6?J%W@3\#&P2_':BG2@)O2ALKW5-^_&-0B\Z=OA\YW M8K\Y42SBXI!>R_$>Z8WX?6+:-O].L:`.0/K)3C[]DO\89!\3!'[]Y<'WR.LK M+S*]1P=^/`]#$H7W^/=[\CUZY_K6M[<__.N'?RG*KW%X^FB:D].-I@Z\M[2O6PYPHC@TB8EJ18W]M]8P3)8:' MT2O_O+L\46QB.<##$!%[VV_WN[W.K[]L^N*7`ZH;7ULZ`FK,`-I:#:BA]7K] M2@#-C3`ZSW>NV)S&[96@&_V.WM$W`GT)*%4@LY0/G=7(&'U0"F4BD__;S7#V M(47`-?VK1H%NW?M+N=%=B4`'Y#T'_^JWEP*K<>\O)79O):R]]D#O[PKK*L[D M'O2>]6?Y!'#?/Q/WB7P$)$;;+-S^2AST?L\8;"8OZZ%Z&8[_(69P_^QO@=I@ M&_;L!$P)&(T"0C;'J:]5C!."\W*L/OAQL`52>K5((30EX`37;H'3:LO].^>"X3N20\-()+=Y(X`R5 MPG:A-#`/G'&*CG.TLT#0IKN)/([G&I( MQ+=S5Y\NWR/36OK98!NZS>SO]@S\%G`NNB;9-/\T\^J?U)]"E,^?DOWOC*P4 M4$WXZ&9\Q.48.F&$70JB$5&&ONOZS["??"T`AXW!64]0#L^%-E:RO(07*E^N M+N__P"\8'2B0"5YW,A-O][8?KFR^OE2N15`3)C$I M_F<>#EI^P<7-]?7YYSN`S@*),2 M6+P'NMIK'W)FW<%E7!P;7F&F;!+I#2-VY#+&0R=Z_M3DU*U:L//XT-NQX6=/ M5_5>HU,-167HD:.W8Q&*WE?[S1X'*XYIK7![_,5\).$O8%+'3AB"00V5"`L%<>Z5KAQ MO8E&)%!,OGWE0SG#)CM5^V'E(8K8CYX`.];8@:KKM>6\H%JRO/$$V-G`]SIJ M9Z`W6>K%,?!R@&@3#MIJU;BFWF3952OV];;:[NTYO48N%;E4ZK94#!4>KFJ# M)AQM5U,Z+*;*:[9C9):O9I':L+0./M!Q*5K/5FGVRFNV( MSAMD-9O@,<1&!D[W%1:5U6SUX[04;UG-5D,;+JO9Q%%OXK#S^-"3U6Q'QM`C M1T]6L]7>M,IJMF-:RA(]6.7JRFNT(K*NL9CN:E2PK>X2K[)'5;#5F M>>,)(*O9CL#`RVJV)ARTR1(=P4MT9#7;,AX)`PO_/&#X]%C\(LTL>T""Z``7?IS\KSI>?3!=(*_3#=>,/]P:;W9 MZJ&O&I\8_3)P*L5LZ5S$U:-@!WJO72YVN2I#Y//[\<3UIX2\(QX9.E%X$0RZKHQZ'1RT\'DI\"ZE[.J1JSH@.-`&+X*71B[GU=+VI%T] M1+6CMWKMW!#5U:]]*9!+Z;EZ3JH.NWG8S.\*9:;F+\E#]-(JX(&H`%XPG'1-(:U`%<`+RY<7P50JM9C#>`W^XGP1<+%D M=L:GXR]?7Z.[KBRW4,-;*$I>41I<>B%RY17!L^[Y8B=^]:YA;I.Q:65^V?62BN"ZI'85A8(;)^FA<71;D M%A7!DGU"LF_3(XNZLT]@];D6:ZD^#X?))F2JE4TJG MN#P]*N.W_-RU]`W%M6]Z28F/$OG*[.]ZBJI MR,IC^1[W#2_4:"7BO$"C]0ZKSJ2\2GG=2EXW;99VE)(JB.&M=O?;/=.T'Q5W M9@_\E^FZ9*J\,[UOF#;TCKB/@6G#%OC?NJ;VVEUE['O1R)WB/6BT0\7Q+#?& MW`SX%)&`A)&:[8Z3\U?%:*M@L%O:&R4D5AP06WF8*@^QX^*=37;R=CTE$DS" M]D^`NNYM=+75[ZGZ7L_1I-1+J3^TU+<-_"`K,O^,WE-7N>J])&+Y6DFKKB1]L,9'A*-TC$="KJ5*J]F3O5;NG M:GK_9^&Y)X6SB<+94?56I]'"*8B]K'9CB>T_%-L)+3_VHB9[1_(DK/R3,&$V M`*\ZZJ#75;66=C"-)F5E.E@^[MM_"?7BEPKVK/.)A.$D%2 MZ58RW>J(/#09&UNW=1STY/02(?:-,M^JIDI)K(C7,<2S^IU6TV>0"**49,)5 M3962])3*3V[0.G+2FQAJ2>9DM53$\ MJBV])2'4DLRYDCE7,N>J[!B5VNX=-'0N@M0+HN!DRE5C'"^9L3P-1#09>]D2.A3E-LV#*PNT-9#5(,%N MFP2YV49FUXX'MUP$Q':B#P"?ZT332Q):@3/!01HS^71MGD]GW/OPV6C1SS/Y M=/V3MS2'C#],,3&7#,=.^T%`D\I"Y<$,X8=X`L\WE0F\FV!K4X#$5H:P'F+7 MQ+R3>()SL?O:CW0>-CP>F.C]O_]I#=Z$"G&=1TS\44R+-C(/E8!8Q'E"7%7, M0;/)D#[/89W`+(J@8GHV&X--`7L,"$$2G2D(\(4_GI@>PAOZB@F_VW@[/)E\ M=\((D^&N<60W/N(N><1Y\@A84=%(^>C8%R:%FB)-WYP\%GYD%.!XX:.`_TAD MTU7^W8+5ZKI(<8<2W2,6I3]]+A`)Z1-AWIUI_1,[(;V/P M.A=<"A:\#["!16<^,KH,2=J-S7R"/S["US@*(R`CDO3!=$W/HN^* M"D(#5-9_3'Y.[HR]&`6'#WF9O8GR_1D6%OZ_26\'\^9X)KT8`#G+$2M?Z MEB28P45GZC%93[9C@P\`FLD:.>2)4('^=_^LDZJ#`'[U8I(H,M!>/JR-?V(S MB++T/%2;RO/(L4:P`+@J1!6@/)OP(5#Q;O+=&IG>(ZC'O%J:7X0:X+%11:>,'6&&8(AP0X'"0>PQ>![RQG`EH`W.,&CI9K2XHT3/E M*M-^17@2>HS@>0#.!5!EJ+S_#@HW`DP4$"#'`KQ1+0).`TVQ*1CLV:#KG$>^ MWOE/``;`N.PQJ\F6IQJ]])UO!K;B/X`[@7^FSG-XQH7NY=(TJW7.+2N(BWGA+)0\,=>PY[,H_[RY/P$9:#CB?(7H@;WNM MMMXQM$Q);/+VPG+Z0#/"^=J[=LP';H\V!K"U',#3SLE;O=6GNP).[\6O*T!T MCE8#1 M62TGG1P:VP&['.ES^V]0X?CI`R'@N%(_>W/!Z:Z$N+49X1?!,+LBT49=>6$4 MQ'C=G]0=>9?XM>#Z@2V-IHL(3\%//>:OX"A:Y@26TAT(+5SX%_B+9/K.]+YM M:1E[*Y9,]^0MD[G,[Z!Z M]B:W?@Y\"SR!\$/@CV_`<@9T4-0F+EY9PJQKJ['5M5ET%\))D5;=&?0@[T;WZ$-G0`M*Z^RE'I)@9GL19:!OAJ-?29@!MK.Q:/Z6RT M+#/L;H;OB/L8F/:V(KS&H]%Z[>XRW3,#\6KTKGBS_;)6^U,ZRY7LFM@7XTX+X2=7N(^?4],I7:RI9WJ MQJG17H95'K"Y8$B^8G?GPMNVWHS"VZ1R$)U+9SA-0[WK:D^55_V?<^=9E7W* M)DM=)I.E]E>DVSOK+"O2W95NAZW9W1GL&T\YGP2.JQAEGFVT"C2@A=A&,=Y" MH^$L6KP@E#X77$["W&!'E0^.9WJ68[K*]?4%BXLSNZHP+:6@FF+1XX`\^>X3 M!NLP_#/WU.2((`GRSP7+_UTF43H%HJ2!MF@4^/'C2/E?TXNQVEVGY.JBNQR*E)<#E]PM4Y,QZ9/60@5RBR%W@GGZ`Q\&L;P,LHA%H!E M>S1E")LT>%ZP6*?(?!3S.,D1&H*CI:18>+R$J]*PM/3RC0IA@D++(C/@Y6TAM M*LX^2ST'YE0D,]$X*>E#J=#@\Z@]2<_IF*"D)WAJ[C6Y=R/SI%B@-WR/9P6%J+WP\>Z/4<(;I M;:G;@H>`L1LQ)\=D(^"242'?RA3NGMIJZVIG1J$PA(L0/<-2 M1G8!\<%\_Y?);DINPH)B&I;T1NB3[&VP MAMBQ?7&C0G<*S!3EB$33(/S@&SX#=O9.A%D;`-0C\>C.Q?(#V%V@DI[$\"F$ MI]9*3&HJW>!/?P3#KW>9DZ9BDDK1A_;8EIQR'+ZC;=W:J^9*#.\=L^-\4&+\ M/#_)[&&;5MS`E;M\U(Z6M2!(5U'9QJ?76?`26&R.NZ!/(-RO7HKS?\_D1),7\4D.2T)"*)FF).HE9F'Y8='96;DT61&SB^:NJR@>@&[6$M5">KR M*IP%A*RFB&C&=L'B#\&S3B4^=<'EG'?9>%@V'GY)]>'+RY![HA3KBE=V;-$= MW6'8HK=^/$'I!OD#$3/F$$MW1QF&L$V2[!*47E.X=;C.#5(['K3? MBL@+"A,5W0GD9LGDKI ME-(I+D^/ROA5U/5MD46D:=H37EH=^4L3;M7YQ+R%K3;V*!NR@=Q.WNW1=8C; M2HL96I*&*3PKI:1*26V\I`IBA,MKLKO("&<]1F@ZP0;F6`23*T)G7A'0.Z)F M^=7VDNX=5IU)>97RNI6\G@K/RN,WO-7N?KMGFO8C2XG-&=UQ[TBGUAY;ZMH'_Y(;^\'Y%M1OZ&NT&&K+9J<&9 MW[[W0F4>#AJ&JAW6HDN!EP*_3X$_N#$70>`%,>;5!@D.O_A%\-M$0$^DR*4P MNXH:\4^*IQ1/@?EW_(:RVEWO-0G#UPH?"),TGFRR>R0">C552M6>[+UJ]U1- M[_\L//>D<#91.#NJWNHT6C@%L9?5;BPO\RT?F^P=R9.P\D_"A-D`O.JH@UY7 MU5K:P32:E'$IX]7*>%?M#UJJWF\U6L8%L=H5[W(+#:::[*0=5*4=\D!LTS(4 M4=):#GI2IH/M[[;QGUPK\6.T[%: MK)\U[08ZW^-;M@25+4%E2U`!@P[]SKS"OR5CTZGA+[R9OO$5`3Z2S'+'+ M`'2UU>D)ST\9)WJ9@@*=)'>\HC.N/CJIVC/G=D_M&0?322*(JR`ZJ5JG"2=7 M-]GPB(#>$>FD:OVDCJ9V>[)6\O`ZJ7(_J=MDPR,">D>DDZKUDW1PDS2UW3U8 MM$$$B15$+57N*C5ZCRX">D>DEJIUE;J@EEIJKZ\+S]+C5TO5>DMTAJ-U[T>FVV0[)@)Z!TP$$]0?JZ9; MSN(8FPA(1(\SJ"_![QT[Q(&#EC,R*V,HRC."!*X$]--\KU9A4DV^L( MDOY6<$MF>\EL+YGMU4`'48;FUNUDM5C-!J2V])"+4D4[YDRI=,^2H[1J6V>P<-G8L@]8(H.)GQU1C'2V9\ M5=+8JZ4:++BU.,]#9GRM7T*'HMQ.R63+O[!\E0<_L$E`,SD2="@-7K-<$WK1 MJ6M._3AZ/72^$_O-VI20!!$&+N-YBES^8Y!]3+#Y]9_)]^C=ZYO?7O[P[]^^)>B_/K@>P2N,+WP,QN7?6[_'8<1)EI]($!]"^@) M]]R2X6\GG\_#&T\;?&UI7S%AX^NM'YY;_\1.Z.!8D)OA,!SY`?E(D[+B$-^- MKXZ25T\GY/R[$YXHC@V<-JW(L;^V]?Z)$GL.>\&?=Y4E*X-N.\A+ MIKNA[PWR',T_.K9E3LX]^\YQ';B039G'(?-;0F^LA%YO]7NZ;I1,]M*`;ZT& M'G@#@E4NY6<@:*]FOJ%50+\9$#JK0=B*"DCK*R^,@ABUPI^>.<:Y2_\E]B4? M++$%:;HKX>H,>EVME0-K[:M+@'4I#7LK8>WV!RV]WWH!K'D[^#'M)7E+DKSB MF^'GP/$L9V*Z5]XG@/G^F;A/Y",@,%II"&?P6&W1=+W5Z2TVSEL#]2(,_T/, MX/[9WP*QU<8-]O;&KHAQ6%Z.SR@@6VB.UFJ#U]&Z/>TE&"$T+\;I@Q\'6Z"T MVA+J/4-K=ULO0`K!>3E.SM,V;%IM'[L]H]7KZR_!"AX MSC@>)S]>QB092[@YQ*NMM#[H97N-[6#8!?PK#S0>LF@+V]):;<_[G=;6&&1@ M[(@$*KEMT5AMZG6MH^V"1PK);IB@9ML6D36VWN@/=D`D!61'/&#);XO':M,. M.Y#V+G@D@.R"1W9&MCD:[=7VO`\NRM9H9'#L@L46L*\QW"UCAT4QJ_GOK!&Q M8Y?<#.]&9D#>F2&Q+_SQA'BAB;OON\BWOMU,\"-LRB/GR8FF][A'2>-&180T M_:M&??G6O;\4,>/D;1+^*ZV$;1)A916[F?UM-J*ILA]4Y0YCADJIA6TOJOA+ MZ`K=V.0P66"@2'(AQK1]/<$&`A((0]A=E#>ZS&E6RKW3V&0UAW^&2 M2:3ZK#!/9`^KJ\2DD&-%M5\W^90\E:CF4-6D_!X?4_6\[V/,X?V%8+8=L45D MK^1?HU"5YO/X>-HD5*7Y/$*F2O,IPP='Q,"#+2*5-@U9U"3%;;<(M6<@0(NMR/"15I<$;FR MJ4*7_!&3/W^9;IPSMV:4??X],+U(,DZJ;JFZCY(K4G77FS]2=CEV8DV2EAX;1B1LK_FEZ,8Y+U/?)8]E9>P4Q1K/8,>$Y*@6V>0*[R(IJ9]V# M;?REL$IAW5)8.U)8I;"*)ZP+7`%=U;5.TV%-C-3[FDL$IAK8>PZF?Z M0'AN'G_TI]KDJB3]\6#Q'Q'B?"*@)Y):.@A^"QR\5T:+3I?_67CN2>&LB\TL M$>>%VV=YZGUH]*2P;BRL6E=X;DIA;9[9;PW45J\CK;Z4S;HHTGY/>&Y*897" MRH2UU6AA%22L4VU2SX7IX;Q18BM^H)#O$R>0&3Z[U+D*QNK]$Z`<=['28\!7 M/6-PT"B16`)^Y.)['"68M78?C=!UT5>\8F$TLG0>I MC^NACXT#%N5(897"NJ7ST&Q/5Y!@TUX;--V1243&#R106O(L7!!^RH8'538\ MZ*G=5E_M]66/)D'$?1OT:E[OO67@J7VPE%XIHU)&-SQ,EUE)@LBH=!NJ[9/4 M:QNJ(=V&0Z,G5?+:3D>-[@,C`GI21M?V*FIT-RY!(DW5IC7Q:C7SP26B1)I$ MB#**@)X,B6_F]!EJIZ7#OX,I*RFPQV)0*S]GE)U@I(P*+:/:V:#1QXLBH"<- M_Z:&WV@;JJY+@:VAP#9)J>IGO8,5"$D9E3*Z85[1P0Z)1)#1?+3GEPCC(=G7 MPCU+O]";@/B!38+?3@"FA%X4MM>ZIOWX1J$7G;KFU(^CUT/G.['?G"A86!9. M3,OQ'NF-^'UBVC;_3K&@0:CTDYU\^B7_,<@^)@C\^DL2SIG^% M_QJ:WKKWM<'7ED8_GRB._=O)!Q,>8']MMULG;Q-6)\2V7&(&KV$)C(HB."N! ML[+V\?SV]RL0,?@,__C*9'^;E5Z5_:`J=R1PADI!XDH#P_'8OTETHIBN\^C] M=O)W'$;.<)K*PQ#HE;QOYCGTFOL148:^Z_K/F$?&Q#.,QV,S^`A M2'\3>:.8G#F*'0?T/GC*!!#U;85X-ER'G>%'`165R:,"`/78O@VDA.9OD5U^\_W"_\>P[O](6]SH_IC1?P:J5KO*6V[U&3;(P)Z(NDD8?RB5[INJ)V&M],61`]5ZQG] M14(YTE%V;3F&KBV+%5FW?5!%)H*$"Z+(]AJ.FC_,:;(I$P$]62E8/DD6:+QV MIRM#6@U/>=@R06$N_V'A0\^#P/0>R9AXT;MI=LEGT@2(]HD2`]3TRI`^[42QB>6`.(:_G5Q]^G#RMFL8 MW78_1Y2*H"Z-.A],)_C+=&-R'H;QF"6DW#KAMP\!(5=X<@=^_3PC*]CT)QOH.Q.J>O/W< M_4_[H]&^G"%))1!6*C_)F_[R77B,"TM[1PGJK9"@%DI0U^A6)$"+<=@+V2Y! M&]K$LW,XX'G^D/G,< M(M"W"-OY=R>Z*!%,JS\-Z/3#?_]PL_C#[YT7\(`&3YCY[S7VZ:>5[BYI:Q MH^<0^_/NWNMD9/HB;0&NO@BO2I"ME824F\9O>ZL M%:D$OX*B6?N:<`W#_N3+8X/%^A+B;>#S=G2M9W1TKKC*1JSL=4S=Y_#*^TRS M;+\0W'"#DGDB@?E(Z!\O0>&F%FXC$_`"^G:*POEU0H*O%/X\F0VT#?TR+/=N M1)CEP;D+.S03=W(+X4!7P`LW(]W,KG!3LG57KVE]8+0S:FT&;JE(&CDDC5V1 M[*U$LCW0M8[^4BP/[DGL2IS^:@GH:IJA'\CER/3@+DOT_3\Q[#:N/*!*3/7E M330BP?W(]/AKN%>,AV1@K=D2KG*M#6!KVOI/7KWO#:U]492Y\/NB:!<$]'-G M#Q1=@-:>*+J*E)T<*3M?C?:+2*D#*?7J2;F0AB^VQFM?6[335=+16._GM5H= M32O#"=D2[?V9K/1)[*99L!:8L1?3??7FQ#!Z_3S)#X;ZGM3&51C&Y#.0D=QX M*`3VY5P4IARRMS=VNS%$?0BL9Z7^T@DMUP_C@-P,B\D_1ZC8%`6.7DDCEU>#GW-'A'C[1!7)*Q4/)2Q`]T-M;/:DQ..O5O)YT MYQKAFSA0F#90KCPLC'.>B/+9-3WEU0G6#^/'DY^52>!C##U4AGZ0KQ8&*78\ MRXUI.HG/;1*H"ZP8'N*I.#QSYOK(5QZ(\HCV%+@.WPBW(/`WT`AA[$9H:O'! M-IE@R3$_$0U`"_@!_,$?#D$Q!>Q%MA,0^ON9@O!.XF#BPQ[8']+"98J)$]+7 M>/2P.J9?S(@^3E4"$IE`0GS2V`?D4;E_(],\4.D;Z%4%$!^FG#*\4'JL/#O1 MB".<)\=(BG-$,S&T/'@ M:8#?'6``%REMPSA/:$,/(CW356[)$_%B`BO0IH33!_VNBF-N/=\[_2<&R1HZ M*>#\;8S:"7E->PQ;I1`/-FTD"C[>RJUG_#)VHHC0Y_L@<^]\K#6'+Y=%_B5/ M"DSXK<#%$6!$:]']9Z2-#^C!^^!J0G_&SR'>8'K3&<(LIFI>RK]S:-'WOA4YH`J8?SP-X"+K\>_Y]^32(?ML+?"3= M`O'A-7!A.(0?0')5!5TH9*8#=ALNH=94\9_X(P("RSAT0'Y#YHHE5?L(%SZ: MY%I]YFK[X5D(2[+"@-V4E@GM.7*^!R`!9\/8&O'?"&$L*Q*.LL!UETKI,A$' MO84R;D8*:$7X3/ZAD#`Z#TTG@%40?".1\D1CH!PZSA;XAA(&?2O-JYF M?B5][YGR">5E[+@N(L7O1N*8<33RL2_"/%>0?(L2Y53EF8!4PE\GH`1@7PMO M`R(MU+I)4M!/,[K])_6G$+V`GY8T!.@:AMIM]PLF)04[R<"@2MD!CPVU+<@: M^S/^L%259.B"$HLC]#SIY739!\2T0)9P+;-7G>W7'J_J[["KG:NI>69ZHZ!* M"8_R!NE."75"NI)1*U`E"ZO?9$L.Q8-J,RK[\,91N+25!Q5WC!"C6J=G)KB8 MF.U6P.XE4D[XV3JN4*J7F)4;NO`KFCP%HQ-COO[X[=$(UM$SK#V4P"$[32;V MF7)^=Z'T]#[38`%S,OA)<\C=A>1I="E2=0],P$?39P-5+;-P[UX1]QMW(=TEX^I$$$*>X MJ=@I`94OY8K9J:W$DCI;P`"3;??!Z[.1O,PS@+'=ELHOGD'.`]A3A*'21RO69VJ;OTTD^J7Q=OZ:TJV&A MEU6NEF=IX1:X"0.[/]O)*ODU*6](+J="GV7Q(QXWMZ_9)FT"`NA%V3WL4?G. M5_T?YPHFV`/S10TS`"4]K&8AHA?#W2>X&JC,1?YD6:OP"?G0#=8.,.VO;/LSOP>6#_%\;!5)DZQ$75&M%8$,"]P/.F-A1_23SKT('= MM1DD._=LGY"+*5"=?:9\(4S-F["19ND^IR;+]V&PPM7E^AEGW?X2%V"3K=$Z M;V"SRII#!_FE%I=:7&IQD;5X4K:@8%G,:]22MD^CP;"KQ``Y1D9!.[)=Z+3@ M))O>O,*E;O(I"^4D9S`TIFE9L#AA];E3&LD$5L2^`0X](J;WEF`5BK].=#+#:6>M8N.]A1X MN%UP3%H`:0&D!3@\"X[=`F05?E3]I^H]59!/Z059C'Y"2'!JT5BE@Z=#LUJ; M1]E7:N#<QD]]H5"07JRX< ME&)J2^*8HY/--#8[?P%EFCYD0KMAL-R@9U#596K99<<<4L/N[0!G)Z#+-+0% MO)-N)CP7!&6TD+@T<6'54S'F5)_U'HDD2C]+@5%=,.-8;/F4 M/)6HKAXK*^6W[DS55P^L2SKUB,A>R;]&H2K-Y_'QM$FH2O-YA$R5YE.&#XZ( M@0).5#XB7&KGP32"*U*'UYQ!O(MLAA^VD97H^2JY(U5UO M_DC5+;=-Q\#`.B:&#U8O3=:)5_)/6/ZMTZU\4HSC&1[!.6 M?5*AUIM_4J$VC:,-4JB'VV)DG3I`5BQK.+2LJO8=N:G;V/GS?TTO-H.IHN^1 MQ[MAN_>@P&&8*4K.;8!'Z(O1G^D,TTE:F8M&D@7QR(YJ=+MJI]417AZDN&\K M[O]NII0O*BLPSK1]%JQ+"9<2OF<)U\^T?7;4D!(N798#N2QMM6_TU8&N"2\/ M4MRE0G^!RZ*WA1%2PE_BLC0ZRB)(>&U(_U-5>.UW-J/P4'S>&+EZ:K+R M>%,*ZP!7055WKJ)HF70$IL.()[))3+BFL4ECK(:SZF3X0GIO''_VI-KDJ27\\ M6/Q'A#B?".B)I)8.@M\"!^^5T=+0O_M9>.Y)X:R+S2P1YX7;9WGJ?6CTI+!N M+*Q:5WAN2F%MGMEO#=16KR.MOI3-NBC2?D]X;DIAE<+*A+75:&$5)*Q3;5+/ MA>GAO%$<`1W@R&QTF/`5SUC<-`HD5@"?N3B>QPG M*[V^\-R4PBJ%E?F+`WEF+5V'XW0==%7O&)A-+)T'J8_KH8^-`Q;E2&&5PKJE M\]!L3U>08-->&S3=D4E$Q@\D4%KR+%P0?LJ&!U4V/.BIW59?[?5ECR9!Q'T; M]&I>[[UEX*E]L)1>*:-21C<\3)=928+(J'0;JNV3U&L;JB'=AD.C)U7RVDY' MC>X#(P)Z4D;7]BIJ=##(EOYO09:J>E MP[^#*2LIL,=B4"L_9Y2=8*2,"BVCVMF@T<>+(J`G#?^FAM]H&ZJN2X&MH<`V M2:GJ9[V#%0A)&94RNF%>T<$.B?8DH_37H>]%"2(%$'^:@?$G]:>0!,[PISFX MLE?\@D^C+]DTD/1+A*&6[&OAGOP7^)R`:;G$#%X#5T=%JLX2=99\E$]7GR[? M?P(J&;VS#I+TX_GM[U=`2LWQV+\\/G/$F4%Z9KTOQ;X$X!?!J9BN\^C]=O)W M'$;.<'J2O'L=V/$PDCK-7DA'EVHI%B`@"HG>%W M\XD$YB-1AJ83<)*:$4*I/&+S=L5&H@,NI1)-.^MK13@G0"0&XBKB6?YX0KS0 MQ.NP]!0^$R4@KHF81#YHW`1=\]D,[!!^B)0IB>`:RW_TG/_"7Y[-DB6@V^VI M>J]3E(#*M4)!I;7TL\$RE;:KJJBIAKOR%-.V'90050$I^6A.%:.=6WW*!0B1 MZ4U!$X0QR$.IJ[#5RIK&IK(=@$@&CH5B&4:^]2T13A!8BP21"1B3\<3UIX2$ M5-U1H<[NH6.@%11LQ1Q&N%`\`E)M!@HH:*9*."[/(^)1'-E[)CAMN'R!U\ZZ M_?G52\%DVCKR(]--UV?9RL,P>FI_EL:@UG-K/##1N9@J/B@W2@\D'IHR`-3Q M;3`BRN_$`\7G4A*>VV/'"/WISG0!)/STT0R^$7KS>X906/WBWF9! MB+P8BX1:OD42#.P/@3]6(G@A+E'Z_\]$&8,B82:1+:[4TP`9F5OA]$*VPN&: MV(WPZYGR!83+LOP8'C+T@]S?9IX)\.-U@8VM%IC)/K^[4#I:Y[2CG8$&H_>A M3":+#!^7&6U8%#^F3`(X.;4JJX3I>L3VD]#[E@J]D7HET8^J[K/R.? MZ=Y/">/QV`Q`$L(E-A)6`6AD)YHJ=AS0^^`I7(<3SX:+Y[W$U^((3TUVDRO8 M5Q:U6-3BFH9("N0#$-XH7ZXN[__`R_/1&"XBBZN#!^2A"YI1RY(C^177[S_< M+_Q[#N_TA;W.C^F-%S?7U^>?[P!J"Z34G(1D013FYJ_WMQ^N;[Z\5IZ\3]&#Y=[Z0,;J4H\U>DW!>'F;K M+@BS'21B*E[LUP*[28+#L$5O_7B"X@[R!R)FS"%V1W<>#6&/($ENY64R+EIT M,^64_VMZ9XK.[.:A0MXB)#B*@-X1G767B+.QH"*RU5('AYMU(H*\"J*KRCN' M6Z2KSG$'(%L+'AJ](])+)>*\0"^="L_*X]=(U7I/:>?3)ML>$=`322<)XQ>] MTG5#[31\HHT@>JA:S^@O>L;=9',C&R<>2>/$Q8JLVSZH(A-!P@519'L-1\T? MYC39E(F`GFS643Y)%FB\=JL(274]><^G'T>NA\)_:;M6?_ MR:N99F0V(`4G_S'(/B:*\]=?XO#TT30GKR^=T')]3-&Z&5[D\J=O&>,N_#`* MZ4'O.TP#^VQ.,9,KO"??HWWGBZ\;6E?T51/%$<&\0!LX#L MK^UN]T2)/8==R;)B3Q2;6`[8N_"WDZM/'T[>=HQNM]/J9.B7#N\A":+/$*2W MGB#MOM$?Z%J-"/([S9V\\CY3G?][X(=AD22:_E6CY&C=^]K@:TNCGV=(TU]/ MFE:KI1N=$DFS`/+#$R-!3Z M1_ZL=++\]H+1T];C;K2T(NI;PU499BNXVM,W$/E!J]?D`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`0F\"K!W703I-%82/T)O)T;\K38H5HJKIONB7#\Z7X=JB=1 M23@KD)OOB[1VW4FX?#>VB5N_1`H[VN8G1X,7K^D=,!&1A,8,"3?=&6&+^@.2 M\,6N[OM_8B>:7GEA%,3TG.`&VV+?CTR/0_4I227?,D>XHVV2_-5J#4I)_MH6 MC?W1K[B)V-H#ZF@;Y(+MA8)%1/9'0![#)_8+:+A!NIB."0<0ONC)2M7 M?P$A-T@ST[OM/1&RB(U`*G$I^39(2FMWNH=5B=267;AF&-X,OYCXGN@FN$5[ M-)^>O&C3TCQ3"%]SV!%_79-2VZ=!C.<8B0WL4/ MH6,[9C#%AO,W0YIS/T\$75O)X):F]0<=$1A<,MJS_O!BWNN%H[Y]\7Z1%JI. M`(S5`M`VVOTM!6"A1[_PWGR7AN5+6H,E[=B/Y-HWO0*&(S^([DDPOB0/T?UT M0A9@MTGE0:>G=;J=-7S.@5HJ:@C[!\LP*H>X\R%^,H,>;DX;U(N8'3:K7R.V:9(4]'_TPN(Z6)% M[^^FX]UX_*[I):%+T'DBUX[YX+C847YK-U3OKK:R[6XKC;)O`4@)7$L=GJ_7 MCF?YK@<,^'9A3IS(=#_$GGWM6J7P;X-D_D&O;_3W*K*MU*6H%OD-"DKU=JNW MRX)E@1QK1.S8S:S3.9]]<(^QF;0>>P>Y'9R\+;TMQ"3")O;L9O:WV1XC*OM! M5>ZP6E\I=:;`B[IHK)E$X<>!\LPXD(R?<.#G+3HH[&$$Q<(I#@L:C@C96V2N MSB,JR[DA;HB(`)KLSA8VS.$Y<%C3NDB)V>+:L M&6*2G&HUA$&[]8V42EP8!@K`%*G$I8B)I<1Y2D)#^"-U>,T9*`!3I`Z7(B:6 M#D_.X!K"(*G$:\[`TIFR?E)#Y6N0)NUL.M%3,E`\!M($AH;P[Z`:='F#_'+5 MZOQ$UM@,IEL.92V)TU7@7,GRW63V@A`<;QSV?$#'_#".U2-=U9:AJ]UN3\I[ M[3B^#OM_'R/2NXFY<69L.N/E*"5<'(->F/!5KD%GF98'9'-)N(GD=TOT*M-) M;;75,51#[TB)%8^E1X[>;A*KG?6,)@NK.%:TPFUQVFVDR?Y2+;AW?.CMII9. MI:2*Q\HC1T]*:HVM9X5[4-[GJ,E>TGYX5\6)4.,)0+7:Z@GQG59+U7NM32?$ M2PD7BL&-)\"NX>.-1X0?I<"+8[KW=QX\7US89.>MIJ=%S<9^-V6GZZK>UM2> M-I`"7SN6RS/AS>7\K-MHE9XWZMGX>F7^GJ5?6-7V@Q_8)*`%S0F]*&RO6=$W MO>C4-:=^'+T>.M^)_69M933%@OH:Z2<[^?1+_F.0?4P02+IS;M;4874C".S4 MP_JOA6$\9FW47MH4PM!D4XCW,TTA2!@Y8VP!H@Q-)U!8"^%G,U1L[-H"/\FIR2J7%#/CG6P/(=M#"-$>HM=M M2GN(=O_P48:#YU,+P)29;'>CF\]V[\XA]LGQ2(8Z@>,U97C[TD?EP)35Z.L?#L MEW)^$#G?4XIHL\U0%:'$1;:)]=KVATH,+G_@3EDGV#%L"``AC'^]FA#`'8N; M#YD24S+?)7;IWPFS(,"%$<]%M)&"F!&>VY;X=8R5NUX.7QH;>KE[&O$KL] M<_-'N03KQ[2:H[?K$FP=TM$_U!(4QSVH,)R!T["4R%<(ENG0S)Y?G/'$=8B- M/Q$+4U!<9WA(?^'@?F(MF'M\Z.VFK#IG@ZXR)6:PI]:"1\Y3N2(E>B]TS MO2-7I#C>1(7!ADOGR;&)9RM3A[BRYE=T%AX?>CMN<&J)JPPP'"'3:HZ>7'\R MNI`CP5^^:T9TM+#A_AL2^\BZQ+!:>^$2N'?.!>APO+DO6&U&6G!15_AV' MD3.+!NV4XYJ;@)*[>: M>*^8GHT?#%G;+&N;A:AM'FA-J6V6P]HJ\5`./^MK_]V^)/O*9=^>^]3+<[8J M._.],UW3`UN3G](F-_BU2]MO-O8[-BE3N^V!VM/D?+;Z<;S9V.\J[QVMJVK- MEG=QC'J%G?*S&%86&7'D!+.WH[FM=T"9U+VLA?"N%:X M8UYD7(D<[+8OCC9V=$>5!)`CMQK$[,830$I[C2U[A=OF7"P\GPS09(_NH`$R MB?T^]R\8&M35@='H,=0UY7BSL:_R^*=AZ93;IT,6TBMOHA$)WO\3XU7PN!#S M]C`A\P6YDT8CZ=K/N>6\AT^):%`)$B()&)Z4W[*LUB2$O7\TPSL/ZD_A2CE/R6: M=D;BC$%/'0ST`LFRT!<=$V1Z:0A,F00X0PB@^W>94!AGW!%/(8A\Q50>`O\; MT`((#)KE[]BC^B8;770>/P*M%:--$WH-9>AXX.'3*90(_B,9$P"/7GY[F MW(\(8/!,`J($Q$*53;.)F=ST#4-[0S6<VKR+1E8 M`0,_XS%A0_@G3FYLA54O-W$41J9GT[/S7*\(=I*T7TZ+E1I=TQKR9F._6\I@ M3VT9NMKM-KJ"OJ88;'+E>P'40?6'1]ZLA_$ MT;'TR-';36+W-VY83&$5QXI6N"U^+QL_U(1[QX>>+&,_&E8>.7I24FML/2O< M@[['4>%R$UH][QK;1J9*`E"MME*#O>JT6JK>:_TL);R.#&X\`78-'\LNB&*8 M[OV=!\\7%S;9>:OI:5&SL=^QBXRNZFU-[6D#*?"U8[D\$]Y,\8UB''([D&.2;Z:9KR$#CV8ZXK#6LH5"J,K5Y'U31M5PAM M\A#E6_=X=OD@ME6CTU9;_=[60"(H(8%?[;0U$QT>2F@;M!S/LN)PBCV>Y=B(3):9M@<_WY0@DQ`3[#*P*C_0@0 M8".8$:(2.:>VX\94!"S7C$.2O,:'2QW$,&T.\Q@0UN<*%TZ%5!CTU+[1+Q(A M-ZUWA6S-+A4FGT5-C`MG#!_A<2%?"OY#3N)F.E29-EH!BO:0F%$,)*8"$T(!"KZ2Z[Y%Y`K]@)BNK2=UZ,)MY7>V:S=55NMWBS=DEY7P\`?4U"M M$38L2Z4)[=`B`[1Z[#$3PGQS(,Z#,^5/S^;-RM#>S:J3C$(J[O>Q&UD$:"K/ M(\:B$\4,(TH)L MY4(3FBZAP&)#)"HB'G`%>TWZ,]_Q!J`8,AG>8E)(7?^9(FUZJ^$$T0&,HA6" M:GW7+<_T["^C04M3Y8J4*[+F*[*: M4YP]%.<;JXOS7W(\7PE-7HZQ\.R7\SZB+A,L%+"QSY0+.I5-U M]E3)+N8"%L=?*2E=?)&_5!C.N"?!&#.>"%9!FY@3 M\HN#Z9K$QI^(A2DH.#=2[H0$9^[QH;>;LNJ<#;K*E)C!GCHW'SE/Y8J4Z+UP M1;;/](Y)X$Q4&&RZ=)\+*EBJBL_#XT-MQ@U-+7&6`X0B95G/T MY/J3T84<"?[R73.BQ5]RMR(X^XX/O=UTT;XZ3.R9EX=T!J2$-A.]'1?@(8_[ M#K4`-VV_4E;%*7WP8(@ZSJO*5M?OYJGU:]+:@ZQ[M\8!YS[*Z M6%87"U%=/-":4ETLI]%6XB,F%)IU4%MZ3[]$[U[>^O?WA7S_\2U%^I1=_8?&(W#CA.^S?&5ZQ MF606T!;NNR7#WTX^:_I7^"]FX]S[VN!K2Z.?3Q3'!C;B6^RO'0.^QY[#[J"M M0,,3Q2:6`S(3_G9R]>G#R=MVJV,8>H>#NQJ"!-@X/'TTS./IQM<6A=J8@;2]'M)>R]"[W=ZOOVSZ^HUH^SX)_>Q`WLYZ MH+4UA$U?OR&P$R?8"=3N>E`[K9;>:ZV%ET+PUGC;87A16 M7I_PXC/.NTK_&/*_AEM(!:@QE7%"5A9&S()>-,6X[4"I`6(?/!=`+:9?L\FU-&O]\, M_TQ[;E_0EMMWM./V]FBU-A:^;K^(UK;`58B@D4-P1A&VVALBB"U@]X,@]B'] M$!!RQ;N0WIK1+@*9-_V3N(A/&QFF:;/Z8E-H*L!D%8NZZS%I;2!\+\'D/>_P MEK1M^0]V;=F!*;T5J,RKNXTAJ0*-51SIBX%&5C2_XQH9K,"#*;76YJ@4H:D$ MEQ4\:6MK<=E@M9>#"VV5N#4WVOK)V\^=_^CZ1[U[N3FH^+(2`5Q%8B#CY_9_ M](]&>T?XRMB6)CYMEB5PG=0>?J0'"G&([[B`)\"3B!?!IQ#6&.M9^6YZ/YV0 M\^]..(/;!AMQO=L>]+0=MK8;A`9VB;SL MCG1AY56$]`9!!KW=ZJUPT=?AG#CMX97W&6#W#\GB#0(5,XC.0?\2%/?!T'YY M*)81*:H(R\%Z+$%%Z0/#V*=RKIJY'6T?-@DV:$Z$(^'#<\].(;0<$EXZH>7Z M(?A2:3!\>Z^F`UY-?"95`K04]%M;T+Q"H\<)*.,,H\+W'Y-7KH+Z9 MT.4.BN2:F.$BPA>?=S`^[-R_I)YM5[X0Q46&*-&SK_C#(88_AZ:%RAN[H=#A M?8KG>Z<6IBZY]"333WG);C4?`T+8`GMVHE&N1[YBP_XQQ(8IH!H'O-^)T3I3 MX+4C\XG05BD^W3&QYOH1-L5%BM"_T,>'M*>*Z?EX4JG`!;1',GR`31P^$/\* M!CZ!>JHJS[F'T[-[;.$R=`(%R;JZG$;^*?V@4%/S2/$_J_#`^D,<@2E2QH[GC..Q,C&GC.)IPQD@'B`) M:-,6TI0T2#%B#B,$.T0BS/>@43E:<&F8$%P%G`C>P;KFA-6WISGRU;F"OV5T MJYEM4%/H7[.D6\WZ_C&;MXQ9V:BF]+8X&V5%;)E(.IN>LCB)9776S/*$VCRO M-FUGDR;(]#H+9I61L>G090MK>HN&)X=#JJB\A@GO"HJ M$=4%JLCH#M3VQF6T1RFF@NBB:GTDT$6;UO8?I<$1`;WZZZ)JW2*CVU+U5E=X M/AZ_+JK<+SH8DT4P."*@5W]=5+5?=%!=)(*8"J*+*O>+-FW0=I0&1P3TZJ^+ MI%_4#%U4K5]TGYY/-=GL9.BM;T8B,(-?H+.VP[NN'E;?:*F]C=M]'*6H"Z+5 MJO6P[OW(=)MLNT1`;V:DP%H-V&URT1N\D=NH24FJH$),3Z+.>)N-,SI4`=)U1L@MF%\$1;B4,Z-&Z$B5.!B=K\U*6O(M'( MMS'_!O^69.417O4%SXTMH7@,8?$\RJ?81K MPR@=^(A/<89TAB0\P(XM>#7<#6KLR;%HYO,PP"6MF+#NG<`^G9A!-/T)_Q`1 MUP5E$9LNWCH!,*;,70S/E'N?9DYGJ'R$B<8#==3!S>0Q_#ARXU_)#+&R` M_Z)2BUV:[!S&UBB/:`ZA1'(I\NFS35D*MM4;FTG`#'T>^\KSR+%&V9U^ M_DYX-TI\"+\'!,#U&-X/L*#&IHV+D2Y#?#7\/<3',[O,G@#+DR]@MJX2"N%# M.554KE80F!R4\,"8IL\[U&WPXX@]V8SF'DW7;)[^N:!-54S;#AR)/ MJR+X"L3[Z+B]"0!`^\SB"P+R3TS"2"Y#07R(:U"M3(?NVWNH$*E5K!$'J;5N MA)=.*30&28$,V&!8H01THDVKI,"N>JSX*8JH?@S\,=4>'WS?INKN,H@?E7,; M=P6X:Z"JX16C4-\PM#7NA$7L&&PZK8SRL!"5KG,P MS]A$FBK@@#S&<)$+.?7KUQR_W%Y]_ICLCW*;Y'E=WM"QLEO@`O(K57.>@ M\EQ%[RUC6H%90'\T+\R$L/T8\:PI\UELIGJ=B.Z3X3+ZG`G5Y$R=(DRT6"H% M`6QD[/$;\7F6'P1L>\DM`_>6_/QMDPD(?&*9%+!+_\3P>G#^1KF+T'(SL%1E MY#^3)[0]<^_!%SS[L6OCDX9Q0(T">3+=F"($[X:]Y=^QQWA`.8>H\$(^O!L8 MG7"+5I*!ESLA*<6XI/GV7@W-,1VO^- MP7%'1K*ED0-FZ%MT!CO"E3G=BT4[E>Q-[Z>2!^B=)]1%&Q\ZF7^P^$$SKU5Q M+__!A]U^N]]B0D3[16S]7`:.RL25],TS>HF3?TG%LQ*L4>?L%: M/NZJTR4=4IHS/X*Z[%Q> MEI@^H"O#A0ZK,%,\LE#(,,9]6V'M4XG/K@0]G85W](6:VN02EE_Q-MW\4#$W M(U5Y,#G<**-/#E@8+HSSRU=%?J]ML8[!=LA]=$,OI%(>?_=&F&T0?GD1^FF^GBPK`GK-HG1 MYZ]1$B_OHSE54&,LTALV`7XZU"'P@+E8`IYX>`CU?_S@F\+Z3:9"D'?NDA_S M'AY]$(LEQ2%39EPSL\#.G%]UQY6KKFFM5^;/KQS'^3DQ%A=\L_=[#!M!=GF( MX(Q\UP:+FKQ7[[U1"&WLC3>ZJ/?AQ9[R;QS$H.$_JIL]$&;7#T-F>(=LYT_U MTMBG!?,XP!U^#U$I9:7E\P#^O`,H[16@X-X]A66X"J"BCD3C\+\QV"B,\U,3 M!*0.XX>Q$S$;-G%-VFT`M?`"TG,+#78";98+'CRR+>_=JMRQ8*\Q=/X:O#&5 M",<;@K6B!PAIT-^RP&;1%W&L*"3XK$N)ECXMK> M&G3:^P;L34@M[+/CNN@E`D7^!A[BTR:T$9)C)5;P89KA`3T+>LTHFW9KFZE[,53WRC^XMR2LEXH>_'(7CP- M3HD4`3U97"5[\=2B"D'VXJFI*A*B9NH8*J)D+QY1=)'LQ5-3723=(EES?F2Z M2/;BJ:DNDG[1<>@B$<14$%TD>_'45!=)O^@X=)$(8BJ(+I*]>&0O'MF+1_;B M.2ZM)GOQ-,;%DKUX9"\>D7KQU"FKLY1$L#49E(4G)\^\C,D%%FI[,RF5QD M7`G4ANO\ET\C3ZH1,)7?)D-"^\]$YG=L;$.PKNN9P-=O6+V%[54L"UO5**;B MQ31/&Z?(FK15CJI,`M`)@4/KE%W^.I^5>?%WP5?6A"K"AWZG[J5#I>),^8+Z M#$N*B\WFDL8#\*OK?"/N-"V[2*JV8H\^AY9.(6)D,1ZFPJF`QUG1RG`_B'+UZ/,//5/>$']&N!985(X8`:@Z/ MYQ&A%5Z@$S+8Z7J8!/[0H>[M,B"Q7CYM3!>?<)"* MZ<7+K9X9\CN#C8TK#$WK8W&,'S^.:*]%RB!6!A'05&GL.L&G/9L@+F;2.`EY M?(7-BW#V\BUY(AZ8[;ND#Q.KH,#'=_'>U4_&*S]B#;YG*I<$>SW1UE,@W/RY M9QF%L=U&2,6(]G**HY$?L#X4Z0SIY,=I!C7AS3PR$%BU)KU\,G$=BR?XFU$< MT3HAVGZ.]P>@`[*EH!Y44).*--NQ:4%;``KJT4.-BK]B>[X`E"7M.T9`(F>[ MX67:AX2[-2$]HI+35<[L\HJV"S,#%-6S==B-\XHU= MNCR9P8*'(V4(Q.>%ZDP+.^%>*\U>A,YAE.?"W45)+\P%9J]I7/8PM60YO`LO M%*RR+-']&,(^5)E9-6=6!SG9$>^,RJ*=+`_#%J/UXPE*-\@?B%AG#K%/8.@S MY)C%S[Y3T]\0WAWN%%DNOH-FO(B\/%.O.Z,!N-\-8:A\!3V_ M8(U%B=#[K)O?F+LE9JQ(YJ]@OB$B\X]*-^\QYZX0:+#3@`X&01>&'?;(>^'R MED1`KX+TO!=AOR)/3TCTM5IS7PJW%&XIW+4UY=46!>$1#1MCE^L`RSNL@OU^ M?2@!$*%^0@3T=BD$$D!]E8B?D/I)BJ<43RF>=3"?U>Z$KW@629/])!'0DS7^ MJU522VVWL-EVHZO\14!/"NIJ0>WK'55KZ<+S\?@-9[7[SJM<=F63O201T!/) MB1>GI\0"Y70J/"NEI$I);;RD"F)`J]UY?O*]4WK8BLGP3[2>Y6#!6A&\)A'0 M$TD]">/1UXA_4CRE>`K,O^,WF=7N.6]O[A33QE)"6BPZ)*3)7I((Z-4_&E:M M&]]CTPF%YZ,4TT:+J=QM'MYT5ISQ2Z*(9?RRP9;F>?`M:9\2\H&TM&J\P3Z4 M".C57U-5Z^WK:M\8J-UVHUMIBH">%%1!3:H(`BJ(2:WZ!/0)S*D?3+-Y[HZ7 MF-8PM;=-=JU$0*_^BJI:W[^M#=1^JR\\'Z68-EI,Y1;U\/:TVBWJE\")R*D_ M'.9WJ&G326S@9OOQ0S2,W73CVF0?2P3T!%!:.Z!U<7-]DPZ-7?]4DG7XIH`T6T+;65XU.HX_Y!;&@%9^BPH:4 M!GC]H?)L!H%YP+"N"&Z3".C57S=)OUX*:(,%U#`TM=_;9\M>X<14$..YMQI2 M*\"XKN6/,8`KF_8*@%[]E93<@DH!;;"`MK2VVNT?K'A+!#$5Q(I6NP6])`\1 M[8)/9PGG)D@.'0^VIH[WV&1'2@3TZJ^IY(94"FB#!;2GMMJZVC$:70DMB#&M M=DMZZT]--YHJKF,^."Y.Y!;)H(K@4XF`7OWUE=R;2@%ML(`>W*#N25#IKW.# MQA,0?YJ!\2?UIQ!GNO\T!U?VBN43R9?9ZE_H^.X\C`DP.\X1/UG\^LV^L%GB M#WY@DX!.V4Z`H>1\S>:`TXM.77/JQ]'KH?.=V&_6CNM.@&*8,_%)`?\L+G+=-9<>(_WWI/OT3O7M[Z] M_>%?/_Q+47Y-'K/NYN0^3%Z.X,LM&?YV\EG3O\)_<53EO:\-OK8T^OE$<6P0 M'.RS:'_M=#LG;TOB8S:`?A+A7'1V,_O;[/)1V0^J%D8/TC'&2'CE:N9\8-+EVT)!*3:\>K3Y7OD M7DL_&Z`B>Q%59TQME<"_#,[*U&N!R0NG2BI.J)BA,O2QR(\W/Q6:4/N&;@69 MRQ)Z9J2OJ4=06`4`PAOER]7E_1]X>=X#80:(OWQV!.Z`/'0M@LHP&5S'K[A^ M_^%^X=]S>!=>F-YY<7-]??[Y#L"V0%+,20C.Q`UX&1^N;[Z\5IZ<@1VDYB_S\S89NKF?;:VS0<:[$(T:6'8 MX<@CYL*C]^+U?1Q#+G9&7\[`$!@]*=Q2N(_9E%>;B4M/?R:F8RMV'&`_HFA$ ME`D)')^V+#K8?#01LL=$0*^F`ZBJS6VL$?^D>$KQ%)A_QV\^J]T)7V%,AH0' M:SDO@I\D`GHR>7%-89W:;G553>L*STDIJ(T6U+[>4;76P?I,BB"F@AC.BIL0 M>98_)DID?B>R^9#H#-RC$R]T39TL^I22*B55>$D5Q(#NK1%1Y#PYD4/"@P5K M1?":1$!/)/4DC$=?(_Y)\93B*3#_CM]D5KOGO+VY4TS[[SB,Z%3N(9%35T1G MH_#1L(J;N&B:JFF-;N$B`GI23.5N4W3367'&;SI<.S\JE,\$Y=.X:6>"!OM0 M(J!7?TU5K;>OJWUCH';;C9YR(0)Z4E`%-:DB"*@@)K7J$]`G,*=^,.7FD]B* MXR6F-4SM;9-=*Q'0J[^BJM;W;VL#M=_J"\]'*::-%E.Y13V\/:UVB_HE<")R MZ@^'^1TJ]KFBL\YP_+;MQP_1,';3C6N3?2P1T!-`:>V`UL7-]"65>Y4C]VR5KM3_40B)1R9`0#@A"$./4-KZB4)2);OA;$; M8?$H^8ZST.2QJNA<%EYE5;L9T#L]M=,]6)&!%%,IID);5A$$5!#+6NV>]<*< M.-A#R25F2&!;^D_LA([LF'1X].JOFJ33+P6TP0+:UOJJT6GT,;\@%K3B4U38 MD-(`KS]4GLT@,`\8UA7!;1(!O?KK)NG72P%ML(`:AJ;V>_MLV2NU_#$&<&737@'0J[^2DEM0*:`-%M"6UE:[_6,?%UH'*UKM%O22/$2T M"S[F%`DU>UL$1TH$].JOJ>2&5`IH@P7TX+.W11!408QIM5O26W]JNM%4<1WS MP7&=:"J4017!IQ(!O?KK*[DWE0+:8`$]N$$505#S!O47.F,[^UJX9^D7-IC[ MP0]L$M"1U0F]*&ROV5!M>M&I:T[].'H]=+X3^\W:V=<4"VKGTT]V\NF7_,<@ M^Y@@\.LO<7CZ:)J3USC_(]>N?ZUK>W/_SKAW\IRJ_) M?4E7^\\X%\;RX=OWZ)8,?SOYK.E?X;\XS/'>UP9?6QK]?*(X]F\G'[`3H?VU MT^V>*+'GL#O^O+L\46QB.2`@(6+VMM5N=36MFT&9?]L.D!@Y2(P92'HK(>GK M':VE;PH(]BN^QW;%.U*EOQ(6+0]&X56[0;***H.2(+EV/'(SO`B([43P<.JN M7>#`>""CZ7X@)#P?TYC(!L3Z>NN'YUG^V\UP&([\@'RD0W[C$-]WRQS!SV80 M3>\#TPL1']\+WTWS?SG_[H1%?'O:2GQ[M(PG0WI3K$JF1H%A55)#WY3[NQ+B MEDS,*2J;\&9XSBOM;M,.,7?$B@/`ZK_TD&DCT;@CIAE\X[F2UZY5"AF,E630 M^\:@V^YEQ-@&J0H(4I2.2@C2VE0N=B'%@^^1UVG'@]NDX<'!N-]>B6Q;&_1; M_5]_60SU3CCM@8&==0QR`K((AX2$FK-\\ MN,XC7>8A>`IQ$&PF_3-@K?9&VEK?Z/3R+NW*]Y<#[@IV]E<[$]K6D-)%>>&: M(6C3+RR!\2:XQ6TEX\`E'\8+4$BUQ-@/$K-U,_R0A!HO_#`*SSW[DA_P+5-XJ^B_L6G=%(:285]%_=66 MLM=JZQWC!1A0MGWR/=RJ@DZ&;:E]D4M"VH'8FYG!Y:]\&62K2+EF7ZRUN_W- MP4N],18P?\\J;W>@UVK[E/?["F_:"8Y5U%EMGN8$;34TY3@QU3NB_=763V_K M@[XV*,V5609F%A1*8T+;2](``$ZB<$DK3:P4^PS\>.65_FPTLJNP'5;D#W3Y4"L'`TL!P//9O$F7/'P*!DA?,W)C& M[W[!BTJ$*'MP/@QY:$R55WK[YUS0=0^?N"0K5)25O"P7R+XG4KU1:(#\ZM/E M>Q33EGXVV$I2BO'J/0-_HIC@G7J_G6!G?&[`"E2 M;U8<*FFOZ8?4DD!@=['8UT>0NG.8RC7>"1$)S6ZT2*6/%P7SV&>G@113=OX@ M)GD&R28#HR0G0CMV=+A@J="8-?.4<3967/LL(KN*7^CY3:09K,!3//08Q>$9 MOX<)4O;"R&P`X=^;WTX_WI8O.V]>TLI#F%Y.>,S.5*STY@>'9[7G6NQ*MX@C MYDN?Q2I;7LW(XT4-'4U78`0RM32G9GIZ5\@L`/I!!-B^!L:`$_Q5=1\4%O_& MIU!(LYAF@E5E-@E$&+)WRI]JL7!`%+Z$I2%-=QB,AN5P`K,4S`!T$X_@)I01 M8(KKI&*B1<;U@C[,-&0>8-%I9_`1PYY=H^`L9?_? MK[5N2"6\\KKZTO#Q.,YY"#M=2*R05::(JC_!>>V^:O6_X!S\18]OH45X?%`= MU#WH2F;.V52KB/EX6GPVAQ-GV+#DL*G48#1B&0L6@1@".H08LA#'&'VR.6]:]_M] MI[NN_7ZSJ[B#5XZWLHJ#]B01^$-@(D3S@('Y(X MS2ER8!B\(^.4ZA#PBF=L+EC`P2MRELA$A"AE$"_5AZS_G.89F/!R#G.HP(;& M8+W3%$T]6%'TOFD^P7=:;)B:^P^3S+A1M^W0ACEF-?1DRXO[$[XP'6P>%E^B M;?9(>!YL9*>^D6CW-SOG[[[@6_F"4WILP#0*ZC`,!I/DI&1(;\F#A`B*G(LCJ]-^D\)Y/BG:J8C^?9*@. M=$TG*J:-F3#UU"H,89TQ:/A6&, MH]),RW$.Q.\B"DA'8FK.[B,&*T44A\U835=T%[=VDXO$?!Q$,BT#U"L>\QE! M+3"*PSO2.(2\H:1DI4H,&0`\CXD6]U+E:;A]E0K5=0*!PXVS0S(L0]R="X6` M!G:1Q[[#WM\X3#Q,`A[/R!D;EF$Q,%P4H26YAD_14Y?+[N"`K-M;SM#*%`9^P+R&\K= MLD!JE+Y&E_9-S/+?T`(/(3X.F5?XZR*]MLEB<2HI?52A48"M^?5J&LZE!@X* M$V@,NX#32G$.DU$D?%0*&_'8`7G,8QD9VW2O+`B;3M0O.//M')1+Q0Y9[@=0 M)@QLJEJT3&(I247]'$YHU$:"P!Z`C2_"'\.:[2"`.I>L_:R"F+T#ME0X52;8 M1=]@QH\2T'U:HAQ_QF'"D/U;A50F7!8<).*]9`1"/MHBQQ1$D,&>+&4&(;62 MY`'/0#8"<_;0ASAK!H;%Q((0F\VW[0MF\L-\!JK!.CVSST567LY2^34(,(CF M-Y?(Z]I#KA)CLF`K"GO-\@1?-FJ"NFA^UDW0TO94G-)SM#L1)`B&1,>X!HAJ M@1UZ`-1#Z`GD@)@"'B#.;+=.5C,B$RK/[9Y@=1N5HEQ^6R!0Y:.HNZSLF-T- M+.>8PV)V!)B&=.H>W2UETE/<]P48EM3*H]GMJ?/[0\$3.'HLJR&O=JN0(GP) M00HIH"&J='!:1!"[T>6MV"Q=X*9-4.=>-$GO8(7I@)B'O>CU M7V*@``>>$LX0_5*:07A"B",Z8PUKNNLZKMNKJ_F:&!T($68R)D$MDZN.,=8] M:X5B05]1":LD'XKB=O<1BA_QVG]94/-G]+!6VU]GN?BH*L]#;'-JO4VMVS5, M1W&E\5=DJY2L%KEJ$]V_5[N!&9`]NU5LT';RUY!"1"2('5&:>'WS/OW-*VUK MPXVPMANUX=4@MZODKK_+U-O1P?.Z&H8!Y M[[7=DSWY-&"5'*D:30DWN$2(RS^$?Z'T>TA!][0_F.TTPF(5TV*\897+R^L+ M1'A[!O>_)PMK)A:G?8O%DBHZ9XC`,U/_>;M8#KDQ98SA'%*(D8G?W]%5A9>Q M0:2]TRI=U8O!IT[O,8,0-0VG*76YVA;,5 M8,PG"$L_T1Q5!KO/?L+0O\+;EH5K^DKOC!\7P'A5`/3/?TS@>F/"9#X30PRL M1['X+X;5GXN:.6E7`:60T-7XZR!_!;CQ@&0W+YX/15JQ7/`)LND\)IM!D[+9 M0'-CIY[>36^*`BL8%7I[+\-X@?G1+:9'YY@879F\Z'*98QB;B8(H[%CEPS7S M>-+N/FXU7/BOUX#-V,+WGT*NH/Q87@J_0)+N7I)L=[^B)/-Q"ODS/'6./83T MZ8"^DW;O.Z!O!>;F?668VW(WF=G.@]>T:\W03JN##=(O@T%^O7K\OK0_N;6P M,N;]Y?7Y47D!2\?[8?=7X!TJZFRIZ8QB=@UQ-I65RA8`%NA^!?LB?':;04B: MLAOXUQ;U(2+VP6/I.UM=+GZMH@]3B+1!8H:FN8_B.UC)=R MP`D0&!&&*D>H'\)@2!@.`BX"QNOG<>T\/%%!BE\8=+MNQW6W*$S1^ZN5KT=I M)M1MHL"76.'T>V_*WBHB3%H'H7@CA8W6/+?M==D"#0A"BJTGK(&"-2$H`J@F M3Y(0,FG26*L']3-E.BG8O0=!96)B=#NV[6).:"!J>E3@J2!6H9H9 M[*5,S8RFY5"=L[C-J$(4:>:Y4(4T_^16G!-Y1QRQ?;K[GXFQO3 M[S)K4F:-2L=>ZV(Y_]S8PJZ4T4K8:-7$%[TVW#TFR\$64>XC[IILNZ^B1-V- M?P_^4'XF[DJK/0[YY*YHZ9.E5G6(&7%W`J:O%_&!D$YI3+$.%_")&: M!!(RP(81D.V65]_I2(:A]>P:$TZPB=9D&D0(Y)\Z,Z@OT[R^C$O$3@D:M:R@ M"=,"'8^=T8(9[1SA`E:+991'Y5)9`-%%H$(_K8N)S[0PX`,#LFH8:^/M;G0C M@DK+"5IMTQ8&.G"'Q@L(F29F>[M%,_^RUEIFOD(]51D#T4A$$U!OK63$-&"7 MTYLU-TQJ$6\5T\3?GO>H.2+F6;\`6!0WV?+AT!SRD>9(9P M[D('+'+8M&<;;VJNZ&+9TEXBEQ/P\Q.9H$\O,D>"SMIJL;F_1SE@1X/DR,/.@;=2:2[6JI47E\6UT718ZMHYJ!IV_T;QOOV" M%>).=I0*72P5MEW/%@OWH6#'W0O5;Y*;HLR'\@C3,*K+;*KH[\/'/JV+53D_ MC3AB\<=_'!U=*)5=0Y#*;FV<"HL?'142@*3A[O44AH`9$^_A!7N@MQ"#]J]G M098EKX^/Y_-YZV&LPY;2L^-NN^T>X\?'./"9'9\M$A@/PD!PF/_L)YK\>&UV M>/_'8YQ*OL9_B8K_`5!+`P04````"`#@@FY#P?A303\.``"\Y@``%0`<`&)O M;F4M,C`Q,S`Y,S!?8V%L+GAM;%54"0`#,S^%4C,_A5)U>`L``00E#@``!#D! M``#M76UOX[@1_EZ@_\'-?7:D(Y(FP5A1`)O+J745,D=?_CPH9/\ M7]DT9&=A(G_+/1(E766UJZ5MH?ZKG35KJY_:QR?MT^/#M[!_(/N@U?HHN$\? MZ*"5&'`63<;TTT'(1F-?&9[\-A1T\.F@QP.:=//1A],C)?_3!0_Z-`AI7_X1 M&F`*)'O(@*%B@J.JI!!Z*I(\U=A\&/TC/H MB`91>#^X'RNGDYV^FN4ZE9N`<$'"X;7/7^M#D--8`X"KWV,63:#&9:UK>/!- M\"+Q<,$HN&L*(C68T!5<>D,T.0_Z"MA8=?!7&D'-T8K7TCMRKGIF/9^>AZ'# MR"W+U6#,N>>)F/9O&>DQGT4.C%5)UF#0+0^>Y9-&E[0'9JLH4X,1WXD0)(!3 M,V]?R[PS&K$HF1&D^\FI(I*O;?GZ=N#&J*(6%Y:/HD_DS66`YT3JG6,N:428 MO\Q4,Y-OB>Y!KRR3[W M"D_S59;#1;&?THG1]M%QFM;\E/[\ M6Q:03#7[I$?]Y'F_+3;(NF4;YEW$0DC.K%;.VN6,S;%X+HIV$^%E*N6?)0J+ M26+:HA/&HU&BKB)^,GNA"!DX3.7K^2OR8&I@!RJ-A;,'7%HD# MPD%,J'S1\EC:_$`]*NV7T8",4@`CS"C6%/K,**I9.\'`6A;Z3I)<5LM2L5E3 M6"E:7M?O8W5FUS.`_?1D`KH2PHDW13.0&"JJ7R'@85R9Q-"S9#8?\6RX6$^0]EZ]>7ZL M%JN^<-Y_9;YO'%,0/1D:NZN9 M^:7,C`3662C#[%5U)E<-E2^&QXA[/X;QBV[']0NK3A#K4;@Y ME(C%`5#`@;@HD+/3GL=4-<;%$8".)M3>LFI%ETQ4J0)>I%D4P,4.L$:S"`(Q M49(/U%YG)\\FV"CZ;&`0IZSIC/'` M)\1WFBO+$HVB3(L"G,1N(9KGP?-3NA,#$,Y7M6X41Y4(JOGY,P9^--,`J!0$ MD,7%G>-6J;(V`+#@]E0@0UY74?E4>@,@I M-VT4,V7S$0^;\WZ?3>WJ$M:_"=)0)H?!E!8!A!M%'000XH#B06W\#FC_BHB` M!<^AC(OB49P4,R_I@'G,%%Q`A!M%)@00./;8\O*MYH3I%M9QO])H>HKJEH>F M9<^%=MO:UI-9<"T=:7I((I:^,._"SW3`!2+AN8==FM\*H(A6.D"Y;U$:^P$Q'%.BD]9"Q@EE:T14+R!@5/: M8%/5%8B)_B*DA5W!!\:W:J$5`F(-[EG:?I8W'3$1C\2GX0-]H4%,S;MK2RT1 M$%+A1J5,?-'LAI"A]B^&<$;FS1'0HG$J$S5S^Q'S,ZV13E*33>G`0L/F<+)H M.>+L^X*'T?T@<1Q5FZ/BA7DT?)39C;$\HA="P!)@0C,AL+/5WGYLEQX5`D5V M\[8(R'%X_5<`P,S-]`(Q7_K3>7_$`A9&(ME;D;\0%BAGO@_F MOYEK&`#9)O('@(5XL"7'-9>9;&V"3:32A@GQDG:ZCV_V\DAM_BS3''/AW2:( M@4?(.IH-!^:<_#+=HN3.GE6R*?19@=C'7AO?%H3Y%=%;V(%0?6]95T+@JIN% MVH5]2:?_FB8()S5;RA9HI.SK"O[")(6?)]]"Y4JS_.C+ZT#9->VG.FS;U1<PR3:ZXJS\(Q#]DTX"I_ MH$D[K8(U-)I[9[35G']`45%=+(#<5'BP<6$1(KX3=,.@ZLH*2,DN?*#.@>7* M#]OM&+T%C!I><2PVEVU/;Z#/%@LJ;Z)W(ARF<$<]`09>XR(X5L[TLU=ZE>12 MD_Q,=D>)+^'4<(QB9;O2_-+'+-U8UGX+<_>(+D'5<(VBDE6U@^8F"",1)PNJ MLHODG!61-UBP;E&Q$YS#X6IX_WG%>5R3A#_0?NQ-,X?9-_>BS`^U";=-JM&4 M@1!J6/H%Q=M6@UU%E.&JR^R52A#PO<9E]DK(B%?U9+B03"I/_-R372&H!)1X M\XN]A@*014"VNX.7KINRX\2\O[=DOD.9#""[FQ1#2V,X4B9-!URS@`3>BI-X MI1($I*]Q$J^$C'BCL+3?H[2?'$*9KYWE[YPT#7&`,`*ZW5V\X@-M5J"(MUH] MT'$Z28&IU8OL!*%Z>)CGZBJK-968YFM8;=.`F1W@FP` M3L2;M_+6)];>)V:&5V]4>"RDIAM.`+([Q[`&)WAWU^9.A^06VB[5%9N^XRD0 M365MMNLB/?$DX]KY+>'5)S"!3,T.2:(@@O:4,$ M$TZ51VF)2,UN`A4/Y/6.J$F&^"!&BNTQ$5-P*BTU1?N;P-!W+GZH=77YNH(- MF@6!YG&T``!Q]7IF\K6Z[FE(^\F]:A"2%@2:1]("`,35J9G)Y_U_Q6&4I'`0 MB@K-,1$$>045C,=MI2.6%M-8?$HJY/DA&0-\M<;C"(;:U\4FV3 M+6^Q"2(8%1":*DHE1EB(H^C"=T?L!Z"U2`VDU_>(AKI'?1T`CU,V67$K+L1O M<8I=-$5RTRYB#`&SH=EZ']G1+Q],IK\Y&9OCUQC1E> MQ"7L)1#)QYO.P"VM<9^\8HH8<=7<'=,UCT6M;C%5N$=>,06,>&/1$I!DVWJ= M(E&X3TZ1`$9\TY0;I/.!S`QJ]XP%K7OB'@NHP?=0;2[M*Q\6WF+B5S;FPKK@ M:)"I:1'N1]>$B?0#]]5+=*MJ M13""K'05EO%6!8PX:4L[XFHT]OF$9M>7PYU7*]@DDJ&8$*=::E\3%6'^"LF9 M+]K)!$DWD5$0,,29TO1FFR7>+3;!)I)IPP1.;C87HZC#/%%Z="N-3HZW$9ZH MY\^OV;@@0DS428:1YLYDF-AVAD3^--P=B6*1.$'^!%574N"Q,?%O`H>2](IZ M$0PH",F+8VI%U(@C&R=D]FKT>'1!!Z\[+J]Q]K\!?;Z[(Y4YJ.2']P"?$ MCR;9/4W7L>PH>L<"-HI'V8^7^G(L6+RNJQ)AS]/7*);2LNV#.(XD%2]1=,2Z MEJQJ-39O`AGBJ^%9E4(OJV@/.,W#W>3Q*[AY*E"OB=B;@(;'IE7]WIFFP>\[6Y:F5T"GEPRYY)X.&O8TO(IS#S`@0`%0`<`&)O;F4M,C`Q,S`Y M,S!?9&5F+GAM;%54"0`#,S^%4C,_A5)U>`L``00E#@``!#D!``#M?5MSV[C6 MY?M4S7_(]#RG$]\DN^OT?"7?\KG&B5RVNWM.34VQ:!*2>4*1;I!THC,U_WTV M*%FB)%Q)0-A2\M+MV`"XUUX@`2QL;/SC/[Y/TG>OA!9)GOW^R\&O'W]Y1[(H MCY-L_/LO?SQ>OS_]Y=U__(__^E_^\=_>OW_WB62$AB6)WSU-WUV&9?A(P^AK M\5;_'53_]?0=^^'X_9?\]?WAQX.C=__[X]%O!\>_'1[]GW?_]^[S_WMW]?#X M[OV[;]^^_1I#"V7=PJ]1/GGW_CU[3IID7Y_"@KP#P[+B]U^>R_+EMP\?6/GO M3S3]-:?C#X"OXRZSD;]^+9*7TMZ.WL@_S:.PK%VEM.N=L`3[U_NW8N_9K]X?'+X_ M.OCU>Q$O[((R<;EX3+.!DP^S/_X"[GKW[A\T3\D]&;VK;?VMG+Z0WW\IDLE+ MRC#6OWNF9/3[+T]Y1FI&/IX=?62/^N\7>1:3K"`Q_%#D:1(S:L_#E/GGX9F0 MLOCE'6O]C_N;%;Q/8502FF2,M0^LP`>=ECZ`NX'T@$WA2,1P-7]BK!EVM&PFB)K#4M&'1'E%/H M2(R3%S;B?R&EH7&J5IP;:DBR9F-6"(=USSAY2LF@*&!*:\RZH+J55R6B%8EO MD_`I2:'#&W=)20,6S+O-LS$\<'))GDR[([>J&Y.TIV7\NFZ,TIXV\>NZ,H!1[6IA>)D64YD5%R5*=NLE&.9VT^HZW:-D" MH'N2,J7M+H29Z"/TT@(,8S)A.S)T6[/"Q%-!_J[`7U=L4=+28%4K%@R]S*.* MTB+O%RZP:"RW]:XF9WDYL/HNO36X,`QZ;)+5 MPM`M-+?R(/ADD2PF\=NCF$7=]^[JC49X<)I'*T]+V6YH3KFX:DRCL'BJ@57% M^W$8OGQ@'\4/)"V+M]_4G\GW'P_FVY__??[K8+'K`Q#)#?Q8O#TE#9](6C\[ M$!<.#AN"LB?+'\.G)>''%8N7)`_HJNW0T=Y:G?36;V<#;0,;LA^7?89I# MXM]_*6E%O+-VD89%,1S52[_!]T2KVZW7"0X/''(I^29*N%W2I>"5"X9/\:$O MMIHV7JX,MAR:-@L'AX<.^1'-`R3D<'W.YTF`AD^0MX]@=X*"C7F92Z)6YY<. MF5K"XC-V[(NQF:P_>"I81%8I86NU8'!X[)(AWBRUXP#&L9]/Q8FWEP=6^TS& M@/^Q3:'7,*V%C?(BI'2:9.,_P[2232RTZ@>')_Z)XW`A>)>T(?&Y['E[K68; MX,4]B0B8#6/P%U)>5)3.)D#"ETQ2+3CL[1!S2B1\POJ^"'O;WIZ"F1*"FL6" MP_X.$;)A.9^`4U\$W%'R$B;QU7>VX4+@I1^6SX3.X*E?'(W:P>'I#M&E"XC/ MXIG?Z83&AVX5R-D.,;-INF`A_-'_MRS/(B45G-+!D4M1PMV7;16`@)8#?U^X M6=#/71K.U/Q&Y(_TTR:N%ARY5!SL?],42`2,>=,;UJ.?P,ZK[U%:L6,RG_(\ M_I8L]37NFZ6N'APYU22LOVJ:B`1,>A,F--A:VG^T0XRL6"WPNC=QH3%GT1J* MN.6#(P12@S8?8@@"Y,$&F&J+&J>R8//>0I& M%;-@=`T-3K>)X`B!5&"DSADA$S#K33MXTSKNPBD3.O1EGM4*P1$"/<&("+GT MPT$G8,Z;Z'!9D<>\$;@$J-7LB2L%1P@D!@L,*A`*6/0G.FR<`]!Z!?EU@B,$ M8H2=MU`"4+"QZTVRN"0T>0W+Y)48L2BK%APC$#%LO(PJC`(NO>D<%^%+4H;I M+0D+,GQ*D_'L\+F:37G%X!B!UF&!3PV4`D:]Z2#S;\E]/@U3H\_K>HW@&(': M8>_CRH4G(,^;],$.,CW.#S*IB>.4#HX1""(62!-!$Q#F334Q&@%Y8P("O<0& M77QD`K:\R2@-,Y>"C]E:?K-><(Q`=+'+H0"D@$YO*HU@=-:2+Y5U@V,$NHR: M$Z-YRQHZ`9\MM)G-TS3L-QM#+SQ?_)54U`B.<2DN6GSH8!*PX$UG:0Z]6J\2 MOT)PC$M?,7I_))`$='D35!H0]4:PX'@_1)-U2(+P:F\RB>3`JVQ<$M<*3O9# M)%%!%!#I32-IM?TC\2>I4_(2'P5T@P&WP*6*-6DJO<0+\'W42(; MVM25@Q,$DD@K/C6Q"?CTIH1L8C6:F@0G"+2.5GP)L`CX\19UHIIN=8@C"DYP MZ2(6EG-BG`)>YTH#H/^PFGC!5SJ&U63D.YB;H;=SN1EZF'(S]'1S,_1^YF;@ M'-CN8MAS,_1,3OSW]B\W0V]G6UF,:C*YYPF_UZN"Y14KE<,>B@6U:TI MY.)!E@F"9_%-453&M,TJ!3T$:^G.E#6PX,L;L6'ML"K9=6_L5*HA9XV:00]! ML$%GXM8!(-7Q M!;=Q[J"&W_S M9QI^W^E2UX*&WQ<'D/+1[)F&W^_OBH9OR!1:#?^>O)*L(CH9EM>+!GV<2U?Q M(,9%@$QL?PA34LP-92J7:425@E,$0>T&#"F0().S/]&\*.YH/I(&.S=*!:<(=ML-Z%@W'9L( M/5=7LO$\<;;.O$M8)SC%N6$NGH#)H6"3GS^1#,Q-X;T>Q!/P+#.5Y3F:&R][ M@^0U@U,$V^1R+@2OEP8N;.KT`TFAS3'8_#FD7TD#L6S>(*P4G"+8+V_#G0(2 MMHS(E^2%DBBII6C6WR8Y+9-_SV\5%?(FJ16<(M@O;T.<"I.]K,J"E!9LJZ!* M&U:S;`YA\45PAD`W:/.&\)%@2["\L/(F MB_()N869J@X[R]+!&0(AH=U\;PT$M@S)\$KGJZ:^76RCGIXKZP9G"$0'(]KT M(&%+EGR3E822HE3/[M9*!F<(-`<]G_/YXN'!E@1YF2;V$[B#?0F&V?)WMJ3(;5B4($2@;W0A M4(X,6_KCY>3J&KPP2RY5@>7+4*YS,LHIF95[#+^3XNH[N``,3[*03NOI`$OY M!C7!PVD->C:B2`=19T\-SA!H+$8S)M?.L)>T6;#&OZ/Y:\*"(JYSNC#RG&3@ M>5FV6.VZP1D"]46+4C-(V)(SSX\1+FR>?[?FILNVY*05@S./THT9(X)].C4\ M;)F;+^>G9K!*ZQ6Q^1+Q1PU'&V<8U-]>HW:`5<@4(DZ M\N`OQ*GMD=&#`TQY'VL'\CL]S^Z?IT;7CY(='&!-_5@3IJ"6#V?/#HX>'#A= MXULX.5I[72!]"O#LV=E1P+0KAT>-R4)[?/0+*=GH7\NY,*LXG_Y1,%5V$?J M#SB_`O@"P7&P;;^F,E]@.__,4DZRO/5O2]?T+=7!D,*2-9&J MKD;M0)__`;_>+5QD[YRUX%/.PE$!H204F%<,C/N!7FNQ!^R=I]:(V&5XH']D MF]=*0$^ZR5[!#SGEW;C6LJ7@X!#!4=&MDMS62?9.9UM*:K$\7Y04+WF1S":, MT'G#;)PP"("ME'W.-5L`^`@B%[?](3=R#K;3X[RS9S<9@*YJ!X+78"U1AM_U M.H>T"7``@K!)C[U#PSOV#K`+AI![$E?1K(,NKJ0OWRZE%`X7\EI@.H)(RZT. M#3H.P7;B'?Q`"2Q#+LGL_PWD\_N<-91>_4;`"0@V:K8^JS?T#[X3]>OV;\YX MC+K'9G4`CF!'R)0H7;I%>+$=SM^T_&T6FTA3R$CK`50$>S:NJ-T`BNUP_J;) M,+=X"9/X[?#4VW'H;!;0J)SWMVL0G(-`S'75"_0]@.W`O_AC=1=.6W_8YW4! M,@(1S_57?04LPJ0`FV;3BL2-2^=-*5ZK#L`12'T.6>;BM7<4?]LA6%9"KX*# M(P32G_40'B/TV`[]"^QG4Y3"5A2>I#%P"@*ESTH4GA(EMB0!,`;-U[.#Z.\J MH000U6K$JUK(5=8%R`A$NK94\8G7!(TM><"&V0:"O;(N0$:@V3GFF0\:6V8" M?2=8^82#$Q#H&!P/[K)`NSR-)H+FD,G()`D;,RFBM18LN@```B M0N(ZB=@R).0VS\:/A$Y8:)CL,Z^L#*`1*')MR1)\YS518TN^<$]>YB.4-L&B M*@`0@<1FEU8Y5FP)%'C6SL6'6Z8F#)_29#R_5=>,7T$KX`8$`IM[RJ7PL65- MX'^*&A=#&W^\&W4!,@*Q;1O?[@W0\C0(?GFNS1S6MA57WPF-DD*:\4A9-S@X MQJNO6>!9`EK`,S99C>,$*Q-P<`("&QWJODJ$QSI.]F, MG"8\:_F.O-"#([>1>YX&Z>R+#XO#)G6B=HLR18ZE%)-^GU'!Y$ M<*QE&!(>-V%WI?^5PQ`F]_=&0;#/H\+=T=T"-,B2!#W`Q+Z8W[0NOXUMK22@ M\7TW2.=I&Q>2-(O.#JUF#NPN9X;9/8DJ2N<9C`O]M8RP9G#8:[&0,354M"S1 MJ`4&NM1D-!8D"M]Q/CLZB/8A&>L"Y_ET\>-_)H2"-+#VLMQZ`8^'EL2N@33Z[,/HF>ZG*HD9_(%Q9:-0"M`A"WUJ\JPJF14B1 MI93EV7O8BL_#!4H$\6Y.^5Q!BFQ)R;/WJ!6?1PN4"`+=G/*Y@A19'M?YB;BK MR4N:3\G;98O%_&I-":7RBH`5C8!@M,PR@2=-P+I#8L+A#H@)?>QB0A^OF""X M#UD'T4\QP6!^WM\-,:'?64SH_Q03YA.!_FZ)"7U;*\C^3S%AX8G=%!,L=H4? M24SH[YZ8T&\G)O1_"#&AOWMB@AF?*TCW7TSH[YZ88,;G"E)D8L(R`6HCPXY: M2I!5`YR[("2(+Y56@]L7&>%H!V2$4^PRPBE>&>&TG8QP^E-&,)N9G^Z&C'#: M648X_2DCS*<`I[LE(YS:6CN>_I01%I[831G!8E?XD62$T]V3$4[;R0BG/X2, M<+I[,H(9GRM(]U]&.-T]&<&,SQ6DUF0$P5+I;7%YD4^>DJP.Y%]>J@$_%4E, M9O']BQLV!N7":M%2JENK@'P7A`7!HLL&]GW1'8YW0'A_]'EC\5 MA-;WR]3#]MO51K.;P=)$3KEQ0X`/ MDR"S]1[0TF%8=1W'.VY]IR=0MCP75@)%%C/B9[^EWW.::MGVCEM-G(UMEAJW M5/CY@7H`VIGAMKJ":KKG[TI5N<]Q;HJ.)^UB#8&G#X/1F"/"?H[Z*5;\(J@PWF[O:$M5`'23\`,NTK\ M)HO2*F;IKJ]"FD$QK>FG:QN`@EW8R[+?,5MZ2M!9[67U_$*^S1?A!;L#@7M[ M`+]@83I;N,RHK0'USN$H@W&I6NX_1F333[L,FXD?_R?/H(SU3H*Y): MX!J7&JR^J*))(G]<4@)$ML.X82^S5KEPEM0"E$Z%5&VA1,F$)H'KT)#MQCDA M$)?.X89)M,'#DAS#2D%#61>0(PA45+YD?$8UT2$+'KZHBC*?$&K.IJ(FH$5P M_5]++K6P(=M>NJ,Y3"+*Z5W*IOQ9S*[">6$S,ZVYCT9M0.UR6;ZE.9`V4&0; M2T*[M894C=K!T8'3I;KVW$B;(4."UZ$BVS?:"L&XYD[;81KMMM!YE:0Q?+N4 M0^UJ0<"$X!)&[=>,SQT/DKU='H$0=)%/7JJ2T*)IKSQ61U(%C$9P"V)+'O3` M8=L&N0^SL6HFLR@#$'`$A7>:KZS!L:?U6V1$^0%KE`(8.`*KUQPK\7[3<+GV MOR/^QS4+:$.$:DP_\":0?`8G3JJ)DI*5<@`)08CO1F?G4\&Q7$""-U7C<_A= MCX1F.8""(,I6EX1-RP4D^(MW9-)!A^4SH!@S5N"VI!7`QA,:V>77Y="NQ"C;MO07' MOFV>W":%!I6@,0<4"C$*J/.FKVSL=]W!C`=^$8[)@8Q#234`ZE$E M:Q,LI8]*0)^]P,NYY2Q,E"1UV.C2!D54';<.F.U2$G-`AB8D`1/>9!FA*OM' M0495>IN,9.'^&K4!ME,9S=UKI0U.P*F_O'G"`4&+5)WJ`-RC#M2%57UT`EJ] M:46#^!6Z8U(`XJOO+S"7EY&X61A`>52-NE`FPB(@R)N.5/>BF\E+F%#VF;AX M#NF8R"0C?H6@W_=]%*$M41(\`K+LY>>Z3(K:Z.'HJBB325B2^"ZQP#84&>(3$-9" M!Q$0=I]/P[23#7]V&X-G3(X0C"U.U%>EQ7947)W(C%03J1 M[_FE@Z.C'1LPE&`$?C_8[LDU-N,OIUW.H-F96"RW:686?2;E;BV1/#G6B8X]^&DW#U)9X,CK,@? M:9@5\+:R(_+GT^9?5"%7VHV`X[R?HVM#-;^SF.)&=KRN::1R]VVS,&#"<9C. ME`8UF4V`R([462`-UZZH2_:VEP`2!I+\"4IP_2ZRN+;-)*'%RNJ M`08$!^)$;P9G\JF%!]D1N-D7/Z?*KM6&A-9!.TM8-IB*C$,>?PQ:F#(V@J;AM&H/5M6_9 MS/R5DW%L#AY;NL*'ZJE(XB2DTX>0#4@/91Y]5:SIA74`HLMYSY:7\`J8V`[` M-8QDH6?#46/%I%P-JBL#:*?!6MI+>@4M`BXU\6$[0[<%4G$,OUM@5QGI[#$D MC%U?0.[2,)(/O?(*`-)C")_IJ\:G4H8,VWF^&N,L^^-EQ7)'WA&:Y'&=4?(+ M^5;_13J.ZM0'Z`C._UG:0=$'C.W8H,#TA^>0DJ(#V6L-`'@$!PV=LLU%;.^` MHBC1)]\8^-Q$+`2A-DJTUM&I"S`0R+'=B#,$:^]PH2%GBXB193#/.:S&XF%V M_*\J(ZRABS1GP8NUU::T&C8/SD"0S^LH?Q:K7GVY9ML.!JQ4))Q MO?9^S.M[@2BYR">3/)M]<@#(O)*H1W1I$V`C.%QFH1MT=X*]@X2&W%]]A[Z: M%$3ZVFM5#HY.$)PS<\@F!ZV]PX)RVM9-:7Y@[BB9)-6DS>?<3NO@"@1;=_:( MM^(.;&<1[V@>$1(7U^`X!C#,(C*DLX7GS&'2M;.J,H#&L(ZV,@G716OOO*(E MBN;F1!NYM&OYEL?J_"6E7`ZS?DQHP8 M75)Y()$%]3HF%=?NGVMVMQ?T^XGF13$_X@83O3`MAO3J>ST5'V;DT8'I)1 M]ER&TGB;-!F[`-D]&A[S$?:<"DYNLE/VA$$`CNW/#:V?`-2OSURO0WL]A M(9%A#X$8V>I%%4R_11BQ13P_TC`F;%JCYFV]*`!"$(MED30^0'21S658UO+: M3#%G5Y/`O#,K55,R:3V`ZC+2RMLD3`,TMB#G-4N5`RJW/$!S&H"E'Y^N)H#/ MG`06MH!E:XSAFNC8IP[O923S`!ZV>ZB>OZR7!6@(8MXD+XQ((N3BL!=K+)"3 M.%_U01PGLP?.4+SE*)O%:PQIO:,+G_HZ-AH&]V2<+3=>U[4F6^T'1S[S(+;= MX'/@`N?AR!QSFS*:`='-:F`\`B'1%G^;R)Q''# M!\SVF.&\$R%J6/(0WVU%F+#(F0SX34@QCS#Q$5KR9L7T5B.@9+,P.-2;T+6P MYJ*BE%T.J8@5X98'`"Y7QM*`$)$[^7,`B?G[$.NQF,+6*H#F>6Y1'7`+FC6R MA#?%0IB/"EOL1L-(]<;^1F'`A&SUR_>Z8%XNP(,M%*,[1TC7N]W)0N3+4F3\WRP=$I M@H6KV.<*CC:A(`N16%CZ5TZ_WF3UH8)"BZ65"H`-P?JT-4T<+,@B&!:FLCVB MXIG$G_(\UN)II0)@0[!L;?NB!@07`PJ34O#0S(MO,7 M)@[B?U7SF9($`VW[\TL(\ MBV:K<:.9]48M@(D@ZTG;";8`CKU==N&]/[SQ;FF.2+!6U0/S$:0R4?J7HUGK M(<.VFVE.GM"ZLK!\4=_:2@7`6I"._6/&,N;"([. M7*X]I3M)NB0(-AR,$.[#9I,0Y_GT$9ZMV';2J`VNZ+G5=)&B?9 M6!G\N5H0,"'05+1?,SYW/$C(ML46B)3\K)4$-`BTE(X$<3$AVQ-C<<<5+$KT MF1+4`'0(]):.C$FQ(=LE>[/U(1^5WT)*UDY1:?,HK0_($8@REEC50(ILA^VZ MHN#LBK*+7JZ3[^PG]7D_<27`B$#3ZDRC5>/M6"P(8!+$B'$J(I-D%<$ ML`AB%;HI>CH(L1VF'411-:GJFS\OR0LE45(G](&?4U([/XL'DYR6R;_KWPLA M2HBW]0AP((*0B6Y=Q*XOL&U-"LV5!V'(J@%0S`)"M^_"`I]\\Q+''IG'3+S. MM\H\WMBVQ:VRXX\NEYB=M\H.NF^5U0A_;I7I:-7''UVN4-ULE=7TMM\JJR'_ M<%MEQP=.5[%6M\IJAMIOH-10?[BM,D"]>UMEW9E&NU76?B_F^&!'-(SZ1=/; MBZDQ(=LMNPA?DC),:VTLGJ5"4ZD7HBJ`;T=T"_'T2HX-VSY:P]CBEH"UY#Q, MV6TF#\^$E)P\D^M+[GIEK4EUAR>`]W9$KM#K&9U=@6Y;KRB7,\Y[\A(FM``/ M?0:WPM*9@91NZBEK`^H=D2XD'4`7)K+]O*:X)F&Q60QP8(Z$T*)K$X]TDVY[ M27=6\XZVBKH6A.5+TIM>5_7N94-/O?K^`I-8(I.-NC<:'+>Y!TUTJ>UB;=S& M)I%T9*MIZ&,N502NI&2+H-4WR*Y']D&"LIL:Z/C0I0JA)3?9I5B@5,H=@$Q\ MZIJAYOC0Z7K50A:AVNN"J8T`#S+]R`)'N-0ABV2AE8`DWQ:]O$)Z#8`//(H/ M;@;B-AY`)B])3%?)3*JJ@!>!J&#"C3&[#9S(I">)T0W=H]GAVS$M:`Q\@D!/ M<,J]%#DR_8B#_NI[E%;LI`A+)/`M6:Y>N`?SU=4!-P))HCOC^EB1R4C-3C@< MK<.0Q;Q)*P)6!$#$27>ZS:<,NK[!%DAOANF?)*2/WW)K M_6?>7G!\A.","XYNL^(2;''Z+:#`XV4[F"U;!/<@"%)!U&.63L$6CF\.YCJO MI`<>6S4(SD&0'A9/CUGZ!-LE7RVP0%F['0;*@G,0Q%0AZC`+G]B[>LQ'AQF, M2D*M]YJ55L%-N/71+78=CF/L752VC7V2UOLC`!:W4NJJ%RRPRZ\^VU;6=6X+0F,W6;U5Q/9(JP?%QBZ6@,FJ'*=ITY8F:,3F"BD#O MU@]QZ;E.&D\C1?,S6F9C)_S(^^$L$P*-8V&.\!W$ZAQG<8SCF)7"Z_KA%E^E=V-0&ARQ:95@^$[J) M632_+D\XX) M]OB;K("%L6ZV'$&-X/C$6\C.JDFJ;#BL1Q`[(7L;.*J&&I`US4)`P^$U9-ETX*<#!0OR:F`[@J-!IE3H8+)V8,20C\-V?!PN;$=PI,<2'RN8 M[!W`D`[6UU5MQ$V2W*91VY%;LQ$`AN"RE5;#N!%";$<>;O,P*^["J4+":18+ MCGL(#BBT4'$V06`[4L#ZW^.\_ZF%9$YI@(7@*$`K;@18L$7PKV+[(PMG$8,D MODR***^DA"GK`F0$:\O.`JD0&;;H^F:OT[J[G5\!P"%8@W9\Z];AV`ML%TPR MFI_C0?ROJBB9W=>$"&-%Q37`9`2+4`,&M/#(8\,];IP=6(D67H8R?@YATCN+ M1J[(,&-/DNV,&=0.COOVIL721VH&$8MJ`N,N5ROB*&(3/_*4%$UD^[!39CFB MN.=RQ=,FHEC.('\(4>!#MHG6.5RUY_1(OXV0XIXP^EN$!]GNF06.<.V:620+ M;7J]YDQR^1EAV:FG]?V6+&-UDD7)2YC>9`8I.#JU"X.6Q]5PQ]'5H@>0Q2,; M(5)GV6C3'/C%=W#ZEGO&"G!DP6*#5NV!9WR'V/OH$PODR!((&B#1S7?1MDGP MC^\0_JWV#`YX;-D!5T79BY#2*=M9GQCMU:Q6`Z`>(PLLL:P&*-^K]B@_'UJ1 MGZ^*,IFPO,:SU!_W^31,R^G=O),K]6?-ZL'Q:0LEI97)4@5:HRJ8ZG)C7RQ! M&[F2HT%K8_LI0F\H4*K@S*K0I6=L\O+'R'9A]'#Z#`R?5Y.V7,.T1QTJU:`40^E[Q=QT0VP!V M?0!$TZ:;[/%;SE84PHF7<4.`S_=R?4N$KF-V?8)$WRPF,EIB==$48/2]V-X> MKVNH79]1T3:,*85VB%VT!`A]+Z^WQNL::-3S-L4T" M9TC1BIJ/T$P%)NUT3IJ3C]Z"""SDI#ESN?W?*B=-[4\=_;Z!8!]$3BLY:[*F MNV0H9XA3$+"W@C-]TP/E6IZTE0SE#''.`0$!4BRN)42[R5#.$"<1$'A?!<=Y M-AI'R5#.$%Q^:4J%#B9?R6DZ)D,Y^8@@:8,E/E8PN=?6+.>/._F(($6#(1-J M0,[EL#H[]-MULGF6O]1I^*%;\)>&RCI@MLLH"A?K0TU,]G+,&%(A7%-HU`+3 MG1Z^4*X!-9UKP$@3F+U,,UOF!,=BSR4YJF5?FUPS`I)JN7>>$:5@XUD>9D.: MC.<7C;#,#_*!1;L!`.8[B$7GM>`09@C17DH9`6=W]"WP_8[`(UB@M9PC804P MV'<<2DM.%)"C0PRF\:M?XZ#N(XF3UK8=5M,DDTWT=1;8"" M0$#H]D+*L0EH\G:T$^`B3D0I85`+EX!&>QK*/)!LOCXJY)0H:H#)B#-2BN8O*CP""NPI)"LA M@(MK'$7NYY<&4Q'AD6@=N]9?NZHWE$2%Q<`^I:4F!@)9\M;GF`AB!8 MH<7'2H)&0)3OJW]GO6IY+>,@B[72'>M4!^"[I9R8@Q.P:B\(@ED>IFF]9I1J M61L%P<#=4C5D,`1^MB=<#.")<;W%EL_F&H,Q)748[#Q<_#;YNTK@]]-[`C]0 MHF:D0Y,`>@XY*\G/Q;>1M&@% MH.V6'-$:HR#>V%X`!KM@/4W"+")_)GE:;\85L&;+7TD69F5Q3U)VAF?#8HU5 M5/>6P06[)5U8Q2V@?LMGFNHD$4]A06*&"]:/-:!65VV+8G072:\&3&"%3]D? M8".M'SRLX=^E8:9.W63:#GC9WNBD^7#-ZP34;8#Q+E?#.A<+F'B9\YJ8H]V' M(U!V\SR='+I<:[>Y;$"72_[B38$4V3FIKLF$3@Z=+K$M)'RJOGD-*SM?G'`-*PVQ<8S^?+HO,]_(&WT(:S[XUQ;`JBS*L MP\N_5(*@+F?/`L_ZSIU@8XQV[!]DEQ=T1?F)LJG]33;;8/Y$\T(ZH-M_6G!R MY#OA`Z9>)_00LCL2:N?<%$5%XLL*UEWCF<$UMJ+AN>+J.TS%DF*Y=./.$TT; M`Y_@N4K%0J]IZ0!D-R1T[?S7.1V1A.T[LDCKJ^\O"9VI$&_O@\-/D_+9X'$\ M=[3X_U!I^@O9?0U=4<_?/[8<=#Y!VW@6>-3W(0I,/5#@'V2W05B+!*Z'AF+R-!7>%4"# M[]RM6^V\MCUG[XPOD@[\AM%['S8R!,CPG:H653=NX3Q[)Z-QS!^4\W1/LXI. M=@%5OG/W8IIK6/"EO;/F.+I]8W'@J8-K6A"<'/_4/UMZS?EA>W>+@'J"Q8X$ M78<)_3-,Q8F3MVD#N'4?9%5/?K.7=P#'-U2Z"-#JP)XL`3I^2K4=O6!:/%=Z^_J^=O"<\U02K4%=L+#9-`50M)Y_>^Z=W%W@OJ*8(+Z.G?K/FPR>/*;O8P?CKJC>/6WO?62B0W@UGW8-O#D M-WG^$A3G1`ZL'!2Y)T5)$WAP/`MZ95Y[8^M6=3I$JW)P#4U<^W#,H\:F<<7-2CEPG$L-4_\XAR91_&4V!Q*RB7_+L%08"$KL+T32U`9CPK:BTG@)Y:D-AK=]VP`ECPK<,@[K$" M=^W+X2$E_C_KL<5KCUTU`?SO.TP3<7?E^4IZC`B%4NCQOFP^%;/#@X.J?,YI M\F\2T:=3(]T^\"@?^(O7GRAHG?`=C[=1*>Z^-OM@X.3GDNU17J' MN,M.(O@D;<&7/[#&VT-S/]TVB-;2B'OB;.YHIU&[H.+U_-Z])V%[F^)=3QCQ M]%,C[N97U!KQ]KL96HWX:O*2YE-"&M]NX65WRCJ`%,$5".X^%?P^HW`',I5U M;5FJ))M;'I`AN'!AVT1+7(%,GJRG6HJYYZ(,(/">*M+_O'/-'&M^E3B_:3BRI#:MW(]K"M2&!]6LQ5O*E\_A=Y;@7LG(2CE` MA."NK(VNSF>"8SFV%";S6P;4)#3+`10$4T1=$C8MW[DT'*(IT"P08#[.%H/7 M,$G9$'F=TWK[U<4>CN*1\&%"<+.-!U'5J3_W)MO&(K1]4!359+:1=9\47Z\I M(PF<&)WT$5QWM M4-_5J3NODH>!D!-<]>>JU#CUJ+].&[""C M#(`J\]@?\XC6^3]%)Z9L/P?<@^#BJ>UU.(=.M)<``\=POL/97/H(E)'=&_I; MN=E>A@U+L2IIW3B)^=Z8WPPN"V+1:@#`(Q!^MM_'3+R#-YF%,J1T+I6QR-+% MY0K2(7EK5H!KT>Y5NAVPM^QBO+DOU*!F:KOOWLNQ`ESK\=S%_O5>H8OEJ3(\ M!N80^@J>X[MD<:RO1E\\YF68-O]^D1?EE[S\)RGO292/,\92\[(;G2`?E\\' MUWL\IN%O4K!%YPKZ=8L-*\%7>9D:6:"^$(^ MF]NR:*E'0B=.U$'E0\')/^Y^C$./"KKM[FW$R/#^6=_0GL*$8IO;BORG!R>G M/S=G7+I6T*-W+W>'#/AE\IK$)(M]].?FL\'E/^ZFC7O'"OJRY;T;9R>3/:[` M5]>%?9]).O9NZQ@Y_@5OX5='!O>SWN=(=%2[-* MZ\[Q(C0I;`**?HI/VW>XX)W8A4VN^O[PVMO#C+WN\:5$\=JR&>#<'T]2\^)C M00<^VVZJG+]"6@\X\^0X5K)HS]O43IPM*@_+$(L7ABR.!*X]3IHH6UX+#'09 MC"#.DBWW&*^':^#8AXPI#R6\7\RJBS0LBN%HEC-+?H)56`?#DS/?-P=8860-E+;^%,2GU16_FE-35 MP';?M^=:)*0!"5F^"^Y'=F6!OOAC,?^K;*+>ICGPB^^+/*T-3UI0K:78T'XC M9Q]IS4O;C=L`5+XO9+#PKJKPV4O*84C;XGMN@S]I8P#4]V4%UHC4`&HOPXQ(NM4!W@NEPS2?.!V MJ.'/:_2Q_U2CU^6HWD>7BQ:C_(KZ-)K*TC7(/9.E>Q]QY%!4>%U;Z:SQ[)DL M#9AV198V)LN!+"V?D_+B3.M_#T?UGGTZA8_$13Z9Y%EMJF)V:MH<8$9P1MS% M,-K=*UM2M#MD66O3#&!#$&/K@W&Q-[:DEZN.^K1@N%D=L"`(,/7![*87MB2V MZYP2^&="4I7ZKMT.H$,00>F38XX[K$GY[G0A^C$W?K0D93D%8->FZQS#B&I9")Q)8#B[;(X'2<;;&DU\.R#X',!-L+G M@WTOX'6'3SJM(XG/IQJ7N"GK@IO07.RF(E/0!?0@8I-_^%8SF]5*@ZHN(,9Q MA9HF-T;$KL/$IAFY)A:7HN2>X:T+396HH=-I=8MK)&N_2IS? M-!S9NK65^W&M1=OP@/9T7;L;#'N'"+:L-[HZGPF.Y;#T2-@ M+6`U`_8IU5!U9<#L=)6I'P0I9T5`I28^9.?OML`IKFF%0W+17F)]5TN]Y"X- MHWK]IAP"^14`(X8DBZ6(7!^T^U?CS?SL-1LK`ARV"@))B((:S!PL@B"O;M>!5Z^ M328)V/CV$BEZ,[\TF(I!VM/WM@R&O7M&!1[_G,11^#+(XH?7)[FW-TN"B1@$ M/'U/BR`XO[+SDCR5FI\/3E$P$D&PAH&?A1B+\"4IP_2Z MRN+;-%)]2:35P'@$01I&GQ0-//8N2Q20,]X1P4)+A![-_!)?2M<@FZ4`;/\Z@5<-PD]V33:WK5P%GV) M8Q7?UJFJE7F;&\JDSI5_:IMEP#R/:VQ!%Q2ZM&FSO0NR;-T[E-.2'1=FLQ^- M$T?<\@!MQV.G)+#PW12U9JIZ5XY?`^#A"+"2.%^3K28@;!4+QXCB@CCE M:.-M1_R<)O&8W.9AIE2"UXL",`2JCO1UX1/%!R*_?@9))/>6Z:B M18!!$P`*@0IC3EH[G`+R[&D)7""SLVN7%55>G*M9/>B=(+ALO"5I1A@%A-D3 M+#2MJ?/-=&2M;@-@(;A9VRUU#:`"_HZW>U"0Y>I+ROH:P4$6+\Z`1PFQ>CO? M\C*QZZJL*)G']L^O-2S.I\.7^KQY-KXE8;&\/5'4K]JV!ZYW<;N?EA&:=_[I MMP5@_-P$V,W[G+>G/?I].&:XR/?U$)$LA,^$;K;F9GEP![9[`TVY%"SYQ6B1 MG5!\,_"/K'@A43)*X-NOE&I$=0`ALGL%-_TO($P."=FY1NND(5/8K+*']C3D MZC>EX'YY+BMR45$Z^_J+J#5K"'SB^QY"FV-Q%R<@.YJI">$F>_R6_Y.$5#;> M&K<%'O%]&Z+';K'N!V0'1O51P%.)O;ZQ:"WH]7S?S.BW=ZQY`MF95&T>HQZZQ[@=L!V\U873O$`#?]\VE'KO!#+W\$"X>9;U5 M5CZE%KU\[OIC#51UC4:"7M]>_*;.DS7U MOP5RQG4NX@MX]Q7:^&9A<(1+C::-,*Y%'?]#*,*'3`I?-5,K:%%4!?`Y%5.T MA7"1ZW6(6H>#3`2W3!;]M+-?_/,`N_)O+S#,TR,%X@"'N1]WG.:+8) M`9F,O/6$.7WOU^W:&ZM,<2,3BCMG8>D[U6JF9)>K_D93)*HGI:=4F*B";UHX7O MD$[EH-_;><9,T>)0!1^JEY>9V!*FETG!])6*,B>$Q?-UFG^[R48YGYE)IT)$&=3TK509U4.Z#,&@I M;O;4>TJ0%OSQ1R\)0F0"H>6PRU,<:4HE_A<0)H>$3":T3AJNI99=]M#&RFY= MTSIUJ8-L]P-K"ANQG-E*'3G%<6^P*0WZHLBI<,V^NSKD*;([@5VRI_KJ6CS] M1\)EGD%EJD5^:;`8:8K<4_Y5OS(8KC7$^[P81']725'[9S@:%<\Y%5])IJP# M5B/(K6+@?#489&IC4^S@"!R#IZ*D\.[+9H]Z+0!ZCTE4K*SA6R'&%N9XDY6$ MDJ*\"Q->(@=>,0""(#6*D=?YQ&V"PG89R$T6Y1/R&'XGA9*@E9(`!T$F%"L< M<7!AN_WC#=N7/(O@QUF"]"0;#[)XD6%W`#.F5R"`%$L16>-SVK7IH'>&Y^A2 MM^^L'5=@NW*$01^.+BB)D_(ZC.K\/A=YRJ88-$RO"2D&D[R2GH#5;0(<@"%= MBQ4:^5W$S!/VKCNQM6Q\F0?&#T>#*&*&%O2%11\,F_0\%F8IMF MP!$(;JYQV27,O>'\BA:&+X/"TYD=1)A!:Z,@&(@@P,(%73*\]FYSL?.>#E(` M#S#)=4XO\^JI'%7I9M?Z"_H584L^R:MJV!*X`X'XX/)M;>40>W?/V-KES*.O MLTQB!Q+RF\4`"`)EPR6SFVCM769C:Q8_T\A8&-'P*9W'11>P`F%9,V2++T5- M@(O@^B&7Y&HYP/F=.EM/?]AW>C>)[]'8W!7.+^KY4I]3>(81`0#$%_F$Q?F) MYL.*&F#R/L^E5,#MW?)C:5(UR>G;/'PX6F"_R(OZ-"Y#7L\"9+,IS2;``7N^ M#C;SA+U+B2RM@_-IF);3>12O;*6[4A#`[/GLF(=7?@O2MH)D11O$7<[-.XV= MN97$SNI6#?H];Y_+I:BJMS[#U&XVPXGZW_T M'J]K@7F1O&CF!F1!O5TCE?H?<83QFM*@)K,)$%E0KP72=C:\S)B][64`N'U1 M7=[[5@#L0K#K(NKMG,7DFN768F0%GAQ,8'89A=EEGN7T@=#7)"***]8E5U&-B&8/UEX&>N_:Z#4/^"Y>!%'A;E M8\*D-+W>+:T$=B/8.S#PNP8:YZ?;Z46>?U5U[V49L`J!A&_4M]>-MQ9I*M)F M*_:LX>@F*TI8N=6G@R57?`N*@ZTNXT+]+!;4@)V?4&\\57ZA]49!6$C[S8JB M]A['VP(8]@(\G?@9Q[327?U=A>GG/"N?TVG# M*OG'7K,Z@/*=LU?0LSF4&&&R%QCRX22J*SW_*3Z M$*<\0$-P?*`+;1)8V,()9^N?)!NS^&1Y4J?UHD'_`$$$2J>M&"XB>Q%]BL5* M'96VC!!GM^_"J,DN05>M6\0U`0*"\((VI!@!Q!:^]_`<4G(>%JO!+@,6O#2N M-^/.I\LB\PST@V\AC8'Y33:+:OI$\T*:F<;^TX(^AGOE.[W,KIQB M+W304E\+Z^-,[`VYHTE$P.`:F*S#"*H`P!V?(F9_ M@F]A_6L7WPC!HX(^AIO2O7P@I!ZQ%\HH2AS!GOZD-OMIW>SZ/W_.`L#@M8C8 M2=@Q&;!;;V!=R.Y%$DTS'#X2G+:CD_OM>,9>.*3+[G1/F)M7H#CM2YSG`44[ M^CW:@EMPQ&4^5$\%^;MB.7%?ZQN7O,=CKEETJQ&'*:H2]#U.(U9M4H97M-M) M]*!#3^/8A.S@OF,C=&\V3]3/2\)T5) M$UC8QW6Q6GQ0[DZU:C#H^[P5J-/2M`->YZ&72V5H.!K$<3)[TM7WI&1[WL-, MMMNL4Q=@((B[-Z'-$!J.>X`N\ZB:7WDT6W`T,EFV%])TUW%O3V\\5":=J:H` M*QUGUQT,%XEELN)@\-;%,CTG;JY'Y1CPB&46[O&9YXB9?5@U[_)9KP,ON??K M)M2TB08>*2ADIWV;1BH72IN%`1..RR047N=3)<*#['"O!8YP+60MDN58V#/3 M5._).&$I6[+R2S@1#6>\HD'_R.,9@K:#FAB)$_'.C(L+`$-9C'U,OO]/,I62 ML586,'B^_@!%1<4#B<27:EA0Y M&B?7;IN])M=)2N@%6#3.J?PE62D)]GL\_-KM%>$`<2*_&7ZO\LDDS^K1;:91 M#*NR*,,L3K*Q_.,EJ0CH/&:5Z/@E4^)R(MGILO9(0V;)PW3RE*<"@E;*@,T> MSP"TY8(#P&=/./M.NY1,G;ED`X?$H0=?NSX'BYJX64SYF\[F9>=?P M.Y7>NE$>OJ0>XV2[\B*`X^;@&UL550)``,S/X52,S^%4G5X"P`!!"4.```$.0$``.V] M>Y/D-I(G^/^9W7?`=:^-E5FIUK7)UM:8)"*3 M70PR1#*R*OKLOOOAP3<(P,$'@*CNM=WM4@8<=`=^[@`<#O=__Q^?=PEZP7D1 M9^E__.[-U]_^#N$TS*(X??J/W_W\\/;UO_T._8___G_^'__^?[U^C7["*BA9#U^'V0Z]?DV_D\3IQ\>@P(@PEA;_ M\;OGLMS_^,TWM/WGQSSY.LN?OOGNVV^__Z9N^#O>\L?/1=QK_>G[NNV;;_Z? M=S\"U[':5$&:=A2T6[&Z-[\\,,/W[!?2=,B_K%@]#=9&)1LJ+1\(6D+ M^E^OZV:OZ9]>O_GN]?=OOOY<1+\C8X#0O^=9@N_Q%C$&?BR/>_P?OROBW3ZA MC+._/>=X.\Y%DN??4/IO4OQ$)XM^X0?ZA3?_2K_P^^K/-\$C3GZ':,N?[Z^E M`OW0ZZLB^H9P:8O/.YS'67253F-X2&V?\P]ED)._2V^3^(2N#9!+?74J; M'+_'T\:YI;,ZOL1HXFGCVZ%>MSASR5.(QS5_%%J MA5UEG3-[S$PD[38+>QTFU#AG^:B\K*]M4#RR#@_%ZZ<@V']#%ZAO<%(6]5_8 MDO7ZVS>5-?Y]]>?_392PQ#NQLOXNDY9Q M\[_-R.OQJD>L)UR.B^R0A]AHM/@\]-D*'@W9(@LE(:;[`9R^_OG#[_Y[0X9N MMZ@A1#4E^K6F_5__SED8R'66]^+JSY@"0#\%CJ^(JZ%4-W8&LYE0.IU]9$Y]0TQM=*3Y&AM8!$BZ2 MH"ANMQ_*+/QX]CDN(*`0:=SA8X3_(518$Y1M$6M$#`UIYA-<9%,@18YZ_.V! MJ,O'9;8+XE2!GK'&UF$SRK$.+[RA!XB1C_<0*KK!=F!HR$X.7Y-_@BQ,I[$[ MT]+E6+'\T&:(M?,`(O+AEEH3R5C;@\A94>"R`&R(APVM0T/@=`@+WD"[EYW- MZ`O.'[/F.#>#WP\?KAX^N(?M.`2&D%7-O\55+RB>S]*(_L_5;X?X)4B($A5G MY460Y\VL@O?VU$2B7L%P2`A2D$6+_Z)!N4%"BFAHQ\@UB;AZW M6C%;T)#^`[>D*XFS%SQY]D2B4_>(G^(TI7-']D*BMJZ3,)F&:*JH4$7&K#PC1)RR60+=JN\\X:A0&1,JK)0G8)3N%<8` MB$,],D:A;6\18-?H6&5T^!FHP+H+&6AMT'',&/0.Y2`\>X'<=G$BDFGQ.]K: MX6:LR[-J3]:T\VQKIN*?_/@Z%+<^?FS4)C#NX9Y-@+Q\ZR;!N\T=7+;'>7F\ M(V-=DL6/>E+V]*I$?6Y2DSG8LRFE$/2C'G\F&"^6R"L7'T.DP.-:O\IRZ)/<2),:<_4 M0<@=+.`@J<05O29KSFJ$$KUJ:%%-_)479F&^F$$EIG,'S21!Z.2$]57;"W7R MNS<,)@HE[@9,MH0`8`X<*KP!)_9-;59W,H$WLZO#I&H,=?PSH-"EI;QV= M,KZ'2.B["=NF;J%KQKTO'A(E5H;`!@#%MJ]/Z^1SYMU3N/4\\>9)W7AGGH"S M/\7C?CM7\+N)@\7%[=?_B7WW__ MPY_1J\NKM]<7UP]?H:O_^^?KA[^Z5R)3H`[5;!I*[0<.W05'&DD!#QD:$C@+ M%A(XEX8)52T]N1LUYW_/6[I7"C5H9/$Z*L38`_SE`3]D]SAA#[J#G"JF'O0J M(NO`5THP!`]I3#9,J&J.JO:>J("1)$,U0*]17DFU)[0>!+/IH354#2BNK*X' M^0%'G64+M"3(:%RL"E+^1Q!%VZ).8T\48XH42=O8Z>%HW@2HQ]_R(J?6A)%U M#J(&%I%T>M1+6. M^[#8`<`E+'=@9-E\<[:/J5G#08%O'Y/XB>63`JB)CM#!*S.-).+3'4:`&`7J MD'BB+^8"5?$Z^RQGB4^R+0HK&1,F8];VXEZ#8,@3GR'!86=]VWB?'8/$:-,H M4KC:,H[P+MNO-$T]412X!",:DC.JHT]KBP9-DHV7&DH6?=M9^O2`\]TE?@0\ MP1MM;=]C/'G0XG;0B"V5WK&)U+W(_*H52!EL+':U68/,U"U:'\T2N=D.-+ MH1XZ<#EW"X`BP@"TOC@'E+%6"O^`+V%C<\0:N@0VY"]%T2PVWFRFP%`$N@KF M!)\]9BEF*O/M#]]_RQ2&_D4X@9%/R'=06@IKRJ'G7>L!H)K@U@E@+@1=/1!; M/82SOXD.S!8LRL(#?9G"8+F(9!>].'T4L&0HY3-&CT'",J84SQB7*"(',/I+ MQQV(8JX4$6F>9X>G9_*_0=62QF'5E\XTY4K>3'Y$CKUT+,D7MDW>99[MZ&MW MA@.HDK6Y,-)'-VX4T+(K(W#J3%&N1$-_2OL$Z`0\*T#)(B:91:L".WQ.$\3] M9D"M%2KGBON8\\Y&'W;6='NRU)TC??*@2%TG-YZZ3`"'06='OVRWBTNZ,:$A MNQ=96A*+C,G:KH2MDLK^<4\I@[!M:EOS=*/=]FLAO%,TQ9T85L]Q>EP))S@H MJ&QF'9_P5L.KUQE&KQ:ZC>O'&&=EF<>/AY(="!XR&E3KDS-QLGS\#08G<:\N MYF\M_'M=<4?ZPO14R5C3I:\>;>TB(=T(SR,YVG@K7LIA4R>AOBX*YU2(&_D;QT:O#9W8!E*4AEQ*9.MEH#;L5?HR`]*)?GCF\V?_NW-YML__$&M+)6S[@-!-=X]XAQ]_^T&L8*EM.$?OMO\ MVY_^M/G3G[X%]7*)PZJ3-ZR3[]RKH@S48UL^.:(M1O1%$2NL%B1W01Q=I]5E M0H<]A5I"B.W'^4$D$AS^#1&B5.@Z117=!G75VG$`X$S1:$;2UW%:1\NZUQ8X M^H1@0$/HV=.H>UP&<8JCJR"GI1^*LS`\[`[L[=6B+=RKTYPZ`W5R11W+AT11@X(+QP/4QP. M9>UP\,`##9*(.Z+[CH9_^^[-GVBZATK9/78ZP)T-'ERKC*:8@-VU2$B]RYVB MOI7IY$SQ0#TFR"+9OEEU6A';'\#."QDUD_ M]H]&AG(*FYZF)!'I`-4]H-$"37Z\F)HIL*)*DZX\TRMRSHJR)`GRXBOW&CL) MX<*9:SJ\7?GBR1;J-F>%6B/F9KG#^0?J6`*[Y^4=./;8*R33.O$)+2*@Y=3< M48D(/6(=^.34GR1DY<-L7)==5:11>]RUZ(%2FD%5[E1>J$E?5F@JG*K MBT9PJ2]0D?I*XW&`A11U$/610LY)X,6$\Q&(VF5XAL&AH1^QX?&Q:)9X)W,@ M,@"F(I["MZ-0AS6#>!-=+*](6Z*FJ?;UD4TH::9` MK$@(&'^;<9HO.#V0S8\>.6)3!S&8`K=BQ"5OXLT+-3C/[K$L0X,8**F"@L6P MR"#!1<4,+:58J"MKCS>W'QHYSK40'$F;H:K=AA7*+2P4T`9%"P-%>&!;8E30 MUN[1K4*+$/&HA8I%&\T3%U7Y'D!,ET'7&:T MLJ5[,(^#0C#4"D2X,=-P"^W>.(\;M0:[ZYMB4%BZEF$>9JO<9-C2-4-F/5LT M@.N%PZ7B(BO*VRU;L&AL,+&\3!*HY!LG*M$.1W%(5"+"7#!/-E-ZI(G^$QC,[&G+3WE6%'=YME6^ M1NRULJX/?1Z%2O?T5\1_]F`M@C/K'L`CDS]$K'3F[4'T=H_S@"9"NOJ\QVD! M:)X1[L6A@-H0_$D$5;C5/"44)6CK-H%Z!?E'W-%MU7E<063_:*Z20/">\L8,6$USKY3%3!SF#&;G@;JQ M>P710THX)@/Q9+-N[#['8*PBJH')0-58E@U@TMFV] M0>2_$LQJ@K&UI4/*"E_L\RPZA/P_/="9Z9+R%:;3WKWZ`*`G%I4%XFY&?8N+ M+"T.2440=->[NU+11\BVZ6NFF](O#2%J2UP[H6!@*07UZ'Y"<4 MMI)@3N2R?H6!!`_/F*KC(67^KI1HS+@XO;H3.6;I],E_^5%W0J-9#N\J M).X5;;AV^C@CC"OYY^S6S%.LU9#WHDBY`CA2L,M08P_N9!G)^MQ4"@AP%0-H MK:L"1)Z1_5`FZ$9%]I4W7N0IDMW2Z`D;=4',,(6?S"W,T_!7%* MEZ7;M/V;.O@*0.O`M:671W3[U+]O$*6J=DF(G/"[/ZT>O@7V:9F+>/%,_@LC M(MNG(,\#A*9/%"NN),'>[+!@2!,.)@8P\^",,N5LXM.9Q/0LXL%1W426RBW%-.3* MEQV9L4YXIPZMT^`MD8Z7NCL0YEIGR#G>9CGF[1Z"S[BX^DP.1UD>Q6F0'Z]+ MO&.ES0DE&;F$R<7WG\ICRXI?=?1\=*TQE#Q!K7:2S'/5?K+CQ$*/[*.UWK// MTEK'G0\C]F5VN]KY-JH_[H&%L#NT9#.'Z+<0[Q2]NLNSE[@@G_F*_"G%V[AD MV86[0^K>"%E0X?&GPQ;T=\;E<3-W;[.\X:.:184_TH#6[J4R4!XQGUM%QI!; M[2W+X#,Q#QS0KEV2,-6M8FIN%,L_#I"^X]\ M=)((_@Y.T(%8$[CQJJ):>6L-?>TS43+W"QH,7<*C'@-HV?2"\HR3YJJBI73@ M`=7)(OH_JURB*FUQ[?.<*I1[10&"2_1H&B#+HF<&EZ`PB4$[^QZ8`9]CIXC^ M(A/CB^K`5S63M.$#KA[S1S%LN`,D@/9GM;5%0;KK*R`4`TYB75= M5'`_1$E3][))(>S\Z#-!"HIUBO$V3_"/[M&NP]`0^#``N=.!\Z"(0P,%J-H[ M1W_-MQ[Z&\3:>G%0@4K!_NYMKFPEAG0*,`(@=^B_C)-#JX[.`EA[U^:Q2/W^=VNO1V3S9]**I\^X<"1S1,BKX>(IO^_8$_8/)P^V:( M>-#B9@IW>_K^"XZ?G@E?9P08P1-^?]@]XOQV*R16UFT*#?NQKMNF<@YA7-.C MJ@/$>Z!OYL2J1S[M+^<*WNX[>?YP#U;829@=ZND,P#K7SLJ6F*3E-^[)%PU5 MR#I31ZN>O51/`ZE[&V+?=52'7*"6PF!K,:=+G4;^=DM?$K]-LD^0K;&:S'Y> M%[44PLZN*0-PNV5/]A&C\*HH`&1BA-PHX%FQ>CM$>6%1$1&.SH\_%_0&JWG] M>!82$Q#3W,B0QX83.G-QSV0N\9B_F"&S[@:=']$KVA.Z3K_J//-N>_/F"+;( M`+02!DUS#\YTQ'*DYP[Q;L(5M.R=?Y MG'4SL-*H#?6D\QER:$/-AY!XG4U^/E638FDPWU=)9(+V6!J(,%GVEU:THCBZR'8V\ MUNT@903V_:,RSD?OO%\_TI:HV]2+72%8"D5NTV]8P6V4[=EZYDV*(#6T!#\O M`%<6GZ(7Q8$8&'R[996-R:;T%YY1IGB;Y761GMO\(@GBG>I]@&$_]I^+&\HI M/`"OZ-FM'D,A/:+4?;#WCTWM*?)OWH];C9LKL'%6*E`WCS>SN(D4NI98ZKMHXW#7ZPRUHEZAGER;(?@F2`\MZ3=K0 M"\^4K'H]$>HUL+MC]&.?*,%X;X.H!/A"20BHSY.H<'H6LMUG<8]#'+_0-V%$ MV:_3%S*L67Z4J>"4GMPE*`#+*D]70'I!O!MTFZ*Z(]3VA$A7J.G+D^0%"PA. M%[>$"T[=C[7@>2LX7>_CE04'V8Y%)#]KE:D,/ M[L%^^32P;$*UL4$VT):<*D+;`>(]N$V6.UW,5Y3T*_YBD8@6,?(@H3(&"L&L MUE8SPZ=08VT*.*WF=\LQ.>%?8OZ_UR-60G66!I&[R+@&D6HD=1IKCE[5A+0" MP-C>PG5RZDGBG8EKGWOU,@'@2)HQ0_2Y5*QZI8V5]6LT=!ZH4E\.B`Z1I:Q# MY$E^=U.QFE]]U)D1;.F510HLEUIRE^-]$$=U#IJZXD+*WX5I]X)3._1`KX"2 M`Q6NZJU)IT0/.?PU)>_)4RV<.`BUM%3*C$GIR_9Q'L+U2FP.;Q\VEW?!8#JV>S%*DHO+CZGR-<(LN=-?-0X">K@V\E1R#G6H_Q`[&M5/\-T M2SE&[H:I9$AR"E$L)0A_?CBFTS*03C]^* MC5U'"F_$'NL'';'D08>IV%OQWB M'!.>HP-E3W^Y!Z"UKJ`0>00/145#\_M65*@E\\DI,TDZPLMSP.[8M_3NG2P? MY9%Y8S#I8K_S(F\\&(9#33/$H$/%,K@U!]"Z5RS`%?*88GEV/SY%K(X(S)6) M@BB*/:D^#H:=5I%\N0:'KZ6+;"Z]WE2:GP#'-I/^G@#A(O=.@/'(?M*]*IH# M=_HVTC/E?,O?FRUS`E1VYHNRJB4V/`$VG9W0"=!L`%H)3^$$"(`S4'7!6+:X M45)M$.4-4#8EV@3A_^Z15Z3WO9V@C1/,*/C+_=]W`"JY:*' MSGUO#]C=_Q5RH=QO^T8`"-OU2='G1J48([ M]= [ZHR%!#YX]&31,+5RVI-O'D,AXL6V#TJ?0)`#T?78Z+N!J]=C&:WP>, MN1;]O0^`B\SN`_8=D;_'>*7(*%;WCN6 M%&`8:JI04;-NK"NIH91#S#(5I4$8[!^='C:(]X%&@JD]4-298C-5?29_P?3> M+JP'@?T#M_VY5]0I(!ZJZG0$6TS?V@1DMB;`IMUT97.&UMBMP;%8 M:9GL9\HCI(#RH*']NLA#3H5RQZR!5[N`\=$5BO4JAM9F]4`"P^<([> M9R5NH0Q9I@WZ<%!7$"Z?6&2PI445SBAUU];ZLY"YE]1N<45#W(J5%B>!UIYF MGA^*.,5%<9'M'LEBP[RW`(NM)K.N?QHIA(K/57/4;>^5<8=,RQ!K\#EQ"B\S MJP_MP`?(P:S@&/C\M/4.172L:P86?@I`;68>J;+#=HX->NNNI'*09T0E@RS1 MV[$'.(],.V!*Q-P;P/EP"BR(.5>3^0`ME5T;QY8W]MJ.-(YU16N0X1"S&M[# M7E3?)=13DT97]:-J@#$&T+H([]'*,Q('PV@VB%$Q_V%#YY6%!L_62#B,R51Y M@#\SZVW6C3^HA-E#-4"]M/C^2.R%?AJL$M.A;+&R0I9%G^(D854>^N_LC;;S MAOW8K[)@**=0:Z&B9_@54D?X>@Z8-+M"=8+I4VOSK"#C#'9D`%`[.#E`9%(D M!1D!IS?+BA/A[)XKP(@4CQ>&<+2:38AFN2UHN7>:FS-((*Y\)96+#$(*&4;> M@K'6S/+7[;VR\H`Y&4FR`YL0ZP&`=1[EFK->\EA@Q-DEZ;:KKIJ M4=O/>^SGHN#[.#B(P)RJ#Y+PS'G*8,\:U#76P0<0&8%U799R/H0H;>CKP4$] M_$-L0<;>(G0:3MBSRZ8F^3U.Z,OQBZPH"U:UG)66KY]Z0R`VLV/[4)P[$@)D M6[1F[!5RTR6J^D2LTPUBW;YF_:+F-;U7"%\$)8(F+`@1#S7FO,LU9`LVNV=_ M=48Z%@JEN84HS?E`:;S9G:TZ-)/LB5<;MH6T:+))@:C0C#+DK%84CR]\R`/" M1*@+Y(.1V2TPKI=">-/`2H55H:1=&B^6,Y.IZ15_-IJ7Y6&C6CR`=%X`1_D: M1HX*U`3$7L>R*F,0?,?H4Y.1O9/6A26LP+R<8D_]L M7_>[+@\/53F(/7#N"*")<^*2;Y-3LMJQYT44WO&W M]/PY?[<'7]T,DR97>-T^?68]@S'D1&7:D9]`5EEC.)*=KZ(^RNR=_FI/.',@ M;;7`9K;##\%GPS!W!96+.1/,CN64,P>LS8S^['KD+LC!]Q5P4@>Y M^[72B`G[^04:H_'OXL)TGL0<]B:3Y!YW9GM[HUZ\02-LJZP`II76HT*^< M#CE?8$Y6+E"XU"3!^@%309N5><]EVV8YJ^OZ6`]`U!F`K\_'_LK__8@+1I@& MY:'*_TSE9V%9'9U%<1HFAXA^\?%0HC0K41+O8GK.*K->2V+@B+8>0MY=@7;! M$3V2?^WWA%'V,(P0T.29M*\PV^T))2U$LP]R7&6K*,C:&D=QD!]13D\U]!CS M'.])HU:\^"4NZ-\[?SND<=G][P(_,?.Q0<%V&RFR&:I#A$Z)B6=1 MUG'Q\2+'45S2?RGC=UH@V(EL(1E#]1V6RO#')GHAI-]1& MBTHQK@8(27NZ]7.!;[=711GOJ/E3J-.PH74-$C@=HNGG@KWG:9KXJR4@4;)9 MHMC4A'$,#<&O`I#S$F3:W;TAO2]%Q[0;1U6U,4^UQP-1;=\+@Q$++#3FQ[[N M'H>8L$33GL`54$7DX-Y-(8%X\=0T]E>Y[$ED]_Y,AS3QN@P&LQE>ID$"D.X% M'?\DT.=DWH]=#]0$.;7)8_J7N+XITY(#(\ M>_(Q#Y[]357PGEMFGG8[R`T/7\KE).YRPNO!V33U=Q&W(XV3G/#`Y1L&+0]R M<<.U!=Z%/SFX]?A39J/V5\/\D=B+'-Q`K9P&82]R;]<_<4X5:FK0AT\YMP7Y MS/)M;U#]N[\ZZZ?TGF0?'\>W0>9Q%;AM9JG,R:F]C%]P<5]?R]YNV[^>\9P@ M*@6&=^$@DR58.C&W94.Z00TQO2]I?T$UO7^ZN[SDV4S)[2;_-$.UF`YT"J3= MU0IX&Z=QB6\(9Y%VO070.J\3,":/-I'^!G&RUXS.WV75"V%=UA&0HE5714`# M59L7,>2T?,#W.,R>"$N@<$<#6@?7,GIYQ+L,1H,Z1/[JG#,![5[:`%$IWMT8 M07+&%<[[+*57JS1B^9#05?7J,TT'BH$W-V!RNQM-`O M$AZ+.YRS M0CMP2Z:EM&Z5]+(,-:.F0(2$EV'RUU:XDI.*[9^U5B+F@$5Z$]%4_JS7Z^I4DR"QF,.J7BNOUL$.^IBARJ^F*Q?X6W M:KODD#RN.R16LT!-UPXA/]1=! M?$:LR(?P&4>'A!6-[:2!N=W2]"]5R,KY\2>7!_CD.@^0>/Y$&#_39GS:4 M9*G>[4::+#8FPM:SZI@7>.YF&2)_H)VC.ASJ_(BZ_2/^`?0K^X1[Y?_G,!G$ MNZPV3J3!(0ER%/7"8L+>B-'#3,B35^7D/I.V,0U5?V!96`O`KJ-S&GVK$>,#O2J+D[1+D@/VX#F M:"??V""J]''(/I>C?9Y%!U8[BOXSQ(7S/%M@,R$YQ8)LA`>Y@F9E"?(R/]#D M/#G>F$$/1/0B`]#TW#_+;QN&L6NP/8..RNZ&02N#]DF]-RIR/`J68S+C!8NIK;A\4A6YK^1-3A,R.^;3M$5NIEX MRK.B$#<;A"X(B4`'GANS_F#CLZ:D5=L./^SGZC4G^]^PJN7R2`N>A%D>\9U" M<0A#C!D/6R(88?2(@[S@6PR>TB%AH;JM<)5LKG<-,"O1VS*8F`@7#NVS,,P/ MN.N^FN"MUG?BT!4-D%!UWJC(>PX$7\SDLL)F\X1UX^Z%XE?NRS4#KPL=O<2/ MY02M'"-SJ(>C4J@TCQ)XK&IF\F2&\KC1)CG2Y/JC@YD+C7E'2\\Q7>;/51YP MOINH1="N'&H66%J5MK6=-`_/:#^^:^%\V;.>[/5CL=)8=C<::X9TN19/@?DB M;OK[[!@DY(P?'%E`G:FS7D/NRF6ODTJEB14MJHF]T;XO0D9#9[ZID.-'=K$\ M:%X-P+[JV!M_.$@?)5YQ`V5TL2L8?T#SH23,\5LD*-4%FY*Y.83JI5,:BHO5/^[\(&0U/ M8:9"*@*KGDD[7-![2'(,*TH:!)4^H4_\`\YO&`TU4G(.,U#'):T'#0IE$WI6 M%(<=WYM-M"20KAQ;%9"T$.UK.D*=GCPW-U^*\-/LT"3IY3:IB)_2>!N'+)ZK M,PHLM#)B`96L'0V3H/$49+<0[VC@)_WCE@:YO]19%FH[U@GTV*#'0XG2K$1) MO(MY2,:/Z%7P52=&`^>[#7KUV/G32Y80"1.Z*%10KK\(.342L3813&DSZ*OJ*/6E\O(]HRNTV[QJ*9SS^W\/]#X3%L*%AF@\:6AMN4H:(>J MCK:/VJ%*ZL]X9RZGFQJU^9QK9YP\'&=O)][%:;P[[.XIS)+ZFN1MEM_N,7T0 MGS[=X*"8%((WJW^7#\5GC8OR@3A_K5)UC7C?[84CZ1TUW2/>OS?&V-HX9=IQ MVLX9)T=/P.?KFN+I]U**YL(*T2HU;Y/LTP?ZMHME,`J2MF[/%+MCV*-#2V,J MNS+Q#:UA1#O;H&YWJ-.?Q[9DL9'(EAT)-]9BDD[([<,,A7"0!&(D&P_C4*'[ M`%IWZ1D4\JBR`_036655(BN.6P_`"IXNZ5-]V%S-\#.TJ9MZGZ(?.OL<%S(? M@I;,KG]`+X50Y;VA&("((XA2.020R=3TSEQ&\[(.;"ZS71`+!W&`4#6A-]!I M)#$$#Z?S&#[]*8(":&Q^9D"(WI;3B_.@I&E(=H\XEV%FK*5=D(SR.D0%;X1X M*_0K;^<:!?)1[DV[;HAGS#,-DKC=_I+E2:2>YI&&=F=YC-.1"G(E\X?25KY, MLG2(>W.L&=\94ZS:KMS$*;XN\4ZZE0`2VX4"5*()FU-*CAB]:]@835L/2A/F M;`EXC6;FT^)*0N4(4#(91I%4W0^G**`O\:N$9X^=;([>0$@Y->/8`CZSBMT?3"TI-#JNC@T,X5[(0ZP[6QC*VJ7H:=9X7N;2\,9T/S:P*R&1;X_%`0/2R*BVSW M&*=LQ"XR5N.-?.6"YLN.,'=(-E&E9V6CTS+K/+=7NY9[]A@,T5AWB#H]HK9+ MU.NS$^9]5G;*TCB,@%]\0,["WPYQ$3-QPW8XMP3N=>6%!3% MO[RP33+<1CZ6\O8IC?].$^CF9"1HNEMB(.4@B.DNZ+'6G[#ES75@_S*&LKGLJ4^C-T(_.YEZW;5.KRX2. M[&K/%$E51R'`4=@3%$Z>XQXH9TZPVUB)7^+R65B(BOY*5`Q=NY4T,B?1RM_S M(O9BB7%3739U/H4^D6^-%.TL!E4[-V*ESU;CJF[/\5.:GS!ML:W4I@%)3HOX+T$.1']&:#J*JL.@97:>3A"'P@II'9(O3]MZI! M,FZPHKEE^)9I]XBK(J=$`.8#6Y^%D%H`I MXVMQ4=@@R@EZ17GY"M7<4"=MS8\G-;0=##L;F8Y_F_P75@[**5C*R?J^E/6< MJ>PSCG/O\:QP;XW2(3M*FS9T4LU8._11^<0RZ'H.P M?(_WY/LL0PRK+-E)6$4K/N?QTW-9B=)-8;B-4[++BH,$\0V@ZZLM*?)[AU@- M[!=)SW<6LHR(9*#NLB0.ZS)T,DT$$+I*K2>71%-GL:)"-9DG;Y/`$]]OGQ@7Q3Y`U/Y@4;G;`V'1FYV?P;R!T>A^)WA^B!-:TT*[]`X;6L>8P*GX4((W M\&@5'1_=(3Q40SO#$T;KH1WH.X4NXM3!0TH2N]XO-??BP;%JW3JTL6X>NOP)KG7ZFS?;&F$DA_9`,HR6YUJ[(O1:N9EO M>3)`/N/>;!Y&1G1TUMWJ>)6#7SOS@W;6YW[(YW#VZ\H+[JV_<" M@[IE6DEE':YJ&8;09*U'K*L_2SI@3H9H`T^(_?NXF[@`(&JTM;-[MS[/TKLV MULPCX"B&7':E)AWO6:\.AX%4-[I<:4H2VR\)5=R/9'42P^%NO,F(!IB*P3-` MX#PXC%>ZPSG]0_"$WY@$+/7(W$Q]A`5&ELT`/KC03S$SP7>'I*;>*MZ]`VB M]B<>HB>383P$IT64V.U#.3?2>1'K(6(2'.LA`Z0/CC&0JL'(/7*!*>&H]'MY MI&P3Q;LJRGC'%K`#ER0A/?CPEM0`@W!'G7O=.HO(?)8L*>759YHO6*5)8XWM MYWD>XUC8[;6-4-7*<3+G1;FVFKE9BA`A6[,&'A91397K>KR[:M.NN_C<[S/-]/$"1>D=VL!;-4&ZRF\)DB,M[TOOM=H*J&W1@ M5_%-)!OBKJ9%E)@JD;=V88Z4:J%0;Q!,HQ]D+; M==K3KQ4/4ITY9=0.Y2''U6>:G%DR39:UMEPN3<:SX/5C#5&M#$U3ASKL*^\@ M_04S_T"WXA7GU=:=K$+,01FG:,NZ<:V':N3W"]$!8&_/3=-F1J*W#33O<_F< M1=?I"]D$,`LG2WQEVH%U-PY8,FDB++)6<%+$:5&'V'TZK&DS./3]3)D^BZ_) M^.I[1Q;CXT,>I$40LM2VY\?N+[JGA0:=V'^+9B*AZ-Y(JB-73E/5>_)4P'S2 MA/=L$V?,#3"U;P'&&CL%FC2B?P`H;\+UY<.M@L["=6ANXC3,DI1T_?$BV,=E MD+P]I-%-$JH?QFO)[.YW]5*(!<<8!07%1U31($J$")4'@=$FD]/;B1G-S`S@ MW)$)?`X*?)9&]_@I+IKHR*?GLCBKSY*25IL[BZM"3KF`3^O`1?O(T0@8`=+X83I[0"2!<>.EL/MJ`7/EU M]8(ZL3-'P#246(K0%HD`K/JQ)L^:]7'03I]RBRZ5PV,11W&0'S\$]&#]@=:" MUYQ1%33V'2<*_@5?2=-V@VAKZC-A[9TOV.#9$#PBL*FPB*>6#?J4^';;.1)K MSYX08OL(@T@D0*T+KPU_4$[^LT/JP1IM/F<"_`PGS.9K"UK*$M\E0:A>I74$ M#MY42#@7'QJPAJAIZ<%2"AM^\2V!?NP]NF6X4;P=GM*)?[<--XKWQ<`;AQL? M7AQ/GU+CJP?)?%J$+;7"O,C,)0L+O&-Q@*R>U'O\B?VB1"R,WCY8@7().&4[ M.TZ(."7BI)NZ\!NMGL3IW0;[SQ-15?;)JI*9`%#0+W/T.5>M#\\!`<4,W1(Z M\$6Y1,E,M(M3>Z]>4"&K6F2OXA05C.0K;W5-@DB@LBGA.*=4V?CGR*XOI(%= M[+,R_QF,UG+!,I@\)BK#:.E_<>5Q&>JTOG2NXY],\-BOS&8,QA6TIHF$;$.> MSX,"1[?I'_YV2#'MZ"+):.@GX\M4L8R[]T/WS$?%",!M3&[W?03[`KI-T1_^ MJ_H&JC["(>\PVM+3<4)TH)"UD9IE\$X(4LY-YT2C!+*NLRS2#`/<+]QZG=YN MMYBRQ>YO'K*S\+=#G..+;+?+4KYU(JQ61#*K.Z]/NZ9VIOQ#9:B[J_7A.D5U MCQM^*X@>,E3UBGBWU5&";1TJ>I>6XI1&Q)I)6$)->G9@.1U90?FO/A-S%!=8 MN;<"$ONASD.)C%!:$[M?Q2V(Y_K<8H1)D$HI`#E?=X8?ZR[D=SG>Q8?=E(/+ M4KT[T;[Y8R+![RA\^WO,JG^?3RU>CI*/9Q8O!\K+$\NRQFC,JBYJB:SFHPPQ MCHJW9+RH"`$9R]N<1W3P.TYEM(2>V$4V2KU$(^D:&1%_3UV3H2QO0L0XZ8;L MQ_ZA\_;2,I&HTFSB,4J44,52U0S=Y$5H[E88&3V\:>60D!>G7ND"4-L MT,=(/(`:8%H$D('GQ$5$S_F!V%U<%.P06<350[W.?\%?$$.[-3 M=X*ZO6QHZ:?.'WQ\86PVU_*`GRD3[;`8P?GQ'*?A\R[(=7'<>E+W10E$:?2% M"5!#XDU@-W26M!4*E%/D$G4U5]H@;SVI!Z@3I#%#G3>AW=!YTN-.-4DS?$4_ MY5E15$E^R!XT2(K;_.HSVZ;>IOA=G"2$`?43*Z,N['I]S*0;8HQ1-XFL.#VZ MS5'5`SES8U3UX4'H]]3I[!VI)\_E.A!\^)3-A:#8A3<0')'.%(*DBQ."H&PZ MH1!4SZ6]U?(!BG2C/%PKU4-L,THY*-GS M&>[+NX)G=4TSF(25;+(92`X(]0VG;>[/I!,R(&YX*GPQZV!KQH M-_F2]M:Q).-;AR&/MO#*H1^"!S#N-@^)+$2#N@'UU5;%M@Z.@2*_XKF/1^'P M9^/>K%72H18/=LIQM@>.$:_:#>!=I9K,.F0T4@S1,^9+]>RI)&1>AJ""3\J, M8]K(1\ZBB/UOD'"[5R<$YS>RMSF[?'A,,'M%=E84\5.*(]D9;KG^[1[P%AP7 M$%S;SNOGOTWN_"IH@)P/ZR_PEY:H_H;#T))_#A,LLF3%<>)"TOJC[=A@/C9Q MU66!7A6'\!D%!0KY2EM4CPGWQ#;@/"?C5O\ERUGB\Q3GQ7.\;[KXJGZP1WZ/ MZ_$M,Q14<;2T6`H9!/;5+?LO\J5'(G.$'NN)K+.L%RA`(CZ:PQL>Y_,N2`$R,3WGG%^FU5=QIII`C3P] MBU!79L"HJ"*(]GD6'4)64KDX)*Q(4]-F7V4+BXC-*[#[(@U`#=.9";EZ+>2I M?R`MB^8_).E,5I5 M/)`%,)2/_X`^Q>4SV2A\>H[)#J9O$LIV\LA6Y!&3W0B3UWF9-HA*2:]'U/ID MSY=`T_"DI._CQ8'L$--2%\0E:6_=>R#C6ZS05K7;H*JE/_%6RK$?.@H``^\` M-1"_TUAC=WA1^9B:1IXYEN3#+47)#"?2PA!YC\NS1YK`-1Q[VJMN[@XF?:X5 M5H4T1+_6325867MC8"Q0'.[X-/[P)RH(^#!&0- M^^W=(7W`MP+JI"5JFF[X-LT3P&N$H)SOZM\]POH89J1@EP/&`=I_R?*/URE[ M%E.`X#X@<(?W(><*P-.FM/9H7X4.U+8*X#C`/=OXS0N MGG'T4Y9%(-P/"-SA?LBY`O=U4\3:^@5[G1@-[T^T@4>H'T6.%/4*V#A`/0,` M!.U50WN=9>4WY;_5_+`S M*V-6@$B(4LR:1IB&,='@#6X)/+8"&CT;MP(@)7.1MN8NS_8X+X]W9+PI>S3T MQ)X![S\KH249X[-6?='BMOO?;'TJ3/L7$Q)W1V&@PG#3TSL"EDTL*M9IP M@UI2Q&@UV+/E.)HM85$1^J=*(##*%,L`B?;4[.TA3^/RD&.RDW@;?Z;_TB<2 M41%95RBE!(*KIF[,]HEUD:=?O>H*9W MIK[=_FFAWIZ";_H:[C8F:\7!NL%%\2,*.D,6=;[@WB(LK45#V[&."EGT&P;[ MF-[TTM-+Q!PLA6XQEI/8]P[*N1<#-UA3Q-MR#Z`?H>VK"F'5[:?!DN#I`P') MC2X4U+!A?,ZOZ3_06WK.X?GQ7?"W++](`IJT8Z#\HP$'DA&:]06GFC9O;)28 M)F#FG:.J=\2ZWU10IZ53V"<0^P;YLV2M]D>C3W:P7%F.!31/96@64SN;=WM% MV08RW.-]$.<%V3R\"VCBMI3*H;S9`U`[N->#R"3>>14E+Z#(Z5!%R#;;'5+7 M-WJ39@^,1_%RSQ",]K2L:Q$5ZM1O9EUO!EP.0=0_KWK@3C+@USVP MQR`P1+!\_F?$.+?A:C2:NL0W\0LMB]J[^"[>'MBU9>?5YC],"RR(9E^O: M;J3T,J.A*LS'^T6L8R$NI$"\[YZ#!U6]NP^17!HPO7C>Q=$R0RFF<*"ZSUJB M4[N*,'<$QE[>3(6]%Y=CR^&BA_H%06$Q%$G.-"SE%K0#^R%*4,G&\?U:@F^_ M6;#^D7G"TV[[K4B*;WI9DCS0GDZ;K;N"CM-G:2=^:1@1'1NZ(%6M$\T4T-E@VT%01DBW$H'1YNMT-F5=$E&D+[,2,Z200@=D]" MMUM1#=TN>>;R/#WE3(][:H4P/]'\Z%Z_8%@38C`,@.;%NB<]5,X[M0&Z]6DM MA(S"A!/>9M2!09,:%B$Y,?T5!SG-8GO(:1FC$S@-3AFFJZ*,=\+ZZ9&B+Z$< M!DNJH69X821&N'V//Y,-]*B5H!TCWC/B M7:^58`7GL\S"M$&YQ[2J;81S>@M",>FU*3!0`9/]M2G^?34'="E[^)0M9@6: M_CQ7_E;N972>;0E(A]YN`8S&@$#K#Z>FU0,DSU/F41A[K M5[(OJ8=GH`^5Y(OJ,ZT MQU/39LDH$'S]ZRDJ3U._=0/R\(QS MS.0[-54?A?L\?5=@W0NE'T\%#B7T277'DT^#KKZ<%S4R%DO!L2?J-9+[>@JJ M%GD>0F-#;"W#M.B MG#@O:*Y6LC=@VX2:O;H4@&(Q!E%;7Y%A,HV56254J$O6`.^XJ2MWN-T63Q0M M>,(%0?1N%Q<%(2G0/CA2H^1^N3;`WW#--@:?/:VZ+ M\(_QK-KSWF3ITVMR]MXA2HM:8@^VOH"9$!_0:Z;!8N9M,K)T8"E+#^1C9Y]C M54S=>'/[N;;'N18R\_5@LT&T*?J5-O8`+ZJ1%S)K:X?='6(N,QI/9X"9FL`Y M:AK.8;CAS3U$3G\&=-@9&_X9A^K[K#@+?SO$19!^ M5`-%3V<7+``YAH#A)"R#546$.!6B9+[`!CI!/>B8SW;`_O,=1S?).'4[2VX M$Q=[7;B$DHUOU0$B/2#2Q6ELA`WG=617/&E27;F-;P`EL*04CMW'-XI+\(&S MV),+<.`P2/84!T/\H`X,K:_9Q6&2%P=!D78790WBL#:!U;P'%Y-+9P@SIDJ*9SFSEK MLEB1DGUW-EV!-+5UU\)LQLZUJY!GT=\.14F_^!9C:1"68%==%+3DB].J%8;9L M418R<(XF*)PDW#U-)%^P:_SR&:,4E]UI8O-':]:'R8$=(6B;D(=;L&-$2G2R M^L\]U9:,-@^:!%_]K)8H*&@D`>WCL2H54]#*)RBB;BF(X M4Y(P;-@TK84EU5G4B-HC3*G.J!!<>7%LG3!U<(!Y<)Q-GQZJ*(F6/UJ=Y\CB MS&C%GC@-XWV07*<&2-:G'IG9X`BHL2;@U2XG=9QY;;!S\2#PV#]#S5=EEVC%C;C59QR;V MY[\J2[)MS=%D]TG'EAH%/W*.S<+R;#5VF7',G%EU@J*)_9V`%H_GX)FEQ<[S M$2TU"GZD&YN%Y?E:[##OD`&ST$QCT[OT69=U*;6FJ/.93QG&%AP+G]*+S07X M#.WV(K%8/P3AHKH]/=L9!<@,R1S'Q@A2Z)YZKEG&$90]S)!_3W*'0;"C#GE1 M`6?&76-3!HC7O[G/CD%2'N\J%51>7(-([=XRPJ21ET+:\O+6.:=#S5KCQ\VU MP5SU;A:-)VHU/&DOK\'D/N%*=7T-P)8_M]>&DV<`LAGWU])W];T/\*^^B]-X M=]C5?[P\8'EBI$F]V'Y[;RBC^!J?@ZUNC'@7J.JC_3OI9>4D2LJ+Y(6DA5T; MSQ8%%.@W6QJ^T+.PEVJV!-/!XV'2)Q2G58#@YQ)M>1'#(]DM?^T\V<(4'1VD M7YBNH.M;E^OTX5-&SR72!6U"1U[:F)ZDL\S,=4IOLME9W664\1)RRV^RO;(Q M2ADFF)D"$^6/NH;F-.R,J*U33(U,5:U8&WK9N)"]Z73EJ\7I2CO;YM#.3LCJ MJ&277[S[9G=44DRP/.5SG)^FX1$4=Z+ID6BM#>-#KTB7L3V=GCPU/5U9YUH> MVM?I&!Z5Y/)``<_LCDJ("69G2[HKGT_1[@@Z.\WL2!36BM6)7Q;:\71Z\M7J M=&2=;75(7R=D=122RP,;?+,Z"B&F6)UX>Z)&9ZBR$XW.N+ZN;W3:2_>9-J?; MD9W(E:BZ&5.)%;I#G*OYC*LR(H537, M]UF:[7%.IBQ]DI2-`-#856X-_^,5;*KVJ$O@O(P$>#IZ>('/Q0H@D5:*`%'Y M`11IS0@55)Q7CC"8%A!<%JXA02,!ZSQ7!AIUJ?"E]2IQK/8@]K$*9R!NKN\#L6^PRE916,= MRA0$=E&EXGR(HK8M:AK[@ACM#/00`AS^F7:HC4@^S_(\^T2LW46P#\*X/$I# MX4V([=L?B$2ZS+D-):I)$:=UZ`TY5=E`9YVIPK5.D<=&K+`6Z\""!ZD7)&F> M/6R)@4U#YB/)<](33RQ8/@U(ETW-]GC+28F$- M,E1A=TEL#P6.X"9J4B_.$]NJ902DN*4=C"CXQJGU\DM:E^EQ`1C6)[`U.2;H)NP,#\=KM M0W'\<9`+Z=VL:R[0+2/#6IZ06TW/FT.7$KL;H,`Q+-Z MBV`$9E>:2_B)LR@.JSL;L*8*=(XU4Y1#B\N:I+X>]4GM5A/'G4Y)D*;6(27, M7.E,E5/C>$D4&ZPP?2+'VC*00(NMNCVB!#[IR0J"N-.0,5RIU4,.*HOIF>(4 MWVYYA9"WU:;^$A=A'N_'3A+=O#.D M2=-DRJ;(9#5K$@QW0G(D$]#-CU&K[K`+M49H*9Q$HHWS+@L^JUN[1_YT&=I` MN=5E,`D\`PK1+VHTB#9#$0](I3_MV:[*M6]$KR%C$6=:];"W\MWE68AQ5+PE MJE M+XF#1^Z0SW'"\FJ567M'[UYI3*`WU"%SW,W8^-'369`DS&FOC-L9:6AWFS?& MZ1`>G3;N`V^\8ABT@8-P/-BWU?NUSH.!QX#>KV=I4ZRR"!*RT8X[H@;\?HW& M:C*%RIU??4GUH+>KTRC!##UL"I@^9/RTUU0OK9XIW,2_'6+R]^,])O_(L5YC M9W5I5[?G26]4#';3O#-J^D2=3CW0PA,9#&NJN8!J])1X,;V8H>Z3E=H[U9V" M2=\U<"V9D.M5;IK"V%,+N6KVZC7?\1K.Y@O?>"^^K'42&4^]UKE'`GNP9JF` M#%RF]"B>H8(7V6Y/3M=$Q+_$6<(FMKC=7F0OF!RNR^*>'[<%G@`W!DOT;%=5 M%QF+(9K;3E';*[N4J_M%5<>C:)?3HIY-6%J%%JE.?T9#Q<2&*VT-9E$$:Q>G3^X/DH?:* MW[)^(;;&>`F:0SMXS3W;W:^@SF?HLX]NN^I3B'UK@ZJOD7^TW]L@_L4-.L=/ M<9K2D(=S_E)TIDAR(_HS8:/Y%J7E'P4 MKM+(PS'X0(PA>Z^/OO]6/0PV+S17,TK#V\^5+=+IF/&?B M(1_]VLF9\O$Q&S?FYVIC?EX;\W.E,>=?I)EV^3?7+8T(#*ZP,XRL%8Z^'!NE MT+BEK916W2S:*;K_O2Z*`XXN6=`EYXE/:F=S7%Q]QGD8$WE49FA"9_:MS!2) MUS0B]768C)6!<,P$R@G\X^Y&V6;W%, M$V;2?&-7G_=QSAV/M?5:<5<"^/;)[5$@X[GF\;/S?1:`U>&`IBJHMS&KI+$U MM$(.1OJ"GKV3A`:PY0A3$J_LERU=7GJ_8ZC(IV,=*_-./=JK.]M&OG5RUF]L MO"QLK>CW:F?;J?N4($/8:?/E^I2DNK>T]=(HWNE8JXYS[!<?! M$ZZWJ7=Y'([=UUKGX.0L&WQLU[1WO-,!-Z4>K56%D8]TK?5J22[\6[,6'>,I7HD" MZI:H+E(Z'@@W5G>I*Y951[ZY>CE]&[N\%3"VLVN9@!.RMU>BV%T__,'9W[OAW;K6^?.,[R2PL;G]GV`2/3/!<#[DCA\U,OOPST"O/ M@P=7=Z=MP"W/S_B%W^F;=AOFQOHMX9=H^#N7"XY,/)B#DS/F\+&U=@?YA?N2 MIX^X\LKRB[?'AE9@Q1O.96VL[-'>:KYOYJRA&:;?!G'^ER"1%U:WRX/EQX)V MQW?4>B*@]40CUK,VGMW[3-$(,%Y8V%#EFVKU[(%RCICWLE;G.-]EK/* MUAP[M!ID&"3A@6^8+]/CG7S*"[")*.:4+_")1:7_KC#Y7,694GV='2= MUL"%V>Z_X75FLT_G0*&\K@`MC\XX.;D#AOE8VWV,YG3)=/):;Y_G!Y!)G)Q(H>0J6.\_#&DX<2?@P@D];3SD5?= MDGY1YXZE!NR?AX6%3.PRQX4%[*N+Q:FYS+K-K_A5EM-5:BX[)[)M M]E;S-D<54_\@2]CBLP&\(?ZBEK7%!_&??K$5#?8R:]Z2UMK_JZ$7#ZZ&7DYJ MF9LVOGY<#;VL?C.DN%OW8=C-7FI]46O9,@/XSZLA+ZZ&7I9?]V;;;(>+G3QN MPUXHM=-SK*@SB(M5>[F>-N%DOV):YV,P=PVFJ'.\/^S]5N M:;N]Z&HWW6C/J3*/BY+,)?D6RY#'^*ESL2L+10`(+=>Q7=1[P*=3`8EBA#="O MM(E#F"B'5BAF+!]7CR*JI"\06_;3B%:'>!_L\&6V"^*Q*E?K?LZ_V*AIHR;L MU7X[4.O'`?XK;^8!NM?$S'(O9*&`66G1OM$5U0$2^[-XWRC*YV@7\!MO"N88 M31IX)9?,F$>&7'J?SXP,+=^=L[-7<4M.&OG#ED\S7GP MS^0O.+XK!,)62TF'#<3X0)21-DRVX>7+++^SP%R(KTB^ID](J%:>?&6>Y8>G M[U[2#Y)7VYBE+>9B`<+SS.67L";U8Z.=+$E#%KZ@%4D877<+TO#=QHF^QY@_ MY*R;+R+A_D3EMF<]59K])1C/*I<(CIS:SQ$NOB`3.C;&[JQHPXTW592<#GP3 MSO>/8$VEVF[/H&I4_4NPJ7]AVVVG!G7(PA=D3871=6=*.2M?OAW5#OE?*C_1 MEV]!QW7;GOE4*;9%V]G4B!^7E./@[%`^9WG\=QR-5I`_/_:2)MW3L9&%-]CZ ML'T[N?9("M:Q^B`-2.(6\%&PE+4BH_:[Z$`_C-B7*P.(V+PGBA)I2BLVVV9'4WZ5^+'XC<*+7`%/' M4]RN&>1(K\8S&QG/K7H\3^+X!M3PQ8YK1NI]`A:RB64_*XK#CI\X[^/BX]L< MX^NTQ$3(\CXH5TF&!__VZ=A,@_%M>WH M[#&>95`7&>.3L*VFMF$Q(SO-,)R`M15?U!)Q\C@MXG#ME*.*;YZ.=06,WYIE M9GHUA)LO?PFI0D]G1$_"I?8_8%>J,SE2M]U(VM M7&L$UU3M7G$7_XSE/\:06K>6J^KZJ+FTH.AS\YBH6-35>/RYBN6N_E/VGFSY M[SC(1[+L.(UJHEH1"UC.D?I;]1]<9X.T,&Z:7"U^#1P\D(9XQ+13"$;]O>T\(%PD^5C!H M8A*/U:R9Q20+">L<1^,;^ZO/])^J4S^T`_MI&:"2"3I1$TIC45!%O$$/61DD M;O>*%N1TOW,S@ZF0R6("1IT4J-!%VKV+TWAWV-&`.W*`EL;R.N'B1++#31WC M%0I40`)Z4<4.JOAQ^LSLGR._VLBO7.IBH:&OA^2E&I(J*1R]IL]',VSXL1FT M;HL7JF0QWQ#[N8H%GWU8Q4:Y^&)6L?$Q=F9+.3O_$*O8/_#(NU[%8$-?#\D_ M5S&U+;:UBFD-L8.G!#A_B4,\+G23O83)5S`?0/?WBZPHWV?E7W%YC\/L*:4O M*3KA[:I%[4?)V;UV+3-\ODP^B(2]1^>M-[@^'( MQ7[2`\P8Z`\S96'J6#MYYV+#4$C?S-BS$C,.$M7K^D..)6&ZHZWL;L0%'H:E[S8WF)09B!ET?J,K[B%O;Q--S0[= M\/<@`1M[>_N(BR0HB@:?M_D]K2G7>:>EV`;H2:VOX@!IA'2KE(2:G8H(93EB M9+W7?^[+2DP03:P&<0CRHV\%(>8+]@'O/:S@`-6LX4[%3*WF+QN=KOG079.- M#I;&Y.BHG"PA4":+=&< M591['^=35+LB\T6Q:RF,U)H1N4G,/E&_55K&_'T_PJ!]T=I19\64>*#+ M/5T!:O*(HCCV*?321C<_%M6OJK#(:=WYX7O02VW@CQ@D-6_;%$VC=4_STQT5 MYN.@-'P0I\/3;@.SM5'ZZW>4KY('L^WH%7ZKF$J+7CR8W]F;A/-)*P%J@^ MZ:%];6+JBRA?_3IZG=3L(*$*N8(E:0Z@2Y@436=^V!:=Q`9&INGJ=,R-J?0= MY]()FAY3:?4VR&,_E(%"@^R1@38O:IBJD_0\@Z3LQ+4A4DL(,4!5#Z=@=\R$ M;?Q>)V5MS&1\+_6'H>B0T^FE7C-^[/7/S`#44V->P+IISWW61!R>'\]Y7KX/ M-"W?3WEVV!..=14)8>36W6-`J83W;$V`*ZOK5Y$B1HMJ8O<1@E/F;GBZ-Y\X M%Y@QMG)*_Q4'R@=@J%DQ[$?!`V1M%*.)R73O$\N314.%\'.0;U/2,FJY1 MW;3X`X;J+[=;U/:'>(<\%X#[7>4"8\"%)%NO0RMDR(7D^6=>D7T7CT/X MRH,]Y@(2-\]27C2B>[+5G*K>8YO.>;J]CJD"EE*;UHTWI@E8?$MCDKPJ4K:0 MR$RF+94IKF7*'6>-F"_4`SFPYJ3I:U$P%#2]D7-M0-WXZ$!]IG'*3!(U0_4Y MV&,3!*ER-E]GUS$YW2?U$TQ-G]P;$S.0RM"T`)(VN#8H&@'IGU&9<=\1T^]O MXMT^B8E,N!8NB;>^6A:-=,W\E%3,CJ]L0PW'O_S^^Q_^?)?^-7V77CZD_TG^ MYP/[$\UFLPO*#;1$0]? M8YSH8E4-^O'.9@WEG&J\FJ?FK"._S9A.YD:6XXJR+&6U=,+0#1'-K[EC]1ZB M6C2V(2(V^Q&C?1!'Z%5CJ>LFQ5?T]^3IE9,Y\1V`ELEI3*;6B"%)J]K MBK39>J9VY)TQTN;0@5HC4!X<7\R15NJV@>>V2"M)WQCM<%#0;'^5;=ECPC9A MX@FS!S>LV%30Q#OP`(BX:+>4Q#IMDT-8'J@IJ^XK`[]N*Z=G,5I"IQT'_>ON M*E5$?@3PR^XEI7')_MQ%ZF<$%%_L]-[Q@IQUB%+3JQR">++X\L/E^?&!?/GL M[,:G(!G8%($V:9+YF6^KZHC(XCI5U^J2MW=BF\;XEMFDIBVZ3EG>91@`>.`H@,HP'(]5,67T.0I5HQMC1H5,+>DG#-:H)DN72S(6MH MW>0+G`I/$*L&'FP=U*,[M-ZJH9UAK=]G)?Y/[J=7;R5'&MJUSV.<"C:!M$%5 M(P]F6#W"/977#.^<]?CANHIO39\TIX61EI;7X#%>A=47/:!KU+3S99[EX]RW M[9I!GC'3-_$N)IN$VE)H%%K6VNZ,2WD>SGK5$#4M?9EW]:CWYAXRY#/F_UT< MA<'^+(T^O#RJYWZLI=UY'^55+!Q-&[%X%=+,EPF7#W-OLG5C/&.B+_%C";3I MHTWM3O4XM^*1Y+'TSZ@K1KHWV=IAGC';O!0J<+XEC>W.N(QC(3R.UR+V;M:5 M(]Z;=\!PSYCY\SS[B'/);970PNX<]W@;3BS_T?G]DF00>S,H&\'9TR:]YQEI MXV+JI/0YOZ"1#N;(!"Y\X<([59O:?AL74R@UK/44^F%.QP9S9`K=7GM\ M>,[RDD8*TZ4<$"0@:>^@_M0XWV+-*-+N-8M#IRTW?D4`*$=?+,FD'7J'N-'> M[TLIW&-'NB9(T.-\B0#.@A9!4Y>/93!TGL?1$[[)@E3K81>;6D?-"+?B^D.; M(-K&@T5(-\Q#=*C'>,:NXN1&`#9IL.H"[M[$C/I MAI!IJ1$E1[=I?0M_'(W]T'_@;8T/+]YY?^I'IFH'9FD_J3K.]T)ZMS;]D[6Y1DF:#0(A*?* MNV1WYNI@#3"Y7=,#EVH\Y.>V#?FYK4-^JO28G'ZEZ`X#HS-=1-J(I07JA$JX M-"K3)>F49`CK4*U/;:A6SN:-)]CM1H!LF_1'?L2"&.I@SV9,4L#U[05[8C+3 M:%1]>&DY:OGFF0_^[,Q_(W("TD:8:'5,SJJG4&\WN:6L M-F+>1=--L4I3S.B(25JD0/?;0WG(\3N"X-UA5Q4-+\Z/MWOVA"!]NJ&[86#9 M;I.^7!7S-I)75>)[RSI".]X3VE==T1=-6=T92MA9POESNMES+BD)/G7"+?I$ MZS2*'T*U3TYTW5P(2()-A+TE\T;Q3&EF?UXOG3>*1TU3 ME\\;'UX\+0*".>NH!`'V#&2?G6*4Z]@@W@>J.D%U+^2%[V;+?X^I[8WXHR@*)_=+ MRC3T#M>9.=#U3E.OTX=/V5]QD*MVQ!/Z\E5?>_).5MD-U5GZS))TAEAO)Z&L M2N$)COYP,BHJPG:BELHPZZ.BDJ_BY52UTYO'RMJ5>0%UI=V=EL*J!H`@ZH^G MI+("@*+[.TMY.2F55XA,P_>L)::R`WT)>OVMJ3=Z:RMGV=A*8J1=?)XJ&ZBM"=J*TRW'JGK/-5U%_% MG.\!?LC*(%E)$TO:]T)Z.*9]A,[(AWMHK'1C[0HBH$>G0.,35/O/&\\C$8SF%7C+:AD2ITY&.XQS4>\QVF!WV.#,+,AG6MG@B"'WH5` M25!%0Z/&RG4=!]-<>$O(Y7Y7!0*=QHF@0MPBQOS#8;]/6``]V`QV]*Q.NE4MEO8N&&(6$&FT).<+57WSS&\!F4&*S3:9O#MYP$.0?+X)] M3/V(2:C>%,I:6\:2C&&=YH'M'M?7Q<>\(GU)3,^1\Y]AR%B0U;]9^G98U'F0:C:0X)[L/_< M"RR;`-<.)75F/2-*BSK$Z->:7`)36UO+A82,XB),LKI*:ZN7<=N5^QVG(5B% M%W!3D&JS<$N)"5#*NR`>2^DSWLQ!T98>EV+)%OXSHK][W6/S+Q:6 MD4V^39R&V0X_!)]QH87JH*4#M`YY%>>?MD"L"0.M:[0"&2YI$Q]`.PH&$;<* M)%@LEUA9_?=$./)/7MLC3I_.TJA)"W\6EO%+7,:XN&S61,`V:'[7]DLNSA\- M(6--O5?:H*I7U'3+/,5M^8"V9]1V[V@7#J[SP=*)U_LI M.QMP8E13;U!+CV@'&\2[<*N_,P2]O_V`@NAOAX+?;VVQ)"V:W0@&,U2*$0U3 M(&E/Z^YQG=[B=GL6AI25XAZ'.'ZA?MH/.#SDQ$[\?3396F>8S+JQKGV&4HYD MU*PC8HD>UAV@M@?4[\*M!LX4]@,NR\HG2(2M?-!!+7/>=.1>-Z=@=ZB?TX$[ MPV=-U^24-#[R+V%I(N&1AG:]SV.7[I[C8[E,QSN,WR*E\X;%ZL^?6EL.\Y[S68M[R-1%2/1+V$NE\W)P)[N'3.0K7--)M9^)$GK7VCNDWK-7.0 M5+/'I;`IHS]7^:,=7WNI&7V/2U0\!X2!.E4R58*T]L`0A!:'A#FE,(\^&O$FJ.ZO2]3#YB*'AC`\S#G.5O^4Q9M9$%1/K!3$$SM-41V M9UPG@>`)H;%GC`!Q"N^T'S0G/7083,@L"W"191]UZM]M8UOW>_R-*#[]W9=9 M'AO-@L\ M.P5DZ'MS#QIWFY?O8?:"\^/M]C+.<4AL35&J[A$D[1U/&J6(4/POBAAL<`2SES];8@6+3S]-LMIG7O=:JZB M=+.P*V61K_'\MJE/AP@AHI0.@SM.4"Q0M,F-6T*("O]* MDL*5;'3?!M4PF\\X'PO\VX%F4WA1)#=0-W?P0'.4:_&A8MT,L78>.?05PRZ^ M/M2-N2E<"AQ^_92]?!/AF".%_&,($/*G_WV#GX+D*BWC\B@Y#8ZVL@:'<1X% MWSUM@7@3YT<^Q;#6\ZX=T[6FFW]/FF10;&)UH@?<#6>YGE_GN0-E(]F=7ODP M.K/\-XHD$WH2URO`C2J%A+`*W/B0*@(Z#YKE0#(),PX2E]66[RR-.$YA:1T, M:.T>)H#R#&%3DR%"5Z\>)GD:KMRLUGZRU5IZ:DPX#LIVHNKG5%4G! MM11,/02YWHU"AKZ[;,'&?=WMR3U^BBDTT_)]L),!9+RI@^V*P*UDV]*V0[2A M#[N7\8$6=S&J45X7"A<$BN04?9U&^//_Q$%/&VK!`8 MV95$B#9W"P_=T'<1`AOW=*_ M(][`+1)&Q[([Z8J!7/NT^D"ZU9Q0>1,GI]**.^E)E/[NQ]&S.XYCQTUQ$->: MV3/RN8A^\FT2R):!01NK=3JH2O#P3E9*!_T#%S7%3_2MZ\UZ$E\\D_^B"8U0U`K[*65L_]5;0I9(=7T]/P.N.J^AY'!_9DF1;9JNIJE3?U@,HNJ754=J^G MM3*(@9,5`8T);4G0C1I(:^O)7&%8<;A&&(U6S)X24%SK!&EZ,:T!2XU));_>YTV5<6JU!^` M?-TFG;A(6P^7<"1!/"-"KVKRK\B2C-J:"`&\"+;T8Q9LE2\6@K+3U!4 MO(]D:.?5?JKFJ-O>Y8,30R'J-/-A3C.?A>L+`7M>8B+%6;/FIE4=@2I1&U'T M,#E$H,FQ]YY$JR']=R1`];"89'1'MRH\O_#MMDG0SQYIGJ413<_/$BHJ%E1X M%_;3BL*E&\%A0TK1V-:O8-1LB6GHUZUW%.%MG++,;#\=XHAFO%Q'Y$O\6+)Z M8$P#\RJ55IFA;=V+^W74%*]"TM!)8+7X)#\[!DEYK$KC*K1NV-#^(_PAI\)A MBC>HBQ?[H!Q@GMMSG9]J,`X3X>F]`B,VLTR\X/2`U8DEZB8.`/Z3 MTKK;S;O0'TDQU<+8,%I\DA2PFJ3F)_2=)*;B*$-TF@6;`()/KQV1SZC#_8G51C@_MDWN M>`&-LT]!'O&(L3L"C6?ZT]LL9W]6`7#Q3]D'[O*C)0">MGS]2%OUCE^H\Q6: M?[7;KOH28GTV,8K-UUB:`/:;!_JR$MX$/5L5;*[UDS-Y=BB?LYRF1O@YC8@= MH4;E=D]_OR.0*JX^XSR,"\SLS#V5^P;RA+^0<2^N$'U-ZLECGW5M_>WJV(1IL'+`G&&QW:R@;GZ[<`>D#:7O;?E,\X? MGH.42U#\A5=QY&$[,O>OM<_;]27;&]51+4;GZG7WO%IWJW:]=1=Q%KJA&8@Q M@2@7E;87J.*C"BUSZ2QV-];7U.?5N_^MZ]?R:URV8:$UN(G^4H]`P>QE0+]= M5":451Y!W.AVO>^N;X`MFX6>S]N)3;"W%;K:[9/LB.ODO./2OL]8%5P<,<$* MYD[H_D[=C^^S\J^XI-D2GU*ZAK0]<:*A](K=DD.>K&^H7(Z_\#:KXJ5./8WD MF["&(VZFBTW?O!-FT!&7J&5GT^N,$U66O.Q8<*,=RR>:(-7N[J6$DI MMB&]37\BW5+AAXTO9YEN4\184KPW.?6-'W3XQ0W@OG'L M\IU=MD68?>VUN,>K=X)/-"H81U^3LS.+5RCJC6)*#]IQB3+.U9>[)U0:%4M[ M0X!%F6N0'_5\/P[Y9O]?NV\-J5(\X;-MB?/;%-,W#TKCN]8G'1C:U49O!=,8L`$C#)/=;9![ M80+756/1W-G08=>F[1[3S)@]9E>U:Z/?.T&C-CYNJUNTYK,=VW;RQ@PVEJWH M^W_:-(C^+F_0M,IK,U1IM*`FY(923^H@M$DKC:@.DO*JGEWZ02=*C)`RF:49 MRVBGPI,T(;>LH=V%:XQ3\651I^B6\PS=Z@'N&2C-Z,Z8X+<9@=`'&G!'SJ)! M\BY+R^?DV/F>NJ`>F-PN&.!2#2'"*!$C18P65<3]BFU^%.DSG+P>I";-W`R@ MD0T^#5-/P-!2$-@%DXKS(7SH&9HU]A$NVBGH`00X_G,J=@;Y1UQ>?0[9$\CW M61EOXY!MO2YQ$>;Q7O5$#TALN<8G4"*A^">C0S4AZE*B#JG+T\Q4V0:/T:.V M,<3KH\C1E#MUTDUQZF]@\)-ECX]X'Q'GTP]X,_E M.?G61\7I0-+>^I%`QK=0T>TV.M3O$'H7]2MLBUMB#S;]R\(<[?L#(6ZR* MH#I)ZDE<5T=0G1S'*R1X<6B$SH6F5,*,0^)"4=?T'I%=;$67+-L(CWSBP:?W M36`::\8<+#_E6:&,JI[8H?VHZ:F2"ZY3=A7+>T*\JRKFL8Z+WJ"VORHDNO*9 MLC[=6[]Y*!#BF1>`P(R=;.ORN]V>11%[QQDD5Y_CDI97O4U594]AM';WL4!Y M%/=IMUO4$B)*R:KDTC@-UV5")PKW0"-I@^2`A>B*GL<]:*7&5.HME9JL(;22 MJ.M=K`E,>YM8.$:)3%Q&LLQ\)/]-_HO\@SK.F=#_/U!+`P04````"`#@@FY# M_+;U3H10``#MC@4`%0`<`&)O;F4M,C`Q,S`Y,S!?<')E+GAM;%54"0`#,S^% M4C,_A5)U>`L``00E#@``!#D!``#M?5MSVSK6Y?M4S7_(G'G.27R5W=4]7\FW M?*YQ+)?MG#-=4U,L6H)D="A2AQ/WT=00YK7\/LPFG[X M^)']3D##[R]^0CY`P\+D'[^]INGL;Y\^L>]_OL3![U$\^73X^?/1I^6'OQ5? M_NUG0C>^_G&T_/;@T__Z>ON8/S\_-/^;_"IPG] M6Y*7OXN&?IJ;2MFN#\(OV']]7'[VD?W5QX/#CT<'O_],1K^!#3Y\^'L21 MC#_D#?A;.I^1?_R6T.DL8`W/_^XU)N-__/82A20W\^?SH\^L_'^_BH;9E(1I M/QQ=ARE-Y[?A.(JG>:M_^\#J_?9XN]'\%W^8DIB&C(1/[(-/\CH^01-K-O(A MCF8D3N?L!_[*Z(S]V#U)==LG+&ZA:;$O@2DGR0D373;M%O.0F/ZPV&< MD=$=]5]H0%-*M)O#*VFA07=1.(%?FEZ1%VVV-LM8:,13&@WSOC.ZC*8S$B9& MSBTJ;:%A?_IQ[(?Z/K/^WL*/`YHI35E72*!?7$;0<<,)C.4&3B.MPDK?@I\B MS_Y/_29M%+'A.]D,OF(0_>"*)L,@2K*8#,:7?O)Z$T0_*HR61E5:@/!(`C8' M/_@P`L($#`X\9'5KFU1X%\O*7K`R#S&.BV+C]G(+- M+<;,FJ:HI(&%F:GI^*4;6:29-4U01]B`7VT1]!'6$`?[Q'T,1;0S^1GFNE/E39_T8(!V.(Z MG5>#PB]K904,-2>4V:9:RR05-+6(>DKA?_-%Q&`\F+%C#1,-Q:A*NUM&P]F8 M5[*Y3:-AXU2U--Y00S_5K*R!W:XQZX+BC>QW#1LGJ<#RCM>P8=RBS31)>V7) M+]M,H[17?ORRS33*L(O*:FA,OC#T,T4E^YCREKM->S->J<:F[:S=>52U--U0 M0]_5J\NBOF7HMSO%[#=%F]K=[I:SWQA#7Q*5;E;),W0HG9KVTF!# MXQI4N%\ITG0BJE!S@R?8U_N-$6((O`LF^T;`VKIT[L8![<"#\:1,.-WPE8 M6&44JT"SO_%D/]!_25A`:;JL*/!?2)!7[VF7]7J')8%6M[$+F^2!G@D9_CZ) MWCZ-"/W$VL_^D`/Y^/E@$>;YW^&O5JW9/O'AM%[V.33X>*/!94K[\6;C_7BX MK![^N,/G9J#JXHM/L_PP\./PE08K5QC'T;2291>MB72!90DT,:U9\G'B^[."7!*DR?)OMEE> M_+6WVB==!GX">Z5\H=__21,.UR\BNHJE/ M0PG!NQ^#(8Y<,JO)%)]>$1P^KT<.>*TQ+L/,2&[!)KP.JRH"?>*D3?U5#P^? MUF/$M!;STB.94#8=A>F]/Q5-M;Q/O=Z1T\ZI1\LNE6(L?`I/T%-X"1:(_>`6 M5J8__R>92SG<^A:`.UTKU2.1"X;/XBEB%B^SF-GHAB9#/_@G\>/K<'0%,XZ` M2-'G`!_CN*KD4HZ'3V-[X!H`=MI)`#0J`D?$9,UQ+Y,U2KV'JP3\`8K1Q-=S$(N'(A^^AR MU0<$(X;B)O!%0^;&-X"TUT:V."`$=+E0;TR[U@.):322+T&YWP+RLS;2)P$C MH+$-8DVQG"XPW<#?J92:G>]ACOC<9CH%@`248A9J-A&Q'9(^H:NOP5SG[:=S M"XZ`S#J2#5CFT_898%-G@Z*\'4;'@G:4^F53'@*_.+1:MD=RA*A=UCLX.7-U M!"%LW#J^@YW!7T`3OE?!R*D&X#KM:H:\\(\OS`%;.IA\(_%+E)`[-UUR)VV- M@[[X)8I&/V@0@-5WXM97QM?HET;U>`>G!Z[ZJ+AU.EU3HS2`B4W*2-[F8(OUY?O\8R,L;Y`>)SN0H+@4,';OJ6FCSQ.^(M5!WHG-NI#-ST"WSBRTFTR*_`##2<]49F0F?EZE%-+H: M]WNO=^I4Z]0Q+[\/2>#8#W;;9]<0I-9ST4G*P>REMBQBQ2^C)$WR,YV\M3"8 M%;'\&IVI5L7>0>^SJTZGW?*+A"@)7%`-K5XC_-FNBK%=IE8-&NH_YUC+D9H\P`-<)?Y=E M5'4P+/,*@+(3D]V:_#$G\&JP.]$!R[G'W;0 M85<_;]0]):6`FG-WLN=.L_3T3G$Q[^#,Z:&MML5%LJ8*6B=K-R\ M99.NB[_0V1+J%`U$'Q5FA7?0 M(45MT>B,JJ+`V(FKCBA,5&`T'1K4`F!12*1ZI/"[HC'<3O1&C<HB*K@PBL'2]?G0//\AD*R:M\I[;-!D2)L4B@1XH2U?T,7C",O[KD0P) M0(:A[9ZDBQOM&L%RO&*>VSN+QKPKL5BZPH^![F7.N'G^O*I$HE]_YKF]U&A, MYT[;+=W@QT#?0TQF/AU=_V0A)RQ8,S]Z+TRC[K0:I3VW5R"-R=:%9.EB/P8? MT&5[RP@H;O3HC\D[C;=UV3^-4C]`,@9'X5!)(^=KS^W%UAHC\B8$6SD!,/1* MX74S^40K*^:Y3=1182Q68+&55``#W]L7F`#C]<]AD+$<)K2[NNVX3#QJS*09A M*PD!!FH7EYY5JV+/;:;!BLMA3YQ/\,!8?'*_#B[=,&0/(K"3C]T$I%[=*?4;9$)7Y"!B\! MG13/+ZM]05[0.T:AJEGP!@V<`G]HI>*V&`,?H[D?&$T,VR6\8Q2ZFKUI@0M0 M0'TK1;9R@@TU[9ROO6,4TIL%RD7@!'2W4I\SFOEY,R$*9<%ILZJ`0T4GU[6+8XQZRZ'\3YVCM!H;HI*./S+((C M(+B5&EOI<3SE[:^M3[T3%.I:)6JY6`2\ME),ZX]&M`#RX-/1;;C8299PRQ1T M96'O!(785HE[370";VAE?-PC27T:DM&U'X>P7$E@,YI-LSRRX(J,Z9#*<_&H M"GLG**2W2MZ@B4[@#>;Q=PB7=4;+.>\$A:)6B6L!&@&WQOJ9^WV;:G%;(Z;2 M.\&FO5G8MHN1"GS"6(_;]HG]YFM\2P9FS MY]BVVZ23X4U8!H"@D,#DAA8,H7)0G+!-<+C$82HG8*[,S*\N"0U%(5U8M#KG6$K7#HUU;!>2 M1S@$V\3%VQTT^7X)K:LPT,_/"J6>7(S*@]50""?-#QSZUK"4,`^# M#ZTS2QDXCK@0V`>%]-*XMZA,@"(CGSCY.906RE4L3@3=N=!PQ(4W('F$?*44E9%LS5;>77T!)= M2MCX2&`QF,'.81A-0JIW8*!=%LSU:PC!FI;`D?E1L%-G%W#\Y)79)PO8R+G( M)JRY0=4C M&`TX8'KX%0RC091O)S,=TYM,X?S\POJ+)+$K\8#!F5U'S57VQS`=S%.F9M]?_NB<4#?X: M4/*+J-)-V:Y+.4&70?D/)'YZ!=[T75-1$DSU:^C76G;H4CK1'.6%G[^Y.V4K M@<)^RRC.VSR""7H8$_03Y7*K0FW>X<&OH657MDV7,I?>P"">WR`LF?$V!.-E MTW6(B\3!M,J#V7X-0=O`&EW*?GI/?I0BR>,HA#\.20FR_KQG6A48\]?0NJL9 MIKG,JFVYT)"_>_M^G4'H:]@.(%U(DV4?MK([P`+'9*Y.![;H-4Z=*%C91,-4WP+HY>$ MQ'D,\FTXRU)VT@F,!#1G2,>%F_@YX*1#XIC$DYLS7F-75/:YGEM&M#I=GJW" M:J]H,@PBQHW&HDM2RCL\_-S`4FKUBZ:K)$%!:":*S;C2DM)EC11<)VYQ+R-W MMYXD===AA*'$&MU&61:(.W(ULPH;5ROBO.R3*$)H-#G@SVBZ,#O1];9/J]SU M.4F\M=&T950/,'EJ;2+CVE(YB\E+00-1[(@J6)4SJ>E@[42WVGT.S.%D5MS` M8UO+O%E^H".Y24H!3^?N90V!B.O?IK%^7A1 M1#P]ESN6F3?H506V1+&%J.,A)DA1R+9*9:9X"V4.TU`N#)KJ,]+B8`<4QU3Z MC)NCZX26F>???-F.(G(XQ:[(8F=_ZQ8M\S4MZ=*;B6A4#XSWW M`S<_Y"NGL(C[2I973BL,Y54K!].@.!6Q0;!J$JAGHTXN)O@F>21@5@J#39'@ M]UM(P=0__'ADW4$-?PF80!%Y[,Y;*QFLL17-/N>Z/_TX]L-J>JA@-35(7TE< MY*U^AKH3^,U\%!#/1SK%O,.MY[+M+/@6^+6[H$EQ:++30$9]LTJ7?1H848SB MNERS4_R"@B3)IL4459%W=55@'Z="@%T?T,7;CLW>#9L8[_!O'`;KK.5 M+&7$JN.">=5@/Z>R@%U_J8J_$]O(RP@*A/E*8QF/1$87?N"'0_+T2MB5N9R* M5Y*R:$TG3R$L0Z!*85$/49*GS]!Z64]=W#MQ=X:R;%[N8CHX\@^]4Q1'(=K& M%2QY=S%9FJ4#IYNL):S+P$\26,^S]7K_)Y6EPQ:6\4Y1A$UQJ%)PR@5B:=)U M2F\9V%4T]6DHX77W8^\4QI\B^5+ZN;E2/=XKBH$Q` M*]\'S`&BR"!N*_BR_$@M+'('<6Z\41X_O[SV+PW`U*G`.T5QG&;D%P;(.I0B M?!-U#C'I9^EK%--_K[=42D?8+NB=HD@J5<,!N(@ZE?Y[%^UMDF3&I!>%O%,4 M,:*U"2^AZ5!Z;A[2098FJ1^R?$&&C)=*>J8[S5* M>ZR8)#Y<:9T@\%TZ7LE?O8%7.[X(27@^7&%>) MZ!(4')FF&R)9;UZ7%?-ZN*2Z2G1OXVDNC_1^#ZZF4YH6P34A.[UBR7=(Z#;U MCJ111M!=M8MG>)`*8*[@,O6\5FITO>-:O0.3W`LQK4)4W7R"O`[T:WK MI-^[(JE/`R<=?;FO#< MAK,(H@O7^?=V7J871*GH%`/`*,Y`-9G9I%4?H-L(%G-&A1$J>@4!M-,33'UB MS`@MHW,;OR*@E-WO8,H\;/V3KV3Z0F(1A[M?`BRGIXXFQN?0)@+D-CI%P!.[ MEC,8_QG%P4A.T\Z'`,KIOK0F2P(\EF)$[)(DFQ/N)`%?^H4!/(H#P.JSGP%, M2V$?;@/^_(`]_YJG)+XGTJWWYI=@`J?'?*9D";:7/%"-176T;-MX\)ZW79A] M]M3>#3%?_?$_*8F!B]?Y M'7N\4'&M0J\",)C["Y`ZG"JT"`V07;B`L0*YR&U=G'?L(%?>S3"J!\R'2][0 M(%OA+OJPNW##8X4PSW:>Y*8Z$&[9-$J!:5`$=U?@4^$8(JQ=N!["`WE8R0T. M5Z9!$>+=J!ML8'6[Q6_.#8XJN<'1RC0HH@P:=8,-K&Y5`-,]A;[,(RP)L)UJ M/!67B4;H+$D`;F\`%OEUKZ>S()H3;0VF]Z[!U%FN M]EJEP?1L:3"]=PU&I$OTVJC!]*II,+UW#4:D2_3:J,&8N<$&UG<-AJM+]-JH MP9BYP0;67U"#Z>'78':7B4;HNJ#![";1A#V56H&1%0/CM$-_Z0GU%S6\=_6E M4%^.WD-PA$$A9]@UG3,4FHY%:U>0?\[>Y1^SS?(9?OGGK+;\<_8N_]19*9^U M2OXYLR7_G+W+/R))Y*R-\L]9-?GG[%W^$4DB9VV4?\S<8`/KN_S#E43.VBC_ MF+G!!M9?4/XYPR__["X3C="YE7\$I"ZW])?1]`5V2XL]59'!)F6[*SHB\4)` M6#R:TD]7B$6$UZL5S-4.0>AL1Q"RAOY=+RKTHN-WO4BH8)QCUXO.NZ07G5?3 MB\Z[IQ>M1JW\W1!]F6BW')@'OSITKJ,.B;!U2A0J'6XLEL"C;9M]"Z.7A,3Y M$Q/YZA;^.8(^%="?VOA>,+$A&P;IVN]KEQ[LZ^G]W`\:%*! M3W,]O6?Q[EN;]/3S-DX,1N@L/6&$HV^7NL"?-'W=68@EFRNQ9-LRBW642)5O M]/>`#L2'-UM>HS^U6+*+K1>69K`-BUCVS#BMN$5RZ[("2WV!L?TN2I+;0`>K20U'=F$N//CM]B@SM7)K;Q=8;5\5<>AV.VGLPSEX&R<`('4AF M9?<'I6?9RH+03!0'12I#<@9_36Q=.*;>R79^,7^&WU2HK9)2 M8!KW#R5H$L@?CY7@NG!&O0.2050*J9)28!H4QS=*]C1)WT;6A7L'DD<.E/JH MLBR8"474L9))O@-HXNO"O8/++$FC*8G-G4!1$DR$XNBDH@MHH>O":>M#',&* M/IT_!&S%'(ZN_\KHC&T[M"9_C=)@*O MH]1FU=`IMI%VX1CU(@-30I=13@J;'X(!4+P-K\T5GVH>*)2GHI?1=):E)$[* M&.6A69(B`!1%#'I%]O3@=>$@]-$/)ZJ)>O4-P'8?-EYK.MZ"8NN,T#V%RM&U M]!5@1Z&H;9$A8:S<;EL'74XY6SPQKV1MXSO`CR(R>H<2/G.UAC6!#5%H7\:T&WN/&+W` M@]HEC@W25Q+O8%9-&I)28!L`[FFAX`.=K[^@0 MA>QED7DA2@'CCM-U[,Z;=ZI@<4D10.H^V*C2HD`/F8##?2E<#9UL/Y"8_84_ M(0>R[BLI!M9QJHKIL:=YL+V#2\#ZOO0P><]E06Z$YC%PZX8KNBZW#&!UKX$9 M=,[ M.BV7T"D.1G,?LU;1)_3Q"9RBE;'K_1&T(J4)6.OZYXR$BH0 M+D(CH-=8YT-!+_/?V^G,IS$;WBY?_7A"9,H>OX#7Z[F_A%*59@DB`=7[4NH$ M*[8KFN1(!^/K)*53/R6C!W^>7U(6+=@D1<`V[@78*NLU)28!>\8J62,WOF`. M(6#H]!':/1A7H%2[`C"&^UNP50@V1"B@VU@*:X3NQVCN!^G\D;R1,-/888F^ M!ZCN`_ZJD"D').#.6-1JA+N;+,UBL@"PNOTE8H[_M7=TU+H94@E'P%K+DL&R MS5TZ=W][K6B'QHVUS0^!B@JWU.PT>2V1%FWZ2M+7"+9';S!JYR.SZ&:;604` M$44\#L_P_$6E":XNW&Y[)$$Q(4$/4IE M&-Q>0Q/TPXF'HT"]3[OC,R[!UXD*=DQ_YOT@=1:<\V*L=*NX6PP(_T8=LZZ8@A@@B`>RG5S!]4L-5MBH` MPZ$0?1OU%2YF6[<%&SD:%P"!V73(SOAS0*(-J$Y9,`$*:;@>[89P'=_N,Z1Z M%_RL+":OH,HA8%&4.U=0;#*L'"[9#K:SN,)4L8NN>8".C MR&8"\-MP,!ZS$(U)KL$\1_ES73&YC*;3*"S&2##"HI#(G^K4"29#<9'4@A/5 M-P/.^X8B7-<_H7O0A$C'&JW"WM$)BCNE#3H!!Z_CFXERMK?;7QX*'V(RI=FT MRM1CIW:P7SM$4&U_L6(06Y<>,>QU'N)H2,@HN0&C,^/XX9`,XD)X*HPM5<]4 MA<%@.)0T*WL<7;RV+E6ZU5(7D>@+`7*)]S)*N`'\.L7`.NU0T/2\08G4UE7* MDA_L,XJX]*:L^U#BY3,>L*Y[H6'QB(E&8+&L&)!TZEZ[7K:P9.WD8E[Z+_V` M8[VJ`#8*`4)-C4J]-L';A9!DSOL$%R01;K$:?XLQU91,!(*X4"/3%U'X&%$&9[\)8Z29''##!8K?I`,XNN?^2IT M$)*O-`B@N?*H*(,JO*-3%`*!'F&<;9XQ5K:D/_^(ZI*^7048`L4NOPG2 M^5B[\`Z'@ZRFISBBH"RN$(SA=^'%#H=I3D]1B$'&K!L[CQA]%U[WL)#;\A2% M#E2)0<$24X2R"Y'5S[$_(FPB5K.]_2D8`45`E$6J^1`[$4<-M.2AHH4LRAY# M@?55F*I6$=)R8!YD84[UUPT:@#L13[T%3[D@X'X/]D"A-VJ0QF=;@JH3<=2+ M4`EVB*&>S;>_!3N@$`XE)(E$(2Z23L0Z%DQL`X*'=#F,*[&Z_@! M%($^Q&EW?S2B12N+CK!,-%8$/`SB_'02S)'';L.ZAT["]5G@MGADJW[OR&T. M17V>.:J272.@#GGF0"UK:@9N4BX&P%'HBK;8W\5F*ZJY$5++S7V&+Y/7*!@E M1<"MCFJ\708@H]#_*M&I!M9<-/$^0S8N(R@0)F0$?TBB@(Y8JI#5PC<9C`#AV"3PZ?22X&2U$(&&X1 ML!#XY?+Z2Q2-DGLBHY3WN7>&0BK@,B7HGB(4EH($V#/T;FG=3'`NZZ,;'WIG M*/;]!E1RVF_IH!Y;[]3OF+DWH]CQ5^R32P"63N#3*/4#ISRRFR6#<3[4],/1 M$XG?Z)`D3U'`TW/4A;PS%-$X!NPJL%@Z@L?097.]ZB&.QE3674M?>6+_Z\7=2LI9LI24L MY)VAD)ZJ,*\`U:4<85<$VCRD!2O@Z=,H3NF_\_^4L"XIY9VA$*>JT*Y"A?KL MFQV494$)\7T47OK)J^B(5/2]=X9"EC+A3XT'QP%W0ZLRD]68=XY"G:K2._E8 M;!UW(UIM%T>;=["KT&%V_;5WCD*NJK;"WH)A*[.5>UIA&(HV02[\5V,SI2SK MG:,0MHPHUP-E*]D5AA%[&5ZG7DUO?>F=HU"V]!CCL\U#5#OOU'G!;4@F+"S( M\?HYSTX.V\(O/@W9^#4(UW\G5ZF59;US%&)8'?[U,-I*-(6AMP_25Q(+32:; MTJ4%O7,4^ED=7]``:"O3E/LSQRH>(+$-"A6M#OER;`+>C74T]^N]]4*69=># M72D`S@#S.F#U@HRCF!3?/?L_27+]$XP'D&GHQ_-\^03&&D))@!3DYBKF4&5X M:2._ZIVCT/&,UIA-FT/@KL8*8!UW%3U$%D=O-(&&W43Q"MX%"+!IM[@J*D=_`9P7.#]7Q!"Z+`&_:^W$(2Y)D^3:)AI0H*@*F:9^$*`&YEG-PVS"L:9"GW8KNB!)@&A69H@^L-2()[/ZV4"+E.W0]' M"\"Y3L;>#PJB)(NUPNXJU@BF1:$JUAK]C;`*W*B507M_$O92$!GUH3'^A-QG M+/O+8%R\%33(TB3UPQ%82C5I&-4#9D2A1=;R`KYC5;"#P)U:&?\G@+\PZ(X5 MS!U*5!.8$H7$N#^7DEM"X%06X@OWF<*!/4,2@JM2DBQ>W7"3J:%HQ7Q-G%:V M!F$I[\A=RH95LQ8BEBIS`_=[`(!BSE?:6"3M"S&]IW/8OEU_A".?@X0S/LD* M1.^)'4(P!(HY4\&40(,7P.E";H>5K]]IY';8_1@,@>)\S;C+BJ!T(1_$C"D8 MW@5C*?T#*HK_C.+OMV'^_J7T`(Q?`.R"XB2L,LD<-!W*#[&"R9+D)Z]DE-^P MUV%YHP#8!<616&66.6@LY8Y`Q7)^\5Z'W?Q#L`.*0[#*K)906$H0X?X@>P6N M/_I7MGBS5H?1TN=@$10'7I5YW<%2.X$$HNL19:MHKIC!"+CT*5-"5QAL)8A` MU$]93&RQ(33:!^V4`@/A4J8,MT,"0#C200@B@_GK@S44452PJAQ`1R%%*=G9 M)-4`6Y<2/G"L9-:%P22X%"H]NI6(;&5W:""F?UN,ZX>C=>OY,ZM6.0".2Y2J MTG.EV&PE?M@F=9\'J;!=GY$XG0-"]ES';%H`='BHNFS10^#GAE\U2V-1H"SK M'6WE,=CGZ=OJ41YA,Y79\C6K`)@H5`9-/@3G=$9@NW`^*\1Y,7^&WU:OS*"D=>M+,`$*V:,FKUQ4EDZ$W0;E1--9 M!LMO?8(%)<`D*#21FD1+T5DZ'T9!^%,T3G_X+"'`QIO:VO1+RX.Y4"@FEIQ! M`VN'#I5OLCBD*0M.#4'$AL`\*R:6F+Z@`6CIO=CHVW!$_(>Q] MQ=OI+([>BI<'E=1+2GG';J_,6^)>B=#2\;13\O\@KW08:'3US0_!`"@BA&I2 MS`-EZUT#G)OT.XUH775AL!0*4:]1\68+K:U3;IQ^H0HRDA<$"Z$0\W2Y-/2$ M$D8<)]]VG*$_'&;3+&#!,^64\/#G@'!RPPO-(W$;6S\!QL>M"6HYF%UKU#ZM M1Q0_)80JCZ>2%0,CX=86ZXU)*X1-G>?C.?I]AAHSP-:Y$^#CK?O@'3T!/OZ, M6Q;:Y*/F"7`.]OT$6.?P[/@S"HG(C-KJ)\`YW/<38)TM^_$!;@%IF]7J)\`Y MTBZ<`%<_*SP^:(V4E+.E=U:8H^K"(7#C4M)!NZ2D*K/`%MI.'"'[,\HV#$PD M'^4'8XE*0Q(5`:.T1CTZ$.[4Y.@Z=,FX##2Y(X"47/A@LB%Y>B4D+:!?S+_Z M_XKB/`/&CNRA>G;1TB^`Y5LC&NGY56UC=.C`NGAH/#/O2X)+5NN%+KL+F)([^D9VVG"3Y4$O MI<.(Q9,!(E'05M4`%84H5(&?S2YIUR!=$!3MIOP[/G3_+(@6:LQQ\%Z3$ MNMD!CP]1:$<*I@0K,P$MT07^4F$$O M3:%>!6`PIR*4+[)S_3Y!PG>R-556PE9VV?N_7'L-JT[G,;M8*)L>OP>W0\CFD$WM$`R%79%ORH=6Z`5N8AP:[/(:<7\XC#-H)_5?:$!3MR_R/OAS=KS/8FWS M=OF!S@/WDE+`4X7KPLHH0'92$V\833/&3U`0FHGCNJ_*DM)X/2FX]VB\G3"G M(Z?ZG0EYQK%V1QVYMEL[UNX8A6"F8$H_UN[8^`MB\G][X M-/[##S+AW%NO5C"7^X!))9T<%[`!VU)0F_O#DX4!KZ>S()H3$*SD/OS1T#E,D'4H?(T];@MNR-(4PP9PT^_5;J!1&BSF5%*IXPO:\#IT M$W:0OI)XUUYJ7Y`7!#LY547JN($.L@Y=>*U"OLPZ3N,-+4P%(E`-/2B\3XWK M+@HG\%?3*_+B\FFT_.=-+KSR"P`M%6ZVVH-P&T([,IUL=YROH?$HHI9DIN5W M$R&8+BA;Y1ZBD:F.][EW?()"ZQ#RQ*=5#*4+^M4V.J6&Q2\`!D$1B",F2X_< M,AJ4,M9CE/2'?V4TH45L]SAYC6(B3`^G+`-0442TR(C@J!=J2"@5K*]T-/1G M_7#T!`NI813^X0A:-W4POB#!)/9'BD%37`)@H@AL,"1-!O!@`1G'YSY1!'51N'\\RI/&P&HV'*\`H[NM9HG$#E=MG ML*3+EYLL;_@MI7?!L.I:1K,2,`:*N)=*"QLCC)UX(6MS:RT[8%>4`)N@48$, MM`(IFDZ\=747^6&RB`*3J@3KS[SC4X2ZSQ8Y(GE@&T:7KG&Q0>UY,:BICS8X M7X-)4*@^E9@5H.G2`U";=OD6^D6D,QDQ83O*I'0KRX*Y4"A'%VI-;5Z&N7WW8/!?74#(R"/,-F=[5 M"E%):"@*&4%F1IX(JPFL"Z?/EN]5G+I/S:/+'G\N4V#KPL%T[8L5IR@$!`53 M?'I%<%">2$L]628!&93VCGN8$I.;=%ECE%U(+UQ>:Z\1LW=2YJPO).SM%!H. MZ

OVH#> MH4L@YD90I+6J5B'8U?VU(1H8LI MYE:0)PJJ5!]8U?U%)A<>M<+>H03*!E;0S3Y5M4JPK?N+4GOU*P[\+F5'WA3[ M+_TXGK.PIZG1^>-F,3"24\76DH^H(5I+3XSK;MUAJX\U>N?6M+/K)*53=C9< M9")[C.9^D,X?%F.$]%Q#HZAW?(8F\$9D2(Y8IHWL_61C1U,^ZTY3I3W\K:: M7.#X2D,ZS:;+OX2UG3A(LD(M8`[WDHP1=1SJJT!&9I&=-EAZY930H-?+F4IJ=H\[1PPCA+%CT8*$4P6VE-#M'<9O.D#EJIC0[^8PB9,<2C1NH M4&:FLYY/]^0SBI0XA@2J(:%,2)>_2+%XL_,^"J-9_F01>"!_,Z@L`U!1A-9H M[@@U\3A.+6?(G7##IU$*\+H/I5$38L!B&9?C!'("'I>Z%(M:9N^"LF0M@YA. M%H^*L2PM\N%4NP*P@ON(&1VB./P:@K259LXNU0_Q\O["`X%VL8AW.;7"`H#2 M?;Q+12H5H&HGD,.@PME+Y'GR&86,8ZBQ2M'4S@O7V#B\;O)%%,?1#W#F2W_F M#]GCC:(+-_J%`3T*:4=*CF#LU01G*Q$D-!K1 MX2+D1ML]MLJ!F5"(8[7=@8M+0'\K$P)LPEU<<)Y?@?=KM6G0B0@<,_/.@@(W(B=73V\+B*/_S7`1!$/ M94J<#(V`-&.E#S`+0K%-:YB5X!'0;"RW M8:!Y\91ZX<_KA]3[X4CK40:=XF"TMJETYO`$/K%GG4XP7C/4?A#D^H)4==WY M$,"U34&3`1&PA$,DZT-K1_EA0%2L[OJ3F.3Y+!;W2^[H7QF%OY\_$OA#3-1\ MUJ@2#-9*.:TV9(&/.([NJNP"&J@/VR:)F0`3T.DXRDOLI1O/R8C?M:M0"]BC M;6)7990"UAU'AUU&TUE`_7!(_J!1D-L]@:U\]$9"/TR31Q*PFXD[,#4VR/5K M!KNU31&SBEQPEZ5.3-H^KVGF^:M>_(2,F$%(F.0U+RYL.KFIN;H9R-A8-VE! MR&64I,G3*[A$WNCEU5F=&YVU*@:RCZWUYW7&S3X[?X%)Z!O0%N=<#')7>@C\ M4)XVT:0.:#P.S<0"!9RN;&Z*+MP;M9MP\>30?8(>?'D M$(6THF"*3Z\(#LI;I9H^?:=*P6A:#YC$?1J=NAVZ!O(N/#Z53X47VVNS?AS[ MX23O-1?S]2>+V;+_PX]'A5F2098FJ9_?9+K/!-'-C?T6T.`^:4\UWQ',*LU8 MR-*5W%D>R`'C:9PZ/1>H:Z4O,=M]W89%8,J7.$JDZQG[O^:='+G/-H3);X4V M0I'NTM9:&@Q[FR09&5UEL#^>%&!SNR0EJR?7/TD\I,EZB\U=9)M6!O9TG^[< MJL]5-$'="]*(WJFOV^UNHGA,*(L98+>LKG_.:%R(5,N>V."PJ/QM8`O36X'N M!TE-B]6].=XA_W:\.#UR?[T6D_\*+&3IKGRQ.+T.V^VQB[F*;58;]]B=WP(^ MW%\9QN2Q`@O92A'0#9L_"9V\PJ31A_6V/R'+A==#3(>R4/@]M0#(M2G7M]<*H+$UQR]VW-^V[6SEF4"A1M0UWM(^SGN` M44.`2/?/0:#J!!7,9RMI1ROZ0=U-N:,U4:UV`6LY75IS6R3QW-0*L+.&H)T/E^G%K;?CBR M%MD>VU<1$DY']TJM`%JZ<WU[3I`U`2C=.6!U9 MSE9>,9X[[_.^\V4$!<+<<&$2!73$`BE7U]#8#7`_>;T)HA].+C^O&E)JA\;5 M9EDQ[V`KO;$+.*K7:C<_]`YP)-M5FU44_;Z+YOW&\?8-SP,<*71Y9"EHY4-Y MOU8<@B%0Y`)1,,6G5P3'[;5BRSWW3G+/6/PQ&`)%UML*?74+0Q>N!=^3E$U' M#W'T1F'QIZK6%M2HK-T,*\,#(DB_5+OQ'5@!1>J8JOP)O6$;8H=NLZ[3FR7/T2,91N&0!F0#\W-D M;PAIXN>`$Q0)@.VZ77.6LO2R,`;OO2+0YB%=Y"&;!22G/!SUIU&^_^G;QM(3QQC\J0QN,"X_7_D0DRG-IK*A3546K(4BS_&^ M/4G3,);NCS9RH/-G3%,2C<>;S1=IU?ROO9[;*PO[IE]I"EO7+S$,''R1W3AJ M".R((B'VOH<(F35L75C$X"8LS0D[_%[*3.'H3S_.XY=NHOB)Q&]T2))!?!GX M5"J[&-4#O>V7G'@P#K+%_E$\T^6Y\!L%]J2!';`,=U-^$K MXX`Z@::!;S);@&>&_6'QDW>`(SO_7EVD MJIFZ=/_KBT]#AGT0PLIL%B6T6*)#M_'#"67PP2ZI;"+2K`%,A^(`;]]3D)%Y M:E^S0I3QJ029>]])&5H(Q^V:IEQL=Y5HY%R[Q<%H*,Y- M36G6=181XMHW5E"/1,M]`_0Q(_\HE0,SH3C9;,HQ=J#6OM6!VB-@/3;SZ>AJ M@63Q+C-L,?.W7Y5[K6H5@F%1'#LTY4/Z-JA]RP*U0V_0.]@CP\NM@.FPD?=NW7YQ%YB;X!K4P^8$`4"K!=OS'%;^N]>[1KF!L:^N'0TAI&4AF8$X7R M:V4-H\0I<)L]A_A:FIWB:$C(*+D!6ZX#S>ZBF^`4.9"SDNM\[,]C]<,3^[_JOC+[Y`9N3BS3,VP=J$@JNSJ6N7!:"C47!MNP84F\(?69N_?EU>@ MT&J;\0JA#'MD+,.ZSK.9+[=>MF__7I'4IT%RX"*W)KNH'D1)%A<;A56;'DG` M=H"749(F^9WEEU+25!V)N%[%WLGQF7F7%5ZZ@$KI,$]IRJ['LI2ORU2SHAR< M>@6AF2BVD3:,O=E)3?!W(8MGCNT9?D61N7/C.^_DQ/V[4YHD\<=@#IPN9.RL M_L;HVB#AB*6=OO>G1)GSLXF?`S)0["$Y'L)WI>:,X#;7:(5)Y4Z23U2_,(!W M_U!,I='%%&,7\H]6?P@'UK[IO'2?-0_G?W[UPX4N=Q_ET0ED=)]-7TA<9QRR MU0:@S?WS+@8.5G'$LFLN2TE3L>QLF[/>YCMG3OQ]LPG`G_M77Q"[.\]:'=.KOFTT`[IS& M&F%W=IZUZB;"_24\'>>ZW6F8%'9?YYK+4KI>U&3R#6HOCI9V=C MTNI%/+ZKYW^;]+/T-8KIO\F(^U[>Q7P9T/,`O8T\LLZA?'<1\&DZ*0-&TX MAF!DVH/]?N'3EE,<(3%[(%GKM.94?`^R5=[0B=.:4Q1Q.1P/V>=IS:DX@J=5 M'GD]G071G)!2K_U*%(MX81DP"X[HG,8HY[N8PB!=./39VLHH?83[/9@#Q]7( M/?N'Q!B6CDK<^@8SFV)]L_H&8*.X!>EN;;-E"DO'!^X]0#TFK+_R>BBCR(K3(\_5,BN/A/HL>OQ-OL&NJ M%X&I%@RQ"7+35`Q3^U7'QI<+C80F+Z3_/XH\U<+;$PY:`;0@CE]H=JFQ9R/C>&YR_[Y? MG%BZ]GU.*X`6''$;G?%]H9%KOZ&):$&Q"HTC\1M8G6_.U664W'+),\MP5_YW M%J=^'Z7_)"E[&'<2,H;+^3QU8A6;_'V@#442[_TO9_9HWMKOB#8Y(RSNR68Q M$9S5<+X"6+_8L:+0"+6?\40TXE46$7E'1FP_P.)&63[T1M1@Y8\"0;_RV5^# M-K7U.FD[PSQD1OHC"J":`-9/^SSYYO^Z=W+V?@+8K'%MO;_:O8YP15D"\G#D MHAN4?QMX^I6/!)LWK:T79.UF_FMN\^M8X-C<=/?K!8.^)4L7/MQ7PS]HCD1:%5346C;HDYT/T6;@-=W+="%R6N_@-RR M)11[]JR@:!"RH65T)5$>]]P,8.17E#:=6-G6P\TEO]]GLJX__3B?%Q?IN8*P#)C%?;IF'>8$:VTYKBYD?"HC4^9K MVOT8#(%C'R9GBD^O"`[*5RZV?/=.];"%Z'N`Z#[)KGF7U,#4A31&"Y=<`!W$ MCRS"MW152=TYA47!2.XSSLH9E'93!3`T;SK(^V^IW<4R/U\Y"R5F>2E`[O3L MVYA2;4R6D@[!6MYV)(VH];)GKO4*>B?G[M\PL\;F%BQ+*8GV2NB,QE7HS(L! M:J35,21] MM9ZQP;ZT,C"2>]',FAMH0,6174;;'Q:+H7I^(*D$C.+^S2\+_"LA=BG'"HXE MA'ME;X]+"*'D9YZPQ/6+0%N'C`>H3QG/SUUULE7,ZL7\P@_\D`5Q$))^B:-L M!@..ZDT=G>+>Z6?W(HP6!?R^I(_Q_;!R^ZCH]#.*(')]"DU/+7.`[Z>6(1@" M1THF.5/:IY8YG"Z\]K)V?8[CW]`0_H[ZP=IL?A%])#L,M54U&!E%TJ*ZHX,= M.[@]:Y5OU7@W6_+_'HSS2+I@#D@OH^DT"O-.I-BTF58'!D*1.\@.T>*=7C6[ M6#JF;7*K7R/C<95JP"XHKO>X\!>Q/5`\6F_N)^5KU!7\HUP<[(`BM,J%7^S: MP=+YL2M_6-ZH_"I(6;L>L`R*JQPN/81C$$M/Z+AR%65R@6H5@6U07'EP MZ2P\BU@ZR-[U%H?ZX2%F_?#TP-EKWERA6:4:B@L!%/ M1B&[Z\U&$K`*3!5QSL[%7./-:V59,!,*'4E%I(!^/7B=T`OY4!E0M7RH*@MF M0J$,:?)IY`S;*#%?C;B".?$-6OU&[JC_DD_SPB<(M`UL7'GAN,HSW]`"%"J-#I8$3[""TI+>UZ_K,Z0$* M_<2<6VUP+9#-EH$^LO1"TN\!*0IEHQZ-`ECOERTTQS`426`;':6%U^*LW+IP M*%<]0Q49X,$L6AT>H.HV=42K0_?WDK3,;2Y:'8I?"&O5>C9/YZ,0IU;?`&P< M\H."&#Z=6S"Z(#;ED(3*`^SJ=:G;;7L79)NG["6A(^K'\R>?Y8+1BMX6 ME0&SX-W,*Z=!!2Q+ZHQ;MM?`[OTI_+&T\E,>PJ@+@Z%0J``*)@7T:\*S)._'ASIWH3B,92*>R%#G);4(#0.HIP%=C\&0Z"XLV5*G=H!ROAL9:'8`$4,38B;OA,\C#82GMA-WCB/DK)?T8!M"611TOL?`BH M4`A/>LS(,-A*0&$YK.7Y=A$/&TX4@2P[7P(N')*2/CHKW0T]&?]`#H748L"7!(>`I7WI M*@*6+N+H.XD%0LC6%][I<0M5#BX(`1G[TC"D9`CEB)UO`(O[BT#;IA5:O]QF M6X_6-V%_^4A5_@:PN(]IV36ND(%RJVT]+>_V;."/\(J:C";F+_%`ITFY_ M"E9`H65(2>+SRH?B^,5KY+>BCE'H(M5&:AULG7@/&D-.VM-C%!*-#N<&WJ*% MVM;;R6C3&]NZNW&,0@VR["(["'&^__LMC(D?L%=FO\`T.0@7(.:<*\.BG9A! M%6`)%$J2.=?5D-IZ^[:1^W=<(Q27!Z^R&/Q6?AU/L[AW>H)7K%)3;H120+>% M9$+[HSO/G523\[P.,`F*T)QFB2]!%5R$,-;2W*:28AD[:9H_\MT/1ZO4$T-* MJCV!;2N!B[A5-!D&49+%1'+)KU(]0&L3#VK?9"G\R.(ZQN*5]>1B/ICE>3W" MR1WQ$Z+YS+9^70`&A>Q2@0%.[ZQN@2[<#UQEQWL:DM"'84@WY7WY>S"'^V>& MJO,HT.C$2+MPM7")ZEN8S,B0CBE,1DH95E0&S()"Q9%P)B!9C@AECBI#1Y=I M=+7J`Q.Y?R3(5J^W8(DN7('>WWZDZWX?./Z)_$CV4K#^.ZP)KNGS1WZ%3;ED"1!W_??@6_2NQYUJHV M[_34_=M>;GUKRQ8HTH/MV;MNHBRVYERKRL">[D/`G/K6EBE09.'?MVO1-WOC MUJHRL*?[Z#:WKK5IBL92]J-UK>=7$A-_G$I#H6-M6\+6-=L6 M.59]=P+3N7^TWJ$3%?AMW>U-H]0/T)[\5$K4V.H#H-/3!A3`=1NVFZ!YZJ.H M`)J-(^C*W-92?4\+=A?.=^YH2BK4#E#&YS8QI2CE1_*?T0\2 M!(IT'QM?`1P4EP]%AN:,T3P`;A-$UMCY&`0\:%0"QL`D2E08>:MB[D+2R"WE MY9&PUU%F)$S(/3$(7]@L!^;!%.ZF3:B6.,6#BD(E%XW0?OR=0(N'KRP!]GV4 MTC$=YDQY>ZSC#%J%3O_Z:0NR:+5E*ZSM!))SK4Z2M=9T)EQ7'^U"?BKS-2*M-R M\K\&>"@N!HH,SUND28"@5"0?HZ0__"NC"67M&HS'R6L4B]^(4Y8!J"BR+1EP MIH:#7+L4SBD&TJ6Z#C"%TTMYM2?2BHB[H%OR-IXER:*B-L"I`4R&Z1*?+L>" MQ;@)9A2BIAUON0U3`K2E#S[EY5CA?08V0)$JR8@R/NN[L+H4?7L;#J,I>?9_ MDD1)[\:78`JT&IHQPQQDMN)D,9"\M,M]%`[AC\6;<],/1*O%X'[8@;[#B M,8U2K5FU=WK>"CE.:X*P8PQ;;_Q@\#QFML'X$II,TQM_F"<"& MD*0_C3+I56_=*L!X*#0^.T[`=S`S6]AZCPB#(SV2V>(FPV#<'PX9R.21#`E] M8\O[)S+,8K#GOWW!<6R5:L"(*.*BFG0HCNID=-Z9IL0/IX7&`AO/D:6B:P]W1J1,0WS$YTO&1VQB+\'F9RK'Q(9BC\[L3'F);CYF)'&"?\>:BB"'WZ2Y$+=,X.U`5 M!<(KQ);;"C]='@GH!6N)XM)KU0<&0''&ID>48']8'7@78M;W'=W:^XQB`U&# M=9%0;6:"+H3`UXUV[7U&L20TI4[M`&5\*+-OW,U4[\XO/P`0*`Z91.;E[."V MVNXVKEQ`0'\*ZZ>A'UY%810_D?B-#DDBIT12!("BV)0;D*1$@S)*_&O\)1J- M8S)7)$38_`P`H=C@&-##18`R(/Q/V*1=1GZ2/E,FT^GU)6DA`(OB5,2`+@T\ M*&/"O\:74?1=U9G6WP`4%*<21CUIN_EN`[1%&G'&&C@8WX9)Z@=!?K^>O^B7 M?0X`4>1+M+:\5X.U%$=ME\U22X4+<_Z'7@]!BFRIP;FQ(UP4#>1PL,#-300. M]T3>2'C]5^8'7Z,P?0WF)0CRX5"S.%C`?49J`2\^TB&! M\SV8!?-ABA;I$F!="N0M]MMN?>KT#%`<@=5CF8\(12ZO8WN;1 MH.L;*?3?9`1+S[O(%X="*4L"?!03>!5*C2!V*7#VZ15L>N$GFR%>?1;V-\DO MU%W,UY\L'BGI__#CT2#'GWQA\8');5C$`WZ)HT2:Z;_\T<1&0E= M<,@XGI`^>_MM$.9O"XI64@W^)%BZM7NG_=C&5K0Q0B]\)$R>W,#?J`MR?@]X M;>WHMP?#V(IT+CG?/H.;+[($#)@DI23A_7#TE$VG/I,ZGN@DS!.)@TF*"Z?, M!%%`65)R%R'/NZW0"'86%_(.CBN\W6?I`8-XXH>+*Q67L.*'IHW\!0$/)9I7 MURW\8)7#MARB#W3)6&+QZ1<`X[O$0/MN"I@=Q09/Y1C\M90;:UF*R-X5*/:; MN_\E(7]E4.7U6VX-YW1P`:,PE9^E'^6RZ+*J(!*%7H] MM\]OUG&*.HA17K18*]V#<7\THD7KKG_2E,5)99)%.68".46^0DFT(KN4O M;5[#JB2=NU#EBE_6T.(V/_0.CL^=#J&O40`4)T6K[J.4K.5>'1U>NP[O`$=( M`L_\DN%1'UHGU.[2LMY%)UJ>[5U&TQ<:^AMI8R1.*"L&Y!RZZF"<=IGU+KT* M`"**A`-J&O@=S01E)WK9,KNVHQ/I57)OH[<[)*6`FA-7?8S3+)V>)2L&<%#< M:U=:G-^=U-#VW8G^_HDUE$6KY#;]_U!+`P04````"`#@@FY#PUPYJ=04``![ M#0$`$0`<`&)O;F4M,C`Q,S`Y,S`N>'-D550)``,S/X52,S^%4G5X"P`!!"4. M```$.0$``.U=;7/;N+7^WIG^!UY_NG>FBB/;V6XR23OR6]8SCN6QE=WN=#H= MB(0L-!2@!4C;:J?__1Z`I$2*!`A2M`UO^"6121S@.>_/BY"[QYS M01C]M#=\\W;/P]1G`:%WG_:^3LX'/^YY?_W+'__P\7\&`^\SIIBC"`?>=.6= MH@A-./*_B4S>`_$W/WKRQ]'@BMT/#MX.#[V_OSW\,#SZ<'#X#^\_UU_^ZYW= M3KR!]_#P\":`'"*5PQN?+;S!0)8C_#E>("]"_`Y'5VB!Q1+Y^-/>/(J6'_;W MI=P4^1'FA$JI?5G&V_>'$G>(%YA&YXPO3O$,Q6'T:>^W&(5D1G"PYX&B5'R8 M,FJ5F4I=2/AP^(;Q.TCR=KC_MR^7MPIGEFU(Z+="ZL;E.&AKR_=LE9)S/E!@2$RHB1/T-B!+H5,7A^_?O]]7;+&DL M!G<(+=>)9TA,5=+TA3+7;RH$"+W'(JH62=Y5"%%$?%$MHUY)D6%1 M1!"_6@!>5"0'`J+5$HM*:M2;"E@B6G)-(?"FHI0`+SGVY9>O]:_W^XC[G(48 M$/C1`#\N0T11Q/CJ'/Y>&X11&B^J,PDBOB\1[T.B`:2"K])?R]4+I0)0AWC> M1T0I@\H%*B7UMWRR7!(Z8^F?\$#Z]P<)>`+BGOSQ]>9"7S4HU4Z9'\LZ9D2# M,QJ1:'4!6?*%*FC/(V`=8XIUX5GQ`9X12A3,X=LA5(N9>/XG9.4E>7FYS#[N M;^?PQS]L9Q\+'(SI7]1O(%!`;DI6UAJI?)K$++LII*FDCT(_#K6%IF+[!2YR M6;8BZ831`%,H`GX(%I)`^NTQ"F7==SO'.!()51;IS(0=`$NW8%&<,G8ROCH] MN[H].Y6_;L>7%Z>C"?QQ/+H<79V<>;<_G9U-;GO>VO-VC:#VC^8X(H#/EL2B MD)G1PS:,>G\O%/&/GN%&#*_M+<:S\5+V+P&2Z1/5")B9/;)C]G8"_WTYNP)6 MQ^?>^/KL9C2Y@`0]IZTY/4%B?AZR!UM*-^G-C+YKP^C)Z/8G[_QR_$O/J);1 MXU@0BH4XQ<+G9"G+AB[(;;Q8(+X:SV[)'84AE8^@D^.KCCR,%:^!29_@E..= MKC`/093<%!N"50.7BZ+G@8=#9>,WL&CQ2F>IK52X8G9](?;II>R M`RGL2>G>ZCJKWT;,5W,B,!!<+&%$F`NB:MZ9F3C:9D+E,CB6V7CY?'I.=)S\ M@CB',5):#:W_,MO]W;;=,[G>SOJ8R6)!(A7O@([/"5/#44PW`VA3`C,;I?%Q M+BO5.RIDUE.D[QS!3SQ!CYMAPN:!F8+2&#@1]91L;W%M@Q`OE\D,/@HWYMO$ M`TM3;4T$S(R51M+YK/-OV,R3N7LR^WXRSH;5&QS*`.\U@M'9!)H%`2DV\7WM M6S-?I8%XFH^G,O+R.?7,Z+^WJ<"_Q:#LF8QBB.RCVGIJ9.*@-!+?R'M)!CT! M3Q%G[R[>;A=W/RB-\SN(NWO_F_WZO]Y+GL)+)F@:=N$C:3YF#RD%(3KQD*3H MWC]LXMEYNLN/S>R5XABY#'H6V@:Y\XR8DYC9*<4V#`'OGJW&D>_BAU/YSLQ/ M*092BH+WK+0(A^=YT;XU,U.*AU2$QGMN&L7(\ZQ4/#?S40J.%./E/14M`^=Y M4HPIS/24(R&:('I/E'4T/4_-UC,S&:4P1R;=&W^7$'N>C_ID1HH.2_$/8[B] MYZW+*'"ARFLL9N:U%.YH&A'NJ7[2R,8ICA`).PAM9!F9W>%I8AMIV;V+/*6+ M##OSD6&-DY1"*%TZB3?LW>0IW>2@,SS=Y"G=Y*@S-SFJ<9.GV`^S<9.CWDV>TDTF^#&*LYVL'>9G=IE2 M"*Y3ETDQ](Y3LZFJR@4JWYC)+`7LDCQZ/EIMP:HB1?_:S$PI>I?+J*>GU01W M8=1?\=Q(R%$I5E>8XNX'XRWGN`NDU*0Q$U0*NAEGN7O"=B.L4,G9)3735PJ2 MV=#75X"-5RMLU8+5+\U45:SV*:U7Z+^OY@L6"M3H7YO)*06(*I]5"ST8+-H9:.FI"[4>EJ(>&CSYJWHR1`RTC-5'MH]IU/7V` MNA4CA5Z:X;V9G5*40,=.WQMKM_RJT+Z8DYB9*D4-]`NP^C9G)ZZ&%F35M$/O MRMN?ZMCJ6Z2V?!5J0JN49N[*2WQJN>MK1]LUCX7Z*= M#U_I/]_VQ[!4?;N6:^FS.<>S3WORJJE!=J/4/T'I-X^+,$LB2S#>;3R)CC=!6?))7*7S%=9&43D M7X-,;B`?#88'@\/AFT<1;*S?!,1&QV8@,KD6(*JOC[,L/A.0Y;ZS+=%X_YNF M8%5HI>`^#B.1/1ELLFJDO^$N-A.@"K'T]ZY`JNZXLT&2E\O^V!E+U;UY5F#R M@NN_!IML6L$I7;%G`V4MI'[M:I'R]7LV\R<_!)H-6*+;O]+/!D,G('SN7 MOWW=GQ6`3$C]:@&A?'6@:FPHOI,C!+N:*^2\("6KK_>RVAS^L#,,R\HS!R'J MI'CS!8JVD/*YG&TR:8'0>(VFC:=D,O)'BP_6?-&CE4&VI7;EJ?J.RF9(&+UJ M#<9\NV?[EE?EI:J90`O33JCZBK:#POH?D:( MKRXBO)"CJ3T/386\\#?ZM#=#H;H.5R6$_B%AP42))ITQR(F2,)1'*'S:BZ"T M+.DTN=KOTY[/<4#D9P'CTXA$L=3X,V?Q,BN=0*G)@%AV@_]I`JW14]Y0%H]`RR#FZ4G&-6H&>-I$2SUDC8[7G-T3>7GS.>/K(ZZ/,841 M6C1*]2CJ"\\@^RIM\PK8*6NKEAU*C8J_<,B-S6;CF5HW183J5#E,H@ZP1C^@ MV`>*+VB$.?1;'5:LA-3"*2^9$%B,:;KI4-Q@'Y-[B6E$@VP'S\IAI=LHH['+ M.)ICGFSPRP=0W?E.:P$V4TP&&(]#YG_+-$NNC_X09<\[(GA']7(P-?I5[.U5 M.V=7KFEH`U3?*U`^?8U6LN3\+$*2A9L:-X>MKX9E2UMJ@=U4VQJM1MM;Z&H& M<2@G_J!2A^<)H/'LAHAO-QAJLA@?KSYC=L?1^0ZB#P$!?')H<5$T0RW4YBJ>L@4B=(OF M0#U\WB&&!4:-=E\IR:Z:%U_P8HJY`^I4@=+@OX$A,S@V`^J=@5^!28/^'!$N MZRA M&J1-%7210@/&FG'Z"5M,"54XU@M,(SE6(@'FZ7*(M/481>OR'(Y^[ZJ8+K2: MM++E1I4X5,7:@-3&--9'-M69RQEU6V#6133P0]:-NH!.I9R:?;XH:U,/KP!; MV]W5W'3E4CUM`58[>[58QA'F(G^FCS->:D1GCC#F+.!0JV,$5Q,RW4P#7(,3 MR"6?=VLGE`0MDZMC7FH6ZP92 MCV<6>K\23`IC86ZY*5Z9+HN;!S%'*=BZZ;0X;Z;#K!&/ZAV?!;2 M:\2_G:`EB5!X'M/@,O2=J?MK$>JFA6/NSY&021&=QRKQ*X% M8YJ@WDEQ9T(TS>#6Z;RVD#$W9YR[)6Y=7U6>29'T9T]CZ<77"NPU)[ZLZV[G MB&_7P>K9<\==K6`VU'%=E6^:+'4XQY@>_2NF6"Y6.PF9D`*RG)=OBCI3Q#S: M3LW>`WM,G9(UB= M"%SE&B_QA5CB-&NY+9SWK&N.%R1>N/V%=*6';OZ",R'2GB`,*D&/,3][]#$. MQ)CB+P`:\#G34C1"VUSCR0-[11J7T=:$:'-AKE$0J/]1F*S-RH8[B9N-N?Q? MPE6QS)$0Y(YV$LMZZF#M[BK:VS!/C4B#D./C,6R*7M_K.OQV\8<:E'7J=RNGH?NM<;J2O\&E36 M(J\-6$MC1?B2W,O6L[B:*8D2C!:,1^3?RA?3%7T.A[1W4$<7W&F1HT-!Y!WA MVTQX0":E2]3=]`XM6/.VI%QZAY@U@M,&7?/-''26H4W@V)G>G!F>1JHBZ[\Q9E9IJLDDXGAWC\(ZCP!V_,X'3Z0,_ MH2ZYQ#2`+Q^HO<1(#B>'[BA5A["A9@?.:W9@55/(F0%961-R&?JOH-JPQJN; MO6&(9GM11L&_8J'.NCO'N(OITZ<:L)I`U_9)OB!PC^1Z%+ED2VYY=+A3HD?; M1E&'.BBV.#5JKJ>2"[.5A5J@Y1:@W4/.F?"22Y?($ARB)>9`_! M1=S?^]]4D=WL<4$G#^Q7C+C+578+77:VRIQC_/NQ2TZ;72USSF+^NS%,3IF= M[4+N?S\.DU-F-[M,YIAC-(LVO=[7:Y:\+KM9Y?7;HN9TA/5Y+O(X1207FKJV MTLF,LZ%RSJQFJ@.H6PB;.[I%+G*68Z0Q)W?I[@LY.')FZ-H`J_;$%KQ,//D: MT^2`)6>T,V`S<'`7.#DW[R^:-0;"O;IU_N7`E..V,*9@Y#98NN//?)YO^!W(/^>L!-5R&9-9=*T7I+?8@+/5S=8K2Q['0;822UM*/45&Z2]VGI3%H*4 M:>#2X0JMJ2*&'6$AD1!^)BPYU5O((V_NH5E4^WS4T4>E,MRJ`+M0PF*>/#E& MY"L-,%?+>L?)65A`H'O!S&:X=U/>H?!F<\0ZU>5ZX./MRR1'9]?L%S,C(/1/8P2[O!GM?$8'+*T1[SU4F1M'6-M MMF?5MFN39^NE@V@?.^LP*=VWW$UGCAJ%<:PI]3VA_OQL"=M7\92N=^^^J MTKE_4I.GGZ+4_SNHYYMI:SBSB!-?'7$$S;+*OW!&FTO]*`NP+=1TJ,=D"=/T M^93NW,XYE*CQJ*_J7A6<_;GSEK1N/I%.->J\NY/N]LB"64)%HR=S1-,BT]'Q MSP!CO>'0B?T,SZWR\UL>/7YWEJ]46;<4G_$9)FKA"305+[_W269RW`AGJMQX(.JY;#V%@[-;IR6K<4 MH;5F"=%IO]G1/>F6!N:.GDX.X)RI MB&RXDI//R;D.4?ZPZ!?7OSGRYI:0)\>>#FBLLY:CG6G&"^ M<*)C;(VUO:ZGT',),`U^)3@,G&99@[B]ZC^KV3AY-)GS'JZ#W/246W<.?:V' M:-8MJ^_%!:T:R;YD+ZP"FO8&G@C_Q$*HM]U9?%:!29X M-\!AZ`SJ;4`[N)B3GY@5W%JE;^/E,GDEKX<]#]G#6?*G MPY]5'6:=TAAM3J!WZ7Q\';#VY#GIL#9HZPZ!3.XFW?D\+6U]Z+;&*CZFU-F,J M=U<$I^4I]->TA:2MPFUW'J0XIMLXU#\;H-E%ZQ0^._$FI6:U9^NX/_ESZ]16+R`P&N[(`L``00E#@``!#D!``!02P$"'@,4````"`#@@FY#P?A3 M03\.``"\Y@``%0`8```````!````I(&F_```8F]N92TR,#$S,#DS,%]C86PN M>&UL550%``,S/X52=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`X()N0\4> MU%600P``G'H$`!4`&````````0```*2!-`L!`&)O;F4M,C`Q,S`Y,S!?9&5F M+GAM;%54!0`#,S^%4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`."";D." MS7`L``00E#@``!#D!``!02P$"'@,4````"`#@@FY# M_+;U3H10``#MC@4`%0`8```````!````I(%KP0$`8F]N92TR,#$S,#DS,%]P M&UL550%``,S/X52=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`X()N M0\-<.:G4%```>PT!`!$`&````````0```*2!/A("`&)O;F4M,C`Q,S`Y,S`N M>'-D550%``,S/X52=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``%TG $`@`````` ` end XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Long-term Debt (Details 2) (USD $)
Sep. 30, 2013
Estimated future royalty payments [Line Items]  
Remainder of 2013 $ 197,000
2014 853,000
2015 1,050,000
2016 1,289,000
2017 1,384,000
Thereafter 8,477,000
Total $ 13,250,000

XML 71 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Details 1) (USD $)
Sep. 30, 2013
Dec. 31, 2012
fair value on a recurring basis [Line Items]    
Accrued stock compensation $ 171,174 $ 218,850
Fair Value, Inputs, Level 1 [Member]
   
fair value on a recurring basis [Line Items]    
Accrued stock compensation 171,174 218,850
Fair Value, Inputs, Level 2 [Member]
   
fair value on a recurring basis [Line Items]    
Accrued stock compensation 0 0
Fair Value, Inputs, Level 3 [Member]
   
fair value on a recurring basis [Line Items]    
Accrued stock compensation $ 0 $ 0
XML 72 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions (Details Textual) (USD $)
2 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Related Party Transaction [Line Items]        
Accounts payable - related party $ 555,361 $ 555,361   $ 418,922
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Gross 2,000,000 3,331,250 1,105,000  
Sale of Stock, Price Per Share $ 0.60 $ 0.60    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Percentage After One Year   20.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Remaining Percentage   80.00%    
Forty Seven Equal Monthly Installment [Member]
       
Related Party Transaction [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award   33,334    
One Final Installment [Member]
       
Related Party Transaction [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award   33,302    
American Donor Services [Member]
       
Related Party Transaction [Line Items]        
Accounts payable - related party 555,361 555,361    
Recovery of Direct Costs   1,558,360 1,004,036  
Mr Godfrey [Member]
       
Related Party Transaction [Line Items]        
Servicing Fees, Net   5,000    
West Coast Tissue Services [Member]
       
Related Party Transaction [Line Items]        
Recovery of Direct Costs   $ 577,200 $ 389,500  
Mr Cook [Member]
       
Related Party Transaction [Line Items]        
Number Of Stock Collateralized For Loan   1,850,000    
XML 73 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions
9 Months Ended
Sep. 30, 2013
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
(14)           Related Party Transactions
 
Guy Cook, our former President and Chief Executive Officer, formerly served as a board member of West Coast Tissue Services (“WCTS”) and American Donor Services (“ADS”). Mr. Cook did not received any compensation for his board service for either entity as of the date of his resignation. Mitchell Godfrey, a director, is on the board of ADS and also serves as secretary and treasurer for ADS. Mr. Godfrey receives $5,000 annually for his service to ADS.
 
ADS and WCTS recover tissue from donors.  We reimburse them for their recovery fees, which are comprised primarily of labor costs. The approximate aggregate amount of all transactions with WCTS for the first nine months of 2013 and 2012 was $577,200 and $389,500, respectively, and the approximate aggregate amount of all transactions with ADS for the first nine months of 2013 and 2012 was $1,558,360 and $1,004,036, respectively. These relationships benefit us as these entities provide us with donors, thus insuring that we have a pipeline of current and future donors, which is necessary to our success. As of September 30, 2013, we had an accounts payable balance of $555,361 to American Donor Services.
 
On June 27, 2012, the Board of Directors granted a waiver of certain provisions of the Company’s Code of Conduct to allow an entity controlled by two of our former CEO’s adult children to become a distributor of the Company’s products.  This entity acquired inventory from Allograft Tissue Management, a non-affiliated distributor that had previously acquired inventory from the Company.  The affiliated distributor, Silver Forest Fund, LP, exchanged products initially purchased from the non-affiliated distributor with Bacterin for different Bacterin products of equivalent value. Other than product exchanges and payment of amounts owed by the non-affiliated distributor, there have been no other direct transactions between Bacterin and the affiliated distributor. Mr. Cook pledged 1,850,000 of his shares of Bacterin stock as collateral for loans made to the affiliated distributor by independent third parties.
 
On April 5, 2013, Guy Cook resigned from his roles of Chief Executive Officer, President and Chairman of the Board effective immediately. The Board unanimously voted to have Kent Swanson, an existing independent director, serve as Acting Chairman of the Board. Our current Chief Financial Officer, John Gandolfo, and our Chief Operating Officer, Darrel Holmes, served as interim Co-Chief Executive Officers until the Board appointed Daniel Goldberger as the new Chief Executive Officer on August 14, 2013. Mr. Goldberger received inducement grant stock options to purchase up to 2,000,000 shares of the Company's common stock, with a per share exercise price of $0.60, which was the closing price of the Company’s common stock on the August 14, 2013 grant date. The option will vest over five years, with 20% of the underlying shares vesting after one year and the remaining eighty percent (80%) vesting in forty-seven (47) equal monthly installments as to 33,334 underlying shares, beginning September 15, 2014, and one final installment as to 33,302 underlying shares.
XML 74 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants
9 Months Ended
Sep. 30, 2013
Other Equity Transactions [Abstract]  
Other Equity Transactions [Text Block]
(10)           Warrants
 
In the fourth quarter of 2012, the Company issued 297,991 warrants with an exercise price of $2.30 to a broker in conjunction with the August 24, 2012 financing arrangement with ROS. These were recorded in “Other Assets” and will be amortized over the life of the financing term. In addition, on July 23, 2012 the Company issued 300,895 warrants with an exercise price of $1.03 to a private party resulting in $342,485 recorded in “Other Expense”.
 
The following table summarizes our warrant activities for the nine months ended September 30, 2013:
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Average
 
 
 
 
 
 
Exercise
 
 
 
Shares
 
Price
 
Outstanding at January 1, 2013
 
 
7,321,667
 
$
2.20
 
Issued
 
 
4,352,215
 
 
0.72
 
Exercised
 
 
-
 
 
-
 
Expired
 
 
(533,173)
 
 
2.00
 
Outstanding at September 30, 2013
 
 
11,140,709
 
$
1.63
 
 
We utilize a lattice model to determine the fair market value of the warrants accounted for as liabilities. The 1,570,565 warrants issued in connection with a 2010 bridge financing, the 375,000 warrants issued in connection with a 2010 debt financing and the 4,254,387 warrants issued in connection with the second quarter 2013 equity financing were accounted for as derivative liabilities in connection with the price protection provisions of the warrants in compliance with ASC 815. The warrants issued in the second quarter of 2013 resulted in a warrant derivative liability of $1,485,313 as of the issuance on June 5, 2013. There were an additional 143,700 warrants in the first quarter of 2012 as a result of the LPC share issuance triggering the anti-dilution clause in the original warrant agreement and an additional 97,828 related to the second quarter of 2013 equity financing. The lattice model accommodates the probability of exercise price adjustment features as outlined in the warrant agreements. We recorded an unrealized gain of $246,337 resulting from the change in the fair value of the warrant derivative liability for the first nine months of 2013. Under the terms of the warrant agreement, at any time while the warrant is outstanding, the exercise price per share can be reduced to the price per share of future subsequent equity sales of our common stock or common stock equivalents that is lower than the exercise price per share as stated in the warrant agreement.
 
The estimated fair value was derived using the lattice model with the following weighted-average assumptions:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
 
2012
 
Value of underlying common stock (per share)
 
$
0.68
 
 
$
1.55
 
Risk free interest rate
 
 
0.72
%
 
 
0.38
%
Term to expiration/implied expected life
 
 
5.96 years
 
 
 
4.15 years
 
Dividend yield
 
 
0
%
 
 
0
%
Volatility
 
 
63
%
 
 
62
%
 
The following table summarizes our activities related to number of warrants used in the derivative liability for the nine months ended September 30, 2013 and 2012:
 
 
 
2013
 
2012
 
Balance at January 1
 
 
1,649,707
 
 
1,506,007
 
Derivative warrants issued
 
 
4,352,215
 
 
143,700
 
Derivative warrants exercised
 
 
-
 
 
-
 
Balance at September 30
 
 
6,001,922
 
 
1,649,707
 
XML 75 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule Of Concentration Of Risk Revenue By Geographical Region [Table Text Block]
Revenue by geographical region is as follows:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
United States
 
$
24,285,028
 
$
24,084,836
 
Rest of World
 
 
530,610
 
 
773,202
 
 
 
$
24,815,638
 
$
24,858,038
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:
 
Accrued stock compensation
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
$
171,174
 
$
218,850
 
Level 2
 
 
-
 
 
-
 
Level 3
 
 
-
 
 
-
 
 
The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.
 
Warrant derivative liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
2,223,332
 
$
984,356
 
 
Acquisition contingent consideration liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
-
 
$
91,740
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:
 
Warrant derivative liability
Balance at January 1, 2013
 
$
984,356
 
Gain recognized in earnings
 
 
(246,337)
 
New warrants issued
 
 
1,485,313
 
Balance at September 30, 2013
 
$
2,223,332
 
 
Acquisition contingent consideration liability
Balance at January 1, 2013
 
$
91,740
 
Gain recognized in earnings
 
 
(91,740)
 
Balance at September 30, 2013
 
$
-
 
XML 76 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
9 Months Ended
Sep. 30, 2013
Subsequent Events [Abstract]  
Subsequent Events [Text Block]
(15)           Subsequent Events
 
On November 5, 2013, the United States Patent and Trademark Office issued US Patent No. 8,574,825 entitled “Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors” to the Company.  The issued claims in the patent are for a method to produce a demineralized cancellous bone matrix, such as Bacterin’s OsteoSponge® product line.   Bacterin has a pending divisional application in the United States to pursue protection on other aspects of its bone demineralization technology and is pursuing protection on related applications in Canada, Europe, and Korea. 
 
On November 14, 2013, the Company received a waiver from ROS for failure to achieve $10.5 million of revenue in the third quarter of 2013. In exchange for the waiver and reduction of future quarterly minimum revenue thresholds, the Company agreed to issue 1,500,000 shares of restricted stock to ROS by December 2, 2013. If the Company does not or is unable to issue the restricted shares by December 2, 2013, the Company agreed to pay an additional exit fee in the amount equal to 3.5% of the aggregate principal amount of the loan.
XML 77 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 13, 2013
Document Information [Line Items]    
Entity Registrant Name Bacterin International Holdings, Inc.  
Entity Central Index Key 0001453593  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   51,744,136
Trading Symbol BONE  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
XML 78 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business Description [Policy Text Block]
Business Description
 
The accompanying consolidated financial statements include the accounts of Bacterin International Holdings, Inc., a Delaware corporation, and its wholly owned subsidiary, Bacterin International, Inc., a Nevada corporation, (collectively, the “Company” or “Bacterin”). All intercompany balances and transactions have been eliminated in consolidation. Bacterin’s biologics division develops, manufactures and markets biologics products to domestic and international markets.  Bacterin’s proprietary methods are used in human allografts to create cell scaffolds and promote bone and other tissue growth.  These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and regeneration in knee and other joint surgeries.
 
Bacterin’s device division develops and licenses coatings for various medical device applications.
 
An operating segment is a component of an enterprise whose operating results are regularly reviewed by the enterprise’s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance. The primary performance measure used by management is net income or loss. The Company operates in two distinct lines of business consisting of the biologics and devices divisions. However, due to the immaterial revenue from devices to date, the Company reports as one segment.
 
The Company's revenue is derived principally from the sale or license of its medical products, coatings and device implants. The markets in which the Company competes are highly competitive and rapidly changing. Significant technological advances, changes in customer requirements, or the emergence of competitive products with new capabilities or technologies could adversely affect the Company's operating results. The Company's business could be harmed by a decline in demand for, or in the prices of, its products or as a result of, among other factors, any change in pricing or distribution model, increased price competition, changes in government regulations or a failure by the Company to keep up with technological change.  Further, a decline in available tissue donors could have an adverse impact on our business.
 
The accompanying interim condensed consolidated financial statements of Bacterin for the three and nine months ended September 30, 2013 and 2012 are unaudited and are prepared in accordance with accounting principles generally accepted in the United States of America. They do not include all disclosures required by generally accepted accounting principles for annual financial statements, but in the opinion of management, include all adjustments, consisting only of normal recurring items, necessary for a fair presentation. Interim results are not necessarily indicative of results which may be achieved in the future for the full year ending December 31, 2013.
 
These financial statements should be read in conjunction with the financial statements and notes thereto which are included in Bacterin’s Annual Report on Form 10-K for the year ended December 31, 2012. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentrations and Credit Risk
 
The Company’s accounts receivable are due from a variety of health care organizations and distributors throughout the world. Approximately 98% and 97% of sales were in the United States for the nine months ended September 30, 2013 and 2012, respectively. One customer accounted for approximately 5% and 6% of the Company’s revenue for the nine months ended September 30, 2013 and 2012, respectively.  One customer represented 19% and 21% of gross accounts receivable at September 30, 2013 and 2012, respectively. The Company provides for uncollectible amounts when specific credit issues arise. Management believes its estimate for uncollectible amounts have been adequate during prior periods, and management believes that all significant credit risks have been identified at September 30, 2013.
 
Revenue by geographical region is as follows:
 
 
 
Nine months ended
 
 
 
September 30,
 
 
 
2013
 
2012
 
United States
 
$
24,285,028
 
$
24,084,836
 
Rest of World
 
 
530,610
 
 
773,202
 
 
 
$
24,815,638
 
$
24,858,038
 
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
 
The preparation of the financial statements requires management of the Company to make a number of estimates and assumptions relating to the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the period; the carrying amount of property and equipment and intangible assets; valuation allowances for trade receivables and deferred income tax assets; valuation of the warrant derivative liability; inventory reserve; contingent consideration from acquisitions; royalty liability; and estimates for the fair value of stock options grants and other equity awards upon which the Company determines stock-based compensation expense. Actual results could differ from those estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
 
The Company considers all highly liquid investments purchased with an original maturity date of three months or less to be cash equivalents.  Cash equivalents are recorded at cost, which approximates market value. At times the Company maintains deposits in financial institutions in excess of federally insured limits.
Receivables, Policy [Policy Text Block]
Accounts Receivable
 
Accounts receivable represents amounts due from customers for which revenue has been recognized. Normal terms on trade accounts receivable are net 30 days and some customers are offered discounts for early pay.   The Company performs credit evaluations when considered necessary, but generally does not require collateral to extend credit.
 
The allowance for doubtful accounts is the Company's best estimate of the amount of probable credit losses in the Company's existing receivables. The Company determines the allowance based on factors such as historical collection experience, customer's current creditworthiness, customer concentration, age of accounts receivable balance, general economic conditions that may affect a customer's ability to pay and management judgment. Actual customer collections could differ from estimates. Account balances are charged to the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Provisions to the allowance for doubtful accounts are charged to expense. The Company does not have any off-balance sheet credit exposure related to its customers.
Accounts Payable Related Party Policy [Policy Text Block]
Accounts Payable - Related Party
 
Accounts payable to a related party includes amounts due to American Donor Services, a supplier of donors to the Company. See Note 14, “Related Party Transactions” below.
Inventory, Policy [Policy Text Block]
Inventories
 
Inventories are stated at the lower of cost or market.  Cost is determined using the specific identification method and includes materials, labor and overhead. The Company calculates an inventory reserve for estimated obsolescence or excess inventory based on historical usage and sales, as well as assumptions about future demand for its products. These estimates for excess and obsolete inventory are reviewed and updated on a quarterly basis. Increases in the inventory reserves result in a corresponding expense, which is generally recorded to cost of tissue and medical devices sales. Inventories where the sales cycle is estimated to be beyond twelve months are classified as Non-current inventories.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment
 
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, generally three to seven years for computers and equipment, and 30 years for buildings. Leasehold improvements are depreciated over the shorter of their estimated useful life or the remaining term of the lease. Repairs and maintenance are expensed as incurred.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill
 
Goodwill represents the excess of costs over fair value of assets of businesses acquired. Goodwill and intangible assets acquired in a purchase business combination and determined to have indefinite useful lives are not amortized, instead are tested for impairment at least annually and whenever events or circumstances indicate the carrying amount of the asset may not be recoverable. In its evaluation of goodwill, the Company performs an assessment of qualitative factors to determine if it is more-likely-than-not that goodwill might be impaired and whether it is necessary to perform the two-step goodwill impairment. The Company conducts its annual impairment test on December 31 of each year.
Derivatives, Reporting of Derivative Activity [Policy Text Block]
Derivative Instruments
 
The Company accounts for its derivative instruments in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815 “Accounting for Derivative Instruments and Hedging Activities”. The only derivative instruments presented in the accompanying consolidated financial statements relates to warrants issued in connection with certain debt financings. The Company has not designated its warrant derivative liability as a hedging instrument as described in ASC 815 and any changes in the fair market value of the warrant derivative liability are recognized in the consolidated statement of operations during the period of change. See Note 10, “Warrants” below.
Intangible Assets, Finite-Lived, Policy [Policy Text Block]
Intangible Assets
 
Intangible assets with estimable useful lives must be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment whenever events or circumstances indicate their carrying amount may not be recoverable. Intangible assets include trademarks, customer lists and patents and include costs to acquire and protect Company patents. Intangible assets are carried at cost less accumulated amortization. The Company amortizes these assets on a straight-line basis over their estimated useful lives of five years for customer lists and 15 years for all other intangible assets.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
 
Revenue is recognized when all of the following criteria are met: a) the Company has entered into a legally binding agreement with the customer; b) the products or services have been delivered; c) the Company's fee for providing the products and services is fixed or determinable; and d) collection of the Company’s fee is probable.
 
The Company’s policy is to record revenue net of any applicable sales, use, or excise taxes.  If an arrangement includes a right of acceptance or a right to cancel, revenue is recognized when acceptance is received or the right to cancel has expired.
 
The Company ships to certain customers under consignment arrangements whereby the Company’s product is stored by the customer.  The customer is required to report the use to the Company and upon such notice, the Company invoices the customer and revenue is recognized when above criteria has been met.
 
The Company also receives royalty revenue from third parties related to licensing agreements. The Company has royalty agreements with Nufix, RyMed and Bard Access Systems. Revenue under these agreements represented less than 1% of total revenue for the three and nine months ended September 30, 2013 and 2012.
Non Cash Consulting Expense [Policy Text Block]
Non-Cash Consulting Expense
 
From time to time, the Company issues restricted stock awards to consultants and advisors to the Company. These awards are measured at fair value at each reporting date, recognized ratably over the vesting period and are recorded in non-cash consulting expense.
Advertising Costs, Policy [Policy Text Block]
Advertising Costs
 
The Company expenses advertising costs as incurred. The Company had no Advertising expense in the nine months ended September 30, 2013 and $50,000 for the nine months ended September 30, 2012.
Research and Development Expense, Policy [Policy Text Block]
Research and Development
 
Research and development costs, which are principally related to internal costs for the development of new technologies and processes for tissue and coatings, are expensed as incurred and included in general and administrative expenses.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
The Company accounts for income taxes under the asset and liability method of accounting for deferred taxes as prescribed under FASB ASC 740, Accounting for Income Taxes.  Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When applicable, a valuation allowance is established to reduce any deferred tax asset when it is determined that it is more likely than not that some portion of the deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and that are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. There are no significant interest and penalties recognized in the statement of operations or accrued on the balance sheet. See Note 12, “Income Taxes” below.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]
Long-Lived Assets
 
Long-lived assets, including intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets. No impairment was recorded during the nine months ended September 30, 2013 or 2012.
Earnings Per Share, Policy [Policy Text Block]
Net Loss Per Share
 
Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding. Shares issued during the period and shares reacquired during the period are weighted for the portion of the period that they were outstanding. Diluted net income (loss) per share is computed in a manner consistent with that of basic earnings per share while giving effect to all potentially dilutive common shares outstanding during the period, which include the assumed exercise of stock options and warrants using the treasury stock method.  Diluted net loss per share was the same as basic net loss per share for the nine months ended September 30, 2013 and 2012 and the three months ended September 30, 2013 and 2012 as shares issuable upon the exercise of stock options and warrants were anti-dilutive as a result of the net losses incurred for those periods.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
 
The Company records stock-compensation expense according to the provisions of ASC 718.  Under ASC 718, stock-based compensation costs are recognized based on the estimated fair value at the grant date for all stock-based awards.  The Company estimates grant date fair values using the Black-Scholes-Merton option pricing model, which requires assumptions of the life of the award and the stock price volatility over the term of the award.  The Company records compensation cost of stock-based awards using the straight line method, which is recorded into earnings over the vesting period of the award. Pursuant to the income tax provisions included in ASC 718-740, the Company has elected the “short cut method” of computing its hypothetical pool of additional paid-in capital that is available to absorb future tax benefit shortfalls.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
The carrying values of financial instruments, including trade accounts receivable, accounts payable, other accrued expenses and long-term debt, approximate their fair values based on terms and related interest rates.
 
We follow a framework for measuring fair value. The framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
 
Level 1: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets.
 
Level 2: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
 
Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the nine months ended September 30, 2013 and 2012, there was no reclassification in financial assets or liabilities between Level 1, 2 or 3 categories.
 
The following tables set forth by level, within the fair value hierarchy, our assets and liabilities as of September 30, 2013 and December 31, 2012 that are measured at fair value on a recurring basis:
 
Accrued stock compensation
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
$
171,174
 
$
218,850
 
Level 2
 
 
-
 
 
-
 
Level 3
 
 
-
 
 
-
 
 
The valuation technique used to measure fair value of the accrued stock compensation is based on quoted stock market prices.
 
 
Warrant derivative liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
2,223,332
 
$
984,356
 
 
Acquisition contingent consideration liability
 
 
 
As of
 
As of
 
 
 
September 30,
 
December 31,
 
 
 
2013
 
2012
 
Level 1
 
 
-
 
 
-
 
Level 2
 
 
-
 
 
-
 
Level 3
 
$
-
 
$
91,740
 
 
The valuation technique used to measure fair value of the warrant liability is based on a lattice model and significant assumptions and inputs determined by the Company.
 
Level 3 Changes
 
The following is a reconciliation of the beginning and ending balances for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ending September 30, 2013:
 
Warrant derivative liability
Balance at January 1, 2013
 
$
984,356
 
Gain recognized in earnings
 
 
(246,337)
 
New warrants issued
 
 
1,485,313
 
Balance at September 30, 2013
 
$
2,223,332
 
 
Acquisition contingent consideration liability
Balance at January 1, 2013
 
$
91,740
 
Gain recognized in earnings
 
 
(91,740)
 
Balance at September 30, 2013
 
$
-
 
 
During the nine months ended September 30, 2013, the Company did not change any of the valuation techniques used to measure its liabilities at fair value.
 
Items measured at fair value on a non-recurring basis:
 
The Company’s royalty liability is carried at its estimated fair value based upon the discounted present value of the payments using an estimated discount rate.  The Company did not have access to a readily traded market for similar credit risks and the estimated interest rate was based upon the Company’s estimate of a market interest rate to obtain similar financing.  The Company originally discounted the $16.8 million of estimated payments at an interest rate of 16.7%. This was adjusted to an estimated royalty total of $13.8 million as of December 31, 2012 and was not adjusted in the first nine months of 2013.  Accordingly, these inputs are classified as Level 3 inputs.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
There are no recently issued accounting standards for which the Company expects a material impact to its consolidated financial statements.
XML 79 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details Textual) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2013
Subsequent Event [Line Items]    
Revenues, Total $ 10.5  
Stock Issued During Period, Shares, Restricted Stock Award, Gross   1,500,000
Percentage Of Additional Exit Fees On Loan   3.50%